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ABSTRACT 
 
With more than 33 million people living with HIV/AIDS, and an infection rate that 
is increasing rather than falling among high-risk groups, the 30-year history of the AIDS 
epidemic has been characterised as ‘islands of success in a sea of failure.’ Given the 
lack of a medical cure for the disease, the world has looked to social marketing 
campaigns to promote behaviour change that would decrease infection rates. Under the 
best of circumstances, change is difficult, and health behaviour change, especially when 
it relates to sex and politics, is even more challenging, so social marketers have a 
difficult task that calls on every technique at their disposal. There is an increasing 
expectation that HIV/AIDS social marketing interventions will yield measurable results, 
and that involves fully understanding the AIDS landscape, marketing theory and 
practice, and the evolving medical picture relating to the pandemic. 
This research explores links between social marketing and HIV/AIDS while mapping 
their marketing connections to both the conventional and alternative medical 
communities. To better understand the HIV/AIDS landscape, early research focused on 
three diverse countries— Mexico, Uganda, and the United States—selected for their 
significant cultural, economic, and political differences. 
Given the multiple social perspectives and fields of knowledge involved in this 
project, a transdisciplinary approach using mixed research methods was selected. Mixed 
methods for collecting and presenting data included case studies, content analysis, semi-
structured interviews, a quantitative survey, and in-depth reaction interviews. 
Through analysis of 18 social marketing campaigns in the three countries selected for 
study, the content, focus, purpose, and implications of the controlled public 
dissemination of HIV/AIDS information were examined. Key informants with 
professional and academic credentials in the areas of marketing, advocacy, and 
HIV/AIDS medicine were interviewed to learn rationales behind the campaigns and to 
explore political and economic factors that affect HIV/AIDS health activism. The last 
major phase of information gathering surveyed more than 340 patients at a clinic in 
Houston, Texas, to ascertain their knowledge and perceptions about HIV/AIDS 
treatment and prevention information. After the survey data was compiled, reaction 
interviews from key informants provided additional input. Informed by this wealth of 
secondary and primary research, an Integrated Social Marketing Conversation (Marcon) 
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Model was created to demonstrate that social marketing campaigns should be localised 
and customer centred, with participants engaging in an ongoing conversation at every 
stage. The communication model offers valuable guidelines for more effective 
dissemination of HIV/AIDS prevention and treatment information to high-risk, high-
interest target audiences such as HIV-positive people and the organisations that work 
with that subculture. 
Because this research crosses so many boundaries and addresses an actual need, it 
should be of interest to a wide variety of individuals and organisations in both academic 
and professional fields. From marketers to medical practitioners to activists associated 
with HIV/AIDS issues, this project’s findings will apply to their concerns. Also, 
HIV/AIDS organisations—both government agencies as well as private groups—should 
find information in this work that addresses their ongoing efforts. 
While investigating existing models for HIV/AIDS communication, it became 
evident that most research and communication models have focused on how HIV/AIDS 
prevention programmes are working and what is effective, but little has been done in 
regards to treatment options and information. For that reason, the integrated social 
marcon model presented in this thesis is an important addition to the body of practical 
literature on this topic. 
Finally, the volatility of the issues examined here and the contacts made during five 
years of work offer multiple possibilities for follow-up research and fieldwork with 
opportunities to make a positive contribution in the battle against the HIV/AIDS 
pandemic. 
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TRANSDISCIPLINARY GLOSSARY 
 
AIDS – Acquired Immune Deficiency Syndrome 
The last and most severe stage of the clinical spectrum of HIV-related diseases. HIV 
wears down the body’s immune system, so people who have HIV may develop AIDS as 
their immune systems become weaker and unable to fight off infections (Global AIDS 
Alliance, 2009). 
 
AIDSCAP – Aids Control and Prevention Project 
Sponsored by Family Health International (FHI), a global health and development 
organisation established in 1971 whose science-based programs aim to bring lasting 
change to the world's most vulnerable people (Family Health International, 2010).  
 
AVERT – Averting HIV and AIDS 
An international AIDS charity that collects and disseminates statistics and other 
information about the disease (AVERT, 2010a). 
 
ARV/ART – Antiretroviral Drugs / Antiretroviral Treatment  
Antiretroviral drugs are the class of drugs used to treat HIV/AIDS. ARVs do not kill 
HIV, but they do slow its growth (Global AIDS Alliance, 2009).  
 
AZT – Azidothymidine 
The first drug approved to treat AIDS (1987), but it did not prove to be reliably effective 
(Segala, 2003). 
 
B2B – Business to Business 
When a business sells products or provides services to other businesses. Although B2B 
business activity exists both online and offline, the acronym is often used to describe the 
online variety (Marketing terms.com, 2010). 
 
BCC – Behaviour Change Communications 
A core strategy in the response against HIVAIDS in many countries, ‘BCC is the 
process by which information and skills are shared and disseminated to people in the 
specific target audience with the intention of influencing them to adopt sustained 
changes in sexual behaviour or attitude, or to engage in other health-seeking behaviour’ 
(Long, 2006, p.5).  
 
BTL – Below the line 
Using channels such as online, search, direct mail, direct response TV, direct response 
print, inserts, and promotions to reach targeted individuals, as opposed to above-the-line 
(ATL) mass media such as television, radio, newspapers, magazines, and yellow pages 
(Russo, 2006). 
 
CALD – Culturally and Linguistically Diverse 
The divisions of race, ethnicity, and culture have been found to affect HIV exposure and 
timeliness of diagnosis in both developing and industrialised countries. Globally, health 
and human service organisations are recognising the need to enhance services for 
culturally and linguistically diverse populations (Centers for Disease Control, 2010b). 
 
CAM – Complementary and Alternative Medicine  
A group of diverse medical and health care systems, practices, and products that are not 
considered to part of conventional medicine. Complementary medicine is used together 
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with conventional medicine and alternative medicine is used in place of conventional 
medicine (National Center for Complementary and Alternative Medicine, 2010). 
 
CDC – Centers for Disease Control and Prevention 
The United States federal agency whose mission is to protect public health and safety by 
protecting health and promoting quality of life through the prevention and control of 
disease, injury, and disability (Centers for Disease Control, 2010a). 
 
CENSIDA – Mexico’s National Centre for Prevention and Control of HIV/AIDS 
Since 1988 this national agency has actively promoted prevention and control of 
HIV/AIDS through public policy (CENSIDA website, 2010). 
 
CFA – Center for AIDS Information and Advocacy  
Based in Houston, Texas, CFA advocates both locally and nationally for better 
treatments and better access to care for those living with HIV/AIDS and works with the 
Houston medical community in the search for a cure (Center for AIDS Information and 
Advocacy, 2010). 
 
CSM – Condom social marketing 
Programs that market condoms through traditional retail channels and usually include a 
focused IEC effort. Condoms are mainly sold, though a minority may be distributed 
free. There is typically one condom social marketing program per country (Condom 
Social Marketing, 2010). 
 
CSW – Commercial Sex Worker 
Individuals who exchange sex for money, food, clothing, shelter, or other basic 
necessities. Those involved in exchange sex are at high risk of contracting HIV/AIDS 
(Global AIDS Alliance, 2009). 
 
Downstream Social Marketing 
Marketing that aims to influence behaviour in individuals, as opposed to Upstream 
Social Marketing, which targets the level above the consumer—such as government 
leaders, NGOs, and other policymakers—to affect long-term social mobilisation and 
change that benefits the downstream individuals (Andreasen, 2006).  
 
Drug Cocktail – See HAART 
 
FBO – Faith-Based Organisation 
Nonprofit groups based in a religious ideology that often sponsor humanitarian projects. 
 
GFATM – Global Fund to Fight AIDS, Tuberculosis and Malaria 
An independent international partnership that funds grants written and overseen by 
partnerships of local organisations in 128 countries (Global AIDS Alliance, 2009). 
 
HAART – Highly Active Anti-Retroviral Therapy      See Drug Cocktail 
Most commonly used drug treatment, first available in mid-1990s.  Uses a cocktail of 
three classes of drugs, which suppress but do not eliminate the virus (Segala, 2003). 
 
HIV – Human Immunodeficiency Virus 
A retro-virus that damages the human immune system thus permitting opportunistic 
infections to cause eventually fatal diseases. HIV can be transmitted through blood, 
sexual contact, or during pregnancy, labour, delivery or breastfeeding (Global AIDS 
Alliance, 2009). 
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HIV-positive 
The HIV virus is detectable in the blood, but there are few or no symptoms.  Many HIV 
people do not realise they are infected (Segala, 2003). 
 
HIV prevalence rate  
The total number of persons (usually adults aged 15-49) with HIV infection alive at any 
given moment in time (Michiels, 2001).  
 
IAEN – International AIDS Economics Network 
Their principal objective is to help AIDS economists and policymakers in developing 
countries interact more effectively with global colleagues to promote compassionate, 
cost-effective responses to the pandemic (International AIDS Economics Network 
website, 2010). 
 
IEC – Information, education and communication 
A critical technique for achieving universal access to HIV prevention, treatment, care 
and support. However, IEC must be combined with other interventions to succeed 
(UNAIDS, 2010). 
 
IMC – Integrated Marketing Communication 
A synergistic approach to marketing in which disciplines such as advertising, sales 
promotion, public relations, and direct marketing work together in a consistent fashion 
(Kitchen & De Pelsmacker, 2004). 
 
IRB – Institutional Review Board 
Also known as an ethical review board, an IRB reviews research projects that involve 
human subjects to ensure subjects are not placed at undue risk, and that they give 
uncoerced, informed consent to their participation. IRBs are often associated with 
academic institutions, but there are also independent IRB services. 
 
Marcom or MarCom or MARCOM – Marketing Communications 
Traditionally, the most frequently used tool by social marketers has been mass media 
campaigns, called social marcoms campaigns (Noble, 2005). 
 
Marcon or MarCon or MARCON– Marketing Conversations 
Thanks to the growth of social media, marketing is becoming more participatory and 
personalised (Moran, 2007). A Google search for ‘marketing conversations’ locates 
numerous blogs, twitter accounts, and other online discussions about this change in 
marketing strategy. 
 
Marketing Mix – The 4Ps of Marketing 
The combination of product, price, place (distribution), and promotion. 
 
MRS – Market Research Society 
With members in more than 70 countries, MRS is the world’s largest association for 
market, social, and opinion research. Its Code of Conduct is designed to support 
professional industry standards and to reassure the general public that research is carried 
out in a professional and ethical manner (MRS website, 2010). 
 
MSM – Men Who Have Sex with Men  
After significant decreases in HIV/AIDS infection rates in the first decade of the  
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disease, transmission rates among MSM are once again on the rise in the U.S. and many 
European countries due to sexual risk behaviours (Coates, et al., 2008). 
 
MTCT – Mother-to-Child Transmission      
Mother-to-child transmission of HIV can occur during pregnancy, labour and delivery, 
or breastfeeding. Prevention of mother-to-child transmission is one of the most cost-
effective interventions available (Global AIDS Alliance, 2009).  
 
NGO – Non-Government Organisation 
Groups that are not part of a government, sometimes called non-profit or civil-society 
organisations. 
 
NIH – National Institutes of Health 
A part of the U.S. Department of Health and Human Services, NIH is the largest source 
of funding for medical research in the world (National Institutes of Health, 2010). 
 
PAHO – The Pan American Health Organisation  
An international public health agency with more than 100 years of experience in 
working to improve health and living standards of the countries of the Americas (Pan 
American Health Organisation, 2010). 
 
PANCEA –Prevent AIDS Network for Cost-Effectiveness Analysis 
An NIH-funded research project that gathers information to help increase the efficiency 
of HIV prevention programs. PANCEA has studied prevention in India, Russia, Mexico, 
South Africa, and Uganda (Prevent AIDS Network, 2010). 
 
PEP – Post-Exposure Prophylaxis 
Taking prescribed antiretroviral medications (ARVs) as soon as possible after exposure 
to HIV, to avoid HIV infection. PEP must begin within 72 hours after exposure to HIV 
(AIDS.org, 2009). 
 
PEPFAR – President’s Emergency Plan for AIDS Relief  
Proposed by President Bush in 2003 as the U.S. government’s 5-year, $15 billion 
response to the HIV/AIDS pandemic. In 2009, legislation authorised up to $48 billion 
over the next 5 years to combat global HIV/AIDS, tuberculosis, and malaria (About 
PEPFAR, 2010).  The acronym is sometimes said to stand for Purchasing Expensive 
Pharmaceuticals from American Retailers since Bush appointed former head of 
pharmaceutical giant Eli Lilly to head the initiative (Pisani, 2008, p.285). 
 
PLWHA – People Living with HIV/AIDS 
Globally, more than 33.4 million people are living with HIV/AIDS. The number has 
increased every year since the disease was identified in the early 1980s (UNAIDS, 
2009a). 
 
PMTCT – Prevention of Mother-to-Child Transmission    See MTCT 
 
PSI – Population Services International 
A leading global health organisation with programs targeting malaria, child survival, 
HIV, and reproductive health.  PSI was the first international organisation to use social 
marketing to combat AIDS (PSI website, 2010). 
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PSP-One – Private Sector Partnerships for Better Health 
USAID’s flagship project to increase the private sector’s provision of high-quality 
health products and services in developing countries (PSP, 2005). 
 
SM – Social Marketing 
Defined in 1971 by Kotler and Zaltman as ‘…the application of the principles and tools 
of marketing to achieve socially desirable goals’ (Kotler & Zaltman, 1971, p.5). 
 
SMART – Social Marketing Advances in Research and Theory 
A Canadian-based international conference first held in Alberta in 2004. 
 
SPSS – Statistical Package for Social Sciences 
A popular computer program used for statistical analysis. IBM owns the company. 
 
STD/STI – Sexually Transmitted Disease/ Sexually Transmitted Infection 
Infections transmitted through vaginal, oral, or anal sex, which are an important risk 
factor for HIV transmission (Global AIDS Alliance, 2009). 
 
TD Research – Transdisciplinary Research 
Characterised by the intent to solve real world problems that are complex, multi- 
dimensional, and not confined by the border of a single discipline. TD research pulls 
from both scientific and academic expertise to develop knowledge and theory that 
integrates science and society (Tress, et al., 2006). 
 
UNAIDS – Joint United Nations Programme on HIV/AIDS  
A joint venture of 10 United Nations organisations with goals for HIV prevention and 
treatment (UNAIDS, 2009b).  
 
UNESCO –United Nations Educational, Scientific and Cultural Organisation 
A founding cosponsor of UNAIDS and the lead organisation for HIV prevention with 
young people in educational institutions, with the goal of universal access to prevention 
programmes, treatment, care and support (UNESCO web site, 2010). 
 
Upstream Social Marketing – See also Downstream Social Marketing 
Social marketing partnerships that include governments, non-government organisations 
(NGOs), international agencies, and private businesses working in conjunction with 
downstream targets to create long-term social change (Andreasen, 2006). 
 
USAID – United States Agency for International Development 
The U.S. government agency responsible for the majority of foreign aid for HIV/AIDS 
(USAIDS, 2005b).  
 
WHO – World Health Organisation 
An agency of the United Nations, founded in 1948 to act as a coordinating authority on 
international public health (World Health Organisation website, 2010). 
 
World AIDS Day– December 1 each year since 1988 
Established by WHO to raise awareness of the HIV/AIDS pandemic. For several years, 
the theme was Stop AIDS. Keep the promise (World AIDS Day, 2009). 
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CHAPTER 1 
INTRODUCTION 
1.1 OVERVIEW 
This project is best introduced as a thesis of threes; it encompasses three intersecting 
topics, incorporates research from three countries, draws perspectives from three 
disciplines, and examines the global implications of cultural, political, and economic 
factors. 
The combination of topics—social marketing, HIV/AIDS, and conventional and 
alternative medicine (CAM)—is unusual but vitally important, given the tragic scope 
and devastation of the HIV/AIDS pandemic. This research explores links between social 
marketing and HIV/AIDS while mapping their marketing connections to both the 
conventional and alternative medical communities. Although it is not unusual to find 
literature relating to aspects of any two of these topics, all of these concepts are rarely 
woven together. However, initial study indicated justification for connecting these ideas 
and examining implications that emerged. 
The researcher began with three preliminary hypotheses: 
H1. International organisations, in conjunction with pharmaceutical companies 
with vested financial interests, use social marketing to selectively disseminate 
HIV/AIDS prevention and treatment information. 
H2. Social marketing campaigns for HIV/AIDS are likely to be targeted toward 
specific audiences in rural and/or economically depressed communities. 
H3. These social marketing campaigns tend to establish conventional products and 
treatments as the norm while ignoring increasingly accepted alternative 
modalities. 
To better understand the HIV/AIDS landscape, early research focused on three 
diverse countries— Mexico, Uganda, and the United States—selected for their 
significant cultural, economic, and political differences. Through analysis of 18 social 
marketing campaigns in those countries, the content, focus, purpose, and implications of 
the controlled public dissemination of HIV/AIDS information were examined. Key 
informants with professional and academic credentials in the areas of marketing, 
advocacy, and HIV/AIDS medicine were interviewed to learn rationales behind the 
campaigns and to explore political and economic factors that affect HIV/AIDS health 
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activism. The last major phase of information gathering surveyed patients at a clinic in 
Houston, Texas, to ascertain their knowledge and perceptions about HIV/AIDS 
treatment and prevention information. After survey data was compiled, in-depth 
reaction interviews from key informants provided additional input. 
Informed by triangulating this combination of qualitative and quantitative 
information, the researcher created a transdisciplinary audience-centred model designed 
to localise and personalise communication regarding health choices available to prevent 
and treat HIV/AIDS. 
 
1.2 OVERALL RESEARCH AIM  
The overall aim for this project was to explore the overlapping landscapes of 
HIV/AIDS, social marketing, and conventional and alternative medicine with the goal 
of better understanding those shifting relationships and of using that new knowledge to 
design a communication model for disseminating information about HIV/AIDS 
prevention and treatment options. 
 
1.2.1 Research questions and sub-questions 
Due to its ‘logical and intuitive appeal’ (Onwuegbuzie & Leech, 2006), a sequential 
mixed methods approach was chosen for this research design. ‘Philosophically, it is the 
“third wave,” or third research movement, which moves past the paradigm wars by 
offering a logical and practical alternative’ (Johnson & Onwuegbuzie, 2004).  
Formulating mixed method research questions is especially difficult since both 
qualitative and quantitative components must be incorporated within the same inquiry 
(Exploring, 2007). Another complication with mixed methods research questions is that 
they evolve as the research progresses, according to Onwuegbuzie and Leech: ‘Research 
questions occupy a place in the mixed methods research process that is central, 
interactive, emergent, and evolving’ (2006). Writing two or three overarching ‘grand 
tour’ research questions, each accompanied by five to seven more narrowly focused 
sub-questions is an established approach in mixed methods research (Plano Clark & 
Creswell, 2011; Opfer, 2011). 
(See Chapter 4, Sections 4.2, 4.3, and 4.4 for further discussion on methodological 
choices for this study.) 
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With the initial hypotheses and the overall research aim as context, three ‘grand 
tour’ research questions, each with a series of specific sub-questions, were constructed 
to provide a framework for this study.  
 
Research Question 1: 
How have the evolving landscapes of HIV/AIDS, social marketing, and conventional 
and alternative medicine forged global and national relationships and interactions? 
Sub-questions and the chapters where those questions are addressed are as follows: 
1. What is social marketing?  (Chapter 2) 
2. How does social marketing work and what can it accomplish? (Chapters 2 & 3) 
3. How has social marketing been used to combat HIV/AIDS in both developing and 
industrialised countries?  (Chapter 2) 
4.What political and economic factors affect dissemination of information about 
HIV/AIDS treatment and prevention? (Chapter 2) 
5.What role have the media played in the HIV/AIDS dialogue?  (Chapter 2) 
6. Which are the primary HIV/AIDS treatments offered by conventional medicine 
and by CAM (Complementary and Alternative Medicine)? (Chapter 2) 
7. What is the current and projected scope of the disease in Mexico, Uganda, and 
the United States? (Chapter 2) 
 
Research Question 2: 
Could social marketing influence better-informed behavioural change by including 
both conventional and alternative medical information in HIV/AIDS campaigns? 
Sub-questions and the chapters where those questions are addressed are as follows: 
8. What are specific examples of recent HIV/AIDS social marketing campaigns in 
the target countries?  (Chapter 5) 
9. What commonalities and unique characteristics can be identified as regards 
purpose, sponsors, target audience, dissemination methods, media mix, 
messages, product promotion, and appeals used? (Chapter 5) 
10. From the viewpoint of opinion leaders such as marketers, humanitarian activists, 
and medical practitioners—both conventional and alternative—what factors 
influence choices about dissemination of HIV/AIDS information? (Chapter 7) 
11. How are sponsorships selected and how are campaigns evaluated? (Chapter 7) 
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12. Do international business interests influence social marketing’s dissemination of 
HIV/AIDS prevention and treatment information, thereby establishing 
conventional products and treatments as the norm? (Chapter 7)  
 
Research Question 3: 
What practical contribution could social marketing make to bridge the knowledge 
gap between conventional and alternative medical choices for HIV/AIDS prevention and 
treatment? 
 Sub-questions and the chapters where those questions are addressed are as follows: 
13. Where do recipients of HIV/AIDS information learn about the disease? (Survey, 
Chapter 7) 
14. How credible do these recipients consider their information sources to be? 
(Survey, Chapter 7) 
15. What perceptions and knowledge do these recipients have about HIV/AIDS? 
(Survey, Chapter 7) 
16. How do recipients of HIV/AIDS information perceive their choices as regards 
 prevention techniques and treatment modalities? (Survey, Chapter 7) 
17. Could social marketing bridge the knowledge gap between conventional and 
CAM choices for HIV/AIDS prevention and treatment? (Chapter 8) 
18. What elements should be incorporated in a social marketing campaign to 
effectively communicate about HIV/AIDS prevention and treatment options? 
(Chapter 8) 
 
1.3 IMPORTANCE OF RESEARCH 
 
 This research is important because it is both global and local, and because it is 
academic as well as practical.  Also, this project takes a transdisciplinary approach to 
examine connections between topics that often would be considered separately. This 
holistic style of inquiry involves collecting and analysing a great deal of information. 
The integrative process applies Tress and colleagues’ knowledge cycle, in which 
existing expertise is applied to solving real-world problems, followed by reflection on 
how to make the knowledge assessable to others (Tress, et al., 2006). 
 Because the research crosses so many boundaries and addresses an actual need, it 
should be of interest to a wide variety of individuals and organisations in both academic 
and professional fields. From marketers to medical practitioners to activists associated 
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with HIV/AIDS issues, this project’s findings will apply to their concerns. Also, 
HIV/AIDS organisations—both government agencies as well as private groups—should 
find information in this work that addresses their ongoing efforts. Additionally, the key 
informants and the survey respondents who participate in the research will have a forum 
for their observations and opportunities to share knowledge and make new contacts 
through being involved with the project. Finally, increased visibility generated by 
publication of these research findings will contribute to knowledge and, it is hoped, 
increase understanding and commitment to education about HIV/AIDS prevention and 
treatment. 
 
1.4 DEFINITION OF TERMS  
 One commonality of the disciplines under study is a high jargon factor—each uses 
numerous acronyms and terminology that can be confusingly obscure to those outside 
the discipline. Also, a number of these specialised terms have powerful connotations 
and cultural associations that are considered insulting or biased by specific groups.  
Adding to the verbal complexity is the fact that the meanings associated with some 
terms are in flux; what was once acceptable may now be deemed inappropriate or 
condescending. This is especially true of ethnic terms such as black or white, where the 
politically correct designations vary across time and geography. For this project, the 
U.S. Census Bureau’s terminology was used when referring to ethnic groups (Fact 
sheet, 2010). 
Social marketing draws on much of the established terminology in commercial 
marketing, such as the 4Ps (product, price, place, and promotion), and IMC (Integrated 
Marketing Communications), but social marketing adds such descriptors as ‘upstream’ 
and ‘downstream’ to distinguish between policymakers and consumers. Social 
marketing is increasingly confused with social media, especially when the two terms 
intersect, creating social media marketing. Marcom, the coined term for marketing 
communications, is sometimes being replaced by marcon, short for marketing 
conversations, to indicate the move toward personalised, participatory communication. 
HIV/AIDS, an acronym for Human Immunodeficiency Virus/Acquired Immune 
Deficiency Syndrome, has an even shorter history than social marketing, but 
encompasses a world of specialised terminology, especially in relation to the gay 
community. The terms heterosexual and homosexual are fraught with hidden meanings 
and pitfalls. Both terms are rarely used in everyday speech, but the slang terms people 
are more likely to use can be abusive. Homo, used as a pejorative slang term since the 
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1920s, is the Greek root for ‘same,’ thus its connection to ‘homosexual,’ but it is also a 
Latin word meaning man, as in ‘homo sapiens’ (Baldi, 2010).  Homosexual, which is 
not currently considered sex specific, was first used by ‘Victorian scientists who 
regarded same-sex attraction and sexual behaviour as symptoms of mental disorders or 
moral deficiency’ (AVERT, 2010d). Homosexual men and women adopted the term 
‘gay’ to distance themselves from the connotation of being abnormal or ill.  
The term gay may come from the nineteenth century French slang for a homosexual 
man—‘gaie’ (AVERT, 2010d). Gay is used to describe both homosexual men and 
lesbian women, but has become more associated with homosexual men. In the 1960s 
gay rights came into everyday use and was associated in a positive way with a sense of 
identity for homosexual individuals. Lesbian, currently used to refer to homosexual 
women, is derived from Lesbos, the Greek island where the lesbian poet Sappho lived. 
‘Straight’ as a description for heterosexual people is an equivalent term to 'gay’ 
(AVERT, 2010d). Numerous specialised terms have come out of the closet and into 
everyday use as the HIV/AIDS epidemic has become a topic of public discourse. 
Acronyms such as MSM (men who have sex with men), PLWHA (people living with 
HIV/AIDS), and CSW (commercial sex worker) are commonly used to segment target 
markets for social marketing initiatives. Where HIV/AIDS and social marketing 
intersect, new terms such as condom social marketing (CSM), have arisen.  
Organisations involved with HIV/AIDS social marketing often use acronyms, such 
as WHO (World Health Organisation) and UNAIDS (Joint United Nations Programme 
on HIV/AIDS). Types of organisations are also designated with acronyms; NGO (non-
government organisation) and FBO (faith-based organisation) are two examples. 
In the medical arena, acronyms pepper the literature, from abbreviations for 
cumbersome treatment names such as HAART (Highly Active Anti-retroviral Therapy) 
to CAM (Complementary and Alternative Medicine). To help the reader wind his or her 
way through this alphabet jungle, a glossary of acronyms and special terms is provided 
in the preface of this thesis. (See Transdisciplinary Glossary, pp. viii-xvii.) 
 
1.5 RESEARCH FRAMEWORK 
 Given the multiple social perspectives and fields of knowledge involved in this 
project, a transdisciplinary (TD) approach using mixed research methods was selected. 
Wickson and colleagues explained that transdisciplinary research is ‘performed with the 
explicit intent to solve real world problems that are complex….multidimensional, and 
not confined by the boundaries of a single disciplinary framework’(2006, p.1047). This 
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project also fits Wickson’s contention that transdisciplinary methodology evolves in an 
‘iterative relationship with the research…in response to the research context and the 
learning and changing perspectives of stakeholders’ (p.1048), who become 
collaborators in generating new knowledge. Tress and co-authors agreed that TD studies 
cross scientific and academic boundaries to develop integrated ‘knowledge and theory 
among science and society’ (2006, p.16). Additionally, a transdisciplinary approach 
incorporates the concept that complexity and paradox exist as a result of different levels 
of reality, an idea inherent in many non-Western cultures and one that is useful in 
integrating the contradictions that often surfaced as this project evolved. Finally, TD 
research emphasises the importance of critical reflection, both on the personal level and 
across different bodies of knowledge and their methodological approaches (Wickson, et 
al., 2006).     
Mixed methods for collecting and presenting data included case studies, content 
analysis, semi-structured interviews, a quantitative survey, and in-depth reaction 
interviews.  These techniques were chosen based on the nature of the problem, personal 
experiences, and resources. A QUAL-QUAN-QUAL ‘sandwich’ provided abundant 
opportunities for cross triangulation while allowing the researcher to take advantage of 
the precepts of TD research. For each research phase, precise, detailed protocols were 
created and implemented to insure credibility and rigor. 
 
1.6 THESIS STRUCTURE  
The thesis consists of nine chapters and six appendices: 
 • In Chapter 2, a contextual literature review describes the AIDS industry and the 
roles of social marketing and the medical community. (The literature review was 
ongoing through all research phases due to the constantly changing landscape of the 
HIV/AIDS pandemic.) The chapter begins with a broad look at the three topics under 
study, then focuses more specifically on the HIV/AIDS landscape in Mexico, Uganda, 
and the United States through cultural, political, and financial overviews of each 
country. 
 
 • Moving from general to specific, Chapter 3 is a theoretical literature review that 
discusses the most common theories of health behaviour change used by social 
marketers, including Stages of Change, the model used by the Centers for Disease 
Control and Prevention (CDC) for all HIV/AIDS campaigns. Some consideration is also 
given to a discussion of whether social marketing is an effective public health tool with 
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the ability to effect lasting behaviour change. Since the major theories of health 
behaviour change include communication processes, this chapter also discusses 
branches of communication study and effects of emerging communication channels 
such as social media. Strategic and creative approaches that HIV/AIDS social marketers 
might find particularly useful for putting theory into practice are examined.  This 
chapter helps limit the scope of inquiry, providing a framework as well as benchmarks 
for an ongoing dialogue. 
 
 •  Chapter 4, a methodology for collecting and analysing secondary information, 
offers an overview of the research approach, and discusses exploratory research, the 
project timeline, and ethical considerations that must be considered when investigating 
such a sensitive topic as HIV/AIDS. Protocols for the literature review and the content 
analysis are presented and evolution of the methodology is discussed. 
 
 • Content analysis is used to examine three groups of six campaigns from the three 
countries under study in Chapter 5. To better manage the wealth of data collected, the 
information is divided into two broad groups: campaign design and campaign 
implementation. Cross tabulation matrixes are used to explore commonalities and 
differences between the 18 campaigns. An in-depth case study of an exemplary 
campaign for gender equity is included to demonstrate how a representative HIV/AIDS 
social marketing initiative can use tenets of the discipline to promote behavioural 
change. 
 
 • In Chapter 6, a methodology for collecting and analysing primary data discusses 
using a ‘sandwich’ of semi-structured interviews, surveys, and reaction interviews as the 
research moves from global to local in scope.  A detailed protocol is presented for the 
survey design, sampling, data collection, and analysis. This chapter also outlines the 
method for constructing a communication model that integrates accumulated secondary 
and primary information to create a practical approach for an HIV/AIDS social 
marketing campaign.  The chapter closes with a critical analysis of the methodology. 
 
 • Chapter 7 reports the results from the pre-survey interviews and from the survey 
responses. This chapter explains how the pre-survey interviews and pilot tests by 
experts guided the design and content of the survey. Survey results for three categories 
of information—media sources/credibility, perceptions and knowledge about 
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HIV/AIDS, and conventional and alternative treatments—are examined on three 
different levels. 
 
  • The culmination of the research project is presented in Chapter 8, which begins 
with a report of reaction interviews to the survey results. To address gaps in knowledge 
identified during the research project, the final phase created a communication model 
for an HIV/AIDS prevention and treatment campaign. The chapter discusses the 
elements and pitfalls of a communication model, then proposes a customised approach 
built on the secondary and primary data collected for this study. This new model 
represents a significant contribution to knowledge. 
 
 • In summation, Chapter 9 synthesises the trends and implications suggested by the 
research and maps relationships between the three topics under study. The initial 
hypotheses are revisited and the global implications of cultural, political, and financial 
factors relating to HIV/AIDS are examined.  The chapter also includes a reflective 
critical review, discusses contributions to knowledge, and suggests future research 
directions. 
 
 • The wide variety of references—secondary and primary—is documented after 
Chapter 9. Sources consulted cover a variety of disciplines and are taken from a 
multitude of publications and media. Due to the ever-changing nature of the data, a 
number of sources were taken from online publications, which often offered the most 
up-to-date material available. 
 
 • Appendices A through F include all documents and background materials 
mentioned throughout the thesis. Appendix A is an informal reflective log of the 
researcher’s personal and professional five-year journey, in keeping with the reflective 
research approach. Appendices B and C include research documents such as 
questionnaires and surveys, summaries such as a description of campaigns used for the 
content analysis, and documentation such as lists of interviews.  Appendices D and E 
contain peer-reviewed works from this thesis that were respectively published or 
presented in academic settings. Lastly, Appendix F includes the SPSS tables used to 
support the information presented in Chapter 7. 
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1.7 CONCLUSIONS 
 This combination of topics—social marketing for HIV/AIDS as related to 
conventional and alternative medicine—is one that has not been explored in the manner 
outlined in this study, so the potential for contributing to gaps in the current body of 
knowledge is significant. Also, at the conclusion of this project, the researcher will have 
amassed a wealth of new data that will offer cross-disciplinary publication possibilities 
in various social marketing and communication venues, as well as in relevant niche 
publications, health marketing, and alternative medical journals. Additionally, the 
communication model will offer valuable guidelines for more effective dissemination of 
HIV/AIDS prevention and treatment information to high-risk, high-interest target 
audiences. Finally, the volatility of the issues examined here and the contacts made 
during five years of work offer multiple possibilities for follow-up research and 
fieldwork with opportunities to make a positive contribution in the battle against the 
HIV/AIDS epidemic. 
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CHAPTER 2 
CONTEXTUAL LITERATURE REVIEW 
CONVERGENCE OF SOCIAL MARKETING, HIV/AIDS, AND CAM 
 
2.1 INTRODUCTION 
This review defines and contextualises the relatively new discipline of social 
marketing, then scrutinises how recent dissemination of HIV/AIDS information has 
used social marketing techniques, usually in partnership with the conventional medical 
establishment. Alternative medicine's reported high percentage of use by some 
categories of HIV/AIDS patients, often in conjunction with mainstream medicine, and 
the possible ramifications for audiences of HIV/AIDS social marketing campaigns are 
also investigated. This chapter is meant to provide context for understanding the 
HIV/AIDS landscape and for examining how social marketing and the medical 
communities play vital roles in what has become a multi-billion dollar industry. In the 
interest of looking in more depth at social marketing theory, strategies, and practices, a 
theoretical literature review is the focus of Chapter 3. 
Areas of literature reviewed in this chapter include social marketing (history, theory, 
and practice), HIV/AIDS (history, scope, and projections), social marketing as a tactic 
for combating HIV/AIDS, health communications and pharmaceutical-dominated 
marketing, health activism, CAM (Complementary and Alternative Medicine) and 
conventional medical approaches to HIV/AIDS, and an overview of media coverage of 
these issues. Since information regarding the topics that comprise this study was 
constantly evolving, the literature review continued throughout the project, with the 
ongoing goal of identifying additional knowledge gaps, especially relating to conceptual 
relationships across disciplines. 
The areas where social marketing, HIV/AIDS communications, and the conventional 
and alternative medical establishments overlap were of particular interest during the 
literature review. Societal issues such as evolving public perceptions, the changing 
political landscape, international economics, and media agendas related to these topics 
are pertinent since they affect the global HIV/AIDS situation on a daily basis. In 
addition, the medical status of HIV/AIDS evolved dramatically during the research, 
changing both the message content and the methods for information dissemination. The 
researcher was especially intrigued by these shifting and overlapping relationships.  
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This chapter begins with a broad look at these topics and the areas in which they 
overlap, and then focuses more specifically on the three countries selected for study. 
There is widespread agreement that HIV/AIDS is not just a medical condition, so any 
research on the topic must consider the collision of cultural norms, political agendas, 
and financial concerns. Therefore, the three countries are each profiled in some detail. 
These socio-political HIV/AIDS snapshots of Mexico, Uganda, and the United States 
provide a framework for understanding and interpreting data collected during the four 
research phases of this project. Because of the scope and volume of information, this 
chapter’s content is confined to providing a broad overview of the AIDS industry in the 
three countries. The chapter that follows focuses more specifically on social marketing 
theories and their application, especially for HIV/AIDS campaigns. 
 
2.2 QUESTIONS ADDRESSED DURING THE INITIAL LITERATURE REVIEW  
• What is social marketing?   
• How does social marketing work and what can it accomplish?  (See Chapter 
3 for more in-depth discussion of this question.) 
• How has social marketing been used to combat HIV/AIDS in both 
developing and industrialised countries?   
• What political, cultural, and economic factors affect dissemination of 
information about HIV/AIDS treatment and prevention?  
• What role have the media played in the HIV/AIDS discussion? 
• Which are the primary HIV/AIDS treatments offered by conventional 
medicine and by Complementary and Alternative Medicine (CAM)?  
• What is the current and projected scope of the disease in Mexico, Uganda, 
and the United States?  
 
2.3 SOCIAL MARKETING  
Social marketing is a youthful discipline first defined in1971 by Kotler and 
Zaltman as  
‘...the application of the principles and tools of marketing to achieve 
socially desirable goals…and includes the design, implementation and 
control of programmes calculated to influence the acceptability of social 
ideas and involving considerations of product planning, pricing, 
communications, and market research’ (1971, p.5).  
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Since the term social marketing was first coined, the definition of the discipline has 
been evolving. Social marketing might be considered the precocious offspring of a host 
of communications and marketing theories and models. Like any youngster, the 
discipline has experienced the tribulations of adolescence, and some predict a difficult 
path yet ahead before it achieves widespread acceptance and respect. However, in many 
instances, social marketing has already proven to be an effective catalyst for positive 
change, both for individuals and for broader social policy, but image problems and 
ethical concerns still plague the discipline. 
 
2.3.1 The birth of a discipline 
In a global community that values convergence and integrated approaches, social 
marketing might represent the epitome of these concepts, the veritable ‘Renaissance 
method’ of modern marketing. In their seminal article, Kotler and Zaltman concluded 
social marketing could prove to be the ‘bridging mechanism’ between behavioural 
science and the ‘socially useful implementation of what that knowledge allows’ (1971, 
p.12).  
Social marketing's roots in commercial marketing are undisputed, with a strong 
influence by the 4Ps of marketing—product, promotion, price, and placement—although 
this model is sometimes viewed as insufficiently customer-based for social marketing’s 
framework (Niblett, 2005). Unlike cars or toothpaste, the social marketing product is 
often complex and intangible, requiring effort or even sacrifice from sometimes 
reluctant consumers (McDermott et al., 2005). For these reasons, Dev and Schultz 
(2005) suggested modifying the 4Ps model to substitute solutions for product, 
information for promotion, value for price, and access for place.  
Despite this ongoing discussion, there is widespread agreement that social marketing 
ideally combines a unique mix of several essential elements. Behavioural change, 
informed by research, is the purpose behind any social marketing intervention. Also 
required is consumer orientation, in which the social marketer segments and profiles the 
target audience with the aim of building a long-term interactive relationship. Another 
common element is facilitating a voluntary exchange from which both parties derive 
benefits. Finally, the successful social marketer thinks strategically to plan long term, 
setting specific and measurable objectives, using the marketing mix, and considering the 
competition, such as the appeal of competing behaviours (Dev & Schultz, 2005; 
McDermott et al., 2005; Andreasen, 2006). 
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This unique mix of elements specific to social marketing sets it apart from its 
‘relatives’: commercial marketing, social advertising, socially responsible marketing, 
public relations, and education. Perhaps an even closer kinship could be claimed with 
another relative newcomer, Integrated Marketing Communications (IMC), which has some 
parallels with social marketing in that IMC also takes a holistic, long-range view of image, 
branding, and persuasion while incorporating a mix of tools and techniques. IMC, 
however, while advocating social responsibility (Densen, 2005), does not necessarily have 
social change as its primary objective. More recently, widespread use of the term social 
media has given rise to confusion about social marketing, as discussed in Chapter 3. 
 
2.3.2 A tumultuous ‘childhood’ 
As early as the 1960s, commercial marketing technologies were being incorporated 
into health education campaigns in developing countries (Ling et al., 1992) and have 
continued to play an important role in influencing individual behaviours of populations 
at risk for diseases such as HIV/AIDS, malaria, and alcoholism (Rogers et al., 1991). As 
this new approach to healthy behavioural change established a track record, Kotler and 
Zaltman (1971) asserted ‘social marketing’ could also be effective when applied to a 
range of other social goals as varied as brotherhood, safe driving, and family planning.  
Ten years later, Bloom and Novelli’s investigation (1981) found many social 
marketing campaigns lacking rigor and theory. They recommended using research to 
segment audiences, design programmes, and create strategic campaigns. Social 
marketing's popularity grew as its potential for improving health and well being was 
publicised in numerous medical journals by Lefebvre and Flora (1988) as well as by 
Hastings & Haywood (1991).  As the link between public health and commerce 
(Hastings & Saren, 2003), social marketing has become the primary tool international 
organisations such as UNAIDS use to combat global health issues. When the effort 
extends beyond informing to persuading, it is called ‘health activism’ and involves 
‘attempts to change the status quo, including social norms, embedded practices, 
policies, and power relationships’ (Zoller, 2005, p.361). 
To raise social marketing’s global profile professionally and academically, several 
institutes and organisations have been established, from the UK (National Social 
Marketing Centre), to Scotland (Institute for Social Marketing), to Canada (Social 
Marketing Network from Health Canada), to Australia (Social Marketing Downunder) 
to Washington, D.C., (Social Marketing Institute). Conferences, textbooks, and Internet 
listservs as well as a professional journal are dedicated to the discipline. 
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2.3.3 Social marketing ‘grows up’ 
In its early manifestations, social marketing usually concentrated on influencing 
behaviour (either encouraging change or trying to prevent particular kinds of undesirable 
behaviours) among specific ‘downstream,’ or consumer, audiences. Looking back, some 
observers now comment social marketing was in danger of being pigeonholed as a 
‘downstream approach,’ which was too narrow in focus and did not effect the kind of 
sweeping long-term social mobilisation and change that was the true goal. Although 
social marketing was sometimes able to effectively use the power of marketing to create 
awareness among specific target audiences and even to persuade members of those 
groups to consider or adopt lifestyle changes, it became increasingly obvious to many in 
the field the burden of deep societal change could not rest exclusively on the 
downstream targets (Andreasen, 2006).  
Hastings and Donovan called for the discipline ‘to embrace a broader perspective 
that encompasses not just individual behaviour, but also the social and physical 
determinants of that behaviour’ (2002, p. 4). From the other side of the Atlantic, 
Andreasen, who was instrumental in founding the Social Marketing Institute in 
Washington, D.C., noted the goal of his latest book was to ‘reposition social marketing 
as an approach to social change that reaches both upstream and downstream’ 
(Andreasen, 2006, p.viii). When social marketing can build partnerships that include 
governments, non-government organisations (NGOs), international agencies, and private 
businesses—so-called ‘upstream’ audiences—working in conjunction with downstream 
targets, then the entire social fabric of a community can be permanently altered 
(Andreasen, 2006).  
 
2.3.4 The media shape HIV/AIDS discussion 
Social marketing advocates such as Hastings and Andreasen agreed a crucial goal 
lies in moving issues up the public, media, and policy agendas in a society (Hastings & 
Saren, 2003; Andreasen, 2006). Public agendas include individual communication 
through such means as polls, chatrooms, and blogs—technologies that empower 
individuals by providing public forums that bypass traditional mass media.  Social 
marketers can also influence the media agenda, which is instrumental in agenda-
setting—telling the public what to think about (Protess & McCombs, 1991).  In addition, 
the way the media frame issues can greatly affect how those topics are perceived by the 
public. For example, AIDS was originally framed in the United States as primarily 
affecting the homosexual community, resulting in stigma and lack of public concern 
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about the disease. Rogers, Dearing, and Chang (1991) examined media coverage of 
AIDS in the 1980s and identified four stages in the media’s coverage of the burgeoning 
epidemic. At first, the disease did not even appear on the media agenda; when it did, 
there was a marshalling of scientific facts; next, the media personalised the disease 
through case studies and stories. Nowadays, media focus is more concentrated on 
exploring political action alternatives. This progression has been reflected in policy 
changes in the United States; when AIDS was framed as a threat to political stability, 
upstream audiences saw benefits in forming partnerships to combat the disease 
(Andreasen, 2006).  
Framing, then, is an important technique in social marketing, as it is in many 
associated fields such as public relations. Andreasen called framing a neutral, academic 
term for the pejorative ‘spin’ (2006, p.46). In its most objective role, framing provides 
context, but it can also shift blame and manipulate data. For example, in their book, 
Selling Sickness, Moynihan and Cassels (2005) argued the conventional medical 
establishment was successfully marketing false illnesses to the public (and then 
supplying the drugs to ‘cure’ those disorders). To help counter this pharmaceutical 
industry marketing, Moynihan writes reports for the World Health Organization (WHO) 
on how to better use data in health policymaking (ABC Queensland, 2005).  
Framing can also be associated with branding; in an interesting marketplace reversal, 
some for-profit businesses align themselves with social causes to differentiate their 
brands from their competitors. Examples include The Body Shop, which has been 
successful with its social message approach, and Benetton, whose vivid ads have 
included depictions of a dying AIDS patient and a baby’s bottom stamped ‘HIV 
positive.’ This series of ads created publicity and visibility for the company but alienated 
retailers (Joachinsthaler & Aaker, 1997).  
It becomes clear social marketing can only solve complex social ills if it builds a 
network of partnerships and alliances to combat problems on several fronts. The 
challenge is to operate in the maelstrom of cultural, political, economic, and social 
concerns while bringing about voluntary behavioural changes among both downstream 
and upstream audiences. 
 
2.3.5 Image and ethics 
Like the once-popular advertising slogan said, ‘Baby, you’ve come a long way’ 
(Virginia Slims, 1969), but social marketing is still experiencing growing pains and its 
critics are unrelenting. Beyond marketing-based criticisms of behavioural manipulation, 
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detractors also say the very market segmentation so central to social marketing 
perpetuates gender and stereotypical problems. When a particular group is targeted, such 
as female prostitutes for HIV/AIDS interventions, critics say, other groups may 
stigmatise that market segment. Also, the use of fear appeals draws mixed responses, 
both from observers and from the targeted audiences. The use of incentives, central to 
most social marketing approaches, also has potential pitfalls because they can be 
interpreted as coercion or bribery and not deliver the long-term behavioural change 
desired (Dholakia & Dholakia, 2001, p.498). 
Lastly, social marketing, like many adolescents, is still not taken seriously by many 
managers and policy makers, according to Andreasen, who contended the discipline has 
poor brand ‘positioning’ and suffers from image problems, in part due to a lack of 
academic stature and inadequate publicity about its successes (2006, p.215). Regardless 
of disagreements about how the discipline might evolve, practitioners and policy makers 
agree it is a concept with boundless potential to use the demonstrated power of 
marketing for the good of society. 
 
2.4 HIV/AIDS ENTERS THE PICTURE  
Perhaps the most highly visible social problem in the world today is HIV/AIDS. 
Since it was officially diagnosed in the early 1980s, HIV/AIDS has become one of the 
most deadly health issues worldwide, with an estimated 33.4 million people—2.1 
million of them children under 15 years old—living with the disease in 2008. In 2008 
alone, 2.7 million people were newly infected with the virus and at least 2 million died. 
Contrary to popular perception, about half of the infected were women and heterosexual 
transmission has become the most common means of infection (UNAIDS, 2009a, 
2009b). Although epidemiological data indicate that globally the spread of HIV peaked 
in 1996, the number of people living with HIV worldwide has increased every year, due 
to a combination of continuing high numbers of infections and increased life spans for 
those receiving antiretroviral therapy. HIV/AIDS has become both a horizontal epidemic 
(affecting both sexes) as well as a vertical epidemic (being transferred from mothers to 
children) (UNAIDS, 2009a, 2009b). 
The history of the pandemic has included increasing hysteria as the death toll 
climbed, unfulfilled hopes for various promising treatments, optimism with the 
discovery of antiretroviral therapy, disappointing vaccine failures, and the development 
of sometimes controversial alternative treatments that complement or offer options to 
drug cocktails. 
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2.4.1 HIV/AIDS definition and treatments 
Perhaps one of the most confusing aspects of the disease (but important to anyone 
creating an informational campaign) is the difference between being HIV-positive and 
having AIDS.  Simply put, HIV-positive means the HIV virus is detectable in the blood, 
but there are few or no symptoms. People at this stage often do not realise they are 
infected and unknowingly transmit the virus to others. HIV infects the T-helper cell, a 
particular type of immune system cell. The virus slowly reduces the number of T-cells 
until the infected person develops AIDS. An even more important laboratory marker is 
viral load, which is measured in the number of copies of the virus existing within the 
patient per volume of blood. These two factors are monitored to determine when AIDS 
treatments should begin (Segala, 2003). 
The development of AIDS can take two to 15 years, but about half of all people 
infected with HIV will develop AIDS within 10 years. After that occurs, AIDS 
compromises the host’s immune status, causing illness and eventually death through 
resultant malignancies and infections. Currently, treatments focus on preventing 
development of symptoms and diseases associated with HIV. Controlling rather than 
eradicating the virus is the goal of most treatments; the medical establishment classifies 
the disease as a chronic condition (Segala, 2003).  
In 1987, AZT (azidothymidine) was the first drug approved for treatment of AIDS, 
but AZT treatments were not reliably effective. By the mid-1990s, a number of new 
drugs were being used and physicians were hopeful the disease could be eradicated from 
patients’ systems. The most successful drug modality to date is Highly Active Anti-
Retroviral Therapy (HAART). This approach, which became available in the mid-1990s, 
involves treatment with a ‘cocktail’ of three classes of drugs, which suppress but never 
eliminate the virus (Segala, 2003). After more than a decade of HAART, it seems that 
many HIV patients are living longer but getting older faster—showing early signs of 
dementia and bone weakness associated with the elderly. A large-scale multi-city study 
in the U.S. found that over half of the HIV-positive population was suffering from what 
some physicians have termed HIV-associated cognitive motor disorder. Whether this is a 
result of the drugs or of the disease, or some combination, is still under study (France, 
2009). Another complication is that the rate of drug resistance among circulating HIV 
strains continues to increase, which raises long-term treatment concerns (Sepkowitz, 
2006). 
Overall, drug treatment regimens are complex, complicated by problems with 
toxicity, compliance, side effects, and cost. The cost of current treatments clearly 
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separates the haves from the have-nots; only one-fifth of infected people in developing 
countries are receiving antiretroviral therapy, primarily due to cost constraints 
(Sepkowitz, 2006). 
 
2.4.2 Complementary and alternative medicine (CAM)  
Alternatives to Western or conventional medicine are collectively referred to as 
Complementary and Alternative Medicine (CAM) and cover a wide range of treatments, 
from ‘folk medicine’ to acupressure, to biological treatments such as oxidizing agents 
like hydrogen peroxide. Many of these are not accepted by mainstream medicine as 
effective treatments for HIV/AIDS or its accompanying infections, but globally the 
World Health Organisation (WHO) reports that 80% of people use some type of 
modality that would be considered CAM in the U.S. (Hanna, 1998). Some CAM 
treatments for HIV/AIDS, either used alone or in conjunction with drug therapies, have 
shown positive effects according to CAM practitioners, but have not been approved by 
the U.S. Food and Drug Administration. Most commonly, many CAM practitioners 
recommend a comprehensive antioxidant ‘cocktail’ with high levels of nutrients to 
decrease oxidative cell damage and boost immune function (Tindel, et al., 2005). 
Numerous alternative treatments for HIV/AIDS are known in the CAM medical 
community, but they are not widely available and few of the infected are aware of those 
modalities. However, CAM practitioners say extensive research regarding benefits of 
these treatments has not been pursued because they cannot be patented and therefore 
will never generate profits for the pharmaceutical companies, so funding for clinical 
trials is difficult to obtain (Tindel, et al., 2005). As a result, the body of clinical evidence 
regarding CAM treatments is limited in comparison to the amount of scientific studies 
for mainstream medicine. 
In the early years of the HIV epidemic, before HAART, CAM use was prevalent in 
industrialised as well as in developing countries since the few conventional medical 
treatments available often had negative side effects. In the population in general, studies 
indicate that the use of CAM for a range of symptoms and diseases, often in 
combination with conventional medical treatments, is still a common practice. A 2009 
study published in AIDS Patient Care and STDS found that CAM is still an integral part 
of HIV therapy, especially among infected women. CAM usage was found to range 
between 60% and 90% among HIV-infected individuals using HAART, with women 
reporting higher CAM use than men. In this study, CAM was used almost exclusively in 
tandem with conventional treatments (Liu, et al.). 
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2.4.3 The role of the CAM controversy in this study 
The ongoing conflict between conventional and alternative medicine is a global 
dialogue, but it is especially active in industrialised nations such as the United States 
where the medical industry exceeds $2 trillion annually and is projected to double by 
2017 (Holland, 2007). By contrast, Americans spend about $40 billion on alternative 
medicine each year (Barnes, et al., 2009) and even more—over $48 billion in 2010—on 
health care for their pets (APPA, 2010). It is worth noting that much of the conventional 
health care expenditures are paid by various insurance or federal programs, but the 
majority of alternative medical expenses are paid by individuals, out of their own 
pockets. 
As noted in the previous section, trend watchers see a steady upward movement in 
alternative medicine use, with CAM services and products representing a sizable market 
sector in the overall healthcare industry in the United States and in many other countries 
as well.  According to MedausPharmacy, which has been specialising in compounded 
medications for 70 years, ‘What began as a passing fad in the 1960s has today crossed 
decades, genders, and ethnicities (and) today national surveys estimate that in a given 
year, 40% of all Americans incorporate some type of CAM therapy into their healthcare 
routine’ (MedausPharmacy, 2008).  
On its website, MedausPharmacy goes on to say that  ‘Government health agencies 
and the conventional medical community now recognize the scientific validity of CAM 
therapies’ (2008), but a quick Google search for alternative medicine validity shows the 
debate about the validity of CAM modalities is very much alive, with 3.13 million ‘hits’ 
for the topic (Google, 2011). The first two listings from that search, both from Nature 
Medicine journal, encapsulate the opposing arguments nicely. Brown, author of the 
book, Mavericks of Medicine, is defending his work against criticisms that it does not 
include sufficient scientific studies to support his claims for the validity of alternative 
treatments (2008). In the same issue, Strasser publishes ‘Reply to: The validity of 
alternative medicine,’ in which he says that unscrupulous ‘pill  pushers’ operate in both 
alternative and ‘orthodox medicine’ venues and their claims should be viewed with 
suspicion (2008). 
Underlying this ongoing debate, clinical research accumulated over the past two 
decades offers some evidence that supports CAM approaches for treating HIV/AIDS 
and its related ‘opportunistic’ infections. Numerous studies have evaluated the benefits 
of CAM treatments such as antioxidants, natural anti-virals, immune modulators,  
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micronutrients, amino acids, hormonal, enzymatic, and glutathione boosters used in 
conjunction with conventional medicine (Adams, 2006).  
Given the global economic demographics of the disease as well as cultural and 
social aspects discussed throughout this thesis, the need for inexpensive and effective 
treatments has encouraged legions of clinical trials for conventional therapies, and to a 
lesser extent, for alternative therapies. As noted earlier, due at least in part to the 
scarcity of funding for CAM clinical trials, scientific data for conventional treatments 
has far outstripped those designed to test alternative HIV/AIDS modalities. However, 
HIV/AIDS research activity overall has gained momentum with recurring failures to 
find a vaccine for the disease. One highly publicised example was Merck’s humiliation 
when it tested a vaccine initially deemed promising, but as the trial progressed, the 
vaccine alarmingly ‘appeared to increase the rate of HIV infection in individuals with 
prior immunity against the adenovirus vector used in the vaccine’ (Sekaly, 2008, p.7). 
Merck discontinued the study after those findings surfaced.  
As with conventional medical trials, not all alternative clinical trials have been 
successful, but according to CAM practitioners, many have offered promise, and a 
significant number have yielded positive results. Clinical data collected by universities, 
medical institutions, and other research groups include a range of specialised studies on 
the effects of one or more ‘natural’ substances, sometimes used in conjunction with 
conventional HIV/AIDS drugs. For example, the possible curative properties of green 
tea extracts have been the focus of numerous clinical trials. In a 2009 study, researchers 
investigated the ‘therapeutic potential of green tea-derived-epigallocatechin-3-gallate 
(EGCG) to mitigate the neuronal damage characteristic of HIV-associated dementia 
(HAD)’ (Giunta, et al., p.217). The resulting data suggested ‘EGCG attenuates the 
neurotoxicity of IFN-gamma augmented neuronal damage from HIV-1 proteins gp120 
and Tat both in vitro and in vivo. Thus, EGCG may represent a novel natural compound 
for the prevention and treatment of HAD’ (Giunta, et al., 2009, p.223). 
Centuries-old medical approaches have also been subjected to scientific study 
relating to their potential to combat HIV/AIDS. Motivated by the scientific evidence 
that ‘anti-retroviral therapy, the current HIV/AIDS treatment modality…does not offer 
an ultimate cure to HIV/AIDS,’ a group of microbiology and immunology researchers at 
the Indiana School of Medicine tested a ‘panel of extracts of traditional Chinese 
medicinal herbal plants for their activities against HIV-1 replication’ (Park, et al., 2009, 
paragraph 1). Their results demonstrated that ‘TXE and VAD (two of the extracts tested) 
inhibit HIV-1 replication, likely by blocking HIV-1 interaction with target cells…and 
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point to the potential of developing these two extracts to be HIV-1 entry inhibitors’ 
(Park, et al., 2009, paragraph 4). 
Other studies that suggest alternative HIV/AIDS treatments might be effective are 
taking place around the globe. For example, a group of researchers from the College of 
Medicine at the University of Nigeria published results of ongoing work regarding the 
safety and effect of fractionated neem leaf extract (IRAB), determining that this natural 
substance was ‘safe and increases CD4+ cell levels in HIV/AIDS patients,’ indicating 
IRAB ‘may be useful in the formulation of multi-drug combination therapies for 
HIV/AIDS’ (Mbah, et al., 2007, p.369).  
In many studies, there is a ‘bridge’ between conventional and alternative medicine. 
For instance, using CAM to alleviate complications brought on by anti-retroviral drug 
therapy was the focus of a randomised, controlled trial conducted by three major 
research hospitals in Houston, Texas. The 24-week study tested various blends of 
lifestyle alterations, niacin (a B-complex vitamin), and fenofibrat (an anti-retroviral 
drug), and concluded that ‘a combination of fenofibrate and niacin with low-saturated-
fat D/E is effective and safe in increasing HDL-C, decreasing non-HDL-C and 
hypertriglyceridemia, and ameliorating hypoadiponectinemia in patients with HIV/ART-
associated dyslipidemia’ (Balasubramanyam, et al., 2010, p. 2246). 
Some research further blurs the line dividing conventional and alternative medicine. 
Noting that ‘natural products can provide novel anti-AIDS chemotherapeutic leads that 
are structurally unique or have new mechanisms of action,’ the Natural Products 
Research Laboratories released a broad study of anti-HIV natural products from several 
compound classes, including terpenoids, coumarins, alkaloids, polyphenols, tannins, and 
flavonoids. They reported their research led to the discovery of the ‘modified betulinic 
acid derivative, DSB [PA-457], which is currently in Phase II clinical trial and is the 
first-in-class HIV maturation inhibitor (MI)’(Yu, Morris-Natschke & Lee, 2007, p.108). 
As the disease enters its third decade and the data base grows, it has become 
possible to conduct studies that take a broader look at CAM’s efficacy in combating 
HIV/AIDS symptoms over time. A holistic approach toward HIV/AIDS treatments is 
supported by studies such as the one conducted by a group of researchers at Yale 
University to examine relationships among non-conventional practices (CAM), 
adherence, and immune functioning among individuals with HIV. Using information 
relating to participants’ lifestyle, spirituality, and use of conventional and CAM 
therapies, combined with their medical history of CD4 count and viral load, the 
researchers determined that ‘religious practice was associated with adherence, and 
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CAM was associated with viral load,’ leading them to conclude that ‘participation in 
non-conventional practices in HIV populations may lead to positive health and health 
behaviors’ and that those findings had important clinical implications (Nightingale, et 
al., 2011). Similarly, a previous study from the Johns Hopkins School of Medicine had 
found that HIV patients with lipodystrophy (changes in body-fat distribution as a result 
of prolonged highly active antiretroviral therapy) were likely to use CAM therapies. 
Since there are few effective treatments for lipodystrophy, the study revealed almost 
three-fourths of the patients were inclined to use CAM supplements and visit CAM 
providers. Study results indicated ‘more conventional CAM, such as exercise, diet, and 
vitamins as well as meditation/prayer were perceived to be effective for lipodystrophy as 
well as for improving the overall sense of well-being’ (Cho, et al., 2006, p.481). 
As the timeline for HIV/AIDS clinical literature extends, one might expect to see 
more reviews such as Ullman’s examination of five controlled clinical trials evaluating 
the homeopathic treatment of people who had AIDS or who were HIV-positive. Ullman 
points out that ‘homeopathic medicine developed significant popularity in the nineteenth 
century in the United States and Europe as a result of its successes treating the 
infectious disease epidemics during that era. Homeopathic medicine is a medical system 
that is specifically oriented to using nanopharmacologic and ultramolecular doses of 
medicines to strengthen a person’s immune and defense system rather than directly 
attacking the microbial agents’ (Ullman, 2003, p.133). The review covers clinical trials 
in India, California, Oregon, Arizona, Hawaii, New York, and Washington, and 
references more than three dozen other studies and articles on this topic. Ullman 
concludes, ‘As a result of the growing number of people with drug-resistant HIV 
infection taking structured treatment interruptions, homeopathic medicine may play a 
useful role as an adjunctive and/or alternative therapy’ (Ullman, 2003, p.140).  
The newest and perhaps the most promising treatment modalities for HIV/AIDS 
involve nanotechnological solutions. For example, HIV CAM treatments using noble 
metal nanoparticles have been successfully proven to kill HIV-1 in vitro for severely ill 
HIV patients (Adams, 2006). In their August 2005 study titled ‘Interaction of silver 
nanoparticles with HIV-1,’ Elechiguerra and colleagues stated, ‘[i]n this work, we 
demonstrate that silver nanoparticles undergo a size-dependent interaction with HIV-1, 
with nanoparticles exclusively in the range of 1–10 nm attached to the virus’ (2005, 
paragraph 1). In other words, the study concluded that through this interaction silver 
nanoparticles ‘inhibit the virus from binding to host cells, as demonstrated in vitro’ 
(Elechiguerra, et al., 2005, paragraph 1).  
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Medical literature shows a variety of viruses have been successfully treated with 
silver-based drugs for more than 100 years (Rentz, 2003), but interaction of 
nanoparticles with biomolecules and microorganisms is an expanding field of research 
(Elechiguerra, et al., 2005). A number of studies have verified the virotoxic efficacy of 
oligodynamic noble metals in tackling some of the most formidable viral organisms, 
including HIV and its co-infections (Zhong Yin, 1991, Dean & Wilcoxson, 2001, 
Adams, 2006).  
Continuing Elechiguerra and colleagues’ work, Lara et al. recently published their 
study of the mechanism underlying silver nanoparticles’ HIV-inhibitory activity. The 
report concludes that ‘silver nanoparticles are effective virucides as they inactivate HIV 
particles in a short period of time, exerting their activity at an early stage of viral 
replication (entry or fusion) and at post-entry stages. The data presented here 
contribute to a new and still largely unexplored area’ (Lara, et al., 2010, p.8). 
Nevertheless, the volume of clinical evidence for alternative modalities is still sparse 
compared to those undertaken for mainstream medicine, but given the high percentage 
of the population that utilises CAM approaches and the ongoing clinical studies for 
alternative HIV/AIDS treatments, alternative medicine continues to have a role in the 
overall medical picture for the disease. 
Although alternative and complementary medicine are intersecting topics for this 
thesis, the scope of the controversy about the validity of CAM treatments is clearly one 
that far exceeds the reach of this inquiry. Therefore, in the area of alternative medicine, 
the emphases for the purposes of this study fell into three categories, which are outlined 
in the three ‘grand tour’ research questions and their accompanying sub-questions (See 
Section 1.2).  First, as part of the initial exploration into the intersections of the three 
main topics—HIV/AIDS, social marketing, and conventional and alternative 
medicine—the researcher sought to understand the history and context for alternative 
therapies in relation to HIV/AIDS. 
Secondly, in looking at dissemination of information about HIV/AIDS prevention 
and treatment options, the researcher examined the kinds of medical information 
presented in social marketing campaigns directed to various target audiences. As part of 
the third research question, knowledge and perceptions about HIV/AIDS prevention and 
treatments—both conventional and alternative—were explored through a survey, and 
then a communication model that incorporated a broad range of prevention and 
treatment options was proposed.  
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Even though the researcher has some personal experience with alternative medicine, 
(See Appendix A—Reflective Log), in the body of this thesis she has taken care to 
attribute any claims of its effectiveness to secondary sources consulted in the literature 
review or to those alternative practitioners and researchers interviewed over the course 
of this study (See Appendices B.7, B.8 & B.9). When considering CAM issues, the 
researcher has primarily focused on the three areas outlined above to make this project 
manageable and to keep it on target with the original research aim. 
 
2.4.4 HIV and social marketing 
Since social marketing is a key tactic for combating HIV/AIDS in both developing 
and industrialised countries, extensive literature exists detailing campaigns past and 
present (Kaiser, 2006a). Studies document the status of the epidemic and attempt to 
draw conclusions about the results of campaign efforts. On the other hand, critics charge 
social marketing messages are not always on target and point to the continuing increase 
in prevalence rates globally.  
Nevertheless, where HIV/AIDS is rampant, social marketing is widely used to 
motivate low-income and high-risk audiences to adopt healthy behaviours. Population 
Services International (PSI), the first organisation to use social marketing to combat 
AIDS, has typically focused on prevention messages and brand-specific advertising. 
These campaigns are a major expense for drug companies, which spend an average of 
two-and-half times more on marketing than on research (Hamber, 2005). With this kind 
of investment at stake, critics say the conventional medical establishment uses influence 
and financial clout to shape dissemination of health information (Moynihan & Cassels, 
2005).  
Additionally, in the wake of widespread media coverage about selective reporting of 
clinical drug trials, U.S. political leaders have questioned ‘whether the pharmaceutical 
industry has systematically misled physicians and patients by suppressing important 
data on their drugs’ (Graham, 2004, p.21). These concerns, combined with reports 
documenting the deplorable state of public health care, are spurring public interest in 
complementary and alternative medicine (CAM), creating a more positive climate for 
alternative treatments in general (Tindel, 2005; Abraham, 2007). For example, in the 
UK, media coverage of controversial public funding for CAM, long supported by Prince 
Charles, has brought the topic to the forefront of public attention (Booth & Henderson, 
2006). That dialogue continues, with Prince Charles defending complementary medicine  
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against charges of ‘quackery’ and in turn being called ‘well meaning but medieval’ by 
the conventional medical establishment (Booth, 2010). 
 
2.5 THE AIDS LANDSCAPE IN THREE COUNTRIES 
After reviewing the world of social marketing and its relationship to the many 
aspects of HIV/AIDS, it was clear HIV/AIDS is not just a biomedical phenomenon but 
has social, cultural, and political roots. Therefore, the next step toward understanding 
factors that affect social marketing initiatives was to develop overviews of the HIV/ 
AIDS landscape in the three countries under study. These country snapshots of Mexico, 
Uganda, and the United States consolidated literature review information and offered a 
more manageable framework for future study of this complex combination of topics. 
 
2.5.1 Mexico: affluence and poverty live side by side  
With about 110 million inhabitants, Mexico is the most populous Spanish-speaking 
country in the world. Three quarters of the population live in cities, with 20 million 
crowded into the capital, Mexico City, (U.S. Department of State, 2008), where the 
contrast between riches and rags is painfully evident. Mexico City is a modern 
international business and arts centre surrounded by sprawling shantytowns and plagued 
by political turmoil and environmental concerns. A popular response for many Mexicans 
is to search for work in the United States. More than a million poor Mexicans are 
arrested each year trying to cross the U.S. border illegally and hundreds die in the 
attempt (Country profile: Mexico, 2008). They leave behind towns and villages virtually 
empty of able-bodied men to be husbands and fathers. Even within the country, 
migration is an established pattern; many women also leave rural homes to take jobs in 
inner city factories, only to fall victim to violent crime, exploitation, or illness. 
Although Mexico is a major oil producer, prosperity is only a dream for most 
Mexicans; poverty and disease are the realities. Almost 30% of Mexico’s population is 
under 15, with about 700,000 more males than females. Overall, however, life 
expectancies remain relatively high: 73 years for men and almost 79 years for women 
(U.S. Department of State, 2008). Average life spans could drop, Mexican health 
officials fear, as the newest offspring of poverty and ignorance—the AIDS epidemic—
impacts more and more vulnerable populations.  
The 2007 national census revealed that half of new HIV/AIDS cases in Mexico were 
occurring among those between 10 and 24 years old (Tizcareño, 2008). Unless it is 
curbed, this trend bodes ill for the future and predicts additional diversion of resources 
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from other health, welfare, and education priorities. Mexico ranks 13th globally and third 
in the Americas in the total number of HIV cases reported, but the increase has been 
continuous since 1981. With an estimated average of 4,000 new cases annually, AIDS 
has become the No. 4 cause of death for Mexican men in the 25-to-44 age group 
(Epidemiological fact sheets, 2006, pp.2-7). 
AIDS has been reported in all 31 states of the Mexican Republic, with more than 
half of the infected living in Mexico City. Although the epidemic is largely concentrated 
among men who have sex with men, higher rates of HIV infection are also being 
documented among injecting drug users and women. Of the estimated 180,000 people 
living with HIV/AIDS in Mexico, almost one-fourth are women (International 
HIV/AIDS Alliance, 2008). As male partners infect more women, heterosexual 
transmission is on the rise and in some parts of the country is now the predominant 
mode of transmission. Official estimates of the adult prevalence rate are still relatively 
low, ranging from 0.3% to 0.4%, but the disease is responsible for about 6,200 deaths a 
year (International HIV/AIDS Alliance, 2008).  
Although Mexico has had HIV/AIDS programs since the early 1980s, only recently 
has there been a more unified national response in recognition that the disease has 
become a complex healthcare challenge, with psychological, social, ethical, economic, 
and political dimensions. Policy makers have realised it is critical to coordinate 
interdisciplinary responses from diverse organisations (Stewart, et al., 2001, p.5), Since 
the AIDS epidemic in Mexico is still concentrated in vulnerable populations, political 
and healthcare leaders are faced with both the challenge and the opportunity to step up 
prevention measures before the disease spreads to the general population as it has in 
many parts of the world. There are, however, cultural obstacles to be overcome, in 
addition to political and economic hurdles.  
According to Mexico’s National Centre for Prevention and Control of HIV/AIDS 
(CENSIDA), changing how Mexicans view gender roles and erasing widespread 
prejudice against gays will be necessary to combat the disease effectively. Mexico’s 
commitment to this problem is a matter of public record. Regional heads of state 
endorsed the Neuvo Leon Declaration in 2004, a pledge to focus on HIV/AIDS 
treatment and prevention (USAID, 2005a). The 2008 Secretary of Health, Jose Angel 
Cordova Villalobos, said the decline in new HIV cases will be achieved mainly through 
education and awareness. To that end, Villalobos is collaborating with international 
leaders to focus on ‘feminisation of the epidemic’ —strategies with a gender perspective 
(Sanchez, 2008).  
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In addition to Mexico’s new political regime, an army of international groups and 
national activist organisations are publicly committed to making treatment available to 
the infected and to changing cultural norms that contribute to the spread of the disease. 
Dozens of social marketing campaigns directed to specific target groups are underway 
across the country.  
 
2.5.2 Uganda: the crisis continues 
Winston Churchill once referred to Uganda as the pearl of Africa because of the 
country’s natural beauty and tropical climate. But the Sub-Saharan African country of 
over 30 million also suffers from decades of political corruption, extreme poverty, and 
increasing rates of HIV/AIDS infection despite years of prevention programs. 
Uganda remains one of the most impoverished countries in the world—placed 154 of 
177 on the 2007 World Development Report (Country profile: Uganda, 2009). With one 
of the highest population growth rates in Africa, and half of its citizens under the age of 
15, the future is not promising. Diversity and civil unrest make it difficult for political 
leaders to unify the country; Uganda is home to more than 20 tribes who speak 30 
different languages. English is the official language and 85% of Ugandans are Christian; 
12% are Muslim and only 3% follow traditional religions (Country profile: Uganda, 
2009).  
Although an estimated 1.3 million live in the capital city of Kampala, agriculture—
primarily coffee exports—is the basis of livelihood for more than three-quarters of the 
populace. With a per capita income of only US$217, about 40% of Ugandans live below 
the poverty line (NationMaster, 2010). 
Much of the country’s problems are inherited from generations of political 
upheavals. Uganda developed from the 19th century kingdom of Buganda, which became 
a British protectorate in 1894. Uganda became independent in the early 1960s. A series 
of leadership changes followed, with the brutal Idi Amin dictatorship of the 1970s 
bringing human rights and economic disaster. Successive regimes have struggled with 
internal dissent, corruption, and ongoing economic and health issues.  
Government leaders see education as an important avenue for improving the overall 
situation in their country, and in 1997 began providing free primary education for up to 
four children per family, but schools lack staff, classrooms, furniture and books. 
Dropout rates are high and adult literacy stands at 67% (Country profile: Uganda, 
2009). 
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Even fewer Ugandans have access to health care; doctors, nurses, equipment and 
medicines are available to less than half of the population. Safe water is a problem for 
more than a third of Ugandans, contributing to the country’s average life expectancy of 
49 years (Country profile: Uganda, 2009). 
However, the greatest health issue in Uganda since the late 1980s has been 
HIV/AIDS, when the country was devastated by the epidemic, with prevalence rates as 
high as 30% in urban areas, especially among pregnant women. When President 
Museveni came to power in 1986 at the end of the civil war, ‘slim disease’ had already 
spread through urban sexual networks and along major highways. Uganda’s national 
program to combat HIV/AIDS is often seen as a model for Africa. The program  
promoted the ABC approach (abstain, be faithful, use condoms), ensured a safe blood 
supply, and began HIV surveillance (AVERT, 2010c). Strong government leadership 
promoted national public education campaigns and encouraged grass roots efforts.  
Within a decade, the number of people living with AIDS had dropped dramatically, 
to less than 6%, although some of that decrease was attributed to a rise in AIDS-related 
deaths since treatment was not widely available. Nevertheless, behavioural changes such 
as increased abstinence and monogamy, a rise in the average age of first sex, a reduction 
in the average number of sexual partners, and more frequent use of condoms were seen 
as significant contributors to the decreased prevalence.  These behavioural changes were 
arguably in response to the national initiative that mobilized the entire population in the 
fight against AIDS. For those already infected, Uganda received funding in 2004 from 
the World Bank to offer free antiretroviral drugs (AVERT, 2010c).   
More recently, however, AIDS prevalence is on the upswing yet again, with numbers 
in urban areas over 10%. About a million Ugandans are living with AIDS and 1.2 
million children have been orphaned by the disease.  Experts speculate that several 
factors may be contributing to an increase in infections. Their explanations include a 
general complacency or ‘AIDS fatigue’ resulting from the availability of drug 
treatments, where the perception of AIDS has changed from a death sentence to a 
treatable, manageable disease. With reduced fear surrounding the disease, experts 
speculate, risky behaviours have increased (AVERT, 2010c).    
Also, the government’s controversial focus on abstinence is blamed in part for the 
increase in infections. Although abstinence has always been a part of the government 
prevention program—an element in the ABC approach noted earlier—to receive funds 
from the American government program PEPFAR (President's Emergency Plan for 
AIDS Relief), a focus on abstinence is required. PEPFAR is channelling large sums of 
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money to Uganda through pro-abstinence and anti-condom faith-based organizations 
(FBO), approaches that are being further supported by Evangelical churches in Uganda. 
Between 2004 and 2007, prevention spending tripled in Uganda, but as a result of 
pressure from PEPFAR, some Ugandan teachers report being instructed by U.S. 
contractors to not discuss condoms in schools. Billboards across the country promote 
abstinence to prevent HIV infection and sometimes discourage condom use (AVERT, 
2010c). After several years of condom shortages, UNAIDS data shows a decrease in the 
frequency that condoms are used during sex with non-regular partners (UNAIDS, 2007). 
Unfortunately, it appears the AIDS crisis in Uganda is far from over. Women 
continue to be the most affected; almost 60% of HIV infections in the country are 
among women, due in part to statistics that show Ugandan women tend to marry and/or 
become sexually active at an earlier age than the males and often have older and more 
sexually experienced partners. Intergenerational sexual relationships play an important 
role in young women’s disapportionate risk of HIV infection, and the number of young 
girls with partners more than five years older is rapidly increasing. Heterosexual 
transmission remains the primary mode of HIV infection in the region, with extensive 
transmission to newborn and breastfed babies (UNAIDS, 2009a). 
Although all HIV/AIDS education initiatives fall under the purview of the Uganda 
AIDS Commission, there seems to be a disconnect between official policy regarding 
prevention and treatment initiatives and national legal directives. While HIV/AIDS 
programmes usually address stigma and discrimination against certain population 
groups, three-quarters of the African countries—including Uganda—have laws 
criminalizing consensual gay sex. Ugandan members of Parliament have proposed 
legislation that would further criminalise homosexuality in the country, a move that 
would dramatically affect the estimated 500,000 gay Ugandans. ‘If the Bill is enacted,’ 
according to Consultancy Africa Intelligence, ‘accessing homosexual groups and also 
funding for programmers aimed at homosexuals groups would become even more 
difficult. Programme implementers would also be facing prison sentences of up to seven 
years for attempting to address HIV & AIDS in the homosexual population’ (Nel, 2010). 
A recent bright spot on the HIV/AIDS horizon for Uganda may be the results of a 
medical trial of 840 men aged 15-49 that indicated male circumcision decreases the risk 
of HIV infection (Gray, et al., 2010). In response to growing evidence that male 
circumcision can reduce the rate of HIV infection in men by as much as 60% and greatly 
reduce their female partners’ likelihood of developing cervical cancer, PEPFAR is 
helping fund the procedure in several African countries (Renton, 2009).  
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2.5.3.The United States: minorities, MSM are most at risk 
The United States of America, sometimes termed ‘the great melting pot,’ is a 
multicultural country made up almost exclusively of immigrants. Geography and climate 
vary dramatically from border to border in a country that is about two and half times the 
size of the European Union and slightly larger than China. (Country profile: United 
States, 2010). The 307 million citizens are predominately of European origin, mostly 
traceable to the UK, Germany and Ireland. National census figures in 2000 showed the 
three major ethnic groups as 75% white, 12.5% Hispanic and 12.3% black. Less than 1% 
are native Americans (U.S. ethnic groups, 2010). 
Hispanics make up the largest minority, with the bulk of this group having roots in 
Mexico. The majority of the black population lives in the southern part of the country. 
Although the main language is English, Spanish is spoken by an increasing number, 
especially in states that share a border with Mexico.  Of the two major religions, 
Protestants outnumber Roman Catholics two to one (U.S. ethnic groups, 2010). 
The U.S. is fifth in the world in per capita income, averaging $33,000 per year, but 
the U.S. Census Bureau estimates that 39 million live below the poverty line, including 
13 million children. Roughly 25% of both blacks and Hispanics fall into this category 
(U.S. Census Bureau, 2008). 
Despite eras of strong political and social disagreement, since the colonists 
successfully won their independence in 1781, the U.S. has only had one country-wide 
conflict, the War Between the States, which ended in the mid-1860s. The government is 
a constitution-based Federal Republic with a strong democratic tradition and two major 
political parties (Country profile: United States, 2010). 
The official beginning of the HIV/AIDS epidemic occurred in 1982, when the U.S. 
Centers for Disease Control established the term Acquired Immune Deficiency 
Syndrome (AIDS) and referred to four risk factors: male homosexuality, intravenous 
drug abuse, Haitian origin, and haemophilia (Kaiser, 2006b). The first International 
AIDS conference was held in Atlanta three years later. Since the beginning of the 
epidemic, more than half a million people have died of AIDS in the U.S.  An estimated 
one million are living with the disease, but as many as one-third of those are unaware of 
their status. As a result, those un-diagnosed patients are responsible for transmitting up 
to 70% of the new infections that occur (UNAIDS, 2009b). 
Obviously, the country’s response to AIDS has produced mixed results. 
Transmissions to unborn children have been much reduced, but every year there are 
approximately 56,000 new infections. In March 2009 the U.S. capital, Washington D.C., 
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reported an HIV prevalence of at least 3% among people over 12 years—similar to rates 
in some parts of sub-Saharan Africa. Stigma and discrimination toward HIV-positive 
people still persist, and thousands of uninsured or underinsured Americans struggle to 
access HIV care and antiretroviral therapy (AVERT, 2010b). Although the United States 
spends more on HIV/AIDS than any other country, much of the money goes to sex 
abstinence campaigns rather than for treatment. Americans with adequate insurance or 
personal funds can receive HAART and monitoring for about US$10,000/year 
(Sepkowitz, 2006).  With treatments improving survival rates in affluent countries, 
however, a sense of complacency appears to be driving a decline in safe sex practices, 
which experts fear could dramatically increase infection rates. The most current 
UNAIDS data indicates that progress in reducing the number of new HIV infections in 
the U.S. has essentially stalled, and in fact transmission rates among men who have sex 
with men (MSM) has steadily increased since the early 1990s as a result of a rise in 
sexual risk behaviours (UNAIDS, 2009b). 
Also, minority ethnic groups continue to be disproportionately affected.  Although 
African-Americans represent only 12% of the population, they account for 46% of HIV 
prevalence and black women are 19 times more likely than their white counterparts to 
become infected through heterosexual contact (UNAIDS, 2009b; AVERT, 2010a).  
In the early years of the AIDS epidemic, the general public considered HIV/AIDS a 
gay disease, and prevention efforts did not have widespread support. The disclosure that 
several well-known entertainment and sports personalities, including film star Rock 
Hudson and basketball legend ‘Magic’ Johnson, had AIDS helped create public 
awareness. Gay activists, who understood the communication industry, gave AIDS a 
political face when they ‘battered down the doors of the medical establishment, 
assaulted the pharmaceutical industry, and took the press by storm’ (Pisani, 2009, 
p.308). When U.S. presidents began to break the silence by setting up support and 
funding for HIV/AIDS, the disease became an issue on the public agenda. 
AIDS advocacy groups have been increasingly successful in gaining political 
support; President Clinton established the White House Office of National AIDS Policy, 
and in 2003 President George Bush allocated US$15 billion for PEPFAR’s five-year 
program. This initiative was reauthorised in 2007 for another five years and US$30 
billion, with the abstinence stipulations discussed earlier, but was primarily directed to 
international efforts (AVERT, 2010b).  
In the first 100 days of President Obama’s term, Act Against AIDS, a five-year 
communications plan, was launched to ‘put the HIV crisis back on the national radar 
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screen’ (Obama, 2009).  The campaign began with mass media to increase public 
knowledge about the severity of the AIDS crisis in the U.S. The next step was designed 
to encourage increased HIV testing among the two groups of African-Americans most 
severely affected, gay or bisexual men and women. This first national HIV/AIDS 
campaign in more than a decade uses a broad coalition of government, NGOs, and 
business groups to spread the word that someone is infected with HIV every 9 ½ minutes 
and aims to combat complacency about the HIV/AIDS crisis in the United States 
(Obama, 2009). 
 
2.6 SO DIFFERENT...YET SO SIMILAR  
Although these three counties occupy widely divergent political, cultural, and 
economic positions in the world community, such is the overreaching global nature of 
this disease that many of the same problems and questions emerge when examining their 
HIV/AIDS social marketing campaigns. 
 
2.6.1 Campaigns focus on prevention  
Most campaigns focus on prevention messages over treatment information. PSI, the 
principal contractor for USAID’s 2005 behavioural change campaign in Mexico, puts a 
strong focus on prevention messages and brand-specific advertising, especially of 
condoms. Using established communications strategies to target specific audiences, social 
marketing assistance includes procuring and distributing pharmaceuticals, over-the-
counter drugs, and condoms (USAID, 2005a). While this so-called ‘manufacturer's 
model’ makes products widely available at lower than market costs, some critics say it 
also perpetuates reciprocal relationships with the pharmaceutical industry and often 
establishes conventional products and treatments as the norm (Moynihan & Cassels, 
2005). Brand-name condoms and related products are always sold (not given away), 
albeit at reduced prices, because PSI's policy is ‘when products are given away… the 
recipient often does not value them or even use them’ (Population Services International, 
2005). On the downside, when subsidies to manufacturers end and promotion decreases, 
retail prices are usually raised, with a resultant decline in sales by low-income groups. 
PSI also trains government officials in marketing and communication techniques, further 
solidifying the relationship between policy makers and the traditional medical industry.  
The Global Policy Forum terms these prevention messages the ‘health belief model,’ 
which supposedly prevents the spread of AIDS by an infusion of information. The health 
belief model relies on the supposition AIDS will decrease if people are well educated 
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about how the disease is transmitted. ‘This logic, often promoted by international 
financial institutions, ignores most of the available data we now have on AIDS 
prevention initiatives,’ according to the Forum (Basu, 2003, p.1). For example, the 
Ugandan government's extensive education program has been widely hailed as a model 
for reducing AIDS among some segments of the country. Unfortunately, AIDS has not 
subsided in many of the rural and poorer areas, where 87% of the population lives (Basu, 
2003).  
Looking beneath the favourable publicity about Uganda's program demonstrates how 
easily statistics can be manipulated. In sectors where the numbers of those living with 
HIV infections have declined, the reduction can be attributed to an increase in deaths 
rather than a reduction in new cases (Basu, 2003). The Ugandan model fails to take into 
consideration the major epidemiological predictor for AIDS infection is not ‘risk 
behaviours’ but rather a low income level. Writing in The Lancet, Dr. Paul Farmer noted, 
‘Their risk stems less from ignorance and more from the precarious situations in which 
hundreds of millions live’ (Farmer, 2001, p. 404.). Since HIV/AIDS is officially 
categorised as a chronic disease that can be managed but not cured (Beaudin & 
Chambré, 1996), the majority of funding in Uganda— as well as in other countries 
where HIV/AIDS is widespread—is earmarked for prevention messages.  
As organisations that use social marketing techniques analyze their results, more 
questions emerge. For example, PANCEA, a NIH-funded research project in Mexico, 
Uganda, and three other countries, collected and analysed output, cost, and quality data 
from 200 prevention programs. PANCEA studied the eight prevention modalities that 
are commonly part of the core prevention response to the HIV epidemic in most 
countries. Although PANCEA concluded, ‘For several, there is a substantial body of 
scientific evidence suggesting they are effective,’ the organisation comments that for 
condom social marketing as well as for information, education, and communication 
(IEC) efforts, ‘the evidence of effectiveness is less clear’ (PANCEA, 2005). 
 
2.6.2 Stigma creates an 'underground epidemic' 
Another commonality is the role of cultural stigma in HIV/AIDS prevention and 
treatment (What does culture, 2002). HIV has been called an ‘underground epidemic’ 
because of stigma and discrimination associated with the disease, which often discourage 
people from getting tested or accessing care, according to a 2003 report from the 2nd 
Forum on HIV/AIDS/STD in Latin America and the Caribbean. The Forum study 
warned categorizing the epidemic as ‘self-contained’ is a mistake, and pointed out a 
35 
 
lesser-known fact of stigma and discrimination is ‘it prevents allocating resources in the 
most needed areas and populations’ (HIV infection, 2003, p.12).  
In many communities people are reluctant and embarrassed to openly discuss 
HIV/AIDS. To address this reticence along the U.S.-Mexico border, the SPNS (Special 
Projects of National Significance) Border Health Initiative is administered by the U.S. 
Department of Health and Human Services. Relying heavily on social marketing 
campaigns, SPNS utilizes Spanish language media to blanket the transient communities 
with ‘bold’ HIV messages designed to ‘reverse the cultural norm that topics related to 
sexuality, including HIV, are not discussed in public’ (Innovative, 2005) and to educate 
Mexicans about the risk of the disease. HIV/AIDS is a significant problem along the 
2,000-mile border between the United States and Mexico, where mobility, poverty, and 
lack of access to health care complicate prevention and care (Innovative, 2005). 
 
2.6.3 Financial toll threatens economies 
Finally, the economic factor is a global consideration spanning cultures and 
continents and underlying all HIV/AIDS public policies (UNAIDS, 2006). In many 
parts of Africa, for example, AIDS is the main threat to social sustainability, where it is 
estimated up to half of all of today's 15-year-olds will die of the disease (Conflicts, 
2005). Of 18 countries in Sub-Saharan Africa that recorded declining life expectancies 
in the 1990s, all but one (Togo) were considered to have a general HIV/AIDS epidemic, 
which the World Bank defines as having an HIV prevalence of more than 5% in the 
adult population (Michiels, 2001). The two extremes are a low level epidemic, where 
HIV has not spread to more than 1% in any population (e.g. Middle East), to a ‘hyper- 
endemic’ state in which HIV prevalence in the general adult population exceeds 15% 
(only in South Africa) (Bertozzi, et al., 2008, p.65). 
Likewise, in many Latin American countries recent reports show the disease is 
increasingly affecting the youngest and most productive populations as well as poor and 
marginalised groups. This trend bodes ill for the future and predicts additional diversion 
of resources from other health, welfare, and education priorities (HIV Infection, 2003). 
Recognizing expanding HIV/AIDS populations will damage the global economy, 
governments in both developing and industrialised countries, in conjunction with 
pharmaceutical companies such as Pfizer, have launched a variety of organised 
offensives, which include political commitment, law enforcement, government policy, 
and social marketing and community mobilisation (Pfizer, 2006).  For example, the 
Mexican pharmaceutical market is one of the most lucrative in the world and the most 
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profitable in Latin America. A recent survey reported that Mexico is the largest 
consumer of pharmaceuticals in Latin America and the ninth largest worldwide. 
Pharmaceutical sales jumped from 6.83 billion dollars in 2002 (Gonzalez, 2003) to 11.3 
billion dollars in 2005 (Espicom, 2005). Given these numbers, it seems safe to say that 
major pharmaceutical companies will continue to vie for partnership status in social 
marketing campaigns and that condoms will be more accessible and socially acceptable. 
According to the pharmaceutical industry's own tax records, in 2002, Merck spent 
13% of its revenue on marketing and only 5% on research and development (R&D); 
Pfizer spent 35% on marketing and only 15% on R&D; and the industry overall spent 
27% on marketing and 11% on R&D (Basu, 2003, p.5). With this kind of investment at 
stake, critics say it is not surprising the conventional medical establishment uses its 
influence and financial clout to shape dissemination of information about HIV/AIDS 
(Hamber, 2005).  
This repression of information was acknowledged by the International Committee of 
Medical Journal Editors, which includes editors from The Lancet, New England Journal 
of Medicine, Journal of the American Medical Association, and Annals of Internal 
Medicine. These editors publicly declared selective reporting of clinical drug trials 
occurs. ‘Irrespective of their scientific interest, trial results that place financial interests 
at risk are particularly likely to remain unpublished and hidden from view,’ according to 
the editors (Graham, 2004). In the wake of this revelation, some U.S. political leaders 
called for public examination of ‘whether the pharmaceutical industry has systematically 
misled physicians and patients by suppressing important data on their drugs’ (Graham, 
2004, p. 21).  
Content of social marketing messages about HIV/AIDS, the role of stigma and 
culture, and the economic realities of the global medical market created by the epidemic, 
form a complex and politically charged environment that influences public dissemination 
of information about health care options and offers a multitude of possibilities for fresh 
interpretations of the cross-disciplinary relationships and concepts involved.  
 
2.7 HOW HIV/AIDS HAS CHANGED THE LANDSCAPE OF PUBLIC HEALTH 
 
During the decades since HIV/AIDS became a global issue, perhaps the principal 
constant has been the controversy over what lessons have been learned and what to do 
next.  Following are a few of the divergent voices weighing in on the complex issues 
surrounding the epidemic: 
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Too little, too late: 
 
 ‘Even where resources are plentiful, many people with HIV disease do not 
receive the prevention and care interventions they need. Even in wealthy 
countries like the United States, more than one-third of all HIV infections are 
undiagnosed and a large portion of the HIV-positive population receives 
substandard care. Across the globe, many people in need do not receive 
services simply because services do not exist’ (Academy, 2006). 
New treatments are not perfect:  
‘Today, with the current widespread popularity of antiretroviral therapy, 
CAM is likely to be used in a more complementary rather than alternative 
fashion. Also, since effective antiviral drugs are available, people may be 
more interested in using CAM for HIV-related conditions that do not respond 
to highly active antiretroviral therapy (HAART), e.g., wasting syndrome. 
CAM is very important to provide the immune support the body will need for 
extended years of drug treatments and to battle the onslaught of drug side 
effects brought on by powerful new drugs’ (Hanna, 1998).  
Progress leads to more problems: 
 An epidemiologist who worked for international AIDS groups in Asia for 
10 years points out in her controversial book, The Wisdom of Whores: 
Bureaucrats, Brothels and the Business of AIDS, the convoluted paradoxes of 
HIV/AIDS ‘successes’:   
 ‘The more effective our prevention programmes are, the less treatment we 
will need. But the more effective our treatment programmes are, and the 
longer people live with their infections, the healthier and more sexually active 
they are, the more prevention programmes we will need because people 
become less frightened of the disease and consequently will not practice safer 
sex. We need to make sure we have the money and the staff to bump up 
prevention services as more people get treated’ (Pisani, 2008, p.165).   
Information strategies have not targeted key groups: 
 UNAIDS’ 2009 AIDS Epidemic Update clearly says that countries are not 
reaching the right audiences with their AIDS prevention and treatment 
programmes: ‘The common failure to prioritise HIV prevention programmes 
for key populations is especially evident’ (UNAIDS, 2009b, p.9). Groups 
listed as often needing more focused prevention programs include injecting 
drug users, men who have sex with men, sex workers, prisoners, and mobile 
workers. In addition, UNAIDS reports a lack of prevention programs that 
address high rates of infection among older heterosexual couples and young 
people in intergenerational partnerships.  Finally, the ‘typical shortage of 
programmes specifically designed for people living with HIV’ is lamented 
(UNAIDS, 2009b, p.9). 
Hope for a better tomorrow: 
 ‘We can only hope that the years ahead will be characterised not just by 
better drugs, new vaccines, and improved prevention methods, but also by the 
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adoption of the humility necessary to control a disease that is transmitted 
through sexual activity and drug use — two of proper society's least favourite 
topics. The prime mover of the epidemic is not inadequate antiretroviral 
medications, poverty, or bad luck, but our inability to accept the gothic 
dimensions of a disease that is transmitted sexually. Only when we cease to 
dodge this fact will effective HIV-control programs be established. Until then, 
it is no exaggeration to say that our polite behaviour is killing us’ (Sepkowitz, 
2006, p.2414). 
 
2.8 CONCLUSIONS 
This contextual literature review covered a massive amount of ground and raised 
more questions than it answered, but it confirmed that this research area deserved further 
study. The confluence of the three topics opened up fascinating, albeit incredibly 
complex, issues.  The three countries were chosen because they offer an intriguing 
variety: From the U.S. at #5 in per capita income (US$33,000) to Mexico at #47 
(US$5,200) to Uganda at #156 (US$217) (NationMaster, 2010), but the problems do not 
stop at country borders and many commonalities exist. The medical landscape is 
constantly changing; conventional medicine says no true cure is in sight, and the track 
record of standard treatments shows increasingly severe complications. Some alternative 
medical practitioners insist AIDS can be cured, but that alternative treatments have been 
overshadowed by the widespread use of HAART. Social marketing has been an 
important component of prevention and treatment programmes all over the world, but 
information gaps are plentiful and infection rates are still increasing among many at-risk 
groups. Nevertheless, the power of social marketing to motivate positive behavioural 
change is highly regarded by policy makers and activists alike, so funding continues to 
be allocated for social marketing interventions. 
To better understand how social marketing can effectively address an epidemic such 
as HIV/AIDS, the following chapter takes an in-depth look at the foundations upon which 
social marketing is based, strategic and creative approaches used by practitioners, and the 
best practices for implementation. 
 
 
 
39 
 
 
CHAPTER 3 
THEORETICAL LITERATURE REVIEW 
HOW SOCIAL MARKETING WORKS: THEORIES AND STRUCTURES 
 
3.1 INTRODUCTION 
Although social marketing is not a theory, it informs and structures its framework 
using psychology, sociology, anthropology, and communications (Kotler & Zaltman, 
1971). This array gives social marketers a lot of options but also can result in strategies 
that are not well grounded in recognised theory. Also, as global communication becomes 
more personal and immediate, social marketing must consider how to best adapt its 
message dissemination to efficiently reach target audiences. The evolution of social 
media and its ready acceptance around the world is revolutionising communication, but it 
may not be a replacement for traditional media in social marketing campaigns that target 
impoverished populations. Social marketers have never had more opportunities to blend 
scientific methods and the art of creativity for the purpose of motivating change for the 
good of individuals and society.  Kotler and Zaltman saw this potential when they 
concluded social marketing could be the ‘bridging mechanism’ between behavioural 
science and the ‘socially useful implementation of what that knowledge allows’ (1971, 
p.12).  Almost 40 years later, Kotler and Zaltman’s observations still stand as a seminal 
work in the history of the discipline, although social marketing approaches have been 
consistently refined and evaluated for efficacy in motivating short-term behavioural 
change at the individual level and long-term societal transformation at the policy level.  
Therefore, this chapter will survey the most common theories of health behavioural 
change, which encourage people to act in different or more positive ways.  Since the 
major theories of health behaviour change include communication processes, this chapter 
also includes discussion of the branches of communication study and the broad effects of 
emerging communication channels.  Finally, to cross Kotler and Zaltman’s bridge from 
behavioural science to social implementation, there is a discussion of strategic and 
creative approaches that might be useful for HIV/AIDS campaigns. In keeping with this 
melding of theory and practice, sources for this chapter include both social marketing 
researchers and practitioners. The toolbox of theories and techniques available to social 
40 
 
marketers is vast, so this review helps limit the scope of inquiry and provides a 
framework for ongoing dialogue in later research phases. 
 
3.2 QUESTION ADDRESSED IN THIS CHAPTER  
• How does social marketing work and what can it accomplish? 
Traditionally, the most frequently used tool by social marketers has been mass 
media campaigns (Stead & Hastings, 1997), which are called ‘social marcoms 
campaigns’ (Noble, 2005). Social scientists question whether social marcoms are an 
effective public health tool or, as critics say about commercial marketing, if social 
marcoms are just another facet of consumer culture that sells peoples’ lives back to them 
(Pappas, 2006). The answer is far from clear. 
 
3.3 DOES SOCIAL MARKETING WORK? 
YES: Pappas, in discussing social marketing communications created by Better 
World Advertising in San Francisco, many of them for HIV/AIDS prevention, said social 
marketing is important because it works…when it is well done. Pappas commented it is 
‘hard to do well, but it’s not that mysterious. Corporations spend billions on 
advertising—they wouldn’t do it if it didn’t work’ (2006, paragraphs 2, 5). His key 
concepts for good social marketing are: inclusiveness, research, creativity, testing, and 
evaluation. 
NO: Pappas also said ‘bad social marketing is bland, safe, and pretty ineffective’ 
(2006, paragraph 6). He attributed this to social marketing often being channelled 
through government agencies, which are cautious and careful not to offend, or because 
marcoms suffer from scarce resources, government regulations and censorship, or lack of 
understanding how to motivate change (2006). 
10% YES; 90% NO:  Studies show social marcoms campaigns have a poor rate of 
success in changing people’s behaviour. Rossiter and Bellman (2005) found social 
marcoms are only successful in 10% of cases, compared with 50% of commercial 
marcoms that succeed in increasing consumer purchases or product usage rates.  There 
could be several reasons for this low rate of success, Noble suggested. First, behavioural 
change is harder to effect than changes in consumer spending.  Second, social marketers 
target audiences in some of the least accessible sections of society, often minority ethnic 
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groups. Also, when those targets are from ‘culturally and linguistically diverse’ (CALD) 
communities, the challenge is even greater (Noble, 2005). 
YES: In many developing countries, social marketing programmes have become an 
essential component, if not the main component, of national family planning and HIV 
prevention strategy. Meekers and Rahaim compiled a database covering 555 years of 
experience with social marketing programmes that distributed and promoted use of oral 
contraceptives and condoms.  They reported that in 2002, social marketing programmes 
in 69 countries sold almost 1.6 billion condoms, more than one half of all condoms 
available from public sources (Meekers & Rahaim, 2005). 
NOT SURE: It is difficult to gauge how well social marketing campaigns perform 
since there is no uniform measure of success—some evaluations examine short-term 
results, such as condom sales or immediate behavioural change. Long-term behavioural 
change is more difficult if not impossible to measure, especially in HIV/AIDS social 
marketing where there is such a short history. As discussed in Chapter 2, data indicates 
some of the HIV/AIDS behaviour changes achieved in the past two decades have not 
been permanent. An example is the trend for men who have sex with men—MSM—
discontinuing safer sex practices after two decades of being ‘careful’ (Krochmal & 
Herman, 2003). 
In their efforts to effect broader and more lasting behavioural change, social 
marketers have adopted the commercial marketing concept of using both downstream 
and upstream marketing approaches that target individual consumers (downstream 
audiences) as well as policy makers (upstream audiences such as governments and 
NGOs). Dann noted ‘safe sex social marketers have historically used upstream 
marketing to broaden the distribution base of condoms and safe sex information’ (2006, 
p.4). Dann also pointed out that upstream social marketing can involve such ‘solutions’ 
as legislative controls, which remove the choice for voluntary change. Although 
upstream social marketing can facilitate the exchange process, ultimately, Dann argued, 
the consumer must have the freedom to accept or reject the ‘offer’ for social marketing 
to take place, or ‘social marketing simply ceases to exist where legislation or coercion 
takes precedence over voluntary choice’ (2006, p.6). 
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3.4 THEORETICAL CHOICES FOR SOCIAL MARKETING  
By the very nature of its founding tenets, social marketing is at home with health 
activism and health communication. In discussing theories and models with connections 
to social marketing, Lefebvre commented that they ‘reflect a public health bias in that 
most social marketing programmes…are designed by people with advanced degrees in 
social and behavioural science [who are] advancing public health goals’ (2001, p.507). 
People creating and implementing the campaigns, however, are more likely to have 
backgrounds in marketing or communication. 
Because social marketing draws from such a range of disciplines and theories, the 
literature contains discussion of theories relating to general behavioural change, with their 
connections to economics, politics, and culture. HIV/AIDS social marketing 
interventions frequently use behaviour change communication (BCC) as a core strategy. 
In a manual for HIV/ AIDS peer educators, Long defines BCC as ‘the process by which 
information and skills are shared and disseminated to people in the specific target 
audience with the intention of influencing them to adopt sustained changes in sexual 
behaviour or attitude, or to engage in other health-seeking behaviour’ (2006, p.5). 
Another category of discussion centres on personal motivators, since people do not 
always respond in the same ways to incentives or disincentives.  
In a perfect world the social marketer has the freedom to move amongst these 
various disciplines and theoretical frameworks, choosing those elements best suited to 
the purpose and audience where behavioural change is deemed desirable. In reality, it is a 
daunting array of theories and tools without clear signposts to point the way through 
the maze of choices. This chapter focuses on choices most relevant to HIV/AIDS social 
marketing campaigns. 
 
3.4.1 Theories of health behaviour change 
Early generations of HIV social marketing campaigns frequently built their messages 
around the health belief model (Montgomery, 1989), which is based on barriers and 
benefits and often uses fear or anxiety-arousing messages. This model holds that 
individuals will be more likely to change their health-related behaviour if they recognise a 
health risk or condition as important, if they view themselves as susceptible to that risk 
or condition, and if they regard the benefits of change as outweighing the barriers. After 
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study of a cohort of homosexual men at two different time points, Montgomery and 
colleagues concluded although the health belief model has been successfully applied to a 
variety of less complex and less threatening health conditions, that the ‘special features 
of AIDS may require development of more adequate theoretical frameworks’ (1989, 
p.323).  
Hastings and colleagues noted fear appeals have been ‘embraced with enthusiasm by 
social marketers’ (2004, p.962), but caution fear appeals, in addition to encouraging 
‘health fatalism,’ may actually have negative long-term effects on the brand. A more 
effective use of fear, especially for young people, according to Backer, Rogers, and 
Sopory, is a positive rational/emotional approach, which uses fear to grab attention, then 
relates the fear to a positive outcome (Backer, et al., 1992). Terblanche-Smit investigated 
whether use of fear increases the likelihood of adopting appropriate behaviour pertaining 
to HIV/AIDS— if accompanied by high efficacy messages. They found ‘encouraging 
evidence for the persuasive power of fear appeals to improve knowledge and to influence 
attitudes about HIV/AIDS, especially among adolescents’ (2008, p.302). The study 
confirmed a causal relationship between susceptibility and fear. Terblanche-Smit 
concluded, ‘Future AIDS campaigns targeted at adolescents must communicate the target 
audience’s susceptibility to the disease to ensure they experience a relevant fear that will 
drive them to change the way they think about HIV/AIDS and ultimately influence them to 
modify their sexual behaviour to safe sexual behaviour’ (2008, p.305). 
Lee added to the discussion of the practical aspects of fear with four key points: 
1) Consider the target’s stage of change; ‘If in the precontemplation stage, fear may 
work to “wake them up,” but if in the contemplation stage, fear may immobilise 
them’ (2009). 
2) If fear is used, always follow up (quickly) with a solution. 
3) Sometimes it is more effective to direct a fear message to a spouse or a friend than 
the target. 
4) A credible source is critical (Lee, 2009). 
In a report prepared for the UK's National Social Marketing Strategy for Health, 
McDermott and colleagues (2006) found nutrition social marketing interventions were 
based on a number of behaviour change models. The most common was the social 
cognitive theory, which emphases observational learning and self-efficacy and is 
frequently used in campaigns where individuals have choices of how to respond to their 
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environments (Lefebvre, 2001). The social cognitive theory explains how people acquire 
and maintain certain behavioural patterns; this theory also provides a basis for 
intervention strategies (Bandura, 1997). Evaluating behavioural change depends on 
environment, people, and behaviour, which are constantly influencing each other. There 
are both social and physical environments; the social environment includes family 
members, friends and colleagues, while the physical environment includes factors such as 
the size of a room, the ambient temperature, or the availability of certain foods (Glanz et 
al., 2002). 
The next most popular model, according to McDermott's report, was the 
transtheoretical model, popularly known as stages of change, which assumes few people 
are ready to take action and must be moved through early stages of indecision. In 1982, 
psychologists developed the Stages of Change Theory, which challenged the change 
paradigm that ‘assumed change occurred dramatically and discretely’ (Prochaska, et al., 
1994, p.14-15).  The stages are:  1) precontemplation, where the client denies there is a 
problem and resists change, 2) contemplation, where the client acknowledges a problem 
exists and plans to take action in the future. A chronic contemplator who substitutes 
worry for work is not uncommon, 3) preparation, where the client is committed to take 
action ‘soon,’ but may still need to completely convince him or herself, 4) action stage, 
where there is a commitment of time and energy. The danger at this stage is equating 
action with change, 5) maintenance is more challenging than action and outside support 
is crucial.  Prochaska and colleagues said a linear progression through the stages of 
change is possible but rare; only 20% permanently conquer their problems on the first 
try (Prochaska, et al., 1994). 
Lefebvre pointed out one of the few population-based models available to social 
marketers is diffusion of innovation, which segments any target group into different 
types of adopters (innovator, early adopter, early majority, late majority, and laggard) 
and suggests the marketer begin with one or two segments (2001). Diffusion research 
focuses on conditions that increase or decrease the likelihood that new ideas, products, 
or practices will be adopted by members of a given culture. Diffusion of innovation 
theory says that media as well as interpersonal contacts provide information and 
influence opinion and judgement (Rogers, 1995).  
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Lefebvre also mentioned the theory of reasoned action, which holds that peoples’ 
behaviour is predicted by attitudes toward a particular belief and how they think others 
will view them (2001, pp.507-515). According to this theory, behaviour is principally 
influenced by intentions to change and those intentions are influenced by people's 
perceptions of what important referent groups think about the behaviour. 
Communication may play a key role in shaping these perceptions and thereby increasing 
the likelihood of behaviour change. 
On a broader policy level, upstream appeals often reference the goal of sustainable 
development, which takes a long-term, generational view and focuses on people’s 
power to make decisions about the future of their society (Dubois, 2003). 
In regards to HIV/AIDS interventions, however, Coates and colleagues pointed out 
behaviour changes effected by cognitive-behaviour approaches, communication theory, 
peer education, or diffusion of innovation are ‘statistically significant,’ but ‘rarely 
sufficient to reduce sexually transmitted or HIV infections’ (2008, p.38). They 
concluded that behavioural strategies are essential in a comprehensive HIV prevention 
campaign but are not sufficient in and of themselves to reduce HIV transmission (2008, 
p.39). 
 
3.4.2 Communication theory  
These theories of health behavioural change, when used as the foundation for social 
marcoms, are all affected by the communication process, so, it is important to consider 
how communication activity positively or negatively contributes to health behaviour.  
Communication scholar Gerbner described three relevant branches of communication 
study: 
• Semiotics, which is the study of signs and symbols and how they combine to 
convey meaning in different social contexts.  Semiotics includes verbal, 
nonverbal, and visual and aural signs and symbols. 
• Media effects, which studies resultant behaviour and interaction through 
exposure to messages. 
• Message production, which is the study of how communication is organised 
through social institutions and systems such as mass media, political 
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organisations, government, and advocacy groups. Message production can be 
influenced by sociology, political science, history and public affairs (Gerbner, 
1956). 
Although these three areas of communication study continue to be important in the 
design and implementation of a social marketing campaign, Thackeray and Neiger 
suggested a dramatic shift in the traditional ‘top down’ communication model, in which a 
sender relays a message through a channel to a receiver, with social marketers acting as 
gatekeepers of information (2009). They posited that the communication process, at 
least for those with access to the Internet, is ‘changing from being unidirectional to 
multidirectional as consumers become active participants by creating, seeking, and 
sharing information using a variety of channels and devices’ (Thackerary & Neiger, 
2009, p.171).  
The participatory nature of online social media channels such as Twitter, Facebook, 
and blogs where viewers/readers converse and create content has grabbed the attention of 
commercial marketers, but HIV/AIDS social marketers have been slower to adopt social 
media techniques. However, government agencies such as CDC and NGOs such as 
Population Services International (PSI) have begun to incorporate social media into their 
prevention campaigns, especially when targeting younger audiences with access to  
the Internet. In July of 2010, internationally known HIV/AIDS activist Rae Lewis-
Thornton hosted the first-ever HIV/AIDS-themed social media gathering in Chicago—a 
Tweet-up—aimed at spreading the message about disease prevention (Chaney, 2010).  
For those marcoms audiences who actively use new media, this shift in the 
communication process could affect a) who delivers information, because consumers 
become creators and senders of messages, b) how information is delivered, since both 
social marketers and consumers will send messages using new technologies, and c) how 
information is sought, as consumers proactively seek out information.  In support of 
their hypothesis, the researchers cited a 2005 study by Hesse, et al., which found 49% 
of adults said they go first to the Internet for health information, while only 11% said 
they went to their health care provider first (Hesse, et al., cited in Thackeray & Neiger, 
2009, p.174).   
In response to studies such as this, PSI, the largest social marketing organisation in 
the world, used targeted Behaviour Change Communications (BCC) in Mexico to focus 
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on gender equity and prevention messages addressed to young people under 25. An 
innovative example of PSI’s initiatives is a campaign called Menos Etiquetas, which relies 
heavily on ‘peer educators’ but reinforces that strategy with BTL (below the line) 
techniques such as blogs, an array of promotional materials in places frequented by 
youths, and creative Bluetooth viral marketing (Massingill, 2009). 
Thackerary and Neiger agreed traditional media channels are not obsolete but are 
likely to be supplemented with these new technologies that could extend reach and 
effectiveness (2009, p.175). In a discipline where targeting audience segments is 
imperative, the ultimate targeting strategy is tailoring, where computer databases make it 
possible to store a large number of alternative messages on a topic like AIDS prevention 
and send on request a message that fits precisely with the situation (Singhal & Rogers, 
2003, p.170). Cautionary notes concerning new media relate to the target’s media access 
and literacy as well as the potential for consumer information overload; the social 
marketer must be proactive in soliciting consumer permission to receive information 
(Thackerary and Neiger 2009, p.174-5). 
Numerous studies are underway to determine the extent to which the Internet and 
social media are changing how people use traditional media and in which groups this is 
occurring.  Media use by the social marketers’ segmented target market is obviously a 
critical factor in dissemination of social change messages, but many of the studies are 
focusing on more mainstream audiences than groups where HIV/AIDS might be a major 
concern (UNAIDS, 2009b).  
 
3.5 MOVING FROM THEORY TO ACTION  
Once the theories are assimilated and choices are made about how to incorporate 
scientific method into social marcoms, it is time to cross the ‘bridge’ to practical 
application, where the creative process comes into play. According to Andreasen (2006, 
p.137-8), the social marketing approach involves a series of steps that give structure and 
direction to the process. That progression should include: 
1) Selects the target audience segment or segments and determines the amount of 
focus to be given to each group.   
2) Listens to the target audience through background reading, formal research, expert 
advice, and informal conversations 
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3) Designs a course of action  
4) Pre-tests the programme with the target audience and monitors results 
5) Crafts programmes that use a media mix 
6) Expects—and makes—mid-course corrections 
At this point, HIV/AIDS social marketers might consider Singhal and Rogers’ 
contention that behaviour change communication strategies that focus solely on 
individual-level changes subscribe to one or more mistaken assumptions. The first 
assumption mentioned is that all individuals are capable of controlling their context, 
when cultural, economic, social, and political factors may affect the availability of such 
services as testing and condoms. The second assumption is that all persons are on an 
‘even playing field,’ when in fact women and the poor are more vulnerable to HIV/AIDS. 
The third assumption of behaviour change communication strategies, according to 
Singhal and Rogers, is that all individuals make decisions of their own free will, when for 
example women in many cultures cannot control if they have protection during sex. The 
last assumption is that all individuals make preventive health decisions rationally (2003, 
p.212). 
Coates and colleagues argued that lowering HIV incidence will require ‘elevating the 
debate on HIV prevention beyond the incessant controversies over individual 
interventions’ and that policy makers, donors, and advocates must demand national 
prevention efforts tailored to their epidemics and that address environmental 
vulnerability factors (Coates et al., 2008, p.40). 
 
3.6 STRATEGIC APPROACHES 
Informed by research and guided by science, the social marketer’s next step is to 
construct a plan to motivate behavioural change in the target audience. Given the unique 
situation surrounding HIV/AIDS audiences, social marcoms strategies should include 
both cultural and socio-economic factors that combine behaviour strategies with a 
variety of communication approaches at multiple levels of influence (Coates, et al., 
2008, p.39). 
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3.6.1 Cultural considerations 
HIV/AIDS is no respecter of boundaries of any kind, but attitudes and perceptions 
regarding the disease vary greatly depending on cultural traditions, so the social marketer 
must consider how messages will be interpreted, especially in groups that are culturally 
and linguistically diverse (CALD) (Noble, 2005). Examining every aspect of culture is 
beyond the scope of this review, but high- and low-context communication and cross-
cultural factors are likely to affect the design of HIV/AIDS interventions. 
Hall developed a typology that suggests cultures are distinguished by low- and high-
context messages (Mueller, 1996, pp.114-117). In the case of low-context culture, most 
of the information is in explicit code using words or symbols. This informational style is 
typical of most Western cultures.  On the other hand, in high-context, or 
transformational, cultures, up to 90% of meaning is communicated through non-verbal 
aspects.  For example, informational ads would attempt to change behaviour by 
providing objective facts; transformational ads would attempt to move a consumer 
emotionally (such as through fear).  
International campaigns often must be adapted to match the culture of the target 
audience because a low-context, cognitive approach may not work with a high-context 
audience. LoveLife, South Africa’s major multi-million HIV/AIDS prevention campaign 
was launched in 1999 using an informational appeal approach that emphasised condom 
use and ‘positive sexuality.’ Not only did the campaign not produce the desired results, it 
was the world’s first organisation to have funding discontinued by the Global Fund to 
Fight AIDS, Tuberculosis and Malaria (GFATM) (Terblanche-Smit, 2008, p.174). 
Noble suggested four key issues to adapting social marketing marcoms campaigns for 
use with CALD audiences (2005):   
1) Segment the audience—This is usually done on the basis of language and/or 
country of birth, but that kind of segmentation can be too broad.  An alternative is 
acculturation, the journey immigrants travel as they enter and adopt cultural and social 
traits associated with the new host country.  This process is bi-dimensional; immigrants 
assume some aspects of the host country culture without ever losing all the cultural 
traits of their birth country. This combination of cultural attitudes often affects attitudes 
toward behaviours social marcoms are targeting.   
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2) Adapt pre-existing messages—International campaigns often try to translate the 
concepts that have worked in other countries. This can be tricky due to cultural 
differences and language style.  The translated message must be credible; it should not 
sound outdated or condescending. Unfortunately, the kinds of witty plays on language, 
such as puns, which marketers frequently rely on, cannot be satisfactorily translated. 
3) Establish source credibility—the source of the message plays an important 
cultural role in how it is perceived.  Messages from groups perceiving as “helping” 
organisations are received more positively than official government agencies.  Some 
ethnic groups are more trusting of information delivered by a person rather than by an 
institution. 
4) Coordinate and integrate campaigns –Social marketing’s close relative, Integrated 
Marketing Communication (IMC), is based on the premise that communication efforts 
have a better likelihood of success when organisations integrate and coordinate to give 
clear and consistent messages across all internal and external communication (Noble, 
2005). 
 
3.6.2 Socio-economic considerations  
According to Meekers and Rahaim, social marketing programmes are classified as 
using either a non-government organisation (NGO) model, which heavily subsidises 
products, or the manufacturer’s model, which uses temporary interventions with a 
‘realistic exit strategy’ and often differ in terms of branding, pricing, and distribution.  It 
is usually assumed that the manufacturer’s model is more feasible in middle-income 
countries with well-developed commercial infrastructures, and the NGO model is more 
suited for lower-income countries with less well-developed commercial infrastructures 
(2005). Niblet cautioned partnerships are key to this process because social marketers 
‘do not have the infrastructure and the marketplace environment commercial marketers 
take for granted’ (2005, p.3).  
Additionally, social marketing can be carried out under one of three different 
management structures. The most common structure for health-oriented social marketing 
programmes—used in 70% of the campaigns studied— is management by an NGO, 
particularly in countries with a low per capita income (less than US$3,000) and 
urbanisation of less than half of the population (Meekers & Rahaim, 2005). Under the 
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second structure, the social marketing intervention is managed by local organisations, 
often based in a health clinic. The third option, most likely to be used in countries with 
high per capita income and a strong commercial sector, is to partner with a commercial 
organisation. Meekers and Rahaim also noted that in a middle-income country with a 
well-developed commercial sector, it might be counterproductive to use the NGO model 
with a highly subsidised product that competes with existing brands (2005). In fact, 
Population Services International discontinued its focus on condom social marketing 
(CSM) in Mexico for this very reason (Massingill, 2009). 
The most insidious cultural problem in countries around the world, especially related 
to HIV/AIDS, is the stigma and discrimination that are frequently associated with the 
disease and those who are infected. In spite of decades of social marcoms designed to 
eliminate stigma against HIV/AIDS, discrimination—social, economic, and political—
continues to stall efforts to promote testing and treatment (International HIV/AIDS 
Alliance, 2008).  Even market segmentation for the purpose of social marketing targeting 
can contribute to stigma and perpetuate stereotypes, such as the short-running San 
Francisco area campaign with the theme, AIDS is a Gay Disease.  Jones recommended 
social marketers launch campaigns that are not overtly or covertly sanitising, 
sanctimonious, or moralising (2006). 
 
3.7 CREATIVE APPROACH: 
In designing their creative approach, social marketers should remember change can be 
motivated in different ways. Pappas pointed out people can be persuaded to change 
through positive messages that encourage and attract them: ‘getting them on the 
bandwagon.’ Another option to effect change is through disturbing people or causing 
them discomfort, so they are challenged to change. Pappas said, ‘We like it (social 
marketing) when it makes us feel good, but we don’t like it when it confronts our reality, 
shocks us, airs our dirty laundry, or makes us think too much. But, ultimately, what is 
the role of controversy? We need to leverage the scarce resources we have and we need 
to get people’s attention’ (2006, paragraph 7). So-called reality-based social marketing, 
such as the AIDS is No Picnic campaign, which used graphic photos of real people in the 
later stages of AIDS in an effort to shock gay men in San Francisco into using safer sex 
practices, are attention-getting, but get mixed reviews from the target audience. Krochmal 
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and Herman said reactions ranged from ‘righteous indignation’ by HIV-positive men 
who felt exploited and exposed to ‘hearty encouragement’ from those who welcomed 
the attempt to show the reality of those with the disease (2003).  
Social marketers are sometimes criticised for using attractive people or celebrities as 
campaign spokespeople. Losh asked, ‘Is it wrong to use attractiveness or celebrity if 
people respond?  Can campaigns shock and still remain humanising?’ (2006, paragraph 
7).  A danger with controversial campaigns, Losh contended, is they run the risk of 
‘creating cognitive dissonance among the grassroots level’ (2006, paragraph 9). 
However, being too fearful of offending when dealing with an issue like HIV/AIDS 
can sabotage the campaign, some marketers believe. For example, Losh gave a brief 
historical overview of the careful creative approach to depicting HIV/AIDS in the United 
States.  In 1986, the surgeon general’s report depicted condoms but not faces of people. 
During those early years of the epidemic, informational materials used medical 
illustrations and impersonal images such as shaking hands, toilets, and doorknobs, 
relying on symbols instead of a more humanising approach to the disease. In 1988 the 
surgeon general sent a brochure illustrated with faces and headshots, but no condoms, to 
197 million households. Yet another surgeon general report in the early 1990s showed 
group photos, bar charts, and condoms, but no individual faces (2006, paragraph 3).  
‘American campaigns are stymied by Puritanism about the body and sexuality,’ Losh 
concluded (2006, paragraph 5). Using confusing and innocuous symbols to illustrate 
HIV/AIDS messages is not just problematic in U.S. campaigns.  Pisani recalled a 
‘baffling’ Indonesia campaign showing people playing pool with the slogan, AIDS, Wait 
a Second (2008). 
The opposite approach to these non-confrontational and sometimes confusing 
images are sociological images, compelling visuals that ‘span the breadth of sociological 
inquiry,’ according to Contexts (AIDS is a mass murderer, 2009), the online magazine of 
the American Sociological Association. An example of an AIDS awareness campaign 
using this technique was AIDS is a Mass Murderer, an ad series depicting women having 
passionate sex with Hitler, Stalin, and Saddam Hussein, who were all shown with evil 
expressions and appeared much older than the women. This campaign created a spirited 
dialogue on the magazine’s blog and also raised issues about how campaign visuals could 
be interpreted in several different contexts (AIDS is a mass murderer, 2009).  
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Sometimes a shocking image or a controversial approach generates its own media 
sensation. Reaction to an explicit or disturbing campaign element can take on a life of its 
own, which may increase visibility or might result in image problems. I Am African was 
another HIV/AIDS campaign that spawned intense debate and accusations of racism. For 
this campaign, international celebrities were depicted with African ‘war paint’ and 
wearing ethnic garb such as tribal necklaces and Bedouin shawls. The intended message 
was everyone has a common ancestry, so everyone should be concerned about the AIDS 
epidemic in African countries (Media, 2006). 
The words that accompany images also can generate strong responses. The scope of 
the HIV/AIDS epidemic has changed public discourse by breaking the silence about 
topics that were once considered taboo. Depending on cultural factors such as religion 
and demographic categories like age, taboo topics might include sex before marriage, use 
of condoms, alternative lifestyles, women’s rights, homophobia, and prostitution 
(Massingill, 2008). 
One strategy for coping with a taboo topic is to represent it with a symbol, which is 
the ubiquitous red ribbon in the case of AIDS. Used globally, the red ribbon symbol has 
contributed in giving worldwide visibility to the disease and offers a means of ‘branding’ 
HIV/AIDS communication activities (Singhal & Rogers, 2003, pp.254-5). In the case of 
HIV/AIDS, branding has also been achieved through the annual observance of World 
AIDS Day on December 1 (World AIDS Day, 2009). Branded items can contribute to a 
health behaviour change in at least four significant ways, according to Lefebvre. They 
can mark tribal or brand identity, become a social objective by prompting dialogue, 
create ubiquity and thereby raise awareness of the issue, and cue action by reminding 
audiences of the desired behaviour (2010b). The use of external incentives, central to 
most social marketing approaches, also has potential pitfalls because they can be 
interpreted as coercion or bribery and not deliver the long-term behavioural change 
desired (Dholakia & Dholakia, 2001, p.498).  
The personal benefits inherent in self-interest appeals, however, are frequently used 
to advantage. Based on the well-established Maslow’s hierarchy of needs, self-interest 
appeals target common human needs ranging from physiological to safety, social, ego, 
and self-fulfilment (Wilcox, 2002). 
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3.8 CAMPAIGN EVALUATION 
A recurring theme in the literature about HIV/AIDS social marketing is whether two 
decades of campaigns have been effective or if they should have accomplished much 
more. Policy makers who once saw social marketing as the best tool for motivating  
social change now cite studies that indicate short-term behavioural modification—not 
permanent change—has perhaps been the outcome of much of the HIV/AIDS prevention 
efforts.  
A lack of global coordination means that countries report infrequently, using 
different indicators, so it is impossible to find reliable data about levels of infection or 
effectiveness of programmes (Coates, et al., 2008). Bertozzi and associates concurred: 
‘Providing evidence for the effectiveness of a prevention programme is a much more 
complex task than proving the effectiveness of a drug, vaccine, or biomedical prevention 
intervention such as male circumcision’ (2008, p.67). Bertozzi and colleagues also 
pointed out that in many countries there is little or no correlation between data 
collection regarding knowledge of HIV/AIDS and measuring the effect of specific 
interventions (2008). 
Evaluating social marketing campaigns in a consistent, comparable manner is difficult 
at best. Part of the problem, according to Miller, is that campaigns should be evaluated 
both on short-term and long-term results.  Not surprisingly, short-term results are easier 
to tabulate. Miller suggested short-term evaluation might include a series of criteria, 
beginning with, ‘Did the campaign reach the target audience?’ The next question of 
concern relates to simple message comprehension and acceptance (‘I could understand 
the message,’ ‘The message was believable,’ ‘The message was relevant to me.’). 
Affective (emotional) and cognitive (rational) responses to the campaign are also an 
important way to calculate short-term results. Affective responses might include 
feedback on how the message made the respondent feel and cognitive responses might 
relate to what the message prompted the respondent to think about. Finally, immediate 
behavioural responses can be measured fairly quickly, but tracking long-term behaviour 
outcomes can, in the instance of HIV/AIDS, take decades—even generations—to fully 
understand. Miller cautioned that evaluation should also include the question, ‘Is the 
change we (probably) observe due to our efforts’? (Miller, 2006). 
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The need for accountability is great, but the challenge is getting everyone—donor 
countries, philanthropies, multinational organizations and countries highly affected by 
the pandemic to collaborate. As Coates and associates pointed out, ‘One can improve 
the science, but what good will it do if the science and best practices are not 
implemented…measured and achieved? That, presently is not the case’ (2008, p.48). 
Singhal and Rogers offered a similar reflection: ‘The world is doing a rather poor job 
of utilising known communication strategies to control the spread of HIV. We must do 
better in the future’ (2003, p.76).  But, they also see reason to be optimistic:  
‘Communication strategies can help break the silence about HIV/AIDS and move the 
discussion from the personal-private to the public-policy sphere’ (Singhal & Rogers, 
2003, p.253). 
In pursuit of understanding how social marketing campaigns have helped to break 
that silence and move the world toward positive social change, Chapter 4 details a 
methodology for comparing 18 HIV/AIDS social marketing campaigns as the first phase 
of this research study. 
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CHAPTER 4 
METHODOLOGY 
COLLECTING AND ANALYSING SECONDARY DATA 
 
4.1 INTRODUCTION 
The central purpose for this project was encapsulated in the overall research aim: 
 To explore the overlapping landscapes of HIV/AIDS, social marketing, and 
conventional and alternative medicine with the goal of better understanding those 
shifting relationships and of using that knowledge to design a communication model for 
disseminating information about HIV/AIDS prevention and treatment options. 
This proposed inquiry may seem straightforward enough, but initial research 
revealed a universe of complexities swirling around this convergence of topics. Peoples’ 
attitudes varied wildly; there were the ‘head in the sand’ thinkers who ignored the topic 
in hopes it would somehow disappear; others found it unpleasant and unfit for polite 
society; some were frightened to even discuss HIV/AIDS, as if they could become 
infected merely through conversation; and still others had solidified their opinions and 
were uninterested in other viewpoints. Perhaps most distressing were the ‘voyageurs,’ 
who relished discussing the more explicit sexual aspects of the disease’s transmission. 
To begin to comprehend the nuances suggested by the research aim, it was necessary 
to be aware of the nature and capabilities of social marketing; to understand the context 
for the HIV/AIDS pandemic’s cultural, political, and economic concerns; and to explore 
conventional and alternative medical communication regarding prevention and 
treatment of the disease. Understandably, bringing together these divergent components 
was complicated, requiring carefully constructed research questions and sub-questions 
that called for the flexibility provided by multiple research methods. Analysis therefore 
involved both qualitative and quantitative approaches, combined with reflective 
synthesis and some informed crystal ball gazing. The topic was constantly in motion—a 
global moving target—as the pandemic progressed, as campaigns were launched, as 
treatments evolved, as the body of knowledge expanded. In addition, such a volatile 
topic demanded attention to ethical considerations at every stage of the research.  
Research for this project is presented in four stages: 1) collecting and analysing 
secondary information through an ongoing literature review, 2) conducting a cross-
cultural content analysis that bridges the gap between secondary and primary 
information and between qualitative and quantitative techniques, 3) collecting and 
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analysing primary information by means of semi-structured interviews and surveys, and 
4) constructing a communication model designed to aid in the dissemination of 
information about HIV/AIDS prevention and treatment options. At each stage, a mix of 
methods— both subjective and objective—moved the process forward. This project was 
both a personal journey of discovery and a professional opportunity to participate in a 
crucial global dialogue that will undoubtedly shape the lives of future generations. 
 
4.2 RESEARCH APPROACH 
Because this study as originally conceived was global, complex, and paradoxical—
involving three broad topics, multiple disciplines, often with contradictory perspectives, 
and cultural, political, and economic factors in three countries—the amount of material 
available to the researcher was overwhelming. Guided by the initial hypotheses (See 
Section 1.1) and exploratory research, the overall research aim was constructed to give a 
framework for the inquiry. The aim was designed to be broad enough to allow the kind 
of far-reaching examination the researcher envisioned for this project. As Johnson and 
Onwuegbuzie asserted, ‘All research in the social sciences represents an attempt to 
provide warranted assertions about human beings and the environments in which they 
live and evolve,’ but ‘the bottom line is that research approaches should be mixed in 
ways that offer the best opportunities for answering important research questions’ 
(2004). 
The traditional research paradigms were considered. A purely quantitative study, 
which uses what is termed a positivist philosophy, holds that the social observer should 
be separate from the entities subject to observation, that all social science inquiry should 
be entirely objective. The researcher is expected to eliminate all biases and be 
emotionally detached and uninvolved with the objects of study (Johnson & 
Onwuegbuzie, 2004). 
By contrast, qualitative purists, also called constructivists or interpretivists, reject 
positivism; they contend multiple-constructed realities abound, and they dislike 
detached and passive styles of writing. They also point out that ‘fully objective and 
value-free research is a myth, even though the regulatory ideal of objectivity can be a 
useful one’ (Johnson & Onwuegbuzie, 2004). It was quickly apparent that a 
monomethod approach using either of these paradigms would not be appropriate for the 
transdisciplinary mix of topics and ideas included in the research aim. Luckily, there 
was a third option, as explained by Johnson & Onwuegbuzie: ‘Today’s research world 
is becoming increasingly interdisciplinary, complex and dynamic; therefore, many 
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researchers need to complement one method with another, and all researchers need a 
solid understanding of multiple methods used by other scholars to facilitate 
communication, to promote collaboration, and to provide superior research’ (2004). 
Although recent by academic standards, the mixed methods approach, (also called 
integrating, synthesis, quantitative and qualitative methods, multimethod, and 
multimethodology), has been gaining credibility since it was first employed in the late 
1950s (Creswell, 2003). Campbell and Fisk pioneered the use of a ‘multimethod matrix’ 
to examine data collected by various means (1959). This combination of quantitative 
with qualitative is now commonly viewed as a complementary approach rather than two 
alternative methods.  More recently, mixed methods has been called the ‘third research 
paradigm,’ recognizing that both qualitative and quantitative approaches are useful, and 
proposing to ‘collect multiple data using different strategies, approaches and methods 
…so the resulting mixture is likely to result in complementary strengths and 
nonoverlapping weaknesses’ (Johnson & Onwuegbuzie, 2004). 
The various rationales for mixing qualitative and quantitative approaches, as 
discussed by Collins and colleagues, were also investigated.  These rationales include 
participant enrichment, instrument fidelity, treatment integrity, and significance 
enhancement (2006). The fourth of these—significance enhancement, i.e. mixing 
quantitative and qualitative techniques to maximize the researcher’s interpretations of 
data—was considered the most relevant for this study due to the diverse data 
necessitated by the broad range of the research aim. 
Alongside determining the research mixing rationale, Onwuegbuzie and Leech 
recommended that researchers proposing to employ a mixed process should determine 
their purpose or purposes for mixing qualitative and quantitative approaches (2006). 
Greene, Caracelli, and Graham identified five general purposes of mixed-methods 
studies: (a) triangulation (seeking convergence and corroboration of findings from 
different methods that study the same phenomenon, (b) complementarity (seeking 
elaboration, illustration, enhancement, and clarification of the results of one method), 
(c) initiation (discovering paradoxes and contradictions that lead to a re-framing of the 
research question or questions), (d) development (using the results from one method to 
help inform the other method), and (e) expansion (expanding the breadth and range of 
the investigation by using different methods for different inquiry components (1989). 
Although every mixed methods study has one or more of these five purposes, this 
study utilises aspects of each of these purposes, offering opportunities to cross-validate 
and triangulate and thereby providing balance in a project that included a wealth of 
59 
 
subjective but meaningful material. The richness of the combined data enhanced the 
overall study, and the paradoxes encountered along the way certainly were reflected in 
the evolution of the overall research questions. As shown in the research timeline 
(Figure 4.1), the sequence of data collection helped inform the phases that followed. In 
the final analysis, the variety of perspectives and the varied sources of data were 
invaluable as the mixed design contributed to the goal that is so often the desired results 
of mixed methods: ‘not to search for corroboration, but rather to expand one’s 
understanding ‘ (Johnson & Onwuegbuzie, 2004). 
 
4.3. RESEARCH QUESTIONS 
 
Research questions can be based on theories, past research, previous experience, or 
managers’ practical need to gather data for decision-making in the workplace. 
Regardless, the research questions are central to the inquiry since they serve as 
‘signposts’ for the reader, ‘foreshadowing the specific details of the study’ 
(Onwuegbuzie & Leech, 2006). In quantitative research studies, the questions 
tend to be developed a priori, whereas research questions are more likely to be 
developed either a posteriori or iteratively in qualitative research studies (Onwuegbuzie 
& Leech, 2006). 
Coming to the overall research questions for this project was not a quick 
process…there were cumbersome versions that seemed to grow more wordy and 
awkward as the months went by. Creating over-arching umbrella questions that met the 
established criteria of being feasible (able to be investigated with resources available), 
clear (include key terms to use in researching the topics), significant (have the potential 
to contribute to the field), and ethical (Opfer, 2011) was a more challenging task than it 
first seemed. An overview of the project garnered approving interest from marketing 
professionals during a presentation at the Academy of Marketing’s Doctoral Colloquium 
in July of 2007 (Marketing, 2007). The abstract, A practical approach to cultural 
change, is shown as Appendix E.4. These experts pronounced the topic worthy and the 
work done so far on track. Their principal suggestion for change was to refine the 
central research questions. Eventually, the questions became less convoluted, and at first 
glance, perhaps innocuous. But beneath the surface lurked a quagmire of ideas, 
opinions, and a host of additional questions—too many to answer in one thesis, or 
perhaps even in one lifetime. In time, a series of sub-questions for each research 
question was also developed to be addressed—and frequently revisited—over the course 
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of the project. The grand tour questions, which directed the sequence of the research 
design, were: 
 
RQ 1: How have the evolving landscapes of HIV/AIDS, social marketing, and 
conventional and alternative medicine forged global and national relationships and 
interactions? 
RQ 2: Could social marketing influence better-informed behavioural change by 
including both conventional and alternative medical information in HIV/AIDS 
campaigns? 
RQ 3: What practical contribution could social marketing make to bridge the 
knowledge gap between conventional and alternative medical choices for HIV/AIDS 
prevention and treatment? 
(See Section 1.2.1 for a complete list of sub-questions. They are also listed in the 
corresponding areas of this thesis where they are addressed.) 
 
4.4. RESEARCH DESIGN 
Research methods should follow research questions in such a way, suggested 
Johnson and Onwuegbuzie, which ‘offers the best chance to obtain useful answers’ 
(2004). Since mixed research is essentially pragmatic, using induction (discovery of 
patterns), deduction (testing hypotheses), and abduction (finding the best set of 
explanations for the results), it requires researchers to take an eclectic approach to 
method selection (Johnson & Onwuegbuzie, 2004). The design choices for a mixed 
researcher are numerous; the literature provides a host of possible designs and 
configurations. Harrison and Reilly undertook an examination of major marketing 
journals to determine how mixed methods were designed in more than 2,000 articles 
(2011). They identified four primary mixed methods design types: 1) exploratory 
design—the most common—(which was usually either an instrument design where 
qualitative findings were used to develop scale items for a quantitative survey OR a 
taxonomy development design where qualitative results were used to develop a 
classification system); 2) explanatory design (where quantitative data is collected and 
analysed, with a qualitative follow-up to better understand the initial findings); 3) 
embedded designs (researchers collect both quantitative and qualitative data 
sequentially or concurrently with one kind of data playing a supporting role or both 
taking a supporting role in a case study, ethnography, narrative, or other qualitative 
research design); and 4) concurrent designs (where qualitative and quantitative data are 
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collected simultaneously, analysed separately and then merged) (Harrison & Reilly, 
2011).  
Additionally, Harrison and Reilly identified a hybrid design, which incorporated 
aspects of multiple design types, and is sometimes used when required by the research 
rationale. The hybrid design described drew on literature and in-depth interviews to 
develop an instrument, as in an exploratory design. The instrument was developed using 
exploratory factor analysis. Next, a follow-up phase of interviews was used to further 
interpret the findings from the survey data. Finally, data were presented separately and 
then mixed in the discussion section of the report (2011). 
The hybrid design’s flexibility was appealing for this study. Several factors made 
this project both exciting and challenging but demanded a customised research design. 
First, the histories of social marketing and of HIV/AIDS—separately and together—are 
relatively short. Social marketing was first defined as a profession in 1971 (Kotler, 
1971), and HIV/AIDS was not recognised as a disease until the early 1980s (Segala, 
2003). Communication efforts to combat the pandemic span only the last two and a half 
decades, and many of those efforts have enjoyed qualified successes at best (Singhal & 
Rogers, 2003). A mixed methods approach to examining HIV/AIDS communication has 
precedent in the literature, when Janz and colleagues published their evaluation of the 
effectiveness of 37 AIDS prevention projects more than a decade ago (1996). Janz and 
her fellow researchers began by collecting quantitative survey data about AIDS 
interventions that were reported to be effective. Next, qualitative data from in-depth site 
visits identified factors that contributed to success. The site visits also provided case 
examples that provided context for understanding why the interventions were effective. 
This combination of methodologies provided a more thorough understanding of the 
complexities of the activities and the reasons for their effectiveness (Janz, et al, 1996, 
p.81). 
This study’s research questions called for a mix of proven research methods, 
including content analysis, informal and semi-structured interviews, and a quantitative 
survey to examine perceptions and effects of social marketing HIV/AIDS campaigns. A 
qualitative blending of all the data would tie the findings together. 
Further, the sequential nature of the research design lent itself to a holistic approach 
since data from one phase informed and developed the next phase. The forward 
sequential movement could not be expected to be unwaveringly linear, however; 
research phases were expected to overlap, which prompted backtracking and 
reinterpretation, thereby enriching overall understanding. 
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Likewise, using techniques that facilitate the marriage of exploration and explanation 
suited this project’s aim perfectly. The research design, as shown in Figure 4.1 – 
Research Timeline, plots the research journey through a maze of information and ideas. 
Additional principles used to develop this design were set out by Mertens (2003). 
Mertens’ criteria included giving priority to qualitative collection and analysis, 
beginning the integrative process at the data collection stage, and using a 
transformative/emancipatory theoretical perspective. Transformative scholars assume 
knowledge is not neutral but is influenced by human interests; ‘all knowledge reflects 
the power and social relationships within society…an important purpose of knowledge 
construction is to improve society’ (Mertens, 2003, p.4). 
At all times, the researcher strove to remember the practical nature of the inquiry, 
which is spelled out in Lefebvre’s integrative model for social marketing: ‘Behaviour 
change is an incremental process that must start with people’s current realities and the 
suggested behaviours must be relevant to their lives—not a theory or research finding’ 
(2010a). Lefebvre stressed that audience research is the key to understanding the 
‘determinants, context, and consequences of behaviour’ and must be front and centre in 
any research design that hopes to market behaviour change to a target audience (2010a). 
As with any topic where discovery is ongoing, the body of information was 
extremely volatile, changing faster than academic research could trace its route. 
Therefore, the most current secondary information was often found at that 
undiscriminating repository of truth and fiction—the Internet—and required careful 
sifting to locate the credible and relevant nuggets. As a result, the reference list is 
peppered with URLs in addition to the expected books and journal entries. 
Even more current and often more perceptive than published material is primary 
information gathered through interviews and surveys. Those insights can be difficult to 
collect, however, due to cultural and language differences, distance, political and 
professional reticence, and most challenging of all, the stigma associated with 
HIV/AIDS.  
Finally, the unusual combination of terms—social marketing, HIV/AIDS, and the 
controversy about conventional and CAM treatments—mandated simultaneously 
following three distinct research trails, all the while keeping an eye out for intersecting 
paths. 
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Exploratory Research ….. 
Qualitative, secondary & primary: Informal literature review and discussions 
                Formulate initial research aim  Revise overall research questions…… 
        Literature Review (ongoing)……………………………………………………….. 
 Qualitative, secondary information used to ‘frame’ the problem, provide context,  
 source of campaigns for content analysis 
 
          Phase 1 ….. 
 Quantitative, content analysis matrix of 18 campaigns from three  
  countries 
                    Phase 2 ……… 
   Qualitative, semi-structured interviews w/ key informants  
                Phase 3..…… 
     Quantitative, surveys of downstream targets 
     Qualitative, reaction interviews with key  
     informants 
       Phase 4 ….………. 
       Integrative, communication model 
         Analyses, Reflections…… 
        Quantitative, qualitative 
 
Figure 4.1—Research Timeline  
 
At the end of each research phase, the information collected and analysed was 
reviewed to ascertain if any corrections in the methodology were indicated. This 
methodology evolution is discussed in more detail at the end of each methods chapter. 
 
4.5 ETHICS ACROSS TWO CONTINENTS  
Any research that involves human subjects will be exposed to intense scrutiny from 
university research/ethics departments charged with the responsibility of protecting the 
rights and welfare of research subjects. This project required approval by universities in 
two countries.   
Through Sam Houston State University in Texas, The National Cancer Institute’s 
Human Participant Protections Education for Research Teams course was completed 
and IRB (Institutional Review Board) approvals were obtained for human subject 
interviews. (IRBs were obtained initially for interviews with inmates in the Texas Prison 
System and later for interviews with HIV/AIDS key informants in Texas and Mexico.) 
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At Teesside University, the guidelines of the UK Market Research Society (MRS) 
Code of Conduct provided the ethical underpinnings for the project. MRS, the world’s 
largest association for market, social, and opinion research, is considered the ‘voice of 
the profession’ (MRS website, 2010). Its Code of Conduct covers all aspects of 
professionalism in designing and setting up projects using every kind of research 
method. Based on those guidelines, a comprehensive request for ethical approval was 
submitted to Teesside’s Research Ethics Committee, detailing the research protocol to 
be followed. This request assessed such considerations as 
• dealing with possible discomfort, distress or inconvenience to participants  
 and/or researchers, 
• following procedures for respecting confidentiality, 
• addressing potential conflicts of interest, 
• assessing safety risks, and 
• providing explanations and obtaining informed consent from human subjects. 
 After the ethics committees for both the Teesside Business School and the 
University had approved the application, research could proceed along the lines set up in 
the protocol.  
 
4.6 COLLECTING AND ANALYSING SECONDARY INFORMATION 
 For citizens of what is often called the ‘post-information age,’ there is an 
overwhelming amount of data available on any topic imaginable, much of it free for the 
taking. Never before has secondary data been so readily accessed and perhaps never 
before has the plethora of words been so intimidating. Researchers have taken note that 
‘developments in technology have led to a considerable increase’ in the numbers of 
databases and information systems available, particularly relating to health issues 
(Sorensen, et al., 1996, p.435).  There are both advantages and disadvantages to using 
previously collected data.  On the positive side, the information already exists, which 
gives the researcher a ‘head start’ and reduces the amount of time the study might 
require. There is likewise a reduction in the cost of the study. Use of secondary data 
offers the researcher access to generations of information, which can facilitate a broader 
perspective. This use of accumulated knowledge is a way to replicate and confirm 
previous results (Kuhn, 1970), allowing the researcher to participate in the evolution of 
scientific progress by using existing data to help solve new puzzles and anomalies. 
 Disadvantages of secondary data are readily apparent; in addition to the fact that the 
information was not assembled with the specific objective the researcher has in mind, 
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the selection, quality, and collection methods are not under the control of the researcher 
and may be impossible to validate (Sorensen, 1996). Despite those potential 
shortcomings, secondary data’s value is undisputed and is generally the starting point 
for any study. In the case of this study, initial exploratory research on the combination 
of social marketing, HIV/AIDS, and alternative medicine led to a conference 
presentation, presented jointly with a medical colleague, at a UNESCO conference in 
Paris in the autumn of 2005. Feedback at the conference was intriguing, and a thesis 
topic was born. The poster, Curing AIDS: why successful HIV/AIDS treatments are 
unknown to world government policy makers, is shown as Appendix E.1. 
 
4.7 LITERATURE REVIEW 
Using a literature review to summarise and synthesise broad themes is the standard 
initial approach to a research question (Cooper, 1984) and was the starting point for this 
study as well. The researcher considered various ways to organise the review. A 
chronological organisation was not appropriate since there were three intersecting topics 
to consider and the researcher anticipated travelling back and forth in time to explore 
relationships between the topics. A methodological approach was unacceptable since the 
researcher was more interested in the content of the material than in the specific 
methods used to collect the information. A thematic organisation around a single topic 
or issue was not suited to the variety of topics under consideration.  
Instead, the researcher chose to use a two-phased literature review: first a qualitative 
integrative review was used to ‘frame’ the research problem and provide context for 
themes and trends, then a theoretical review was undertaken. The results of these two 
reviews are presented in Chapters 2 and 3 in this thesis. Areas of literature reviewed 
included social marketing (history, theory, and practice), HIV/AIDS (history, scope, and 
projections), social marketing as a tactic for combating HIV/AIDS, health 
communications and pharmaceutical-dominated marketing, health activism, alternative 
and conventional medical approaches to HIV/AIDS, and an overview of media coverage 
of these issues. Literature review continued throughout all research phases as new and 
relevant material became available. 
Information came from all quarters, from chance encounters at conferences and 
seminars, to postings on social marketing listservs, to books and articles that seemed to 
appear at opportune times. Thousands of travel miles were logged, from a fact-finding 
visit to the Institute for Social Marketing at the University of Stirling in Scotland, to 
conferences in Canada, Mexico, Hungary, and Switzerland.  
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4.7.1 Questions addressed during the literature review  
• What is social marketing?   
• What can social marketing accomplish and how does it work? 
• How has social marketing been used to combat HIV/AIDS in both developing and 
industrialised countries?   
• What political, cultural, and economic factors affect dissemination of information 
about HIV/AIDS treatment and prevention?  
• What role have the media played in the HIV/AIDS dialogue? 
•   Which are the primary HIV/AIDS treatments offered by conventional medicine and 
by CAM (Complementary and Alternative Medicine)?  
•  What is the current and projected scope of the disease in Mexico, Uganda, and the 
United States? 
 
4.8 CONTENT ANALYSIS METHODOLOGY 
Content analysis of a number of HIV/AIDS social marketing campaigns was included 
in the research design of this study as a means of deconstructing a group of campaigns 
and identifying both commonalities and important differences that affected their 
effectiveness. 
The content analysis process began by enumerating criteria for selecting a group of 
possible campaigns to consider and then narrowing that list to a manageable sample of 
campaigns for analysis. Initial examination of the campaigns recorded quantifiable 
elements.  Informed by the literature review and by issues raised during the early semi-
structured interviews, a cross-cultural content analysis method was adopted. Cross-
cultural content analysis, as defined by Ahmed (1996), merges traditionally quantitative 
content analysis with qualitative semiotic concepts. Ahmed used a cross-cultural content 
analysis to compare advertising in a highly collectivist and high-context culture (India) 
to a highly individualistic and low-context culture (United States). His research 
indicates analysis of only the verbal content of advertising is not sufficient because 
advertising generally communicates its messages through a marriage of verbal and 
visual content. Although cross-cultural advertising research is relatively new, content 
analysis is well established in the social sciences as an unobtrusive method for 
examining trends through written and pictorial components (Krippendorff, 2004). Since 
content analysis is characterised as empirical, exploratory, and inferential, it was an 
ideal method to organise and examine data from 18 HIV/AIDS social marketing 
campaigns in the first phase of this research. 
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4.8.1 Questions addressed during content analysis research 
• What are specific examples of recent HIV/AIDS social marketing campaigns?  
• What commonalities and unique characteristics can be identified as regards 
purpose, sponsors, target audience, dissemination methods, media mix, messages, 
product promotion, and appeals used? 
 
4.8.2 Choosing campaigns for content analysis 
Each campaign considered for the content analysis had to include the essential 
elements required for a social marketing campaign—a behavioural change goal, 
consumer orientation, facilitating a voluntary exchange with mutual benefits, and use of 
the marketing mix. (See Chapter 2.) 
In addition, campaigns selected must have been actively in use as recently as 2004, 
be connected to one or more recognised HIV/AIDS organisations, and be sponsored by 
a medical entity such as a government health office, a not-for-profit health services 
provider, or a pharmaceutical company.  
Campaigns that matched these criteria were located through online websites, news 
articles, journal articles, published reports, organisation fact sheets, and email responses. 
From about a dozen qualifying campaigns in each country, six each were chosen 
from Mexico, Uganda, and the United States, using a pragmatic and judgemental 
selection based on availability of data and a diversity of campaign purposes, targets, and 
results. 
 
4.8.3 Initial analysis of campaigns selected 
Once the 18 campaigns were selected, the next step was to collect as much 
information as possible. It was important to accumulate a variety of materials for each 
campaign, including images. The materials were then organised in three large binders, 
one for each country. In addition, electronic copies of materials were assembled 
whenever possible. Next, a standardised questionnaire was used to assess content, focus, 
approach, and targeted audiences. Questionnaire to assess prospective campaigns for 
content analysis is shown as Appendix B.1. This 5-page questionnaire was based on 
several content analysis instruments collected from researchers and presenters attending 
the 2006 Social Marketing Advances in Research and Theory (SMART) conference. 
One of the most helpful documents collected at that conference was an acronym-
resistant questionnaire for condom social marketing (Condom social marketing, 2010). 
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From the questionnaires, a summary fact sheet was created for each of the 18 
campaigns selected for content analysis. Sample summary fact sheet for content analysis 
campaign is shown as Appendix B.2. While this initial analysis was underway, a ‘work 
in progress’ poster presentation was presented at the SMART conference in Canada in 
the autumn of 2006.  The poster, Social marketing strategies for combating HIV/AIDS in 
developing countries: examining traditional campaigns, is shown as Appendix E.2.  
To better cope with the volume of accumulating data, a decision was made to focus 
first on the Mexico campaigns in more depth.  Examination of those campaigns revealed 
five important considerations in combating the disease in that country:  
1. Build alliances with diverse groups 
2. Include prevention messages 
3. Address stigma 
4. Focus on cultural norms 
5. Recognise population mobility’s affect on disease transfer 
A presentation based on this initial research was part of a special panel session 
during the AIDS in Culture III conference in Mexico City in the winter of 2006. The 
abstract, Getting the word out: promoting cures through social marketing, is shown as 
Appendix E.3.  The trip to Mexico City offered opportunities to begin a series of semi-
structured interviews with key informants connected to some of the campaigns in 
Mexico and the United States. This is another example of overlapping research phases. 
The diversity of information that was being generated prompted interest in the visual 
and verbal persuasion techniques used in the campaigns as well as the role of 
controversy in promoting behavioural change. An outgrowth of this research was a one-
and-a-half-hour workshop presentation during an American Communication 
Association conference at Taos, New Mexico, in the autumn of 2007. This presentation 
included examples of HIV/AIDS campaigns’ visual and verbal persuasion approaches 
and preliminary reflections on the cultural, political, and economic factors that surround 
the disease. Workshop handouts for the presentation, Motivating change: visual and 
verbal persuasion in HIV-AIDS social marketing, are shown as Appendix E.5. 
The concurrent research process continued: conducting semi-structured interviews 
and collecting additional information on the campaigns under study, both in Mexico and 
in the United States. In the spring of 2008, a USAID-sponsored project, PSP-One 
(Private Sector Partnerships for Better Health) hosted an online social marketing 
conference. The Mexico campaign research formed the basis of a panel presentation that 
included a recorded script and a PowerPoint show (published online) about the vital role 
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of partnerships in HIV/AIDS social marketing efforts. The online presentation, Taking 
taboo topics public:  how social marketing partnerships combat HIV/AIDS in Mexico, is 
shown as Appendix D.1.  
This virtual presentation led to additional interview contacts, including the director of 
Population Services International in Mexico. Later that spring, a peer-reviewed paper 
featuring the Mexico campaigns was presented at the VII International Congress on 
Public and Non-profit Marketing in Szeged, Hungary, and published in the conference 
proceedings. The paper, Creating a culture of change: social marketing’s global 
initiative against HIV/AIDS, is shown as Appendix D.2. 
In addition to the expanding sources of secondary and primary information, 
monitoring social marketing listservs proved to be a valuable means of tapping into the 
ongoing dialogue about the theory and practice of social marketing. These listservs also 
posted conference and publication opportunities.  International calls for proposals were 
highly competitive.  One of the more rigorous contests for presentation slots was for the 
biennial International AIDS conference. A poster featuring three of the social marketing 
campaigns directed toward women was presented in Mexico City in August of 2008 and 
the presentation abstract was published online by the International AIDS Society (IAS). 
The poster, Until AIDS do us part: social marketing campaigns empower women at risk 
in Uganda, Mexico, and the United States, is shown as Appendix E.6 and the abstract is 
shown as Appendix D.3.  
To avoid being overwhelmed by this wealth of information, cross-tabulation 
matrixes were developed to compare the 18 campaigns. A matrix format was chosen 
because it can accommodate a range of information; it is capable not only of tabulating 
those attributes that can be easily quantified (e.g. audience, media mix, sponsors), but 
can also look at framing and cultural relevance (Porter, 2002). The source of health 
message frames for the matrix came from Beaudoin’s multilevel analysis of HIV/AIDS 
posters from sub-Saharan Africa. Beaudoin used consequences, prevention, self-
efficacy, sources of HIV/AIDS, benefits, and barriers (2007). Those same message 
frames were used in the content analysis matrix for this project. This diversity of 
comparative information had the potential to provide a framework for making 
predictions about the effectiveness of campaigns, which would be extremely important 
as research progressed. The two resulting matrices were presented in poster form at the 
First German-Austrian Swiss AIDS-Congress (SODAK) in St. Gallen, Switzerland, in 
June of 2009.  The poster was published on the SODAK website, and the abstract was 
published in a special issue of the European Journal of Medical Research. 
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The poster, Working toward a world without AIDS: how social marketing inspires long-
term cultural change, is shown as Appendix D4.1, and the abstract is shown as 
Appendix D4.2.  
 
4.9 EVOLUTION OF METHODOLOGY 
 After selecting the campaigns and collecting and analysing data, it became clear the 
research should be more narrowly focused on two countries. This was due to the volume 
of material collected, the need to set some time limits, the repetitive nature of much of 
the information from the Mexico and Uganda campaigns—especially as related to 
condom social marketing efforts—and the availability of contacts and resources in 
Mexico and the United States. Therefore, after the content analysis was completed, 
Uganda was removed from the remaining phases of the project. 
On the other hand, the original research scope limited the social marketing 
campaigns in the United States to those based in the southern part of the country. It soon 
became obvious, however, that to have a representative sample, it would be necessary to 
include national initiatives. However, one regional campaign that met all selection 
criteria was included, The New Faces of HIV/AIDS in Houston, since it won national 
recognition and inspired campaigns in other cities. Additionally, Houston’s rates of HIV 
infection were twice the national average, with black people accounting for more than 
half of the new infections each year (AVERT, 2010a), so the city is under national 
scrutiny by the Centers for Disease Control and Prevention (CDC).  
In Chapter 5 the cross tabulation matrices are presented. Commonalities and 
differences for the 18 HIV/AIDS campaigns in Mexico, Uganda, and the United States 
are discussed.  
At the end of Chapter 5, a case study was added to the original research design as a 
way to demonstrate the fusion of information from the three topics under study and to 
provide a bridge to the Phase 2 research. Case studies are frequently presented in social 
marketing literature (National Social Marketing Centre, Showcase, c2010) and are 
widely used in studies of social groups and ‘consumer tribes’ in particular since case 
studies are considered an effective way to examine a group without control or 
manipulation (Mitchell & Imrie, 2011). 
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CHAPTER 5 
CONTENT ANALYSIS 
DECONSTRUCTING 18 HIV/AIDS SOCIAL MARKETING CAMPAIGNS 
 
5.1 INTRODUCTION 
This research phase created an important bridge between the secondary and primary 
data collection as well as an opportunity to integrate quantitative and qualitative 
approaches. Although quantitative content analysis when used alone is limited to 
counting operations, it is a useful technique for examining and organising volumes of 
information in a systemic fashion.  When combined with qualitative methods, however, 
content analysis is the route to drawing inferences that can be corroborated using other 
research methods (Stemler, 2001). In this case, collecting and categorising significant 
amounts of data provided a framework both for direct comparison of quantifiable 
categories and for identifying more elusive trends and patterns.  
With three target countries and dozens of campaigns underway in each, a massive 
amount of information was available through secondary sources alone. Data collected 
during the literature review about current political, cultural, and economic factors in the 
target countries was vital to understanding the environment in which HIV/AIDS social 
marketing takes place. (See Chapter 2.) 
For greater manageability, the wealth of data assembled for content analysis was 
divided into two broad groups: campaign design and campaign implementation. Matrix 
categories were informed by literature review of commercial and social marketing 
theories, techniques, and practices. (See Chapter 3.) The cross tabulation matrices 
provided an easily referenced visual comparison of the 18 campaigns. Once the matrices 
were complete, it was possible to make direct quantitative comparisons. These 
comparisons led to an integrative qualitative analysis that identified emerging patterns 
and trends. To demonstrate how an HIV/AIDS programme can use social marketing to 
promote gender equity, an in-depth case study is presented at the end of this chapter. 
 
5.2 AIMS AND OBJECTIVES 
• Assimilate the accumulated information about the HIV/AIDS landscape in the 
three countries under study 
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• Using established criteria, select a representative group of campaigns for Mexico, 
Uganda, and the United States 
• Analyse the campaigns using comparative matrices 
• Identify emerging themes and implications 
• Use these findings to inform subsequent research phases 
 
5.3 QUESTIONS ADDRESSED DURING THIS RESEARCH PHASE 
• What are specific examples of recent HIV/AIDS social marketing campaigns in the 
target countries? 
• What commonalities and unique characteristics can be identified as regards 
purpose, sponsors, target audience, dissemination methods, media mix, messages, 
product promotion, and appeals used? 
 
5.4 THREE COUNTRIES, WORLDS APART 
A sample of six HIV/AIDS social marketing campaigns was selected for each of the 
three countries initially targeted for this study—Mexico, Uganda, and the United States. 
Although commonalities exist in the HIV/AIDS social marketing campaigns 
implemented in these three countries, there are significant differences in their economic, 
political, and cultural situations.   
 
5.5 CAMPAIGN SELECTION  
Criteria for campaign selection consisted of 1) inclusion of the essential elements 
that define social marketing campaigns, as discussed in Chapter 2; 2) recency, the 
campaign must have been in active use as recently as 2004; 3) available data, through 
secondary and primary sources; 4) involvement by at least one recognised HIV/AIDS 
organisation; and 5) sponsorship by a medical entity such as a government health office, 
a not-for-profit health services provider, or a pharmaceutical company. Each country 
had numerous HIV/AIDS social marcoms from which to choose but making sure the 
campaigns selected for this study met the above criteria required careful documentation 
using a standardised questionnaire. (See Appendix B.1.) Once the selection process was 
complete, the three groups of campaigns met the goal of the question:  
What are specific examples of recent HIV/AIDS social marketing campaigns in the 
target countries? 
The 18 campaigns identified for further study provided an interesting variety of 
styles and approaches but also demonstrated considerable overlap in categories such as 
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target audiences, purpose, and implementation. A summary of the 18 campaigns used for 
the content analysis is shown as Appendix B.3. 
 
5.6 EXAMINING THE CAMPAIGNS 
Content analysis of the 18 campaigns focused on the question: 
• What commonalities and unique characteristics can be identified as regards 
purpose, sponsors, target audience, dissemination methods, media mix, messages, 
product promotion, and appeals used? 
For ease of presentation, the items of analysis were divided into two groups: 1) 
Crafting the Message (Figure 5.1) and Disseminating the Campaign (Figure 5.2). In 
keeping with content analysis methodology, the categories were established using 
emergent coding and were mutually exclusive and exhaustive (Stemler, 2001). (See 
Chapter 4 for additional discussion of the methodology.) 
Matrix A focused on the design of the campaigns, beginning with such basic details 
as dates, message, purpose, audience, and sponsors/partners. This information was 
available through campaign materials or publicity about the campaigns, and as needed 
from marketing experts associated with the campaigns. The underlying foundations 
were also categorised, including frames for the messages, theoretical underpinnings, and 
references to cultural roots. These categories were developed and coded based on 
literature review of similar studies, as described in Chapter 4. The last category on this 
matrix was a simple dichotomous question regarding whether the campaign was adapted 
for additional use, either in that country or in other countries.  
Matrix B used commercial marketing techniques to categorise dissemination tactics 
for the campaigns, including the media mix (both traditional and new media), products 
(if any) distributed through the campaign, whether interventions or special events were 
used, the kinds of spokespersons recruited to present the campaign message, and 
whether there was a clear ‘call to action’ (a focused command to the audience to act). In 
light of findings by recent cross-cultural advertising studies (See Chapter 4.), the matrix 
categorised visual as well as verbal campaign approaches. In recognition of marketing’s 
fundamental question—Were goals met?— outcomes, as provided by campaign 
evaluation materials or representatives, were recorded. Since some campaigns were still 
ongoing at the time of the content analysis, long-term results were not available. 
HIV/AIDS acronyms used in the matrix—such as MSM, PLWHA, and CSW—are 
defined in the Transdisciplinary Glossary. (See pp.viii-xvii.) 
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Figure 5.1— Cross tabulation matrix comparing 18 HIV/AIDS campaigns: 
Crafting the Campaign 
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5.7 SUMMARY OF FINDINGS FOR MATRIX A 
Name: The campaign name, the first column in each matrix, was the official name for 
the campaign, which appeared on all materials and in all media. This slogan was 
generally short, catchy, and the defining identifier for the campaign. 
 
Dates: All campaigns were selected for currency—active at least as recently as 2004—
to make them more comparable. The longest running campaign in the 18 selected for 
study was Mexico’s Programa Hombres, which began in 1999 and has continued to be 
updated and adapted for use in Mexico as well as in many other countries. Half of the 18 
campaigns had been adapted or updated, so they were in use at the time of this analysis. 
Even campaigns such as Tú No Me Conoces and New Faces of HIV, which had more 
limited timeframes, influenced subsequent social marketing efforts to target audiences.  
 
Message: Each campaign message was unique, respectively exhorting audiences to 
abstain from sex, build monogamous relationships, change stereotypical thinking about 
women and gays, practice safe sex, protect unborn children from HIV, get tested for 
HIV, contribute to efforts to find solutions, and recognise global humanity.  The 
campaigns showed a broad mix of messages, ranging from individualistic behaviour (get 
tested, abstain from sex, be faithful) to altruistic group behaviour (solidarity among 
mankind, change the world).  Despite these differences in the primary message, central 
to each campaign there were universal prevention and anti-stigma themes, combined 
with a commonality of general purpose, namely to stem the tide of the HIV/AIDS 
epidemic. 
 
Purpose: Using emergent coding, marcom purposes were divided into 1) seek testing, 2) 
stigma/discrimination, 3) prevention, 4) cultural changes, 5) political mobilisation, and 
6) donations/volunteers. Although each campaign had a primary purpose, most also had 
secondary, or related, purposes as well. For example, cultural change is central to most 
HIV/AIDS campaigns since cultural norms are widely recognised as a principal factor in 
spreading infection. Likewise, reducing stigma and discrimination is an underlying goal 
of most HIV/AIDS initiatives. Some campaigns had both short-term and long-term 
purposes, such as those with a prominent ‘get tested’ message that also sought to reduce 
stigma long-term by creating a dialogue about HIV/AIDS. Purposes ranged from 
immediate and specific (such as to get donations/volunteers), to generational (gender 
equity, for example). 
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Audience: Audiences were divided by Upstream or Downstream, Female or Male, and 
by age ranges. Also, when campaigns targeted particular lifestyle groups, that 
information was entered into the matrix. All 18 campaigns had a downstream audience 
and seven also targeted upstream decision makers. All but one of the Uganda campaigns 
was specifically aimed at downstream audiences. Nine of the campaigns narrowed their 
targets even more, focusing on specific lifestyle groups. As previously discussed in 
Chapter 2, social marketing cannot motivate long-term change by appealing to 
downstream audiences alone, so social marketing campaigns usually have underlying 
social change objectives. Some of the campaigns, however, were specific in targeting a 
particular niche audience. Three of the U.S. campaigns targeted broad audiences and did 
not focus on particular age, gender, or lifestyle groups.  
 
Sponsors: Partnerships ranged from local to international, and sponsors included a mix 
of corporate, government, not-for-profit, and pharmaceutical or medical companies/ 
organisations. Every campaign involved multiple entities. Five campaigns had support 
from local, national, and international groups. Half of the campaigns had partners from 
at least three kinds of organisations. 
 
Frames: The six message frames used here have a general basis in public health theory 
and are specifically based on an assessment of HIV/AIDS posters (Beaudoin, 2007). 
The most common frame used was prevention (11), followed by self-efficacy (9), 
sources of HIV/AIDS (6), benefits (5), consequences (3), and barriers (2). (Most 
campaigns used more than one frame.) (For more about framing, see Chapter 2.) 
 
Theory: As explained in Chapter 3, social marketing draws on theories from several 
disciplines and, in some cases, seems to disregard formal theories altogether. 
Determining which theories might underlie the campaigns was the most difficult 
category to code in this matrix and involved two researchers carefully examining the 
campaign designs against established definitions of the most common theoretical  
models for health communication. The most common behaviour change theory used in 
this group of campaigns was Social Cognitive (7), followed by Health Belief (4), 
Diffusion of Innovation (3), Reasoned Action (3), and Stages of Change (1).  
 
Roots reference: Every campaign could be said to have at least a passing reference to 
cultural roots in its makeup, but in some campaigns, the roots reference was more 
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integral to the campaign and more pervasive throughout the campaign.  Roots references 
ranged from recognition of long-standing cultural norms such as cross-generational sex 
to use of language, attire, and symbols, to selection of spokespersons. Further analysis 
of the strength and influence of roots references is beyond the scope of this study. 
 
Adapted: More than half of the campaigns (10) were considered successful or important 
enough to warrant adaptation for use in other countries or for updating and re-use in the 
same country.  
 
5.7.1 Commonalities vs. differences in campaign design 
These 18 campaigns shared a number of common concerns and objectives, but each 
had a unique theme and a distinctive focus and approach. It was important to 
acknowledge both the commonalities that linked these campaigns as well as the unique 
elements that set each initiative apart from its neighbours. Since these are all HIV/AIDS 
social marketing initiatives, each used the tools of social marketing and spoke the 
language of HIV/AIDS. However, each campaign employed a customised toolbox and 
had a distinctive voice and inflection.  
In keeping with social marketing practices, each campaign sought to motivate 
changes in behaviour, whether it be to discontinue unhealthy behaviour such as multiple 
sex partners or to adopt healthy behaviour such as fidelity. In some cases, the 
exhortation was to change deep-seated attitudes and beliefs, such as rethinking 
masculinity or considering the idea that common DNA connects all human beings. 
Audiences were variously asked to make changes for the good of themselves, those they 
loved, and society as a whole. 
The primary short-term purposes for the campaigns varied, but all had at their core 
the long-term goal of stopping the spread of HIV/AIDS. Appeals also varied widely, 
from personal (affordable condoms allow you to live the ‘good life’) to global (help 
wipe out poverty and disease). The only agreement was that there is not one single 
‘right’ way to stop the spread of the disease. This group of campaigns, despite the 
common criteria for their selection for this content analysis, nevertheless demonstrated 
the international divergence of approaches and philosophies about combating the 
pandemic.  
The majority of the campaigns had clearly defined target audiences, and it can be 
noted that those campaigns were the ones most likely to be adapted and re-used, 
suggesting precise targeting may contribute to perceived effectiveness. It also was 
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apparent that those campaigns with a wide variety of sponsors/partners tended to be 
long-lived and adapted for repeated use, due in part to the collective resources those 
collaborations provided. Clearly, campaigns with numerous partners have more political 
and financial resources. Also, international organisations with a proven track record for 
HIV/AIDS social marketing are more likely to receive grant funding than smaller, 
unknown groups.  
In terms of framing, the most common frame used was prevention, closely followed 
by self-efficacy, which indicated that individual behavioural change was a priority. The 
three campaigns with the broadest target audiences were all U.S. campaigns with 
altruistic messages and goals. Despite extensive support and outstanding production 
values, however, two of those campaigns were short-lived (Be the Generation and We 
All Have AIDS) and have not been adapted for re-use. The ONE campaign has been 
successful in attracting more than 100 partners and signing up over 2 million members 
since 2002, but this initiative, although it set out to reach a broad audience, has launched 
hundreds of specialised promotions for specific groups, such as college students. 
Although cultural roots appeared in every campaign, those cultural links were not 
always appropriate or well accepted by the target audience. For example, the I Am 
African campaign sought to convey a cultural message by showing war paint on the 
faces of numerous international celebrities. Unfortunately, this approach angered many 
and created a firestorm of controversy; detractors felt so strongly about the campaign 
that they created cynical anti-ads.  The difficulty of using cultural references effectively 
while avoiding offensive stereotypes was sometimes a difficult balance and not all of 
these campaigns were able to find that compromise. 
However, if adaptation for further use is an accurate measure of success, some of 
these campaigns have been very effective.  
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Figure 5.2—Cross tabulation matrix comparing 18 HIV/AIDS campaigns: Disseminating the Message 
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5.8 SUMMARY OF FINDINGS FOR MATRIX B 
Media categories were grouped as traditional or new media, and then subdivided 
into media outlets based on an initial examination of the media mix in the campaigns 
collected during the pre-selection phase. 
 
Traditional media: Subdivided into six areas: 1) print ads, 2) printed materials, such as 
brochures or booklets, 3) out of home (including billboards, posters, transit ads, flyers), 
4) direct mail (not email), 5) radio, and 6) television. Every campaign used at least one 
medium from this category; six campaigns were heavy users of traditional media, 
incorporating four or more types of media. 
 
New media: Subdivided into five areas: 1) website, 2) YouTube, 3) email, 4) social 
media, and 5) other (e.g. Bluetooth viral marketing). Three campaigns used three or 
more of these techniques. All but one campaign used a website created specifically for 
that initiative. A majority (12) of the campaigns used only one medium in this category, 
usually the website. 
 
Products: Items produced or branded particularly for the campaign were used in 11 
campaigns. The most common was condoms (7 campaigns). Some items were given 
away through sponsor support, but others were sold at reduced prices. 
 
Intervention: Interpersonal contact was an important element of 12 campaigns, ranging 
from telephone hotlines to peer education workshops to interactive games. 
 
Events: Sixteen campaigns incorporated special events into their promotion mix. These 
included entertainment venues such as dances and political events such as rallies on 
college campuses. 
 
Speakers: Spokespeople prominently used in advertising and other campaign media 
were divided into 1) celebrities, 2) community leaders, 3) anonymous, 4) audience 
members, 5) media personalities, and 6) actors. Media personalities and celebrities were 
the most popular spokespeople (7 campaigns). Three campaigns featured community 
leaders and one used community leaders who were also part of the target audience. Four 
campaigns used actors or anonymous models. 
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Visual: Campaign materials were classified either as realistic, abstract, or cartoons. 
Fifteen campaigns used realistic depictions; one used abstract visuals, and two used 
cartoon characters. 
 
Verbal: Campaign materials were divided by messages presented in the first, second, or 
third person. Eleven used first person, six used second person, and three used third 
person. (Two campaigns used mixed verbal approaches.) 
 
Call to Action: Every campaign asked the audience to take action of some sort, from 
specific (abstain from sex) to general (be more tolerant of other peoples’ differences). 
Looking in more depth at the calls to action was beyond the scope of this project, but 
could offer interesting insights and cross reference opportunities. 
 
Outcome: This category, too, offers a wealth of future analysis possibilities. For the sake 
of this study, outcomes were classified as 1) ongoing (campaigns still active)—six 
campaigns, 2) quantified (specific results have been recorded)—seven campaigns, 3) 
uncertain (results not clear or were not evaluated)—three campaigns, and 4) not 
tabulated (evaluations underway but not complete)—two campaigns. 
 
5.8.1 Commonalities vs. differences in disseminating the campaign 
In looking at the media mix, traditional media dominated most of the campaigns, 
most particularly those in Mexico and Uganda that targeted downstream adults. The 
three Mexico campaigns aimed at youths (Menos Etiquetas, Programas H and M) used 
new media, but also included significant amounts of traditional media in their overall 
mix. Of the U.S. campaigns, only MTV Think and ONE used more new media than 
traditional media. These choices were apparently based on audience access, preferences, 
and literacy.  
The most common product was condoms, which could be cross-referenced to 
pharmaceutical sponsorship and prevention messages.  The Afford Good Life campaign 
was built around sales of condoms, and the PMTCT (Prevention of Mother to Child 
Transmission) campaign relied on Nevirapine and test kits from medical partners. The 
ONE campaign reinforced its message through branded items (bracelets, tee shirts) that 
were sold on the website. 
Special events and interventions were part of the promotion mix for most of the 
campaigns, pointing to the increasing importance of innovative ‘edutainment’ and 
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interpersonal communication. Many of the campaigns focused on ways to disseminate 
their message in casual, fun settings. They also provided anonymous ways to gain 
information, such as through hotlines. The popular interest in celebrities was reflected in 
the frequent use of media personalities and other recognisable spokespeople.  The New 
Faces of HIV campaign went one step further, showing HIV-positive community 
members in printed materials such as ads, posters, and direct mail pieces. This technique 
resulted in considerable publicity for the campaign, but also proved so painful for some 
of the people who had agreed to appear in the campaign materials that those individuals 
secluded themselves and declined to continue to act as spokespeople for the campaign. 
Realism dominated the visual approach for the campaigns, whether they were 
images of well-known people, as in We All Have AIDS, the anonymous models in 
campaigns such as ABCs or Be the Generation, or telenovas (soap operas) that 
dramatised HIV issues. Notable exceptions were the three Mexico campaigns aimed at 
lower income youths, which used eye-catching abstract images (Menos Etiquetas) and 
cartoons (Programas H and M) as part of their media mix. There was a consistent effort 
to mix HIV/AIDS information with fun, games, humour, and drama. 
Verbal messages were predominately presented in the first or second person, which 
further indicated a desire to make the message personal and immediate and integrate it 
into everyday life. 
Overall, the media and promotion mix used a wide variety of techniques to make 
HIV/AIDS a topic that was interwoven into people’s lives at every turn. This once-taboo 
topic was inserted into every kind of media, event, or social interaction people might 
encounter in their everyday lives. It then became difficult to avoid the onslaught of 
messages, especially for those who were part of the target audience. The goal of the 
message approach was to woo the audience into seeking out those communication 
channels that contained HIV/AIDS messages. The audience benefited by being 
entertained, and, social marketers hoped, were motivated to adopt healthy behaviours.  
The most recent campaign of the group to target young people (Menos Etiquetas) and 
the One campaign went beyond using passive media and incorporated new media, 
combined with permission marketing, to urge the target audience to actively seek out 
information about HIV/AIDS. 
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5.9 CONCLUSIONS: PATTERNS AND TRENDS  
All campaigns were influenced by—and in some cases limited by—cultural, 
economic, and political realities in the country where they were being disseminated.  
But an integrative qualitative examination yields several trends.  
First, collaboration was essential; each campaign involved multiple organisations 
and community groups designed to build participation in and acceptance for individual 
and policy change. From a worldview, each country’s HIV/AIDS problem has far-
reaching implications. Recognising that expanding HIV/AIDS populations will 
devastate the global economy, governments in both developing and industrialised 
countries, in conjunction with pharmaceutical companies such as Pfizer, have launched 
a variety of organised offensives, which include political commitment, law enforcement, 
government policy, social marketing, and community mobilisation (Pfizer, 2006). 
This global cooperation encourages alliances such as those forged to support the 
campaigns in this study. From a practical standpoint, these partnerships are necessary 
because social marketers do not have the luxury of the kinds of resources enjoyed by 
commercial marketers. Rather than work in the commercial spirit of competitive 
marketing, the strategy is to build a network of groups with common goals and varied 
resources.  
The Investing in People campaign was a good example of building local, national, 
and international alliances with common goals. Investing in People was centred in 
Mexico City, where the country’s most HIV/AIDS cases are found. A half-dozen 
organisations joined forces for this five-year campaign. A key technique was personal 
communication through workshops and conferences. Trained female advocates and 
local HIV/AIDS leaders openly discussed sex before marriage, a once-forbidden topic in 
this strongly Roman Catholic country.  
Secondly, most HIV/AIDS campaigns have a stronger focus on prevention messages 
than on treatment information, with condom use—promoted as ‘safe sex’—being a 
frequent tactic. In keeping with its inclusive approach, social marketing assistance 
usually involves procuring and distributing pharmaceuticals, over-the-counter drugs, 
and condoms. It also supports capacity building and financial sustainability programmes 
for non-government organisations (NGOs) or for-profit companies (USAID, 2005b). In 
fact, promoting the use of condoms is such an integral part of HIV/AIDS social 
marketing that the practice has its own acronym: Condom social marketing (CSM), 
which is central to the Afford Good Life campaign strategy. This five-year health  
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initiative promoted Protector brand condoms, Pilpan oral contraceptives, and Inject 
injectable contraceptives at subsidised rates.  
In recognition of cultural obstacles, the campaigns each address aspects of stigma 
and traditional cultural norms. USAID, whose infectious disease objectives are designed 
‘to contain and reduce HIV/AIDS in vulnerable populations,’ focuses on reducing 
barriers to behaviour change and thereby preventing the HIV/AIDS epidemic in 
countries such as Mexico from becoming generalised to the population at large (USAID, 
2005a). It is generally recognised that changing how people view gender roles and 
erasing widespread prejudice against gays will be necessary to effectively combat 
HIV/AIDS. HIV has been termed an ‘underground epidemic’ because of stigma and 
discrimination associated with the disease. Reducing stigma and discrimination 
experienced by sex workers, gay men, men who have sex with men, drug users, and 
people living with AIDS is the central purpose of the VIDA Digna (Life with Dignity) 
campaign, funded by GlaxoSmithKline to urge tolerance and acceptance of people’s 
differences. 
Modern-day mobility and lifestyle patterns are also considerations in crafting social 
marketing campaigns for at-risk populations, especially for migrant populations or in 
border areas. Studies of highly mobile groups such as truck drivers, seasonal employees, 
and sex workers have identified travel or migration as a factor related to increased 
HIV/AIDS prevalence. Higher rates of infection are also frequently found along 
transport routes and in border regions. In addition, migration and mobility also increase 
vulnerability to HIV/AIDS for the partners at home (Population mobility, 2001, p.4). 
The Tú No Me Conoces (You Don’t Know Me) campaign used Spanish-language media 
to promote awareness of HIV risk and testing for Latinos living on the California-
Mexico border. 
Matching media choices to the target audience was vitally important, as analysis of 
these 18 campaigns suggested. Multiple media in more than one language was used to 
ensure the message reached its intended target.  Media choices needed to reflect 
audience access and levels of literacy.  Also, audience preferences for formats such as 
edutainment media like telenovas had to be considered when selecting the media mix. 
Marketers who created these HIV/AIDS campaigns needed to keep in mind the dual 
role of controversy—both cultural controversy and moral controversy—due to the 
disease’s connections to sexual practices, ethnic background, and gender roles. Those 
who did not sufficiently pre-test their campaigns learned a painful lesson when 
campaigns were criticised as racist, sexist, or anti-religion. Other outside influences, for 
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example funding tied to issues such as abstinence, influenced the marketers’ decisions. 
Every campaign design had to consider the fact that social marketing messages about 
HIV/AIDS, the role of stigma and culture, and the economics of the global medical 
market form a complex environment that influences public discussion about topics once 
taboo in ‘polite’ society (Massingill, 2008).  
Overall, this content analysis yielded reams of useful information that addressed the 
research questions for this research phase and moved the project forward. A 
representative sample of recent HIV/AIDS campaigns was located, selected according 
to established criteria, and compared using matrices that facilitated identification of 
campaign design elements and dissemination methods. The selection process itself was 
an important part of this research phase, demonstrating that there were numerous 
campaigns in the three targeted countries from which to select.  Because the 18 
campaigns that were selected all had to meet a list of pre-determined criteria, they 
already had much in common, but there were distinctive strategies and approaches that 
made their comparison worthwhile. Setting up the matrices for comparison was another 
major step in this research phase; this visual format expedited examination of a large 
amount of data. 
Tables 5.1 and 5.2 summarise, respectively, the commonalities and the differences 
of the 18 campaigns.  
 
1. Seek to motivate changes in behaviour 
2. Long-term goal is to curb HIV/AIDS infections 
3. Most common frame: prevention 
4. Include cultural roots (but not always appropriate to audience) 
5. Traditional media dominate media mix 
6. Most common product: condoms 
7. Edutainment and interpersonal communication included in promotion mix 
8. Realism is dominate visual approach 
9. 1st or 2nd person verbal approach is most used 
10. Mix HIV messages with fun, games, humour, and drama 
11. Campaigns reflect alliances with multiple organisations 
12. Messages address stigma 
Table 5.1—Summary of commonalities in 18 campaigns 
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1. Appeals vary (ranging from personal to global) 
2. Target audiences vary (range from narrow to broad) 
3. Short-term goals (range of specific purposes) 
4. New media, when used, was primarily to reach youth audiences 
5. Abstract images and cartoons were directed to lower income youth targets 
6. Each campaign was influenced by culture, economics, and political realities 
in the country where it was disseminated 
7. Media selected and language(s) used reflected the target audience’s access 
and literacy 
Table 5.2—Summary of differences in 18 campaigns 
 
The content analysis, in combination with the ongoing literature review, created a 
bridge to the next research phase: collecting and analysing primary information. Chapter 
6 summarises the methodology used to collect and analyse both qualitative and 
quantitative primary data for the next part of this study. 
_____________________________ 
 
5.10 CASE STUDY  
To add the richness of detail that underlies greater understanding, a noteworthy 
campaign with international significance was investigated in greater depth through 
additional secondary research, combined with personal contacts and semi-structured 
interviews. The result was a case study that looked beyond the statistics at how unique 
cultural and political issues were addressed to achieve campaign goals. This case study, 
a combination of secondary and primary sources and a fusion of quantitative and 
qualitative methods, offers valuable insights into the complex world of HIV/AIDS 
social marketing and marks a transition to Phase 2 research. The campaign explored in 
the case study—directed to young men in Mexico—was judgementally selected to 
showcase how social marketing is used in HIV/AIDS prevention. The campaign, 
Programa Hombres, is widely considered one of the most successful gender equity 
interventions and has been adapted for use in more than 20 countries around the world. 
Additionally, the campaign has been in use long enough to have a track record that 
provides valuable evaluative data. The unabridged version of this case study was 
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published in 2011 in an international social marketing text, Social marketing for public 
health: global trends and success stories.   
Chapter 4, Love, sex, and HIV/AIDS: using social marketing to redefine gender norms 
among Mexican youth, is shown as Appendix D.5. 
This campaign is exemplary in several ways. It has been in continuous use since 
1999 and has met or exceeded goals and expectations. The campaign used audience 
research to craft a culturally appropriate approach and used a mix of social marketing 
techniques to disseminate a consistent message. It also has evaluated and measured 
behaviour change effected by the campaign. Programa Hombres is presented here as a 
representative HIV/AIDS social marcom that uses the tenets of the discipline to promote 
behavioural change. 
 
Gender equity—Programa Hombres, Mexico 1999-present 
Background 
Links between traditional gender attitudes and the spread of AIDS prompted a 
partnership of NGOs to develop Programa Hombres. Since 1999, this initiative has been 
used in more than 20 countries, including Mexico, to persuade young Latino men to 
question traditional norms related to manhood.  
Programa Hombres is designed to change how young men view gender roles and to 
urge them to consider the costs of stereotypical definitions of masculinity and femininity 
as well as the benefits of changing health-threatening behaviours. Program H’s 
conceptual framework began with a ‘mapping’ of masculinity to understand how men 
view what it means to be male. Men who were inclined to be more gender-equitable in 
their attitudes provided insights in the best ways to change the prevailing views about 
manhood. 
Target Audience 
Program H targets young men 15 to 24, mostly from low-income groups. Many of 
these Mexican teens are already sexually experienced according to a 2001 report on 
reducing HIV infection among youth. This study of 2,064 Mexican students found that 
24% of the males and 7% of the females were sexually active, with over 90% of those 
teens reporting sexual debut before age 15 (Stewart, et al., 2001, p.12). 
Campaign Objectives 
Knowledge objectives: The initiative was designed to first provide opportunity and 
information that would spark a thoughtful assessment of life choices: 1) question 
traditional social norms related to manhood, 2) reflect on the advantages of more 
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gender-equitable behaviours, and 3) re-think what it means to be a man (Institudo 
Promundo, 2008a). 
Belief objectives: Since research indicated young men generally decide and control 
how and when young women have sex, promoting gender equity, with a strong focus on 
sexual health, was crucial.  
Program H was designed to change traditional beliefs that  
•  men should initiate sexual activity early in life; 
• men should have multiple sexual partners; 
• men should maintain control over their female partners; and 
• unsafe sex is more enjoyable than safer sex (Institudo Promundo, 2008a). 
Behaviour objectives: Translating these cultural shifts into new behaviours was the 
key to both short- and long-term successes for the programme. Specifically, Program H 
sought to reduce the number of sexual partners and increase the use of condoms when 
both partners agreed to have sex. In the long term, however, Program H aims to create a 
culture where both sexes 1) adopt more gender-equitable lifestyles, 2) make healthy life 
choices, and 3) build respectful relationships (Institudo Promundo, 2008a).  
Positioning  
For the young men targeted by Program H, the challenge is to redefine ‘what it 
means to be a man’ (Nascimento, 2005). Programa Hombres repositions manliness to 
include responsible monogamous relationships, safe and loving sex, and respect for 
women. 
Campaign strategies 
Successful campaigns speak to the target in culturally sensitive ways. In this 
situation, the challenge was to present the messages in words and images that honour 
the culture while working to change the very pillars of centuries-old societal norms. 
Involving Program H’s target audience at every stage was a key strategy on the path to 
accomplish this cultural balancing act. Youths from two low-income communities of 
Rio de Janeiro developed the campaign materials, which have been adapted for use in 
other Latin American countries as well as in India and Tanzania, and more recently, the  
Balkan region in Europe. From radio spots to postcards, and from YouTube videos to 
special events, campaign materials promote a new male identity that is ‘cool,’ 
responsible, open to conversation, and respectful toward his partner. 
Intervention activities for each campaign consisted of two main components: 1) a 
field-tested curriculum with a manual and an educational video for promoting attitude  
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and behaviour change, and 2) a lifestyle social marketing campaign for promoting 
changes in community or social norms (Nascimento, 2005). 
A curriculum product to promote change 
The educational techniques, manuals, and accompanying videos that make up the 
curriculum for Program H are termed ‘social technologies,’ a concept developed by 
Instituto Promundo and defined as ‘all educational material, methodological procedures 
or tested techniques, validated and with a proven social impact created with the aim of 
solving a social problem’ (Instituto Promundo, 2008b). 
The curriculum provides a framework to examine gender issues, a 20-minute 
cartoon video, and 70 activities organised under five themes. Activities include role-
plays, brainstorming exercises, discussion sessions, and individual reflections for small 
groups. The intervention is designed to be used over a six-month period for a total of 
120 hours. To serve as gender-equitable role models for the young men, adult men 
facilitated the exercises (Pulerwitz, et al., 2006, pp.12-13). 
Pricing strategies 
Making the programme materials as widely available as possible, especially to high-
risk groups, is the overriding consideration in setting prices. The five-volume manual, 
available in English, Spanish, and Portuguese, can be downloaded at no charge from 
Instituto Promundo’s Web site, or it can be ordered in a bound volume for US$50. The 
20-minute cartoons for both programmes, with their accompanying discussion guides, 
are offered on VHS for US$15 or on DVD for US$20 (Instituto Promundo 2008a). 
Place strategies 
With more than 77% of Mexico’s population living in cities, most national HIV 
prevention programmes focus on urban populations (USAID, 2005a). Young men are 
less likely than young women to seek health services, making it difficult to reach them 
with information and other services, so Program H takes information to them in the 
communities where they live. Entertainment venues such as bars, community dances, 
and parties proved to be effective ways to reach the target audience. In addition, the 
Mexican Ministry of Health adopted Program H and 10,000 copies were printed with  
the government’s seal, lending official credibility to the initiative (Instituto Promundo, 
2008a). 
Promotion strategies 
Unlike many developing countries where social marketing is used to combat 
HIV/AIDS, Mexico has a high average literacy rate; almost 93% for men and 90% for 
women (U.S. Department of State, 2008). As might be expected, young people are more 
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likely to use the Internet, although of Mexico’s 110 million people, only about 20% 
have access to the Web (Internet World Stats, 2007). The Latin culture is 
family/relationship oriented, so personal communication is often more effective—and 
more credible—than mediated communication channels. Nevertheless, social marketers 
are increasingly incorporating new media tools to stretch their budgets while expanding 
their reach to young computer-savvy audiences. At part of that outreach, comprehensive 
information about Programa Hombres is available online and the cartoon videos can be 
viewed on YouTube (Instituto Promundo 2008a). 
In addition to the curriculum, Alliance H—Promundo and its partner 
organisations—developed a ‘lifestyle social marketing’ process to promote gender-
equitable lifestyles among young men. For Program H, young men in the target 
audience identified their preferred sources of information and cultural outlets in the 
community. Messages that it is ‘cool and hip’ to be a more ‘gender-equitable’ man were 
presented via radio spots, billboards, posters, postcards, and dances (Instituto 
Promundo, 2008b). 
Promundo also partnered with SSL International, makers of Durex condoms, who 
provided a branded condom, Hora H, at production cost. Hora H condoms were 
distributed in non-traditional venues and shops such as funk balls and cafes as a central 
part of the campaign. Promoting the use of condoms is such an integral part of 
HIV/AIDS social marketing that the practice has its own acronym: condom social 
marketing (CSM) and manufacturers’ agreements such as the one with SSL 
International is common. Population Services International, however, has discontinued 
CSM in Mexico due to administrative and political hurdles and because Mexico, unlike 
poorer countries, has many condom brands vying for market share (Massingill, 2009). 
The Program H campaign was called In the Heat of the Moment, a theme chosen 
because young men said they frequently heard their peers say, ‘Everybody knows you 
should use a condom, but in the heat of the moment…’ (Pulerwitz, et al., 2006, p.14).  
The campaign’s theme and media mix, combined with easy access to condoms, present 
a persuasive message encouraging young men to respect their partners, to avoid using 
violence against women, and to practice safer sex.  
Evaluation 
To assess Program H’s impact in Mexico, researchers adapted Promundo’s Gender-
Equity in Men (GEM) Scale to fit the cultural context of young men in Mexico. The 
adapted scale measured traditional attitudes about gender roles related to HIV/AIDS and 
pregnancy prevention, violence, sexual relationships, domestic chores and care giving, 
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and homosexuality. Informants also provided information on HIV-related risk, such as 
STI symptoms, condom use, and number of sexual partners (Pulerwitz, et al., 2006).  
Overall, Program H evaluations showed group discussions that prompt critical 
reflection about the costs of traditional manhood, and a media campaign that 
demonstrates gender equitable behaviours encourage young men to make changes that 
protect themselves and their partners from HIV infection. Findings indicated 
improvements in both condom use and a reduction in reported STI symptoms with 
groups that participated in Program H training (Hutchinson, et al., 2004, p.4).  
The conclusion was that addressing unequal gender norms, especially machismo 
attitudes, is a vital part of HIV prevention strategies. These changes can conceivably 
extend into future generations, leading to a culture with stronger, healthier personal 
relationships.  
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CHAPTER 6 
METHODOLOGY 
COLLECTING AND ANALYSING PRIMARY DATA 
 
6.1 INTRODUCTION 
Much can be learned from existing literature, but when it is time to move from 
general to specific information gathering, it is necessary to collect new material that 
speaks directly to the research questions. This chapter is informed by the results of the 
content analysis, as reported in Chapter 5, and has the task of describing the 
methodology for the next research phase: collecting and analysing primary data, which 
included interview and survey techniques. This chapter outlines an integration of 
qualitative and quantitative methods to answer queries unique to this study. The same 
kind of integrative methodology was applied to analysing the resulting data and to 
designing a customised communication model with both theoretical and practical 
applications. 
To collect the primary information needed, a QUAL-QUAN-QUAL research 
‘sandwich’ was used. This research design takes advantage of mixed methods’ 
‘methodological pluralism or eclecticism, which frequently results in superior research 
compared to monomethod research’ (Johnson & Onwuegbuzie, 2004).  
A quantitative survey was inserted between a series of semi-structured interviews 
(pre-survey) and reaction interviews (post-survey). There is precedent for this 
combination of methods, especially in marketing research. Chisnall observed that 
‘questionnaires and interviewing...are opposite sides of the same coin’ (2001, p.173), so 
their interdependence makes them suitable research companions.  In today’s world of 
increasing electronic ‘high tech’ interaction, this research design went against the trend 
to collect data from afar. Instead, primary research was conducted almost completely 
through ‘high touch’ personal interaction. Both interviews and surveys involved 
personally speaking with the respondents and called on the researcher’s skills in 
persuasion and the ability to project a non-judgemental attitude. The only exceptions to 
this personal approach were situations in which distance or other barriers precluded 
face-to-face communication. In those few cases, the telephone or email, usually in 
combination, were used. Chisnall commented the personal interaction between an 
interviewer and the interviewee is a conversation with a specific purpose that can yield 
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data of ‘impressive quality,’ especially in situations where the topic is sensitive or even 
taboo (2001, pp.173-180), which is usually the case with HIV/AIDS. 
This chapter outlines the methodology for collecting and analysing this sensitive 
primary data as the researcher moves from global to local in scope. A rationale is 
presented for the interviews, both pre-and post-survey, and a detailed protocol describes 
the method for the survey design, sampling, data collection, and analysis. This chapter 
also outlines the method for constructing a communication model that integrates 
secondary and primary information to create a practical approach for an HIV/AIDS 
social marketing campaign.  Finally, the role of reflection in integrative and 
participatory projects such as this is explained.  
 
6.2 SEMI-STRUCTURED INTERVIEWS WITH KEY INFORMANTS (PRE-SURVEY) 
Semi-structured interviews with opinion leaders from the three areas of expertise—
marketers, humanitarian leaders, and medical practitioners (both conventional and 
alternative)—explored the rationale behind the content choices, cultural influences, and 
economic factors influencing the public dissemination of HIV/AIDS information. These 
key informants included those who design and implement social marketing campaigns 
in the targeted countries, representatives of companies that participate in those 
campaigns by providing supplies and other forms of support, and public image experts 
and medical practitioners of both conventional and alternative medicine, especially 
those involved in prevention and treatment of HIV/AIDS.  
The value of this kind of ethnographic qualitative research has become widely 
recognised as a result of Strauss and Corbin’s grounded theory approach, which holds 
that the processes of data collection and data analysis are closely connected, with each 
informing and guiding the other (1998). Qualitative inquiry was once regarded as only a 
preliminary foray prior to quantitative, or ‘real,’ scientific analysis, but researchers have 
come to accept that some kinds of information can only be collected by in situ 
immersion in actual social settings. As a result, grounded theory is now used by social 
researchers across a range of disciplines, from ‘pure’ ones such as sociology to applied 
disciplines such as health studies (Strauss & Corbin, 1998). Grounded theory’s two key 
principles are perfectly suited to this research project: 1) the foundation for qualitative 
research is participants’ understanding of their social environment, and 2) researchers 
should creatively tailor their approach to their own research settings and interests 
(Strauss & Corbin, 1998). 
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Interview questions were administered in a uniform way to those people identified 
through exploratory and secondary research as key informers. Questions were designed 
to collect both procedural information and expert opinions. Interviews were conducted 
via email, phone, or, when possible, in person. A standard bank of questions assured 
uniformity, but open-ended questions also allowed for variance in opinion and opened 
the door to new research directions. The question banks for pre-survey interviews are 
shown as Appendix B.4 (Mexico interviews) and Appendix B.5 (U.S. interviews). 
These interviews, which focused on issues that surfaced during the literature review 
and the content analysis, are summarised below. All of the interview respondents had 
some involvement with HIV/AIDS social marketing campaigns and some of them had a 
direct connection with one or more of the content analysis campaigns in Mexico or the 
United States. The interviewer’s challenge was to establish a rapport with the 
interviewees, who held widely divergent and often passionate views on the topics 
discussed, and to report their comments as objectively as possible. 
 
6.2.1 Questions to be addressed during pre-survey interviews 
• From the viewpoint of opinion leaders such as marketers, humanitarian 
activists, and medical practitioners—both conventional and alternative—what 
factors influence choices about dissemination of HIV/AIDS information?   
• How are sponsorships selected and how are campaigns evaluated? 
• Do international business interests influence social marketing’s dissemination of 
HIV/AIDS prevention and treatment information, thereby establishing 
conventional products and treatments as the norm? 
 
6.2.2 Analysis of interview data 
 Since the interview collection period was concurrent with much of the secondary 
data collection and analysis (See Figure 4.1—Research Timeline), it was possible to 
weave the interview information into paper and poster presentations of the work in 
progress, as noted in the Chapter 4. Additionally, some of the interviews were 
conducted while attending HIV/AIDS or social marketing conferences. (See Chapter 4.)  
Several of the interviews with key informants in Mexico became part of a case study 
focused on two of the content analysis campaigns and was published in 2011 as a 
chapter, “Love, Sex, and HIV/AIDS: Using Social Marketing to Redefine Gender 
Norms Among Mexican Youth,” in Social Marketing for Public Health: Global Trends 
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and Success Stories. Editors for the book included Philip Kotler and Nancy Lee, two 
internationally known key figures in social marketing. (See Appendix D.5.) 
 
6.3 SURVEYS OF DOWNSTREAM TARGETS 
Informed by quantitative and qualitative research from the first two research phases, 
Phase 3 called for field research of a designated downstream audience to ascertain 
knowledge and perceptions about aspects of HIV/AIDS. Due to the sensitive nature of 
the topic, surveys were anonymous, but respondents signed informed consent forms. 
Those surveyed were not necessarily HIV/AIDS patients; their principal commonality 
was that they were all receivers of information about HIV/AIDS prevention techniques 
and treatment modalities. They were surveyed at an HIV/AIDS clinic in Houston, 
Texas. Respondents were told their participation in the study would help guide the 
design of a model for effectively disseminating information about HIV/AIDS. The 
Informed Consent Form is shown as Appendix C.1. 
 
6.3.1 Questions to be addressed during Phase 3 research (survey) 
• Where do recipients of HIV/AIDS information learn about the disease? 
• How credible do these recipients consider their information sources to be? 
• What perceptions and knowledge do these recipients have about HIV/AIDS? 
• How do recipients of HIV/AIDS information perceive their choices as regards 
prevention techniques and treatment modalities?  
 
6.3.2 Research design 
In structuring the survey instrument, Onwuegbuzie and Teddlie’s framework for 
dealing with data in mixed methods research was a useful guide. In this approach, 
researchers analysing quantitative and qualitative data within a mixed methods 
framework were advised to include at least some of the following seven stages:  1) data 
reduction—(e.g. exploratory thematic analysis for qualitative data and descriptive 
statistics, exploratory factor analysis, or cluster analysis for quantitative data); 2) data 
display–(pictorial descriptions of matrices, charts, or graphs); 3) data transformation–
(converting quantitative data into narrative form for qualitative analysis or converting 
qualitative data into numerical codes that can be presented statistically); 4) data 
correlation—(quantitative data being correlated with qualitative data or vice versa); 5) 
data consolidation—(quantitative and qualitative data combined to create new variables 
or data sets); 6) data comparison –(comparing data from quantitative and qualitative 
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sources); and 7) data integration—(qualitative and quantitative data integrated into a 
coherent whole) (2003). Of these seven stages, this project utilises: 1) data reduction 
(descriptive statistics for survey data), 2) data display (extensive use of matrices, charts 
and graphs for data reported throughout the study), 4) data correlation, 6) data 
comparison, and 7) data integration (examining qualitative and quantitative information 
to correlate, compare, and integrate the communication model and the concluding 
discussion. 
The principal goal of the surveys was to collect categorical quantitative data. This 
kind of descriptive research design is a useful way to count and describe specific 
features or characteristics of certain kinds of people and has the added advantage of  
‘giving insights into behaviour as well as measuring particular attributes and habits’ 
(Chisnall, 2001, p.35). In marketing, descriptive research can be used to develop 
profiles of types of customers and their preferences. In this case, it was important to 
have a baseline profile of the target audience for the model that was to be created in 
Phase 4.  
As Wellings and Macdowall pointed out, survey investigation is the ‘mainstay of 
data collection procedures,’ with the knowledge, attitude, and behaviour (KAB) survey 
being a popular method for ‘investigating comprehension of messages and self-reported 
behaviour changes’ (2000). Understanding where the target audience has obtained 
information about HIV/AIDS and how credible those sources are perceived to be would 
guide the researcher in choosing communication channels for a future campaign. Also, it 
was important to clarify the target’s perceptions about aspects of HIV/AIDS. For that 
purpose, the second part of the survey included 20 statements ranging from innocuous to 
provocative, which could be divided into broad categories.  After being written, 
rewritten, and mercilessly revised as the instrument evolved, statements were arranged 
in four different sequences (creating four versions of the survey) to mitigate bias based 
on responses to previous statements. Versions 9.2, 9.3, and 9.4 of page 2 of the survey 
are shown as Appendix C.3. The researcher also considered that KAB survey data is 
limited in its ability to monitor changes in a broad social context since the focus is on 
individuals, who ‘are particularly susceptible to the influence of the social desirability 
response’ (Wellings & Macdowall, 2000). The third section of the survey was designed 
to learn which HIV/AIDS treatments, including a variety of alternative treatments, were 
familiar and which ones were perceived as being effective. For statistical purposes, 
respondents were also asked to answer nine demographic questions. 
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Since data collection requires interaction between investigators and respondents, it is 
considered a reactive technique whose very intrusion can interject bias into the process 
(Chisnall, 2001, p.47); however, a non-reactive technique would not have yielded the 
kinds of information needed. Throughout the process of developing the research design, 
possible sources of error were considered, with particular attention to developing the 
most reliable sample possible given logistical limitations, creating clear and 
straightforward questions, organising fieldwork for objective administration, and coding 
data for tabulation and analysis without compromising anonymity.  
 
6.3.3 Sampling 
Judgement or purposive sampling, also called non-probability sampling (Chisnall, 
2001, p.111), was used for this survey due to time and resource limitations. This kind of 
sampling, also sometimes referred to as expert choice, occurs when sample selection is 
‘dependent on human judgement, and not on the rigorous application of probability 
theory’ (Chisnall, 2001, p.111).  The target group for the survey was people working at 
or visiting the Montrose Legacy Community Health Services clinic, one of the major 
HIV/AIDS health clinics in Houston, Texas, located in an area where many of the city’s 
gay residents live. The director of the HIV prevention programme for the City of 
Houston, who conducted extensive research in the Houston metropolitan area, 
recommended this site. The director was interested in the outcome of this study and 
assisted in gaining approval to administer the survey. Based on Raosoft’s sample size 
calculator, a 5% margin of error with a confidence level exceeding 93% was sought. 
The possible population size for the Legacy Clinic was calculated to be 75 to 100 
patients per day on average, according to clinic administrators (many patients come to 
the clinic every month), so a generous projected population size of 2000/month with a 
50% response distribution was factored into the calculator, which then called for a 
sample size of 283 valid responses (Raosoft, 2004).  To exceed this minimum sample 
size, the researcher’s stated goal was to collect a minimum of 300 completed and valid 
responses. No quotas were set for variables such as gender or ethnic affiliation. 
Both reliability and validity are considerations in any research design. This survey is 
simple and is not time sensitive, so it could be replicated in the future with a similar 
target audience to compare findings. The survey could also be replicated with different 
target audiences for the purpose of comparison. Bias is unavoidable in any survey, but 
as noted above, efforts were made to limit bias whenever possible. Although survey 
results could not be generalised to the general public, from the results of the survey it 
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should be possible to make inferences related to those people who visit STD or AIDS 
clinics in the Houston region. Further research would be required to learn if these results 
are indicative of knowledge and perceptions about HIV/AIDS in other parts of the 
country. 
 
6.3.4 Survey instrument 
Design of the survey instrument, which took place over several months, involved 
examination of work done to date, review of the research questions for the entire 
project, and additional secondary research. Also, other HIV/AIDS surveys conducted in 
the Houston area were examined. U.S. Census categories were consulted to refine the 
demographics section of the survey, particularly regarding ethnic groups (Fact sheet, 
2010). 
A panel of experts was assembled to act as consultants and to pilot test the evolving 
versions of the survey. In addition to supervisors at Teesside University, this group 
included HIV medical and marketing experts, communications experts, qualitative and 
quantitative researchers, and administrators at three Houston clinics, including the 
Legacy Clinic. A list of survey consultants is shown as Appendix C.5. The survey 
underwent nine iterations before the final instrument was deemed ready to administer. 
During this process, questions were discarded or rewritten, language was edited for 
clarity, the sequence of some questions was altered, scaling methods were refined, 
demographic categories were clarified, and the survey format was revised for simplicity 
and readability.  In addition, based on suggestions from Houston clinic administrators, a 
Spanish language version of the survey was created. Translation issues arose, especially 
in regards to translating the alternative HIV/AIDS treatments. The Spanish-speaking 
medical consultants at the clinics were not familiar with many of the listed treatments, 
so Spanish/English medical dictionaries were also used. Since Spanish varies greatly 
between the Spanish spoken in Mexico, in Spain, and in other Spanish-speaking 
countries, a back translation (translating the Spanish version back into English) was 
done by a bilingual speaker who had lived and worked in the city for a number of years. 
The completed survey instrument uses closed ended, open ended, nominal scale, and 
Likert scale questions. Likert’s attitude scale was deemed appropriate for much of the 
data collection because it has been in use for decades, during which time it has been 
shown to have good reliability and to give useful information about the degree of 
respondents’ feelings (Chisnall, 2001, p.212-17).  
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The three-page survey begins with a brief description and an initial filter question, 
followed by seven sections: 
Filter question—Have you seen or heard information about prevention and treatment 
of HIV/AIDS?  
The survey administrator stopped the survey if the answer to this question was No. If 
Yes, the respondent was directed to continue. 
Section A—(Addresses sub-question 13) A multi-response section that uses a nominal 
scale to list 20 possible sources of HIV/AIDS information and asks recipients to check 
all that apply. 
Section B—(Addresses sub-question 14) Uses a five-point Likert-style scale to measure 
the respondents’ perceived credibility, from Not at all Credible to Extremely Credible, 
for each of the sources listed in Section A.  
NOTE: Both Sections A and B offer an open-ended Other category. 
Section C—(Addresses sub-question 15) Includes a list of 20 statements, presented in 
varying sequences (four versions of this page of the survey will be used). Respondents 
are asked to indicate their level of agreement. These statements grew out of an 
integrative analysis of Phases 1 and 2 and seek to obtain respondents’ opinions and 
perceptions. Many of the statements reference hotly debated stereotypes, social issues, 
and medical controversies. A Likert scale with six choices, from Strongly Agree to 
Strongly Disagree, is used. A number of reverse-phrased questions are included, which 
reduces bias since respondents will have to read each question carefully to be sure of its 
meaning (Field, 2009, p.675). 
Section D—(Addresses sub-question 16) A multi-response section that uses a nominal 
scale of HIV/AIDS treatments—both conventional and alternative—and asks 
respondents to mark all they have heard of. 
Section E—(Addresses sub-question 16) Using the list of treatments from Section D, 
respondents are asked to mark all that they think can be effective in treating HIV/AIDS. 
Section F—The first five demographic questions establish age, gender, sexual 
orientation, ethnic identification, and education level. Ethnic groups were defined by 
consulting the current U.S. Census categories for ethnic background. The next two 
questions are designed to identify respondents who work or volunteer with HIV/AIDS 
organisations. The last question seeks to establish if the respondent’s HIV status is 
negative or positive. 
Section G—This open-ended question solicits additional comments respondents would 
like to make. 
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 HIV/AIDS Knowledge and Perceptions Survey (English) is shown as Appendix C.2. 
HIV/AIDS Knowledge and Perceptions Survey (Spanish) is shown as Appendix C.4. 
 
6.3.5 Data collection 
External field research requires careful planning and clear criteria for collecting data. 
An instruction sheet ensured data collection techniques were consistent across all times 
of collection, which occurred during two two-day sessions over the space of three 
weeks. These guidelines included directions for 1) approaching possible respondents, 2) 
introducing the survey project, 3) answering questions respondents might ask, 4) getting 
consent forms signed, and 5) collecting, 6) coding and 7) transporting the surveys.  
Guidelines for Data Collection is shown as Appendix C.6. 
 
6.3.6 Data evaluation 
Before beginning the process of tabulating, analysing, and interpreting data, it is 
important to identify potentially important relationships between variables. One way to 
approach this is to develop a series of working hypotheses, which are a result of a priori 
thinking about the subject, preliminary investigation of related information, or advice 
from experts (Chisnall, 2001, p.42-4). To this end, an outline of desirable survey outputs 
was created to clarify how the data could be used to answer the research questions and 
contribute to the overall aim of the research. This outline formed the initial contents 
structure of Chapter 7. 
After data collection is completed, the information must be aggregated, edited, 
coded, tabulated, and analysed.  
Editing—Every question must be checked to see if it has been answered or if the 
respondent has declined to answer.  
Coding—Numerical values must be assigned to survey responses. 
Tabulation—After editing and coding, survey responses were converted to electronic 
format using SPSS (Statistical Package for the Social Sciences) software, one of the 
most widely used programmes for statistical analysis in social science (SPSS, 2009). 
These computerised data mining techniques allow researchers to discover trends and 
patterns of behaviour that previously went unnoticed.  
 
6.3.7 Data analysis 
Section F—The first step was to examine the demographics of the respondents and 
develop a profile of those who completed the survey. Initially, the demographics of 
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greatest interest were age group, gender, sexual orientation, ethnic group, and HIV 
status, as these are the categories that many HIV/AIDS campaigns target, as 
demonstrated by the content analysis in Chapter 5. 
Sections A and B—Were divided into Traditional mass media (1-7), Online media (8-
12), and Interpersonal sources (13-19). These groupings did not appear on the survey 
instrument to avoid bias in survey responses. They are based on the media mix 
responses tabulated during the content analysis and through input from the survey 
consultants. 
Sections D and E—Were divided into Alternative treatments (1-15) and Conventional 
treatments (16-18). They were not so designated on the survey instrument, also to avoid 
bias in responses. The groups are based on information obtained from conventional and 
alternative medical sources during pre-survey interviews. 
Section G—Comments from the open-ended question were collected for anecdotal 
information. 
The next step in the data analysis was to use SPSS to create simple descriptive 
analyses of the responses to sections A, B, C, D, and E. For Section A, responses were 
reported in terms of the actual number of total respondents who selected each medium 
and the percentage of the total sample those responses represented. For Section B, the 
number of total respondents who rated each medium as Not at all Credible was 
compared with the number who answered Credible or Extremely Credible. Again, 
percentage comparisons were also made. For Section C, responses were grouped 
judgementally into categories suggested by pilot testing and interviewees. To provide an 
initial overview, the responses were reported as percentages of those who 
Agree/Strongly Agree, Disagree/Strongly Disagree and Not sure/No Opinion. For 
Sections D and E, there is a simple comparison of percentages of total respondents who 
are familiar with each treatment and the percentage that thinks each treatment can be 
effective. This descriptive overview of responses provided a basis to move into more 
complex analysis. 
Additional analysis involved cross-tabulation of responses against demographic 
variables using Pearson’s chi-square test to determine measures of association. The chi-
square test is commonly used to compare observed frequencies in certain categories to 
the frequencies one might expect to get in those categories by chance. Assumptions that 
must be met for the test are that in the 2x2 tables, all expected frequencies should be 
greater than 5 to be valid and significance should be less than 0.05 (Field, 2009). Row 
and column frequency percentages will be used to interpret those statistically significant 
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associations between variables since the percentages will reflect data patterns more 
reliably than the simple frequencies, which will be dependent on sample sizes. (Field, 
2009, p.686-701). If the results of these analyses indicate further calculations are needed 
to fully answer the research questions, additional analysis could be undertaken. 
 
6.3.8 Data disposal 
Data will be securely stored during the course of the study and will be destroyed by 
the researcher five years after collection. Respondents’ anonymity will be maintained 
throughout, in keeping with the MRS Code of Conduct (MRS, 2010).  
  
6.4 CONSTRUCTING A MODEL (PHASE 4)  
To address the gaps in knowledge identified during this study, a practical 
communication model was constructed for a social marketing campaign. This model 
was informed by the data collected during Phases 1-3 that aim to identify successful as 
well as unproductive messages and approaches for HIV/AIDS campaigns.  
 
6.4.1 Questions addressed during Phase 4 research (communication model) 
• Could social marketing bridge the knowledge gap between conventional and 
CAM choices for HIV/AIDS treatment and prevention?  
• What elements should be incorporated in a social marketing campaign to 
effectively communicate about HIV/AIDS prevention and treatment options? 
 
6.4.2 Strengths and weaknesses of models 
The model for this project is unique in that it not only builds on the extensive 
literature review collected for this study, but also incorporates data from the content 
analysis, pre- and post- survey interviews, and survey responses to create a customised 
practical model directed to a target audience similar to the one surveyed.  In addition to 
drawing on considerable secondary and primary data, this model also integrates CAM 
aspects, a component not presently included in HIV/AIDS social marketing messages. 
The methodology for constructing this model involved integrative analysis of qualitative 
and quantitative data, including examination of established communication, behaviour, 
HIV/AIDS campaigns, and social marketing models examined during the literature 
review.  
Mortensen described a model as a metaphor that allows a complex idea to be 
presented in a simpler, abstract form (1972). Models are therefore useful in aiding 
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understanding of new concepts, but also run the risk of over-simplifying complex 
subjects (Chapanis, 1961). Keeping these strengths and weaknesses in mind, the 
communications model for the HIV/AIDS campaign was created using current model 
approaches, which incorporate a nonlinear, constitutive view of communication 
(Littlejohn & Foss, 2009). 
 
6.5 EVOLUTION OF METHODOLOGY 
As this methodology was developed, it was soon apparent that creating a survey 
instrument is a complex process and that the questions needed considerable tweaking, 
testing, and rewriting. To that end, the group of consultants mentioned previously was 
formed and versions of the survey were emailed back and forth as the final instrument 
was formulated. Getting approval to conduct the survey called on all of the researcher’s 
powers of persuasion and required great patience as weeks dragged into months waiting 
for several levels of administrators to agree. In addition, practical considerations 
involved recruiting and training students to help with the survey and developing specific 
guidelines to keep the survey process consistent during each survey period. Strong 
people skills emerged as one of the most essential elements for success at this stage of 
the research.  
Once the survey responses were collected, another learning curve involved the 
logistics of installing SPSS and learning how to put the data into the programme for 
analysis.  This is where the pragmatic, left-brain skills came to the forefront. 
After survey responses were tabulated, the need for reaction interviews required 
locating additional contacts and prevailing on those busy professionals to schedule time 
for in-depth interviews. Once again, interpersonal skills were important. An early 
version of the research progression had envisioned using a focus group for reaction data, 
but the complicated logistics of arranging a focus group across the range of distances 
and disciplines proved unrealistic. Additionally, the methodological shortcomings of 
focus groups (Gibbs, 1997) caused the researcher to conclude that in-depth interviews 
would be preferable in place of a focus group.  
All in all, this portion of the research was much more time-consuming than 
originally anticipated, and the sandwich of qualitative-quantitative-qualitative not only 
required shifting from one kind of research approach to another; it also involved shifting 
from right to left brain and back to right brain thinking and working. These shifts in 
cognitive approach offered many opportunities for reflection, which is an important 
aspect of transdisciplinary research, as discussed in Chapter 1. Personal reflections—
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both on the subject of the research and on the experiences during the research 
progression—became an important part of the integrative and participatory process 
(Tress, et al., 2006).  The researcher’s informal notes and observations of what she had 
learned about the subject as well as her comments about negative and positive 
experiences helped shape the forward movement of the project and contributed greatly 
to the concluding chapter. Inspired by Bridges’ Reflections on a reflective log (1999), 
the comments and informal record of experiences for this project have been gathered 
into a reflective log, which is shown as Appendix A. 
 
6. 6 THE JOURNEY THROUGH THE RESEARCH PROCESS: A SUMMARY OUTLINE 
 
As is usual with mixed methods research, the research process was fluid. The 
sequential phased process was constantly evolving, as this outline demonstrates, noting 
additions, deletions, and changes from initiation of the research process through final 
reflections and conclusions. 
 
a) Initial components of the research concept  
• Three intersecting topics: HIV/AIDS, social marketing, conventional/alternative 
medicine 
•  Cultural, political, and economic factors in 3 countries: Mexico, Uganda, and 
United States 
• Perspectives from 3 disciplines: marketing, advocacy (political discipline), and 
medicine (science discipline) 
 
b) Three beginning hypotheses 
  
c) Exploratory research  
 
d) Overall research aim (evolved during phases 1-2) 
 
e) Selection of mixed methods rationale/purposes 
 
f) Research questions and sub-questions formulated  (evolved throughout research 
process) 
 
g) Select mixed methods research design (evolved during phases 1-3) 
 
h) Literature review (ongoing throughout entire process) 
Addressed RQ1 and sub-questions 1-4 
 
i) Phase 1 research (content analysis of 18 campaigns from 3 countries) 
Addressed RQ2 and sub-questions 8-9 
+Added national United States campaigns (See Section 4.8) 
+Added case study (Section 5.10) 
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j) Phase 2 research (semi-structured interviews with key informants) 
Addressed RQ2 and sub-questions 10-12 
 -Deleted Uganda from Phases 2 & 3 (See Section 4.8) 
 +Added IRB from Sam Houston State University (See Section 4.4) 
  
k) Phase 3 research (surveys and reaction interviews) 
Addressed RQ3 and sub-questions 13-16 
 +Added survey consultant team (See Section 6.3.4 and Appendix C.5) 
+Added approvals from Legacy Clinic (See Section 6.5) 
-Deleted Thomas Street and City of Houston STD clinics from survey 
considerations 
+Added Spanish version of survey (See Appendix C.4) 
+Added Pearson’s chi-square tests (See Section 7.5) 
+Added Cronbach’s alpha analyses (See Section 7.6) 
>Changed to in-depth interviews in place of focus group for reaction data   
 
l) Phase 4 research (communication model) 
Addressed RQ 3 and sub-questions 17-18 
+Added a 4-stage choice-based process (See Section 8.8) 
>Changed from the original concept of a ‘dummy campaign’ to a 
communication model for a social marketing campaign (See Section 8.9) 
 
m) Analyses and reflection 
 +Added Reflective log (Appendix A) 
 +Added transdisciplinary glossary (See pp.xiii-xvii) 
 
n) References  
 +Added entries through the final edit of the thesis 
 
o) Appendices 
 +Added Peer-reviewed and published work from this thesis (Appendix D) 
 +Added Peer-reviewed and presented work from this thesis (Appendix E) 
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CHAPTER 7 
PRIMARY INFORMATION ANALYSIS 
 
7. 1 INTRODUCTION  
By this point, the researcher had navigated across boundaries of many kinds: 
social, cultural, geographic, political, and historical. Also, the journey involved 
frequent circumnavigation of disparate topics: HIV/AIDS, social marketing, and 
complementary and alternative medicine (CAM). Much of this journey was taken by 
vicarious means—studying what others had published in a variety of formats—but 
some information was gained in a more personal way by travelling to conferences in 
the United States, Mexico, Canada, and Europe, where there were opportunities to be 
exposed to current academic research and to participate in conversations about 
practical responses to the epidemic. Back-grounded by this transdisciplinary review 
and further informed by analysing HIV/AIDS campaigns from three countries, it was 
time to move from contemplating global issues to examining localised concerns. The 
path of transition from general to specific and from secondary to primary information 
integrated qualitative and quantitative research techniques that generated specific 
conversations about HIV/AIDS. 
A QUAL-QUAN-QUAL ‘sandwich’ of interviews with key ‘upstream’ 
informants, surveys of a typical ‘downstream’ audience, and reaction interviews 
formed the basis for understanding how information about HIV/AIDS is selected and 
disseminated at the local level. This chapter highlights lessons learned during pre-
survey interviews, which helped shape the questionnaire that was administered to 
more than 350 people at an HIV/AIDS clinic in Houston, Texas. The survey, 
designed to assess knowledge and perceptions about the disease by a high-risk 
audience, provided pivotal data for this research study and was analysed on several 
levels, as reported in this chapter. The survey results and reaction comments about 
the data comprise Phase 3 of this project and were vital to creation of the 
communication model and the HIV/AIDS social marketing process presented as the 
final research phase in Chapter 8. 
 
7. 2 PRE-SURVEY INTERVIEWS: STRATEGIES BEHIND THE CAMPAIGNS 
The goal during this research phase was to explore behind the scenes: marketing 
rationales, political influences, and financial considerations that influenced campaign 
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choices, ranging from broad considerations such as sponsorships to specifics such as 
message and appeal.  The best sources for this information were key decision makers 
from the organisations or agencies that launched the campaigns, social marketing 
experts who designed and evaluated the projects, and medical practitioners who 
participated as content experts or acted as liaisons with the medical community. This 
section explains some of the inner workings of HIV/AIDS social marketing 
campaigns and allows opinion leaders with widely differing viewpoints to describe 
their perspectives.  
These interviews were conducted as both informal and formal conversations. 
Many of the informal interviews overlapped with Phase 1 research and were 
conducted in person, via email, or by telephone. The formal interviews were 
conducted in person after much of the secondary research was concluded. The key 
informants interviewed were chosen from among the many contacts who participated 
in exploratory interviews or were recommended during secondary research. The pre-
survey interviews were judgementally selected to represent a variety of disciplines 
and viewpoints. Convenience and availability also influenced the selection. A list of 
key informants interviewed pre-survey is shown as Appendix B.8. This accumulated 
information is important because it presents a cross-disciplinary look at these issues 
in a way that has not been done previously, thereby filling a gap in existing 
knowledge. 
 
7.2.1 Aims and objectives for interviews 
• Interview a variety of opinion leaders who are knowledgeable about HIV/AIDS 
social marketing campaigns.  
• Gather both quantitative and qualitative information from these key informants, 
probing for both factual background as well as professional opinions. 
• Reflect on their responses in relation to the original research questions. 
 
7.2.2 Questions addressed in the interviews 
• From the viewpoint of opinion leaders such as marketers, humanitarian 
activists, and medical practitioners—both conventional and alternative—what 
factors influence choices about dissemination of HIV/AIDS information?   
• How are sponsorships selected and how are campaigns evaluated? 
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• Do international business interests influence social marketing’s dissemination 
of HIV/AIDS prevention and treatment information, thereby establishing 
conventional products and treatments as the norm? 
 
7.2.3 Highlights of pre-survey interviews with upstream opinion leaders  
 
Dissemination of information: from famine to feast? 
A long-time HIV/AIDS counsellor and activist in the Houston area remembers 
when people were simply given their test results, with no counselling and no groups 
or Internet sources to explain their treatment options. From the standpoint of 
policymakers, the disease did not get on the political agenda until detailed data 
became available. A social marketing expert who directed the City of Houston’s HIV 
prevention programme said the city’s HIV/AIDS prevalence rates began to be 
reported by demographic breakouts in 1999. When city leaders saw that 62% of those 
infected were African American, administrators declared a state of emergency and 
began to allocate funds for prevention initiatives.  Houston is now a national model 
for HIV/AIDS research and resources for those who want information. 
A doctor who recently completed his conventional medical training in Texas saw 
a lot of AIDS ads when he was in high school, but hasn’t seen much public 
information about the disease in the last couple of years. He said he never learned 
anything about HIV or AIDS from the ads other than you should always protect 
yourself when having sex. He thinks education in campaigns would be very helpful 
because it would broaden people’s knowledge about the disease so they would better 
understand how HIV/AIDS is transmitted and care options for those infected. 
A wealth of information can be confusing for the infected without some kind of 
structure or process. A Houston activist and administrator for an agency that locates 
housing for people living with HIV/AIDS said the newly diagnosed can be 
overwhelmed by the plethora of facts. ‘There is too much information available once 
someone is positive, but the truth is, by the time the person wraps their head around 
what is going on, it is an avalanche of information that oftentimes cannot be managed 
properly.  It is important to have someone like a case manager available who can guide 
you through the maze to achieve the desired service or outcome,’ she said.  
 
Sponsorships: Not easy at the local level 
As discussed in Chapters 2 and 3, sponsorships for HIV/AIDS campaigns are 
central to most programmes with a national or international scope. A doctor at an 
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HIV/AIDS clinic in Germany co-directed a documentary of interviews with HIV-
positive people from all walks of life. The film, Blissfully Lost, was financed by 
GlaxoSmithKline and was screened at the 2009 German-Austrian-Swiss AIDS 
Congress (SODAK) in St. Gallen. The doctor and her co-director, a South African 
filmmaker, had complete control over the content of the documentary, but they said 
GlaxoSmithKline did almost nothing to promote the film’s premiere during the 
conference, where the pharmaceutical giant had a prominent booth. Conferences such 
as the Congress are a testament to the financial stake the medical industry has in the 
AIDS epidemic; much of the conference costs are underwritten by pharmaceutical 
companies, which go to great expense to have a strong presence at such events, where 
they promote new modalities and drugs.  Market forces are always a factor in the 
HIV/AIDS equation; the director of Population Services International (PSI) Mexico, 
said his agency recently stopped condom social marketing in Mexico, due to 
administrative and political hurdles and because Mexico has many condom brands 
vying for market share.  
On the local level, sponsorships are extremely important but very scarce. The 
Houston HIV activist said most major corporations would give to larger organisations 
with national exposure, but very little is done by sponsors/donors on the local level. 
Also, some agencies are barred from using sponsors. Additionally, city or county 
agencies cannot have pharmaceutical sponsors, but privately owned clinics can do so. 
So, local groups are more likely to form coalitions to combat HIV/AIDS or to seek 
grants from local government.  In addition, if local groups apply for funds from 
national agencies such as the Centers for Disease Control and Prevention (CDC), 
there are restrictions on message approach and content. For example, campaigns that 
use CDC funds cannot appear to encourage sexual activity. To make the most of 
those resources that are available, activist organisations work hard to make sure local 
policy makers understand the impact of the disease and to tie HIV/AIDS to other 
social challenges such as addiction and incarceration. On the other hand, city-
sponsored campaigns can use internal media such as the metro bus system for free, so 
the City of Houston HIV office makes use of bus placards to promote campaign 
messages and organise community volunteers to help distribute posters and 
brochures. 
Lessons learned 
The City of Houston HIV office has collected a massive amount of data about the 
disease in Houston, assembling statistical data from various sources and using focus 
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groups and surveys to better understand the disease’s scope and effects in the area. 
One commonality the research pointed to was a feeling of pride, whether it was pride 
in culture, in ethnicity, or in being gay. Focus group responses indicated a need for a 
sense of belonging. An anonymous gay key informant said, ‘As terrible as this 
sounds, there was a time when it was cool to be an HIV-positive gay man…you were 
the “in thing.” Now, I don’t see us having any identity at all.’ 
Putting a public face on the disease was a key strategy for an award-winning 
campaign to encourage testing that Torma Communications, a Houston marketing 
agency, helped design for the city’s HIV office. The campaign, New Faces of HIV in 
Houston, used a focus group comprised of members of the target audience to 
determine the most effective way to reach the target, to construct the campaign 
message, and to refine materials. The agency’s owner served as a facilitator and 
organiser of the process rather than the sole designer. One of the focus group 
members, who was also one of the people who was pictured in the campaign, said the 
use of real people who lived with the disease every day instead of caricatures or 
cartoons caught the interest of the media and resulted in extensive free publicity for 
the programme.  
The marketing agency’s owner agreed the campaign’s reach was greatly extended 
by the media response to the local faces, but offered a note of caution. Although 
many people like the idea of being a celebrity, ‘be sure those appearing in the 
campaign are ready for that kind of public exposure,’ she said. The campaign 
launched on World AIDS Day, tying in to an established international event that 
increases visibility for HIV/AIDS issues each December 1.  The campaign was 
successful in short-term results, showing a substantial increase in testing and calls to 
the publicised hotline number.  But, long-term behavioural change is the hardest to 
measure, according to campaign sponsors. 
Still, gaps in knowledge about HIV/AIDS treatments are a recognised problem for 
all groups, according to City of Houston research figures. Younger Houston men in 
particular—both gay and straight and both white and Hispanic—seem ill informed 
about how the disease is spread and treated. Overall, knowledge about treatment for 
HIV/AIDS had the lowest rating for all participant groups, including the HIV-positive 
MSM (men who have sex with men) subset, clearly an area of weakness. 
However, conversations are taking place, prompted both by behaviour change 
communication efforts like the Faces campaign and informal discussions led by area 
activists. Some of the topics and the candid approach to them are controversial. Why 
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even use controversy? One marketer’s answer to that question was ‘because it gets 
people talking.’ He pointed out AIDS has made it okay to talk about a lot of things in 
public that were once unacceptable. It has altered public discourse in profound ways. 
‘We have crossed the conversation barrier and made people not only consider 
themselves, but their family and friends as well.’ 
 
7.3 SURVEY RESULTS: DOWNSTREAM PERCEPTIONS 
With these key informants’ observations and facts as background, the next step 
was to go downstream—to the target audience—for primary data. As described in the 
methodology in Chapter 6, this quantitative survey was designed to gather baseline 
information establishing the perceived knowledge level of a high-risk, high-interest 
downstream audience regarding AIDS treatment and prevention choices, as well as 
their perceptions about information sources and their opinions regarding cultural and 
economic issues that surround the disease. The survey process took about nine 
months, from design through analysis. Both the process and the results were 
informative. This section of the chapter traces the survey progression from creating 
the instrument to preparations for administering the questionnaire, to data collection 
and tabulation. The data was then analysed in terms of simple descriptors, followed 
by cross tabulations to determine significant associations. Lastly, responses to 20 
statements of fact and opinion were divided into three groups and tested for 
reliability.  
 
7.3.1 Aims and objectives: 
• Create a survey instrument designed to ascertain perceptions and knowledge 
about HIV/AIDS health choices. 
• Obtain a sample of at least 300 valid responses from a targeted population. 
• Correlate survey results with information from the key informant interviews. 
(See Chapter 6 for a detailed protocol for the survey design and sampling.) 
 
7.3.2 Questions addressed in the survey 
• Where do recipients of HIV/AIDS information learn about the disease? 
• How credible do these recipients consider their information sources to be? 
• What perceptions and knowledge do these recipients have about HIV/AIDS? 
• How do recipients of HIV/AIDS information perceive their choices as regards 
prevention techniques and treatment modalities?  
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7.3.3 Organising the survey  
In keeping with the questions listed above, the completed survey instrument was 
divided into sections designed to learn A) where respondents obtained information 
about HIV/AIDS, B) how credible they believed those sources to be, C) opinions 
about HIV/AIDS cultural, medical, and social issues, D) HIV/AIDS treatments 
respondents knew about, and E) HIV/AIDS treatments they believed to be effective. 
A final section collected demographic data describing the respondents’ age, gender, 
sexual orientation, ethnic identification, education level, involvement with HIV/AIDS 
organisations, and HIV status. (The evolution of the survey design is explained in 
Chapter 6, Section 6.3.4.) 
 
7.3.4 Administering the survey 
The site selected for the survey, formerly known as the Montrose Clinic, was 
founded in 1978 near downtown Houston, Texas, to provide STD testing and 
treatment to gay and bisexual men. When the AIDS crisis began, the clinic became 
the first HIV antibody-testing site in the state and the second in the nation. With the 
help of various federal and local programmes, the clinic grew to provide HIV/AIDS 
prevention education, social services, and medical care for men and women living 
with the disease. In 2005, the clinic became part of Legacy Community Health 
Services and expanded to be a full-service community health centre that provides 
healthcare services in a ‘culturally sensitive, judgment-free, and confidential 
environment’ (Legacy website, 2010).  In addition to HIV/AIDS testing, education, 
treatment, and social services, Legacy also provides no-cost or low-cost healthcare 
for other chronic health conditions. The centre serves over 20,000 men, women, and 
children each year (Legacy website, 2010).  
Gaining approval to conduct the survey took four months and involved email 
contacts, telephone conversations, and personal meetings with Legacy administrators. 
The survey instrument was fine-tuned at the suggestion of Legacy staff members and 
the researcher’s Institutional Review Board (IRB) approval from Teesside University 
was accepted. Logistics for conducting the survey were discussed and survey dates 
were set.  
 
7.3.5 Collecting the data 
The base of operations for data collection was a small folding table in the foyer of 
the clinic so everyone entering could be asked to complete a survey instrument. Simple, 
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colourful signs—in English and Spanish—were placed on the entry doors and over the 
table. (Facsimiles of the survey signs are shown as Appendix C.7. A variety of small 
gifts and candy was placed in a ‘grab bag’ and each person who completed a survey 
could select an item. Although the gifts were inexpensive trinkets, most people were 
pleased by these small incentives. A few people asked if there was an incentive to take 
the survey and seemed happy with their modest reward. Other respondents just wanted 
to participate and did not select a gift. The survey sample was by convenience and 
consent; everyone who entered the clinic while the surveys were being administered was 
asked to participate. Since there was also a pharmacy at the clinic, some people only 
came to pick up medicines and were less likely to agree to take the survey since they did 
not have to wait for an appointment. This non-probability sampling is often used when 
there are time and resource limitations (Chisnall, 2001). 
The guidelines for survey administration that were prepared for this survey were 
strictly followed in all respects to ensure consistency of survey administration, 
anonymity of respondents, and security of the data. Consent forms and surveys were 
always kept in separate folders, and the four different versions of the survey were 
equally distributed.  Guidelines for survey data collection is shown as Appendix C.6.       
As required by the methodology, surveys were collected on four different days over 
a three-week period. The response rate was excellent; more than 90% of the people who 
visited the clinic agreed to participate. Clinic administrators expressed surprise at the 
high rate of participation and asked for tips on getting similar responses to future in-
house surveys. Personal observations about the survey process are included in the 
reflective log shown as Appendix A. 
At the end of each survey day, responses were hand coded with the date. (Each of 
the four versions already had a code printed on the bottom right hand corner designating 
the version number.) Completed survey responses were carefully transported and stored 
in a secure location until they could be edited, coded, and tabulated. 
 
7.3.6 Data cleansing 
When survey responses were examined, 11 had to be discarded due to incomplete 
responses, most because the respondent was called to his/her appointment before 
completing it; a few respondents agreed to take the survey, then returned it with one or 
two pages left blank. Thirteen Spanish language responses were collected and included 
in the database. Valid responses were numbered and entered into four SPSS (Statistical 
Package for the Social Sciences) files. (Since there were four versions of the survey, the 
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responses to each version were entered as a separate file, then the responses to Section C 
were re-ordered, and the four files were merged.) There were 342 valid cases in the 
merged file. The next step was to clean the data, checking all system missing entries 
against the original responses and correcting the data entries as needed. Next, to 
determine accuracy of data entry, the first 50 responses were checked against the data 
entered for each case. Minor coding errors were discovered in fewer than 5% of the 
cases, so then every fifth original response was compared with its corresponding data 
entry, and corrections were made as warranted. Overall, fewer than 2% of these cases 
required coding corrections. The handwritten comments from Section G of the survey 
were transcribed in a separate document. Comments from Legacy Clinic survey 
respondents is shown as Appendix C.8. Some data was re-coded to simplify analysis. 
For example, in Section C, Not Sure was combined with Neither Agree Nor Disagree 
responses. In Section F, Prefer Not to Say regarding sexual orientation was combined 
with system missing entries, and on the HIV status question, Don’t Know and Prefer 
Not to Say were combined and shown as system missing entries.  
 
7.4 DESCRIPTIVE FINDINGS 
Once data was entered and cleaned, the first output was to run descriptors of each 
category to begin to answer the questions addressed in the survey. These initial results 
were shared with the Legacy Clinic administrators as well as with other key informants 
during survey reaction interviews. (See Chapter 8.) This preliminary information was the 
basis for a work in progress poster presented in April 2010 during an area research 
conference sponsored by the College of Humanities and Social Sciences at Sam Houston 
State University in Huntsville, Texas. The poster, Positive or negative: HIV/AIDS 
knowledge & perceptions, is shown as Appendix E.7. 
 
7.4.1 Demographics of respondents 
The demographic profile of the Legacy Clinic respondents was interestingly diverse.  
Age: The age of respondents, which was expected to be a significant variable in 
responses to many of the survey questions, was well reported, with 340 (99.4%) 
responding to this question. The largest age group, as shown in Figure 7.1, was the 37-
47 year-olds, which represented more than 30% of the respondents, followed by the 26-
36 year-olds, with 26%, and the 48-58 year-olds, with 22.5%. Young people 18-25 were 
15.5% of the sample, and those 59 or older made up only 5.3% of respondents. People 
under 18 were not included in the survey due to legal concerns. 
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                Figure 7.1—Age group distribution of survey respondents.  
 
Ethnicity: Regarding ethnic group distribution, the two largest groups were 
white/Caucasian at 37.1% and black/African American at 35.7%. The next largest ethnic 
group was Hispanic at 15.5%. Those identifying themselves as multiracial made up 
5.3% of the total and the remaining ethnic groups were each less than 3%. As with age, 
more than 99% of the 342 respondents provided ethnic group information. 
Gender: There were almost twice as many male as female respondents: 62.9% men 
compared to 31.9% women. Research done during survey design indicated the gender 
demographic question should be asked as, Which gender do you most identify with? 
since respondents were likely to include transsexual and transgender individuals.  
Sexual orientation: Also in response to target audience research, the sexual 
orientation category offered three choices: heterosexual (42.4% of respondents), 
homosexual (38%), or bisexual (9.9%).  
 
Figure 7.2—Education levels of survey respondents. 
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Education background: Overall, the education level of respondents was high, as 
shown in Figure 7.2, with 48.2% having high school diplomas and an additional 33% 
being college graduates.  
Religious affiliation: Less than half of the respondents chose to provide their 
religious affiliation. Of those who did respond, the greatest number identified 
themselves as Baptist (12%), Catholic (12%), and the more general Christian (11%). 
Non-denominational, none, and agnostic together accounted for another 14%.  
Involvement with HIV/AIDS groups: Relatively few respondents were in paid 
positions with HIV/AIDS organisations (6.7%), but almost twice as many (11.4%) were 
unpaid volunteers with such organisations.  
HIV status: Not surprisingly, given the audience traditionally served by Legacy 
Clinic, more respondents were HIV-positive (54.1%) than HIV-negative (31.3%), and 
14.6 % did not give their status. 
 
7.4.2 Responses to Section A: sources of HIV/AIDS information  
At the suggestion of survey consultants, the timeframe of 4-5 years was incorporated 
during one of the many survey revisions. Sources were grouped into three categories. 
Traditional Mass Media included TV, radio, books, newspapers, magazines, out of 
home (billboards, transit ads, posters, flyers, brochures), and events (seminars, 
workshops, conferences). New (Online) Media included medical websites, HIV/AIDS 
groups’ websites, blogs/online bulletin boards, online newsletters/ journals, emails, and 
social media (Facebook, Twitter, etc). Interpersonal Sources included community 
organisations, religious organisations, educational institutions, conventional medical 
doctors, alternative medical doctors, friends/family members, and fellow workers. These 
groupings were informed by the content analysis of 18 HIV/AIDS campaigns (See 
Chapter 5) and by input from the survey consultants.  Percentages selected do not add 
up to 100% because recipients could mark as many sources as they wished, so a total of 
all percentages is not meaningful. Additionally, since respondents were relying on 
memory rather than formal media logs such as those used by Arbitron (Arbitron 
website, 2010), these responses should be viewed as being filtered by perception. 
 
Question addressed 
• Where do recipients of HIV/AIDS information learn about the disease? 
Traditional mass media sources: As shown in Figure 7.3, each form of traditional 
media was selected by a third or more of the respondents, with television being the most 
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popular (70.2%), and events such as seminars, workshops, and conferences being least 
popular—selected by only 32.7%. 
 
Figure 7.3—Traditional mass media selected: Number and percentage 
 of respondents who selected each of seven traditional media sources. 
 
New media sources: Overall, as shown in Figure 7.4, new media were much less 
likely to be sources of information about HIV/AIDS than traditional media. The most 
popular new media source was medical websites (38.6%), while blogs/online bulletin 
boards, and social media (Facebook, Twitter, etc) were each selected by fewer than 
13%. Surprisingly, HIV/AIDS websites were only used by about a third of the 
respondents.   
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Figure. 7.4—New media selected: Number and percentage 
 of respondents who selected each of six new media sources. 
 
Interpersonal sources: Interpersonal sources, especially family and friends (48.2%), 
community organisations, and conventional medical doctors (35.7% and 35.1% 
respectively), were generally more popular sources for HIV/AIDS information than new 
media, but not as frequently selected as traditional media, as shown in Figure 7.5. 
Alternative medical doctors (12%) were the least likely interpersonal source, according 
to respondents. Religious sources were only selected by 16.7%, which was in keeping 
with the response to the religious affiliation demographic question, in which 35% of the 
50% who responded to the question expressed a religious affiliation. 
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Figure 7.5—Interpersonal sources selected: Number and percentage 
of respondents who selected each of seven interpersonal sources. 
 
Other sources listed by respondents were varied, ranging from ‘mother’ to ‘case 
worker’ to ‘self,’ but did not add significantly to the information already collected. 
 
7.4.3 Responses to Section B: credibility of HIV/AIDS information sources 
This section used the same media groups as in Section A, but it should be noted that 
recipients could mark media sources in section A which they did not rate in section B, 
or vice versa. A number of conclusions can nevertheless be inferred from the data. For 
ease of initial comparison, only three points of the Likert scale were used in these 
figures; Credible and Extremely Credible were combined to compare with Not at all 
Credible responses. Other possible responses were Somewhat Credible and Undecided. 
For the same reasons explained in Responses to Section A, percentages do not total 
100% and the number of responses does not total 342 (the total number of survey 
respondents). 
 
Question addressed 
• How credible do these recipients consider their information sources to be? 
 
Credibility of traditional mass media sources: In general, as shown in Figure 7.6, 
television was the most credible traditional medium (56.1%), closely followed by books 
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(55%), while out-of-home sources (billboards, transit ads, posters, flyers, brochures) 
were rated the lowest in believability of the traditional media group. Radio was the 
traditional medium least likely to be considered credible, with 8.8% designating it as 
Not at all Credible. 
 
 
Figure 7.6—Credibility of traditional media: Number and percentage of 
 respondents who answered Not at all Credible vs. Credible or Extremely Credible. 
 
Credibility of new media sources: Using the same kind of comparison, as shown in 
Figure 7.7, medical web sites were considered credible by more respondents (57%) than 
television, and HIV/AIDS groups’ websites (53.3%) were comparable to magazines in 
believability. Notably, social media were most likely to be considered Not at all 
Credible (14.9%).  
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Figure 7.7—Credibility of new media: Number and percentage of 
 respondents who answered Not at all Credible vs. Credible or Extremely Credible. 
 
Credibility of interpersonal sources: In terms of credibility for interpersonal 
sources, conventional medical doctors (57%) outranked television and were equal to 
medical websites, as shown in Figure 7.8. Also, a variety of other sources were listed as 
credible, including the Legacy Clinic, fiancé, self, and ‘person with HIV.’ 
 
Figure 7.8—Credibility of interpersonal sources: Number and percentage of 
respondents who answered Not at all Credible vs. Credible or Extremely Credible. 
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7.4.4 Responses to Section C: perceptions and knowledge  
In this section, statements of knowledge and perception were arranged in four 
different random orders on survey versions 9.1 through 9.4 (See Chapter 6, Research 
Design, Section 6.3.2), with no groupings specified. The four versions were equally 
distributed among the respondents. For the initial report of simple descriptive responses, 
statements were grouped judgementally according to broad categories that surfaced 
during the literature review and from interviews that helped formulate and refine the 
statements. Initial categories included: I.) Stigma: Cultural Stereotypes—statements 
1,3,4,10,13,15 (See Table 7.1), II.) Medical: Prevention and Treatment—statements 5, 6, 
8, 9, 11,12,16 (See Table 7.2), and III.) Global Socio-Political issues —statements 
2,7,14,17,18, 20 (See Table 7.3).  Note: all statement numbers used in this report 
correspond to version 9.1 in both the English and Spanish versions (Only one version of 
the Spanish survey was created since it was correctly anticipated that most respondents 
would prefer English.) Statement 19 is considered separately because it was the only 
first person question and did not logically fall into one of the three categories outlined 
above.  
 
Question addressed 
• What perceptions and knowledge do these recipients have about HIV/AIDS? 
 
This section of the survey is a combination of opinion and fact-based statements, but 
many of the so-called ‘facts’ are extremely controversial, with advocates who are 
convinced the statement is truth, and others who will argue just as vehemently it is 
fiction. For example, most conventional medical doctors would be certain that statement 
12, Alternative medical treatments for HIV/AIDS have shown promising results, is 
without merit, but some CAM practitioners are confident alternative modalities hold the 
solution to the epidemic. Nevertheless, the goal was to learn what the respondent 
believed or perceived to be true, which marketers must accept as that individual’s own 
reality (Griffin, 2010). 
Fact or fiction arguments aside, knowledge levels are important for those designing 
communications about the disease. For example, in regards to HIV/AIDS prevention, it 
would be important to know if respondents believed condoms ensure safe sex 100% of 
the time, or if they were aware of studies that indicate the failure or leakage rate for 
condoms is at least 20% (Crosby, et al., 2008), and possibly as high as 30% (Carey, et 
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al., 1992). On matters of stigma, responses to statements that link HIV/AIDS with 
‘immoral behaviour’ provide a context for shaping future messages about the disease. 
Likewise, attitudes toward global issues such as the controversy that surrounds pharma’s 
financial connections to the AIDS industry imply the target audience’s levels of 
awareness and activism. For this initial comparison of Section C statements, the rating 
categories Agree and Strongly Agree were combined as were the categories Disagree 
and Strongly Disagree. The system missing entries, Not Sure, and Neither Agree nor 
Disagree were collectively reported as Not Sure. 
 
Responses to Stigma: cultural stereotypes: On the whole, as shown in Table 7.1, the 
survey respondents had a high percentage of disagreement with each of these 
‘moralistic’ statements that represent some of the common stigmatising and 
discriminatory stereotypes toward people with HIV/AIDS. Given the demographic 
makeup of the respondents, especially the high percentage of HIV-positive people 
(54.1%), the only surprising responses were the significant proportion who agreed with 
or were ambivalent about these statements, especially the 23% who were not sure if 
HIV/AIDS resulted from immoral behaviour. 
 
Stigma statements Agree % Disagree % Not sure % 
1. Poor people are more likely to get AIDS. 21.1 57.6 21.3 
3. HIV/AIDS is primarily a gay disease. 7.3 82.4 10.3 
4. Getting HIV/AIDS is usually a death 
sentence. 
13.2 70.7 16.1 
10. HIV/AIDS is God's way of punishing 
the wicked. 
6.7 83.9 9.1 
13. People with HIV/AIDS (do not)* 
deserve the same rights in the workplace as 
other workers. 
5.5 88.1 6.4 
15. HIV/AIDS infections are often a result 
of immoral behaviour. 
14.9 61.7 23.4 
     *reverse phrasing was re-coded for analysis 
Table 7.1—Responses to cultural stereotypes statements: More respondents disagreed 
with each statement than those who agreed or were not sure combined. 
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Responses to Medical: prevention and treatment statements: As shown in Table 
7.2, the majority of the respondents disagreed with this list of prevention and treatment 
related statements, with the exception of statement 12, where responses were split 
almost evenly between Agree and Not Sure. This would seem to indicate a high level of 
ambivalence or a lack of knowledge about alternative treatments for HIV/AIDS.  
Regarding statements of fact, it is noteworthy that almost one third did not know if 
an HIV/AIDS vaccine is available (Medical experts predict no vaccine will be available 
for at least another 20 years: Padian, et al., 2008). More than a fifth were not sure if an 
HIV-positive woman could avoid having an infected baby (Prevention of mother-to-
child transmission is one of the most cost effective interventions available: Global AIDS 
Alliance, 2009).  Likewise, more than a fifth were not sure if antiretroviral drugs are a 
cure for the disease (Drug cocktails suppress but do not eliminate the virus: Segal, 
2003).  Also troubling is the 18% who believed condoms to be a fail-safe barrier to 
infection (Failure rates have found to be as high as 30%: Crosby, 2008). Also, a 
significant number was woefully lacking information or misinformed regarding 
statement 16, where the medical evidence overwhelmingly shows that women can 
contract the disease more easily than men during unprotected sex (Gates, 2007). 
 
Medical statements Agree % Disagree % Not sure % 
5. Antiretroviral drugs are a cure for 
HIV/AIDS. 
8.2 68.4 23.4 
6. Giving antiretroviral drugs to people not 
infected is a good way to prevent HIV/AIDS. 
10.3 58.5 31.3 
8. A pregnant woman with HIV/AIDS cannot 
avoid having an HIV-positive baby. 
12.5 66.7 20.8 
9. You cannot get HIV/AIDS during sex if 
condoms are always used. 
18.4 68.1 13.5 
11. An effective HIV/AIDS vaccine is 
available. 
15.2 53.2 31.6 
12. Alternative medical treatments for 
HIV/AIDS have shown promising results. 
43.3 14.6 42.1 
16. It is biologically easier for woman to get 
HIV/AIDS than it is for men. 
21.9 39.8 38.3 
Table 7.2 —Responses to prevention and treatment statements: 
More respondents disagreed with each statement except Statement 12. 
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Responses to Global: socio-political issues: As shown in Table 7.3, responses to the 
socio-political statements are somewhat mixed, but there are indications of awareness 
about global issues and trends. More than half support prosecuting people who 
knowingly infect others and agree that the AIDS industry is profitable for drug 
companies. Almost 60% are not aware that globally HIV/AIDS infections are more 
likely to occur through heterosexual contact than by homosexual contact. As was the 
case with some of the medical statements, the percentages of Not Sure on well-
documented trends such as statement 18: Young people under 25 account for almost half 
of new HIV/AIDS infections globally, is somewhat surprising and disturbing. 
 
Socio-political statements Agree % Disagree % Not sure % 
2. Globally, the number of people with 
HIV/AIDS is decreasing. 
8.8 65.8 25.4 
7. People who knowingly expose others to 
HIV/AIDS should be prosecuted as criminals. 
54.5 19.8 25.7 
14. Treating HIV/AIDS is a lucrative business 
for pharmaceutical companies. 
51.7 16.4 31.9 
17. HIV/AIDS prevention efforts often receive 
more funding than treatment efforts. 
24.3 27.5 48.2 
18. Young people under 25 account for almost 
half of new HIV/AIDS infections globally. 
45.9 12 42.1 
20. Worldwide, more people get HIV/AIDS 
by heterosexual contact than by homosexual 
contact. 
21.1 57.6 21.3 
 
Table 7.3—Responses to socio-political statements: 
 Responses to these statements were mixed; respondents agreed with three statements, 
disagreed with two and were not sure about the remaining statement. 
 
Response to Statement 19: I am not personally worried about getting HIV/AIDS:  
19.6 % agreed; 51.7% disagreed, 28.6% were not sure. Since more than half of the 
respondents said they were HIV-positive, the validity of this response is called into 
question and this data was not used in later analysis of Section C. 
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7.4.5 Responses to Sections D & E: HIV/AIDS treatments  
Figure 7.9 gives a side-by-side comparison of the percentage of the 342 respondents 
who had heard of each treatment (left) to the percentage who thought each treatment 
was effective. Respondents could mark as many as they wished in both sections, so the 
numbers do not add up to 100%, but the responses are useful for comparisons. Although 
they are not so labelled, the first 15 treatments listed are alternative medical modalities, 
and the last three are conventional medical treatments. In every case, the percentage of 
respondents who had heard of a treatment was greater than the percentage that thought 
that treatment could be effective against HIV/AIDS.  
 
Question addressed 
• How do recipients of HIV/AIDS information perceive their choices as regards 
prevention techniques and treatment modalities?  
 
An older conventional modality from the late 1980s, AZT (Azidothymidine), was 
the best-known treatment (51.2%), but only 35.1% considered it effective. It is 
intriguing to note that HAART (Highly Active Antiretroviral Therapy), sometimes 
called ‘drug cocktails,’ and which is the most commonly used conventional treatment 
for HIV/AIDS, was only recognised by 40.1% of respondents and was deemed effective 
by 39.8%. Porcine liver extracts and Venus flytrap were the least recognised (1.8% and 
3.2% respectively).  
Under other treatments known or considered effective, several respondents listed 
‘cocktails’ and antiretrovirals as well as alternative treatments that included ozone, 
DCA, CM4, and black walnut hull extract. Clearly, many of the respondents did not 
know HAART is an antiretroviral cocktail. 
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Figure 7.9—HIV/AIDS treatments: Percentage of respondents who had 
 heard of alternative and conventional treatments (left), and the 
 percentage who considered those treatments effective (right). 
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7.5 STATISTICALLY SIGNIFICANT RELATIONSHIPS 
Using SPSS 15.0.1 (SPSS, 2007), cross-tabulation tables were run to search for 
significant relationships between responses from each of five demographic groups (age, 
gender, status, sexual orientation, and ethnic group) against survey sections A, B, C, D, 
and E. Pearson’s chi-square test of association was used, which is a common method for 
determining relationships between two categorical variables. Field (2009) describes 
Pearson’s chi-square test as ‘an extremely elegant statistic based on the simple idea of 
comparing the frequencies you observe in certain categories to the frequencies you 
might expect to get in those categories by chance’ (2009, p. 688). Field also specifies 
the importance of looking at row and column percentages to interpret test results, which 
will reflect the patterns of data more reliably than the simple frequencies since the 
frequencies will be dependent on sample sizes in different categories (p.692). 
A chi-square probability of 0.05, (meaning the finding has a five percent chance of 
not being true and a 95% chance of being true), is commonly interpreted by social 
scientists as justification for rejecting the null hypothesis that the row and column 
variables are only randomly related (Field, p. 697).  However, for practical application 
in the business world, a 90% chance of being true (probability=0.1), can’t be considered 
proven, but those relationships would be considered as part of the larger picture 
(Creative Research Systems, 2010). Therefore, when a number of significant 
associations emerged relating two variables, ‘borderline’ associations were also 
examined for a tendency toward significance.    
Tests of association have other possibilities for error; if the survey sample is not 
truly random, a significance test may overstate the accuracy of the results since it only 
considers random error (Creative Research, 2010). In addition, when using significance 
tests, the expected frequencies should be greater than five although it is considered 
acceptable in larger contingency tables to have up to 20% of expected frequencies below 
five (Field, 2009, p. 691-2). With these cautionary notes in mind, a number of 
significant relationships emerged in the data from each section of the survey. 
 
7.5.1 Section A: sources for HIV/AIDS information: cross tabs with significance 
Looking at the relationship between gender and individual traditional sources (See 
description of source groupings, Section 7.4.2), only four revealed significant 
differences between males and females.  Collectively, these are shown in Table 7.4. 
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Kind of media selected Male Female 
Television 60.3% 39.7% 
Radio 57.3% 42.7% 
Magazine 70.6% 29.4% 
Out of Home 57.7% 42.3% 
 
Table 7.4—Relationships between traditional media sources and gender: Males were 
more likely than females to get HIV/AIDS information from these sources. 
 
Men were more likely than women to obtain HIV/AIDS information from television 
(!2 = 13; df = 1; p<0.001), radio (!2  = 9.32; df = 1; p<0.003), and out-of-home media 
(!2  = 6.62; df = 1; p<0.011). Compared with women, men had a strong preference for 
magazines (!2  = 4.91; df = 1; p<0.028). 
 
When the relationship between status and traditional media sources was examined, 
three were found to have significant differences, as shown in Table 7.5. 
 
Kind of media selected    HIV-Negative  HIV-Positive 
                 Television        40.9%       59.1% 
                     Radio        46%       54% 
               Out of home        44.1%       55.9% 
 
Table 7.5—Relationships between traditional media sources and HIV status:  
HIV-positive respondents were more likely than HIV-negative people to get HIV/AIDS 
information from these sources. 
 
Respondents who were HIV-positive were more likely than those who were HIV-
negative to obtain information about the disease from television (!2  = 5.16; df = 1; 
p<0.024), radio (!2  = 8.07; df = 1; p<0.005), and out-of-home media (!2  = 4.7; df = 1; 
p<0.031). 
 
When looking for relationships between demographic variables and individual new 
media sources (See Section 7.4.2 for an explanation of this grouping), status was once 
again the most frequently significant variable, as shown in Table 7.6: 
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Kind of media selected HIV-Negative HIV-Positive 
HIV/AIDS websites 27.4% 72.6% 
On line newsletters 48.4% 51.6% 
Social media 53.8% 46.2% 
 
Table 7.6 —Relationships between new media sources and HIV status: HIV-positive 
respondents were more likely than HIV-negative people to get HIV/AIDS information 
from websites and newsletters and less likely to get information from social media. 
 
HIV-positive people were more likely than HIV-negative ones to get information 
from HIV/AIDS websites (!2 = 6.18; df = 1; p<0.014) and online newsletters (!2   = 
4.68; df = 1; p<0.032), but less likely to consult social media sources such as Facebook 
and Twitter (!2  = 5.74; df = 1; p<0.018).   
Not surprisingly, there was also a significant association between age group and use 
of social media; but curiously the 26-36 age group was more likely (52.4%) than the 18-
25 year-olds (26.2%) to obtain information from social media sources (!2  = 27.23; df = 
4; p<0.001). In the older age groups, cell sizes for social media selected were less than 
five, so were not considered.  
Additionally, sexual orientation was a significant variable for HIV/AIDS groups’ 
websites as information sources, with homosexuals (51.4%) being much more likely 
than heterosexuals (32.4%) or bisexuals (16.2%) to use this medium (!2  = 15.58; df = 
2; p<0.001). 
When examining individual interpersonal sources (See description of this grouping 
in Section 7.4.2), for relationships with demographic variables, status surfaced again as 
a significant variable in three sources, which are shown as Table 7.7. 
 
Kind of source selected HIV-Negative  HIV-Positive 
           Educational institution       48.8%      51.3% 
              Friends/family       44.4%       55.6% 
             Fellow workers       52%       48% 
 
Table 7.7—Relationships between interpersonal sources and HIV status. 
 
Those who were HIV-positive were more likely than HIV-negative respondents to 
obtain information from educational institutions (!2  = 6.96; df = 1; p<0.009) and 
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friends and family (!2  = 7.10; df = 1; p<0.009), while HIV-negative respondents were 
more likely to consult co-workers (!2  = 10.25; df = 1; p<0.002).   
The only other significant association to surface for this group of sources was 
between conventional medical doctors and ethnic group; where white/Caucasian showed 
a much higher reliance on MDs (51.7%) than did the other two main ethnic groups 
(blacks/African Americans: 28.8% and Hispanics: only 9%). (!2  = 21.11; df = 6; 
p<0.003). The other ethnic groups did not have sufficient cell counts to be considered. 
Printouts of significant cross tabulation tables and Pearson’s chi-square tests of 
association for the media sources discussed in this section are shown as Appendix F.1.a. 
 
7.5.2 Section B: credibility of sources  
Fewer categories with significant associations surfaced in Section B, with status 
once again having the most noteworthy differences. HIV-positive people were more 
likely than HIV-negative respondents to view educational institutions as Credible (58% 
vs. 42%) or Extremely Credible (57.4% vs. 42.6%). (!2  = 9.98; df = 4; p<0.042). Also, 
those who were HIV-positive were more likely than HIV-negative respondents to view 
their co-workers as Not at all Credible (81.6% vs. 18.4%) (!2 = 14.85; df = 4; p<0.006).  
Printouts of significant cross tabulation tables and Pearson’s chi-square tests of 
association for source credibility discussed in this section are shown as Appendix F.1.b. 
 
7.5.3 Section C: knowledge and perception statements: cross tabs with significance 
The 20 statements from this section of the survey were divided into the same 
groupings as those used in the descriptive analyses discussed previously: stigma, 
medical, and socio-political statements. 
 
Statistically significant responses to Stigma: cultural stereotypes  
When looking for relationships between the same five demographic variables used 
above (age, gender, status, sexual orientation, and ethnic group) and the individual 
knowledge and perception statements in the stigma group (See Section 7.4.4 for a 
discussion of this grouping), status was once again the most frequently significant 
variable for three of the statements and showed a tendency toward significance in two 
others as shown in Table 7.8. Only statement 15: HIV/AIDS infections are often a result 
of immoral behaviour, did not show a significant association with status. 
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Stigma statements—Strongly Disagree HIV-Negative HIV-Positive 
1. Poor people are more likely to get AIDS. 31.4% 68.6% 
3. HIV/AIDS is primarily a gay disease.** 38.4% 61.6% 
4. Getting HIV/AIDS is usually a death 
sentence. 
27.9% 72.1% 
10. HIV/AIDS is God's way of punishing the 
wicked.** 
39.4% 60.6% 
13. People with HIV/AIDS (do not) deserve the 
same rights in the workplace as other workers.* 
32.8% 67.2% 
*reverse phrasing was re-coded for analysis 
 **shows a tendency toward significance 
 
Table 7.8—Relationships between stigma statements and HIV status:  
HIV-positive respondents were more likely than HIV-negative people 
                    to strongly disagree   with each statement. 
 
Statements 1, 4, and 13 each showed a strong association with status (!2 = 9.85; df 
= 4; p<0.044, (!2 = 11.98; df = 4; p<0.018, !2 = 11.91; df = 4; p<0.019). Statement 3 
(!2 = 8.58; df = 4; p<0.074) and statement 10 (!2 = 9.42; df = 4; p<0.052) displayed a 
tendency toward significance. In every instance, although both agreed with the 
statements, HIV-positive people were more likely to strongly agree than those who were 
HIV-negative. Statement 1 also showed a tendency toward significance with ethnic 
group; whites were much more likely to agree (43.6%) than blacks or Hispanics (both 
23.6%). (!2 = 35.41; df = 24; p<0.062)  In this case, as in most cross tabulations 
involving ethnic group, only blacks, Hispanics, and whites consistently had sufficient 
cell counts to be considered. 
 
Statistically significant responses to Medical: prevention and treatment  
When looking for relationships between demographic variables and the individual 
knowledge and perception statements in the medical group (See Section 7.4.4 for a 
discussion of this grouping), ethnic group was significant for three of the statements and 
showed a tendency toward significance in one other as shown in Table 7.9. Only 
statement 6: Giving antiretroviral drugs to people not infected is a good way to prevent 
HIV/AIDS, did not show any significant associations.  
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           Medical statements—Disagree Black Hispanic White 
5. Antiretroviral drugs are a cure for HIV/AIDS.  33.6% 15.5% 41.4% 
9. You cannot get HIV/AIDS during sex if 
condoms are always used. 
29.2% 14.6% 46.7% 
11. An effective HIV/AIDS vaccine is available. 22.2% 16.2% 47.5% 
12. Alternative medical treatments for HIV/AIDS 
have (not)* shown promising results.** 
26.7% 23.3% 43.3% 
*reverse phrasing was re-coded for analysis 
 **shows a tendency toward significance 
 
Table 7.9 —Relationships between medical statements and ethnic group:  
Whites were more likely than blacks or Hispanics to disagree with each statement. 
 
This group shows a significant pattern in which whites were much more likely to 
disagree with each medical statement than either blacks or Hispanics, and blacks were 
more likely to disagree than Hispanics. (Statement 5: !2 = 40.55; df = 24; p<0.02; 
Statement 9: !2 = 45.21; df = 24; p<0.006; Statement 11: !2 = 50.45; df = 24; p<0.002; 
Statement 12: !2 = 33.37; df = 24; p<0.098). As with previous group comparisons, other 
ethnic groups had numerous cell counts below 5, so were not considered. 
Responses to statement 12 also indicated a significant relationship with age, 
showing that the 37-47 year-olds were much more likely to agree (38.6%) than 18-25 
year-olds (12.5%) or 26-36 year-olds (21.6%) (!2 = 37.99; df = 4; p<0.003). 
Sexual orientation was significant for Statement 8: A pregnant woman with 
HIV/AIDS cannot avoid having an HIV-positive baby) Heterosexual people were more 
likely to disagree (50.9%) than homosexuals (33.3%) or bisexuals (15.7%). (!2 = 9.85; 
df = 4; p<0.044). Conversely, homosexuals were more likely to disagree (50%) than 
heterosexuals (35.9%) or bisexuals (14.1%) with Statement 16: It is biologically easier 
for women to get HIV/AIDS than it is for men. (!2 = 16.91; df = 8; p<0.032).  No 
significant relationships were found for Statement 6: Giving antiretroviral drugs to 
people not infected is a good way to prevent HIV/AIDS. 
 
Statistically significant responses to Global: socio-political issues 
When looking for relationships between demographic variables and the individual 
knowledge and perception statements in the socio-political group (See Section 7.4.4 for 
a discussion of this grouping), results were mixed. Ethnic group was significant for 
three of the statements and showed a tendency toward significance in one other as 
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shown in Table 7.10.  Additionally, status was significant for two statements in this 
group and sexual orientation was significant for one statement. 
 
       Socio-political statements--Disagree Black Hispanic White 
2. Globally, the number of people with HIV/AIDS 
is decreasing.**  
34.3% 11.8% 47.1% 
14. Treating HIV/AIDS is (not)*a lucrative 
business for pharmaceutical companies.  
27.2% 17.4%   48.9% 
20. Worldwide, more people get HIV/AIDS by 
heterosexual contact than by homosexual contact.  
28.2% 11.5% 50% 
 *reverse phrasing was re-coded for analysis  
 **shows a tendency toward significance 
 
Table 7.10 —Relationships between socio-political statements and ethnic group: 
 Whites were more likely than blacks or Hispanics to disagree with each statement. 
 
This group shows a significant pattern in which whites were much more likely to 
disagree with each socio-political statement than either blacks or Hispanics, and blacks 
were more likely to disagree than Hispanics. (Statement 2: !2 = 36.29; df = 24; p<0.53; 
Statement 14: !2 = 39.43; df = 24; p<0.026; Statement 20: !2 = 39.8; df = 24; p<0.024). 
Status was significant for statement 14 above; HIV-positive people were much more 
likely than HIV-negative ones to strongly agree (77.3% vs. 22.7%: !2 = 11.66; df = 4; 
p<0.021). Likewise, status was significant for Statement 7: People who knowingly 
expose others to HIV/AIDS should be prosecuted as criminals, where HIV-positive 
people were much more likely to strongly disagree (81.5% vs. 18.5%) than HIV-
negative individuals (!2 = 15.25; df = 4; p<0.005). 
Statement 17: HIV/AIDS prevention efforts often receive more funding than 
treatment efforts, and 18: Young people under 25 account for almost half of new 
HIV/AIDS infections globally, had no significant relationships with any demographic 
variable. 
 Printouts of significant cross tabulation tables and Pearson’s chi-square tests of 
association for stigma, medical, and socio-political statements discussed in this section 
are shown as Appendix F.1.c. 
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7.5.4 Section D: recognised HIV/AIDS treatments 
When the relationship between status and treatments known was examined, five 
were found to have significant differences, which are shown in Table 7.11: 
Treatment known HIV-Negative HIV-Positive 
Vitamins-oral 22.6% 77.4% 
Minerals-oral** 21.9% 78.1% 
Peroxide-IV** 9.1% 90.9% 
Peroxide-oral** 10% 90% 
Nutritional supplements 23.7% 76.3% 
AZT 24.8% 75.2% 
HAART 25.8% 74.2% 
Pharm. antibiotics 21.9% 78.1% 
                       ** shows a tendency toward significance 
Table 7.11—Relationships between treatments known and HIV status: 
 HIV-positive respondents were much more likely than HIV-negative people 
 to recognise each of these treatments. 
 
Not surprisingly, in every case, HIV-positive respondents were much more likely to 
have heard of these treatments: Vitamins-oral (!2  = 5.47; df = 1; p<0.020); Nutritional 
supplements (!2  = 7.43; df = 1; p<0.007); AZT (!2  = 20.38; df = 1; p<0.001); HAART 
(!2  = 10.91; df = 1; p<0.002); and Pharmaceutical antibiotics (!2  = 17.44; df = 1; 
p<0.001).  Additionally, three other treatments showed a tendency toward significance 
that reflects the pattern of HIV-positive respondents being more likely to have heard of 
treatments. Those modalities were: Minerals-oral (!2  = 3.38; df = 1; p<0.067); Peroxide-
IV (!2  = 3.74; df = 1; p<0.054); and Peroxide-oral (!2  = 3.17; df = 1; p<0.076). 
Examining the relationship between sexual orientation and treatments known 
resulted in three being found to have significant differences, which are shown in Table 
7.12. 
Treatment known Heterosexual Homosexual Bisexual 
Nutritional supplements 30.4% 58.2% 11.4% 
AZT 38.4% 51.2% 10.4% 
Pharm. antibiotics 35.6% 53.4%       11% 
 
Table 7.12—Relationships between treatments known and sexual orientation: 
Homosexuals were much more likely to recognise each of these treatments. 
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For each treatment, homosexual respondents were far more likely to know of the 
modality than were heterosexuals or bisexuals (Nutritional supplements: !2  = 12.79; df 
= 2; p<0.003); (AZT: !2  = 12.48; df = 2; p<0.003); (Pharmaceutical antibiotics: !2  = 
11.04; df = 2; p<0.005). 
There were only two significant associations between known treatments and ethnic 
background in which expected frequencies were above five. In both of those cases—
Vitamins-oral and Nutritional supplements—whites were more likely to know of the 
treatments than blacks or Hispanics (Vitamins-oral: 57.7% white, 18.3% black, and 
13.3% Hispanic: (!2  = 17.27; df = 6; p<0.009); Nutritional supplements: 49.4% white, 
25.3% black, and 10.8% Hispanic (!2  = 17.14; df = 6; p<0.010). 
Understandably, a significant association was found between age and AZT, with 
34.9% of the 37-47 year-olds recognising the modality, compared with only 9.1% of 18-
25 year-olds (!2 = 14.97; df = 4; p<0.006). 
 
Printouts of significant cross tabulation tables and Pearson’s chi-square tests of 
association for treatments discussed in this section are shown as Appendix F.1.d. 
 
7.5.5 Section E: HIV/AIDS treatments considered effective: cross tabs with 
significance 
Examining the relationship between status and treatments considered effective 
showed seven to have significant differences, which are shown in Table 7.13. 
 
Effective treatment HIV-Negative HIV-Positive 
Silver colloid-IV 75% 25% 
Vitamins-oral 22.9% 77.1% 
Minerals-oral 18.2% 81.8% 
Nutritional supplements 22.4% 77.6% 
AZT 27.5% 72.5% 
HAART 23.9% 76.1% 
Pharm. antibiotics 17.4% 82.6% 
 
Table 7.13—Relationships between treatments considered effective and HIV status: 
 HIV-positive respondents were much more likely than HIV-negative people to 
 consider each of these treatments effective, except for silver colloid-IV. 
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With the exception of Silver Colloid-IV, which has much smaller counts than the 
other treatments shown in this table, HIV-positive people were far more likely than 
HIV-negative respondents to consider these treatments effective: Vitamins-oral (!2  = 
5.21; df = 1; p<0.023); Minerals-oral (!2  = 5.46; df = 1; p<0.020); Nutritional 
supplements (!2  = 7.61; df = 1; p<0.007); AZT (!2  = 6.23; df = 1; p<0.014); HAART 
(!2  = 13.59; df = 1; p<0.001); and Pharmaceutical antibiotics (!2  = 21.45; df = 1; 
p<0.001). In the case of Silver Colloid-IV, 75% of HIV-negative people considered the 
treatment effective while only 25% of HIV-positive respondents agreed (!2  = 5.21; df 
= 1; p<0.023).  
Nutritional supplements also showed significant relationships when cross-tabulated 
with age, ethnic group, and sexual orientation. Whites (37%) were somewhat more 
likely than blacks (31.5%) and far more likely than Hispanics (12.3%) to consider 
nutritional supplements effective (!2  = 21.35; df = 6; p<0.003). Additionally, 
homosexuals (59.2%) were much more likely than heterosexuals (29.6%) or bisexuals 
(11.3%) to view this treatment favourably (!2  = 12.31; df = 2; p<0.003). And finally, 
those aged 37-47 were most likely (36.0%) to consider nutritional supplements 
effective, followed by 48-58 year-olds (33.3%), and 26-36 year-olds (18.7%); 18-25 
year-olds were the lowest with 7% (!2  = 12.87; df = 4; p<0.013).  
Significant associations also surfaced for ethnic groups in relation to UVBI, 
selenium liver support, peroxide-oral, and porcine liver extracts, but the cell counts were 
under five in each. Lastly, a significant relationship was found between sexual 
orientation and pharmaceutical antibiotics, with homosexuals being more favourable 
(56.1%) than heterosexuals (32.7%) and bisexuals (11.2%) (!2  = 12.97; df = 2; 
p<0.003).   
Printouts of significant cross tabulation tables and Pearson’s chi-square tests of 
association for treatments discussed in this section are shown as Appendix F.1.e. 
A list of cross tabulation tables that showed NO significance is shown as Appendix 
F.2. 
 
7.6 SECTION C: FURTHER ANALYSIS OF GROUPINGS 
Principal component analysis was used to look for patterns in the 20 statements in 
Section C. This initial analysis showed some correlations, especially in the stigma 
grouping discussed earlier (See Section 7.4.4.) However, since the 20 statements were 
extremely diverse and many were subjective in nature, statistical associations were 
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somewhat tenuous, but did point toward groupings along the lines developed previously 
(Stigma, Medical, and Socio-political).  To ascertain reliability, statements with reverse 
phrasing were ‘turned around’ prior to running a Cronbach’s alpha analysis on each 
group to measure the consistency of the questions. According to Field, Cronbach’s alpha 
is the most common measure of scale reliability, and a value of 0.7 or 0.8 is often 
quoted as acceptable for cognitive tests such as intelligence assessments (2009:674).  
However, when ‘dealing with psychological constructs, values below 0.7 can 
realistically be expected because of the diversity of constructs being measured’ (Kline, 
1999, cited by Field, 2009, p. 675). Wincent and Westerberg also cite research where 
alpha values were ‘rather modest’(":0.58 and 0.50), but point out they are within the 
minimum level for exploratory studies, which can consider values down to 0.50 as 
acceptable (2005, p. 279).  Field cautions that Cronbach’s results can show higher 
values when there are a lot of items on the scale and not because the scale is necessarily 
reliable (2009, p. 675). Wincent and Westerberg also note the Cronbach’s alpha 
coefficient depends on the number of items in the construct (2005, p. 279). 
With these guidelines and cautions in mind, Cronbach’s alpha analyses were used to 
test whether the three subjective groups’ items were homogenous.  The stigma group 
(re-named the Hedonist/Moralist) was analysed and showed a strong reliability 
(Cronbach’s ":0.685). Analysis indicated, however, that re-grouping and re-coding 
some of the remaining statements would provide higher reliability, so the Cautious 
Optimist/Raving Pessimist group (Cronbach’s ":0.619) and the Global Activist/Political 
Ostrich group (Cronbach’s ":0.514) were created.   
Printouts of reliability statistical tables using Cronbach’s alpha analysis are shown 
as Appendix F.3. 
 
7.6.1 Group 1: The hedonist or the moralist is aware of stigma and stereotypes toward 
those affected by HIV/AIDS and has strong opinions about how people living with 
AIDS are treated in society. He or she probably knows people who are affected by the 
disease and may be personally HIV-positive. The statements included in this group 
analysis are shown as Table 7.14. 
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Poor people are more likely to get HIV/AIDS.** 
HIV/AIDS is primarily a gay disease. ^ 
Getting HIV/AIDS is usually a death sentence. ** 
HIV/AIDS is God's way of punishing the wicked. ^ 
HIV/AIDS infections are often a result of immoral behaviour. 
People with HIV/AIDS (do not) deserve the same rights in the workplace as other 
workers. ** 
                      **With statistical sig. relating to status 
    ^With a tendency toward sig. relating to status 
 
Table 7.14— Defining statements for the moralist or hedonist: The moralist would be 
likely to agree with these statements; the hedonist would probably disagree. 
 
7.6.2 Group 2: The cautious optimist or the raving pessimist may not have the most 
current facts, but likes to believe the future looks somewhat promising regarding reducing 
the rate of HIV infections. He/she harbours hope that people with AIDS can look forward 
to increasingly effective treatments. The statements included in this group analysis are 
shown as Table 7.15. 
 
Globally, the number of people with HIV/AIDS is decreasing. ** 
Antiretroviral drugs are a cure for HIV/AIDS. (ethnic/status) ** 
Giving antiretroviral drugs to people not infected prevents HIV/AIDS. 
You cannot get HIV/AIDS during sex if condoms are always used. ** 
An effective HIV/AIDS vaccine is available.** 
Alternative medical treatments for HIV/AIDS have shown promising results. ^ 
** With statistical sig. relating to ethnic group 
^ With sig. relating to age and a tendency to sig. with ethnic group 
 
Table 7.15—Defining statements for the cautious optimist or the raving pessimist: 
 The cautious optimist would be likely to agree with these statements, 
 while the raving pessimist would probably disagree. 
 
7.6.3 Group 3: The global activist or the political ostrich is aware of some of the global 
issues surrounding HIV/AIDS and is not sure policy makers and leaders are making the 
right choices regarding the disease. He/she has some strong opinions about prevention and 
treatment policies but may not fully understand complicated medical issues. The 
statements included in this group analysis are shown as Table 7.16. 
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A pregnant woman with HIV/AIDS cannot avoid having an HIV-positive baby.* 
Treating HIV/AIDS is a lucrative business for pharmaceutical companies.^$ 
It is biologically easier for woman to get HIV/AIDS than it is for men. * 
HIV/AIDS prevention efforts often receive more funding than treatment efforts. 
Worldwide, more people get HIV/AIDS by heterosexual contact than by homosexual 
contact. $ 
Getting HIV/AIDS is usually a death sentence. ^ 
People who knowingly expose others to HIV/AIDS should be prosecuted as criminals. ^ 
 * With statistical sig. relating to sexual orientation 
  ^ With sig. relating to status 
  $ With sig. relating to ethnic group 
 
Table 7.16—Defining statements for the global activist or the political ostrich:  
The global activist would be more likely to agree with these statements, although he/she 
would not always be correct regarding statements of fact. 
 
These three groupings help to build profiles of the target audience that could be 
useful in better understanding the customer, thereby contributing to a more focused 
strategic marketing approach. 
 
7.7  CONCLUSIONS  
Pre-survey interviews helped form a picture of the local situation regarding 
HIV/AIDS in the Houston, Texas, area. Increasing HIV/AIDS prevalence rates indicate 
a need for information, and more importantly, as key informants indicated, for education 
about treatment and prevention of the disease. It was apparent during pre-survey 
interviews that although plenty of HIV/AIDS information is now available from a 
variety of sources, it is fragmented, confusing, and incomplete, particularly regarding 
treatment options. After interviewing key informants from medical, advocacy, and 
marketing disciplines, it appeared that people either are not accessing important 
information or, even if they have information, they do not understand the complexity of 
the disease and its treatments. Funding at the local level for educational campaigns is 
sparse, and national funds, when they can be obtained, often come with stipulations 
regarding message content. Gaps in knowledge are a recognised problem, especially for 
HIV-positive MSM in Houston, according to statistical research compiled by a coalition 
of agencies in the city. The AIDS epidemic has changed the nature of public discourse, 
making once taboo topics open for conversation and debate. 
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These observations and background statistics helped shape a knowledge and 
perceptions survey directed to visitors of an HIV/AIDS clinic in Houston. The 
demographic highlights of the 342 valid responses included: 66% male; 42% 
heterosexual, 38% homosexual, and 10% bisexual; 37% white, 36% black, and 16% 
Hispanic; 48% high school graduates and 33% college graduates. Regarding HIV status, 
31% were negative and 54% were positive.  
Responses from each of the four sections of the survey were illuminating and 
individual comments were informative and poignant.  
   
Information sources and credibility 
‘We need more education in schools. Many people believe the numbers 
are going down drastically and there is a readily available cure’. 
 
‘Knowledge is power!’ 
 
‘Censorship of information based on religious beliefs is 
unethical…some religious organisations try to enforce their beliefs on 
those in need.’ 
 
‘It’s sad we have gotten comfortable with these diseases. To really 
educate yourself, you have to make an effort.’ 
     —Legacy Clinic survey respondents 
 
In summary, as shown in Table 7.17, based on data supplied by the 342 respondents, 
without separation by any demographic classification, the top six sources (by 
percentage) of ALL information sources MOST likely to be the basis for information 
about HIV/AIDS were in descending order: 1) television, 2) magazines, 3) 
family/friends or 4) newspapers (both 48.2%), 5) radio, and 6) books. However, when 
asked to rate the credibility of those sources, the top six rated as Credible or Extremely 
Credible were: 1) medical websites or 2) conventional medical doctors (both 57%), 3) 
television, 4) books, 5) HIV/AIDS websites, and 6) magazines.  Significantly, three 
traditional media sources appear in both ‘top six’ lists: television, magazines, and books. 
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      Most popular sources  
      1.   Television 
2. Magazines 
3. Family/friends  
OR Newspapers (both 48%) 
4. Radio 
5. Books 
      Most credible sources 
1. Medical websites 
      OR Conventional MDs (both 57%) 
2. Television 
3. Books 
4. HIV/AIDS websites 
5. Magazines 
 
Table 7.17—Summary of the MOST popular and the MOST credible sources 
of HIV/AIDS information. 
 
At the other end of the spectrum, as shown in Table 7.18, the six sources LEAST 
likely to be the basis of information about the disease were, beginning with the smallest 
percentage: 1) alternative medical doctors, 2) social media, 3) emails, 4) blogs/online 
bulletin boards, 5) religious organisations, and 6) e-newsletters.  However, the six 
sources with the lowest credibility rating—the six with the highest percentage of Not at 
all Credible responses—were, beginning with the highest percentage: 1) social media, 
2) fellow workers, 3) religious organisations, 4) emails, 5) family/friends, and 6) 
blogs/online bulletin boards.  No traditional media sources fell into this least credible 
group.  
 
Least popular sources  
      1.  Alternative MDs 
2. Social media 
3. Emails 
4. Blogs/online bulletin boards 
5. Religious organisations 
6. E-newsletters 
      Least credible sources 
1.   Social media 
2. Fellow workers 
3. Religious organisations 
4. Emails 
5. Family/friends 
6. Blogs/online bulletin boards 
 
Table 7.18—Summary of the LEAST popular and the LEAST credible sources 
of HIV/AIDS information. 
 
Treatments and effectiveness 
‘I am not very familiar with HIV/AIDS and its treatments or lack 
thereof. It's okay to say I am not very educated in this matter.’ 
 
‘Lots of treatments....I didn't know any of them.’   
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 ‘I have been positive for 30 years and have never taken any drugs ever 
for the illness.’  
 
‘I didn’t check any treatments because I have never heard of any of 
 them.’  
                  —Legacy Clinic survey respondents 
 
As indicated by survey data and by comments such as the ones above, 
respondents were woefully uninformed about both conventional and 
alternative treatments for HIV/AIDS. These survey results confirm previous 
studies (See Section 7.2.3.) showing a knowledge gap about treatment 
options, especially among HIV-positive people. Given this audience’s 
relatively high level of education, the obvious conclusion is that this high-
risk, high-interest group is not well educated about HIV treatment facts. This 
is a cause for concern and a justification for action. 
 
Knowledge and perceptions 
‘Taking this survey made me realise how much I don't know about 
HIV/AIDS.’ 
 
‘Having four friends with HIV, I still don't know what they go through 
to stay well every day. I feel it’s not an open subject to talk about.’  
 
‘I have had a family member living with AIDS for 10 years. I have 
seen her almost die five times. I believe given funding a cure could be 
found. I have to hope.’  
           —Legacy Clinic survey respondents  
 
Responses to the knowledge and perceptions statements also indicate a lack of 
knowledge about established medical facts, such as how HIV infection can be prevented 
(For example, 32% agree or don’t know if condoms are 100% effective against 
infection.), the status of an HIV/AIDS vaccine (Over 46% either think there is an 
effective vaccine or don’t know if one exists). Additionally, although the majority of 
responses repudiated discriminatory and stigmatising statements such as HIV/AIDS is 
God’s way of punishing the wicked, almost 16% either agreed with that or were not sure. 
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Responses to socio-political questions were more uniform, with more than half agreeing 
that treating HIV/AIDS is a lucrative business for pharmaceutical companies and that 
people who knowingly expose others to the disease should be treated as criminals. Once  
again, a lack of knowledge about global disease trends was apparent when more than 
half (57.6%) disagreed with the established statistic that more people worldwide get 
HIV/AIDS by heterosexual than homosexual contact. 
Cross tabulation analysis for statistical associations between responses to the four 
sections of the survey against demographic variables (age, gender, sexual orientation, 
ethnic group, and HIV status) showed the most frequent relationships to involve HIV 
status. Of a total of 81 significant (or with a tendency toward significance) relationships, 
36 (44%) related to status, followed by 21 (26%) relating to ethnic group. Surprisingly, 
gender was only a significant factor in four cases, which all related to media sources. 
These findings further support the conclusion that an educational campaign regarding 
HIV treatment options should target HIV-positive individuals. The three profile groups 
that emerged during reliability analyses can provide useful background in developing 
such a campaign. 
In the following chapter, key informants discuss their reactions to the survey results 
and provide updates on the changing AIDS landscape from medical and advocacy 
perspectives. Their comments, in combination with information amassed during this 
research project, will assist in crafting a communication model for HIV/AIDS social 
marketing directed to an audience similar to the surveyed group. 
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CHAPTER 8 
AN HIV/AIDS COMMUNICATION MODEL  
PUTTING KNOWLEDGE TO WORK 
 
8.1 INTRODUCTION 
To address the gaps in knowledge identified during this research in a practical way, 
the final phase of the project was to create a communication model for a social 
marketing campaign. This model drew on the most effective techniques identified by 
secondary and primary campaign analysis, was informed by insights from opinion 
leaders associated with different aspects of HIV/AIDS, and utilised information gleaned 
from survey responses. As discussed in Chapter 7, these responses provided useful 
insights regarding popular sources of HIV information and their perceived credibility, as 
well as feedback about treatment options, and opinions on cultural, medical, and socio-
political issues. 
At this final stage of the project, the researcher had accumulated a rich resource of 
quantitative and qualitative material, that when examined in a holistic, transdisciplinary 
manner, had meaningful theoretical and practical implications. Building an effective 
communication model for an HIV/AIDS campaign directed to a targeted audience 
involved numerous choices that integrated theory and practice from academic sources 
and from professionals. Incorporating successful ideas gleaned from researchers and 
stakeholders meant bridging the boundaries of several disciplines and reconciling the 
many paradoxes inherent in a multi-dimensional, complex global problem.  The 
challenge was to see the HIV/AIDS conundrum from a holistic ‘big picture’ view, and 
then to craft a customised approach for a targeted audience with a specific 
communication goal. Using this kind of transdisciplinary approach was an ideal way to 
draw together a large body of disparate data and transform it into a plan for practical 
implementation. This integration of disciplinary knowledge cultures led to the 
development of new common methods and, through reflection, to a choice-based 
communication process that addressed knowledge gaps identified during previous 
research stages. 
The information available for this transdisciplinary fusion was extensive and 
diverse, encompassing theory and processes for social marketing in general and the 
lessons learned from previous HIV/AIDS social marcoms. Those lessons were often 
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ambiguous and contradictory, especially regarding use of fear, cross-cultural 
approaches, and reality-based social marketing. The relatively brief history of 
HIV/AIDS social marketing and a lack of scientific campaign evaluation added to an 
uncertain overall picture. A diverse group of key informants from multiple disciplines 
offered both collaborating and wildly divergent viewpoints. Survey data from more than 
340 respondents at an AIDS clinic in Houston yielded intriguing glimpses into 
knowledge gaps and misperceptions about the disease from an audience the 
researcher—and the Legacy Clinic administrators—had expected to be much better 
informed about the disease. In addition, those respondents’ media use patterns provided 
useful direction for future message dissemination, and their comments offered valuable 
anecdotal information. Up-to-date medical information made the message content for 
the model current and in line with recommended modalities.  
Before beginning the integration process for this wealth of material, reaction 
interviews to the initial survey results were conducted with two respected HIV/AIDS 
doctors (one alternative and one conventional), administrators at the clinic where the 
survey was conducted, and a long-time HIV/AIDS nurse/activist who was the director of 
a major AIDS research consortium in Houston. The question bank for the reaction 
interviews is shown as Appendix B.6.  
From this amassed quantitative and qualitative material, a four-stage process was 
developed to demonstrate how to understand the target audience, create a plan to 
motivate behaviour change, take action to promote that change, and evaluate short- and 
long-term results. This customised campaign process used choices and inputs tailored to 
an HIV/AIDS social marcon specifically for HIV-positive individuals. Based on this 
process, an audience-centred, participatory ‘marketing conversation’ model was created. 
In keeping with the participatory style of social marketing, which always involves 
interpersonal conversations and interventions, this model was called a social marcon, or 
social marketing conversation (Moran, 2007), to indicate the importance of 
transdisciplinary participation and social interaction. As explained in Chapter 7, analysis 
of survey research, buttressed by secondary and primary qualitative information, 
revealed a need for a prevention and treatment campaign directed specifically to HIV-
positive people, so the application of the model was based on unique inputs from this 
research project.  However, the communication model and its practical application, as 
presented in this chapter, are adaptable for other HIV/AIDS audiences. 
This chapter first summarises key informants’ reactions to the survey results, then 
discusses the elements and pitfalls of a communications model. The four–stage, choice-
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based process for developing an HIV/AIDS prevention and treatment social marcon is 
presented next. These four stages form the basis for the researcher’s own integrated 
social marcon model. 
 
8.2 AIMS AND OBJECTIVES 
• Develop a communication model, informed by research Phases 1-3, incorporating 
CAM information about HIV/AIDS. 
 
8.3 QUESTIONS ADDRESSED 
• Could social marketing bridge the knowledge gap between conventional and CAM 
choices for HIV/AIDS treatment and prevention?  
• What elements should be incorporated into a campaign that would effectively 
communicate about HIV/AIDS prevention and treatment options? 
 
8.4 REACTION INTERVIEWS 
At the end of research Phase 3, in-depth interviews were conducted to follow up on 
some of the issues that had surfaced, to seek updates in the ever-changing world of the 
HIV/AIDS epidemic, and to solicit feedback to the survey responses. Key informants 
included Dr. Mark Nichols, vice president of clinical affairs for the Bering Dental Clinic 
in Houston, Paul Simmons, executive director of the Center for AIDS in Houston, and 
Dr. Jacques Clermont, collaborator for INSERM, France’s National Institute of Health 
and Medical Research. Also, Tina Megdal, senior director of client services, and Amy 
Leonard, health educator, both with Legacy Clinic, provided observations on the survey 
results.  A list of key informants interviewed post-survey with brief biographical 
information for each, is shown as Appendix B.9. 
 
8.4.1 The conventional medical doctor’s perspective 
Given that Houston has the fourth largest population of people with full-blown 
AIDS in the United States (behind New York City, Philadelphia and Chicago), the city’s 
AIDS facilities often serve as national and international models. Houston’s infection 
rate is nearly twice the national average, with African Americans accounting for more 
than half of the new infections each year (Bering Omega website, 2010). Bering Omega 
Community Services provides healthcare and social services to one in three people with 
HIV or AIDS in the Houston area, targeting the 50% of those living with HIV/AIDS 
who are ‘indigent, uninsured, and under-served HIV-positive individuals and their 
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caregivers who have no other healthcare alternatives’ (Bering Omega website, 2010). 
Dr. Mark Nichols is one of the world’s foremost authorities on HIV oral pathology for 
immune-deficient individuals.  Under his direction, the Bering Omega Dental Clinic has 
become a United Nations model agency. 
Nichols commented that Houston’s high HIV/AIDS prevalence rate can be 
attributed, at least in part, to the city being a ‘gay mecca’ in the southern United States 
and that a high concentration of minorities have returned to the city because they feel 
comfortable in its gay community. To reduce future infections, Nichols supports 
informational campaigns directed to youths beginning as young as age 10. He doesn’t 
think abstinence programmes are working and advocates supplying teens with condoms 
to reduce the risk of infection. He realises that is not a popular idea because many 
Americans have problems dealing with the concept of a sexually transmitted disease.  
He was not surprised by the survey responses indicating lack of confidence in 
conventional HIV/AIDS treatments (35% thought AZT was effective and 40% thought 
HAART was effective) ‘Drug cocktails don’t work for everyone,’ Nichols said.  About 
one-third of survey participants were unsure if an HIV/AIDS vaccine was available and, 
although Nichols knows there is no vaccine for the disease, he shares their ambivalence; 
‘I am pessimistic about a vaccine,’ he said. For those who do take drug cocktails, the 
financial cost is high; as much as $20,000 a year for medical care, drugs, and treatment 
for HIV-related illnesses. Nichols pointed out more than 50% of Bering Omega’s clients 
earn less than $6,000/year, so without subsidised funding at clinics such as Omega, 
HAART treatment would be impossible (The 2009 poverty level guideline in the U.S. 
was $10,830/year.) (U.S. Department of Health, 2009). Beyond those immediate 
problems, Nichols agreed with the survey responses that the larger challenge is to 
remove the stigma associated with HIV/AIDS. 
 
8.4.2 The HIV/AIDS advocate’s perspective 
Unfortunately, as is the case worldwide, prevention efforts are not curbing the 
spread of HIV in the Houston area (Bering Omega website, 2010). The Center for AIDS 
Information and Advocacy (CFA) bridges ‘the gap between the science of HIV/AIDS 
and the community’…advocating locally and nationally for better treatments and better 
access to care for people living with HIV/AIDS while keeping the community 
‘informed, updated, and involved in the search for a cure’ (Center for AIDS website, 
2010). Paul Simmons is a board-certified nurse for HIV care, but has spent the last five 
years in advocacy positions. As director of CFA, Simmons commented that he 
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remembers when hospitals had special units for HIV/AIDS patients to separate them 
from the general population. This served to further accentuate the stigma and 
misperceptions associated with the disease. Although the medical hysteria is gone now 
that HIV/AIDS has shifted from an acute to a chronic disease, Simmons agreed with 
Nichols that Americans are conflicted about sexuality and PLWHA are still highly 
stigmatised. He believes in involving HIV/AIDS patients in every facet of 
communication programmes: ‘When patients are informed and involved, they can have 
a profound influence’ on curbing infection rates, Simmons said.  
But lack of information is not the problem. ‘The 50,000 HIV/AIDS cases in Houston 
are not the result of cognitive information deficits; the problem is high-risk behaviour.’ 
He thinks an answer might lie with a new treatment programme the CFA is launching in 
Houston. The HIV/AIDS equivalent of the ‘morning after’ birth control pill, Post 
Exposure Prophylaxis (PEP) starts HIV drugs within 72 hours of a suspected exposure 
to HIV. Houston is the second city in the U.S. to offer a PEP programme, and Simmons 
has high hopes it will help reverse the increasing rate of infection. He said the upsurge 
in risky behaviour and the ensuing rise in infections are occurring because ‘HIV-positive 
people are fatigued; they have technology-mediated sex lives and they are tired of that.  
People with HIV are the medical equivalent of skydivers; they are risk-takers and thrill 
seekers.’  
 
8.4.3. The alternative doctor’s perspective 
Dr. Jacques Clermont has been involved in cutting-edge nanotechnology research 
for alternative HIV/AIDS treatments for more than a decade. He directed a clinic in 
Mexico that treated AIDS patients using those modalities. He was surprised that survey 
participants were ‘incredibly ignorant about the number of treatments available for 
HIV/AIDS as well as their effectiveness’ and that so many respondents ‘didn’t know 
what HAART was even though they were probably receiving it.’ Clermont said the 
attitude toward alternative treatments in Mexico is much more positive than in the U.S. 
‘In general, people are more inclined to use indigenous/traditional medicine. They are 
acclimated to it and it is cheaper.’ But, as shown by survey respondents’ positive or 
neutral view of alternative treatments for HIV/AIDS (44% agreed that alternative 
treatments have shown promising results and 42% were not sure), CAM is finding 
increasing favour in the U.S. According to Clermont, this is due in part to the public’s 
lack of trust in pharmaceutical companies and concerns about side effects of synthetic 
medicines. ‘Ninety-two to 96% of all Americans, led by women concerned about their 
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children, are using alternative medicines.’ Clermont said this movement toward CAM 
would not be possible without medical websites, one of the survey respondents’ most 
credible sources for HIV/AIDS information.  
Clermont also pointed out market forces influence information available through 
traditional mass media. ‘In the U.S., 26% to 45% of broadcast media advertising is paid 
for by mega-corporations. The synthetic conventional medical business wants 
everything to be a chronic disease [creating] lifetime drug treatments and therefore 
lifetime sales. AIDS has become a for-profit industry.’ Although almost 20% of the 
survey recipients agreed that condoms always ensured ‘safe sex,’ Clermont pointed out 
that 60 years of research has proven time and again that condoms have on average an 
80% success rate. ‘A 20% failure rate may be acceptable if you’re trying to have two 
babies instead of four, but for controlling sexually transmitted diseases like HIV/AIDS, 
this is a devastating figure.’  
 
8.4.4. HIV/AIDS clinic administrators’ reactions 
Like the key informants above, Legacy Clinic administrators Tina Megdal and Amy 
Leonard were ‘surprised and dismayed’ by the many prevention and treatment 
knowledge gaps revealed by the survey. (See Chapter 7.) They were also concerned that 
even small percentages of respondents would agree with stigmatising and discriminatory 
statements such as HIVAIDS is primarily a gay disease (17.6% agreed or were not sure) 
and HIV/AIDS is God’s way of punishing the wicked (15.8% agreed or were not sure). 
Overall, Megdal and Leonard viewed the survey results as an indication that Legacy 
Clinic needed to initiate more conversations with clients about these issues, keeping in 
mind the information sources that were popular and credible.   
 
8. 5 LESSONS LEARNED 
As HIV/AIDS moved from being regarded as solely a health issue affecting specific 
groups to being perceived as a development issue with global ramifications, 
communication programmes, especially for prevention, have been given the task of 
solving a range of problems associated with the disease. When funds became available, 
social marcoms were hastily launched in great numbers. The content analysis in Chapter 
5 revealed many of these campaigns used similar approaches, and that half of the 
initiatives analysed have been adapted for re-use. The importance of strong and diverse 
communication efforts was a given in every initiative, but cultural and moral 
controversies frequently arose in response to the campaigns. 
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After two decades of implementing HIV/AIDS social marcoms in countries all over 
the world, researchers and marketers began stepping back to take stock of lessons 
learned and approaches that seemed to be making a difference. In 2001, a 
comprehensive report by the Food and Agriculture Organisation of the United Nations 
published suggestions for a communication plan for HIV prevention and mitigation in 
Sub-Saharan Africa, where the epidemic had already killed more than 11 million and 
infected another 24.5 million (Michiels, 2001).  The report asserted that the 
communications approach should be research-based, multi-sectoral (using multiple 
agencies and organisations), gender-sensitive, participatory, culturally and socially 
appropriate, and in full respect of human rights. Michiels suggested that whenever 
possible, it was important to ‘empower, strengthen and support community-based 
initiatives rather than imposing externally planned programmes’ and that people living 
with HIV/AIDS should actively participate in problem-solving and implementing 
responses (Michiels, 2001, p.2).  
Also, the report recommended breaking the ‘conspiracy of silence’ surrounding the 
epidemic through information dissemination and using appropriate communication 
programmes to address stigma and discrimination (Michiels, 2001).  Michiels made a 
distinction between the use of institutional communication (to strengthen multi-sectoral 
teamwork, build support of policy-makers, and keep a dialogue open among 
stakeholders), educational communication (to energise training, promote reflection at 
the community level, and increase effectiveness of front-line communicators), and 
social communication (to allow community mobilisation, create social dialogue on 
sensitive issues, and foster informed decision making and social change) (2001).  
Overall, the report concluded that the communication focus in the future should 
concentrate on encouraging safer sex practices and avoiding further infections by 
increasing the knowledge of at-risk groups. In addition, the report recommended 
communication programmes to inform PLWHA about diet, nutrition, and safer sex 
(Michaels, 2001). 
As previously noted in Chapter 2, of the Sub-Saharan African nations, Uganda has 
often been seen as a model for decreasing HIV/AIDS prevalence. A 2002 USAID report 
summarised the factors that contributed to Uganda’s relatively successful national 
response:  
• President Museveni publicly acknowledged Uganda's AIDS problem and  
committed to mobilising efforts against it.   
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• A budget for a national AIDS programme was established early in the 
epidemic.   
• Uganda adopted a multi-sectoral approach to HIV/AIDS prevention.   
• The Uganda AIDS Commission was established.  
• AIDS control programmes were established in several government ministries.  
• Political, community, and religious leaders became involved in the response.   
• Radio messages on HIV/AIDS were broadcast widely.   
• Condom social marketing, backed by USAID, was implemented  
countrywide (Husain & Bery, 2002). 
 
One of the most comprehensive evaluations of multiple AIDS campaigns in the 
United States was published in 1996, and assessed 37 AIDS prevention and service 
projects funded by the Robert Wood Johnson Foundation. The foundation also issued a 
grant to conduct a process evaluation of the initiatives with the purpose of identifying 
lessons learned, including promising strategies and obstacles to implementation (Janz, et 
al., 1996). Not surprisingly, all programmes took a multifaceted approach to AIDS 
prevention. Rated as the top four activities in effectiveness were small-group 
discussions (61%), outreach to high-risk populations (28%), train peers/volunteers 
(23%), and provide safer-sex kits (22%) (Janz, et al., 1996). Interestingly, intervention 
activities that were never rated among the most effective included counselling for the 
patient, family members or significant others, and educating policy makers. The 
researchers concluded recipients of HIV/AIDS information were more likely to learn 
when messages were presented in multiple formats using different communications 
strategies. The central lesson, they concluded, was that AIDS prevention activities 
should be ‘flexible, tailored, repeated, credible, and involve members of the target 
population in the process’ (Janz, et al., 1996, p.95). 
Evaluations of HIV/AIDS initiatives are ongoing, but many of the lessons learned 
are similar to the ones discussed above. In 2009, the National Social Marketing Centre 
in the UK assembled an Internet database, ShowCase, of ‘fully researched social 
marketing campaign case studies to demonstrate that social marketing can achieve and 
sustain positive changes in people’s behaviour to promote healthy lifestyles’ (National 
Social Marketing Centre, 2010). Like the campaign evaluations already mentioned, the 
ShowCase campaigns used a strong mix of intervention techniques.  Also, the health 
campaigns all incorporated national social marketing benchmark criteria, including 
understanding and segmenting the audience, focusing on behavioural theory, and 
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utilising the classic marketing exchange concept (National Social Marketing Centre, 
2010). 
 
8.6 CROSS-CULTURAL MARKETING IN A GLOBAL ECONOMY 
If HIV/AIDS social marketing campaigns are being designed and implemented 
according to ‘the rules’ of the discipline, why is the pandemic continuing to spread and, 
according to some studies, worsen? As discussed in Chapter 2, one of the broad 
criticisms of HIV/AIDS initiatives has been lack of appropriate cultural roots and 
market segmentation. Both of these concepts are integral to the social marketing 
process, but incorporating them into campaign design is complex and difficult. Despite 
globalisation, cultural variations are infinite and target audiences are difficult to 
categorise in neatly defined groups.  The ease and speed of global communication has 
allowed marketers to bridge national borders with ease; global brands like McDonalds 
and Coke are recognised all over the world, but behavioural change concepts are not 
readily communicated across cultures.  
The history of international marketing is full of cultural and translation blunders that 
are amusing in retrospect but were embarrassing and costly for advertisers. Marketers 
have realised one size does not fit all; generic marketing messages are not effective 
across cultural divides (Mueller, 1996). Even in a world where globalisation and 
technology facilitate international conversations, cultural differences, combined with 
economic disparities, are deep and wide. Marketers know that messages must be tailored 
and appropriate. Cross-cultural marketing focuses on the differences between 
communication styles and needs among people of different cultures. The first step in 
cross-cultural marketing, according to Tian, is to recognise that no culture is superior to 
another: ‘There is no room for ethnocentrism in the 21st Century marketing practice’ 
(2009, p.2).  The paradox of international marketing is that the world is becoming more 
homogeneous, with distinctions between national markets fading and disappearing for 
many products, but, on the other hand, the ‘differences among nations, regions, and 
ethnic groups in terms of cultural factors …become more obvious’ (Tian, 2009, p.1). 
Hermeking agreed in a discussion of his research into how culture affects media 
consumption and preferences. The prediction that culturally different markets would 
converge into a world culture that would facilitate standardised global marketing is now 
recognised as an illusion. Cultures are not converging; ‘too many non-cultural hard 
factors and cultural soft factors still exist or arise [requiring] strategies of adaptation or 
localisation,’ Hermeking said (2005, p.1).  He also pointed out that people prefer local 
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brands, so smart marketers localise their products or services and advertise them as if 
they were from the home country rather than from a foreign country (Hermeking, 2005). 
While cultures are often thought of as varying across countries, it is important for 
marketers to realise that variations within cultures may be even greater than variations 
between cultures. Mueller pointed out that each culture has numerous subcultures—
‘groups of people with shared value systems based on common experiences’ (1996, p. 
88-89). Subcultures can be based on categories such as nationality, racial or political 
groups, geography, age, or income. People can belong to several subcultures at the same 
time, further complicating the task of market segmentation. 
Cross-cultural marketing, then, is international marketing on a personalised level. It 
requires finding a balance between localisation and globalisation, and, perhaps most 
importantly, it requires implementing strategies that respect differences while seeking to 
unify brand messages (Defining cross-cultural marketing, 2009).  Without a doubt, 
communicating to people of diverse cultures is one of the greatest challenges in 
marketing communications (Mueller, 1996). 
 
8.7 MODELS ARE STILL PICTURES OF A MOVING PROCESS   
Communication models are a good example of this paradox of globalisation vs. 
localisation. They offer an organised process that can be used for tailoring 
communication messages to specific groups. In other words, models try to standardise 
global trends while providing a blueprint for customisation or localisation. The 
challenge is identifying the best model for the communication goal and tailoring it 
appropriately. In HIV/AIDS social marketing, this challenge is particularly complex—
HIV/AIDS is a global health problem that affects thousands of subcultures. As 
discussed in the literature review (See Chapters 2 and 3), HIV/AIDS issues such as 
stigma, poverty, and medical questions cross all boundaries, but underlying causes, 
motivators, and implications vary widely.  Perhaps because of the overwhelming 
complexity of the problem, social marketing campaigns for HIV/AIDS often repeat the 
same formulas and rely on the same models as used in previous campaigns (See content 
analysis in Chapter 5).  
Volumes of literature discuss the nature of models, their strengths, and their 
shortcomings. In brief, a model is sometimes described as a metaphor that portrays an 
event in an abstract form, thereby bringing order and coherence to complexity 
(Mortensen, 1972). Most importantly, models should have heuristic value, offering new 
ways to conceive of hypothetical ideas and relationships (Mortensen, 1972).  The 
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dangers inherent in using models include oversimplification; abstraction by nature is a 
simplifying process, so the resulting model cannot encompass the complexities of the 
subject matter under inquiry and may miss important points of comparison (Chapanis, 
1961). Critics also warn that a model cannot consider all the possible variables and their 
relationships to the communication process, so models should not be confused with 
reality (Mortensen, 1972). Additionally, Kaplan said using a model limits awareness of 
unexplored possibilities of conceptualisation and may crystallise our thoughts at a stage 
when they would be better left in solution (1964).  
 
8.7.1 Evolution of communication models 
Nevertheless, communicators have been building models since Aristotle developed 
his Model of Communication, and centuries of model building since then have provided 
a staggering number of possibilities for social marketers to choose among. Aristotle’s 
model was prescriptive, designed to instruct people to be effective persuasive speakers, 
but modern-day models are likely to be descriptive, with the goal of describing, 
predicting, or controlling communication (Littlejohn & Foss, 2009). Early models 
portrayed communication as a mechanistic process, showing messages travelling 
through channels in a linear fashion. Shannon’s information theory model (1948), which 
broke the communication process down into eight components, beginning with the 
source and ending with the destination, is often seen as the beginning of the modern 
field.  It offered a general model that provided common ground for diverse disciplines 
such as journalism, rhetoric, linguistics, and speech (Foulger, 2004). It is, therefore, the 
most influential linear model, and a version of it often appears in communication 
textbooks.  
Linear communication models based on the Shannon model are message-centred, 
depicting communication as action in which a source transmits a message through a 
channel to a receiver. This kind of model is described by the acronym SMCR (source, 
message, channel, receiver). In the mid-1950s, Schramm created a circular model that 
showed communication as an interactive process in which messages were encoded and 
decoded by interpreters. This second-generation communication model, which relied on 
a transmissive view, was called communication as interaction. However, the focus soon 
shifted from the exchange of messages to creation of meaning, giving rise to the third 
generation of models. Barnlund’s idea of communication as transaction used a complex 
graphic representation of spirals and arrows to show communication components as  
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interrelated and constantly evolving. This nonlinear modelling represented a shift from 
transmissive to a constitutive view of communication (Littlejohn & Foss, pp.175-177).  
 
8.7.2 Dangers of over-abundant choice 
Due to the cross-disciplinary nature of social marketing, in addition to 
communication models, the marketer also can select from numerous models of 
behaviour change, theories of social change, and social marketing models, just to name 
a few. With this embarrassment of model riches, marketers—like their customers—
might succumb to the paralysis of having too many choices, as described by Schwartz in 
Paradox of Choice. Schwartz contended people want choices, but that ironically, 
consumers can have too many choices, which confuses and immobilises the decision-
making process. For example, when given free samples of jams in a store, 30% of 
people exposed to six jams bought a jar, but only 3% of people exposed to 24 jams 
bought a jar (2009).  Schwartz explained the phenomenon this way: ‘A large array of 
options discourages customers because it forces an increase in the effort that goes into 
making a decision. So consumers decide not to decide’ (2004, p.20). Schwartz also gave 
this example concerning health care: ‘Patients prefer to have others make their 
decisions for them; 65% surveyed said if they were to get cancer, they'd want to choose 
their own treatment, but only 12% of people with cancer wanted to do so. We always 
think we want choice, but when we actually get it, we may not like it’ (2004, p.32). 
These are important ideas to consider from both sides of the marketing exchange 
process when constructing a communication model for social marketing. 
From a practical standpoint, a model—whether a hand-drawn series of connecting 
lines and circles or a sophisticated depiction worthy of a fine artist—must be 
understandable and functional. The illustrative example presented in this chapter 
incorporates the considerations discussed above while selecting from the most 
appropriate multi-disciplinary concepts to construct a model for an integrated social 
marketing conversation. 
 
8.8 PUTTING THEORY INTO PRACTICE: A four-stage choice-based process for 
developing an HIV/AIDS prevention and treatment social marcon 
This customer-centred approach demonstrates how to design a customised 
prevention and treatment campaign directed to HIV-positive people similar to those 
surveyed in Chapter 7, but the process could be adapted for a campaign using other 
motivational messages directed to different audiences. The choice-based process uses 
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background research to organise the most relevant options (See Chapters 2, 3, 5, and 6), 
then uses contextual factors from the secondary research and inputs from the primary 
research to create customised campaign components in each of four stages: 1) 
understanding the audience, 2) creating a plan to motivate change, 3) implementing the 
plan, and 4) evaluating and enhancing the campaign.  Each of the four stages is linear, 
but the simplified model derived from the four stages is circular, with the customer at 
the centre so he/she can participate in every stage, as shown in Figure 8.5.  
The four stages are based on established social marketing plans and processes, 
which use various linear progressive diagrams (Andreasen, 2006; National Social 
Marketing Centre, 2007; Corporate Culture, 2008), to demonstrate how the social 
marketer moves from initial situation and audience research to strategic planning and 
implementation, with testing and updating an integral part of the process.  Although the 
social marketing process is usually depicted in a linear fashion, practitioners are 
encouraged to continuously research and pre-test to refine and enhance as appropriate. 
With HIV/AIDS campaigns, this ongoing assessment is particularly important because 
of the ever-changing political, cultural, and medical landscape. For the model presented 
in this chapter, the choices, the contextual factors, and the inputs at each stage are 
compiled from transdisciplinary secondary and primary information collected during 
Phases 1-3 of this project. Utilising the stages involves examining the choices (in this 
case the choices relate to an HIV-positive audience), then considering contextual factors 
such as those presented in Figures 1 through 4. Next, the marketer applies unique inputs 
collected during primary research to develop a customised campaign. Each of the four 
stages involves making a series of choices, then refining those choices with relevant 
knowledge. The overall movement is from general to specific and from global to 
personalised. The four stages combine theory and practice while melding HIV/AIDS, 
social marketing, and medical research. 
 
8.8.1 Stage 1: Know the audience 
The goal for the first stage was to create a customised profile of the ‘customer in the 
round,’ combining data from diverse sources through fusion and synthesis (National 
Social Marketing Centre, 2007). The resulting profile answers the question, Who is 
expected to change?  The Stage 1 process is shown as Figure 8.1.
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Figure 8. 1—Stage 1 of the HIV/AIDS Social Marcon Process 
This illustrated example yields a profile of the targeted HIV-positive subculture customer.
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In addition to segmentation based on analysis of survey responses, Stage 1 
considered the customer’s level of knowledge about HIV/AIDS prevention and 
treatment options, cultural contexts, risk factors and the target audience’s stage of 
change. The key concept for this stage was research, moving from global (general) to 
localised (specific). Involving the audience from the outset, beginning with planning and 
implementing and continuing through the evaluation/redesign stage, enhances 
credibility, makes the interventions more marketable, and enhances learning and 
behavioural change (Janz, 2001).   
Risk factors were divided into three categories in the AIDSCAP handbook for 
behaviour change communication (BCC):  
• Biological risk factors, which exist because of the biology of the human body, 
include high STD infection rates, being female (because women are more 
vulnerable to HIV infection from sex with an infected partner), age (especially 
girls under 18), lack of male circumcision, and female circumcision. 
• Societal risk factors are social conditions that increase risk or HIV exposure and 
include migration, travelling or working away from home, sexual expectations, 
poverty, illiteracy, and gender discrimination. 
• Environmental factors prevent people from accessing services and products that 
decrease HIV exposure. They include low availability of condoms, lack of STD 
services and drugs, laws discriminating against PLWHA, economic inequities, and 
sexual abuse (Mahler & Flanagan, 2009, p. 7-8). 
Knowing where the customer is positioned in the change process is also important. 
As social marketers know, change is easy to talk about but harder to motivate and even 
more difficult to accomplish.  Heath and Heath say change is hard because people are 
trying to alter behaviours that have become automatic and therefore need close 
supervision by the rational brain.  ‘The bigger the change, the more the effort will sap 
people’s self-control.  When people exhaust their self-control, they are exhausting the 
energy to think creatively, to focus to inhibit impulses, and to persist despite frustration 
or failure. Those are exactly the mental ‘muscles’ needed to make a change.  Change is 
hard because people wear themselves out’ (2010, p. 6). 
After moving through the Stage 1 process, the marketer would have assembled a 
highly personalised profile of the customer, informed by extensive research of the global 
‘landscape’ as well as the unique aspects of the HIV-positive subculture. 
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8.8.2 Stage 2: Plan to motivate change 
The goal for the second stage was to create a customised plan to motivate 
behavioural change in the target audience. The Stage 2 process, shown as Figure 8.2, 
answers the questions, What is the change to be achieved? and When is the timeframe? 
The key concept for this stage is inclusiveness: engaging customers and collaborators in 
the process. 
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Figure 8. 2— Stage 2 of the HIV/AIDS Social Marcon Process 
This illustrated example includes choices to construct a theory-based, participatory plan for behaviour change in the HIV-positive subculture. 
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When constructing a plan to motivate behaviour change, Michiels said the marketer 
should ask:  What causes the gap between existing and desired behaviours? Is it that 
people do not know, do not care, or do not do? If they do not know, they need 
information; if they do not care, they must be made critically aware; if they do not do, 
the social marketer should set objectives for behaviour change (2001). 
Since HIV-positive individuals can be considered a subculture, the social 
marketer should design culturally relevant and language-appropriate interventions. Janz 
and colleagues said, ‘Cultural sensitivity is not just taking a book and putting in ethnic 
names and different hair; [it] needs to be built in and not tacked on’ (1996, p. 88).  
Common vernacular must be melded with formal terminology to ensure understanding 
of important terms and concepts. For example, many survey respondents did not know 
HAART is commonly called a drug cocktail.  
Collaborating with community groups is essential for acceptance of the message, 
Janz said. ‘The first lesson is work with the community, hire from the community, report 
back to the community. Programmes that have come down from on high, the university 
or the health department, have serious problems with recruitment’ (1996, p. 90).   
It is also important to remember the power of anecdotal ‘evidence.’  Schwartz said 
consumers often give more weight to comments by friends and family members than to 
scientific evidence derived from dozens of sources. The word of mouth experience may 
be more believable because it is based on a personal, detailed account (2004). 
After moving through Stage 2, the marketer would have chosen among diverse 
theoretical foundations for the campaign, created specific and measurable objectives, 
and developed innovative communication strategies appropriate for the target customer. 
 
8.8.3 Stage 3—Act to promote change 
The goal for the third stage was to create a customised implementation process 
based on one of several creative approaches. The marketer would consider such 
components as branding and types of messages to create a positive exchange, using an 
integrated methods mix. The Stage 3 process, shown as Figure 8.3, answers the 
questions, Where? and How?  The key concept is creativity. 
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Figure 8. 3— Stage 3 of the HIV/AIDS Social Marcon Process 
This illustrated example includes choices for implementing a customised campaign targeted to HIV-positive individuals. 
164 
 
 
Important creative choices must be made at this stage, based on knowledge of the 
customer and input from the target audience. The marketer builds creative messages and 
appeals that can be reinforced through multiple communication channels and a variety 
of conversations. Instead of lecturing about the facts, marketers can create forums for 
open discussion. These conversations give participants more control over the 
intervention and reduce pluralistic ignorance –the belief that one is alone in one’s beliefs 
or experiences (Janz, 1996). 
Incentives are important to many customers. Janz suggested providing creative 
rewards and enticements such as contests, pay for getting tested, or academic credit for 
being peer educators. She also recommended a menu of choices: ‘Offering A might work 
for awhile, but when they come back, they want B’ (1996, p. 89). For example, some 
Legacy Clinic clients were motivated to complete the HIV/AIDS survey by the promise 
of an inexpensive ‘grab bag’ gift, while others were motivated solely by the opportunity 
to voice their opinions. 
Reaching the target with a message once is not enough; frequency is also important. 
Essential HIV/AIDS messages should be repeated several times. Research shows ‘one-
time only education efforts may increase participants’ knowledge of HIV transmission 
and prevention, but will have little impact on individuals’ attitudes, values, and risk 
behaviours’ (Janz, 1996, p. 90).  
Marcons get customers talking about the message by utilising formal and informal 
channels. Michiels suggested using traditional and popular media in a local context as 
well as cultural expressions such as poems, dances, and drama (Michiels, 2001). 
At the end of Stage 3, the marketer will have a blueprint for a creative campaign 
based on the marketing conversation concept. Also, this localised campaign will have 
been designed to make the most effective use of international branding and image 
recognition. The marketer will also select a diverse mix of techniques that fit the 
customer’s lifestyle.  
 
8.8.4 Stage 4—Review, evaluate, and enhance 
The goal for the fourth stage  was to provide a process for reviewing, evaluating, and 
enhancing the social marcon. The Stage 4 process, shown as Figure 8.4, answers the 
questions, Is the campaign accomplishing behaviour change goals? and  How could it 
be enhanced/improved before re-use?  The key concept is test and evaluate. 
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Figure 8.4—Stage 4 of the HIV/AIDS Social Marcon Process 
This illustrated example gives participants a chance to review, evaluate, and enhance the campaign before the four-stage process begins again. 
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Ideally, the social marketer has collected knowledge and perception information from 
the target audience before constructing the plan and implementing the campaign. Message 
testing is also useful and efficient. Including funds in the initial plan for evaluating short-
term results is crucial and is sometimes part of the funding agreement.  
Moran pointed out testing and making changes would improve most campaigns. He 
noted that using Internet channels makes change quick and cheap. ‘The Web is the biggest 
direct marketing opportunity to ever come along. You can try anything. You can measure 
its impact. You can fix it and measure it again. The more things you try, the more you will 
eventually get right. Don't try to get it perfect the first time. Do it wrong quickly’ (2007, 
p.xix). 
At the end of Stage 4, the marketer has created a dialogue that involved the customer 
and other participants, such as sponsors, in each stage of the process, making 
modifications as warranted along the way. Short-term results can be tabulated, and the 
cycle begins again with the goal of sustaining positive change and motivating change 
among other members of the targeted subculture. 
 
8.9. AN INTEGRATED SOCIAL MARCON MODEL 
This four-stage process can be simplified into a model to better illustrate the central 
concepts. As shown in Figure 8.5, this circular model depicts the target audience at the 
centre and indicates customers participating during each of the four stages in the 
communication process. The model reflects the concept that marketing communication is 
shifting to marketing conversation; that marketers no longer merely deliver messages; they 
initiate conversations. Instead of ‘old-style monologues delivered through media channels, 
marketers and customers share control of the conversation’ (Moran, 2007, p.7). While this 
participatory dialogue is occurring and the communication process is moving through the 
four stages, the global context is always in the background, but the focus is on localisation 
andapersonalisation.
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Figure 8.5—The Integrated Social Marcon Model 
This model is audience-centred and is depicted as circular rather than linear, 
with continuous audience input. Social, political, and economic factors exert background 
influence at every stage. 
 
8.10 CONCLUSIONS 
This chapter represents the culmination of the four research phases that comprised this 
project. At this point, the researcher had the task of synthesising the transdisciplinary 
streams of information that were collected over a five-year period. Using the model 
approach allowed the voluminous data to be categorised and streamlined to create a 
communication model that incorporates CAM information about HIV/AIDS and addresses 
the research question, What practical contribution could social marketing make to bridge 
the knowledge gap between conventional and alternative medical choices for HIV/AIDS 
prevention and treatment? 
Key informants were carefully selected to represent the perspectives of conventional 
and alternative medicine as well as advocacy and marketing topics.  Their input helped 
consolidate and summarise the global and local issues that were of concern in this study. 
These reaction interviews confirmed that HIV/AIDS is a complex and devastating 
epidemic complicated by cultural, political, and economic issues. Even high-risk groups 
are ill-informed, both on the global level regarding trends, and on the local level regarding 
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treatments and practical prevention techniques.  These gaps in knowledge are dangerous 
and likely are contributing to the increasing rates of HIV/AIDS infection.  Although 
information is available from diverse sources, people are confused by the jargon, 
overwhelmed by the volume of material, and perhaps most of all, fatigued by decades of 
‘being careful.’ Now that HIV/AIDS is classified as a chronic disease, it has fallen off the 
critical list on the world’s political agenda, and with the widespread use of HAART, 
alternative therapies are less visible. Although social marketing initiatives have been 
plentiful since HIV/AIDS was recognised as a global health issue, it now appears much of 
the behaviour change has not translated into long-term cultural transformation. Many 
social marcoms have had short-term timelines and were hastily launched without sufficient 
background knowledge or appropriate targeting of audiences that are culturally diverse. 
Also, some campaigns have not appropriately targeted the unique characteristics of high-
risk HIV/AIDS groups in their distinctive cultural context. 
A better approach, many marketers now agree, is creating strategic conversations with 
the target audience and getting the customer involved at every stage of the intervention. To 
address the sub-question—What elements should be incorporated into a campaign that 
would effectively communicate about HIV/AIDS prevention and treatment options? — this 
chapter presents a four-stage process based on proven social marketing approaches but 
tailored to an HIV-positive audience, the high-risk group identified in this study as having 
significant knowledge gaps.  
The four stages: understanding the audience, creating a plan to motivate change, 
implementing the plan, and evaluating and enhancing the campaign, guide the 
communication process. Since marketing research shows customers can have too many 
choices, which discourage action, or too few choices, which may be viewed as coercive or 
monotonous, this social marketing process uses a series of choices at each stage that 
specifically apply to the target audience. Each category of choice is further informed by 
secondary and primary research relating to the situation.  The result is a customised 
marcon, or marketing conversation, devised especially for—and by—the target audience.  
In Stage 1, it was determined that the target audience for this marcon is likely to be 
male, HIV-positive, white or black, and homosexual or bisexual. The target customer is 
unaware of most alternative treatments for HIV/AIDS, feels strongly about stigma and 
discrimination associated with the disease, and gets information about HIV/AIDS 
primarily from traditional mass media, disease-specific online sources, and friends. 
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Stage 2 used the same choice-centred process to construct a theory-based, participatory 
plan for behaviour change. The resulting plan incorporates specific objectives, innovative 
‘edutainment,’ and condom social marketing, keeping in mind how and why people 
change. 
The implementation of the plan devised in Stage 2 was the next stage of the process 
and focused on localising national symbols and events while using engaging visual and 
verbal techniques, combined with appropriate cultural references. The customised 
component in Stage 3 recommends flexible incentives and multiple marketing techniques 
that take into consideration the target audience’s media access, preferences, and literacy. 
Since social marcoms have been found to be unsuccessful 90% of the time (and there 
is insufficient data on the success rates for social marcons), it is essential to include a 
process for reviewing, evaluating, and enhancing the campaign. In Stage 4, the 
conversation with the target audience would be especially valuable for uncovering 
underlying barriers to change, confusion about terminology, or additional knowledge gaps.  
While investigating existing models for HIV/AIDS communication, it became evident 
that most research and communication models have focused on how HIV/AIDS 
prevention programmes are working and what is effective, but little has been done in 
regards to treatment options and information. For that reason, the integrated social marcon 
model presented in this chapter is an important addition to the body of practical literature 
on this topic. The circular, customer-centred model illustrates the changing approach to 
marketing, from passive marketing communication to active marketing conversations. The 
four-stage cycle revolves around the target audience and is constantly influenced by 
international social, political, and economic factors, but the model is highly customised 
and localised to achieve the maximum impact and results. Key informants consulted 
during this project expressed interest in the communication model and promised to 
provide opportunities to further extend this inquiry after this part of the research journey 
draws to a close. 
The next chapter concludes this project by summarising trends and implications 
suggested by the research, discussing the project’s contributions to knowledge, and 
suggesting future research directions. 
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CHAPTER 9 
CONCLUSIONS 
PAST, PRESENT, AND FUTURE 
 
9.1 CONCLUDING THE ‘THESIS OF THREES’ 
In keeping with the concept of a ‘thesis of threes,’ as introduced in Chapter 1, this 
project concludes with a summary of three timeframes: past, present, and future. The past 
30 years saw the onset of HIV/AIDS, followed by numerous social marketing campaigns 
to combat the disease, which was complicated by the changing medical landscape for 
prevention and treatment. Examining the history of the relationship between these three 
disciplines gives context for understanding the present-day HIV/AIDS industry as a by-
product of cultural, political, and economic factors. This complexity makes for an 
uncertain future but offers plentiful opportunities to participate in the global dialogue and 
to make positive contributions.  
This chapter summarises the complexities of this research project from a historical 
standpoint and offers practical suggestions for disseminating HIV/AIDS information to 
upstream and downstream audiences, thereby facilitating better informed dialogues, health 
choices, and policy actions. Gaps in knowledge that are bridged by this work are 
discussed, followed by a critical review of the study and suggestions for future research 
directions. 
 
9.2 PRELIMINARY HYPOTHESES 
After selecting a combination of three topics—social marketing, HIV/AIDS, and 
conventional and alternative medicine—and choosing three countries that provided a 
diverse picture of the epidemic across the globe, the researcher began with three 
preliminary hypotheses that gave background context during the exploratory research:  
H1. International organisations, in conjunction with pharmaceutical companies with 
vested financial interests, use social marketing to selectively disseminate 
HIV/AIDS prevention and treatment information. 
H2. Social marketing campaigns for HIV/AIDS are likely to be targeted toward 
specific audiences in rural and/or economically depressed communities. 
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H3. These social marketing campaigns tend to establish conventional products and 
treatments as the norm while ignoring increasingly accepted alternative 
modalities. 
As discussed in Section 9.4, support for each of these hypotheses was provided by 
secondary and primary research, but the assertions continue to be controversial among 
many opinion leaders associated with the HIV/AIDS industry. This kind of paradox is 
common in transdisciplinary research, especially when investigating such a complicated 
and far-ranging problem. 
 
9.3 RESEARCH QUESTIONS 
As the project progressed, the overall ‘grand tour’ research questions were formulated: 
RQ 1: How have the evolving landscapes of HIV/AIDS, social marketing, and 
conventional and alternative medicine forged global and national relationships and 
interactions? 
RQ 2: Could social marketing influence better-informed behavioural change by 
including both conventional and alternative medical information in HIV/AIDS 
campaigns? 
RQ 3: What practical contribution could social marketing make to bridge the 
knowledge gap between conventional and alternative medical choices for HIV/AIDS 
prevention and treatment? 
To answer these umbrella questions, 18 sub-questions were addressed in this thesis 
using secondary and primary information that synthesised concepts and implications 
across several disciplines. Answering these questions required consulting a diversity of 
sources and reconciling conflicting opinions in search of practical solutions to the complex 
real-world conundrum that is HIV/AIDS. A transdisciplinary, mixed methods approach 
was selected as the most appropriate way to deal with the complexity and paradox created 
by the convergence of the three topics under study. Both qualitative and quantitative 
techniques were used to collect data to answer the research questions. 
 
9.4 THE PAST: A RESEARCH JOURNEY REVIEWED 
Since the researcher was cross referencing such a wide range of ideas and disciplines 
in ways not previously explored, this review of three decades of HIV/AIDS, social 
marketing, and conventional and alternative medicine had the complex task of mapping 
relationships between these topics in new contexts. This report consolidates what has been 
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learned, re-learned, and ignored during the past 30 years, as viewed from the perspectives 
of HIV/AIDS activists (the political aspects), marketers (the cultural aspects), and the 
conventional and CAM medical communities (the biomedical and financial aspects). 
 
9.4.1 The global picture 
With millions of people dead, millions more living with HIV/AIDS, and an infection 
rate that is increasing rather than falling among high-risk groups, the history of the AIDS 
epidemic has been characterised as ‘islands of success in a sea of failure’ (Bertozzi, 2008).  
Although the disease crosses national borders with ease, governments have been less 
united about attacking the epidemic. AIDS has become a multi-billion dollar industry, and 
that kind of money, combined with the international political scale of the disease, has 
brought its attendant corruption, mismanagement, and ineptitude. HIV/AIDS is no 
respecter of position or status, but poverty exacerbates AIDS and AIDS exacerbates 
poverty (Michiels, 2002). Those with the financial means can get treatments that do not 
cure the disease but greatly extend their lives, albeit with sometimes unpleasant side 
effects and a future of technology-mediated routine. The poor, however, often have no 
access to testing or treatment, so the average lifespan in many developing countries 
continues to fall, which has disastrous social and economic consequences. Ignorance about 
prevention is widespread among the educated as well as among the illiterate, despite an 
overwhelming amount of information available through traditional and new media 
sources. Since it is spread through sexual contact and drug use, AIDS is an unpleasant, 
even taboo topic, so many people do not want to know if they are positive, fearing the 
associated stigma and discrimination as much as the physical symptoms. As a result, as 
many as one-third of the infected may be undiagnosed. HIV/AIDS is now classified as a 
chronic disease, but the long-term effects of antiretroviral drug treatments are only 
beginning to become evident, while alternative treatments are mostly unknown and 
seldom used, even as complementary immune support. A vaccine is years away at best, 
most medical experts agree. 
  
9.4.2 Social marketing weighs in 
Given the imperfect biomedical situation regarding treatment, the world has looked to 
prevention strategies, notably social marketing campaigns, to stem the tide of the disease. 
Unfortunately, social marcoms have been found to be far less effective than commercial 
marcoms, because ‘selling’ long-term behaviour change is much more complicated than 
 173 
 
promoting a consumer product. Since social marketing itself is not a theory, but draws 
from a long list of related disciplines, practitioners have a large—and some might say 
unwieldy—toolbox from which to build campaign strategies.  Indications are many social 
marketers disregard this daunting list of theoretical approaches, preferring to be, as Walsh 
and colleagues noted, ‘broadly eclectic and intuitive tinkerers in their use of available 
theory’ (1993, p.115).  
However, as social marketing has evolved since its ‘birth’ in 1971, it has been 
redefined as a way to motivate not only short-term behavioural change at the consumer 
(downstream) level, but also as a way to promote long-term societal change at the policy 
(upstream) level. But, change is difficult and health behaviour change, especially when it 
relates to sex and politics, is even more challenging, so social marketers have a difficult 
task that calls on every technique at their disposal. 
Social marketing has been a major player in the war against AIDS in the three 
countries examined in this study. Uganda, Mexico, and the United States are 
representative of how HIV/AIDS attacks the poor, the religious, and the well to do, all 
with deadly results. Nevertheless, the social marketing interventions from each of these 
countries included in the content analysis in this study have much in common. 
Collaboration was always essential; getting multiple agencies and NGOs to participate in 
interventions was a top priority. Condom social marketing was a popular approach and 
sometimes the centrepiece of prevention campaigns. Mobile groups such as migrant 
workers, truck drivers, and sex workers are at high risk for infection in any country, and 
were frequently the target for prevention or testing campaigns.  Perhaps the greatest 
universal constant in the campaigns in all three countries was the goal of reducing stigma 
and discrimination associated with the disease, considered the most damaging cultural 
obstacle to reducing the spread of the disease and its devastating effects on people living 
with HIV/AIDS.  
There is an increasing expectation that HIV/AIDS social marcoms will yield 
measurable results, and that involves fully understanding both the AIDS landscape and 
marketing theory and practice. ‘To be effective, HIV prevention programmes need to 
understand how the target audience perceives HIV, condoms, monogamy, opportunistic 
infections, anti-retroviral drugs, and the herbal therapies that have been used for 
centuries’ (Singhal & Rogers, 2003, p.158). 
So, it is important that social marketers understand the many facets of AIDS among 
the population where an intervention is planned, and they need to win the confidence of 
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the target. According to Singhal and Rogers, traditional health providers already have a 
high degree of credibility and are usually the first source of help sought by individuals 
when they become ill. ‘In developing countries, traditional healers are much better 
positioned than medical doctors to care for HIV/AIDS patients’ (2003, p.158-9). 
Unfortunately, Western-trained medical doctors, with whom social marketers are likely to 
be collaborating, usually look upon traditional practitioners as quacks (Singhal & Rogers, 
2003).  
 
9.4.3 Gaps in knowledge  
The survey conducted for this study revealed an alarming number of knowledge gaps 
in regards to HIV/AIDS prevention and treatment as well as a lack of information about 
global trends for the pandemic. Despite relatively high education levels (one-third were 
college graduates), respondents were uncertain or misinformed about a number of 
important medical facts regarding how HIV/AIDS is transmitted and how the disease can 
be prevented. Even the most common treatment, HAART, was only recognised by 40% 
and considered effective by even fewer. Respondents were particularly ill informed about 
alternative treatments, although more than 40% agreed that alternative treatments for the 
disease have shown promising results.  
Not surprisingly, since more than half of the respondents were HIV-positive, most 
rejected stereotypical statements about people with HIV/AIDS, although a significant 
percentage either agreed or were ambivalent about several of the stigmatising statements 
in the survey.  
Regarding global economics, more than half of the respondents agreed that treating 
HIV/AIDS is a profitable business for pharmaceutical companies, but they are less certain 
about global trends regarding transmission of the virus and how funding is allocated for 
treatment vs. prevention efforts. 
Although respondents had many sources available to them for learning about 
HIV/AIDS, they tended to put their trust in online disease-specific sources, conventional 
medical doctors, and traditional mass media, especially television, books, and magazines. 
They were least likely to trust social media, fellow workers, and religious organisations. 
 Statistical analysis of the survey data indicated an educational campaign directed to an 
HIV-positive audience would be highly desirable and could be informed by the three 
profile groups that emerged during reliability analysis: the moralist/hedonist, the cautious 
optimist/raving pessimist, and the global activist/political ostrich. 
 175 
 
9. 5 THE PRESENT: REFLECTIONS ON AN EPIDEMIC  
After contemplating the research completed to date, it becomes clear that public 
communication about HIV/AIDS essentially revolves around three factors: culture, 
politics, and money—and not necessarily in that order of importance. Although the 
specifics of these issues vary from one country to the next, the global implications cross 
all physical and conceptual boundaries.  
 
9.5.1 Cultural factors 
Although categorised as an underground epidemic because of stigma and 
discrimination associated with the disease, HIV/AIDS has become everyman’s—and 
everywoman’s—problem. The actual prevalence numbers are uncertain because of 
reluctance to seek testing and treatment, but there is certainty that the global pandemic has 
spread each year since the first diagnosis in 1981. HIV/AIDS is now both a horizontal 
epidemic—affecting both sexes—as well as a vertical epidemic—being transferred from 
mothers to children. The history of the epidemic includes increasing hysteria as the death 
toll climbs, unfulfilled hopes for various promising treatments, optimism with the 
discovery of antiretroviral therapy (HAART), disappointing vaccine failures, and 
alternative treatments that CAM practitioners claim offer encouraging options to drug 
cocktails. In many countries, especially the United States, there is a climate of increasing 
scepticism toward big business in general and the pharmaceutical and media industries in 
particular (Edelman, 2011). As a result, the public may be increasingly receptive to 
‘green’ and natural products of all kinds, including medical treatments.  
Social marketing has gained widespread acceptance among international organisations 
as the tool of choice for campaigns to motivate healthy lifestyle choices by individuals and 
to promote long-term policy changes. These health activism initiatives typically use 
culturally sensitive approaches to build rapport and persuade. However, the visual/verbal 
presentation varies widely, depending on the target audience, and appeals vary from 
personal fear to altruistic concern. HIV/AIDS campaigns are typically targeted to 
audiences segmented by such factors as demographics (often using ethnicity, gender, or 
age), behaviour (such as sex workers), or lifestyle (frequently the gay community). The 
campaigns in Mexico and the U.S. share many commonalities, especially those that bridge 
the border between the two countries, but each campaign reflects the cultural differences 
of the targeted audience. Interestingly, one commonality between the two countries is that 
the highest prevalence rate for HIV/AIDS is found in the prison cultures, but social 
 176 
 
marketing is not being widely used to combat this problem. 
Finally, the phenomenon of complacency, sometimes called ‘disinhibition’ (Abraham, 
2007), may be driving a decline in safe sex practices, especially in Western countries 
where anti-retroviral drugs (ARVs) are widely available and considered a kind of ‘cure’ 
for the disease. This trend toward increased risky sexual behaviour among some groups 
calls into question the way HIV/AIDS information has been presented and perceived. 
 
9.5.2 Political factors 
Politics, the universal tactic of negotiation and compromise, comes into play at every 
level of human discourse and HIV/AIDS is no exception, as policy makers pursue agendas 
with a wide range of goals. Therefore, communication about the disease is invariably 
shaped by political concerns and people live or die as a result of those decisions.  
From a practical standpoint, most campaigns emphasise prevention over treatment 
since there is no known cure for the disease and the primary political directive is to reduce 
rates of infection. It follows, then, that the downstream audience is usually the target, with 
a focus on short-term behavioural change. Additionally, evaluation of campaigns is 
difficult, so measurement of their effectiveness frequently is based on product successes 
such as increased condom sales.   
As previously explained, collaboration is essential, but ‘communication by committee’ 
is time-consuming and fraught with dissention. Still, most social marketing initiatives rely 
on partnerships that cross all boundaries—cultural, political, and geographical—but those 
partners may have differing viewpoints and aims. For example, in 2003 U.S. President 
Bush approved a five-year African aid package, saying his country had a ‘moral duty to 
act…[since] every day of delay means 8,000 more AIDS deaths in Africa and 14,000 more 
infections’ (Campaigners, 2003). Despite these noble sentiments, the plan was criticised 
by many who pointed out a third of the money earmarked to be spent on prevention had to 
be used for projects promoting abstinence rather than safer sex. Similarly, in countries like 
Mexico, which is predominately Roman Catholic, earmarking funds for a disease often 
associated with lifestyles or practices that conflict with the teachings of the church is a 
political hurdle.  
An intriguing political response to the problem of attracting substantial support is the 
‘positioning’ of women as the primary victims— ‘the innocents’—in the battle against 
AIDS. This widespread rhetoric is designed to gain broad political support from faith-
based organisations as well as from political leaders looking for the most acceptable route 
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to public approval. Since women comprise about half of those infected worldwide, this 
marketing approach lends itself to a wide range of emotional/rational appeals. On the eve 
of the June 2007 EU summit, Bill Gates, a major contributor of funds to fight AIDS, 
appealed to the G8 countries to pledge new resources to ‘beat AIDS.’ Gates said in part, ‘A 
top priority must be to address the prevention needs of women and girls…biologically,  
women are twice as likely as men to contract HIV. And many women—including those 
who are married—have little power to ensure their partners are faithful or use condoms. 
A woman shouldn’t need her partner’s permission to save her own life’ (Gates, 2007).  
 
9.5.3 Economic factors 
In the final analysis, it is all about money. Whether the focus of the discussion is on 
individual health care, allotment of national resources, or international business, the 
bottom line is the top consideration and the principal catalyst for action. AIDS represents 
both crisis and opportunity in the world of finance.  
On the global scale, economic concerns about projected costs of AIDS treatment and 
the resultant depletion of resources is spurring policy makers to look for far-reaching 
solutions to avoid a future collapse of their health care systems. In terms of opportunity, 
the disease offers the possibilities of massive profits for aggressive marketers. Promoting 
the use of condoms is such an integral part of HIV/AIDS social marketing that the practice 
has its own acronym: condom social marketing (CSM) (Condom, 2010). After realising 
sales in Mexico of 19 million condoms in 2004, the Washington-based charitable 
organisation DKT International noted ‘dynamic social marketing’ was essential to its 
success (DKT, 2005).  
Even greater opportunities abound when it comes to conventional drug treatments for 
AIDS victims. In industrialised countries such as the United States, Americans with 
adequate insurance or personal funds can receive HAART (Highly Active Anti-retroviral 
Treatment) and monitoring for about $10,000 (£5,000) a year. The cost of current 
treatments clearly separates the haves from the have-nots; only one-fifth of infected people 
in developing countries are receiving anti-retroviral therapy, primarily due to cost 
constraints. Several social marketing campaigns included in the content analysis in this 
study solicited funding to provide treatments and to fund research for an HIV/AIDS 
vaccine, heralded by some in the medical community as the health grail of the disease.  
In this rush to find effective treatments and ultimately, a cure, there have been many 
stumbles and some documented deceits, such as selective reporting of clinical drug trials, 
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as acknowledged by the International Committee of Medical Journal Editors (Graham, 
2004, p.18). Some media critics have termed mainstream media the ‘flagship of 
medicalisation’ (Hamber, 2005). In developing countries, the media have become 
globalised, privatised, and deregulated, resulting in a highly advertising-driven and 
commercial industry. In 2003, the Panos Institute, a global network based in London that 
focuses on ‘amplifying the voices of the poor and marginalised,’ issued a report examining 
how communication has been used to respond to the AIDS pandemic and calling for 
media to support informed debate rather than merely disseminating information (Scalway, 
2003).  
For example, the Ugandan government's extensive education program has been widely 
hailed as a model for reducing AIDS among some segments of the country. Unfortunately, 
AIDS has not subsided in many of the rural and poorer areas, where 87% of the population 
lives. Looking beneath the favourable publicity about Uganda's program demonstrates 
how easily statistics can be manipulated. In sectors where the numbers of those living with 
HIV infections have declined, the reduction can be attributed to an increase in deaths 
rather than a reduction in new cases (Basu, 2003, p.1). 
Finally, some critics go so far as to allege that chronic diseases such as AIDS are too 
profitable to cure (Siegal, 2003; Hoadley, 2007). They point out that medical innovations 
such as nanotechnology are changing the landscape of possibilities regarding treatment 
and new discoveries about the cause of AIDS are not being published in medical journals 
or pursued by conventional medicine. Professionals in the alternative medicine community 
claim that some CAM treatments for HIV/AIDS, either used alone or in conjunction with 
drug therapies, have shown positive effects. However, alternative practitioners say 
extensive research regarding benefits of these substances has not been pursued because 
they cannot be patented and therefore will never generate profits for the pharmaceutical 
companies (Hanna, 1998; Abraham, 2007). 
Therefore, research to date seems to offer support for the initial hypotheses developed 
at the beginning of this study, but by no means is there universal agreement. These three 
factors—cultural content of social marketing messages about HIV/AIDS, the role of 
political expediency, and the economic realities of the global medical market created by 
the epidemic—form a complex and politically charged environment that influences public 
dissemination of information about health care options. The deeper beneath the surface 
one looks, the more relationships, conflicts, and knowledge gaps are uncovered, 
contributing to the body of knowledge about these topics and justifying further study. 
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9.5.4 Hopeful news 
Overall, the good news for social marketers is that HIV/AIDS is not a medical 
problem—it’s a behavioural problem, so in the absence of a vaccine for a therapeutic cure 
of HIV/AIDS, communication strategies potentially represent a key ‘social vaccine’ 
against HIV/AIDS (Singhal & Rogers, 2003, p.206). That idea puts social marketing front 
and centre in the fight against the disease. 
More good news is that social marketers have at their disposal an array of theories, 
tools, and practices. Experts urge social marketers to draw upon the multiple theories 
described in this thesis, plus motivational theories for message development; social 
network theories for message dissemination; organisational development and B2B 
(Business to Business) marketing models for coalition and partnership development and 
management; political theories and agenda-setting research for policy initiatives; and 
cross-cultural theories for international social marketing (Lefebvre, 2001, p.516). 
But there is a cautionary footnote: ‘Fewer than 20% of a problem population are 
prepared for action at any given time, yet more than 90% of behaviour change 
programmes are designed with this 20% in mind,’ according to Prochaska and colleagues, 
who developed the Stages of Change theory (1994, p.15). That may be a reason for 
choosing the transtheoretical model as a foundation for HIV/AIDS social marcoms. 
Prochaska also reported the Centers for Disease Control and Prevention (CDC) adopted 
the Stages of Change model for all of the HIV/AIDS prevention campaigns sponsored by 
that agency.  The CDC’s campaign assessment revealed the number one reason given for 
practicing safer sex was to be a more responsible person, followed by the second most 
common reason: to keep from contracting AIDS (Prochaska, et al., 1994). 
 
9. 6 THE FUTURE: CONTRIBUTING TO THE HIV/AIDS CONVERSATION  
 The overall aim for this project was to design a communication model for effectively 
disseminating information about both conventional and alternative HIV/AIDS prevention 
and treatment options. Informed by the secondary and primary research from research 
phases 1-3, an Integrated Social Marcon Model was created to convey that social 
marketing campaigns should be customer-centred, with participants engaging in an 
ongoing conversation at every stage. The process that underlies this model uses a choice-
based approach, informed by contextual factors and research inputs, to develop a 
customised and personalised campaign. 
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9.6.1 Other contributions to knowledge  
In addition to the social marcon model, this research also contributes to knowledge in 
the following areas: 
• It addresses a crucial gap in the social marketing/HIV/AIDS literature, which has 
mostly omitted emerging CAM information. This research maps connections to the 
increased popularity of alternative treatments shown by recent studies and reviews 
emerging studies that seem to indicate CAM could play a positive role in HIV/AIDS 
treatment. 
 
• It crosses several disciplines—health activism, health communications, alternative 
medicine, social marketing, clinical studies of HIV/AIDS, capability and sustainability 
studies among others—to examine this global concern holistically.   
 
• It looks specifically at several recent or current campaigns in Mexico, Uganda, and the 
United States to draw comparisons and contrasts based on common points of analysis. 
This particular kind of comparison has not previously been undertaken. 
 
• It includes input from the alternative medical community, a group that to date has 
been ignored by the social marketing dialogue, and gives that group an opportunity to 
participate in the dialogue about HIV/AIDS treatment options. 
 
• This research links quasi-clinical HIV/AIDS and social marketing, exploring practical 
ways to disseminate information about new treatment options and demonstrating that 
emerging clinical discoveries—be they conventional or alternative—need effective and 
straightforward communication to motivate change in public policy and individual 
behaviour.  
 
• Keen interest in this research approach from colleagues, from conference 
presentations, and from publishers in several disciplines indicates the value and need for 
such a combination of topics. (See appendices D and E.) 
 
• If the media are unable or unwilling to perform this information/activism function, it 
is essential to employ other ways to reach stakeholders in this vital issue. This project  
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offers an alternative to gatekeeper media routes and is especially viable for new media, 
which bypass traditional media vehicles. 
• It provides an innovative, holistic examination of broad concerns and proposes 
specific techniques and approaches—moving from theoretical to practical and from a 
global viewpoint to local implementation, using a transdisciplinary approach to bringing 
together opinions and perceptions not previously considered in tandem. 
 
9.6.2 Limitations of research 
As with most international research projects, time, distance, and resources are limiting 
factors. Because Mexico and Southern United States contacts were more accessible for the 
researcher, most personal interviews were conducted with key informants in those 
countries.  However, it was also possible to interview a broader range of experts through 
contacts made at international conferences where information from this project was 
presented (See Appendices D and E).  
Sampling for the survey was based on convenience and consent, but a high percentage 
of possible respondents agreed to take the survey and more than 340 valid responses were 
collected over a four-day period. Additionally, the survey required self-analysis and self-
reporting from respondents with diverse racial and cultural backgrounds. The survey was 
constructed and pilot-tested with these limitations in mind and a Spanish-language version 
of the survey was available for non-English speakers.  Due to cost and time constraints, 
this survey was only conducted in one city—Houston—but the clinic chosen for the 
survey site was considered a representative example of an HIV/AIDS clinic in a large 
urban area in the southern part of the United States.  
Finally, by its nature, transdisciplinary research must encompass conflicting 
information, paradox, and complexity, which requires reflection and holistic thinking and 
does not yield precise pragmatic ‘solutions.’  However, this research approach proved to 
be appropriate for this wide-ranging and complicated study and has yielded significant 
new knowledge. 
 
9.6.3.  Critical review 
If beginning anew with this study and having the luxury of hindsight, much time could 
have been saved by focusing more quickly on the overall aim for the study and by being 
more efficient and better organised at every stage of the research. The reflective log (See  
Appendix A), deals with many of these unnecessary side trips and research missteps. On 
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the other hand, what is a research project if not a learning experience where hypotheses  
are created and discarded, and research directions are pursued, then changed or discarded 
in favour of other ideas? 
Because this project was broad ranging, using mixed methods and crossing several 
disciplines from both academics’ and practitioners’ perspectives, it was unavoidably 
chaotic and sometimes overwhelming.  Also, because it was original work (not replicating 
a previous study), extensive methodology was needed, which was written, refined, and re-
written several times before emerging as shown in Chapters 4 and 6.  
Additionally, this project represented a ‘moving target,’ in which the landscape was 
constantly changing, requiring ongoing literature review and updating of interview data, 
and of course, frequent rewrites of the thesis itself. For more about this five-year journey, 
see the Reflective Log in Appendix A. 
 
9.6.4 FUTURE RESEARCH 
Because of the massive amount of secondary and primary information generated during 
this project, the opportunities for future research are extensive.  
In addition to the findings and recommendations presented in this thesis, this inquiry 
raised issues that touch a variety of disciplines: 
 
Behavioural psychology:  HIV/AIDS is not a biomedical problem; it is a behaviour 
problem, and much of the prevention efforts to date have been focused on trying to 
provide a rational solution to an irrational problem. Also, the role of complacency in 
fuelling the increasing infection rate is an intriguing concept. 
 
Communications: The visual and verbal communications aspects of HIV/AIDS social 
marketing, especially as they relate to the use of new media, offer a rich, unmined area for 
further study and comparison.  
 
Cross-cultural communication: This study suggests many avenues for further research 
relating to messages directed to HIV/AIDS subcultures, such as controversial, reality-
based marketing, explicit vs. subtle messages, and cultural adaptation. 
 
Sociology: The idea that HIV/AIDS has changed society’s reticence about public 
discussion of formerly taboo topics such as premarital sex, condoms, gay sex, etc. 
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deserves further study. (See the Transdisciplinary Glossary for more terms that have been 
added to the public lexicon since HIV/AIDS became part of the public agenda.) 
 
Gender studies: The idea of women as the ‘innocent victims’ of the HIV/AIDS 
epidemic is also an interesting line of inquiry. 
 
Marketing: The question of choice—what is not enough, what is too much—is an 
interesting concept relating to HIV/AIDS campaigns for behavioural change. The 
implications of moving from marcoms to marcons is also a timely topic. 
 
Political science/Religion: Since HIV/AIDS has such close connections to religion and 
politics, the idea that many of the ‘helping organisations’ have taken a ‘missionary 
position’ regarding the disease (such as PEPFAR’s stipulations for abstinence-based 
prevention campaigns) is certainly of international interest. 
 
Real world applications: Perhaps most important of all, this researcher’s collaboration 
with practitioners on the clinical side of this issue as well as with policy makers who have 
political clout promises possibilities for practical application of this research. There is an 
opportunity to make a difference—to change the content and approach of HIV social 
marketing and effect upstream as well as downstream change.  
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APPENDIX A 
A REFLECTIVE LOG 
 
 
 
 
Travelling high roads, visiting low places, 
 and following bunny trails 
 from Texas to Teesside and back home again 
 
  A1 
Reflective Log  
2005-2010 
 
 
This is a personal chronicle of my research journey over towering mountains of 
information, past pillars of statistics, through labyrinths of opinion and theory, and 
across ethical minefields. At the same time, there was the academic maze to navigate, 
with its ironclad procedures, reams of reports, and educational conventions. 
This was also an intensely personal journey that took me out of my comfort zone, 
where I encountered people and experiences that would never have touched my 
sheltered university life in Texas. 
Along the way, I logged thousands of actual miles travelling from Texas to 
Teesside, with forays north to Canada, south to Peru and Mexico, and across the pond 
to a number of European cities.  I met a wonderfully diverse group of individuals with 
fascinating—sometimes shocking—knowledge they were kind enough to share.  
This arduous pursuit was undertaken with the realisation there would be dead ends 
and missed markers aplenty, but I hoped by journey’s end logical patterns would 
emerge as the sanity of method came to the forefront. I admit I rambled down a goodly 
number of bunny trails—diversions that yielded no useful result—but isn’t that part of 
the research process? Over the years, I experienced curiosity (which set this endeavour 
in motion), frustration, steep learning curves, exhilaration, and empathy. At one point, I 
was told that writing a PhD thesis was the ‘largest and most self-indulgent thing’ I 
would ever do.  If that is the case, this reflective log is the most hedonistic thing of all. 
Certainly the entire project has been self-serving in that I have received immeasurable 
rewards, which have more than compensated for the time, expense, and discomfort—
both physical and emotional. 
This, then, is my five-year chronology of milestone places and experiences, 
combined with my serious—and sometimes not-so-serious—musings on the mundane 
as well as the profound. 
 
________________________  
2005 
________________________ 
 
Paris, September 2005 
The inspiration for this project was my desire to go to Paris. For years, I had longed 
to visit France. Time was passing and I was still in Texas, although I frequently 
  A2 
presented academic papers in major U.S. cities. So, in the Spring of 2005, I searched the 
Internet for communication conferences scheduled to meet in the City of Lights. 
Success! I found a call for abstracts by an organisation meeting at UNESCO. A 
colleague and I sent a proposal, which was accepted for presentation. In researching and 
writing my part of the paper, I was stunned by the scope of the HIV/AIDS epidemic. I 
also discovered the field of social marketing–heretofore unknown to me–and through 
my colleague I started to learn about the medical aspects of the disease. Our research 
suggested unhealthy relationships between drug companies and dissemination of 
information about medical issues, especially relating to diseases such as HIV/AIDS, 
where billions of dollars were being spent for prevention and treatment programs. We 
reported that companies such as Merck and Pfizer typically spent more on marketing 
their drugs than on research and development. 
Our paper included this statement: 
‘With this kind of investment at stake, it is not surprising the traditional 
medical establishment uses its influence and financial clout to control the 
dissemination of information. It does so by violating the most intrinsic 
human freedom and endangering the most basic of human capabilities—
access to knowledge.’ 
 
The paper was controversial, some even said it was ‘incendiary,’ but my interest was 
sparked. I had found my PhD topic. (And, yes, Paris is now one of my favourite cities; I 
have returned several times since.) 
MILESTONE: 
11-14 September 2005—Curing AIDS: Why Successful HIV/AIDS Treatments are Unknown 
to World Government Policy Makers. Fifth International Conference on the Capability 
Approach, UNESCO. Paris, France (co-author: James Adams) 
 
Teesside, September 2005   
 
While researching the converging topics of HIV/AIDS, social marketing, and their 
relationship to conventional and alternative medicine, I also began looking for a PhD 
program that would fit my life situation and make me eligible for promotion at the 
university in Texas where I teach communication classes. Bear’s Guide to Earning 
Degrees by Distance Learning helped me determine that part-time distance programs in 
public relations/social marketing were available, especially in Europe and Australia.  
Since leaving my job for a full-time research program was not feasible, I began to 
search for an English-language university with international GAAP certification that 
offered PhD marketing degrees via distance learning. Social marketing is not a common 
degree in the United States, so I turned my attention to universities in the UK.  Staff at 
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Teesside Business School agreed to meet with me and discuss my proposal while I was 
in Europe for the UNESCO conference.  In mid-September, the 6 a.m. train from 
London took me north to Middlesbrough and a taxi delivered me to the campus, where I 
found my way to the Business School for an appointment that would significantly affect 
the next five years of my life. 
After discussing my proposed topic with faculty and staff from the Teesside 
Business School, a question I was to answer many times over the next few years was 
broached: ‘Why travel so far to earn your degree and why are you specifically interested 
in Teesside?’  I explained that in addition to offering the kind of program and flexibility 
I needed to advance in my academic career, Teesside was squarely in the middle of my 
roots; my family originally came from Masongill, near Settle, Yorkshire. Masongill was 
the family seat of the Massengills during the Middle Ages.  Daniel Marsingell, a sailor 
from nearby Whitby, immigrated to Virginia in the mid-1650s and was the forbearer for 
the many Massingills now living in the States. I had learned these facts years ago from a 
hefty book in my personal library—The Massengills, Massengales and Variants 1472-
1931, written by Samuel Evans Massengil, M.D., and published in 1931. So, I feel a 
special affinity to Yorkshire and was delighted with the prospect of exploring the area 
while spending my annual residency at Teesside.  
Beyond these personal and professional motivations, however, I was intrigued with 
the idea of tackling a far-ranging project that would challenge me to understand cultures 
outside my experience and would allow me to become constructively involved in the 
international dialogue about social policies to combat HIV/AIDS. Happily, Terry 
Robinson, Reader in Marketing, and Helen Bussell, acting Assistant Dean in the 
Teesside Business School, enthusiastically agreed to supervise my research and my 
enrolment was approved in December of 2005. So at an age when many of my 
contemporaries were looking forward to retirement, I was blithely committing to a 
project that would devour much of my spare time and money for the next five years and 
would require me to travel to Teesside each year for several weeks in residence at the 
university.  
 
MILESTONE: 
December 2005—Officially enrolled at Teesside 
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________________________  
2006 
________________________
 
 
Huntsville, Texas, May 2006 
As one requirement for moving from enrolment to registration at Teesside, I 
completed a graduate level research methods class through Sam Houston State 
University, where I have been a tenured instructor for more than 15 years. This class 
gave me needed background in mixed methods research, with an emphasis on the 
qualitative techniques that would be dominant in much of my work. This class also 
reminded me of the student role I had not experienced in many years; I was accustomed 
to being the professor who assigned, facilitated and graded. Learning to switch back and 
forth between being student and instructor was valuable; it gave me insights that were 
helpful to me as learner and as educator. Also, since I had to take the class online due to 
my own teaching schedule, I gained valuable insights into the pros and cons of this 
method of teaching, which served me well a few years later when I began teaching some 
of my communication classes online. 
 
MILESTONE: 
May 2006—Earned an ‘A’ in research methods and packed my bags for my first residency at 
Teesside 
 
Teesside, May-June 2006   
My first annual trip to Teesside was a learning experience in logistics as I figured 
out how to get from London Gatwick to Kings Crossing to catch the northbound train. 
That was also the year of too-much luggage; I mistakenly packed one massive (and 
extremely heavy) suitcase, thinking its wheels would make it manageable. I soon 
realised my error when I discovered there were no escalators in the London tube and 
elevators were rare and well hidden.  After that experience, with each succeeding year, I 
would travel lighter, although a laptop computer was always mandatory, and it was the 
heaviest item in my luggage.  
Once my luggage and I made it to Middlesbrough that first year, I settled into a 
rented room in a house I shared with other students, one who was a graduate business 
school student from China with whom I developed a continuing friendship.  
 With my journalism background, being curious about people’s lives and asking 
incisive (some might say nosey) questions comes naturally, but following a strict 
research protocol during the interviewing process was a departure from my experiences 
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as a reporter. When I became a graduate student in England, it was helpful to have 
recently gone through the IRB (Institutional Review Board) process for Prison City, a 
book I co-wrote about communication in the Texas criminal justice system.  
Since I often presented papers at international conferences wearing the twin hats of a 
communication faculty member for Sam Houston State University in Texas and a 
graduate student at Teesside, I had to satisfy the research/ethics committees at both 
institutions. Of course, the applications had to be written in American English 
(organization, for example) for SHSU and in British English (organisation) for 
Teesside! Eventually I created my own ‘cheat sheet’ for the z words; for horizon, 
magazine, size, and citizen, it was okay to use z; in most other cases, I should convert 
the z to an s. The language selection in my word processing program was immensely 
helpful and soon all of my academic papers were written in UK English. 
Also, I quickly learned the terms thesis and dissertation have opposite meanings in 
Europe and in the U.S. In the states one writes a thesis as a requirement for a master’s 
degree and a dissertation to earn a PhD. At Teesside, I would be writing a thesis for my 
PhD. This would cause much confusion among my colleagues back in Texas, and meant 
that I would have completed a thesis for my master’s degree (from the University of 
Wyoming) and another for my PhD. So, I began the challenge of life with one foot in 
British academia and the other in higher education in the U.S. 
 
Stirling, Scotland, June 2006 
While I was working on my ethics application, my research proposal, and 
registration paperwork at Teesside, I contacted Laura McDermott, research officer at the 
Institute for Social Marketing (ISM) at the University of Stirling, and asked for an 
interview. She agreed and I was once again on a northbound train, first to Edinburgh, 
where I stayed in a bed and breakfast booked over the Internet. A map of the city and 
questions of bus drivers and various other citizens confused me further, so I had an 
extended walking tour of the city before finding my room. The next day, I retraced my 
path and found the bus to Stirling. As with many of my first visits to a new city, getting 
there was an exercise in critical thinking and problem solving.  
When I reached Stirling, attractively sited in the countryside, McDermott and 
several of her colleagues at the ISM were welcoming and encouraging. They shared 
case studies and behind-the-scenes strategies for some of their campaigns, including a 
draft report discussing which theoretical models were proving most effective in national 
anti-obesity campaigns. 
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Back at Teesside, I struggled to produce a comprehensive ethics application; since 
my project would involve interviews with and a survey of human subjects, and since my 
topic was HIV/AIDS, the application received careful scrutiny. My Teesside director of 
studies, Terry Robinson, was especially helpful as I edited and rewrote the application, 
which had the added benefit of helping me focus on my project’s purpose and protocol. 
By the time I completed my 2006 residency and headed home, the ethics application 
was approved and my request to be accepted as an MPhil candidate at Teesside had 
been submitted. (At that time, Teesside, like most British universities, first accepted 
graduate students as MPhil candidates and, when the student’s work warranted, he or 
she could apply to transfer to PhD status.) 
 
MILESTONES: 
Summer 2006—University of Teesside’s Research Ethics Committee approved my 
application 
September 2006—Registration as an MPhil candidate in the Teesside Business School was 
approved 
 
Texas and Mexico, Summer 2006 
Back in Texas, I taught summer school and attended my 25th high school reunion, in 
a world far removed from my experiences in the U.K.  Many of the 39 people from my 
high school class were at the reunion, and they were mystified that I would, first of all, 
begin work toward a doctorate at an age when most of them were grandparents with 
their golden retirement years in their sights. My colleagues at Sam Houston were 
equally confounded at the thought of me travelling halfway around the world each year 
to study in Europe. Several commented, ‘I can’t believe you travel all that way by 
yourself!’ My students, on the other hand, thought it sounded like a wonderful 
adventure, which of course it already was proving to be.  I explained to some of my 
colleagues that yet another reason I was pleased with my choice was the higher 
education culture in Europe. Everyone I encountered at Teesside and at various 
conferences I attended wanted me to succeed with my research and with earning my 
degree. I never experienced even a hint of the caste system of PhD vs. non-PhD that is 
so prevalent in many U.S. universities or encountered the ‘academic hazing’ I have 
frequently seen in U.S. academia.  
That summer I also took my second trip to a medical clinic in Mexico, where 
HIV/AIDS was being treated using alternative therapies. The clinic’s director was a 
client of The Massingill Agency, my firm that specialises in health care communication. 
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My research into HIV/AIDS medical issues was proving helpful in my work with this 
client. I summarised some of my secondary and primary research in an HIV/AIDS 
backgrounder for a media kit. I was surprised to learn many of the stereotypes about 
HIV/AIDS were false, but generally widespread, perceptions. I learned that in 2005, 
more new infections (13,000 daily) and deaths (8,000 daily) had occurred than during 
any previous year of the pandemic. I also noted that worldwide, about half of the 
infected were women, and heterosexual transmission was the most common means of 
infection. Even more frightening, I discovered that in the U.S. alone, an estimated one-
third (or more) of the HIV infections were undiagnosed.  
The most intriguing fact I learned while working with my Mexico clinic client was 
that an international team of researchers and physicians had begun IRB-sanctioned pilot 
programs using the latest nanotechnology and sub-nanotechnology. The early results in 
the summer of 2006 showed remarkable outcomes in patient blood tests measuring viral 
load reductions. My interest in emerging alternative treatments for HIV/AIDS was 
certainly captured by these statistics! 
 
Lima, Peru, August 2006 
At summer’s end, I travelled to Peru to attend a communication conference where I 
was an invited presenter on advertising campaigns that cross cultural boundaries.  I 
found the discussion about aspirational ads to be an intriguing question that related to 
my research into which behavioural change approaches were effective in combating 
HIV/AIDS. Although many advertising professionals were eschewing aspirational 
approaches as too elitist, some professionals think that is a short-sighted viewpoint, as 
explained in this blog: 
‘An aspiration is defined as “a strong desire, longing, aim or goal. To strive toward 
an end: to soar.” If you were to ask American families what they aspire to, you are likely 
to hear responses about health and happiness, giving their kids a better life, making 
sure college is paid for, vocational fulfilment, contentedness even. You see, while 
American consumers have bought into the cultural narrative that “progress” is 
constituted by attaining the most feature-laden cell phone, the things people 
fundamentally care about are unchanging! (Guest Blogger: Elizabeth Paul, The Martin 
Agency http://blog.communispace.com/index.php/2009/09/09/redefining-aspiration, 
Sept 2009). 
 
Aside from fulfilling a long-time desire to visit Peru, this international gathering of 
communicators raised some intriguing questions for me about culture and advertising, 
and helped me prepare for an upcoming Mexico conference on AIDS in Culture. It was 
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also my first bilingual (English/Spanish) conference, where simultaneous translations 
took place while the speakers were presenting.  
 
MILESTONE: 
3-6 August 2006—Aspiration Advertising Campaigns as Intercultural Conduits (invited 
presentation) Congress of the Americas. Lima, Peru  
 
Banff, Canada, October 2006 
I had attended many academic conferences over the years, but in October I travelled 
to Canada to present a poster at my first social marketing conference.  This was also the 
first poster presentation I had done—my desktop publishing skills and my B.A. in art 
found a practical use.   I had been to Banff before so I already knew it was 
breathtakingly beautiful, especially in the autumn. This conference was an excellent 
introduction to the international world of social marketing. I was fascinated by the 
research presentations, informed by their methodologies, and delighted with the variety 
of people I met. I returned home with a fistful of business cards and presentation 
handouts, some of which helped me plan the Phase 1 of my research—a content analysis 
of recent HIV/AIDS campaigns. 
 
MILESTONE: 
19-21 October 2006—HIV/AIDS Social Marketing: A Comparative History (poster session) 
Social Marketing Advances in Research and Theory (SMART) Conference. Banff, Canada 
 
Mexico City, December 2006 
Ciudad de México was an exciting place to be at the end of 2006. Civil unrest as a 
result of the recent presidential election generated all-night protests in the central 
zócalo, officially known as Plaza de la Constitución.  I was staying in a hotel one block 
from the city square and could hear the protestors chanting and singing through the 
night. During the day, every rooftop and every street was guarded by Policía Federal in 
full riot gear. Since it was also the celebration of the Virgin of Guadalupe, a national 
holiday, in the evening protestors rode through the streets on bicycles, wearing white 
and carrying colourful posters and red roses representing the Virgin, who is said to have 
appeared to a poor Indian on December 12, 1531, and was a key figure in acceptance of 
the Catholic religion by the indigenous peoples of Mexico. This combination of political 
and religious history was the background for the third AIDS in Culture conference, 
sponsored by CENSIDA (Mexico’s National Centre for Prevention and Control of 
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AIDS) and Enkidu, a gay activist magazine. At first, I was taken aback by the explicit 
nature of the some of the presentations, but as I talked with the organisers of the 
conference, I learned much about the disease’s scope and political issues in the 
country’s largest city. Once again, I collected business cards as well as personal stories 
from those attending the conference.  
Language was a barrier, but not an impossible obstacle; the editor of Enkidu served 
as interpreter for all presentations. I sometimes had problems remembering to say 
several sentences and then stop for the interpreter to give my comments in Spanish. I 
have not had the opportunity to attend that annual conference again, but I did attend a 
gathering of the conference organisers and local HIV activists when I returned to 
Mexico City two years later (See 2008 entry.). 
 
MILESTONE: 
9-12 December 2006—Getting the Word Out: Promoting Cures Through Social Marketing 
(paper presented as part of a special panel session, ’Making History: Curing AIDS with 
Nanotechnology’) AIDS in Culture III: Explorations in the Cultural History of AIDS. Mexico 
City (co-author: Lauren Maddox) 
 
Texas, Winter 2006 
What is the question, anyway? 
Refining my overall research question was an ongoing challenge; much easier said 
than done, as the saying goes. Seasons came and went, and my overall question evaded 
perfection, but siren-like, invited interminable tinkering.  While I tinkered, I applied for 
scholarships and grants, signed up for a social marketing listserv I learned about from 
one of my recent contacts, and submitted a proposal for a conference that would be 
close to home—in New Mexico, just west of my home state: only 743 miles (1195 
kilometers) away.  I also found myself struggling to remember to use the correct formal 
style for each project I was working on; I was alternatively working with Chicago style, 
MLA, APA, and also the official style required by Teesside: Harvard. 
 
________________________  
2007 
________________________ 
Huntsville, Spring 2007 
When (a few) funds came rolling in 
Some of the applications I made paid off—literally.  I was awarded the Scott Scribes 
Scholarship for Older Adults (I was glad to have the scholarship despite the name) by 
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the Writers’ League of Texas, which paid most of my Teesside tuition for the year. 
Also, I received a bursary from the Academy of Marketing to attend its 2007 Doctoral 
Colloquium in Surrey later that year.  I was very grateful for both, both for the votes of 
confidence in my work and for the financial assistance they brought. 
That spring also brought to fruition my first book project, which I had been working 
on for over three years as the lead author. Prison City: Life with the Death Penalty in 
Huntsville, Texas, was released by Peter Lang Publishing in April. Although neither 
fame nor fortune came with the publication of Prison City, (the royalties were just 
enough to take a couple of friends out to dinner in Houston), completing this book about 
the execution capital of the world cleared the way for me to focus exclusively on my 
HIV/AIDS research. Also, since Prison City examined how communication techniques 
used by inmates, information officers for the prison system, and community leaders 
affect the political, cultural, and economic landscape, similar issues applied to my 
Teesside project.  Additionally, the Prison City research revealed the incidence of 
HIV/AIDS in U.S. prisons was higher than among any other population in the country, 
which I found to be the case in other countries as well. All in all, the Prison City project 
was a good preface to my thesis work; I now knew I could do a large research and 
writing project that stretched over several years and required synthesising massive 
amounts of information. 
 
MILESTONE: 
April 2007—Massingill, Ruth and Sohn, Ardyth. Prison City: Life with the Death Penalty 
in Huntsville, Texas. New York: Peter Lang Publishing, Inc.  
 
St. Petersburg, Florida, May 2007 
Despite a broken nose (no, not as a result of asking nosey questions; I really did 
walk into a door—duh!), after my spring teaching term was over, my university 
department chair asked that I participate in a seminar, ‘Teaching diversity across the 
curriculum,’ given at the prestigious Poynter Institute in St. Petersburg, Florida. This 
intensive seminar provided useful training in how to better communicate with diverse 
populations and offered suggestions for being more inclusive of various cultural groups, 
including ethnic groups and gay and transgender populations. I quickly realised this 
experience would help me better understand social marketing campaigns directed 
toward specific groups where HIV/AIDS prevalence was a problem. The seminar also 
made me more aware of language and cultural issues that affected messages directed to 
specific audiences. 
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Teesside, June 2007 
When I returned to Texas, it was time to pack (as lightly as possible) for my annual 
residency at Teesside.  I made arrangements for the care of my animal companions and 
flew to Madrid to visit a long-time Texas friend, who lived near the city centre and 
taught English at the Spanish police academy. From Madrid, I took an overnight sleeper 
train to Paris (yes, I had to spend a weekend eating chocolate pastries and fresh 
strawberries in the city where my adventures began), then boarded more trains to 
London and on to Middlesbrough. Along the way, I was reminded that keyboards across 
Europe vary, which made me glad I had hauled my Mac laptop with me, despite the 
bulk and weight. I was also bemused by the subtle differences of design for practical 
items such as lavatories (I spent a minute or so in the public restroom at the Gardens of 
Versailles trying to turn the water on so I could wash my hands—the lever was on the 
floor.) 
That year, I was able to live in an on-campus residence hall, which was much more 
convenient as well as economical. I had a bed, a desk, a tiny bath and the shared use of a 
kitchen. The weeks I spent at Teesside each year were an interesting contrast to my 
multi-tasking life in the States. When I came to Teesside, I had no home or animals to 
care for, no car to maintain (I walked or took the train everywhere I went), and very few 
possessions that required my time. I washed my clothes by hand and dried them on the 
radiators. I didn’t iron and I carried only a few necessities in a tiny purse. I shopped 
carefully for groceries, aware the items I purchased would have to be carried back to my 
room. I realized that, at least for those weeks, having so few ‘things’ was a relief and 
being able to focus only on my research was a wonderful luxury. It also sharpened my 
thinking and increased my productivity. 
During that year’s residence at Teesside, I completed my application requesting 
transfer from MPhil to PhD. This process helped further clarify and focus my study. 
I was honoured to be invited to present my Phase I research during the University’s Post 
Graduate Research Students’ Networking Forum.  And, I was asked to write a short 
article for the postgraduate Business School newsletter.  My article, ‘From Texas to 
Teesside,’ began with this paragraph: 
‘It’s a long way from Houston, Texas, to Middlesbrough, but I quickly felt 
welcome when I first visited the Teesside campus almost two years ago to 
explore the possibility of becoming a distance learning student in social 
marketing… 
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…And ended like this: 
‘Now, when my colleagues and friends hear about my experiences at Teesside, 
they no longer ask “why”; they understand the reason I travel so far each year. In 
fact, I think they are a bit jealous! And, although I have resumed my “regular” life in 
Texas, I look forward to returning to Teesside next summer.’ 
 
Surrey, England, July 2007 
The doctoral colloquium was a positive experience that came at a point in my 
project where advice and encouragement from the professional world was most 
welcome. The conference was hosted by Kingston Business School, which is organised 
around a quad of ancient buildings reached by forest trails. The day of the colloquium 
was filled with presentations by a number of the doctoral students and workshops 
presented by marketing professionals. Practical suggestions abounded, and each student 
presenter received feedback on his/her work from a panel of international experts. In an 
introductory talk, one speaker commented that ‘most people only get one PhD, because 
they don’t want to go through (the process) again.’  I used some of the handouts from 
those sessions to help me at each stage in my project, including the tips to prepare for 
my viva (short for viva voce—‘lively discussion’), or the less poetic ‘oral defence.’ 
The information gleaned from the colloquium and the associated conference proved 
helpful when it was time to respond to questions from the assessors who examined my 
transfer document. Not surprisingly, the assessors pointed out I should clarify/rewrite 
the main research question. I agreed with their assessment and noted I was about to 
begin the second phase of my research, which would involve a number of semi-
structured interviews and should help focus my study. 
 
MILESTONES: 
 2-3 July 2007—A Practical Approach to Cultural Change: Using Social Marketing to 
Combat HIV/AIDS in Mexico, Academy of Marketing 2007, Doctoral Colloquium, Surrey, 
England 
Summer 2007—Teesside Business School approves transfer from MPhil to PhD status 
(later approved at the university level) 
 
Taos, New Mexico, October 2007 
During the autumn term (my Teesside director of studies asked that I learn to say 
‘autumn’ instead of ‘fall’ as we are wont to do in Texas), I prepared materials for a 1 ½ 
hour workshop focusing on visual and verbal persuasion methods in some of the social 
marketing campaigns from my content analysis. This conference setting was an 
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American West version of the Surrey conference; it was in the wilderness outside of the 
old Indian town of Taos. I took a bus from Taos to the campus hosting the conference, 
arriving at dusk and promptly getting lost on the winding forest paths. Finally, the sound 
of flutes led me to the conference centre, where a bonfire warmed the crisp mountain air 
and Indian musicians were performing ancient melodies. Even though I was only a short 
plane ride from home, I was assuredly in another country and another culture. To add to 
the international scene, my assigned roommate was Tugba (pronounced Tuba) 
Kalafatoglu, president of a global management and public affairs consulting firm in 
Istanbul. Tugba told me her firm advised politicians on message development and 
campaign strategies and assisted business leaders with global marketing and cross-
cultural leadership. Her business card joined my growing stack of international contacts. 
My workshop visuals generated a lively discussion about the HIV/AIDS campaigns 
and provided fresh insights from an audience that was not overly familiar with the topic. 
While preparing for this workshop, I had also begun work on a book chapter about 
social marketing in Mexico. Through the social marketing listserv I had been joined 
months earlier, I learned of plans for an international book of social marketing success 
stories and submitted a proposal. I was delighted to receive a contract to write a chapter 
based on my research of two Mexico initiatives.  
 
MILESTONE: 
4-6 October 2007—Motivating Change: Visual and Verbal Persuasion in HIV-AIDS Social 
Marketing, American Communication Association, Taos, New Mexico 
________________________  
2008 
________________________ 
 
Huntsville, February 2008 
2008 was to be the hardest year of my project due to injuries that made travel and 
even typing difficult and painful. I think of that year as being book ended with broken 
bones. A hard fall in the early spring broke my right shoulder and made writing or 
driving impossible for a number of weeks. Luckily, I was able to move some of the 
classes I was teaching that spring to an online format, and my next conference 
commitment was an Internet event. 
 
Internet, March 2008 
This was another first for me—a live online conference. It turned out to require at 
least as much preparation as a traditional conference presentation. I created a 
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PowerPoint, wrote a script to accompany the visuals, and recorded the commentary via 
phone prior to the conference. While the conference was in session, I monitored 
comments and responded to questions. The conference was sponsored by PSP-One 
(Private Sector Partnerships for Better Health), a USAID project to ‘increase the private 
sector’s provision of high-quality health products and services in developing countries.’ 
My script went through an approval process that erased any hint of criticism of the 
financial ties to health care in poor countries. The pro-business ‘spin’ was clear. 
Nevertheless, it was an interesting experience and one of the comments I received 
during the conference was from the director of Population Services International-
Mexico, who provided updated information about PSI’s social marketing approach in 
Mexico. We visited via email and phone and his input became part of the book chapter I 
was writing for Global trends and success stories. 
 
MILESTONE: 
10-15 March 2008—Taking Taboo Topics Public:  How Social Marketing Partnerships 
Combat HIV/AIDS in Mexico (part of a panel titled: ‘Partnership Based Approaches: What 
Works?’), Social Marketing in the Developing World: What Have we Accomplished and What 
Does the Future Hold? 2008 PSP-One on-line conference 
 
Szeged, Hungary, June 2008 
My physical therapists assured me the broken shoulder would be sufficiently healed 
for travel by June, but they were a bit optimistic. Nevertheless, I packed even lighter 
than the previous year, and set off for my conference presentation at the International 
Congress on Public and Nonprofit Marketing. I still am grateful to the many fellow 
passengers that summer who lifted my luggage in and out of the overhead bins and 
carried bags down flights of stairs for me. Conference organisers met my flight in 
Budapest and accompanied several conference attendees to our hotel in Szeged. By this 
point, my annual travel to different international locations had made my passport 
suspect to airport security and customs agents, who questioned me carefully and usually 
required a special security inspection of my person and my luggage. A British customs 
agent was particularly memorable; when she saw my U.S. passport, she sent me to the 
back of the line, then quizzed me at length about how long I would be in England and 
the exact date I would be leaving. But, for the most part, I encountered careful but 
cheerful people who gave me information and helped me understand travel requirements 
of their country. 
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The Szeged conference was attended by academics from universities across the EU 
and I added more business cards and memories to my collection. As usual, some people 
were intrigued by my topic and others were astonished at my choice. One colleague 
commented that she would not want to ‘touch anyone with HIV.’ 
 
MILESTONE: 
12-13 June 2008—Creating a Culture of Change: Social Marketing’s Global Initiative 
Against HIV/AIDS. VII International Congress on Public and Nonprofit Marketing. Szeged, 
Hungary 
 
Teesside, June 2008 
By this point, my annual return to Teesside was a homecoming of sorts. Everyone at 
the Business School welcomed me back and my supervisors made sure I had a desk and 
a computer as well as access codes for my stay. With such efficiency, I was able to 
settle in to work the day after I arrived and moved into my room in Parkside Residence 
Halls, overlooking the expansive and beautiful city park. I shared a kitchen with several 
other summer students, including a group of Chinese undergraduates who were studying 
English so they could enrol in classes in the autumn.  Internet access in my room was an 
added bonus and made it possible for me to work at all hours, even on weekends when 
the library had short hours. 
Amid my growing mounds of data, I began to draft chapters of my thesis. My wily 
director of studies insisted I begin with my methodology chapter, which he knew was 
the most difficult and also the chapter I was secretly dreading. By the end of my 
residency that year, I had several chapters in various stages.  
 
Mexico City, August 2008 
At the end of the summer, I had the opportunity to attend the International AIDS 
Conference in Mexico City. This biannual conference was truly a world event, drawing 
professionals and academics from the medical and social science areas, as well as local, 
national, and international organisations associated with HIV/AIDS prevention and 
treatment efforts. About 25,000 participants gathered in Mexico City, generating 
worldwide publicity. The conference was a whirlwind of demonstrations, concurrent 
presentations, information being dispensed in every possible medium, and informal and 
formal discussions about all aspects of the pandemic. Pharmaceutical sponsorship was 
highly visible, and ‘safe sex’ was a recurring theme.  
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Competition was stiff for presentation slots at the conference, even for poster 
presentations. My poster focused on three campaigns from my Phase I research that 
targeted women. AIDS XVII offered opportunities to make contacts with people central 
to some of the campaigns I examined during Phase I and to conduct interviews with key 
informants as a continuation of my Phase II research. I especially enjoyed my interview 
with the co-director of Instituto Promundo, a Brazilian NGO that partners with other 
Latin America organisations to create and implement HIV/AIDS social marketing 
campaigns. 
Those contacts and interviews also allowed me to update and obtain images for my 
book chapter in Social Marketing for Public Health: Global Trends and Success Stories, 
which would be edited by Philip Kotler, Nancy Lee, and Hong Cheng.  
 
MILESTONE: 
3-8 August 2008 –Until AIDS Do Us Part: Social Marketing Campaigns Empower Women 
At Risk in Uganda, Mexico, and the United States. XVII International AIDS Conference. 
Mexico City 
 
Huntsville, Winter 2008 
After so much travel, my broken shoulder was not healing well, so I declined an 
invitation to return to Mexico City in October to present a paper titled Virtual 
Virtuosity: How the ONE Campaign Uses Social Media to Combat Global Poverty and 
HIV/AIDS, at the 2nd Congress of the Americas. Unfortunately, staying in Texas proved 
unsafe; in November I fell and broke my right ankle, which kept me homebound until 
after the first of the year. But I did finish edits and rewrites on my book chapter, parts 
of which would reappear in greatly shortened form as a case study in my thesis. A 
bright spot during that time was an email with comments from Global Trends editor Phil 
Kotler (known as the ‘father of social marketing’): 
 
"I am absolutely pleased with what I read. Each chapter is a treasure-
trove of information, analysis, campaign description, and evaluation.! 
  
"My regard for the importance of the book has grown immensely. This 
book should have a long shelf life. The campaigns provide classic models of 
social marketing. Any social marketer tackling any of these issues will draw 
excellent guidance into developing his or her campaign.! 
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________________________  
2009 
________________________ 
Huntsville, Spring 2009 
This was a time when I focused on teaching my four spring term classes at Sam 
Houston, learned to manoeuvre on crutches and focused on getting my body back to its 
pre-broken condition. On the research front, I completed my Phase II work and prepared 
a complex poster summarising my content analysis results for a conference in 
Switzerland.  (All of the posters and projects mentioned in this Log are shown as 
subsequent appendices in this volume.) 
 
St. Gallen, Switzerland, June 2009 
In route to Teesside that summer, I first flew to Zurich to attend the First German-
Austrian Swiss AIDS-Congress SODAK 2009, ‘Prepare for the Long Run.’ The 
conference was held in St. Gallen, an hour’s train ride from the capital. In keeping with 
the congress theme, I had a poster presentation in the social science track that used cross 
tabulation matrixes summarising my content analysis research from Phase I. 
This conference attracted about 800 attendees, and the second congress was already 
scheduled for June of 2011. Although the congress call for abstracts included both 
medical and social science tracks, most of the attendees were from the medical 
community. Several medical professionals at the congress commented to me that my 
research on the cultural aspects that contribute to the AIDS pandemic is equally 
important in the battle against the disease and should have had a more prominent role in 
conference discussions. I also received a number of compliments on the production of 
my poster, which again utilised my desktop design skills to create a poster that was 
more elaborate and colourful than most others on display. 
Observations from attending conference sessions and from informal discussions with 
presenters and attendees included: 
 
•  Pharmaceutical companies were much in evidence as conference sponsors and as 
vendors dispensing literature and branded specialty items. 
•  Complacency was widely considered to be a prime enemy in the fight against HIV 
infection, as many people now consider that HIV/AIDS is not an automatic death 
sentence but can be treated with HAART therapy. (Not curable, but controllable) 
•  However, drug-resistant HIV is an increasing problem, fostering research and 
development of a host of new drugs. 
• With so many drugs available, interest in CAM therapy is greatly diminished. 
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• However, presentations included promising reports on the efficacy of green tea extract 
and stem cell studies.  
• Many of the new European social marketing campaigns for HIV/AIDS feature 
condoms as prominent elements, couples in suggestive poses, and graphic language. 
•  This conference primarily focused on HIV/AIDS as a biomedical problem, with culture 
and stigma taking a back seat. 
•  Condoms were repeatedly recommended as the fail-safe prevention method (and 
samples of various brands were available in most vendor booths). 
 
Like AIDS XVII, this congress was a source of interesting contacts as well as the 
newest medical information about conventional AIDS treatments. A highlight was 
attending the Swiss premiere for an HIV/AIDS documentary on HIV/AIDS in Europe, 
‘Blissfully Lost,’ which was created by a doctor who worked at a German HIV clinic and 
a filmmaker from Cape Town, South Africa. I learned about the documentary by 
chance—the only promotion for it was on a postcard I happened to pick up in sponsor 
GlaxoSmithKline’s booth. But the card’s one paragraph caught my attention: 
 
…28 years of public discourse, TV spots, posters, celebrity-upvalued 
campaigns and putting condoms over bananas have left their mark on the 
collective psyche. What do you think of HIV/AIDS? 
 
My interest peaked, I took a taxi to the small art theatre where the screening was 
scheduled. Only a handful of people attended, but I was pleased I had gone. The 
documentary included interviews with a diverse group of people and was designed to 
inform and promote dialogue about the disease. After the screening, I met the creators of 
the film and spent several hours at a local watering hole getting to know the two of them 
and learning about their lives and projects. We have kept in touch about the possibility 
of screening the documentary in Houston at some point.  
After the conference, it was back to Zurich for a weekend as a tourist and then a 
flight to Manchester and the now-familiar train trip to Middlesbrough and Teesside. 
 
MILESTONE: 
24-27 June 2009—Working Toward a World Without AIDS: How Social Marketing Inspires 
Long-term Cultural Change. First German-Austrian Swiss AIDS-Congress SODAK 2009. St. 
Gallen, Switzerland 
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Teesside, June 2009 
When I reached Teesside, I learned I was now attending the 2009/10 University of 
the Year; Teesside had been named to this prestigious honour by Times Higher 
Education.  It was a great achievement, especially for a so-called ‘new university’ like 
Teesside and there were posters and pennants everywhere. Again, I moved into Parkside 
Residence Halls, unpacked my one small suitcase, and connected my laptop. I was ready 
for my annual residency. I soon wished I had brought a fan; Middlesbrough was having a 
heat wave—not that hot by Texas standards, but there is little or no air conditioning in 
Middlesbrough, certainly not in the residence halls or in the Business School offices. 
Sweating (‘glowing’ as Texas ladies are supposed to say) while typing was the only 
choice. 
However, I still managed to organise and categorise my work to date. I refined and 
expanded my thesis outline and continued drafting (and revising) chapters. I also 
updated my literature review to include several articles and books that provided fresh 
insights as well as reinforcement of my own findings from Phases I and II. I consulted 
marketing texts on survey methodology to support my own research design for Phase 
III, using that information as background for writing the survey methodology. And, to 
further order my work in the coming months, I developed a status report form for 
tracking my thesis progress and setting goals for each chapter.  
Additionally, my Director of Studies and I revisited and re-checked my original 
ethical approval on 9 June 2009 and determined there had been no significant change in 
methodology that would impact ethical approval. This was important since I was 
planning a survey of patients and staff at an HIV/AIDS clinic in Houston. 
 The ever-expanding amount of information plus the genuine interest in my research 
topic from people I interviewed or consulted indicated I had chosen a significant area of 
study with many possibilities for making contributions to knowledge. It was also 
heartening that the panel of experts who pilot tested my survey expressed scholarly 
and professional interest in my research, asking that I share the results with them.  
 
Houston, Autumn, 2009 
Creating my survey was time-consuming, but was finally accomplished thanks to a 
panel of experts I assembled to pilot test the instrument. Getting permission to 
administer the survey at a Houston HIV/AIDS clinic was more difficult and required 
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persistence, persuasion, patience, and numerous meetings with clinic administrators.  
Five months later, approval was in hand, and I began to organise the logistics of 
travelling to Houston to survey clinic patients and staff. I recruited several of my 
undergraduate students to help with data collection. Some of the students were naturally 
outgoing and did not hesitate to approach everyone who came into the clinic. A couple 
of students were actually frightened—one told me she feared to use the restroom 
facilities at the clinic. Another student was horrified when she learned we would be 
working at an AIDS clinic. ‘So, some of the people might actually have AIDS? ‘ she 
asked in all seriousness.  
The patients were all ages, genders (sometimes difficult to determine), and ethnic 
group. Their educational background ranged from high school dropout to doctorate. But 
HIV/AIDS was the common thread that connected them all. Some spoke very freely 
about their HIV/AIDS experiences; most were appreciative we were collecting 
information to better inform people about the disease and possible treatments. Both staff 
and patients commented they found information in the survey that made them realise 
they needed to do more research into treatment choices. Some took time to tell us their 
personal stories. One of my student assistants wrote this entry in his own reflective log: 
 
"I remember one guy in particular who came in with a huge smile on his 
face.  When we asked him to participate in our survey, the man smiled, said 
no problem, and took a clipboard from my hand. As he was filling out the 
survey, he began to converse with us about how he got AIDS when he was a 
kid in high school and had no knowledge of AIDS or HIV. He said he's had 
AIDS for about half of his life, and that he belongs to a Houston organisation 
that raises money for AIDS and HIV awareness. He told me he had been 
working for this organisation for about 13 years and last year alone, he raised 
over $100,000 for HIV/AIDS education so kids could be more aware of the 
disease and learn to be safer about sex so they could live the life he never 
got to have. He then finished the survey, handed it to me, gave me a big 
smile and told me thanks for what we were doing. He told us that it meant a 
lot and that we had no clue how big of a difference we were actually making. I 
think I'll always remember him and that conversation because it really did 
touch my heart.! 
 
Some people were intent on taking the survey. One woman did not have her reading 
glasses with her and asked one of the students to read the survey so she could be 
included. The students kept commenting, ‘I can’t believe people are so open.’ By 
contrast, a couple of patients’ only question when asked to participate, was, ‘Is there an 
incentive?’ In fact, we did have a grab bag of candy and small party favours, which the 
respondents seemed to find a sufficient reward. There was clearly a feeling of 
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community at the clinic—people knew each other and were mostly positive and upbeat 
in their attitude toward life.  
The clinic administrators were surprised at the high rate of response to our survey—
we collected more than 340 valid surveys during four days. The elements that seemed to 
make the process go so smoothly included: 
• The ‘goodie bag’ was a fun element—the silly toys and candy made people smile. 
• People responded to the students and the fact the project was education based. 
• A polite but persistent approach paid off. 
• We had a good location in the front foyer; everyone who came in walked past us. 
• We had good signage—colourful and simple in both English and Spanish. 
• People liked being asked for their opinions and wanted to help with the project. 
 
________________________  
2010 
________________________
 
 
Huntsville, Spring 2010 
This spring was a whirlwind of research and teaching as I prepared for my annual 
residency, to take place in April instead of in the summer. This schedule would allow 
me to complete most of my thesis while I was at Teesside, do rewrites and edits over the 
summer and submit the final version by the end of the year. Since I would be leaving for 
England in the middle of the spring term, my three classes were set up as online 
courses—now I could teach from anywhere in the world as long as I had an Internet 
connection. 
The biggest challenge was all that needed to be done before I left Texas. In addition 
to putting all of my survey data into SPSS so I could ‘crunch the numbers,’ I needed to 
do my reaction interviews to the survey data. 
In the odd way that serendipity had so often come to my rescue since I began this 
project, it happened again. This time, the catalyst was a donkey named Ricardo. I am a 
passionate animal lover, and I learned of a no-kill animal shelter on the outskirts of 
Huntsville. I went for a tour, met the owner of the shelter and decided to sponsor an 
animal. I chose Ricardo, a beautiful donkey who had been rescued from the Grand 
Canyon several years ago. My monthly contribution would help keep Ricardo in donkey 
vittles and apple treats. I also learned the director of the shelter had been an HIV/AIDS 
counsellor and activist who helped found the Center for AIDS Information and 
Advocacy in Houston. He provided a referral to that organisation’s director, and to an 
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internationally known HIV/AIDS medical doctor, both who proved to be key informants 
for my reaction interviews.  
I was also excited to receive a copy of the Global Trends book, which was released 
internationally in soft cover that spring. 
 
MILESTONE: 
 Published—‘Love, Sex, and HIV/AIDS: Using Social Marketing to Redefine Gender 
Norms Among Mexican Youth,’ Chapter 4, Social Marketing for Public Health: Global Trends 
and Success Stories. Eds. Hong Cheng. Philip Kotler, and Nancy Lee. Sudbury, Mass.: Jones 
and Bartlett 
 
Teesside, April-May 2010 
On the road again: back to Teesside for my fifth—and last—residency. I was 
determined to work as many hours each day as I could so I would have most of my 
thesis written and reviewed before I returned to Texas. I took only a few items of 
clothing and left my cell phone at home. No distractions. So, I struggled with the SPSS 
data (with the help of a faculty expert in statistics), assimilated my interview data, 
interpreted, edited, wrote, and rewrote. And rewrote. This time I shivered in the chill air 
of April and was grateful for warm water in the down-the-hall bath I shared with three 
computer undergrads in a rented house several blocks from the university. I also 
continued to teach my three online classes; I graded the students’ final projects and 
posted their grades from England. My only leisure time was the Friday I ‘skipped 
school’ and took the train to my favourite Yorkshire town—Whitby, that seaside city 
from which my ancestor sailed centuries ago. Sitting in the train, I enjoyed anew the 
verdant fields, the flocks of sheep, and the quaint train station at every village. In 
Whitby I bought a few gifts to take to friends back in the States and ate lunch at my 
favourite waterfront restaurant. Then, it was time to catch the evening train back to 
Middlesbrough and my waiting laptop. 
 
 Huntsville, Summer 2010 
The writing and re-writing continued through the summer. I was drowning in data 
and some days it seemed I would never find the right words to introduce, explain, and 
conclude each chapter. Formatting proved to be hugely time-consuming. The thesis 
grew to two volumes—one for the body of the thesis, the other for the six appendices, 
even bulkier than the main document. A perfectionist by nature, I urged myself to 
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remember the advice from that doctoral colloquium in Surrey three years ago: ‘The 
perfect is the enemy of the good.’  I was determined to create a good thesis even if it 
could never be quite perfect. By the middle of August, everything was there, from 
abstract and acknowledgements to references and appendices. I was ready for my 
supervisors to do one last ‘big read’ before the volumes were shipped off the examiners. 
While my committee members valiantly tackled my thesis, I mined the chapter on 
my survey results to fashion a paper, which I submitted to the 2nd World Social 
Marketing Conference, to be held in Dublin in April 2011. 
 
Huntsville, Autumn 2010 
In late autumn, I received this heartening email:  
 
"I work for the Research team at The NSMC (previously the National 
Social Marketing Centre) which is based in London, UK. One of our 
resources, which is widely used within the social marketing industry, is 
ShowCase, an online database of social marketing case studies. We are 
always looking for new and innovative examples of social marketing good 
practice to contribute to our growing wealth of knowledge and learning.  In 
searching for suitable projects for ShowCase I came across 'Programme 
H,' which you had written about in the book 'Social Marketing Public 
Health: Global Trends and Success Stories'. Programme H is exactly the 
kind of social marketing/behaviour change project we would like to write 
up and publish on our website. 
Would you be interested in contributing to the write up of Programme 
H for ShowCase? Please confirm whether you would like to be featured 
on ShowCase.!  
 
Of course, my response was an enthusiastic ‘yes.’ The case study has since been 
written and edited and will appear in ShowCase in 2011. 
Additionally, my Dublin proposal was accepted, so I registered for the 2nd World 
Social Marketing Conference and marked my calendar to be in Ireland in April of 2011. 
I’m honoured to be one of the presenters at this international event that will feature the 
social marketing giants from around the world. 
Aside from completing the final edits on both volumes of my thesis, I ended 2010 
with one other positive note: I learned that Global Trends had been published in Google 
Books, extending its reach and usefulness as a social marketing text. 
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 Huntsville, December 2010 
Looking back… 
By the time I reached the fourth stage of this research expedition, I had crossed 
many borders—literally and figuratively. In a literal sense I had traversed many borders, 
trekking outside the ubiquitous portals of the Internet to personally visit an array of 
countries and speak with a diverse mix of people. My travels in pursuit of a degree led 
to encounters with a variety of natural and man-made disasters, but delays and minor 
discomfort were the only tolls I paid. These events stand out in my memory: 
Hurricane:  Sept 2005—My travel companions and I were stuck in London because 
Hurricane Rita closed the Houston airport (and the rest of the city, too). Rita was the 
most intense tropical cyclone ever observed in the Gulf of Mexico, coming inland with 
winds of 120 mph. Luckily, the B&B had vacancies for an extra three days and my 
plastic was up to the challenge. 
Terrorism: July 2007—A bomb at the Glasgow airport filled the southbound trains 
with travellers trying to make their flights in London, so I wedged myself onto a train to 
Surrey. When I was ready to head home from London on July 4, half of Heathrow 
Airport was closed due to another bomb threat, but my flight made it out on schedule. 
Volcano: April 2010—The Iceland volcano disrupted flights in much of Europe for 
several weeks. I was on the first plane out of Houston to Frankfurt after five days of 
closures. Arriving in Frankfurt, I became part of an ocean of people. I saw rooms of cots 
where people had been sleeping for days, and learned there were no flights to England. 
By mere chance I discovered my airline, Lufthansa, was running a few buses to major 
European airports. I managed to get the last seat on a bus headed for London. For 12 
hours we rolled across Europe with two 10-minute rest stops. At midnight, we crossed 
the channel at Dover, and then were deposited at Heathrow at 2 a.m. to make our way to 
our final destination. I spent the rest of the night sitting in Heathrow airport and visiting 
with a journalist from Birmingham who was on same bus. When morning came, we 
took the underground to the central train station, where I purchased a ticket to 
Middlesbrough. I was immensely grateful to be in England and not sleeping on a cot in 
the Frankfurt airport. 
But most of all, I am grateful to the many people who offered encouragement, 
advice, information, and insights. I met supportive and interesting people on trains, 
planes, and buses. Helpful people showed up at my office door in Texas, at my work 
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cubicle in Teesside, and at each conference I attended; my casual reading provided 
important links to people with diverse perspectives on my topic. 
On a personal level, I travelled beyond my comfort level and was prompted to 
extend my range of empathy and tolerance in ways I never before contemplated. 
Through it all, life went on, with its large and small triumphs and tribulations: financial 
problems, divorce, death of a parent, work crises, and losses of long-time friends and 
pets. 
On an academic level, I had journeyed across continents of knowledge previously 
unknown to me, emerging with a fuller understanding of just how much I still did not 
comprehend.  
When I called a temporary halt in my travels to reflect and record, I realized I had 
only charted a miniscule region; there are worlds more to explore. 
 
 
 205 
APPENDIX B 
CONTENT ANALYSIS AND INTERVIEW DOCUMENTS 
 
           
B.1 Questionnaire to assess campaigns for content analysis  
 
B.2 Summary fact sheet for content analysis campaign (sample) 
 
B.3 Summary of the 18 campaigns used for content analysis 
 
B.4 Question bank for pre-survey interviews – Mexico 
 
B.5 Question bank for pre-survey interviews – Houston 
 
B.6 Question bank for reaction interviews (post-survey) 
 
B.7 List of exploratory research interviews 
 
B.8 List of key informants interviewed – pre-survey 
 
B.9 List of key informants interviewed – post-survey 
 
Name                                                                                                                    Fall 2006 
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APPENDIX B.1 
Content Analysis 
Social Marketing Campaign Name: 
Description: 
Year Began: 
 
Country: 
 __ Mexico 
 __ Uganda 
 __ United States 
 
Specifically Disseminated: _____________________________________________________________ 
 
Sponsorship: 
 __ Government dept (s) _________________________________________________________ 
 __ International organization(s): ___________________________________________________ 
 __ for –profit corporation / business(s): _____________________________________________ 
 __ industry association (s): _______________________________________________________ 
 __ pharmaceutical company (s): ___________________________________________________ 
 __ educational institution(s): ______________________________________________________ 
 
Specific intended target group: 
 __ no, campaign is aimed at a mass audience 
 __ yes, campaign is aimed at a very specific group 
 
 Is a specific group being targeted? 
 __men who have sex with men 
 __ teens/young adults 
 __sex workers 
 __people living with AIDS 
 __mature adults (30-64) 
 __parents 
 __at-risk groups 
 __other: ______________________________________________________________________ 
 
 Is a specific gender being targeted? 
 __ no; n/a 
 __ males specifically 
 __females specifically 
 
 Are there any other identifying characteristics of the group being targeted? 
 __n/a; no other identifying characteristics 
 __ yes – Specifically: _________________________________________________________ 
Type of Mixed Media Used: 
 __ billboards 
 __ banners 
 __cartoon / comics 
 __discussion groups 
 __ forums 
 __ literature / printed materials 
 __ postcards 
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2 
 
 __ posters 
 __ radio commercials (Length: __________________________________) 
 __ television ads (Length: ______________________________________) 
 __ training 
 __ videos 
 __workshops 
 __ other: ______________________________________________________________________ 
 
Messages Presented: 
 
 
Slogan/Tag Line: 
_____________________________________________________________________________________ 
 
Message Recommendations / Purpose (check all that apply): 
 __ none 
 __ “safe sex” 
 __ protect yourself/take care of yourself 
 __ use condom 
 __ fewer partners/avoid multiple partners 
 __ monogamy/one partner 
 __ abstinence 
 __ get tested 
 __ don’t share needles 
 __ don’t be afraid of getting AIDS through casual contact situations 
 __ take responsibility 
 __ learn the facts/know the facts 
 __ write for info 
 __ phone for info 
 __ pick up information/brochure/pamphlet 
 __ get help/counseling/treatment 
 __ see your doctor 
 __ talk to your parents 
 __ talk to your kids 
 __ give money/donation 
 __ other: ______________________________________________________________________ 
 
Other Notes on Purpose: 
 
 
Call to Action Present: 
 __ no 
 __ yes 
 
 
Role of Spokesperson: 
 __ n/a/not sure 
 __ announcer 
 __ singer 
 __ average/neutral person 
 __ first-hand experience 
 __ victim/survivor/friend of victim 
 __ expert 
Name                                                                                                                    Fall 2006 
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 __ authority figure 
 __ government / political official 
 __ community leader 
 __ celebrity 
 __ cartoon figure 
 __ other: ______________________________________________________________________ 
 
 Name of Celebrity(s):____________________________________________________________ 
 
 If authority figure, expert, community leader, or government official, what occupation? 
 __ n/a 
 __ police officer 
 __ fire fighter 
 __ judge 
 __ teacher/professor 
 __ minister/priest 
 __ doctor 
 __ nurse 
 __ Other:______________________________________________________________________ 
  
Spokesperson Characteristics: 
 
 Sex: 
 __ n/a or not sure 
 __ male 
 __ female 
 
 Age: 
 __ n/a or not sure 
 __ child 
 __ teenager 
 __ young adult (18-30) 
 __ mature adult (30-64) 
 __ elderly (65+) 
 
 Race: 
 __ n/a or not sure 
 __ white 
 __ black 
 __ Hispanic 
 __ Asian  
 __ Other: _________________________________________________________________ 
 
 
 
 Reference to Cultural Roots: 
 __No/not sure 
 __Yes 
 
 If yes, cite specific examples: 
 __ Language 
 __ Country/area flag or seal 
 __ Clothing / style 
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 __ Music  
 __ Lifestyle 
 Other: ________________________________________________________________________ 
 
Product Promotion: 
 __ No/not sure 
 __ Yes 
 
 If yes, what is the product(s)? 
 __ Book/literature 
 __ Condoms – male 
 __ Condoms – female 
 __ Treatment Kits 
 __ Video  
 __ Other: 
 
Types of Appeals Present (Check all that apply):  Evidence of Appeals on Page 5 
 __ Decision-making 
 __ Fear 
 __ Positive / rational 
 __ Self-interest 
 __ Social-cognitive 
 __ Sustainable development 
 __ Two-step flow 
 
Overall Tone of Message: 
 __ Negative (threat, fear, sad) 
 __ Neutral 
 __ Positive (up-beat, humor) 
 __ Not sure 
 
Social Marketing Elements: 
 
 Product / Solutions:  Is there a clear social marketing product being offered? 
 __ No 
 __ Yes – Specifically: __________________________________________________________ 
 
Is there an “actual product” being offered? 
 __ No 
 __ Yes – Specifically: ________________________________________________________ 
 
Is there an ‘augmented product’ being offered 
 __ No 
 __ Yes - Specifically: ______________________________________________________ 
 
Price / Value:  Are issues of price addressed? 
 __ No 
 __ Yes – Specifically: _______________________________________________________  
 
Promotion / Information: Is adequate information being offered? 
 __ No 
 __ Yes – Specifically: ________________________________________________________ 
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Placement / Access: Are place and placement issues addressed? 
 __ No 
 __ Yes – Specifically: _______________________________________________________ 
 
Other Campaign Notes: 
 
 
 
 
 
Evidence of Appeals: 
 
Appeal: 
• __________________________________________________________________________ 
• __________________________________________________________________________ 
• __________________________________________________________________________ 
• __________________________________________________________________________ 
 
Appeal: 
• __________________________________________________________________________ 
• __________________________________________________________________________ 
• __________________________________________________________________________ 
• __________________________________________________________________________ 
 
Appeal: 
• __________________________________________________________________________ 
• __________________________________________________________________________ 
• __________________________________________________________________________ 
APPENDIX B.2 
Sugar Daddies 
Description:  Working to stop cross-generational sex, which is sex with a person at least 10 
   years older 
Currency:  Began in 2004 - 2005 
Int’l  Orgs:  PSI, National AIDS Committee 
Pharm Co.:   None Mentioned 
Purpose:  Sugar Daddy relationships are a major reason why HUV infection rates are up 
   to 6 times higher for teenage girls than their male counterparts.  Also to 
   break the silence, raise public awareness of dangers involved, and change 
   societal views (PSI Profile) 
Target Audience: Young women (15 – 24), their parents, and older male partners 
Where Dissm.:   Uganda, Cameroon, Kenya, in schools 
Media Mix Used: Television, radio, print, seminars (with media coverage of the seminars) (PSI 
   Profile). Government-sponsored posters, offering chastity scholarships, radio 
   soap opera (CSM). 
Msgs Present: Sugar Daddy + Young Girl = Danger (PSI Profile). Golden Rule approach 
(CSM).   Also, saving yourself for marriage is the right thing to do (GHF) 
Use of Celebrities: Yes, Tim Lwanga, Uganda’s Minister of Ethics and Integrity. Also 
Archbishops (PSI) 
Refs to Roots:  Having a sugar daddy could be a root, as it is a societal norm 
Prod. Promotion:  Deemphasize condoms 
  
APPENDIX B.3 
Summary of the 18 campaigns used for content analysis 
 
MEXICO 
   
1. Investing in People  
This five-year initiative to reduce barriers to behaviour change and care seeking 
began in 2003. It was a localised version of a series of similar campaigns that were 
underway in several countries. Focused in Mexico City, where the largest number of 
HIV/AIDS cases were found, Investing in People was the joint effort of a half-dozen 
international, national, and local organizations. A key technique was personal 
communication through workshops and conference presentations conducted by trained 
female advocates and local HIV/AIDS leaders 
(http://www.usaid.gov/policy/budget/cbj2006/lac/pdf/mx523-023.pdf). 
 
2. VIDA Menos Etiquetas 
Sponsored by Population Services International-Mexico, this gender-equity 
initiative  incorporated the research and successful techniques of Programas H and M 
to reach young people at risk. Menos Etiquetas used peer educators to initially broach 
themes that included gender norms, HIV/AIDS, and stigma. A traditional media mix 
including posters, postcards, stickers and flyers was teamed with below-the-line social 
media such as blogs and Bluetooth viral marketing (http://www.psi.org/mexico). 
 
3. Programa Hombres (Project H) 
Links between traditional gender attitudes and the spread of AIDS prompted a 
partnership of NGOs to develop Programa Hombres. This five-year initiative has been 
used in more than twenty countries, including Mexico, to persuade young Latino men 
to question traditional norms related to manhood. An extensive media mix included 
educational videos available in three languages—Spanish, English, and Portuguese—
interactive workshops, and collateral materials as well as radio, outdoor media, and 
direct mail. The campaign slogan, ‘In the Heat of the Moment,’ urged use of the Hora 
H condom brand, manufactured by the makers of Durex condoms and distributed in 
non-traditional venues such as funk balls and cafes (www.promundo.org.br).  
 
4. Programa Mujeres (Project M) 
Building on their success in educating young men about the costs of traditional 
macho culture, in 2005 the Program H partners and World Education launched 
Programa Mujeres to encourage young women to take control of their sexual and 
reproductive health. This social marketing campaign was based on research that 
included a review of Latin American literature to define the concept of female 
empowerment, focus group discussions with groups of young women aged 14-24 who 
lived in marginalised communities outside Queretaro, Mexico, and interviews with 
empowered young women (www.promundo.org.br). 
 
5. Tú No Me Conoces  (You Don't Know Me) 
The Tú No Me Conoces social marketing campaign promoted awareness of HIV 
risk and testing of Latinos living on the California-Mexico border. The 8-week 
campaign included Spanish-language radio, print media, a website, and a toll-free 
HIV-testing referral hotline. Campaign results included an increase in HIV testing at 
partner clinics; 28% of testers who heard or saw an HIV advertisement specifically 
identified the campaign. (http://www.docstoc.com/docs/43661964/Southern-
California-Border-HIVAIDS-Project-TU-NO-ME-CONOCES). 
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6. VIDA Digna (Life with Dignity) 
Reducing stigma and discrimination experienced by sex workers, gay men, men 
who have sex with men, drug users, and people living with AIDS was the central 
purpose of the three-year Vida Digna campaign, launched in 2005 by the Colectivo 
Sol alliance and funded by GlaxoSmithKline. The campaign was centred in the central 
states of Mexico, a conservative area characterised as having ‘the weakest civil society 
response to AIDS.’ Vida Digna used anonymous testimonials to urge tolerance and 
acceptance of people’s differences (http://www.aidsalliance.org/sw45511.asp).  
 
 
UGANDA 
   
1. ABCs (Abstinence, Being Faithful and Condoms) 
This campaign took a moralistic approach—‘Sex can wait until marriage’—and 
used outdoor media as well as local spokespeople such as community leaders and 
ministers to urge abstinence before marriage and fidelity to spouses. Practical AIDS 
information was provided and condom use was also advocated to reduce risk of 
infection. This program and others like it have generated international controversy 
about whether condoms are effective in reducing HIV prevalence and raising 
associated concerns about increased promiscuity 
(http://www.pbs.org/now/science/aidsdebate.html). 
 
2. Afford Good Life 
AFFORD was a five-year health marketing initiative led by the Johns Hopkins 
Bloomberg School of Public Health and funded by the U.S. Agency for International 
Development. Designed to increase accessibility and affordability of AIDS products 
and services, the campaign promoted Protector brand condoms, Pilpan oral 
contraceptives, and Inject injectable contraceptives. Consumers were encouraged to 
use these products properly and could access them at subsidised rates. A centrepiece of 
the campaign was ‘The Good Life Gameshow,’ an entertainment education quiz show 
using an integrated multimedia approach, including community interaction, and radio 
and television shows (http://www.jhuccp.org/africa/uganda/afford.shtml). 
 
3. Be a Man 
 Targeted primarily to young men 15 to 24, this campaign was launched in 2006 to 
prompt reflection on the costs of traditional male attitudes and behaviours, which 
research has shown contribute to an increase in HIV infections. ‘Society’s expectations 
of men are setting them up for failure,’ according to Vincent Kiwanuka, the Be a Man 
campaign’s coordinator. The media mix heavily utilised radio drama and television, 
including broadcasts during the World Cup. The goal was to encourage sexual 
relationships based on mutual respect and love 
(http://www.hcpartnership.org/Press/press2006-06-21.php). 
 
4. Onelove  
 Launched in January 2009, the South African Onelove campaign aimed to reduce 
new HIV infections in South Africa by 10% by 2011. The focus of the campaign, led 
by Soul City Institute for Health and Development Communication, was on multiple 
concurrent partnerships (MCP), one of the key drivers of the HIV pandemic in 
Southern Africa. The campaign’s goal was to shift social norms away from multiple 
sexual partnerships and encourage monogamous relationships. Onelove challenged 
gender stereotypes and cultural norms that reinforce MCP and highlighted the risks 
associated with transactional, drunk, and intergenerational sex. The campaign used 
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mass media, including the Soul City television drama series, a radio drama, print 
materials, and social mobilisation and advocacy 
(http://www.comminit.com/en/node/286237/347).  
 
5. PMTCT (Prevention of Mother to Child Transmission) 
‘The Social Marketing Approach to PMTCT’ is a Population Services International 
[PSI] project that used a branded franchise network of trained midwives to help 
pregnant women reduce transmission risk during birth. The midwives were also 
trained on HIV testing procedures and counselling skills. The central message of this 
campaign was it is possible to have an HIV-negative baby even when both parents are 
HIV positive. Since 2003, a broad media mix has disseminated this message to male 
partners of pregnant women 25-45, primarily in low-income, low-literary, peri-urban, 
and rural areas of Uganda (http://www.psiwash.org/resources/pubs/Uganda2004.pdf). 
 
6. Sugar Daddies 
Addressing the widespread problem of cross-generational sex (sex with a person at 
least 10 years older), this campaign, begun in 2004, sought to raise awareness of the 
dangers of ‘sugar daddy’ relationships. This practice is a major reason HIV infection 
rates have been six times higher for teenage girls than for their male counterparts. 
Target audiences include young women 15 to 24, their parents (who often encourage 
such relationships), and older male partners. The PSI-sponsored initiative features 
recognised male role models such as Uganda’s Minister of Ethics and Integrity Tim 
Lwanga urging men to ‘stop preying on young girls’ 
(http://psi.org/resources/pubs/cross-gen.pdf). 
 
 
UNITED STATES 
   
1. Be the Generation 
This program aimed to create a supportive environment for HIV vaccine research 
by mobilizing existing community partnerships and networks to educate key 
communities about this research in 20 U.S. cities where HIV vaccine clinical trials 
were ongoing or planned. Coordinated media and collateral materials segment targeted 
audiences by gender, ethnicity, and lifestyle, showing images of two people, one older 
and one younger. Extensive educational materials were available online. The uniform 
message was the young generation’s ‘great cause’ is to end AIDS and that a vaccine is 
the best hope of accomplishing that goal (www.bethegeneration.org). 
2. I am African /(Keep a Child Alive) 
This campaign, heavily saturated with celebrities, promoted the idea that everyone 
has some DNA with connections to an African heritage, so all people should work 
together to help with the AIDS problem. Begun in 2005, donations for AIDS drugs 
were particularly sought. I am African was linked with the Keep a Child Alive 
campaign, which sought to help AIDS orphans in Africa by providing them with 
ARVs [treatment cocktails]. The I am African images of celebrities such as Gwenyth 
Paltrow and Sting wearing ‘war paint’ with the campaign slogan beneath sparked 
controversy about the use of eye-catching visuals that ‘insensitively perpetuate 
stereotypical ways of thinking about AIDS or Africa’ (www.keepachildalive.org; 
http://percipere.typepad.com/media/2006/08/cause_celebre_o.html).  
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3. MTV Think 
This award-winning public information campaign began in 2006 and was notable 
for bringing MTV on board as a major sponsor. The goal was to reach sexually active 
16- to 24-year-olds with information about HIV and related issues, since according to 
UNAIDS, half of new HIV infections worldwide are among people under the age of 
25. Discussion of safe-sex issues, condom use, and HIV testing were urged through 
television and web media. According to sponsor The Kaiser Family Foundation, this 
was a ‘multi-platform, interactive community for the first generation of Americans 
who have lived their entire lives during the AIDS epidemic’ 
(http://www.kff.org/hivaids/phip060506nr.cfm). 
 
4. The New Faces of HIV in Houston 
 Due to HIV high prevalence among African Americans in Houston, in 2002 the 
Harris County Hospital District and the Houston Department of Health and Human 
Services launched a social marketing campaign to raise awareness and increase 
testing among this population. Media included radio, public transit, direct mail, and 
brochures targeting women. Images of both men and women were featured in the 
materials, with the slogan, ‘We look just like you, but you don’t have to be like us. Do 
the right thing. Get tested’ (http://www.hchdonline.com/HIV/newfaces.htm). 
 
5. ONE 
With more than 60 partners, this campaign was set up to rally Americans one by 
one to push for increased donations to fight poverty and AIDS. The campaign had a 
broad target audience, ranging from students to ministers to punk rockers to soccer 
moms. The call to action was ‘We’re not asking for your money, we’re asking for your 
voice.’ In line with this approach, on June 11, 2007, ONE launched ONE Vote ’08, its 
‘largest and boldest initiative ever,’ vowing to make extreme poverty and global 
disease an issue in the 2008 U.S. elections (www.one.org).  
 
6. We all have AIDS 
Launched in 2005 on World AIDS Day, this campaign created by American 
designer Kenneth Cole was heavily supported by celebrities and prominent AIDS 
activists. The message was to reduce stigma associated with AIDS to prevent, contain, 
and eradicate the disease. The consistent theme for all ads was ‘We all have AIDS…if 
one of us does.’ International celebrities participating included President Nelson 
Mandela, Arch Bishop Desmond Tutu, Sharon Stone, Will Smith, and Sir Elton John 
(www.WeAllHaveAIDS.com).  
 
 
 
 
 
APPENDIX B.4 
Using Social Media as a Health Promotion Tool: The Mexican Experience 
Date: _________________________________ 
Code: _________________________________ 
1. What is your academic or professional background? 
2. Describe the health organization you work for. 
3. What health campaigns have you been involved with? 
4. What has been your role in those campaigns? 
5. Background and rationale behind the campaign approach? 
6. Can you describe those campaigns? 
a. What was the target audience or target market?  Describe its characteristics. 
b. When was the campaign executed?  Scope/timeframe of campaign? 
c. What kind of research was conducted before designing the campaign? 
d. Who designed the campaign? 
e. What have you learned by executing this campaign? 
f. What were this campaign’s objectives? 
g. What were the messages disseminated? Why did you choose those messages? 
h. Who were the sponsors/partners? How were they selected? 
i. Were there medical advisers/image consultants, etc? 
j. Campaign strategies—which were most effective? (might include policies, internal PR, etc) 
k. What media outlets were used to disseminate information? Which were more effective? 
l. Was social media used? If so, who decided to use it? Have anybody assessed the used of 
social media? 
m. Who sponsored the campaign? 
n. Budget/funding sources? 
o. How do recipients of information perceive their choices as regards prevention techniques 
and treatment modalities? 
p. What are their unanswered questions, gaps in knowledge? 
q. How is campaign evaluation conducted? (Is there a written report available?) 
r. Role of controversy/political concerns in getting funding/approval for campaigns? 
s. The most important lessons learned? What will you do differently in future campaigns? 
t. Trends you see in the use of social marketing campaigns for disease 
preventions/information? 
u. Possible to get samples of materials? (Okay to reproduce images?) 
 
APPENDIX B.5 
Question bank for pre-survey interviews (Houston) 
 
 
1. Briefly, please talk about your professional background as it relates to HIV/AIDS. 
 
2. How long have you been working with fundraising/communications efforts to combat 
HIV/AIDS in Houston?  
 
3. Which techniques have you found are most effective in gaining the support of 
Houston policymakers/upstream audiences? 
 
4. Did you participate in developing the rationale behind the campaign approach for 
New Faces of Houston? 
 
5. Was it difficult to make the decision to be pictured in the campaign literature? (Only 
addressed to interviewees who were pictured in the campaign) 
 
6. What kinds of problems has being a spokesperson for the campaign created for you? 
(Same as #5) 
 
7. How important are sponsors/partners to successful HIV/AIDS campaigns?  
 
8. Which kinds of campaign media strategies do you think are most effective in 
Houston?  
 
9. How do recipients of HIV/AIDS information perceive their choices as regards 
prevention techniques and treatment modalities in this city?  
 
10. What are their unanswered questions, gaps in knowledge? 
 
11. In your experience, what is the role of controversy/political concerns in getting 
funding/approval for campaigns in Houston? 
 
12. What do you think were the most important lessons learned in this campaign?  
 
13. What would you like to see done differently in future HIV/AIDS campaigns? 
 
14. What trends do you see in the use of social marketing campaigns for HIV/AIDS 
prevention/information?  
 
15. Is there anything you would like to add that I have not asked? 
 
  
APPENDIX B.6 
Question bank for reaction interviews (post survey) 
 
 
 
1. Briefly, please talk about your professional background as it relates to HIV/AIDS. 
 
2. What are your initial reactions to the Legacy Clinic survey results? (Interviewer 
summarises highlights of results and shows charts of result trends). 
 
3. Regarding HIV/AIDS in Houston: What kinds of support have been provided by local 
or national policymakers?  
 
4. What techniques/approaches have been most effective in getting support? 
 
5. How important are sponsorships/partnerships in combating HIV/AIDS?  
 
6.  Do those sponsorships influence which products and treatments are considered 
mainstream? If so, how? 
 
7. What is the role of controversy in getting messages out about HIV/AIDS? 
 
8. After 30 years, what are the most important things we have we learned in the area of 
(medical, marketing, advocacy) for prevention and treatment of HIV/AIDS? 
 
9. Where do we go from here? What would you like to see done differently in the future 
regarding (medical, marketing, advocacy?) 
 
10. In general, how effective do you think social marketing campaigns are in motivating 
people to change their behaviour regarding preventing HIV/AIDS?  
 
11. Can social marketing campaigns motivate lifestyle changes regarding treatments for 
HIV/AIDS? 
 
12. Is there anything you would like to add that I have not asked? 
 
 
APPENDIX B.7 
List of exploratory research interviews  
2005-2010 
 
 
 
Dr. S.K. Banerjee, Homeopathic Physician, Kolkata, West Bengal, India. Email and 
telephone communication, June 2007. 
 
Kemper B. Crabb, Director of the Order of Servants of the King, a charity organisation 
that builds churches, schools, orphanages, and hospitals in remote areas of India, Nepal, 
and Uganda. Personal interview, March 2007. 
 
Sameer Deshpande, PhD, Assistant Professor, Marketing, University of Wisconsin, 
and Faculty member, Centre for Socially Responsible Marketing, Lethbridge, Alberta, 
Canada. Personal communication, October 2006. 
 
Tugba Kalafatoglu, Tugba Kalafatoglu and Associates, Istanbul, Turkey. Personal 
communication, October 2007. 
 
Dr. Susan Kern, Principle investigator, ‘Lazarus Study: HIV/AIDS Interaction with 
HIV/AIDS.’ Personal interview, June 2006. 
 
James Kiwanuka-Tondo, Assistant Professor, Department of Communication, North 
Carolina State University, Raleigh, NC. Personal and email communication, October 
2006. 
 
Dr. Jesus Meza Lueza, Profesor- Investigador, Comunicadio Y Periodismo, Campus 
Cuidad de Mexico. Personal communication, August 2006. 
 
Laura McDermott, Research Officer, Institute for Social Marketing, University of 
Stirling & The Open University, Stirling, Scotland. Personal interview, June 2006. 
 
John Harold Estrada Montoya, Profesor Investigador, Salud Pública, VIH/SIDA, 
Ciudad  Universitaria, Bogota, Colombia. Personal communication, August 2006. 
 
David Olson, Director of Public Affairs, Population Services International, 
Washington, DC. Personal communication, August 2008. 
 
Lars Ivar Owesen-Lein Borge, HIV/AIDS Activist and conference organiser, Mexico 
City. Personal interview, December 2006. 
 
Andrew Waldhausen, Director, Gay & Lesbian Network, South Africa. Personal 
interview, August 2008. 
 
Agustín Villalpando, Editor, Enkidu Magazine, Mexico City.  Personal 
communication, December 2006. 
 
 
APPENDIX B.8 
List of key informants interviewed—pre-survey 
 
 
TEXAS/USA 
 
Françoise Armand, Social Marketing and Pharmaceutical Partnerships Director, 
Private Sector Partnerships One, Bethesda, MD.  Email communication, March 2008. 
 
Dr. Carlos Arreola, a long-time HIV/AIDS counsellor and activist in the Houston area. 
Helped found the CFA (see glossary). Personal interview, March 2009. 
 
Barbara Bijelic, Research Assistant, PSP-One Program, International Health Division, 
Bethesda, MD. Email communication, January 2008. 
 
Susan Diemont-Conwell of Torma Communications in Houston helped design the 
campaign, New Faces of HIV in Houston. Telephone and email interviews, January 
2008. 
 
Dena Gray, a Houston activist and administrator for Houston’s Housing and Community 
Development Department, an agency that locates housing for people living with HIV/AIDS.  
She is responsible for public service funds totalling approximately $12 million annually. 
Gray was also pictured in the New Faces of HIV in Houston campaign. Email interview, 
January 2008. 
 
Maria de la Luz Martinez, Translation consultant, Austin, Texas. Email and telephone 
communication, May 2008. 
 
Beau J. Mitts, Manager, HIV Prevention Program, City of Houston. Personal 
interview, January 2008. 
 
Ken Malone, HIV Testing Project Coordinator, Thomas Street Health Centre, Houston, 
TX. Personal interview, September 2009. 
 
Eric Roland, Senior Director of Marketing, Legacy Community Health Services, 
Houston, TX.  Telephone and email interviews, February 2008. 
 
Karen Russell, Incremental Marketing, Inc., Clear Lake Shores, TX. Email interview, 
February 2008. 
 
Dr. Blair Winegar, Conventional medical doctor who completed his training in Texas. 
Personal communication, October 2009. 
 
Sandy Won, International Center for Research on Women (ICRW), Washington, DC. 
Email communication, February 2009. 
 
 
EUROPE 
 
Dr. Nele Jensen, who worked at an HIV/AIDS clinic in Germany, co-directed a 
documentary of interviews with HIV-positive people from all walks of life. Personal 
interview, June 2009. 
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Daréll Lourens, a South African filmmaker who filmed and edited The HIV/AIDS 
documentary, Blissfully Lost, which was financed by GlaxoSmithKline and was 
screened at the 2009 German-Austrian-Swiss AIDS Congress in St.Gallen. Personal 
interview, June 2009.  
 
Elizabeth Sutherland, PhD, Associate Scientist II, Health Services Research, Family 
Health International, Durham, NC. Personal communication, June 2009. 
 
 
MEXICO/LATIN AMERICA 
 
Pepe Aguilar, Director, DEMYSEX, Mexico.  Email communication, May 2008.  
 
Hilda Peñaloza Andaluz, Coordinadora Administrativa, Population Services 
International, México. Email communication, February 2009. 
 
Gerardo Ayala, Salud y Genero, Mexico. Email communication, February 2009. 
 
Gary Barker, PhD, Executive Director/Diretor Executivo, Instituto Promundo, Rio de 
Janeiro, Brasil. Email communication, April 2008. 
 
Alejandro Brito, Director, LETRA S, Mexico. Email communication, May 2008. 
 
Oliver LeTouzé, Director, PSI México. Email and telephone communication, April 
2008. 
 
Anna Luiza, Promundo Instituto, Brasil. Email communication, February 2009. 
 
Alejandra Megloli, Director, Mexfam, Mexico. Email communication, May 2008. 
 
 Marcos Nascimento, Co-Director, Promundo Instituto, Brasil.  Email and telephone 
communication, May 2008. 
 
Lars Ivar Owesen-Lein Borge, HIV/AIDS Activist and conference organiser, Mexico 
City. Personal interview, August 2008. 
 
Christine Ricardo, Co-Director, Promundo Instituto, Brasil, Email and personal 
interviews, August 2008. 
 
Agustín Villalpando, Editor, Enkidu Magazine, Mexico City.  Personal 
communication, August 2008. 
APPENDIX B.9 
List of key informants interviewed post-survey (reaction interviews) 
 
 
 
Dr. Jacques Clermont, Collaborator for INSERM, France’s National Institute of 
Health and Medical Research, commented from the perspective of an alternative 
medical doctor doing research and working with HIV/AIDS patients. 
 
Tina Megdal, Senior Director of Client Services, Legacy Clinic in Houston, provided 
observations on the results of the survey at Legacy. 
 
Amy Leonard, Health Educator for Legacy Clinic in Houston, provided observations 
on the results of the survey at Legacy. 
 
Dr. Mark Nichols, Vice President of Clinical Affairs for the Bering Dental Clinic in 
Houston, commented from the perspective of a conventional medical doctor working 
with HIV/AIDS patients.  
 
Paul Simmons, Executive Director of the Center for AIDS Information and Advocacy 
(CFA) in Houston, commented from the perspective of a long-time HIV/AIDS activist. 
 
  
Note: All were personal interviews, which took place in Houston in March and April of 
2010. 
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APPENDIX C 
SURVEY DOCUMENTS 
 
           
C.1 Research Subject Informed Consent Form 
 
C.2 HIV/AIDS Knowledge and Perceptions Survey (English) 
 
C.3 Survey: Versions 9.2, 9.3, and 9.4 of Page 2 
 
C.4 HIV/AIDS Knowledge and Perceptions Survey (Spanish) 
 
C.5 Survey Consultants  
 
C.6 Guidelines for Survey Data Collection 
 
C.7 Facsimiles of the Survey Signs (English) (Spanish) 
 
C.8 Comments from Legacy Survey Respondents 
APPENDIX C.1 
Research Subject Informed Consent Form 
 
Title of Project: 
Social Marketing Strategies for Combating HIV/AIDS in Rural and Disadvantaged 
Communities in Uganda, Mexico, and the Southern United States 
 
Prospective Research Subject:  
Read this consent form carefully and ask as many questions as you like before you 
decide whether you want to participate in this research study. You are free to ask 
questions at any time before, during, or after your participation in this research. There 
will be no penalty or loss of benefits to which you are otherwise entitled if you choose 
not to participate. 
 
Purpose and Procedures:  
You are being asked to participate in a research study designed to evaluate your 
knowledge and perceptions about HIV/AIDS. Your responses will help guide the 
design of a model for effectively disseminating information about HIV/AIDS.  
 
This survey is being administered to a sample of people whose principal commonality 
is that they are all receivers of information about prevention techniques and treatment 
modalities available for HIV/AIDS. You should not experience any discomfort as a 
result of participating in this study and you can decline to answer any question. Your 
responses will be strictly anonymous; they cannot be connected to you in any way. If 
this research is published, no information that would identify you will be written. You 
may stop the survey at any time.  
 
This survey is part of a research project being conducted by a Ph.D. candidate at the 
University of Teesside in Middlesbrough, England. For questions or concerns 
regarding this research, contact Ruth Massingill at 80 Waterwood, Huntsville, Texas 
77320, or at 1-936-581-1322. 
 
Authorization: 
I have read and understand this form, and I consent to voluntarily participate in this 
research study. I understand I will receive a copy of this form. I realize I am free to 
withdraw my consent and to withdraw from this study at any time without negative 
consequences.  
Participant Name (printed):______________________________________________ 
Participant Signature: 
_____________________________________________________________________ 
Date: 
______________________________________________________________________ 
APPENDIX C.2  
HIV/AIDS Knowledge and Perceptions Survey 
 
This is part of a research study regarding knowledge and perceptions about HIV, HIV/AIDS, 
and/or AIDS (referred to as HIV/AIDS in this survey). Your responses will help guide the design of 
a model for effectively informing people about HIV/AIDS.   
 
I. Are you 18 or older? (If not, stop survey.) 
II. Have you seen or heard information about prevention and treatment of HIV/AIDS? (If 
no, stop survey; if yes, proceed.) 
 
A. From which of these sources have you learned about HIV/AIDS in the past 4-5 years?  
Check ALL that apply. 
 
!  1. TV  ! 11. Online newsletters, journals, etc 
!  2. Radio  ! 12. Emails 
!  3. Books  ! 13. Social media (Facebook,Twitter, etc) 
!  4. Newspapers  ! 14. Community organizations 
!  5. Magazines  ! 15. Religious organizations 
!  6. Out of home (billboards, transit ads,   ! 16. Educational institutions  
  posters, flyers, brochures)   ! 17. Conventional medical doctors 
!  7. Events (seminars, workshops, conferences)  ! 18. Alternative medical doctors 
!  8. Medical websites  ! 19. Friends or family members 
!  9. HIV/AIDS groups’ websites  ! 20. People you work with 
! 10. Blogs, online bulletin boards  ! 21. Other (Specify)________________ 
 
B. Using the scale below, rate each of these sources of HIV/AIDS information according to 
how credible (believable) they have been in your experience.     
    
  Not at all Somewhat Undecided Credible Extremely
 credible    credible    credible 
   
1. TV  ! ! ! !     ! 
2. Radio !    !  !  !     ! 
3. Books ! ! ! !     ! 
4. Newspapers !    !  !  !     ! 
5. Magazines ! ! ! !     ! 
6. Out of home (billboards, bus ads,  
 posters, flyers, brochures)  ! ! ! !     ! 
7. Events (seminars,  
 workshops, conferences) ! ! ! !     ! 
8. Medical websites !    !  !  !     ! 
9. HIV/AIDS groups’ websites !    !  !  !     ! 
10. Blogs, online bulletin boards !    !  !  !     ! 
11. Online newsletters, journals, etc !    !  !  !     ! 
12. Emails !    !  !  !     ! 
13. Social media-Facebook,Twitter,etc !    !  !  !     ! 
14. Community organizations !    !  !  !     ! 
15. Religious organizations !    !  !  !     ! 
16. Educational institutions  !    !  !  !     ! 
17. Conventional medical doctors !    !  !  !     ! 
18. Alternative medical doctors !    !  !  !     ! 
19. Friends or family members !    !  !  !     ! 
20. People you work with !    !  !  !     ! 
21. Other (Specify)_____________ !    !  !  !     ! 
V9.1 
 
HIV/AIDS Survey 2 
C. Please check the response that best represents how you feel about these statements:  
 Strongly  Agree Neither Disagree Strongly Not   
 Agree  Agree Nor  Disagree Sure 
  Disagree   
1. Poor people are more likely to get HIV/AIDS.  !   ! ! !     ! ! 
 
2. Globally, the number of people with    
   HIV/AIDS is decreasing. !   ! ! ! ! ! 
 
3. HIV/AIDS is primarily a gay disease. !   ! ! ! ! ! 
 
4. Getting HIV/AIDS is usually a death sentence.  !   ! ! ! ! ! 
 
5. Antiretroviral drugs are a cure for HIV/AIDS. !   ! ! ! ! ! 
 
6. Giving antiretroviral drugs to people who are not 
   infected is a good way to prevent HIV/AIDS.  !   ! ! ! ! ! 
 
7. People who knowingly expose others to 
HIV/AIDS should be prosecuted as criminals. !   ! ! ! ! ! 
 
8. A pregnant woman with HIV/AIDS cannot  
 avoid having an HIV-positive baby.  !  !  ! ! ! ! 
 
9. You cannot get HIV/AIDS during sex if 
   condoms are always used. !  !  ! ! ! ! 
 
10. HIV/AIDS is God’s way of punishing  
the wicked. !   !  ! ! ! ! 
 
11. An effective HIV/AIDS vaccine is available. !   !  ! ! ! ! 
 
12. Alternative medical treatments for HIV/AIDS 
  have shown promising results. !   !  ! ! ! ! 
 
13. People with HIV/AIDS deserve the same  
 rights in the workplace as other workers. !   !  ! ! ! ! 
 
14. Treating HIV/AIDS is a lucrative business  
  for pharmaceutical companies. !   !  ! ! ! ! 
 
15. HIV/AIDS infections are often the result  
of immoral behavior.    !   !  ! ! ! ! 
 
16. It is biologically easier for women to get   
  HIV/AIDS than it is for men. !   !  ! ! ! ! 
 
17. HIV/AIDS prevention efforts often receive 
  more funding than treatment efforts.  !   !  ! ! ! ! 
 
18. Young people under 25 account for almost  
 half of new HIV/AIDS infections globally. !   !  ! ! ! ! 
 
19. I am not personally worried about  
getting HIV/AIDS. !   !  ! ! ! ! 
 
20. Worldwide, more people get HIV/AIDS by  
heterosexual contact than by homosexual contact. !   !  ! ! ! ! 
V9.1 
HIV/AIDS Survey 3 
D. Please mark ALL of the following HIV/AIDS treatments that you have heard of. 
! 1. UVBI (Ultraviolet blood irradiation) ! 11. Peroxide–IV    
! 2. Silver colloid–IV ! 12. Peroxide–oral  
! 3. Silver colloid–oral ! 13. Venus flytrap–oral   
! 4. Selenium liver support–oral ! 14. Porcine (pig) liver extracts–transdermal   
! 5. Chelation–IV ! 15. Nutritional supplements 
! 6. Chelation–oral ! 16. AZT (Azidothymidine)  
! 7. Vitamins–IV ! 17. HAART (Highly active antiretroviral therapy) 
! 8. Vitamins–oral ! 18. Pharmaceutical antibiotics (Bactrim, etc) 
! 9. Minerals–IV ! 19. Other (Specify)________________________ 
!10.Minerals–oral 
      
E. Based on your own knowledge or experience, please mark ALL of the following HIV/AIDS 
treatments that you think can be effective in treating HIV/AIDS. 
! 1. UVBI (Ultraviolet blood irradiation) ! 11. Peroxide–IV   
! 2. Silver colloid–IV ! 12. Peroxide–oral  
! 3. Silver colloid–oral ! 13. Venus flytrap–oral    
! 4. Selenium liver support–oral ! 14. Porcine (pig) liver extracts–transdermal   
! 5. Chelation–IV ! 15. Nutritional supplements  
! 6. Chelation–oral ! 16. AZT (Azidothymidine)  
! 7. Vitamins–IV ! 17. HAART (Highly active antiretroviral therapy) 
! 8. Vitamins–oral ! 18. Pharmaceutical antibiotics (Bactrim, etc) 
! 9. Minerals–IV ! 19. Other (Specify)______________________ 
!10.Minerals–oral     
F. Demographics (For statistical purposes only—your responses are anonymous.) 
 1. Age Group: !  18-25 !  26-36 !  37- 47 !  48-58 !  59+ 
2. Which gender do you most identify with?   !  Male !  Female 
3. Sexual orientation:  !  Heterosexual   !  Homosexual  !  Bisexual  !  Prefer not to say 
4. Which of the following groups do you most identify with? (Check only one.) 
 !  American Indian, Alaska Native  !  Hispanic 
   or Pacific Islander   !  White/Caucasian 
 !  Asian/Asian American   !  Multi-racial 
 !  Black/African American or Negro !  Other (Specify) _______________________ 
  
5. Which of the following best describes your education level? (Check only one.)   
 !  8th grade or less 
 !  Some high school 
 !  Graduated high school/have my GED 
 !  Graduated from college 
 !  Master’s degree or above 
6. Religious affiliation: _______________________________________     ! Prefer not to say  
7. Are you in a paid position with an organization involved with HIV/AIDS?     ! Yes   ! No  
8. Are you an unpaid volunteer with an organization involved with HIV/AIDS?  ! Yes   ! No 
9. My HIV status is:  !  Negative   !  Positive  !  Don’t know   !  Prefer not to say  
G. Other comments (Use back of page if needed) 
________________________________________________________________________________
________________________________________________________________________________ 
Thanks for your participation!                       V9.1 © Massingill 2009 
 
 
C. Please check the response that best represents how you feel about these statements: (V9.2) 
 Strongly  Agree Neither Disagree Strongly Not   
 Agree  Agree Nor  Disagree Sure 
  Disagree   
1. HIV/AIDS is God’s way of punishing  
the wicked. !   !  ! ! ! ! 
 
2. Getting HIV/AIDS is usually a death sentence.  !   ! ! ! ! ! 
 
3. Globally, the number of people with    
HIV/AIDS is decreasing. !   ! ! ! ! ! 
 
4. A pregnant woman with HIV/AIDS cannot  
avoid having an HIV-positive baby.  !  !  ! ! ! ! 
 
5. Poor people are more likely to get HIV/AIDS. !   ! ! ! ! ! 
 
6. HIV/AIDS prevention efforts often receive 
more funding than treatment efforts.  !   !  ! ! ! ! 
 
7. Worldwide, more people get HIV/AIDS by 
heterosexual contact than by homosexual contact. !   !  ! ! ! ! 
 
8. HIV/AIDS is primarily a gay disease. !   ! ! ! ! ! 
 
9. Giving antiretroviral drugs to people who are not 
infected is a good way to prevent HIV/AIDS.  !   ! ! ! ! ! 
 
10. I am not personally worried about  
getting HIV/AIDS. !   ! ! ! ! ! 
 
11. Alternative medical treatments for HIV/AIDS 
have shown promising results. !   !  ! ! ! ! 
 
12. Antiretroviral drugs are a cure for HIV/AIDS. !   !  ! ! ! ! 
 
13. An effective HIV/AIDS vaccine is available. !   !  ! ! ! ! 
 
14. You cannot get HIV/AIDS during sex if 
condoms are always used. !  !  ! ! ! ! 
 
15. People with HIV/AIDS deserve the same  
 rights in the workplace as other workers. !   !  ! ! ! ! 
 
16. People who knowingly expose others to 
HIV/AIDS should be prosecuted as criminals. !   ! ! ! ! ! 
 
17. Young people under 25 account for almost  
half of new HIV/AIDS infections globally. !   !  ! ! ! ! 
 
18. It is biologically easier for women to get   
HIV/AIDS than it is for men. !   !  ! ! ! ! 
 
19. HIV/AIDS infections are often the result  
of immoral behavior.    !   !  ! ! ! ! 
 
20. Treating HIV/AIDS is a lucrative business  
for pharmaceutical companies. !   !  ! ! ! !   
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C. Please check the response that best represents how you feel about these statements: (V9.3) 
 Strongly  Agree Neither Disagree Strongly Not   
 Agree  Agree Nor  Disagree Sure 
  Disagree   
1. Alternative medical treatments for HIV/AIDS 
  have shown promising results. !   !  ! ! ! ! 
 
2. Young people under 25 account for almost  
 half of new HIV/AIDS infections globally. !   !  ! ! ! ! 
 
3. People with HIV/AIDS deserve the same  
rights in the workplace as other workers. !   !  ! ! ! ! 
 
4. HIV/AIDS infections are often the result  
of immoral behavior.    !   !  ! ! ! ! 
 
5. HIV/AIDS prevention efforts often receive 
 more funding than treatment efforts.  !   !  ! ! ! ! 
 
6. Giving antiretroviral drugs to people who are not 
infected is a good way to prevent HIV/AIDS.  !   !  ! ! ! ! 
 
7. HIV/AIDS is primarily a gay disease. !   !  ! ! ! ! 
 
8. HIV/AIDS is God’s way of punishing  
the wicked. !   !  ! ! ! ! 
 
9. Getting HIV/AIDS is usually a death sentence.  !   !  ! ! ! ! 
 
10. An effective HIV/AIDS vaccine is available. !   !  ! ! ! ! 
 
11. Poor people are more likely to get HIV/AIDS. !   !  ! !     ! ! 
 
12. I am not personally worried about  
getting HIV/AIDS. !   !  ! ! ! ! 
 
13. Globally, the number of people with    
HIV/AIDS is decreasing. !   !  ! ! ! ! 
 
14. Worldwide, more people get HIV/AIDS by  
heterosexual contact than by homosexual contact. !   !  ! ! ! ! 
 
15. Antiretroviral drugs are a cure for HIV/AIDS. !   !  ! ! ! ! 
 
16. It is biologically easier for women to get   
HIV/AIDS than it is for men. !   !  ! ! ! ! 
 
17. People who knowingly expose others to 
HIV/AIDS should be prosecuted as criminals. !   !  ! ! ! ! 
 
18. A pregnant woman with HIV/AIDS cannot  
avoid having an HIV-positive baby.  !  !  ! ! ! ! 
 
19. You cannot get HIV/AIDS during sex if 
condoms are always used. !  !  ! ! ! ! 
 
20. Treating HIV/AIDS is a lucrative business  
for pharmaceutical companies. !   !  ! ! ! ! 
V9.3 
 
 
C. Please check the response that best represents how you feel about these statements: (V9.4) 
 Strongly  Agree Neither Disagree Strongly Not   
 Agree  Agree Nor  Disagree Sure 
  Disagree   
1. An effective HIV/AIDS vaccine is available. !   !  ! ! ! ! 
 
2. Alternative medical treatments for HIV/AIDS 
  have shown promising results. !   !  ! ! ! ! 
 
3. A pregnant woman with HIV/AIDS cannot  
 avoid having an HIV-positive baby.  !  !  ! ! ! ! 
 
4. Young people under 25 account for almost  
 half of new HIV/AIDS infections globally. !   !  ! ! ! ! 
 
5. Getting HIV/AIDS is usually a death sentence.  !   !  ! ! ! ! 
 
6. HIV/AIDS prevention efforts often receive 
more funding than treatment efforts.  !   !  ! ! ! ! 
 
7. Giving antiretroviral drugs to people who are not 
infected is a good way to prevent HIV/AIDS.  !   !  ! ! ! ! 
 
8. People with HIV/AIDS deserve the same  
rights in the workplace as other workers. !   !  ! ! ! ! 
 
9. Antiretroviral drugs are a cure for HIV/AIDS. !   !  ! ! ! ! 
 
10. HIV/AIDS is God’s way of punishing  
the wicked. !   !  ! ! ! ! 
 
11. Worldwide, more people get HIV/AIDS by  
heterosexual contact than by homosexual contact. !   !  ! ! ! ! 
 
12. HIV/AIDS is primarily a gay disease. !   !  ! ! ! ! 
 
13. You cannot get HIV/AIDS during sex if 
condoms are always used. !  !  ! ! ! ! 
 
14. Poor people are more likely to get HIV/AIDS.!   !  ! !     ! ! 
 
15. Globally, the number of people with    
HIV/AIDS is decreasing. !   !  ! ! ! ! 
 
16. I am not personally worried about  
getting HIV/AIDS. !   !  ! ! ! ! 
 
17. It is biologically easier for women to get   
HIV/AIDS than it is for men. !   !  ! ! ! ! 
 
18. HIV/AIDS infections are often the result  
of immoral behavior.    !   !  ! ! ! ! 
 
19. Treating HIV/AIDS is a lucrative business  
for pharmaceutical companies. !   !  ! ! ! ! 
 
20. People who knowingly expose others to 
HIV/AIDS should be prosecuted as criminals. !   !  ! ! ! ! 
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Encuesta sobre conocimiento y percepción sobre VIH/SIDA (APP C.4)  
  
Esta encuesta es parte de una investigación sobre el conocimiento y las percepciones que tienen las 
personas sobre el VIH y el Síndrome de Inmunodeficiencia Adquirida (SIDA). Para acortar la 
información, esta encuesta menciona SIDA en lugar de Síndrome de Inmunodeficiencia Adquirida. Sus 
respuestas ayudarán a diseñar un modelo de educación para informar a las personas sobre la prevención y 
el tratamiento del VIH/SIDA. 
 
1. ¿Es usted mayor de 18 años? (Si no, encuesta sobre la parada.) 
II. ¿Ha visto información sobre prevención y el tratamiento del VIH/SIDA? (Si no, encuesta sobre la 
parada.) 
 
A. ¿De cúales de estos es recursos usted ha aprendido sobre VIH/SIDA en los pasados 4-5 
años? Seleccione todas las respuestas que apliquen.  
 
! 1. Televisión       ! 11. Periódicos en line  
! 2. Radio        ! 12. Correos electrónicos  
! 3. Libros       ! 13. Facebook,Twitter, My Space, etc. 
! 4. Periódicos       ! 14. Organizaciones comunitarias 
! 5. Revistas       ! 15. Organizaciones religiosas 
! 6.Anuncios fuera de la casa     ! 16. Instituciones educacionales 
 (carteleras, letreros, hojas sueltas)   ! 17. Doctores convencionales 
! 7. Eventos (semirios, talleres, conferencias)  ! 18. Doctores en medicina alternativa 
! 8. Páginas Web escritas por personal medico  ! 19. Amigos o familiares 
! 9. Páginas en la Web creadas por personas   ! 20. Personas con las que trabaja 
 que tienen VIH/SIDA     ! 21. Otro (Especifique)______________ 
! 10. Blogs, tablones de anuncios en line  
 
B. Seleccione la respuesta que major represente cuan creíble(verosímiles) usted piensa que 
son los siguientes recursos que hablan sobre VIH/SIDA. 
 
        No lo encuentro     Algo creíble     Inseguro  Creíble        Extremadamente  
      creíble                      creíble 
1. Televisión      !  !        !        !   ! 
2. Radio           !  !        !        !   ! 
3. Libros      !  !        !        !   ! 
4. Periódicos      !  !        !        !   ! 
5. Revistas      !  !        !        !   ! 
6. Anuncios fuera de la casa (carteleras,  
    letreros, hojas sueltas)    !  !        !        !   ! 
7. Eventos (semirios, talleres, conferencias)  !  !        !        !   ! 
8. Páginas Web escritas por personal medico !  !        !        !   ! 
9. Páginas en la Web creadas por personas 
    que tienen VIH/SIDA    !  !        !        !   ! 
10. Blogs, tablones de anuncios en line  !  !        !        !   ! 
11. Periódicos en line     !  !        !        !   ! 
12. Correos electrónicos     !  !        !        !   ! 
13. Facebook,Twitter, MySpace,etc  !  !        !        !   ! 
14. Organizaciones comunitarias  !  !        !        !   ! 
15. Organizaciones religiosas   !  !        !        !   ! 
16. Instituciones educacionales   !  !        !        !   ! 
17. Doctores convencionales   !  !        !        !   ! 
18. Doctores en medicina alternativa  !  !        !        !   ! 
19. Amigos o familiares    !  !        !        !   ! 
20. Personas con las que trabaja   !  !        !        !   ! 
21. Otro (Especifique)______________  !  !        !        !   ! 
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C. Seleccione la respuesta que mejor represente lo que piensa sobre la siguiente 
información. Seleccione sólo una respuesta. 
              Estoy               Estoy algo Ni estoy    Estoy             Estoy             No estoy  
        completamente   de acuerdo      en acuerdo         algo en         completamente    seguro 
          de acuerdo              ni en acuerdo     desacuerdo        desacuerdo 
1. Las personas pobres tienen un riesgo  
mayor de contraer VIH/SIDA.    !       !  !        !       !  ! 
2. El número de personas con VIH/SIDA  
está disminuyendo.      !       !  !        !       !  ! 
3. El VIH/SIDA es una enfermedad que le  
da mayormente a los homosexuales.   !       !  !        !       !  ! 
4. Ser diagnósticado con VIH/SIDA es usualmente  
una sentencia de muerte.     !   !   !  !  !  ! 
5. Medicinas antiretrovirales curan el VIH/SIDA.  !   !   !  !  !  ! 
6. Recetar medicinas antiretrovirales a personas  
que no tienen VIH/SIDA es bueno de prevenir la  
enfermedad.        !   !   !  !  !  ! 
7. Las personas que saben que tienen HIV/SIDA y  
contagian a otras personas pueden ser acusadas  
legalmente.        !   !   !  !  !  ! 
8. Una mujer embarazada con VIH/SIDA no puede  
evitar tener un bebé que sea VIH-positivo.  !   !   !  !  !  ! 
9. Usted no contraerá VIH/SIDA cuando tiene  
relaciones sexuales si siempre usa condones.   !   !   !  !  !  ! 
10. El VIH/SIDA es una manera en que  
Dios castiga a las personas immorales.    !   !   !  !  !  ! 
11. Hay una vacuna que previene el VIH/SIDA.   !   !   !  !  !  ! 
12. Los tratamientos naturales para el VIH/SIDA  
han ayudado a las personas que tienen la enfermedad. !   !   !  !  !  ! 
13. Las personas que tienen VIH/SIDA merecen  
tener los mismos derechos que tienen otras personas  
en el área de trabajo.      !   !   !  !  !  ! 
14. El tratamiento médico del VIH/SIDA es un  
negocio lucrativo para las compañías farmacéuticas.  !   !   !  !  !  ! 
15. Las infecciones de VIH/SIDA son usualmente  
el resultado de un comportamiento immoral.  !   !   !  !  !  ! 
16. Comparado con los hombres, es más facil  
que una mujer contraiga VIH/SIDA debido  
la manera en que es su cuerpo.     !   !   !  !  !  ! 
17. Los esfuerzos para prevenir VIH/SIDA  
reciben más dinero que lo que se recibe para tartar 
la enfermedad.      !   !   !  !  !  ! 
18. Las personas de menos de 25 años representan  
casi la mitad de las nuevas infecciones de  
VIH/SIDA en el mundo.     !   !   !  !  !  ! 
19. Yo no estoy preocupado(a) de vaya a contraer 
 VIH/SIDA.        !   !   !  !  !  ! 
20. Mundialmente las personas se contagian más 
 con el VIH/SIDA porcontacto heterosexual que  
con el contacto entre personas del mismo sexo.   !   !   !  !  !  ! 
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D. Haga una marca a lado de los tratamientos de VIH/SIDA de los que haya escuchado o leído.  
! 1. UVBI (la irradiación ultravioleta de la sangre) ! 11. Peróxido – IV (intravenoso) 
! 2. Plata coloidal –IV (intravenoso)    ! 12. Peróxido –oral 
! 3. Plata coloidal–oral     ! 13. Atrapamoscas –oral 
! 4. Selenium apoyo de hígado–oral   ! 14. Extractos de hígado de cerdo– transdérmico 
! 5. Quelación – IV (intravenoso)    ! 15. Suplementos nutricionales 
! 6. Quelación –oral       ! 16. AZT (Azidothymidine) 
! 7. Vitaminas – IV (intravenoso)     ! 17. HAART (Terapia antiretroviral altamente activa) 
! 8. Vitaminas –oral       ! 18. Farmacéutico antibióticos (Bactrim, etc) 
! 9. Minerales – IV (intravenoso)     ! 19. Otro (Especifique)______________ 
!10. Minerales –oral 
 
E. De acuerdo con su propio conocimiento o experiencia, por favor marque TODOS los 
casil leros de los siguientes tratamientos del VIH / SIDA que cree que puede ser eficaz en el 
tratamiento del VIH / SIDA. 
 
! 1. UVBI (la irradiación ultravioleta de la sangre) ! 11. Peróxido – IV (intravenoso) 
! 2. Plata coloidal –IV (intravenoso)    ! 12. Peróxido –oral 
! 3. Plata coloidal–oral     ! 13. Atrapamoscas –oral 
! 4. Selenium apoyo de hígado–oral    ! 14. Extractos de hígado de cerdo– transdérmico 
! 5. Quelación – IV (intravenoso)    ! 15. Suplementos nutricionales 
! 6. Quelación –oral       ! 16. AZT (Azidothymidine) 
! 7. Vitaminas – IV (intravenoso)     ! 17. HAART (Terapia antiretroviral altamente activa) 
! 8. Vitaminas –oral       ! 18. Farmacéutico antibióticos (Bactrim, etc) 
! 9. Minerales – IV (intravenoso)     ! 19. Otro (Especifique)______________ 
!10. Minerales –oral 
F. Información demográfica (Sus repuestas serán confidenciales.) 
1. Edad:  ! 18-25 ! 26-36 ! 37- 47 ! 48-58 ! 59+ 
2. ¿Con qué género se identifica mejor? ! Masculino ! Femenino 
3. Orientació sexual:  ! Heterosexual  ! Homosexual  ! Bisexual   ! Prefiero no decir 
4. ¿Con cuál de los siguientes grupos usted se identifica más? (Seleccione sólo una contestación.) 
! Indion Americano, Original de Alaska   ! Hispano 
     O de las islas del Pacífico     ! Blanco/Caucasico 
! Asiatico/Asiatico Americano    ! Mezcla de razas 
! Negro/Africano Americano   !  Otro (Especifique)______________ 
5. ¿Cuál de las siguientes opciones mejor describe su educación académica? (Seleccione sólo una contestación.) 
! El grado octavo o menos 
! Algún instituto 
! Instituto/tiene graduado mi GED 
! Graduado colegial 
! Maestría o doctorado 
6. Afiliación religiosa: _______________________________________ ! Prefiero no decir 
7. ¿Trabaja usted en alguna organización que se encargue de educar, tratar personas que tienen 
HIV/AIDS, o que enseñe a prevenir la enfermedad? ! Sí ! No 
8. ¿Es usted un voluntario en alguna organización sobre HIV/AIDS? ! Sí ! No 
9. Mi HIV estatus es:  ! Negativo  ! Positivo  ! No sé   ! Prefiero no decir 
G. Otros comentarios (Use la parte de atrás de la página si necesita más espacio.) 
________________________________________________________________________________ 
________________________________________________________________________________ 
¡Gracias por participar!                                                                                          V9.1b © Massingill 2009 
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SURVEY CONSULTANTS  
 
 
Jacques Clermont, Doctor of Naturopathic Medicine and collaborator for INSERM, 
France’s National Institute of Health and Medical Research 
 
Solly Diaz, MHA, Division Manager-Southwest Region, City of Houston Department 
of Health and Human Services, Houston, Texas 
 
Hugh Fullerton, PhD., Researcher and retired educator, Texas 
 
Amy Leonard, Health Educator, Legacy Clinic, Houston, Texas 
 
Ken Malone, HIV Test Project Coordinator, HIV Services, Harris County Hospital 
District, Houston, Texas 
 
Tina Megdal, Senior Director of Client Services, Legacy Clinic, Houston, Texas 
 
Beau J. Mitts, MPH, Technical Assistance Manager, HIV/AIDS Care, Treatment, and 
Houston Program, Bureau of HIV/AIDS Prevention and Control, New York City 
Department of Health and Mental Hygiene.  (Formerly Manager, HIV Prevention 
Program, City of Houston Health and Human Services, Houston, Texas) 
 
Wanda Reyes, PhD, Assistant Professor of Mass Communication, Sam Houston State 
University, Huntsville, Texas 
 
Ardyth Broadrick Sohn, PhD., Professor and Director, Hank Greenspun Xchol of 
Journalism and Media Studies, University of Nevada Las Vegas, Las Vegas, Nevada  
 
Christopher White, PhD., Associate Professor of Mass Communication, Sam Houston 
State University, Huntsville, Texas 
 
 
 
 
 
APPENDIX C.6: Guidelines for Survey Data Collection 
 
1) Preparing—Read the consent form and the survey before going into the field. Take the 
survey and think about what questions respondents might have. 
 
2) Organize copies of the blank consent forms and the five versions of the survey in 
separate folders. Be sure to have separate folders for the five different versions of the 
surveys. All folders should be clearly labelled. Have several pens for respondents’ use. 
 
3) Have separate folders for completed surveys and signed consent forms. At no time 
should the consent forms be filed with the corresponding surveys. 
 
4) Approaching possible respondents—Greet the person, give your name and explain 
that you are asking people to take a brief survey about their knowledge and perceptions 
about HIV/AIDS. This is part of a research project to help find effective ways to inform 
people about HIV/AIDS. 
 
5) Time frame/anonymity—Explain that taking the survey will only take about 10-15 
minutes and will be anonymous—names will never be used but their information will be 
important and useful. 
 
6) Filter questions— 
a. Are you 18 or older? (No minors can take the survey.) 
b. Have you seen or heard information about prevention and treatment of HIV/AIDS?  
If NO, say thank you, and do not distribute a survey. If YES, continue.  
 
7) Distribution of different survey versions—Distribute version 1 of the survey to the 
first respondent, version 2 to the second respondent, and so on. After five surveys have 
been completed, begin the cycle over again.  
 
8) Getting consent forms signed—There must be a signed consent form for the survey to 
be valid. Give a copy of the consent form to the respondent and ask him/her to sign and 
return a copy. Stress again that surveys and consent forms will be kept separate and will 
not be linked in anyway. The person’s name will NEVER be used in any way. (If the 
person requests a copy of the consent form, give him/her a copy.) 
 
9) Answering questions respondents might ask: 
Q: Can I decline to answer a question?  YES 
Q: Can I stop the survey at any time?  YES 
Q: Whom can I contact if I have a question? Contact and phone # on the form. 
Q: Why must I sign a form? For a survey to be valid, respondents must give consent. 
 
10) Coding—At the end of the collection period, code the surveys and the consent forms 
using the collection site and date codes provided. Do NOT code the surveys in the 
presence of the respondents. 
 
11) Transporting the surveys—Surveys should be kept in a secure place while being 
transported to the site where they will be edited, coded, and tabulated. 
If you are 18 or older, please take a few 
minutes to fill out our HIV/AIDS survey.  
Your anonymous responses will help us find 
better ways to inform people about HIV/AIDS 
prevention and treatment. 
Thanks for your help!
Grab a  giftf
unny
This research project has IRB approval from the University of Teesside.
Take a  surveyq
uick
Si usted tiene 18 años o más, por favor, 
tómese unos minutos para participar en un 
encuesta sobre VIH/SIDA.  Su respuesta 
anónima nos ayudará a informar a gente
sobre el tratamiento y la prevención 
de VIH / SIDA. 
Gracias por tu ayuda!
Recibir un regalo!
Este proyecto de investigación aprobado por la Universidad de Teesside.
Participar en 
una encuesta 
APPENDIX C.8 
Comments from Legacy Survey (Nov/Dec 2009) 
 
Taking this survey made me realize how much I don't know about HIV/AIDS.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
Great work by everyone pulling together.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
I've been infected for 23 years.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
I am not very familiar with HIV/AIDS and its treatments or lack thereof. New to 
Houston and have never been face to face with HIV/AIDS and its effects and or the 
amount of people that have it. I suppose it's ok to say that I am not very educated in this 
matter.                                                                                                                                                                                                                                                                                                                                                                                                                                                      
Having 4 friends with HIV, I still don't know much about what they go through to stay 
well every day. I feel maybe that it’s not a open subject to talk about.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
We need more help to get good service.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
Thanks for your help.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
Thanks for all you do for the HIV community.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
I am transgender.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
Positive for 30 years and have never taken any drugs ever for the illness.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
Nice to participate.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
Answered "not sure" on items I don't know, #16, yes! But only if the other party is 
unaware of the infected person's condition; #19, depends on the person (ex are they 
rapists, cheating or just dating) question was too broad.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
Lots of treatments.... I didn't know any of them.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
I know that my God is good. I've been exposed since 1992 till now. I'm still here.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
All the best on your research project. Happy and safe Holidays and 2010.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
More education in schools; many people believe the #'s are going down drastically and 
there is a readily available cure.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
If it was not for the good doctors and caseworkers, I would have been very ill. This is a 
good clinic and I love how you all work with me and let me know I am not in the dark.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
The people helping out are doing a wonderful job.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
Part D: Some of these therapies used together can be effective treatments.           
I have been negative for the last 4 years of my life, and was HIV in 1987.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
Knowledge is power!  
APPENDIX C.8: Comments from Legacy Survey 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
Work as LVN for HCHD.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
There are some religious teachings that I disagree with in regard to HIV education. I 
believe a full dissemination of scientifically proven HIV prevention methods should be 
mandatory for any organization funded for such efforts. The censorship of this education 
based on “beliefs” is ethically challenged.  While some religious organizations are 
beneficial in their teaching method, others try to enforce their beliefs on those in need.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
I myself have 2 sons with AIDS. Thanks for your support.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
I feel that people with no insurance is treated unfairly and results are not always correct.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
Thanks.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
Hoping for a cure.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
The research being done in vector treatment looks promising.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
I have had a family member living with AIDS for almost 10 years. In that time I have 
seen her almost die 5 times. With the meds she always got better.  She is living a full 
life and is very healthy. I believe given funding a cure could be found. I have to hope. 
Good luck with your school project.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
I think it's sad that we have gotten comfortable with these diseases and to really educate 
yourself, you have to make the effort. There needs to be awareness.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
I am a Leeper graduate of 2007.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
My daughter is HIV, possibly AIDS, age 33, contracted HIV at 21 from husband-Now 
ex.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
DCA Drug will cure Cancer & AIDS/HIV, but we can’t get it in the USA as a legal 
treatment.  Availability in Canada only.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
My boyfriend is HIV positive.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
I have some thoughts that I am infected with HIV one time and it was horrible.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
Thanks and good luck.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
I didn’t check any treatments because I have never heard of any of them.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
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1Taking Taboo Topics Public:
How Social Marketing Partnerships Combat
HIV/AIDS in Mexico
Ruth Massingill
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PSP-One On-line Conference
March 10-15, 2008
Taking Taboo Topics Public:
How Social Marketing Partnerships Combat HIV/AIDS in Mexico
2Introduction
! Social marketing influences low-income, high-risk
populations to make healthy behaviour changes.
!Key tactic for combating HIV/AIDS
!Spread of infection can be
managed: level and prevalence
of HIV/AIDS are altered by
human intervention/
decisions.
Social marketing has been widely used to influence low-income, high-risk
populations to make healthy behaviour changes. This application of
marketing principles has also become an important tool for persuading
upstream audiences to make long-term policy changes that achieve
socially desirable goals.
As the human, social, and economic costs of the HIV/AIDS pandemic
mount, social marketing is now a key tactic for combating the disease.
This is particularly appropriate since the spread of the infection can be
managed. Passive contagion, a core tenet of classic disease diffusion
models, is not appropriate for HIV/AIDS since human intervention and
human decision-making can alter both the level and the prevalence of the
disease.
3A Case for Social Marketing in Mexico
! Increase in HIV/AIDS cases
each year since early 1980s
! Affecting youngest and most
productive populations as well
as poor and marginalized
! #4 cause of death for men 25-34
! Diverting resources from other
health, welfare, and education
priorities
As the human, social, and economic costs of the HIV/AIDS pandemic
mount, policymakers worldwide are earmarking funds and forming
alliances to combat the spread of the disease. Mexico, where the first
AIDS case was diagnosed in 1983, faces serious threats to social
sustainability as inflections steadily multiply. Recent reports show the
disease is increasingly affecting the youngest and most productive
populations as well as poor and marginalized groups.
Mexico ranks 13th globally and third in the Americas in the total number of
HIV cases reported; unfortunately, the increase in new cases has been
continuous since the early 1980s. With an estimated average of 4,000
new cases annually in Mexico, AIDS has become the No. 4 cause of
death for men in the 25 to 34 age group. Higher rates of HIV infection are
also being documented among injecting drug users and women.
4Overall Research Question
How have alliances of government
decision makers, the health
care community, and AIDS
activists allowed social
marketers to bring about
voluntary behavioural
changes in Mexico?
How have alliances of government decision makers, the health care
community, and AIDS activists allowed social marketers to bring about
voluntary behavioural changes in Mexico?
5A Population of Campaigns
! Six campaigns selected for
comparison
! Examined purpose, sponsors,
audience, where disseminated,
media mix, messages, product
promotion, and appeals
! Commonalities and unique
characteristics identified
! Research methods: content
analysis, semi-structured
interviews with key decision
makers
This presentation analyses six recent HIV/AIDS campaigns in Mexico,
examining their ability to motivate change and their potential for informing
target audiences about new health choices. Analysis of the campaigns
identified the commonalities and unique characteristics as regards
purpose, sponsors, target audience, dissemination methods, media mix,
messages, product promotion, and appeals used. Semi-structured
interviews with opinion leaders were used to explore the rationale behind
the content choices, cultural influences, and economic factors influencing
the public dissemination of HIV/AIDS information. The six campaigns
share a number of common concerns and objectives although each has a
unique theme and a distinctive focus and approach. All campaigns,
however, rely heavily on partnerships and present messages that openly
discuss once-taboo topics.
6Finding #1: Collaboration is Essential
!Social marketers do not have infrastructure/marketplace
environment of commercial marketers
! Build network of groups with common goals, varied
resources.
! Good example: “Investing in People” in Mexico City,
with largest number of AIDS cases …
! Taboo topic: Sex before marriage
Recognizing that expanding HIV/AIDS populations will devastate the
global economy, governments in both developing and industrialized
countries, often in conjunction with pharmaceutical companies, have
launched organized offensives, which include political commitment, law
enforcement, government policy, social marketing, and community
mobilization.
This global cooperation encourages alliances such as those forged to
support the campaigns in this study. From a practical standpoint, these
partnerships are essential because social marketers “do not have the
infrastructure and the marketplace environment commercial marketers
take for granted.” Rather than “divide and conquer,” in social marketing
the strategy is to build a network of groups and individuals with common
goals and varied resources.
The “Investing in People” campaign is a good example of such alliances…
7Partnership Lesson #1:
Build local, nat’l & internat’l alliances with common goals
Investing in People
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…This five-year initiative, which began in 2003, is centered in Mexico City,
where the largest number of HIV/AIDS cases are found. “Investing in
People” is the joint effort of a half-dozen international, national, and local
organizations. A key technique is personal communication through
workshops and conferences conducted by trained female advocates and
local HIV/AIDS leaders, who openly discuss sex before marriage, a once-
forbidden topic in this strongly Roman Catholic country.
8Finding #2: Focus on Prevention
!Messages usually focus on prevention
! Social marketing involves procuring, distributing
pharmaceuticals, OTC drugs, condoms
! Condom Social Marketing (CSM)
!Mexico: largest consumer of pharmaceuticals in Latin
America
! Taboo topic: Use of condoms
Most HIV/AIDS campaigns have a stronger focus on prevention messages
than treatment information, so social marketing assistance usually
involves procuring and distributing pharmaceuticals, over-the-counter
drugs, and condoms. For example, PSI [Population Services
International], the principal contractor for USAID’s 2005 behavioural
change campaign in Mexico, emphasizes prevention messages and
brand-specific advertising, especially of condoms. Under this
"manufacturer's model," partnerships are negotiated with commercial
manufacturers, suppliers, and distributors of health products, and products
are made available at lower than market costs. Brand-name condoms
and related products are always sold rather than given away, albeit at
reduced prices, because PSI's policy is "when products are given away…
the recipient often does not value them or even use them.” In fact,
promoting the use of condoms is such an integral part of HIV/AIDS social
marketing that the practice has its own acronym: Condom social
marketing [CSM], which is central to the Vida campaign strategy…
9Partnership Lesson #2:
Recruit commercial sponsors for additional resources
VIVE Condoms
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The VIVE condom brand, popular in several Latin American countries, is
the centerpiece of recent “Vida” educational efforts directed to prisoners
and other high-risk groups in southern and central Mexico. A recent
survey reported that Mexican society has become the largest consumer of
pharmaceuticals in Latin America and the ninth largest worldwide.
Pharmaceutical sales jumped from US$6.83 billion in 2002 to an
estimated US$11.3 billion in 2005. Given these numbers, it seems safe to
say that major pharmaceutical companies will continue to vie for
partnership status in social marketing initiatives and that condoms will
continue to be more accessible and socially acceptable.
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Finding #3: Stigma Goes Underground
!“Underground epidemic”
! People living with AIDS, esp. women fear rejection by
families and loss of jobs.
! “Vida Digna” in central Mexico, with “weakest civil
response to AIDS”…
! Taboo topic: Alternative lifestyles
HIV has been called an “underground epidemic” because of the stigma
and discrimination associated with the disease.
USAID, whose infectious disease objectives in Mexico are designed “to
contain and reduce HIV/AIDS in vulnerable populations,” focuses on
reducing barriers to behavior change and thereby preventing the
HIV/AIDS epidemic in Mexico from becoming generalized to the
population at large.
Reducing stigma and discrimination experienced by sex workers, gay
men, men who have sex with men, drug users, and people living with
AIDS is the central purpose of the three-year Vida Digna [Life with Dignity]
campaign, launched in 2005 by the Colectivo Sol alliance and funded by
GlaxoSmithKline…
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Partnership Lesson #3:
Involve the target audience from the outset
Vida Digna (Life with
Dignity)
!"#$%&'( !"#$%" *+)08' '/# #)*%()8)/'+),/ ,4 @A7?
)*+',#-+'( 9::T<9::=
.$%/&%#&( @A7? @55)'/%"3 B,5"%+).,3 ?,53 H,*)+)." @%+),/3
J5'F,?8)+-Y5)/"
0"1*'/2'&( H",K5" 5).)/0 P)+- @A7?3 *"F P,(2"(*3 #($0 $*"(*3
8"/ P-, -'." *"F P)+- 8"/
34'#'( E"F)%, < @0$'*%'5)"/+"*3 J$'/'Z$'+,3 [$"("+'(,3
?'/ R$)* H,+,*)
5'1*- 5*6( N(')/)/03 5)+"('+$("3 %,88"(%)'5*3 %,88$/)+G 5"'#"(*
5'&&-7'&( CX$'5)+G &"0)/* P)+- '%%"K+)/0 K",K5"’* #)44"("/%"*
.$'-8'#&( B,88$/)+G 5"'#"(*3 2"G #"%)*),/ 8'2"(*3 8"#)'
0$$'-:&( ?,%)'5 %,0/)+)."3 *$*+')/'&5" #"."5,K8"/+
…The campaign is centered in the central states of Mexico, a
conservative area characterized as having “the weakest civil society
response to AIDS.” Vida Digna uses anonymous testimonials to urge
tolerance and acceptance of people’s differences. The International
HIV/AIDS Alliance’s research indicates people living with AIDS, especially
women, are fearful of rejection by their families and dismissal from their
jobs if their HIV status is revealed.
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Finding #4: Cultural/Gender Norms
!Machismo and homophobia fueling Mexico’s AIDS
epidemic
! Young men often control how and when young women
have sex
! Changing gender norms: “Programa Hombres” and
! “Programa Mujeres”--female empowerment
! Taboo topics: Women’s rights and homophobia
According to Mexico’s National Center for the Prevention and Control of
HIV/AIDS [Censida], changing how Mexicans view gender roles and
erasing widespread prejudice against gays will be necessary to effectively
combat the disease. Speaking at a conference in February of 2006,
Censida’s director, Jorge Saavedra, said machismo and homophobia are
fueling the country’s HIV/AIDS epidemic. Saavedra was quoted in
Dominican Today as saying machismo undermines prevention messages
and “puts women, as well as men, at risk,” and that “fighting homophobia
is one of the best ways to fight HIV.”
Links between traditional gender attitudes and the spread of AIDS
prompted a partnership of NGOs to develop Programa Hombres [often
called Program H]...
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Partnership Lesson #4:
Initiatives must be multimedia & multilingual
Programa Hombres (Project H)
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…This five-year initiative has been used in more than 20 countries,
including Mexico, to persuade young Latino men to question traditional
norms related to manhood since the male youth often control how and
when young women have sex. An extensive media mix included
educational videos available in three languages—Spanish, English, and
Portuguese—interactive workshops, and collateral materials, as well as
radio, outdoor media, and direct mail. The campaign slogan, “In the Heat
of the Moment,” urged use of the Hora H condom brand, manufactured by
the makers of Durex condoms and distributed in non-traditional venues
such as funk balls and cafes.
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Partnership Lesson #5:
Utilize global support for women
Programa Mujeres (Project M)
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Building on their success in educating young men about the costs of
traditional macho culture, in 2005 the Program H partners and World
Education launched Programa Mujeres [Project M] to encourage young
women to take control of their sexual and reproductive health. This social
marketing campaign was based on research that included a review of
Latin American literature to define the concept of female empowerment,
focus group discussions with groups of young women aged 14-24 who
lived in marginalized communities outside Queretaro, Mexico, and
interviews with empowered young women.
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Finding #5: Population Mobility Danger
! Travel or migration factor in AIDS prevalence
! Risk to partners at home
! U.S./Mexico: Border health initiative to make testing and
care more accessible and acceptable…
! Taboo topics: Sex outside of marriage, prostitution
Studies of highly mobile groups such as truck drivers, seasonal
employees, and sex workers have identified travel or migration as a factor
related to increased HIV/AIDS prevalence. Higher rates of infection are
also frequently found along transport routes and in border regions. In
addition, migration and mobility also increase vulnerability to HIV/AIDS for
the partners at home.
Not surprisingly then, HIV/AIDS is a significant problem along the 2,000-
mile border between the United States and Mexico, where mobility,
poverty, and lack of access to health care complicate prevention and care.
The SPNS [Special Projects of National Significance] Border Health
Initiative is administered by the U.S. Department of Health and Human
Services to raise awareness about HIV and to make testing and care
more accessible…
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Partnership Lesson #5:
Construct trans-border alliances
SPINS Border Health Initiative
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…In many of the rural border communities people are reluctant and
embarrassed to openly discuss HIV/AIDS or the sex worker industry.
Relying heavily on social marketing, SPNS utilizes Spanish language
media to blanket the transient communities with “bold” HIV messages
designed to “reverse the cultural norm that topics related to sexuality,
including HIV, are not discussed in public” and to educate Latinos about
the risk of the disease. SPINS border outreach initiatives are designed to
be culturally sensitive to the Latino culture, which values trust and
relationship building.
17
Conclusions
!Communications about AIDS is
complex and highly political
!HIV/AIDS crosses all boundaries;
no one unaffected
!Social marketing is able to create
upstream and downstream
behaviour changes
!Partnerships are crucial
!Taboo topics must be discussed
As demonstrated by these six Mexico-based campaigns, the content of
social marketing messages about HIV/AIDS, the role of stigma and
culture, and the economic realities of the global medical market created by
the epidemic form a complex and politically charged environment that
influences public dissemination of information.
As HIV/AIDS social marketing establishes a track record in Mexico,
organizations using such initiatives can begin to analyze long-term results.
Nevertheless, it already seems clear that the power of social marketing is
a strong tool for motivating change and informing target audiences about
new health choices. Over a period of less than two decades, alliances of
HIV/AIDS social marketers have been able to operate successfully in the
maelstrom of cultural, political, economic, and social concerns while
bringing about voluntary behavioral changes among both downstream and
upstream audiences.
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ABSTRACT 
Social marketing [SM] is a key tactic for combating HIV/AIDS. When SM builds successful 
partnerships with upstream audiences who focus on downstream targets, a community’s social 
fabric can be permanently altered. 
This paper scrutinises how SM techniques are used to disseminate HIV/AIDS information, 
often with conventional medicine’s sponsorship and alternative medicine’s increasing influence. 
Analysis of eighteen SM campaigns from Uganda, Mexico, and the U.S. indicates public 
communication revolves around 1) cultural content of SM messages about HIV/AIDS, 2) 
political expediency, and 3) economic realities of the global marketplace, forming a complex 
environment that influences dissemination of information about health care options. Semi-
structured interviews with opinion leaders involved in designing, sponsoring, and implementing 
selected campaigns provide insights into lesson learned so far from these initiatives. 
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CREATING A CULTURE OF CHANGE: 
SOCIAL MARKETING’S GLOBAL INITIATIVE AGAINST HIV/AIDS  
INTRODUCTION 
For more than three decades, social marketing, “the application of the principles and tools of 
marketing to achieve socially desirable goals,” (Kotler and Zaltman, 1971: 5) has been widely 
used to influence low-income and high-risk populations to make healthy behaviour changes.  
Although these campaigns often created awareness among specific target audiences and even 
persuaded members of at-risk groups to adopt lifestyle changes, it became increasing obvious 
that the burden of deep societal change could not rest exclusively on these downstream targets 
(Andreasen, 2006). As a result, social marketing has come to be seen as a tool for social change 
on all levels. When social marketing can build partnerships that include governments, non-
government organizations [NGOs], international agencies, and private businesses—so-called 
upstream audiences—working in conjunction with downstream targets, then the entire social 
fabric of a community can be permanently altered (Andreasen, 2006). 
Therefore, social marketing has been a key tactic in combating HIV/AIDS, both in 
developing and in industrialized countries, for the past 20 years. These campaigns typically 
define a purpose relating to a specific target audience, use a variety of media to disseminate the 
campaign message, and are based on a recognized behavioural change model (McDermott, et 
al., 2005). Numerous international organizations now have a track record of designing and 
implementing social marketing campaigns in countries where inflection rates are on the rise. As 
the human, social, and economic costs of the HIV/AIDS pandemic mount, policymakers 
worldwide are earmarking funds and forming alliances to combat the spread of the disease.  
This research explores links between social marketing and HIV/AIDS while mapping 
connections to the conventional and alternative medical communities. It is not unusual to find 
literature relating to any two of these terms, but rarely are all woven together. This project 
defines and contextualises social marketing, then it scrutinises how dissemination of HIV/AIDS 
information uses social marketing techniques, usually in partnership with conventional 
medicine. Alternative medicine’s increasing influence and the consequent ramifications for 
audiences of HIV/AIDS social marketing campaigns are also investigated. This combination of 
topics—social marketing for HIV/AIDS as related to conventional and alternative medicine—is 
one that has not been explored in the manner outlined in this study, so the potential for 
contributing to the current body of knowledge is significant. 
RESEARCH QUESTIONS 
1. What is social marketing? What can it accomplish? How does it work? 
2. How has social marketing been used to combat HIV/AIDS in both developing and 
industrialised countries?   
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3. What political and economic factors affect dissemination of information about 
HIV/AIDS treatment and prevention? What role do the media play? 
4. What are specific examples of recent HIV/AIDS social marketing campaigns?  
5. What commonalities and unique characteristics can be identified in this population of 
campaigns as regards purpose, sponsors, target audience, dissemination methods, media mix, 
messages, product promotion, and appeals used? What lessons have been learned so far? 
METHODOLOGY 
To answer these questions, this study began with a comprehensive literature review, 
followed by content analysis of a population of 18 social marketing campaigns selected from 
three countries that represent diverse situations regarding the disease. This analysis provided 
context for semi-structured interviews with key informants from selected campaigns. The ethical 
guidelines of the U.K. Market Research Society Code of Conduct were examined and adhered to 
throughout the course of this study.  
Literature Review: Areas of literature reviewed included social marketing [history, theory, and 
practice], HIV/AIDS [history, scope, and projections], social marketing as a tactic for combating 
HIV/AIDS, health communications and pharmaceutical-dominated marketing, health activism, 
Complementary and Alternative Medicine (CAM) and conventional medical approaches to 
HIV/AIDS, criminal justice concerns as relating to prisoner health care, and an overview of 
media coverage of these issues. 
Content Analysis: A population of six HIV/AIDS social marketing campaigns was selected for 
each of the three countries targeted for this study—Mexico, Uganda, and the southern United 
States. The HIV/AIDS initiatives that were included each contained the recognized elements of 
social marketing campaigns, as well as several additional criteria selected by the researcher. 
Previous literature review revealed widespread agreement that social marketing combines a mix 
of several essential components:  Behavioural change, informed by research, is the purpose 
behind any social marketing intervention. Also required is consumer orientation, in which the 
social marketer segments and profiles the target audience with the aim of building a long-term 
interactive relationship. Another common ingredient is facilitating a voluntary exchange from 
which both parties derive benefits. Finally, the successful social marketer thinks strategically, 
setting specific and measurable long-term objectives, using the marketing mix, and considering 
the appeal of competing behaviours (Andreasen, 2006; McDermott et al., 2005). 
Beyond meeting this definition for social marketing, criteria for campaign selection 
included currency—active as recently as 2004— implementation by a recognized international 
organization, and participation of a major medical organization or pharmaceutical company. The 
points of analysis were easily comparable aspects: purpose, target audience segmentation, where 
the campaign was disseminated, media mix used, messages presented, and types of appeals 
employed. The most common social marketing appeals to motivate health-related behaviour 
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change were determined through extensive literature review and informal interviews with social 
marketing researchers at the Institute for Social Marketing at Stirling University in Scotland. 
Semi-structured Interviews: Interviews to date have included representatives from 
sponsoring organizations Population Services International, Instituto Promundo, Mexfam, 
Democracy and Sexuality (DEMYSEX) and LETRA S, as well as campaign spokespeople, 
health agency officials, medical practitioners, and community HIV/AIDS activists.  
FINDINGS 
I. CONVERGENCE OF SOCIAL MARKETING, HIV/AIDS, AND MEDICAL COMMUNITIES 
The areas where social marketing, HIV/AIDS communications, and the conventional and 
alternative medical establishments overlap were of particular interest. Societal issues such as 
evolving public perceptions, the changing political landscape, international economics, and 
media agendas related to these topics are pertinent since they affect the global HIV/AIDS 
situation on a daily basis.  
Research question 1: What is social marketing? What can it accomplish? How does it 
work? 
Social marketing was first defined as a discipline 35 years ago, but has rapidly gained 
recognition as a “bridging mechanism” between behavioural science and the “socially useful 
implementation of what that knowledge allows” (Kotler and Zaltman, 1971:12). Social 
marketing's roots in commercial marketing are undisputed, with a strong influence by the 4Ps of 
marketing—product, promotion, price, and placement—although this model is sometimes 
viewed as insufficiently customer-based for social marketing’s framework (Niblett, 2005). 
Social marketing ideally combines several elements. Behavioural change, informed by 
research, lies behind any social marketing intervention. Also required is consumer orientation, 
which segments audiences and builds long-term interactive relationships. Facilitating a 
voluntary exchange with mutual benefits is necessary. Successful social marketers think 
strategically, set long-term objectives, use the marketing mix, and consider the competition 
(Andreasen, 2006; McDermott et al., 2005; Dev and Schultz, 2005). 
As early as the 1960s, commercial marketing was incorporated into health education 
campaigns in developing countries (Ling et al., 1992) and continued to play an important role in 
influencing behaviours of populations at risk for diseases such as HIV/AIDS, malaria, and 
alcoholism (Rogers et al., 1991). When the effort extends beyond informing to persuading, it is 
called “health activism” and involves “attempts to change the status quo, including social 
norms, embedded practices, policies, and power relationships”(Zoller, 2005:361). 
In 1981, however, Bloom and Novelli found many social marketing campaigns lacked rigor 
and theory. They recommended using research to segment audiences, design programs, and 
create strategic campaigns. Social marketing's popularity grew when its potential was publicised 
by Lefebvre and Flora (1988) and Hastings and Haywood (1991) in medical journals. As the 
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link between public health and commerce (Hastings and Saren, 2003), social marketing is the 
primary method international organisations such as UNAIDS use to combat global health issues. 
Hastings and Donovan (2002) as well as Andreasen argue social marketing should be 
repositioned as an “approach to social change that reaches both upstream and downstream” 
(Andreasen, 2006: viii). However, Niblet cautions partnerships are key to this process because 
social marketers lack “infrastructure and the marketplace environment commercial marketers 
take for granted” (2005:3).  
Although social marketing is not a theory, it informs and structures its framework using 
psychology, sociology, anthropology, and communications (Kotler and Zaltman, 1971). Social 
marketers may employ the health belief model (Basu, 2003), the transtheoretical model of health 
behaviour change [stages of change], diffusion of innovation, social cognitive theory, or theory 
of reasoned action (McDermott et al., 2006; Lefebvre, 2001: 507-515). Nevertheless, many 
disregard theoretical approaches, preferring to be “broadly eclectic and intuitive tinkerers” 
(Walsh et al, 1993: 115). Despite criticisms of manipulation, overuse of fear appeals (Hastings 
et al, 2004), and improper use of incentives (Dholakia and Dholakia, 2001), social marketing 
demonstrably effects social change. 
Research question 2: How has social marketing been used to combat HIV/AIDS in both 
developing and industrialised countries?   
Perhaps the most highly visible social problem in the world today is HIV/AIDS. Since it 
was first diagnosed 25 years ago, HIV/AIDS has become one of the most deadly health issues 
worldwide, with an estimated 40 million people—2.3 of them children—now living with the 
disease. Contrary to popular perception, about half of the infected are women and heterosexual 
transmission is now the most common means of infection (UNAIDS, 2006). HIV/AIDS is called 
an “underground epidemic” because of associated stigma and discrimination, which discourage 
people from getting tested or accessing care (HIV infection, 2003). 
Where HIV/AIDS is rampant, social marketing is widely used to motivate low-income and 
high-risk audiences to adopt healthy behaviours. Population Services International, the first 
organisation to use social marketing to combat AIDS, uses targeted Behaviour Change 
Communications (BCC) to focus on prevention messages. Brand-specific advertising is often an 
integral part of HIV/AIDS campaigns, representing a major expense for drug companies, which 
spend on average two-and-half times more on marketing than on research (Hamber, 2005). With 
this kind of investment at stake, critics say the conventional medical establishment uses 
influence and financial clout (Moynihan and Cassels, 2005) to shape dissemination of health 
information.  
Research Question 3: What political and economic factors affect dissemination of 
information about HIV/AIDS treatment and prevention? What role do the media play? 
Additionally, in the wake of widespread media coverage about selective reporting of clinical 
drug trials, U.S. political leaders have questioned "whether the pharmaceutical industry has 
systematically misled physicians and patients by suppressing important data on their drugs" 
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(Graham, 2004: 21). These concerns, combined with reports documenting the deplorable state of 
public health care, are spurring public interest in complementary and alternative medicine 
[CAM], creating a more positive climate for alternative treatments in general (Tindel, 2005; 
Abraham, 2007). Likewise, in the UK, recent media coverage of controversial public funding 
for CAM, which is strongly supported by Prince Charles, has brought the topic to the forefront 
of public attention (Booth and Henderson, 2006). 
Examining the media’s role from a dissemination standpoint, clearly new interactive 
methods of building social networking communities have revolutionised how target audiences 
access and use information, significantly altering the international dialogue about HIV/AIDS. 
Many of the campaigns analysed rely heavily on online media, especially if they are targeting 
young, politically active, or well-educated audiences. 
In toto, these factors form a complex and politically charged environment that influences 
dissemination of information about health care options and offers a multitude of possibilities for 
fresh interpretations of the cross-disciplinary relationships and concepts involved.   
II. DECONSTRUCTING 18 HIV/AIDS SOCIAL MARKETING CAMPAIGNS 
Research question 4: What are specific examples of recent HIV/AIDS social marketing 
campaigns?  
Dozens of social marketing HIV/AIDS campaigns are underway in the three countries 
targeted for this study. Campaigns from Mexico, Uganda, and the U.S. demonstrate how NGOS 
and government leaders use social marketing to motivate changes in cultural attitudes and 
health-related behaviours. The campaigns selected for study: 
MEXICO 
1. Investing in People  
This five-year initiative to reduce barriers to behaviour change and care seeking began in 
2003. It is a localised version of a series of similar campaigns currently underway in several 
countries. Focused in Mexico City, where the largest number of HIV/AIDS cases is found, 
“Investing in People” is the joint effort of a half-dozen international, national, and local 
organizations. A key technique is personal communication through workshops and conference 
presentations conducted by trained female advocates and local HIV/AIDS leaders. 
2.  VIVE Condoms 
The VIVE condom brand, popular in several Latin American countries, is the centrepiece of 
recent “Vida” educational campaigns directed to prisoners as well as other high-risk groups in 
southern and central Mexico. Population Services International, the primary sponsor for this 
campaign, uses both traditional [pharmacies, health clinics] and non-traditional [bars, hotels, 
brothels, salons] sales outlets to make condoms accessible and socially acceptable. The slogan is 
"Vive to mejor momento" or "live your best moment.” 
3. VIDA Digna (Life with Dignity) 
  6 
Reducing stigma and discrimination experienced by sex workers, gay men, men who have 
sex with men, drug users, and people living with AIDS is the central purpose of the three-year 
“Vida Digna” campaign, launched in 2005 by the Colectivo Sol alliance and funded by 
GlaxoSmithKline. The campaign is centred in the central states of Mexico, a conservative area 
characterised as having “the weakest civil society response to AIDS.” Vida Digna uses 
anonymous testimonials to urge tolerance and acceptance of people’s differences.  
4. Programa Hombres (Project H) 
Links between traditional gender attitudes and the spread of AIDS prompted a partnership 
of NGOs to develop Programa Hombres. This five-year initiative has been used in more than 
twenty countries, including Mexico, to persuade young Latino men to question traditional norms 
related to manhood. An extensive media mix includes educational videos available in three 
languages—Spanish, English, and Portuguese—interactive workshops, and collateral materials 
as well as radio, outdoor media, and direct mail. The campaign slogan, “In the Heat of the 
Moment,” urges use of the Hora H condom brand, manufactured by the makers of Durex 
condoms and distributed in non-traditional venues such as funk balls and cafes. 
5. Programa Mujeres (Project M) 
Building on their success in educating young men about the costs of traditional macho 
culture, in 2005 the Program H partners and World Education launched Programa Mujeres to 
encourage young women to take control of their sexual and reproductive health. This social 
marketing campaign was based on research that included a review of Latin American literature 
to define the concept of female empowerment, focus group discussions with groups of young 
women aged 14-24 who lived in marginalised communities outside Queretaro, Mexico, and 
interviews with empowered young women. 
6. SPNS Border Initiative 
The SPNS [Special Projects of National Significance] Border Health Initiative is 
administered by the U.S. Department of Health and Human Services to raise awareness about 
HIV and to make testing and care more accessible. Relying heavily on social marketing, SPNS 
utilises Spanish language media to blanket the transient communities with “bold” HIV messages 
designed to “reverse the cultural norm that topics related to sexuality, including HIV, are not 
discussed in public” and to educate Latinos about the risk of the disease. SPNS border outreach 
initiatives are designed to be culturally sensitive to the Latino culture. 
UGANDA 
1. ABCs (Abstinence, Being Faithful and Condoms) 
This campaign takes a moralistic approach—“Sex can wait until marriage”—and uses 
outdoor media as well as local spokespeople such as community leaders and ministers to urge 
abstinence before marriage and fidelity to spouses. Practical AIDS information is provided and 
condom use is also advocated to reduce risk of infection. This program and others like it have 
generated international controversy about whether condoms are effective in reducing HIV 
prevalence and raising associated concerns about increased promiscuity. 
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2. Afford 
AFFORD is a five-year health marketing initiative led by the Johns Hopkins Bloomberg 
School of Public Health and funded by the U.S. Agency for International Development. 
Designed to increase accessibility and affordability of AIDS products and services, the 
campaign promotes Protector brand condoms, Pilpan oral contraceptives, and Inject injectable 
contraceptives. Consumers are encouraged to use these products properly and have access to 
them at subsidised rates. A centrepiece of the campaign is “The Good Life Gameshow,” an 
entertainment education quiz show using community interaction, and radio and television 
shows. 
3. PMTCT (Prevention of Mother to Child Transmission) 
“The Social Marketing Approach to PMTCT" is a Population Services International [PSI] 
project that uses a branded franchise network of trained midwives to help pregnant women reduce 
transmission risk during birth. The midwives are also trained on HIV testing procedures and 
counselling skills. The central message is that it is possible to have an HIV-negative baby even 
when both parents are HIV positive. Since 2003, a broad media mix has disseminated this message 
to male partners of pregnant women 25-45, primarily in low-income, low-literary, rural areas. 
4.  Trust Condoms 
Designed to reach people in rural, isolated areas of the country, particularly women, this 
campaign’s central purpose is to launch a new condom brand. The stated rationale for the effort, 
which began in 2006, is that combating the AIDS pandemic must go hand-in-hand with 
sensitising those who live in outlying areas. The British and Norwegian governments 
contributed funds for the campaign. 
5.  Be a Man 
Targeted primarily to young men 15 to 24, this campaign was launched in 2006 to prompt 
reflection on the costs of traditional male attitudes and behaviours, which recent research has 
shown are contributing to an increase in HIV infections. “Society’s expectations of men are 
setting them up for failure,” according to Vincent Kiwanuka, the “Be a Man” campaign’s 
coordinator. The media mix heavily utilises radio drama and television, including broadcasts 
during the World Cup. The goal is to encourage sexual relationships based on mutual respect. 
6.  Sugar Daddies 
Addressing the widespread problem of cross-generational sex (sex with a person at least 10 
years older), this campaign, begun in 2004, seeks to raise awareness of the dangers of “sugar 
daddy” relationships. This practice is a major reason HIV infection rates are six times higher for 
teenage girls than for their male counterparts. Target audiences include young women 15 to 24, 
their parents (who often encourage such relationships), and older male partners. The PSI-
sponsored initiative features recognised male role models such as Uganda’s Minister of Ethics 
and Integrity Tim Lwanga urging men to “stop preying on young girls.” 
UNITED STATES 
1. We all have AIDS 
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Launched in 2005 on World AIDS Day, this campaign created by American designer 
Kenneth Cole is heavily supported by celebrities and prominent AIDS activists. The message is 
to reduce stigma associated with AIDS to prevent, contain, and eradicate the disease. The 
consistent theme for all ads is “We all have AIDS…if one of us does.” International celebrities 
participating include President Nelson Mandela, Arch Bishop Desmond Tutu, Sharon Stone, 
Will Smith, and Sir Elton John. 
2.  ONE 
With more than sixty partners, this campaign’s purpose is to rally Americans one by one to 
push for increased donations to fight poverty and AIDS. The campaign has a broad target 
audience, ranging from students to ministers to punk rockers to soccer moms. The call to action 
is “We’re not asking for your money, we’re asking for your voice.” In line with this approach, 
June 11, 2007, ONE launched ONE Vote ’08, its “largest and boldest initiative ever,” vowing to 
make extreme poverty and global disease an issue in the 2008 election. 
3. I am African /Keep a Child Alive 
This campaign, also heavily saturated with celebrities, promotes the idea that everyone has 
some DNA with connections to an African heritage, so all people should work together to help 
with the AIDS problem. Begun in 2005 and updated every year since, donations for AIDS drugs 
are particularly sought. “I am African” is linked with the “Keep a Child Alive” campaign, which 
seeks to help AIDS orphans in Africa by providing them with ARVs [treatment cocktails]. 
Images of celebrities such as Gwenyth Paltrow and Sting wearing “war paint” with the 
campaign slogan beneath has sparked controversy about the use of eye-catching visuals that 
“insensitively perpetuate stereotypical ways of thinking about AIDS or Africa.” 
4.  Be the Generation 
This program seeks to create a supportive environment for HIV vaccine research by 
mobilizing existing community partnerships and networks to educate key communities about 
this research in twenty U.S. cities where HIV vaccine clinical trials are ongoing or planned. 
Coordinated media and collateral materials segment target audiences by gender, ethnicity, and 
lifestyle, showing images of two people, one older and one younger. Extensive educational 
materials are available online. The uniform message is that the young generation’s “great cause” 
is to end AIDS and that a vaccine is the best hope of accomplishing that goal. 
5.  MTV Think 
This award-winning public information campaign began in 2006 and is notable for bringing 
MTV on board as a major sponsor. The goal is to reach sexually active 16- to 24-year-olds with 
information about HIV and related issues, since according to UNAIDS, half of new HIV 
infections worldwide are among people under the age of 25. Discussion of safe-sex issues, 
condom use, and HIV testing are urged through television and web media. According to sponsor 
The Kaiser Family Foundation, this is a “multi-platform, interactive community for the first 
generation of Americans who have lived their entire lives during the AIDS epidemic.” 
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6. The New Faces of HIV in Houston 
 Due to high HIV prevalence among African Americans in Houston, in 2002 the Harris 
County Hospital District and the Houston Department of Health and Human Services launched a 
social marketing campaign to raise awareness and increase testing among this population. Media 
include radio, public transit, direct mail, and brochures targeting women. Images of both men and 
women are featured in the materials, with the slogan, “We look just like you, but you don’t have 
to be like us. Do the right thing. Get tested.” 
Research question 5: What commonalities and unique characteristics can be identified in 
this population of campaigns as regards purpose, sponsors, target audience, dissemination 
methods, media mix, messages, product promotion, and appeals used? What lessons have 
been learned so far? 
The campaigns share a number of common concerns and objectives although each has a 
unique theme and a distinctive focus and approach. Each uses a customised media mix to 
disseminate messages to selected audience(s), but core commonalities are evident throughout. 
Behavioural models underlying the campaigns were carefully examined. 
First and foremost, collaboration is essential; each campaign involves multiple organisations 
and community groups designed to build participation in and acceptance for individual and 
policy change. From a worldview, each country’s HIV/AIDS problem has far-reaching 
implications. Recognising that expanding HIV/AIDS populations will devastate the global 
economy, governments in both developing and industrialised countries, in conjunction with 
pharmaceutical companies such as Pfizer, have launched a variety of organised offensives, 
which include political commitment, law enforcement, government policy, social marketing, 
and community mobilisation (Pfizer, 2006). This global cooperation encourages alliances such 
as those forged to support the campaigns in this study. 
Secondly, the campaigns all incorporate prevention strategies, with condom use being a 
frequent tactic. In keeping with its inclusive approach, social marketing assistance usually 
involves procuring and distributing pharmaceuticals, over-the-counter drugs, and condoms. It 
also supports capacity building and financial sustainability programs for non-government 
organisations [NGOs] or for-profit companies (USAID, 2005). 
In recognition of cultural obstacles, the campaigns each address aspects of stigma and 
traditional cultural norms. USAID, whose infectious disease objectives are designed “to contain 
and reduce HIV/AIDS in vulnerable populations,” focuses on reducing barriers to behaviour 
change and thereby preventing the HIV/AIDS epidemic in countries such as Mexico from 
becoming generalised to the population at large (USAID Health Profile, 2005). It is generally 
recognised that changing how people view gender roles and erasing widespread prejudice 
against gays will be necessary to effectively combat HIV/AIDS.  
A number of social marketing campaigns draw on research showing that in many cultures, 
young men often control how and when young women have sex. Some of the traditional gender 
norms the campaigns were designed to change are 1)Men should initiate sexual activity early in 
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life, 2) Men should have multiple sexual partners, 3) Men should maintain control over their 
female partners, and 4) Unsafe sex is more enjoyable than safer sex. Addressing these gender 
norms, especially among young people, is increasingly recognised as a vital strategy to prevent 
the spread of HIV infection (Promoting, 2006). 
 Modern-day mobility and lifestyle patterns are also considerations in crafting social 
marketing campaigns for at-risk populations, especially for migrant populations or in border 
areas. Studies of highly mobile groups such as truck drivers, seasonal employees, and sex 
workers have identified travel or migration as a factor related to increased HIV/AIDS 
prevalence. Higher rates of infection are also frequently found along transport routes and in 
border regions. In addition, migration and mobility also increase vulnerability to HIV/AIDS for 
the partners at home (Population Mobility, 2001: 4). 
Persuasive messages for the campaigns are informed by the tenets of one or more established 
behavioural models. Early generations of HIV social marketing campaigns frequently built their 
messages around the health belief model, which uses fear or anxiety-arousing messages. In the 
long term, however, the use of fear appeals draws mixed responses, both from observers and 
from the targeted audiences. Hastings and colleagues noted fear appeals have been “embraced 
with enthusiasm by social marketers” (2004: 962), but cautions fear appeals, in addition to 
encouraging “health fatalism,” may actually have negative long-term effects on the brand. A 
more effective appeal, especially for young people, according to Backer, Rogers, and Sopory, is 
the positive rational/emotional approach, which uses fear to grab attention, then relates the fear 
to a positive outcome (Backer, et al., 1992). The use of external incentives, central to most 
social marketing approaches, also has potential pitfalls because they can be interpreted as 
coercion or bribery and not deliver the long-term behavioural change desired (Dholakia and 
Dholakia, 2001: 498). The personal benefits inherent in self-interest appeals, however, are 
frequently used to advantage. Based on the well-established Maslow’s hierarchy of needs, self-
interest appeals target common human needs ranging from physiological to safety, social, ego, 
and self-fulfilment (Wilcox, 2002). 
Consequently, the current generation of social marketing campaigns is usually grounded in 
theoretical models other than fear or short-term benefits. In a report prepared for the UK's 
National Social Marketing Strategy for Health, McDermott and colleagues (2006) found 
nutrition social marketing interventions were most frequently based on social cognitive theory, 
which emphases observational learning and self-efficacy and is frequently used in campaigns 
where individuals have choices of how to respond to their environments (Lefebvre, 2001). A 
somewhat similar appeal is the behavioural decision making model, which uses risk 
comparisons and probability (Maibach and Parrott, 1995).  
Another popular approach, according to McDermott's report, was the transtheoretical model, 
known as “stages of change,” which assumes few people are ready to take action and must be 
moved through early stages of indecision. Lefebvre pointed out one of the few population-based 
models available to social marketers is diffusion of innovation, which segments any target into 
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types of adopters (innovator, early adopter, early majority, late majority, and laggard) and 
suggests the marketer begin with one or two segments (2001:507-515). On a broader policy 
level, upstream appeals often reference the goal of sustainable development, which takes a 
generational view and focuses on people’s power to make decisions about the future of their 
society (Dubois, 2003). Typically, each social marketing initiative in this study combines 
aspects from several of these approaches to ensure acceptance and motivate lasting social 
change. 
SUMMARY OF LESSONS LEARNED  
Interviews with key informants revealed important lessons from campaign implementation. 
Most important are that successful campaigns: 1) Build local, national, and international 
alliances with common goals, 2) Recruit commercial sponsors for additional support, 3) Involve 
the target audiences from the outset, 4) Incorporate multimedia and multilingual tactics, 5) 
Utilize global support for women, 6) Construct trans-border alliances, and 7) Tackle once-taboo 
topics openly and candidly. 
ANALYSIS AND EVALUATION  
PRELIMINARY REFLECTIONS 
After literature review, content analysis, and a number of semi-structured interviews were 
completed, it became clear that public communication about HIV/AIDS essentially revolves 
around three factors: culture, politics, and economics. The specifics of these issues vary from one 
country to the next, but the global implications cross all physical and conceptual boundaries. 
Cultural:  
Although categorised as an underground epidemic because of stigma and discrimination 
associated with the disease, HIV/AIDS has become everyman’s—and everywoman’s—problem. 
The actual prevalence numbers are uncertain because of reluctance to seek testing and treatment, 
but it is certain the global pandemic has spread each year since the first diagnosis in 1981. 
HIV/AIDS is now both a horizontal epidemic—affecting both sexes—as well as a vertical 
epidemic—being transferred from mothers to children.  
Social marketing has gained widespread acceptance among international organisations as 
the tool of choice to motivate healthy lifestyle choices and to promote long-term policy changes. 
These initiatives typically use culturally sensitive approaches to build rapport and persuade. 
However, the visual/verbal presentation varies widely, depending on the target audience, and 
appeals vary from personal fear to altruistic concern. HIV/AIDS campaigns are typically 
targeted to audiences segmented by such factors as demographics [often using ethnicity, gender, 
or age], behaviour [such as sex workers], or lifestyle [frequently the gay community]. The 
Mexico and U.S. campaigns share many commonalities, but each reflects the audience’s cultural 
differences. Finally, the phenomenon of complacency, sometimes called 
“disinhibition”(Abraham, 2007), may be driving a decline in safe sex practices, especially in 
Western countries where anti-retroviral drugs [ARVs] are widely available and considered a 
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kind of “cure” for the disease. This may be an example of misperceptions arising out of media 
and social marketing messages. Regardless, such a trend toward increased risky sexual 
behaviour among some groups calls into question the way HIV/AIDS information has been 
presented and perceived. 
Political  
Politics, the universal tactic of negotiation and compromise, comes into play at every level 
of human discourse and HIV/AIDS is no exception, as policymakers pursue agendas with a 
wide range of goals. Therefore, communication about the disease is invariably shaped by 
political concerns and people live or die as a result of those decisions.  
From a practical standpoint, most campaigns emphasise prevention over treatment since 
there is no known “cure” for the disease and the primary political directive is to reduce rates of 
infection. It follows, then, that the downstream audience is often the target, with a focus on 
short-term behavioural change. Additionally, campaign evaluation is difficult, so measurement 
of effectiveness is frequently based on product successes such as increased condom sales.   
As previously explained, collaboration is essential, but “communication by committee” is 
time-consuming and fraught with dissention. Still, most social marketing initiatives rely on 
partnerships that cross all boundaries—cultural, political, and geographical—but those partners 
may have differing viewpoints and aims. For example, in 2003 U.S. President Bush approved a 
five-year African aid package, saying his country had a "moral duty to act…[since] every day of 
delay means 8,000 more AIDS deaths in Africa and 14,000 more infections" (Campaigners, 
2003). Bush’s plan was criticised because a third of the money slated for prevention had to 
promote abstinence rather than safer sex. Similarly, in countries like Mexico, which is 
predominately Roman Catholic, earmarking funds for a disease often associated with lifestyles 
or practices that conflict with the teachings of the church is a political hurdle.  
An intriguing political response to the problem of attracting substantial support is the 
“positioning” of women as the primary victims— “the innocents”—in the battle against AIDS. 
This widespread rhetoric is designed to gain broad political support from faith-based 
organisations as well as from political leaders looking for the most acceptable route to public 
approval. Since women comprise about half of those infected worldwide, this marketing 
approach lends itself to a wide range of emotional/rational appeals. On the eve of the June 2007 
EU summit, Bill Gates, a major contributor of funds to fight AIDS, appealed to the G8 countries 
to pledge new resources to “beat AIDS.” Gates said in part, “A top priority must be to address 
the prevention needs of women and girls…biologically, women are twice as likely as men to 
contract HIV. And many women—including those who are married—have little power to ensure 
their partners are faithful or use condoms” (Gates, 2007).  
Financial  
Whether the focus of the discussion is on individual health care, allotment of national 
resources, or international business, economics is a principal catalyst for action. AIDS 
represents both crisis and opportunity in the world of finance.  
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On the global scale, concern about projected costs of AIDS treatment is spurring 
policymakers to look for far-reaching solutions to avoid a future collapse of their health care 
systems. In terms of opportunity, the disease offers possibilities of massive profits for 
aggressive marketers. Promoting the use of condoms is such an integral part of HIV/AIDS 
social marketing that the practice has its own acronym: condom social marketing [CSM] 
(Condom, 2006). After realising sales in Mexico of 19 million condoms in 2004, the charitable 
organisation DKT International noted “dynamic social marketing” was essential to its success 
(DKT, 2005).  
Even greater opportunities abound when it comes to conventional drug treatments for AIDS 
victims. In industrialised countries such as the United States, Americans with adequate 
insurance or personal funds can receive HAART [Highly Active Anti-retroviral Treatment] and 
monitoring for about £5,000/year. The cost of current treatments clearly separates the haves 
from the have-nots; only one-fifth of infected people in developing countries are receiving anti-
retroviral therapy, primarily due to cost constraints.  
In this rush to find effective treatments and ultimately a cure, there have been many 
stumbles and some documented deceits, such as selective reporting of clinical drug trials, as 
acknowledged by the International Committee of Medical Journal Editors (Graham, 2004:18). 
In 2003, the Panos Institute, a global network based in London that focuses on “amplifying the 
voices of the poor and marginalised,” issued a report examining how communication has been 
used to respond to the AIDS pandemic and calling for media to support informed debate rather 
than merely disseminating information (Missing, 2003).  
Finally, some critics claim that medical innovations such as nanotechnology are changing the 
landscape of possibilities regarding treatment and new discoveries about the cause of AIDS are 
not being published in medical journals or pursued by conventional medicine (Siegal, 2003). 
The conventional medicine community, on the other hand, cites the benefits of international 
alliances and increased life expectancies for those receiving HAART (Sepkowitz, 2006).  
As the international debate continues, these three factors—cultural content of social 
marketing messages about HIV/AIDS, the role of political expediency, and the economic 
realities of the global medical market created by the epidemic—form a complex and politically 
charged environment that influences public dissemination of information about health care 
options. The deeper beneath the surface one looks, the more relationships, conflicts, and 
knowledge gaps are uncovered, justifying further study. 
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of their sexual and reproductive health in a society where traditional gender 
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Relying on global support for the HIV prevention needs of women, the 
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collaborative partnerships with common goals and varied resources; 
involving the target audience at every stage; and crafting culturally 
sensitive multimedia, multilingual messages.  
Next steps: Examples of materials and experiences from participants in 
these campaigns will inspire audiences to contribute ideas for continuing this 
worldwide empowerment of women.  
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MAKING HISTORY: CURING HIV/AIDS WITH NANOTECHNOLOGY 
 
PANEL SESSION INTRODUCTION 
 
 HIV/AIDS has killed at least 28 million people since 1982 (USAID, 2006). The number 
of HIV/AIDS infected now surpasses 50 million. In the 25 years since the first reported cases of 
HIV/AIDS in 1981, the disease has become a global pandemic. Unfortunately, the epidemic’s 
history is a story of largely unfulfilled hopes for various treatments. 
 
 However, new nanotechnology treatments are offering solutions. In 2005, silver 
nanoparticles were demonstrated in vitro to attach and inhibit HIV-1 from binding to host cells 
through size-dependent interaction (see, Elechiguerra, et al., Interaction of silver nanoparticles 
with HIV-1, J. Nanobiotechnology. 2005, 3, 6.).  In 2006, U.S. physicians demonstrated 
remarkable results in follow-up human pilot programs in Texas. 
 
 Social marketing will be a key tactic for informing both policy makers—and the public—
of these successes, because social marketing can operate in the maelstrom of cultural, political, 
economic and social concerns.  
PART I: BRIEF HISTORY OF HIV/AIDS TREATMENTS 
 
The history of drug treatment regimens for HIV/AIDS is complex.  It is complicated by 
problems with toxicity, compliance, side effects and cost. In 1987, AZT (zidovudine) was the 
first drug approved for treatment of AIDS. By the mid-1990s, a number of new drugs were 
being developed, such as Highly Active Anti-Retroviral Therapy (HAART). HAART treatment 
involves a combination of three classes of drugs: protease inhibitors, nucleoside reverse 
transcriptase inhibitors and non-nucleoside reverse transcriptase inhibitors, all of which interfere 
with the enzymes the virus uses to replicate itself. A viral load below 50—the level at which the 
virus is no longer detectable in blood—is the goal of therapy, but is seldom achieved. 
 
Newer research shows, however, that the most effective drug therapies fail to prevent 
replication of the virus. This unfortunate result makes eliminating HIV with antiretroviral 
therapy unrealistic. Also, the virus often develops resistance during therapy, resulting in a steady 
viral load increase. Additionally, co-infections are on the rise. These co-infections include both 
fungal and bacterial infections, as well as common viral infections such as CMV 
(cytomegalovirus, which affects vision) and viral pneumonia.  
  
Fortunately, nanotechnological solutions to HIV/AIDS hold great promise. The 
interaction of nano- and sub-nanoparticles with biomolecules and microorganisms is an 
expanding field of research (see, e.g., Elechiguerra, et al., Interaction of silver nanoparticles 
with HIV-1, J. Nanobiotechnology. 2005, 3, 6.). 
Medical literature shows a variety of viruses have been successfully treated with silver-based 
drugs (Rentz, Viral pathogens and severe acute respiratory syndrome: Oligodynamic Ag+ for 
direct immune intervention, J. Nutritional & Environmental Medicine. 2003, Jun; 13(2): 109-
18).  
 
Emerging medical studies confirm the stellar, broad-spectrum virotoxic efficacy of 
oligodynamic noble metals both in vitro and in vivo (Gordon & Holtorf, A Promising Cure for 
URTI Pandemics, Including H5N1 and SARS: Has the Final Solution to the Coming Plagues 
Been Discovered? [Part II]. Townsend Letter, Feb/Mar 2006. This includes some of the most 
formidable viral organisms like HIV (including co-infections) (Id.; see also; Dean, et al., 
Reduction of viral load in AIDS patients with intravenous mild-silver protein—Three case 
reports, Clinical Practice of Alternative Medicine, Spring 2001; Oka, et al., 1994; Hussain, et 
al., Cystine protects Na, K-ATPase and isolated human lymphocytes from silver toxicity, 
Biochem. Biophys. Res. Comm., 1992, 189.1444-1449; Aiken, In vitro MIC Test Against HIV-1, 
published account via email, AA-90 Results. Vanderbilt School of Medicine, Dec. 16, 1997; et 
al., 2005; Zhong-Yin, et al., Zinc inhibition of rennin and the protease from Human 
Immunodeficiency Virus Type 1, Biochemistry, 1991 Sept 10.30(36): 8717-21). 
 
This portion of the panel and supporting paper will briefly discuss the 25-year history of 
HIV/AIDS treatments, as well as present a synopsis of current nanotechnology treatments.  
 
PART II: U.S. CASE STUDIES (2006) 
 
In 2006, U.S. physicians operating under Investigational Review Board (IRB) authority 
demonstrated highly encouraging results using silver nanoparticles to treat HIV/AIDS patients 
during a pilot program in Texas. This pilot program followed up a University of Texas 
(Austin)—University of Mexico (Monterrey) study published in 2005, which demonstrated 
silver nanoparticles in vitro attached to and inhibited HIV-1 from binding to host cells through 
size-dependent interaction (see, Elechiguerra, et al., Interaction of silver nanoparticles with 
HIV-1, J. Nanobiotechnology. 2005, 3, 6.).  
 
Under this IRB program, patients received oral-only administration of tiny silver 
particles set in water.  HIV-infected patients, after examination and blood test, orally ingested a 
nanoparticle-sized solution for 30 days, then retested for improved CD4 counts and viral load. 
The program consisted of an initial physician examination, two blood tests (one at 15 days, the 
last at 30 days) to measure CD4 and viral loads, then a final analysis of results.  
 
Patients in this pilot program were on both conventional therapy and non-conventional 
therapy. The best results were obtained with patients who were not on conventional therapy. 
One HIV-positive patient showed a remarkable drop of over 68% viral load in only 15 days.  
 
This portion of the panel and supporting paper are based upon three case studies from 
the pilot program. 
 
 
PART III: GETTING THE WORD OUT: PROMOTING CURES THROUGH SOCIAL MARKETING 
 
For more than three decades, social marketing has been widely used to motivate low-income 
and high-risk audiences. Where successful treatments exist, social marketing should now be 
used to inform governmental policy makers and the public of their existence. This appears 
especially true with new nanotechnological treatments now in the process of being made 
available. 
 
Social marketing has been a key tactic in combating HIV/AIDS, both in developing and 
industrialized countries, for the past 20 years. Social marketing campaigns have previously 
focused on prevention and treatment messages; yet, these campaigns have also addressed the 
cultural concerns and stigma related to the disease.  
 
In Mexico, where the increase in new HIV cases has been continuous since 1981, social 
marketing is the tool of choice for promoting positive change, both for individuals (downstream 
audiences) and for broader social policy (upstream audiences), with the goal of preventing this 
“underground epidemic” from becoming generalized to the population at large (HIV Infection, 
2003; USAID, 2005). Numerous campaigns address this challenge, including USAID initiatives, 
whose infectious disease objectives in Mexico target stigma and discrimination. The principal 
contractor for the USAID campaign, Population Services International [PSI], was the first 
organization to use social marketing to combat the AIDS epidemic. In addition to procuring and 
distributing pharmaceuticals, over-the-counter drugs and condoms, PSI trains government 
officials in marketing and communication techniques. 
  
Mexico is a highly competitive market for products such as condoms, according to the 
Washington-based charitable organization DKT International. After realizing sales in Mexico of 
19 million condoms in 2004, DKT noted “dynamic social marketing” was essential (DKT, 
2005). Likewise, PSI, in conjunction with CENSIDA [The National Center for the Prevention 
and Control of HIV/AIDS] and CONASIDA [The National Council for Prevention and Control 
of AIDS], is using extensive condom social marketing in high-risk areas of southern Mexico 
(PSI, 2006). 
 
 Since HIV/AIDS is also a significant problem along the U.S.-Mexico border, programs 
such as the SPNS (Special Projects of National Significance) Border Health Initiative rely 
heavily on social marketing campaigns, using Spanish language media to blanket the transient 
communities with “bold” HIV messages (Innovative, 2005). Innovative media strategies also 
characterize Project Hombres, Project Diversity and Project Mujeres, which were developed by 
a partnership of Latin American NGOs to combat Mexico’s cultural, gender and lifestyle 
barriers (World, 2006).   
 As HIV/AIDS social marketing establishes a track record in Mexico, organizations using 
this technique can begin to analyze results. For example, PANCEA, a three-year NIH-funded 
research project in Mexico and four other countries, is studying the effectiveness of the eight 
prevention modalities commonly used to respond to the HIV epidemic (PANCEA, 2005). 
 Building on these self-evaluations, this portion of the panel and supporting paper use the 
essential elements of social marketing to compare Mexico HIV/AIDS campaigns, identifying 
commonalities as well as unique characteristics in purpose, targeted audience, content/focus and 
strategic approach. The result is a practical overview of how social marketing can successfully 
operate in the maelstrom of cultural, political, economic and social concerns while bringing 
about voluntary behavioural changes among both downstream and upstream audiences. 
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ABSTRACT 
 
Social marketing has been widely used to influence low-income, high-risk 
populations to make healthy behaviour changes. This application of marketing 
principles has also become an important tool for persuading upstream audiences to 
make long-term policy changes that achieve socially desirable goals. As the human, 
social, and economic costs of the HIV/AIDS pandemic mount, social marketing is now 
a key tactic for combating the disease. This paper analyses six recent HIV/AIDS 
campaigns in Mexico, examining their ability to motivate change and their potential for 
informing target audiences about new health choices. Although each campaign has a 
unique theme and a distinctive focus, all share common objectives. Collaboration is 
essential; each campaign involves multiple organizations, thereby building acceptance 
for change at all levels. The campaigns all incorporate prevention strategies, and in 
recognition of Mexico’s cultural obstacles, each addresses aspects of stigma and 
traditional cultural norms. Persuasive messages are informed by the tenets of 
established behavioural models. As a result, alliances of HIV/AIDS social marketers in 
Mexico have been able to operate successfully in the maelstrom of cultural, political, 
economic, and social concerns while bringing about voluntary behavioural changes 
among both downstream and upstream audiences.  
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APPENDIX F 
SPSS TABLES FROM CHAPTER 7 
 
 
  
F.1 Cross Tabulation Tables with Significance  
Or a Tendency toward Significance  
Using Pearson’s Chi-Square Test of Association     
 
F.1.a. Crosstabs: Sources and Demographic Variables   F1 
F.1.b. Crosstabs: Source Credibility and Demographic Variables  F18 
F.1.c. Crosstabs: Perception Statements and Demographic Variables F29 
F.1.d. Crosstabs: Treatments Known and Demographic Variables  F71 
F.1.e. Crosstabs: Effective Treatments and Demographic Variables F93 
 
F.2 List of Crosstabs with No Significance     F114 
 
F.3 Reliability Statistics: Cronbach’s Alpha Analysis Tables  F116 
F 1 
 
CROSSTABS:  SOURCES AND DEMOGRAPHIC VARIABLES 
 
SOURCES VS. GENDER 
 
Which gender do you 
identify yourself with 
    male female Total 
Count 77 18 95 
Expected Count 63.0 32.0 95.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
TV 
81.1% 18.9% 100.0% 
not selected 
% of Total 23.8% 5.6% 29.3% 
Count 138 91 229 
Expected Count 152.0 77.0 229.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
TV 
60.3% 39.7% 100.0% 
sources you have 
learned about 
HIV/AIDS in the last 
4-5 years- TV 
selected 
% of Total 42.6% 28.1% 70.7% 
Count 215 109 324 
Expected Count 215.0 109.0 324.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
TV 
66.4% 33.6% 100.0% 
Total 
% of Total 66.4% 33.6% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 13.001(b) 1 .000     
Continuity 
Correction(a) 
12.086 1 .001     
Likelihood Ratio 13.850 1 .000     
Fisher's Exact Test       .000 .000 
Linear-by-Linear 
Association 
12.961 1 .000     
N of Valid Cases 324         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 31.96. 
F 2 
 
 
  
Which gender do you 
identify yourself with 
    male female Total 
Count 133 48 181 
Expected Count 120.1 60.9 181.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
Radio 
73.5% 26.5% 100.0% 
not selected 
% of Total 41.0% 14.8% 55.9% 
Count 82 61 143 
Expected Count 94.9 48.1 143.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
Radio 
57.3% 42.7% 100.0% 
sources you have 
learned about 
HIV/AIDS in the last 4-
5 years- Radio 
selected 
% of Total 25.3% 18.8% 44.1% 
Count 215 109 324 
Expected Count 215.0 109.0 324.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
Radio 
66.4% 33.6% 100.0% 
Total 
% of Total 66.4% 33.6% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 9.320(b) 1 .002     
Continuity 
Correction(a) 
8.611 1 .003     
Likelihood Ratio 9.301 1 .002     
Fisher's Exact Test       .003 .002 
Linear-by-Linear 
Association 
9.291 1 .002     
N of Valid Cases 324         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 48.11. 
F 3 
 
 
  
Which gender do you 
identify yourself with 
    male female Total 
Count 66 47 113 
Expected Count 75.0 38.0 113.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
Magazine 
58.4% 41.6% 100.0% 
not selected 
% of Total 20.4% 14.5% 34.9% 
Count 149 62 211 
Expected Count 140.0 71.0 211.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
Magazine 
70.6% 29.4% 100.0% 
sources you have 
learned about 
HIV/AIDS in the last 4-
5 years- Magazine 
selected 
% of Total 46.0% 19.1% 65.1% 
Count 215 109 324 
Expected Count 215.0 109.0 324.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
Magazine 
66.4% 33.6% 100.0% 
Total 
% of Total 66.4% 33.6% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 4.914(b) 1 .027     
Continuity 
Correction(a) 
4.382 1 .036     
Likelihood Ratio 4.849 1 .028     
Fisher's Exact Test       .036 .019 
Linear-by-Linear 
Association 
4.898 1 .027     
N of Valid Cases 324         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 38.02. 
F 4 
 
 
    
Which gender do 
you identify 
yourself with Total 
    male female male 
sources you have learned 
about HIV/AIDS in the last 
4-5 years- Out of Home, 
billboards, transit 
ads,posters,flyers,brochures 
not 
selected 
Count 
144 57 201 
    Expected Count 133.4 67.6 201.0 
    % within Sources  71.6% 28.4% 100.0% 
    % of Total 44.4% 17.6% 62.0% 
  selected Count 71 52 123 
    Expected Count 81.6 41.4 123.0 
    % within Sources  57.7% 42.3% 100.0% 
    % of Total 21.9% 16.0% 38.0% 
Total Count 215 109 324 
  Expected Count 215.0 109.0 324.0 
  % within Sources  66.4% 33.6% 100.0% 
  % of Total 66.4% 33.6% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 6.621(b) 1 .010     
Continuity 
Correction(a) 
6.013 1 .014     
Likelihood Ratio 6.552 1 .010     
Fisher's Exact Test       .011 .007 
Linear-by-Linear 
Association 
6.601 1 .010     
N of Valid Cases 324         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 41.38. 
F 5 
 
 
SOURCES VS. STATUS 
 
My HIV status is 
    Negative Positive Total 
Count 24 65 89 
Expected Count 32.6 56.4 89.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
TV 
27.0% 73.0% 100.0% 
not selected 
% of Total 8.2% 22.3% 30.5% 
Count 83 120 203 
Expected Count 74.4 128.6 203.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
TV 
40.9% 59.1% 100.0% 
sources you have 
learned about 
HIV/AIDS in the last 
4-5 years- TV 
selected 
% of Total 28.4% 41.1% 69.5% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
TV 
36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 5.164(b) 1 .023     
Continuity 
Correction(a) 
4.582 1 .032     
Likelihood Ratio 5.311 1 .021     
Fisher's Exact Test       .025 .015 
Linear-by-Linear 
Association 
5.147 1 .023     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 32.61. 
F 6 
 
 
  
My HIV status is 
    Negative Positive Total 
Count 50 118 168 
Expected Count 61.6 106.4 168.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
Radio 
29.8% 70.2% 100.0% 
not selected 
% of Total 17.1% 40.4% 57.5% 
Count 57 67 124 
Expected Count 45.4 78.6 124.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
Radio 
46.0% 54.0% 100.0% 
sources you have 
learned about 
HIV/AIDS in the last 4-
5 years- Radio 
selected 
% of Total 19.5% 22.9% 42.5% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
Radio 
36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 8.071(b) 1 .004     
Continuity 
Correction(a) 
7.388 1 .007     
Likelihood Ratio 8.046 1 .005     
Fisher's Exact Test       .005 .003 
Linear-by-Linear 
Association 
8.043 1 .005     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 45.44. 
 
F 7 
 
 
  
My HIV status is 
    Negative Positive Total 
Count 55 119 174 
Expected Count 63.8 110.2 174.0 
% within sources you 
have learned about 
HIV/AIDS in the last 
4-5 years- Out of 
Home, billboards, 
transit 
ads,posters,flyers,bro
chures 
31.6% 68.4% 100.0% 
not selected 
% of Total 18.8% 40.8% 59.6% 
Count 52 66 118 
Expected Count 43.2 74.8 118.0 
% within sources you 
have learned about 
HIV/AIDS in the last 
4-5 years- Out of 
Home, billboards, 
transit 
ads,posters,flyers,bro
chures 
44.1% 55.9% 100.0% 
sources you have 
learned about 
HIV/AIDS in the last 4-
5 years- Out of Home, 
billboards, transit 
ads,posters,flyers,broch
ures 
selected 
% of Total 17.8% 22.6% 40.4% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within sources you 
have learned about 
HIV/AIDS in the last 
4-5 years- Out of 
Home, billboards, 
transit 
ads,posters,flyers,bro
chures 
36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 4.701(b) 1 .030     
Continuity 
Correction(a) 
4.180 1 .041     
Likelihood Ratio 4.676 1 .031     
Fisher's Exact Test       .035 .021 
Linear-by-Linear 
Association 
4.685 1 .030     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 43.24. 
F 8 
 
 
 
  
My HIV status is 
    Negative Positive Total 
Count 78 108 186 
Expected Count 68.2 117.8 186.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
HIV/AIDS groups’ 
websites 
41.9% 58.1% 100.0% 
not selected 
% of Total 26.7% 37.0% 63.7% 
Count 29 77 106 
Expected Count 38.8 67.2 106.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
HIV/AIDS groups’ 
websites 
27.4% 72.6% 100.0% 
sources you have 
learned about 
HIV/AIDS in the last 4-
5 years- HIV/AIDS 
groups’ websites 
selected 
% of Total 9.9% 26.4% 36.3% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
HIV/AIDS groups’ 
websites 
36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 6.180(b) 1 .013     
Continuity 
Correction(a) 
5.568 1 .018     
Likelihood Ratio 6.316 1 .012     
Fisher's Exact Test       .016 .009 
Linear-by-Linear 
Association 
6.159 1 .013     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 38.84. 
F 9 
 
 
 
  
My HIV status is 
    Negative Positive Total 
Count 77 153 230 
Expected Count 84.3 145.7 230.0 
% within sources you 
have learned about 
HIV/AIDS in the last 
4-5 years- Online 
newsletter, journals 
33.5% 66.5% 100.0% 
not 
selected 
% of Total 26.4% 52.4% 78.8% 
Count 30 32 62 
Expected Count 22.7 39.3 62.0 
% within sources you 
have learned about 
HIV/AIDS in the last 
4-5 years- Online 
newsletter, journals 
48.4% 51.6% 100.0% 
sources you have 
learned about 
HIV/AIDS in the last 
4-5 years- Online 
newsletter,journals,ect 
selected 
% of Total 10.3% 11.0% 21.2% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within sources you 
have learned about 
HIV/AIDS in the last 
4-5 years- Online 
newsletter, journals 
36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 4.676(b) 1 .031     
Continuity 
Correction(a) 
4.055 1 .044     
Likelihood Ratio 4.565 1 .033     
Fisher's Exact Test       .038 .023 
Linear-by-Linear 
Association 
4.660 1 .031     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 22.72. 
F 10 
 
 
 
  
My HIV status is 
    Negative Positive Total 
Count 86 167 253 
Expected Count 92.7 160.3 253.0 
% within sources you 
have learned about 
HIV/AIDS in the last 
4-5 years-Social 
media, facebook, 
Twitter 
34.0% 66.0% 100.0% 
not 
selected 
% of Total 29.5% 57.2% 86.6% 
Count 21 18 39 
Expected Count 14.3 24.7 39.0 
% within sources you 
have learned about 
HIV/AIDS in the last 
4-5 years- Social 
media facebook, 
Twitter 
53.8% 46.2% 100.0% 
sources you have 
learned about 
HIV/AIDS in the last 
4-5 years- Social 
media,facebook,Twitte
r,ect 
selected 
% of Total 7.2% 6.2% 13.4% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within sources you 
have learned about 
HIV/AIDS in the last 
4-5 years-Social media 
facebook, Twitter 
36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 5.737(b) 1 .017     
Continuity 
Correction(a) 
4.914 1 .027     
Likelihood Ratio 5.535 1 .019     
Fisher's Exact Test       .020 .014 
Linear-by-Linear 
Association 
5.718 1 .017     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 14.29. 
F 11 
 
 
 
  
My HIV status is 
    Negative Positive Total 
Count 68 144 212 
Expected Count 77.7 134.3 212.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years-
Edu institutions 
32.1% 67.9% 100.0% 
not selected 
% of Total 23.3% 49.3% 72.6% 
Count 39 41 80 
Expected Count 29.3 50.7 80.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years-
Edu institutions 
48.8% 51.3% 100.0% 
sources you have 
learned about 
HIV/AIDS in the last 4-
5 years-Educational 
institutions 
selected 
% of Total 13.4% 14.0% 27.4% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years-
Edu  institutions 
36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 6.956(b) 1 .008     
Continuity 
Correction(a) 
6.256 1 .012     
Likelihood Ratio 6.820 1 .009     
Fisher's Exact Test       .010 .007 
Linear-by-Linear 
Association 
6.932 1 .008     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 29.32. 
F 12 
 
 
 
  
My HIV status is 
    Negative Positive Total 
Count 44 106 150 
Expected Count 55.0 95.0 150.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
Friends or family 
members 
29.3% 70.7% 100.0% 
not selected 
% of Total 15.1% 36.3% 51.4% 
Count 63 79 142 
Expected Count 52.0 90.0 142.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
Friends or family 
members 
44.4% 55.6% 100.0% 
sources you have 
learned about 
HIV/AIDS in the last 4-
5 years- Friends or 
family members 
selected 
% of Total 21.6% 27.1% 48.6% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
Friends or family 
members 
36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 7.101(b) 1 .008     
Continuity 
Correction(a) 
6.468 1 .011     
Likelihood Ratio 7.127 1 .008     
Fisher's Exact Test       .011 .005 
Linear-by-Linear 
Association 
7.076 1 .008     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 52.03. 
F 13 
 
 
 
  
My HIV status is 
    Negative Positive Total 
Count 68 149 217 
Expected Count 79.5 137.5 217.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
People you work 
with 
31.3% 68.7% 100.0% 
not selected 
% of Total 23.3% 51.0% 74.3% 
Count 39 36 75 
Expected Count 27.5 47.5 75.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
People you work 
with 
52.0% 48.0% 100.0% 
sources you have 
learned about 
HIV/AIDS in the last 
4-5 years- People you 
work with 
selected 
% of Total 13.4% 12.3% 25.7% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
People you work 
with 
36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 10.251(b) 1 .001     
Continuity 
Correction(a) 
9.380 1 .002     
Likelihood Ratio 10.009 1 .002     
Fisher's Exact Test       .002 .001 
Linear-by-Linear 
Association 
10.216 1 .001     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 27.48. 
F 14 
 
 
 
SOURCES VS. SEXUAL ORIENTATION 
 
    sexual orientation Total 
    heterosexual homosexual bi-sexual 1.00 
sources you 
have 
learned 
about 
HIV/AIDS 
in the last 
4-5 years- 
HIV/AIDS 
groups’ 
websites 
not selected Count 
109 73 16 198 
    Expected 
Count 
92.9 83.3 21.8 198.0 
    % within 
sources  55.1% 36.9% 8.1% 100.0% 
    % of Total 35.3% 23.6% 5.2% 64.1% 
   
selected 
 
Count 
 
36 
 
57 
 
18 
 
111 
    Expected 
Count 
52.1 46.7 12.2 111.0 
    % within 
sources  
         32.4% 51.4% 16.2% 100.0% 
    % of Total 11.7% 18.4% 5.8% 35.9% 
 
Total 
 
Count 
 
145 
 
130 
 
34 
 
309 
  Expected 
Count 
145.0 130.0 34.0 309.0 
  % within 
sources  
46.9% 42.1% 11.0% 100.0% 
  % of Total 46.9% 42.1% 11.0% 100.0% 
 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 15.578(a) 2 .000 
Likelihood Ratio 15.750 2 .000 
Linear-by-Linear 
Association 
14.892 1 .000 
N of Valid Cases 
309     
a  0 cells (.0%) have expected count less than 5. The minimum expected count is 12.21. 
 
F 15 
 
SOURCES VS. AGE 
 
Age group 
    18-25 26-36 37-47 48-58 59 + Total 
Count 42 67 98 74 17 298 
Expecte
d Count 
46.5 78.0 90.3 67.5 15.8 298.0 
% 
within 
sources  14.1% 22.5% 32.9% 24.8% 5.7% 100.0% 
not 
selected 
% of 
Total 
12.4% 19.7% 28.8% 21.8% 5.0% 87.6% 
 
Count 
 
11 
 
22 
 
5 
 
3 
 
1 
 
42 
Expecte
d Count 
6.5 11.0 12.7 9.5 2.2 42.0 
% 
within 
sources  26.2% 52.4% 11.9% 7.1% 2.4% 100.0% 
sources 
you 
have 
learned 
about 
HIV/AI
DS in 
the last 
4-5 
years- 
Social 
media,fa
cebook,
Twitter,
ect 
 
selected 
% of 
Total 
3.2% 6.5% 1.5% .9% .3% 12.4% 
 
Count 
 
53 
 
89 
 
103 
 
77 
 
18 
 
340 
Expecte
d Count 
53.0 89.0 103.0 77.0 18.0 340.0 
% 
within 
sources  15.6% 26.2% 30.3% 22.6% 5.3% 100.0% 
 
Total 
% of 
Total 
15.6% 26.2% 30.3% 22.6% 5.3% 100.0% 
 
                                   Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 27.230(a) 4 .000 
Likelihood Ratio 27.492 4 .000 
Linear-by-Linear 
Association 
17.841 1 .000 
N of Valid Cases 
340     
a  1 cells (10.0%) have expected count less than 5. The minimum expected count is 2.22. 
 
F 16 
 
SOURCES VS. ETHNIC GROUP 
 
which group do you identify with? 
    
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/african 
american or 
negro hispanic 
White / 
caucasian multiracial other Total 
Count 6 3 88 42 66 10 6 221 
Expected Count 5.9 2.6 79.5 34.6 82.8 11.7 3.9 221.0 
% within sources  2.7% 1.4% 39.8% 19.0% 29.9% 4.5% 2.7% 100.0% 
not selected 
% of Total 1.8% .9% 26.0% 12.4% 19.5% 2.9% 1.8% 65.2% 
Count 3 1 34 11 61 8 0 118 
Expected Count 3.1 1.4 42.5 18.4 44.2 6.3 2.1 118.0 
% within sources  2.5% .8% 28.8% 9.3% 51.7% 6.8% .0% 100.0% 
sources you have learned 
about HIV/AIDS in the last 
4-5 years- Conventional 
medical doctors 
selected 
% of Total .9% .3% 10.0% 3.2% 18.0% 2.4% .0% 34.8% 
Count 9 4 122 53 127 18 6 339 
Expected Count 9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
% within sources  2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
Total 
% of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
 
F 17 
 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 21.106(a) 6 .002 
Likelihood Ratio 23.099 6 .001 
Linear-by-Linear 
Association 5.224 1 .022 
N of Valid Cases 
339     
a  5 cells (35.7%) have expected count less than 5. The minimum expected count is 1.39. 
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CROSSTABS: 
SOURCE CREDIBILITY AND DEMOGRAPHIC VARIABLES 
 
SOURCE CREDIBILITY VS. STATUS 
My HIV status is 
    Negative Positive Total 
Count 1 8 9 
Expected 
Count 
3.4 5.6 9.0 
% within 
Sources 
11.1% 88.9% 100.0% 
not at all 
credible 
% of Total 
 
             .5%            3.7% 4.1% 
Count 5 14 19 
Expected 
Count 
7.2 11.8 19.0 
% within 
Sources 
26.3% 73.7% 100.0% 
somewhat 
credible 
% of Total 2.3% 6.5% 8.8% 
Count 12 30 42 
Expected 
Count 
15.9 26.1 42.0 
% within 
Sources 
28.6% 71.4% 100.0% 
undecided 
% of Total 5.5% 13.8% 19.4% 
Count 27 42 69 
Expected 
Count 
26.1 42.9 69.0 
% within 
Sources 
39.1% 60.9% 100.0% 
credible 
% of Total 12.4% 19.4% 31.8% 
Count 37 41 78 
Expected 
Count 
29.5 48.5 78.0 
% within 
Sources 
47.4% 52.6% 100.0% 
Rate each of 
these 
sources of 
HIV/AIDS 
information 
according to 
how 
credible 
they have 
been in your 
experience-
events, 
seminars, 
workshops, 
conferences 
extremely 
credible 
% of Total 17.1% 18.9% 35.9% 
Count 82 135 217 
Expected 
Count 
82.0 135.0 217.0 
% within 
Sources 
37.8% 62.2% 100.0% 
Total 
% of Total 37.8% 62.2% 100.0% 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 8.447(a) 4 .077 
Likelihood Ratio 9.022 4 .061 
Linear-by-Linear 
Association 
8.171 1 .004 
N of Valid Cases 
217     
a  1 cells (10.0%) have expected count less than 5. The minimum expected count is 3.40. 
F 19 
 
 
My HIV status is 
   Negative Positive Total 
Count 0 8 8 
Expected 
Count 
2.9 5.1 8.0 
% within 
Sources  .0% 100.0% 100.0% 
not at all 
credible 
% of Total .0% 3.5% 3.5% 
Count 15 14 29 
Expected 
Count 
10.5 18.5 29.0 
% within 
Sources 
51.7% 48.3% 100.0% 
somewhat 
credible 
% of Total 6.5% 6.1% 12.6% 
Count 17 38 55 
Expected 
Count 
19.8 35.2 55.0 
% within 
Sources  30.9% 69.1% 100.0% 
undecided 
% of Total 7.4% 16.5% 23.9% 
Count 26 51 77 
Expected 
Count 
27.8 49.2 77.0 
% within 
Sources  33.8% 66.2% 100.0% 
credible 
% of Total 11.3% 22.2% 33.5% 
Count 25 36 61 
Expected 
Count 
22.0 39.0 61.0 
% within 
Sources  
41.0% 59.0% 100.0% 
Rate each of 
these sources 
of HIV/AIDS 
information 
according to 
how credible 
they have 
been in your 
experience-
community 
organizations 
extremely 
credible 
% of Total 10.9% 15.7% 26.5% 
Count 83 147 230 
Expected 
Count 
83.0 147.0 230.0 
% within 
Sources  
36.1% 63.9% 100.0% 
Total 
% of Total 36.1% 63.9% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 9.045(a) 4 .060 
Likelihood Ratio 11.565 4 .021 
Linear-by-Linear 
Association 
.456 1 .500 
N of Valid Cases 
230     
a  1 cells (10.0%) have expected count less than 5. The minimum expected count is 2.89. 
 
  
F 20 
 
My HIV status is 
    Negative Positive Total 
Count 1 7 8 
Expected 
Count 
3.0 5.0 8.0 
% within 
Sources  12.5% 87.5% 100.0% 
not at all 
credible 
% of Total .5% 3.2% 3.6% 
Count 11 13 24 
Expected 
Count 
9.0 15.0 24.0 
% within 
Sources  
45.8% 54.2% 100.0% 
somewhat 
credible 
% of Total 5.0% 5.9% 10.8% 
Count 8 33 41 
Expected 
Count 
15.3 25.7 41.0 
% within 
Sources  19.5% 80.5% 100.0% 
undecided 
% of Total 3.6% 14.9% 18.5% 
Count 34 47 81 
Expected 
Count 
30.3 50.7 81.0 
% within 
Sources  42.0% 58.0% 100.0% 
credible 
% of Total 15.3% 21.2% 36.5% 
Count 29 39 68 
Expected 
Count 
25.4 42.6 68.0 
% within 
Sources  42.6% 57.4% 100.0% 
Rate each of 
these 
sources of 
HIV/AIDS 
information 
according to 
how 
credible 
they have 
been in your 
experience-
educational 
institutions 
extremely 
credible 
% of Total 13.1% 17.6% 30.6% 
Count 83 139 222 
Expected 
Count 
83.0 139.0 222.0 
% within 
Sources  37.4% 62.6% 100.0% 
Total 
% of Total 37.4% 62.6% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 9.976(a) 4 .041 
Likelihood Ratio 10.886 4 .028 
Linear-by-Linear 
Association 
2.611 1 .106 
N of Valid Cases 
222     
a  1 cells (10.0%) have expected count less than 5. The minimum expected count is 2.99. 
 
  
F 21 
 
My HIV status is 
    Negative Positive Total 
Count 7 31 38 
Expected 
Count 
14.7 23.3 38.0 
% within 
Sources  18.4% 81.6% 100.0% 
not at all 
credible 
% of Total 3.3% 14.5% 17.8% 
Count 13 25 38 
Expected 
Count 
14.7 23.3 38.0 
% within 
Sources  34.2% 65.8% 100.0% 
somewhat 
credible 
% of Total 6.1% 11.7% 17.8% 
Count 25 39 64 
Expected 
Count 
24.8 39.2 64.0 
% within 
Sources  
39.1% 60.9% 100.0% 
undecided 
% of Total 11.7% 18.2% 29.9% 
Count 18 24 42 
Expected 
Count 
16.3 25.7 42.0 
% within 
Sources  42.9% 57.1% 100.0% 
credible 
% of Total 8.4% 11.2% 19.6% 
Count 20 12 32 
Expected 
Count 
12.4 19.6 32.0 
% within 
Sources  62.5% 37.5% 100.0% 
Rate each of 
these 
sources of 
HIV/AIDS 
information 
according to 
how 
credible 
they have 
been in your 
experience-
people you 
work with 
extremely 
credible 
% of Total 9.3% 5.6% 15.0% 
Count 83 131 214 
Expected 
Count 
83.0 131.0 214.0 
% within 
Sources 38.8% 61.2% 100.0% 
Total 
% of Total 38.8% 61.2% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 14.848(a) 4 .005 
Likelihood Ratio 15.338 4 .004 
Linear-by-Linear 
Association 
13.554 1 .000 
N of Valid Cases 
214     
a  0 cells (.0%) have expected count less than 5. The minimum expected count is 12.41. 
 
 
F 22 
 
SOURCE CREDIBILITY VS. AGE 
   Age group Total 
    18-25 26-36 37-47 48-58 59 + 18-25 
Rate each 
of these 
sources of 
HIV/AIDS 
information 
according 
to how 
credible 
they have 
been in 
your 
experience- 
Medical 
Websites 
not at all 
credible 
Count 
6 1 5 3 0 15 
    Expected 
Count 
2.2 4.7 4.6 2.9 .6 15.0 
    % within 
Sources  40.0% 6.7% 33.3% 20.0% .0% 100.0% 
    % of 
Total 
2.3% .4% 2.0% 1.2% .0% 5.9% 
  somewhat 
credible 
Count 
2 2 3 4 2 13 
    Expected 
Count 
1.9 4.1 4.0 2.5 .5 13.0 
    % within 
Sources  
15.4% 15.4% 23.1% 30.8% 15.4% 100.0% 
    % of 
Total 
.8% .8% 1.2% 1.6% .8% 5.1% 
  undecided Count 6 7 11 9 1 34 
    Expected 
Count 
5.0 10.6 10.4 6.6 1.3 34.0 
    % within 
Sources  17.6% 20.6% 32.4% 26.5% 2.9% 100.0% 
    % of 
Total 
2.3% 2.7% 4.3% 3.5% .4% 13.3% 
  credible Count 7 41 31 15 2 96 
    Expected 
Count 
14.3 30.0 29.3 18.8 3.8 96.0 
    % within 
Sources  
7.3% 42.7% 32.3% 15.6% 2.1% 100.0% 
    % of 
Total 
2.7% 16.0% 12.1% 5.9% .8% 37.5% 
  extremely 
credible 
Count 
17 29 28 19 5 98 
    Expected 
Count 
14.5 30.6 29.9 19.1 3.8 98.0 
    % within 
Sources  
17.3% 29.6% 28.6% 19.4% 5.1% 100.0% 
    % of 
Total 
6.6% 11.3% 10.9% 7.4% 2.0% 38.3% 
F 23 
 
Total Count 38 80 78 50 10 256 
  Expected 
Count 
38.0 80.0 78.0 50.0 10.0 256.0 
  % within 
Sources  14.8% 31.3% 30.5% 19.5% 3.9% 100.0% 
  % of 
Total 
14.8% 31.3% 30.5% 19.5% 3.9% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 29.176(a) 16 .023 
Likelihood Ratio 28.049 16 .031 
Linear-by-Linear 
Association 
.015 1 .902 
N of Valid Cases 
256     
a  13 cells (52.0%) have expected count less than 5. The minimum expected count is .51. 
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SOURCE CREDIBILITY VS. ETHNIC GROUP 
    which group do you identify with? Total 
    
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/ 
african 
american 
or negro hispanic 
white/ 
caucasian multiracial other 
american indian, 
alaskan native, or 
pacific islander 
Rate each of 
these sources of 
HIV/AIDS 
information 
according to 
how credible 
they have been 
in your 
experience-
blogs, online 
bulletin boards 
not at all 
credible 
Count 
0 0 7 2 19 1 1 30 
    Expected 
Count 
.6 .4 10.4 4.6 11.8 1.7 .5 30.0 
    % within 
Sources 
.0% .0% 23.3% 6.7% 63.3% 3.3% 3.3% 100.0% 
    % of 
Total 
.0% .0% 3.0% .8% 8.1% .4% .4% 12.7% 
  somewhat 
credible 
Count 
1 0 8 3 14 2 2 30 
    Expected 
Count 
.6 .4 10.4 4.6 11.8 1.7 .5 30.0 
F 25 
 
    % within 
Sources  3.3% .0% 26.7% 10.0% 46.7% 6.7% 6.7% 100.0% 
    % of 
Total 
.4% .0% 3.4% 1.3% 5.9% .8% .8% 12.7% 
  undecided Count 2 2 28 13 42 5 1 93 
    Expected 
Count 
2.0 1.2 32.3 14.2 36.6 5.1 1.6 93.0 
    % within 
Sources  2.2% 2.2% 30.1% 14.0% 45.2% 5.4% 1.1% 100.0% 
    % of 
Total 
.8% .8% 11.9% 5.5% 17.8% 2.1% .4% 39.4% 
  credible Count 1 0 20 14 11 3 0 49 
    Expected 
Count 
1.0 .6 17.0 7.5 19.3 2.7 .8 49.0 
    % within 
Sources  
2.0% .0% 40.8% 28.6% 22.4% 6.1% .0% 100.0% 
    % of 
Total 
.4% .0% 8.5% 5.9% 4.7% 1.3% .0% 20.8% 
  extremely 
credible 
Count 
1 1 19 4 7 2 0 34 
    Expected 
Count 
.7 .4 11.8 5.2 13.4 1.9 .6 34.0 
    % within 
Sources  
2.9% 2.9% 55.9% 11.8% 20.6% 5.9% .0% 100.0% 
    % of 
Total 
.4% .4% 8.1% 1.7% 3.0% .8% .0% 14.4% 
F 26 
 
Total Count 5 3 82 36 93 13 4 236 
  Expected 
Count 
5.0 3.0 82.0 36.0 93.0 13.0 4.0 236.0 
  % within 
Sources  2.1% 1.3% 34.7% 15.3% 39.4% 5.5% 1.7% 100.0% 
  % of 
Total 
2.1% 1.3% 34.7% 15.3% 39.4% 5.5% 1.7% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 37.884(a) 24 .036 
Likelihood Ratio 38.451 24 .031 
Linear-by-Linear 
Association 
15.108 1 .000 
N of Valid Cases 
236     
a  21 cells (60.0%) have expected count less than 5. The minimum expected count is .38. 
F 27 
 
SOURCE CREDIBILITY VS. SEXUAL ORIENTATION 
   sexual orientation Total 
    heterosexual homosexual bi-sexual  
Rate each of 
these sources 
of HIV/AIDS 
information 
according to 
how credible 
they have 
been in your 
experience-
friends or 
family 
members 
not at all 
credible 
Count 
13 8 7 28 
    Expected 
Count 
12.6 12.4 3.0 28.0 
    % within 
Sources  
46.4% 28.6% 25.0% 100.0% 
    % of Total 5.1% 3.1% 2.7% 11.0% 
  somewhat 
credible 
Count 
24 15 5 44 
    Expected 
Count 
19.8 19.5 4.7 44.0 
    % within 
Sources  
54.5% 34.1% 11.4% 100.0% 
    % of Total 9.4% 5.9% 2.0% 17.3% 
  undecided Count 19 35 4 58 
    Expected 
Count 
26.2 25.7 6.1 58.0 
    % within 
Sources  
32.8% 60.3% 6.9% 100.0% 
    % of Total 7.5% 13.7% 1.6% 22.7% 
  credible Count 34 36 7 77 
    Expected 
Count 
34.7 34.1 8.2 77.0 
    % within 
Sources  44.2% 46.8% 9.1% 100.0% 
    % of Total 13.3% 14.1% 2.7% 30.2% 
  extremely 
credible 
Count 
25 19 4 48 
    Expected 
Count 
21.6 21.3 5.1 48.0 
    % within 
Sources  
52.1% 39.6% 8.3% 100.0% 
    % of Total 9.8% 7.5% 1.6% 18.8% 
Total Count 115 113 27 255 
  Expected 
Count 
115.0 113.0 27.0 255.0 
  % within 
Sources  
45.1% 44.3% 10.6% 100.0% 
  % of Total 45.1% 44.3% 10.6% 100.0% 
 
F 28 
 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 16.345(a) 8 .038 
Likelihood Ratio 15.050 8 .058 
Linear-by-Linear 
Association 
.924 1 .337 
N of Valid Cases 
255     
a  2 cells (13.3%) have expected count less than 5. The minimum expected count is 2.96. 
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CROSSTABS:  
PERCEPTION STATEMENTS AND DEMOGRAPHIC VARIABLES 
 
PERCEPTION STATEMENTS VS. STATUS 
    My HIV status is Total 
    Negative Positive Negative 
How do you 
feel about-
Poor people 
are more 
likely to get 
HIV/AIDS 
strongly agree Count 
1 10 11 
    Expected Count 4.0 7.0 11.0 
    % within Statements 9.1% 90.9% 100.0% 
    % of Total .3% 3.4% 3.8% 
  agree Count 21 24 45 
    Expected Count 16.5 28.5 45.0 
    % within Statements 46.7% 53.3% 100.0% 
    % of Total 7.2% 8.2% 15.4% 
  neither agree 
nor disagree 
Count 
29 33 62 
    Expected Count 22.7 39.3 62.0 
    % within Statements 46.8% 53.2% 100.0% 
    % of Total 9.9% 11.3% 21.2% 
  disagree Count 24 48 72 
    Expected Count 26.4 45.6 72.0 
    % within Statements 33.3% 66.7% 100.0% 
    % of Total 8.2% 16.4% 24.7% 
  strongly 
disagree 
Count 
32 70 102 
    Expected Count 37.4 64.6 102.0 
    % within Statements 31.4% 68.6% 100.0% 
    % of Total 11.0% 24.0% 34.9% 
Total Count 107 185 292 
  Expected Count 107.0 185.0 292.0 
  % within Statements 36.6% 63.4% 100.0% 
  % of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 9.845(a) 4 .043 
Likelihood Ratio 10.574 4 .032 
Linear-by-Linear 
Association 
1.374 1 .241 
N of Valid Cases 
292     
a  1 cells (10.0%) have expected count less than 5. The minimum expected count is 4.03. 
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    My HIV status is Total 
    Negative Positive Negative 
How do you 
feel about - 
HIV/AIDS is 
primarily a 
gay disease 
strongly agree Count 
2 6 8 
    Expected Count 2.9 5.1 8.0 
    % within Statements 25.0% 75.0% 100.0% 
    % of Total .7% 2.1% 2.7% 
  agree Count 8 4 12 
    Expected Count 4.4 7.6 12.0 
    % within Statements 66.7% 33.3% 100.0% 
    % of Total 2.7% 1.4% 4.1% 
  neither agree 
nor disagree 
Count 
6 23 29 
    Expected Count 10.6 18.4 29.0 
    % within Statements 20.7% 79.3% 100.0% 
    % of Total 2.1% 7.9% 9.9% 
  disagree Count 28 51 79 
    Expected Count 28.9 50.1 79.0 
    % within Statements 35.4% 64.6% 100.0% 
    % of Total 9.6% 17.5% 27.1% 
  strongly 
disagree 
Count 
63 101 164 
    Expected Count 60.1 103.9 164.0 
    % within Statements 38.4% 61.6% 100.0% 
    % of Total 21.6% 34.6% 56.2% 
Total Count 107 185 292 
  Expected Count 107.0 185.0 292.0 
  % within Statements 36.6% 63.4% 100.0% 
  % of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 8.576(a) 4 .073 
Likelihood Ratio 8.674 4 .070 
Linear-by-Linear 
Association 
.146 1 .703 
N of Valid Cases 
292     
a  2 cells (20.0%) have expected count less than 5. The minimum expected count is 2.93. 
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    My HIV status is Total 
    Negative Positive Negative 
How do you 
feel about - 
Getting 
HIV/AIDS is 
usually a 
death 
sentence 
strongly agree Count 
2 7 9 
    Expected Count 3.3 5.7 9.0 
    % within Statements 22.2% 77.8% 100.0% 
    % of Total .7% 2.4% 3.1% 
  agree Count 14 9 23 
    Expected Count 8.4 14.6 23.0 
    % within Statements 60.9% 39.1% 100.0% 
    % of Total 4.8% 3.1% 7.9% 
  neither agree 
nor disagree 
Count 
19 26 45 
    Expected Count 16.5 28.5 45.0 
    % within Statements 42.2% 57.8% 100.0% 
    % of Total 6.5% 8.9% 15.4% 
  disagree Count 38 55 93 
    Expected Count 34.1 58.9 93.0 
    % within Statements 40.9% 59.1% 100.0% 
    % of Total 13.0% 18.8% 31.8% 
  strongly 
disagree 
Count 
34 88 122 
    Expected Count 44.7 77.3 122.0 
    % within Statements 27.9% 72.1% 100.0% 
    % of Total 11.6% 30.1% 41.8% 
Total Count 107 185 292 
  Expected Count 107.0 185.0 292.0 
  % within Statements 36.6% 63.4% 100.0% 
  % of Total 36.6% 63.4% 100.0% 
 
Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 11.982(a) 4 .017 
Likelihood Ratio 11.916 4 .018 
Linear-by-Linear 
Association 
5.289 1 .021 
N of Valid Cases 
292     
a  1 cells (10.0%) have expected count less than 5. The minimum expected count is 3.30. 
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    My HIV status is Total 
    Negative Positive Negative 
How do you 
feel about- 
Antiretroviral 
drugs are a 
cure for 
HIV/AIDS 
strongly agree Count 
1 10 11 
    Expected Count 4.0 7.0 11.0 
    % within Statements 9.1% 90.9% 100.0% 
    % of Total .3% 3.4% 3.8% 
  agree Count 2 7 9 
    Expected Count 3.3 5.7 9.0 
    % within Statements 22.2% 77.8% 100.0% 
    % of Total .7% 2.4% 3.1% 
  neither agree 
nor disagree 
Count 
29 40 69 
    Expected Count 25.3 43.7 69.0 
    % within Statements 42.0% 58.0% 100.0% 
    % of Total 9.9% 13.7% 23.6% 
  disagree Count 42 53 95 
    Expected Count 34.8 60.2 95.0 
    % within Statements 44.2% 55.8% 100.0% 
    % of Total 14.4% 18.2% 32.5% 
  strongly 
disagree 
Count 
33 75 108 
    Expected Count 39.6 68.4 108.0 
    % within Statements 30.6% 69.4% 100.0% 
    % of Total 11.3% 25.7% 37.0% 
Total Count 107 185 292 
  Expected Count 107.0 185.0 292.0 
  % within Statements 36.6% 63.4% 100.0% 
  % of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 9.332(a) 4 .053 
Likelihood Ratio 10.208 4 .037 
Linear-by-Linear 
Association 
.027 1 .870 
N of Valid Cases 
292     
a  2 cells (20.0%) have expected count less than 5. The minimum expected count is 3.30. 
F 33 
 
 
    My HIV status is Total 
    Negative Positive Negative 
How do you 
feel about - 
People who 
knowingly 
expose others to 
HIV/AIDS 
should be 
prosecuted as 
criminals 
strongly agree Count 
40 43 83 
    Expected Count 30.4 52.6 83.0 
    % within Statements 48.2% 51.8% 100.0% 
    % of Total 13.7% 14.7% 28.4% 
  agree Count 33 43 76 
    Expected Count 27.8 48.2 76.0 
    % within Statements 43.4% 56.6% 100.0% 
    % of Total 11.3% 14.7% 26.0% 
  neither agree 
nor disagree 
Count 
24 55 79 
    Expected Count 28.9 50.1 79.0 
    % within Statements 30.4% 69.6% 100.0% 
    % of Total 8.2% 18.8% 27.1% 
  disagree Count 5 22 27 
    Expected Count 9.9 17.1 27.0 
    % within Statements 18.5% 81.5% 100.0% 
    % of Total 1.7% 7.5% 9.2% 
  strongly 
disagree 
Count 
5 22 27 
    Expected Count 9.9 17.1 27.0 
    % within Statements 18.5% 81.5% 100.0% 
    % of Total 1.7% 7.5% 9.2% 
Total Count 107 185 292 
  Expected Count 107.0 185.0 292.0 
  % within Statements 36.6% 63.4% 100.0% 
  % of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 15.249(a) 4 .004 
Likelihood Ratio 15.945 4 .003 
Linear-by-Linear 
Association 
14.376 1 .000 
N of Valid Cases 
292     
a  0 cells (.0%) have expected count less than 5. The minimum expected count is 9.89. 
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    My HIV status is Total 
    Negative Positive Negative 
How do you 
feel about - 
HIV/AIDS is 
God's way of 
punishing the 
wicked 
strongly agree Count 
2 5 7 
    Expected Count 2.6 4.4 7.0 
    % within Statements 28.6% 71.4% 100.0% 
    % of Total .7% 1.7% 2.4% 
  agree Count 7 3 10 
    Expected Count 3.7 6.3 10.0 
    % within Statements 70.0% 30.0% 100.0% 
    % of Total 2.4% 1.0% 3.4% 
  neither agree 
nor disagree 
Count 
6 18 24 
    Expected Count 8.8 15.2 24.0 
    % within Statements 25.0% 75.0% 100.0% 
    % of Total 2.1% 6.2% 8.2% 
  disagree Count 14 39 53 
    Expected Count 19.4 33.6 53.0 
    % within Statements 26.4% 73.6% 100.0% 
    % of Total 4.8% 13.4% 18.2% 
  strongly 
disagree 
Count 
78 120 198 
    Expected Count 72.6 125.4 198.0 
    % within Statements 39.4% 60.6% 100.0% 
    % of Total 26.7% 41.1% 67.8% 
Total Count 107 185 292 
  Expected Count 107.0 185.0 292.0 
  % within Statements 36.6% 63.4% 100.0% 
  % of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 9.424(a) 4 .051 
Likelihood Ratio 9.413 4 .052 
Linear-by-Linear 
Association 
.173 1 .678 
N of Valid Cases 
292     
a  3 cells (30.0%) have expected count less than 5. The minimum expected count is 2.57. 
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    My HIV status is Total 
    Negative Positive Negative 
How do you 
feel about - 
People with 
HIV/AIDS 
deserve the 
same rights in 
the workplace 
as other 
workers 
strongly agree Count 
0 8 8 
    Expected Count 2.9 5.1 8.0 
    % within Statements .0% 100.0% 100.0% 
    % of Total .0% 2.7% 2.7% 
  agree Count 3 4 7 
    Expected Count 2.6 4.4 7.0 
    % within Statements 42.9% 57.1% 100.0% 
    % of Total 1.0% 1.4% 2.4% 
  neither agree 
nor disagree 
Count 
9 10 19 
    Expected Count 7.0 12.0 19.0 
    % within Statements 47.4% 52.6% 100.0% 
    % of Total 3.1% 3.4% 6.5% 
  disagree Count 29 28 57 
    Expected Count 20.9 36.1 57.0 
    % within Statements 50.9% 49.1% 100.0% 
    % of Total 9.9% 9.6% 19.5% 
  strongly 
disagree 
Count 
66 135 201 
    Expected Count 73.7 127.3 201.0 
    % within Statements 32.8% 67.2% 100.0% 
    % of Total 22.6% 46.2% 68.8% 
Total Count 107 185 292 
  Expected Count 107.0 185.0 292.0 
  % within Statements 36.6% 63.4% 100.0% 
  % of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 11.914(a) 4 .018 
Likelihood Ratio 14.388 4 .006 
Linear-by-Linear 
Association 
.054 1 .817 
N of Valid Cases 
292     
a  3 cells (30.0%) have expected count less than 5. The minimum expected count is 2.57. 
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    My HIV status is Total 
    Negative Positive Negative 
How do you 
feel about - 
Treating 
HIV/AIDS is a 
lucrative 
business for 
pharmaceutical 
companies 
strongly agree Count 
17 58 75 
    Expected Count 27.5 47.5 75.0 
    % within Statements 22.7% 77.3% 100.0% 
    % of Total 5.8% 19.9% 25.7% 
  agree Count 34 44 78 
    Expected Count 28.6 49.4 78.0 
    % within Statements 43.6% 56.4% 100.0% 
    % of Total 11.6% 15.1% 26.7% 
  neither agree 
nor disagree 
Count 
38 50 88 
    Expected Count 32.2 55.8 88.0 
    % within Statements 43.2% 56.8% 100.0% 
    % of Total 13.0% 17.1% 30.1% 
  disagree Count 12 15 27 
    Expected Count 9.9 17.1 27.0 
    % within Statements 44.4% 55.6% 100.0% 
    % of Total 4.1% 5.1% 9.2% 
  strongly 
disagree 
Count 
6 18 24 
    Expected Count 8.8 15.2 24.0 
    % within Statements 25.0% 75.0% 100.0% 
    % of Total 2.1% 6.2% 8.2% 
Total Count 107 185 292 
  Expected Count 107.0 185.0 292.0 
  % within Statements 36.6% 63.4% 100.0% 
  % of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 11.662(a) 4 .020 
Likelihood Ratio 12.139 4 .016 
Linear-by-Linear 
Association 
1.485 1 .223 
N of Valid Cases 
292     
a  0 cells (.0%) have expected count less than 5. The minimum expected count is 8.79. 
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    My HIV status is Total 
    Negative Positive Negative 
How do you 
feel about - I 
am not 
personally 
worried 
about getting 
HIV/AIDS 
strongly agree Count 
8 14 22 
    Expected Count 8.1 13.9 22.0 
    % within Statements 36.4% 63.6% 100.0% 
    % of Total 2.7% 4.8% 7.5% 
  agree Count 26 10 36 
    Expected Count 13.2 22.8 36.0 
    % within Statements 72.2% 27.8% 100.0% 
    % of Total 8.9% 3.4% 12.3% 
  neither agree 
nor disagree 
Count 
24 57 81 
    Expected Count 29.7 51.3 81.0 
    % within Statements 29.6% 70.4% 100.0% 
    % of Total 8.2% 19.5% 27.7% 
  disagree Count 23 40 63 
    Expected Count 23.1 39.9 63.0 
    % within Statements 36.5% 63.5% 100.0% 
    % of Total 7.9% 13.7% 21.6% 
  strongly 
disagree 
Count 
26 64 90 
    Expected Count 33.0 57.0 90.0 
    % within Statements 28.9% 71.1% 100.0% 
    % of Total 8.9% 21.9% 30.8% 
Total Count 107 185 292 
  Expected Count 107.0 185.0 292.0 
  % within Statements 36.6% 63.4% 100.0% 
  % of Total 36.6% 63.4% 100.0% 
  
Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 23.678(a) 4 .000 
Likelihood Ratio 22.979 4 .000 
Linear-by-Linear 
Association 
6.726 1 .010 
N of Valid Cases 
292     
a  0 cells (.0%) have expected count less than 5. The minimum expected count is 8.06. 
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PERCEPTION STATEMENTS VS. ETHNIC GROUP 
 
which group do you identify with? 
    
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/african 
american or 
negro hispanic 
White / 
caucasian multiracial other Total 
Count 3 1 27 9 9 7 2 58 
Expected Count 1.5 .7 20.9 9.1 21.7 3.1 1.0 58.0 
% within statements 5.2% 1.7% 46.6% 15.5% 15.5% 12.1% 3.4% 100.0% 
strongly agree 
% of Total .9% .3% 8.0% 2.7% 2.7% 2.1% .6% 17.1% 
Count 1 1 38 10 35 3 1 89 
Expected Count 2.4 1.1 32.0 13.9 33.3 4.7 1.6 89.0 
% within statements 1.1% 1.1% 42.7% 11.2% 39.3% 3.4% 1.1% 100.0% 
agree 
% of Total .3% .3% 11.2% 2.9% 10.3% .9% .3% 26.3% 
Count 2 2 44 22 62 7 3 142 
Expected Count 3.8 1.7 51.1 22.2 53.2 7.5 2.5 142.0 
% within statements 1.4% 1.4% 31.0% 15.5% 43.7% 4.9% 2.1% 100.0% 
neither agree nor 
disagree 
% of Total .6% .6% 13.0% 6.5% 18.3% 2.1% .9% 41.9% 
Count 2 0 8 7 13 0 0 30 
Expected Count .8 .4 10.8 4.7 11.2 1.6 .5 30.0 
% within statements 6.7% .0% 26.7% 23.3% 43.3% .0% .0% 100.0% 
disagree 
% of Total .6% .0% 2.4% 2.1% 3.8% .0% .0% 8.8% 
Count 1 0 5 5 8 1 0 20 
Expected Count .5 .2 7.2 3.1 7.5 1.1 .4 20.0 
% within statements 5.0% .0% 25.0% 25.0% 40.0% 5.0% .0% 100.0% 
How do you feel 
about - Alternative 
medical treatments 
for HIV/AIDS have 
shown promising 
results 
strongly disagree 
% of Total .3% .0% 1.5% 1.5% 2.4% .3% .0% 5.9% 
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Count 9 4 122 53 127 18 6 339 
Expected Count 9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
% within statements 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
Total 
% of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 33.366(a) 24 .097 
Likelihood Ratio 36.283 24 .052 
Linear-by-Linear 
Association 1.664 1 .197 
N of Valid Cases 
339     
a  21 cells (60.0%) have expected count less than 5. The minimum expected count is .24. 
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   Which group do you identify with? Total 
    
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/ 
african 
american 
or negro Hispanic 
white/ 
Caucasian multiracial other 
american 
indian, 
alaskan 
native, or 
pacific 
islander 
How do you 
feel about-
Poor people 
are more 
likely to get 
HIV/AIDS 
strongly 
agree 
Count 
2 0 6 3 4 2 0 17 
    Expected 
Count 
.5 .2 6.1 2.7 6.4 .9 .3 17.0 
    % within 
Statements 11.8% .0% 35.3% 17.6% 23.5% 11.8% .0% 100.0% 
    % of Total .6% .0% 1.8% .9% 1.2% .6% .0% 5.0% 
  agree Count 2 0 13 13 24 2 1 55 
    Expected 
Count 
1.5 .6 19.8 8.6 20.6 2.9 1.0 55.0 
    % within 
Statements 
3.6% .0% 23.6% 23.6% 43.6% 3.6% 1.8% 100.0% 
    % of Total .6% .0% 3.8% 3.8% 7.1% .6% .3% 16.2% 
  neither 
agree 
nor 
disagree 
Count 
3 1 33 7 25 4 0 73 
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    Expected 
Count 
1.9 .9 26.3 11.4 27.3 3.9 1.3 73.0 
    % within 
Statements 
4.1% 1.4% 45.2% 9.6% 34.2% 5.5% .0% 100.0% 
    % of Total .9% .3% 9.7% 2.1% 7.4% 1.2% .0% 21.5% 
  disagree Count 0 3 31 12 34 6 0 86 
    Expected 
Count 
2.3 1.0 30.9 13.4 32.2 4.6 1.5 86.0 
    % within 
Statements 
.0% 3.5% 36.0% 14.0% 39.5% 7.0% .0% 100.0% 
    % of Total .0% .9% 9.1% 3.5% 10.0% 1.8% .0% 25.4% 
  strongly 
disagree 
Count 
2 0 39 18 40 4 5 108 
    Expected 
Count 
2.9 1.3 38.9 16.9 40.5 5.7 1.9 108.0 
    % within 
Statements 
1.9% .0% 36.1% 16.7% 37.0% 3.7% 4.6% 100.0% 
    % of Total .6% .0% 11.5% 5.3% 11.8% 1.2% 1.5% 31.9% 
Total Count 9 4 122 53 127 18 6 339 
  Expected 
Count 
9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
  % within 
Statements 
2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
  % of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
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 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 35.416(a) 24 .062 
Likelihood Ratio 37.491 24 .039 
Linear-by-Linear 
Association 
.952 1 .329 
N of Valid Cases 
339     
a  20 cells (57.1%) have expected count less than 5. The minimum expected count is .20. 
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    Which group do you identify with? Total 
    
american 
indian, 
alaskan 
native, 
or 
pacific 
islander 
asian/asian 
american 
black/ 
african 
american 
or negro Hispanic 
white/ 
Caucasian multiracial other 
american 
indian, 
alaskan 
native, or 
pacific 
islander 
How do you 
feel about-
Globally the 
number of 
people with 
HIV/AIDS is 
decreasing 
strongly 
agree 
Count 
2 0 9 1 1 1 1 15 
    Expected 
Count 
.4 .2 5.4 2.3 5.6 .8 .3 15.0 
    % within 
Statements 13.3% .0% 60.0% 6.7% 6.7% 6.7% 6.7% 100.0% 
    % of Total .6% .0% 2.7% .3% .3% .3% .3% 4.4% 
  agree Count 1 0 6 4 4 0 0 15 
    Expected 
Count 
.4 .2 5.4 2.3 5.6 .8 .3 15.0 
    % within 
Statements 
6.7% .0% 40.0% 26.7% 26.7% .0% .0% 100.0% 
    % of Total .3% .0% 1.8% 1.2% 1.2% .0% .0% 4.4% 
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  neither 
agree 
nor 
disagree 
Count 
1 3 35 15 25 5 2 86 
    Expected 
Count 
2.3 1.0 30.9 13.4 32.2 4.6 1.5 86.0 
    % within 
Statements 
1.2% 3.5% 40.7% 17.4% 29.1% 5.8% 2.3% 100.0% 
    % of Total .3% .9% 10.3% 4.4% 7.4% 1.5% .6% 25.4% 
  disagree Count 2 1 35 12 48 4 0 102 
    Expected 
Count 
2.7 1.2 36.7 15.9 38.2 5.4 1.8 102.0 
    % within 
Statements 2.0% 1.0% 34.3% 11.8% 47.1% 3.9% .0% 100.0% 
    % of Total .6% .3% 10.3% 3.5% 14.2% 1.2% .0% 30.1% 
  strongly 
disagree 
Count 
3 0 37 21 49 8 3 121 
    Expected 
Count 
3.2 1.4 43.5 18.9 45.3 6.4 2.1 121.0 
    % within 
Statements 
2.5% .0% 30.6% 17.4% 40.5% 6.6% 2.5% 100.0% 
    % of Total .9% .0% 10.9% 6.2% 14.5% 2.4% .9% 35.7% 
Total Count 9 4 122 53 127 18 6 339 
  Expected 
Count 
9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
  % within 
Statements 
2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
  % of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
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 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 36.290(a) 24 .051 
Likelihood Ratio 37.135 24 .042 
Linear-by-Linear 
Association 
9.076 1 .003 
N of Valid Cases 
339     
a  20 cells (57.1%) have expected count less than 5. The minimum expected count is .18. 
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Which group do you identify with? 
   
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/ 
african 
american 
or negro Hispanic 
white/ 
Caucasian multiracial other Total 
Count 3 0 5 0 2 1 0 11 
Expected 
Count 
.3 .1 4.0 1.7 4.1 .6 .2 11.0 
% within 
Statements 27.3% .0% 45.5% .0% 18.2% 9.1% .0% 100.0% 
strongly 
agree 
% of Total .9% .0% 1.5% .0% .6% .3% .0% 3.2% 
Count 0 0 6 2 5 1 0 14 
Expected 
Count 
.4 .2 5.0 2.2 5.2 .7 .2 14.0 
% within 
Statements 
.0% .0% 42.9% 14.3% 35.7% 7.1% .0% 100.0% 
agree 
% of Total .0% .0% 1.8% .6% 1.5% .3% .0% 4.1% 
Count 3 1 11 4 13 2 0 34 
Expected 
Count 
.9 .4 12.2 5.3 12.7 1.8 .6 34.0 
% within 
Statements 
8.8% 2.9% 32.4% 11.8% 38.2% 5.9% .0% 100.0% 
neither 
agree nor 
disagree 
% of Total .9% .3% 3.2% 1.2% 3.8% .6% .0% 10.0% 
How do 
you feel 
about - 
HIV/AIDS 
is 
primarily 
a gay 
disease 
disagree Count 1 1 38 14 39 3 1 97 
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Expected 
Count 
2.6 1.1 34.9 15.2 36.3 5.2 1.7 97.0 
% within 
Statements 1.0% 1.0% 39.2% 14.4% 40.2% 3.1% 1.0% 100.0% 
  
% of Total .3% .3% 11.2% 4.1% 11.5% .9% .3% 28.6% 
Count 2 2 62 33 68 11 5 183 
Expected 
Count 
4.9 2.2 65.9 28.6 68.6 9.7 3.2 183.0 
% within 
Statements 
1.1% 1.1% 33.9% 18.0% 37.2% 6.0% 2.7% 100.0% 
  
strongly 
disagree 
% of Total .6% .6% 18.3% 9.7% 20.1% 3.2% 1.5% 54.0% 
Count 9 4 122 53 127 18 6 339 
Expected 
Count 
9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
% within 
Statements 
2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
Total 
% of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 43.208(a) 24 .009 
Likelihood Ratio 28.976 24 .221 
Linear-by-Linear 
Association 
7.353 1 .007 
N of Valid Cases 
339     
a  22 cells (62.9%) have expected count less than 5. The minimum expected count is .13. 
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Which group do you identify with? 
    
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/ 
african 
american 
or negro Hispanic 
white/ 
Caucasian multiracial other Total 
Count 3 0 5 5 2 1 0 16 
Expected 
Count 
.4 .2 5.8 2.5 6.0 .8 .3 16.0 
% within 
Statements 18.8% .0% 31.3% 31.3% 12.5% 6.3% .0% 100.0% 
strongly 
agree 
% of Total .9% .0% 1.5% 1.5% .6% .3% .0% 4.7% 
Count 1 0 7 2 2 0 0 12 
Expected 
Count 
.3 .1 4.3 1.9 4.5 .6 .2 12.0 
% within 
Statements 8.3% .0% 58.3% 16.7% 16.7% .0% .0% 100.0% 
agree 
% of Total .3% .0% 2.1% .6% .6% .0% .0% 3.5% 
Count 1 1 30 13 24 6 3 78 
Expected 
Count 
2.1 .9 28.1 12.2 29.2 4.1 1.4 78.0 
% within 
Statements 
1.3% 1.3% 38.5% 16.7% 30.8% 7.7% 3.8% 100.0% 
neither 
agree nor 
disagree 
% of Total .3% .3% 8.8% 3.8% 7.1% 1.8% .9% 23.0% 
Count 2 3 39 18 48 6 0 116 
How do 
you feel 
about- 
Antiretrov
iral drugs 
are a cure 
for 
HIV/AIDS 
disagree 
Expected 
3.1 1.4 41.7 18.1 43.5 6.2 2.1 116.0 
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Count 
% within 
Statements 1.7% 2.6% 33.6% 15.5% 41.4% 5.2% .0% 100.0% 
  
% of Total .6% .9% 11.5% 5.3% 14.2% 1.8% .0% 34.2% 
Count 2 0 41 15 51 5 3 117 
Expected 
Count 
3.1 1.4 42.1 18.3 43.8 6.2 2.1 117.0 
% within 
Statements 
1.7% .0% 35.0% 12.8% 43.6% 4.3% 2.6% 100.0% 
  
strongly 
disagree 
% of Total .6% .0% 12.1% 4.4% 15.0% 1.5% .9% 34.5% 
Count 9 4 122 53 127 18 6 339 
Expected 
Count 
9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
% within 
Statements 
2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
Total 
% of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 40.546(a) 24 .019 
Likelihood Ratio 35.501 24 .061 
Linear-by-Linear 
Association 
7.045 1 .008 
N of Valid Cases 
339     
a  22 cells (62.9%) have expected count less than 5. The minimum expected count is .14. 
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Which group do you identify with? 
    
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/ 
african 
american 
or negro Hispanic 
white/ 
Caucasian multiracial other Total 
Count 4 0 8 7 4 1 0 24 
Expected 
Count 
.6 .3 8.6 3.8 9.0 1.3 .4 24.0 
% within 
Statements 16.7% .0% 33.3% 29.2% 16.7% 4.2% .0% 100.0% 
strongly 
agree 
% of Total 1.2% .0% 2.4% 2.1% 1.2% .3% .0% 7.1% 
Count 0 0 17 6 15 1 0 39 
Expected 
Count 
1.0 .5 14.0 6.1 14.6 2.1 .7 39.0 
% within 
Statements 
.0% .0% 43.6% 15.4% 38.5% 2.6% .0% 100.0% 
agree 
% of Total .0% .0% 5.0% 1.8% 4.4% .3% .0% 11.5% 
Count 2 0 23 4 12 2 1 44 
Expected 
Count 
1.2 .5 15.8 6.9 16.5 2.3 .8 44.0 
% within 
Statements 
4.5% .0% 52.3% 9.1% 27.3% 4.5% 2.3% 100.0% 
neither 
agree nor 
disagree 
% of Total .6% .0% 6.8% 1.2% 3.5% .6% .3% 13.0% 
Count 1 3 40 20 64 6 3 137 
How do 
you feel 
about - 
You 
cannot get 
HIV/AIDS 
during sex 
if 
condoms 
are always 
used 
disagree 
Expected 
3.6 1.6 49.3 21.4 51.3 7.3 2.4 137.0 
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Count 
% within 
Statements 
.7% 2.2% 29.2% 14.6% 46.7% 4.4% 2.2% 100.0% 
  
% of Total .3% .9% 11.8% 5.9% 18.9% 1.8% .9% 40.4% 
Count 2 1 34 16 32 8 2 95 
Expected 
Count 
2.5 1.1 34.2 14.9 35.6 5.0 1.7 95.0 
% within 
Statements 2.1% 1.1% 35.8% 16.8% 33.7% 8.4% 2.1% 100.0% 
  
strongly 
disagree 
% of Total .6% .3% 10.0% 4.7% 9.4% 2.4% .6% 28.0% 
Count 9 4 122 53 127 18 6 339 
Expected 
Count 
9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
% within 
Statements 
2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
Total 
% of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 45.213(a) 24 .005 
Likelihood Ratio 39.125 24 .026 
Linear-by-Linear 
Association 
7.517 1 .006 
N of Valid Cases 
339     
a  19 cells (54.3%) have expected count less than 5. The minimum expected count is .28. 
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Which group do you identify with? 
    
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/ 
african 
american 
or negro Hispanic 
white/ 
Caucasian multiracial other Total 
Count 2 0 11 4 3 1 0 21 
Expected 
Count 
.6 .2 7.6 3.3 7.9 1.1 .4 21.0 
% within 
Statements 9.5% .0% 52.4% 19.0% 14.3% 4.8% .0% 100.0% 
strongly 
agree 
% of Total .6% .0% 3.2% 1.2% .9% .3% .0% 6.2% 
Count 0 0 16 7 5 2 0 30 
Expected 
Count 
.8 .4 10.8 4.7 11.2 1.6 .5 30.0 
% within 
Statements 
 .0% 53.3% 23.3% 16.7% 6.7% .0% 100.0% 
agree 
% of Total .0% .0% 4.7% 2.1% 1.5% .6% .0% 8.8% 
Count 1 1 50 16 30 5 4 107 
Expected 
Count 
2.8 1.3 38.5 16.7 40.1 5.7 1.9 107.0 
% within 
Statements .9% .9% 46.7% 15.0% 28.0% 4.7% 3.7% 100.0% 
neither 
agree nor 
disagree 
% of Total .3% .3% 14.7% 4.7% 8.8% 1.5% 1.2% 31.6% 
Count 5 3 22 16 47 6 0 99 
How do 
you feel 
about - An 
effective 
HIV/AIDS 
vaccine is 
available 
disagree 
Expected 
2.6 1.2 35.6 15.5 37.1 5.3 1.8 99.0 
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Count 
% within 
Statements 5.1% 3.0% 22.2% 16.2% 47.5% 6.1% .0% 100.0% 
  
% of Total 1.5% .9% 6.5% 4.7% 13.9% 1.8% .0% 29.2% 
Count 1 0 23 10 42 4 2 82 
Expected 
Count 
2.2 1.0 29.5 12.8 30.7 4.4 1.5 82.0 
% within 
Statements 1.2% .0% 28.0% 12.2% 51.2% 4.9% 2.4% 100.0% 
  
strongly 
disagree 
% of Total .3% .0% 6.8% 2.9% 12.4% 1.2% .6% 24.2% 
Count 9 4 122 53 127 18 6 339 
Expected 
Count 
9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
% within 
Statements 
2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
Total 
% of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 50.452(a) 24 .001 
Likelihood Ratio 54.079 24 .000 
Linear-by-Linear 
Association 
14.490 1 .000 
N of Valid Cases 
339     
a  20 cells (57.1%) have expected count less than 5. The minimum expected count is .25. 
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Which group do you identify with? 
    
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/ 
African 
American 
or negro Hispanic 
White / 
Caucasian multiracial other Total 
Count 2 0 33 6 35 6 2 84 
Expected 
Count 
2.2 1.0 30.2 13.1 31.5 4.5 1.5 84.0 
% within 
Statements 2.4% .0% 39.3% 7.1% 41.7% 7.1% 2.4% 100.0% 
strongly 
agree 
% of Total .6% .0% 9.7% 1.8% 10.3% 1.8% .6% 24.8% 
Count 2 0 25 16 45 3 1 92 
Expected 
Count 
2.4 1.1 33.1 14.4 34.5 4.9 1.6 92.0 
% within 
Statements 
2.2% .0% 27.2% 17.4% 48.9% 3.3% 1.1% 100.0% 
agree 
% of Total .6% .0% 7.4% 4.7% 13.3% .9% .3% 27.1% 
Count 3 3 45 13 33 7 3 107 
Expected 
Count 
2.8 1.3 38.5 16.7 40.1 5.7 1.9 107.0 
% within 
Statements 2.8% 2.8% 42.1% 12.1% 30.8% 6.5% 2.8% 100.0% 
neither 
agree nor 
disagree 
% of Total .9% .9% 13.3% 3.8% 9.7% 2.1% .9% 31.6% 
Count 1 1 10 8 10 0 0 30 
How do 
you feel 
about - 
Treating 
HIV/AIDS 
is a 
lucrative 
business 
for 
pharma-
ceutical 
companies 
disagree 
Expected 
.8 .4 10.8 4.7 11.2 1.6 .5 30.0 
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Count 
% within 
Statements 3.3% 3.3% 33.3% 26.7% 33.3% .0% .0% 100.0% 
  
% of Total .3% .3% 2.9% 2.4% 2.9% .0% .0% 8.8% 
Count 1 0 9 10 4 2 0 26 
Expected 
Count 
.7 .3 9.4 4.1 9.7 1.4 .5 26.0 
% within 
Statements 3.8% .0% 34.6% 38.5% 15.4% 7.7% .0% 100.0% 
  
strongly 
disagree 
% of Total .3% .0% 2.7% 2.9% 1.2% .6% .0% 7.7% 
Count 9 4 122 53 127 18 6 339 
Expected 
Count 
9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
% within 
Statements 
2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
Total 
% of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 39.433(a) 24 .025 
Likelihood Ratio 42.250 24 .012 
Linear-by-Linear 
Association 
4.052 1 .044 
N of Valid Cases 
339     
a  21 cells (60.0%) have expected count less than 5. The minimum expected count is .31. 
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Which group do you identify with? 
 
   
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/ 
african 
american 
or negro Hispanic 
white/ 
Caucasian multiracial other Total 
Count 4 0 9 0 9 3 1 26 
Expected 
Count 
.7 .3 9.4 4.1 9.7 1.4 .5 26.0 
% within 
Statements 
15.4% .0% 34.6% .0% 34.6% 11.5% 3.8% 100.0% 
strongly 
agree 
% of Total 1.2% .0% 2.7% .0% 2.7% .9% .3% 7.7% 
Count 0 0 10 10 17 2 2 41 
Expected 
Count 
1.1 .5 14.8 6.4 15.4 2.2 .7 41.0 
% within 
Statements 
.0% .0% 24.4% 24.4% 41.5% 4.9% 4.9% 100.0% 
agree 
% of Total .0% .0% 2.9% 2.9% 5.0% .6% .6% 12.1% 
Count 2 1 33 13 43 5 0 97 
Expected 
Count 
2.6 1.1 34.9 15.2 36.3 5.2 1.7 97.0 
% within 
Statements 
2.1% 1.0% 34.0% 13.4% 44.3% 5.2% .0% 100.0% 
neither 
agree nor 
disagree 
% of Total .6% .3% 9.7% 3.8% 12.7% 1.5% .0% 28.6% 
Count 1 2 31 11 27 4 1 77 
How do 
you feel 
about - I 
am not 
personally 
worried 
about 
getting 
HIV/AIDS 
disagree 
Expected 
Count 
2.0 .9 27.7 12.0 28.8 4.1 1.4 77.0 
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% within 
Statements 
1.3% 2.6% 40.3% 14.3% 35.1% 5.2% 1.3% 100.0% 
  
% of Total .3% .6% 9.1% 3.2% 8.0% 1.2% .3% 22.7% 
Count 2 1 39 19 31 4 2 98 
Expected 
Count 
2.6 1.2 35.3 15.3 36.7 5.2 1.7 98.0 
% within 
Statements 
2.0% 1.0% 39.8% 19.4% 31.6% 4.1% 2.0% 100.0% 
  
strongly 
disagree 
% of Total .6% .3% 11.5% 5.6% 9.1% 1.2% .6% 28.9% 
Count 9 4 122 53 127 18 6 339 
Expected 
Count 
9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
% within 
Statements 
2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
Total 
% of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
 
Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 39.077(a) 24 .027 
Likelihood Ratio 36.587 24 .048 
Linear-by-Linear 
Association 
1.067 1 .302 
N of Valid Cases 
339     
a  19 cells (54.3%) have expected count less than 5. The minimum expected count is .31. 
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    Which group do you identify with? Total 
    
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/ 
african 
american 
or negro Hispanic 
white/ 
Caucasian multiracial other 
american 
indian, 
alaskan 
native, or 
pacific 
islander 
How do you 
feel about - 
Worldwide, 
more people 
get 
HIV/AIDS 
by 
heterosexual 
contact than 
by 
homosexual 
contact 
strongly 
agree 
Count 
1 0 15 8 6 2 0 32 
    Expected 
Count 
.8 .4 11.5 5.0 12.0 1.7 .6 32.0 
    % within 
Statements 3.1% .0% 46.9% 25.0% 18.8% 6.3% .0% 100.0% 
    % of Total .3% .0% 4.4% 2.4% 1.8% .6% .0% 9.4% 
  agree Count 0 2 23 5 13 1 0 44 
    Expected 
Count 
1.2 .5 15.8 6.9 16.5 2.3 .8 44.0 
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    % within 
Statements 
.0% 4.5% 52.3% 11.4% 29.5% 2.3% .0% 100.0% 
    % of Total .0% .6% 6.8% 1.5% 3.8% .3% .0% 13.0% 
  neither 
agree 
nor 
disagree 
Count 
2 2 52 27 50 8 4 145 
    Expected 
Count 
3.8 1.7 52.2 22.7 54.3 7.7 2.6 145.0 
    % within 
Statements 
1.4% 1.4% 35.9% 18.6% 34.5% 5.5% 2.8% 100.0% 
    % of Total .6% .6% 15.3% 8.0% 14.7% 2.4% 1.2% 42.8% 
  disagree Count 2 0 22 9 39 5 1 78 
    Expected 
Count 
2.1 .9 28.1 12.2 29.2 4.1 1.4 78.0 
    % within 
Statements 
2.6% .0% 28.2% 11.5% 50.0% 6.4% 1.3% 100.0% 
    % of Total .6% .0% 6.5% 2.7% 11.5% 1.5% .3% 23.0% 
  strongly 
disagree 
Count 
4 0 10 4 19 2 1 40 
    Expected 
Count 
1.1 .5 14.4 6.3 15.0 2.1 .7 40.0 
    % within 
Statements 
10.0% .0% 25.0% 10.0% 47.5% 5.0% 2.5% 100.0% 
    % of Total 1.2% .0% 2.9% 1.2% 5.6% .6% .3% 11.8% 
Total Count 9 4 122 53 127 18 6 339 
  Expected 
Count 
9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
  % within 
Statements 
2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
  % of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
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 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 39.799(a) 24 .022 
Likelihood Ratio 39.215 24 .026 
Linear-by-Linear 
Association 
5.690 1 .017 
N of Valid Cases 
339     
a  19 cells (54.3%) have expected count less than 5. The minimum expected count is .38. 
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PERCEPTION STATEMENTS VS. AGE 
 
Age group 
    18-25 26-36 37-47 48-58 59 + Total 
Count 1 6 3 1 0 11 
Expected Count 1.7 2.9 3.3 2.5 .6 11.0 
% within Statements 9.1% 54.5% 27.3% 9.1% .0% 100.0% 
strongly agree 
% of Total .3% 1.8% .9% .3% .0% 3.2% 
Count 5 1 5 2 1 14 
Expected Count 2.2 3.7 4.2 3.2 .7 14.0 
% within Statements 35.7% 7.1% 35.7% 14.3% 7.1% 100.0% 
agree 
% of Total 1.5% .3% 1.5% .6% .3% 4.1% 
Count 10 5 11 5 2 33 
Expected Count 5.1 8.6 10.0 7.5 1.7 33.0 
% within Statements 30.3% 15.2% 33.3% 15.2% 6.1% 100.0% 
neither agree nor 
disagree 
% of Total 2.9% 1.5% 3.2% 1.5% .6% 9.7% 
Count 15 17 31 29 5 97 
Expected Count 15.1 25.4 29.4 22.0 5.1 97.0 
% within Statements 15.5% 17.5% 32.0% 29.9% 5.2% 100.0% 
disagree 
% of Total 4.4% 5.0% 9.1% 8.5% 1.5% 28.5% 
Count 22 60 53 40 10 185 
Expected Count 28.8 48.4 56.0 41.9 9.8 185.0 
% within Statements 11.9% 32.4% 28.6% 21.6% 5.4% 100.0% 
How do you 
feel about - 
HIV/AIDS is 
primarily a 
gay disease 
strongly disagree 
% of Total 6.5% 17.6% 15.6% 11.8% 2.9% 54.4% 
Count 53 89 103 77 18 340 
Expected Count 53.0 89.0 103.0 77.0 18.0 340.0 
% within Statements 15.6% 26.2% 30.3% 22.6% 5.3% 100.0% 
Total 
% of Total 15.6% 26.2% 30.3% 22.6% 5.3% 100.0% 
 
F 62 
 
 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 28.254(a) 16 .029 
Likelihood Ratio 27.695 16 .034 
Linear-by-Linear 
Association 
1.894 1 .169 
N of Valid Cases 
340     
a  11 cells (44.0%) have expected count less than 5. The minimum expected count is .58. 
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Age group 
    18-25 26-36 37-47 48-58 59 + Total 
Count 11 14 17 17 0 59 
Expected Count 9.2 15.4 17.9 13.4 3.1 59.0 
% within Statements 18.6% 23.7% 28.8% 28.8% .0% 100.0% 
strongly agree 
% of Total 3.2% 4.1% 5.0% 5.0% .0% 17.4% 
Count 11 19 34 20 4 88 
Expected Count 13.7 23.0 26.7 19.9 4.7 88.0 
% within Statements 12.5% 21.6% 38.6% 22.7% 4.5% 100.0% 
agree 
% of Total 3.2% 5.6% 10.0% 5.9% 1.2% 25.9% 
Count 24 44 45 25 5 143 
Expected Count 22.3 37.4 43.3 32.4 7.6 143.0 
% within Statements 16.8% 30.8% 31.5% 17.5% 3.5% 100.0% 
neither agree nor 
disagree 
% of Total 7.1% 12.9% 13.2% 7.4% 1.5% 42.1% 
Count 4 8 1 11 6 30 
Expected Count 4.7 7.9 9.1 6.8 1.6 30.0 
% within Statements 13.3% 26.7% 3.3% 36.7% 20.0% 100.0% 
disagree 
% of Total 1.2% 2.4% .3% 3.2% 1.8% 8.8% 
Count 3 4 6 4 3 20 
Expected Count 3.1 5.2 6.1 4.5 1.1 20.0 
% within Statements 15.0% 20.0% 30.0% 20.0% 15.0% 100.0% 
How do you feel 
about - Alternative 
medical treatments 
for HIV/AIDS 
have shown 
promising results 
strongly disagree 
% of Total .9% 1.2% 1.8% 1.2% .9% 5.9% 
Count 53 89 103 77 18 340 
Expected Count 53.0 89.0 103.0 77.0 18.0 340.0 
% within Statements 15.6% 26.2% 30.3% 22.6% 5.3% 100.0% 
Total 
% of Total 15.6% 26.2% 30.3% 22.6% 5.3% 100.0% 
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 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 37.986(a) 16 .002 
Likelihood Ratio 39.001 16 .001 
Linear-by-Linear 
Association 
1.318 1 .251 
N of Valid Cases 
340     
a  7 cells (28.0%) have expected count less than 5. The minimum expected count is 1.06. 
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PERCEPTION STATEMENTS VS. SEXUAL ORIENTATION 
 
sexual orientation 
    
Heterosex
ual 
Homosex
ual Bi-sexual Total 
Count 12 5 1 18 
Expected Count 8.4 7.6 2.0 18.0 
% within Statements 66.7% 27.8% 5.6% 100.0% 
strongly agree 
% of Total 3.9% 1.6% .3% 5.8% 
Count 8 12 0 20 
Expected Count 9.4 8.4 2.2 20.0 
% within Statements 40.0% 60.0% .0% 100.0% 
agree 
% of Total 2.6% 3.9% .0% 6.5% 
Count 19 31 9 59 
Expected Count 27.7 24.8 6.5 59.0 
% within Statements 32.2% 52.5% 15.3% 100.0% 
neither agree nor 
disagree 
% of Total 6.1% 10.0% 2.9% 19.1% 
Count 55 36 17 108 
Expected Count 50.7 45.4 11.9 108.0 
% within Statements 50.9% 33.3% 15.7% 100.0% 
disagree 
% of Total 17.8% 11.7% 5.5% 35.0% 
Count 51 46 7 104 
Expected Count 48.8 43.8 11.4 104.0 
% within Statements 49.0% 44.2% 6.7% 100.0% 
How to you feel 
about - A pregnant 
woman with 
HIV/AIDS cannot 
avoid having an 
HIV-positive baby 
strongly disagree 
% of Total 16.5% 14.9% 2.3% 33.7% 
Count 145 130 34 309 
Expected Count 145.0 130.0 34.0 309.0 
% within Statements 46.9% 42.1% 11.0% 100.0% 
Total 
% of Total 46.9% 42.1% 11.0% 100.0% 
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 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 16.908(a) 8 .031 
Likelihood Ratio 17.302 8 .027 
Linear-by-Linear 
Association 
3.753 1 .053 
N of Valid Cases 
309     
a  2 cells (13.3%) have expected count less than 5. The minimum expected count is 3.52. 
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    Heterosexual Homosexual Bi-sexual 1.00 
How do you feel 
about - Worldwide, 
more people get 
HIV/AIDS by 
heterosexual contact 
than by homosexual 
contact 
strongly agree Count 
15 12 0 27 
    Expected Count 12.7 11.4 3.0 27.0 
    % within Statements 55.6% 44.4% .0% 100.0% 
    % of Total 4.9% 3.9% .0% 8.7% 
  agree Count 17 18 6 41 
    Expected Count 19.2 17.2 4.5 41.0 
    % within Statements 41.5% 43.9% 14.6% 100.0% 
    % of Total 5.5% 5.8% 1.9% 13.3% 
  neither agree 
nor disagree 
Count 
60 53 21 134 
    Expected Count 62.9 56.4 14.7 134.0 
    % within Statements 44.8% 39.6% 15.7% 100.0% 
    % of Total 19.4% 17.2% 6.8% 43.4% 
  disagree Count 39 26 4 69 
    Expected Count 32.4 29.0 7.6 69.0 
    % within Statements 56.5% 37.7% 5.8% 100.0% 
    % of Total 12.6% 8.4% 1.3% 22.3% 
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  strongly 
disagree 
Count 
14 21 3 38 
    Expected Count 17.8 16.0 4.2 38.0 
    % within Statements 36.8% 55.3% 7.9% 100.0% 
    % of Total 4.5% 6.8% 1.0% 12.3% 
Total Count 145 130 34 309 
  Expected Count 145.0 130.0 34.0 309.0 
  % within Statements 46.9% 42.1% 11.0% 100.0% 
  % of Total 46.9% 42.1% 11.0% 100.0% 
 
Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 13.307(a) 8 .102 
Likelihood Ratio 16.158 8 .040 
Linear-by-Linear 
Association 
.024 1 .878 
N of Valid Cases 
309     
a  3 cells (20.0%) have expected count less than 5. The minimum expected count is 2.97. 
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    sexual orientation Total 
    heterosexual homosexual bi-sexual 1.00 
How do you feel about - 
It is biologically easier 
for woman to get 
HIV/AIDS than it is for 
men 
strongly agree Count 
22 7 3 32 
    Expected Count 15.0 13.5 3.5 32.0 
    % within statements 68.8% 21.9% 9.4% 100.0% 
    % of Total 7.1% 2.3% 1.0% 10.4% 
  agree Count 19 10 6 35 
    Expected Count 16.4 14.7 3.9 35.0 
    % within statements 54.3% 28.6% 17.1% 100.0% 
    % of Total 6.1% 3.2% 1.9% 11.3% 
  neither agree nor 
disagree 
Count 56 47 12 115 
    Expected Count 54.0 48.4 12.7 115.0 
    % within statements 48.7% 40.9% 10.4% 100.0% 
    % of Total 18.1% 15.2% 3.9% 37.2% 
  disagree Count 23 32 9 64 
    Expected Count 30.0 26.9 7.0 64.0 
    % within statements 35.9% 50.0% 14.1% 100.0% 
    % of Total 7.4% 10.4% 2.9% 20.7% 
  strongly disagree Count 25 34 4 63 
    Expected Count 29.6 26.5 6.9 63.0 
    % within statements 39.7% 54.0% 6.3% 100.0% 
    % of Total 8.1% 11.0% 1.3% 20.4% 
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Total Count 145 130 34 309 
  Expected Count 145.0 130.0 34.0 309.0 
  % within statements 46.9% 42.1% 11.0% 100.0% 
  % of Total 46.9% 42.1% 11.0% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 16.908(a) 8 .031 
Likelihood Ratio 17.302 8 .027 
Linear-by-Linear 
Association 3.753 1 .053 
N of Valid Cases 
309     
a  2 cells (13.3%) have expected count less than 5. The minimum expected count is 3.52. 
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CROSSTABS:  
TREATMENTS KNOWN AND DEMOGRAPHIC VARIABLES 
 
TREATMENTS KNOWN VS. SEXUAL ORIENTATION 
  
    sexual orientation Total 
    Heterosexual Homosexual Bi-sexual 1.00 
treatments 
that you 
have heard 
of - 
Chelation-
IV 
not 
selected 
Count 
143 122 34 299 
    Expected Count 140.3 125.8 32.9 299.0 
    % within 
treatments  47.8% 40.8% 11.4% 100.0% 
    % of Total 46.3% 39.5% 11.0% 96.8% 
  selected Count 2 8 0 10 
    Expected Count 4.7 4.2 1.1 10.0 
    % within 
treatments  20.0% 80.0% .0% 100.0% 
    % of Total .6% 2.6% .0% 3.2% 
Total Count 145 130 34 309 
  Expected Count 145.0 130.0 34.0 309.0 
  % within 
treatments  
46.9% 42.1% 11.0% 100.0% 
  % of Total 46.9% 42.1% 11.0% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 6.268(a) 2 .044 
Likelihood Ratio 7.075 2 .029 
Linear-by-Linear 
Association 
.580 1 .446 
N of Valid Cases 
309     
a  3 cells (50.0%) have expected count less than 5. The minimum expected count is 1.10. 
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    sexual orientation Total 
    Heter Homo 
Bi-
sexual 1.00 
treatments that you 
have heard of - 
Nutritional 
supplements 
not 
selected 
Count 
121 84 25 230 
    Expected Count 107.9 96.8 25.3 230.0 
    % within treatments  52.6% 36.5% 10.9% 100.0% 
    % of Total 39.2% 27.2% 8.1% 74.4% 
  selected Count 24 46 9 79 
    Expected Count 37.1 33.2 8.7 79.0 
    % within treatments  30.4% 58.2% 11.4% 100.0% 
    % of Total 7.8% 14.9% 2.9% 25.6% 
Total Count 145 130 34 309 
  Expected Count 145.0 130.0 34.0 309.0 
  % within treatments  46.9% 42.1% 11.0% 100.0% 
  % of Total 46.9% 42.1% 11.0% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 12.792(a) 2 .002 
Likelihood Ratio 12.945 2 .002 
Linear-by-Linear 
Association 
6.739 1 .009 
N of Valid Cases 
309     
a  0 cells (.0%) have expected count less than 5. The minimum expected count is 8.69. 
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    sexual orientation Total 
    Heter Homo 
Bi-
sexual 1.00 
treatments that you 
have heard of – AZT 
(Azidothymidine) 
not 
selected 
Count 
82 46 17 145 
    Expected Count 68.0 61.0 16.0 145.0 
    % within treatments  56.6% 31.7% 11.7% 100.0% 
    % of Total 26.5% 14.9% 5.5% 46.9% 
  selected Count 63 84 17 164 
    Expected Count 77.0 69.0 18.0 164.0 
    % within treatments  38.4% 51.2% 10.4% 100.0% 
    % of Total 20.4% 27.2% 5.5% 53.1% 
Total Count 145 130 34 309 
  Expected Count 145.0 130.0 34.0 309.0 
  % within treatments  46.9% 42.1% 11.0% 100.0% 
  % of Total 46.9% 42.1% 11.0% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 12.476(a) 2 .002 
Likelihood Ratio 12.599 2 .002 
Linear-by-Linear 
Association 
4.796 1 .029 
N of Valid Cases 
309     
a  0 cells (.0%) have expected count less than 5. The minimum expected count is 15.95. 
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    sexual orientation Total 
    Heter Homo 
Bi-
sexual 1.00 
treatments that you have 
heard of - 
Pharmaceutical 
antibodies (bactrim, etc) 
not 
selected 
Count 
103 67 21 191 
    Expected Count 89.6 80.4 21.0 191.0 
    % within treatments  53.9% 35.1% 11.0% 100.0% 
    % of Total 33.3% 21.7% 6.8% 61.8% 
  selected Count 42 63 13 118 
    Expected Count 55.4 49.6 13.0 118.0 
    % within treatments  35.6% 53.4% 11.0% 100.0% 
    % of Total 13.6% 20.4% 4.2% 38.2% 
Total Count 145 130 34 309 
  Expected Count 145.0 130.0 34.0 309.0 
  % within treatments  46.9% 42.1% 11.0% 100.0% 
  % of Total 46.9% 42.1% 11.0% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 11.038(a) 2 .004 
Likelihood Ratio 11.091 2 .004 
Linear-by-Linear 
Association 
5.441 1 .020 
N of Valid Cases 
309     
a  0 cells (.0%) have expected count less than 5. The minimum expected count is 12.98. 
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TREATMENTS KNOWN VS, STATUS 
  
My HIV status is 
    Negative Positive Total 
Count 95 144 239 
Expected Count 87.6 151.4 239.0 
% within 
treatments  
39.7% 60.3% 100.0% 
not selected 
% of Total 32.5% 49.3% 81.8% 
Count 12 41 53 
Expected Count 19.4 33.6 53.0 
% within 
treatments  
22.6% 77.4% 100.0% 
treatments that you 
have heard of - 
Vitamins-Oral 
selected 
% of Total 4.1% 14.0% 18.2% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within 
treatments  
36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 5.469(b) 1 .019     
Continuity 
Correction(a) 
4.756 1 .029     
Likelihood Ratio 5.800 1 .016     
Fisher's Exact Test       .027 .013 
Linear-by-Linear 
Association 
5.450 1 .020     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 19.42. 
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My HIV status is 
    Negative Positive Total 
Count 100 160 260 
Expected Count 95.3 164.7 260.0 
% within 
treatments  
38.5% 61.5% 100.0% 
not selected 
% of Total 34.2% 54.8% 89.0% 
Count 7 25 32 
Expected Count 11.7 20.3 32.0 
% within 
treatments  
21.9% 78.1% 100.0% 
treatments that you 
have heard of - 
Minerals-Oral 
selected 
% of Total 2.4% 8.6% 11.0% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within 
treatments  
36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 3.376(b) 1 .066     
Continuity 
Correction(a) 
2.700 1 .100     
Likelihood Ratio 3.622 1 .057     
Fisher's Exact Test       .080 .047 
Linear-by-Linear 
Association 
3.365 1 .067     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 11.73. 
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My HIV status is 
    Negative Positive Total 
Count 106 175 281 
Expected Count 103.0 178.0 281.0 
% within 
treatments  
37.7% 62.3% 100.0% 
not selected 
% of Total 36.3% 59.9% 96.2% 
Count 1 10 11 
Expected Count 4.0 7.0 11.0 
% within 
treatments  
9.1% 90.9% 100.0% 
treatments that you 
have heard of - 
Peroxide-IV 
selected 
% of Total .3% 3.4% 3.8% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within 
treatments  
36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 3.738(b) 1 .053     
Continuity 
Correction(a) 
2.606 1 .106     
Likelihood Ratio 4.574 1 .032     
Fisher's Exact Test       .060 .046 
Linear-by-Linear 
Association 
3.725 1 .054     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  1 cells (25.0%) have expected count less than 5. The minimum expected count is 4.03. 
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My HIV status is 
    Negative Positive Total 
Count 106 176 282 
Expected Count 103.3 178.7 282.0 
% within 
treatments  
37.6% 62.4% 100.0% 
not selected 
% of Total 36.3% 60.3% 96.6% 
Count 1 9 10 
Expected Count 3.7 6.3 10.0 
% within 
treatments  10.0% 90.0% 100.0% 
treatments that you 
have heard of - 
Peroxide-Oral 
selected 
% of Total .3% 3.1% 3.4% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within 
treatments  
36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 3.166(b) 1 .075     
Continuity 
Correction(a) 
2.089 1 .148     
Likelihood Ratio 3.829 1 .050     
Fisher's Exact Test       .099 .067 
Linear-by-Linear 
Association 
3.155 1 .076     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  1 cells (25.0%) have expected count less than 5. The minimum expected count is 3.66. 
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My HIV status is 
    Negative Positive Total 
Count 89 127 216 
Expected Count 79.2 136.8 216.0 
% within treatments  41.2% 58.8% 100.0% 
not selected 
% of Total 30.5% 43.5% 74.0% 
Count 18 58 76 
Expected Count 27.8 48.2 76.0 
% within treatments  23.7% 76.3% 100.0% 
treatments that you 
have heard of - 
Nutritional 
supplements 
selected 
% of Total 6.2% 19.9% 26.0% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within treatments  36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 7.433(b) 1 .006     
Continuity 
Correction(a) 
6.697 1 .010     
Likelihood Ratio 7.781 1 .005     
Fisher's Exact Test       .008 .004 
Linear-by-Linear 
Association 
7.407 1 .006     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 27.85. 
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My HIV status is 
    Negative Positive Total 
Count 68 67 135 
Expected Count 49.5 85.5 135.0 
% within treatments  50.4% 49.6% 100.0% 
not selected 
% of Total 23.3% 22.9% 46.2% 
Count 39 118 157 
Expected Count 57.5 99.5 157.0 
% within treatments  24.8% 75.2% 100.0% 
treatments that you 
have heard of – AZT 
(azidothymidine) 
selected 
% of Total 13.4% 40.4% 53.8% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within treatments  36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 20.377(b) 1 .000     
Continuity 
Correction(a) 
19.293 1 .000     
Likelihood Ratio 20.543 1 .000     
Fisher's Exact Test       .000 .000 
Linear-by-Linear 
Association 
20.308 1 .000     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 49.47. 
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My HIV status is 
    Negative Positive Total 
Count 75 93 168 
Expected Count 61.6 106.4 168.0 
% within treatments  44.6% 55.4% 100.0% 
not selected 
% of Total 25.7% 31.8% 57.5% 
Count 32 92 124 
Expected Count 45.4 78.6 124.0 
% within treatments  25.8% 74.2% 100.0% 
treatments that you 
have heard of - 
HAART (Highly 
active antiretroviral 
therapy) 
selected 
% of Total 11.0% 31.5% 42.5% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within treatments  36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 10.903(b) 1 .001     
Continuity 
Correction(a) 
10.107 1 .001     
Likelihood Ratio 11.128 1 .001     
Fisher's Exact Test       .001 .001 
Linear-by-Linear 
Association 
10.866 1 .001     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 45.44. 
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My HIV status is 
    Negative Positive Total 
Count 82 96 178 
Expected Count 65.2 112.8 178.0 
% within treatments  46.1% 53.9% 100.0% 
not selected 
% of Total 28.1% 32.9% 61.0% 
Count 25 89 114 
Expected Count 41.8 72.2 114.0 
% within treatments  21.9% 78.1% 100.0% 
treatments that you have 
heard of - 
Pharmaceutical 
antibodies (bactrim, etc) 
selected 
% of Total 8.6% 30.5% 39.0% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within treatments  36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 17.440(b) 1 .000     
Continuity 
Correction(a) 
16.416 1 .000     
Likelihood Ratio 18.117 1 .000     
Fisher's Exact Test       .000 .000 
Linear-by-Linear 
Association 
17.380 1 .000     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 41.77. 
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TREATMENTS KNOWN VS. ETHNIC GROUP 
 
Which group do you identify with? 
    
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/ 
african 
american 
or negro Hispanic 
white/ 
Caucasian multiracial other Total 
Count 7 4 111 45 93 13 6 279 
Expected 
Count 
7.4 3.3 100.4 43.6 104.5 14.8 4.9 279.0 
% within 
treatments  
2.5% 1.4% 39.8% 16.1% 33.3% 4.7% 2.2% 100.0% 
not 
selected 
% of Total 2.1% 1.2% 32.7% 13.3% 27.4% 3.8% 1.8% 82.3% 
Count 2 0 11 8 34 5 0 60 
Expected 
Count 
1.6 .7 21.6 9.4 22.5 3.2 1.1 60.0 
% within 
treatments  
3.3% .0% 18.3% 13.3% 56.7% 8.3% .0% 100.0% 
treatments 
that you 
have heard 
of - 
Vitamins-
Oral 
selected 
% of Total .6% .0% 3.2% 2.4% 10.0% 1.5% .0% 17.7% 
Count 9 4 122 53 127 18 6 339 
Expected 
Count 
9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
% within 
treatments  
2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
Total 
% of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
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 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 17.270(a) 6 .008 
Likelihood Ratio 19.226 6 .004 
Linear-by-Linear 
Association 
7.534 1 .006 
N of Valid Cases 
339     
a  6 cells (42.9%) have expected count less than 5. The minimum expected count is .71. 
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Which group do you identify with? 
    
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/ 
african 
american 
or negro Hispanic 
white/ 
Caucasian multiracial other Total 
Count 7 4 119 53 121 17 6 327 
Expected 
Count 
8.7 3.9 117.7 51.1 122.5 17.4 5.8 327.0 
% within 
treatments  
2.1% 1.2% 36.4% 16.2% 37.0% 5.2% 1.8% 100.0% 
not 
selected 
% of Total 2.1% 1.2% 35.1% 15.6% 35.7% 5.0% 1.8% 96.5% 
Count 2 0 3 0 6 1 0 12 
Expected 
Count 
.3 .1 4.3 1.9 4.5 .6 .2 12.0 
% within 
treatments  
16.7% .0% 25.0% .0% 50.0% 8.3% .0% 100.0% 
treatments 
that you 
have heard 
of - 
Peroxide-
Oral 
selected 
% of Total .6% .0% .9% .0% 1.8% .3% .0% 3.5% 
Count 9 4 122 53 127 18 6 339 
Expected 
Count 
9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
% within 
treatments  
2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
Total 
% of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
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 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 12.665(a) 6 .049 
Likelihood Ratio 9.998 6 .125 
Linear-by-Linear 
Association 
.212 1 .645 
N of Valid Cases 
339     
a  8 cells (57.1%) have expected count less than 5. The minimum expected count is .14. 
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    Which group do you identify with? Total 
    
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/ 
african 
american 
or negro Hispanic 
white/ 
Caucasian multiracial other 
american 
indian, 
alaskan 
native, or 
pacific 
islander 
treatments 
that you 
have heard 
of - Porcine 
(pig) liver 
extracts-
transdermal 
not 
selected 
Count 
8 4 119 52 127 18 5 333 
    Expected 
Count 
8.8 3.9 119.8 52.1 124.8 17.7 5.9 333.0 
    % within 
treatments  
2.4% 1.2% 35.7% 15.6% 38.1% 5.4% 1.5% 100.0% 
    % of Total 2.4% 1.2% 35.1% 15.3% 37.5% 5.3% 1.5% 98.2% 
  selected Count 1 0 3 1 0 0 1 6 
    Expected 
Count 
.2 .1 2.2 .9 2.2 .3 .1 6.0 
    % within 
treatments  
16.7% .0% 50.0% 16.7% .0% .0% 16.7% 100.0% 
    % of Total .3% .0% .9% .3% .0% .0% .3% 1.8% 
Total Count 9 4 122 53 127 18 6 339 
  Expected 
Count 
9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
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  % within 
treatments  
2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
  % of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 15.197(a) 6 .019 
Likelihood Ratio 10.539 6 .104 
Linear-by-Linear 
Association 
1.430 1 .232 
N of Valid Cases 
339     
a  8 cells (57.1%) have expected count less than 5. The minimum expected count is .07. 
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    Which group do you identify with? Total 
    
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/ 
african 
american 
or negro Hispanic 
white/ 
Caucasian multiracial other 
american 
indian, 
alaskan 
native, or 
pacific 
islander 
treatments 
that you 
have heard 
of - 
Nutritional 
supplements 
not 
selected 
Count 
7 4 101 44 86 9 5 256 
    Expected 
Count 
6.8 3.0 92.1 40.0 95.9 13.6 4.5 256.0 
    % within 
treatments  
2.7% 1.6% 39.5% 17.2% 33.6% 3.5% 2.0% 100.0% 
    % of Total 2.1% 1.2% 29.8% 13.0% 25.4% 2.7% 1.5% 75.5% 
  selected Count 2 0 21 9 41 9 1 83 
    Expected 
Count 
2.2 1.0 29.9 13.0 31.1 4.4 1.5 83.0 
    % within 
treatments  
2.4% .0% 25.3% 10.8% 49.4% 10.8% 1.2% 100.0% 
    % of Total .6% .0% 6.2% 2.7% 12.1% 2.7% .3% 24.5% 
Total Count 9 4 122 53 127 18 6 339 
  Expected 
Count 
9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
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  % within 
treatments  
2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
  % of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 17.139(a) 6 .009 
Likelihood Ratio 17.363 6 .008 
Linear-by-Linear 
Association 
9.726 1 .002 
N of Valid Cases 
339     
a  6 cells (42.9%) have expected count less than 5. The minimum expected count is .98. 
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TREATMENTS KNOWN VS. AGE 
 
     Age group Total 
    18-25 26-36 37-47 48-58 59 + 18-25 
treatments that you 
have heard of – AZT 
(Azidothymidine) 
not 
selected 
 
Count 37 47 42 31 8 165 
    Expected Count 25.7 43.2 50.0 37.4 8.7 165.0 
    % within treatments  22.4% 28.5% 25.5% 18.8% 4.8% 100.0% 
    % of Total 10.9% 13.8% 12.4% 9.1% 2.4% 48.5% 
  selected Count 16 42 61 46 10 175 
    Expected Count 27.3 45.8 53.0 39.6 9.3 175.0 
    % within treatments  9.1% 24.0% 34.9% 26.3% 5.7% 100.0% 
    % of Total 4.7% 12.4% 17.9% 13.5% 2.9% 51.5% 
Total Count 53 89 103 77 18 340 
  Expected Count 53.0 89.0 103.0 77.0 18.0 340.0 
  % within treatments  15.6% 26.2% 30.3% 22.6% 5.3% 100.0% 
  % of Total 15.6% 26.2% 30.3% 22.6% 5.3% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 14.970(a) 4 .005 
Likelihood Ratio 15.229 4 .004 
Linear-by-Linear 
Association 
10.856 1 .001 
N of Valid Cases 
340     
a  0 cells (.0%) have expected count less than 5. The minimum expected count is 8.74. 
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Age group 
    18-25 26-36 37-47 48-58 59 + Total 
Count 43 59 53 49 12 216 
Expected Count 33.7 56.5 65.4 48.9 11.4 216.0 
% within treatments  19.9% 27.3% 24.5% 22.7% 5.6% 100.0% 
not selected 
% of Total 12.6% 17.4% 15.6% 14.4% 3.5% 63.5% 
Count 10 30 50 28 6 124 
Expected Count 19.3 32.5 37.6 28.1 6.6 124.0 
% within treatments  8.1% 24.2% 40.3% 22.6% 4.8% 100.0% 
Treatments that you 
have heard of - 
Pharmaceutical 
antibodies (bactrim, etc) 
selected 
% of Total 2.9% 8.8% 14.7% 8.2% 1.8% 36.5% 
Count 53 89 103 77 18 340 
Expected Count 53.0 89.0 103.0 77.0 18.0 340.0 
% within treatments  15.6% 26.2% 30.3% 22.6% 5.3% 100.0% 
Total 
% of Total 15.6% 26.2% 30.3% 22.6% 5.3% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 13.938(a) 4 .007 
Likelihood Ratio 14.481 4 .006 
Linear-by-Linear 
Association 
3.963 1 .046 
N of Valid Cases 
340     
a  0 cells (.0%) have expected count less than 5. The minimum expected count is 6.56. 
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CROSSTABS: EFFECTIVE TREATMENTS AND DEMOGRAPHIC VARIABLES 
 
EFFECTIVE TREATMENTS VS. ETHNIC GROUP 
  
    which group do you identify with? Total 
    
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/ 
african 
american 
or negro Hispanic 
white/ 
Caucasian multiracial other 
american 
indian, 
alaskan 
native, or 
pacific 
islander 
treatments 
that you 
think can be 
effective - 
UVBI 
(ultraviolet 
blood 
irradiation) 
not 
selected 
Count 
5 4 115 52 122 15 6 319 
    Expected 
Count 
8.5 3.8 114.8 49.9 119.5 16.9 5.6 319.0 
    % within 
treatments  
1.6% 1.3% 36.1% 16.3% 38.2% 4.7% 1.9% 100.0% 
    % of Total 1.5% 1.2% 33.9% 15.3% 36.0% 4.4% 1.8% 94.1% 
  selected Count 4 0 7 1 5 3 0 20 
    Expected 
Count 
.5 .2 7.2 3.1 7.5 1.1 .4 20.0 
    % within 
treatments  
20.0% .0% 35.0% 5.0% 25.0% 15.0% .0% 100.0% 
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    % of Total 1.2% .0% 2.1% .3% 1.5% .9% .0% 5.9% 
Total Count 9 4 122 53 127 18 6 339 
  Expected 
Count 
9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
  % within 
treatments  2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
  % of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 30.895(a) 6 .000 
Likelihood Ratio 17.748 6 .007 
Linear-by-Linear 
Association 
3.386 1 .066 
N of Valid Cases 
339     
a  6 cells (42.9%) have expected count less than 5. The minimum expected count is .24. 
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which group do you identify with? 
    
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/ 
african 
american 
or negro Hispanic 
white/ 
Caucasian multiracial other Total 
Count 7 4 117 50 126 17 5 326 
Expected 
Count 
8.7 3.8 117.3 51.0 122.1 17.3 5.8 326.0 
% within 
treatments  
2.1% 1.2% 35.9% 15.3% 38.7% 5.2% 1.5% 100.0% 
not 
selected 
% of Total 2.1% 1.2% 34.5% 14.7% 37.2% 5.0% 1.5% 96.2% 
Count 2 0 5 3 1 1 1 13 
Expected 
Count 
.3 .2 4.7 2.0 4.9 .7 .2 13.0 
% within 
treatments  
15.4% .0% 38.5% 23.1% 7.7% 7.7% 7.7% 100.0% 
treatments 
that you 
think can 
be 
effective - 
Selenium 
liver 
support-
oral 
selected 
% of Total .6% .0% 1.5% .9% .3% .3% .3% 3.8% 
Count 9 4 122 53 127 18 6 339 
Expected 
Count 
9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
% within 
treatments  
2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
Total 
% of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
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 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 14.934(a) 6 .021 
Likelihood Ratio 11.141 6 .084 
Linear-by-Linear 
Association 
2.015 1 .156 
N of Valid Cases 
339     
a  8 cells (57.1%) have expected count less than 5. The minimum expected count is .15. 
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Which group do you identify with? 
    
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/ 
african 
american 
or negro Hispanic 
white/ 
Caucasian multiracial other Total 
Count 9 4 120 52 127 17 5 334 
Expected 
Count 
8.9 3.9 120.2 52.2 125.1 17.7 5.9 334.0 
% within 
treatments  2.7% 1.2% 35.9% 15.6% 38.0% 5.1% 1.5% 100.0% 
not 
selected 
% of Total 2.7% 1.2% 35.4% 15.3% 37.5% 5.0% 1.5% 98.5% 
Count 0 0 2 1 0 1 1 5 
Expected 
Count 
.1 .1 1.8 .8 1.9 .3 .1 5.0 
% within 
treatments  
.0% .0% 40.0% 20.0% .0% 20.0% 20.0% 100.0% 
treatments 
that you 
think can 
be 
effective - 
Peroxide-
Oral 
selected 
% of Total .0% .0% .6% .3% .0% .3% .3% 1.5% 
Count 9 4 122 53 127 18 6 339 
Expected 
Count 
9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
% within 
treatments  
2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
Total 
% of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
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 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 13.772(a) 6 .032 
Likelihood Ratio 8.629 6 .196 
Linear-by-Linear 
Association 
1.021 1 .312 
N of Valid Cases 
339     
a  8 cells (57.1%) have expected count less than 5. The minimum expected count is .06. 
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    Which group do you identify with? Total 
    
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/african 
american or 
negro Hispanic 
white/ 
Caucasian multiracial other 
american 
indian, 
alaskan 
native, or 
pacific 
islander 
treatments that you 
think can be effective - 
Porcine (pig) liver 
extracts-transdermal 
not selected Count 
8 4 120 52 127 18 5 334 
    Expected Count 8.9 3.9 120.2 52.2 125.1 17.7 5.9 334.0 
    % within treatments  2.4% 1.2% 35.9% 15.6% 38.0% 5.4% 1.5% 100.0% 
    % of Total 2.4% 1.2% 35.4% 15.3% 37.5% 5.3% 1.5% 98.5% 
  selected Count 1 0 2 1 0 0 1 5 
    Expected Count .1 .1 1.8 .8 1.9 .3 .1 5.0 
    % within treatments 20.0% .0% 40.0% 20.0% .0% .0% 20.0% 100.0% 
    % of Total .3% .0% .6% .3% .0% .0% .3% 1.5% 
Total Count 9 4 122 53 127 18 6 339 
  Expected Count 9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
  % within treatments  2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
  % of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
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 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 17.595(a) 6 .007 
Likelihood Ratio 10.074 6 .122 
Linear-by-Linear 
Association .808 1 .369 
N of Valid Cases 
339     
a  8 cells (57.1%) have expected count less than 5. The minimum expected count is .06. 
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    Which group do you identify with? Total 
    
american indian, 
alaskan native, or 
pacific islander 
asian/asian 
american 
black/african 
american or 
negro Hispanic 
white/ 
Caucasian multiracial other 
american 
indian, 
alaskan 
native, or 
pacific 
islander 
treatments that you 
think can be effective  
Nutritional 
supplements 
not 
selected 
Count 
6 4 99 44 100 7 6 266 
    Expected Count 7.1 3.1 95.7 41.6 99.7 14.1 4.7 266.0 
    % within treatments  2.3% 1.5% 37.2% 16.5% 37.6% 2.6% 2.3% 100.0% 
    % of Total 1.8% 1.2% 29.2% 13.0% 29.5% 2.1% 1.8% 78.5% 
  selected Count 3 0 23 9 27 11 0 73 
    Expected Count 1.9 .9 26.3 11.4 27.3 3.9 1.3 73.0 
    % within treatments  4.1% .0% 31.5% 12.3% 37.0% 15.1% .0% 100.0% 
    % of Total .9% .0% 6.8% 2.7% 8.0% 3.2% .0% 21.5% 
Total Count 9 4 122 53 127 18 6 339 
  Expected Count 9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
  % within treatments  2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
  % of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
 
F 102 
 
  
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 21.347(a) 6 .002 
Likelihood Ratio 19.866 6 .003 
Linear-by-Linear 
Association 
1.756 1 .185 
N of Valid Cases 
339     
a  6 cells (42.9%) have expected count less than 5. The minimum expected count is .86. 
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EFFECTIVE TREATMENTS VS. STATUS 
  
My HIV status is 
    Negative Positive Total 
Count 101 183 284 
Expected Count 104.1 179.9 284.0 
% within treatments  35.6% 64.4% 100.0% 
not selected 
% of Total 34.6% 62.7% 97.3% 
Count 6 2 8 
Expected Count 2.9 5.1 8.0 
% within treatments  75.0% 25.0% 100.0% 
treatments that you 
think can be 
effective - silver 
colloid-IV 
selected 
% of Total 2.1% .7% 2.7% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within treatments  36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 5.212(b) 1 .022     
Continuity 
Correction(a) 
3.652 1 .056     
Likelihood Ratio 5.019 1 .025     
Fisher's Exact Test       .055 .030 
Linear-by-Linear 
Association 
5.195 1 .023     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  1 cells (25.0%) have expected count less than 5. The minimum expected count is 2.93. 
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My HIV status is 
    Negative Positive Total 
Count 96 148 244 
Expected Count 89.4 154.6 244.0 
% within treatments  39.3% 60.7% 100.0% 
not selected 
% of Total 32.9% 50.7% 83.6% 
Count 11 37 48 
Expected Count 17.6 30.4 48.0 
% within treatments  22.9% 77.1% 100.0% 
treatments that you 
think can be 
effective - 
Vitamins-Oral 
selected 
% of Total 3.8% 12.7% 16.4% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within treatments  36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 4.662(b) 1 .031     
Continuity 
Correction(a) 
3.982 1 .046     
Likelihood Ratio 4.945 1 .026     
Fisher's Exact Test       .034 .021 
Linear-by-Linear 
Association 
4.646 1 .031     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 17.59. 
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My HIV status is 
    Negative Positive Total 
Count 101 158 259 
Expected Count 94.9 164.1 259.0 
% within treatments  39.0% 61.0% 100.0% 
not selected 
% of Total 34.6% 54.1% 88.7% 
Count 6 27 33 
Expected Count 12.1 20.9 33.0 
% within treatments  18.2% 81.8% 100.0% 
treatments that you 
think can be 
effective - Minerals-
Oral 
selected 
% of Total 2.1% 9.2% 11.3% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within treatments  36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 5.462(b) 1 .019     
Continuity 
Correction(a) 
4.602 1 .032     
Likelihood Ratio 6.011 1 .014     
Fisher's Exact Test       .021 .013 
Linear-by-Linear 
Association 
5.443 1 .020     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 12.09. 
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    My HIV status is Total 
    Negative Positive Negative 
treatments that you 
think can be effective  
Nutritional 
supplements 
not selected Count 
92 133 225 
    Expected Count 82.4 142.6 225.0 
    % within treatments  40.9% 59.1% 100.0% 
    % of Total 31.5% 45.5% 77.1% 
  selected Count 15 52 67 
    Expected Count 24.6 42.4 67.0 
    % within treatments  22.4% 77.6% 100.0% 
    % of Total 5.1% 17.8% 22.9% 
Total Count 107 185 292 
  Expected Count 107.0 185.0 292.0 
  % within treatments  36.6% 63.4% 100.0% 
  % of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 7.611(b) 1 .006     
Continuity 
Correction(a) 
6.835 1 .009     
Likelihood Ratio 8.046 1 .005     
Fisher's Exact Test       .006 .004 
Linear-by-Linear 
Association 
7.585 1 .006     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 24.55. 
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My HIV status is 
    Negative Positive Total 
Count 77 106 183 
Expected Count 67.1 115.9 183.0 
% within treatments  42.1% 57.9% 100.0% 
not selected 
% of Total 26.4% 36.3% 62.7% 
Count 30 79 109 
Expected Count 39.9 69.1 109.0 
% within treatments  27.5% 72.5% 100.0% 
treatments that you 
think can be 
effective - AZT 
(azidothymidine) 
selected 
% of Total 10.3% 27.1% 37.3% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within treatments  36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 6.232(b) 1 .013     
Continuity 
Correction(a) 
5.621 1 .018     
Likelihood Ratio 6.361 1 .012     
Fisher's Exact Test       .017 .008 
Linear-by-Linear 
Association 
6.211 1 .013     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 39.94. 
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My HIV status is 
    Negative Positive Total 
Count 79 96 175 
Expected Count 64.1 110.9 175.0 
% within treatments  45.1% 54.9% 100.0% 
not selected 
% of Total 27.1% 32.9% 59.9% 
Count 28 89 117 
Expected Count 42.9 74.1 117.0 
% within treatments  23.9% 76.1% 100.0% 
treatments that you 
think can be 
effective - HAART 
(Highly active 
antiretroviral 
therapy) selected 
% of Total 9.6% 30.5% 40.1% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within treatments  36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 13.589(b) 1 .000     
Continuity 
Correction(a) 
12.691 1 .000     
Likelihood Ratio 13.992 1 .000     
Fisher's Exact Test       .000 .000 
Linear-by-Linear 
Association 
13.542 1 .000     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 42.87. 
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    My HIV status is Total 
    Negative Positive Negative 
treatments that you 
think can be effective  
Pharmaceutical 
antibodies (bactrim, 
etc) 
not 
selected 
Count 
91 109 200 
    Expected Count 73.3 126.7 200.0 
    % within treatments  45.5% 54.5% 100.0% 
    % of Total 31.2% 37.3% 68.5% 
  selected Count 16 76 92 
    Expected Count 33.7 58.3 92.0 
    % within treatments  17.4% 82.6% 100.0% 
    % of Total 5.5% 26.0% 31.5% 
Total Count 107 185 292 
  Expected Count 107.0 185.0 292.0 
  % within treatments  36.6% 63.4% 100.0% 
  % of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 21.445(b) 1 .000     
Continuity 
Correction(a) 
20.251 1 .000     
Likelihood Ratio 23.056 1 .000     
Fisher's Exact Test       .000 .000 
Linear-by-Linear 
Association 
21.372 1 .000     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 33.71. 
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 EFFECTIVE TREATMENTS VS. AGE 
 
  
Age group 
    18-25 26-36 37-47 48-58 59 + Total 
Count 49 87 103 76 18 333 
Expected Count 51.9 87.2 100.9 75.4 17.6 333.0 
% within treatments  14.7% 26.1% 30.9% 22.8% 5.4% 100.0% 
not selected 
% of Total 14.4% 25.6% 30.3% 22.4% 5.3% 97.9% 
Count 4 2 0 1 0 7 
Expected Count 1.1 1.8 2.1 1.6 .4 7.0 
% within treatments  57.1% 28.6% .0% 14.3% .0% 100.0% 
treatments that you 
think can be 
effective - Peroxide-
IV 
selected 
% of Total 1.2% .6% .0% .3% .0% 2.1% 
Count 53 89 103 77 18 340 
Expected Count 53.0 89.0 103.0 77.0 18.0 340.0 
% within treatments  15.6% 26.2% 30.3% 22.6% 5.3% 100.0% 
Total 
% of Total 15.6% 26.2% 30.3% 22.6% 5.3% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 10.697(a) 4 .030 
Likelihood Ratio 10.044 4 .040 
Linear-by-Linear 
Association 
6.145 1 .013 
N of Valid Cases 
340     
a  5 cells (50.0%) have expected count less than 5. The minimum expected count is .37. 
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Age group 
    18-25 26-36 37-47 48-58 59 + Total 
Count 48 75 76 52 14 265 
Expected Count 41.3 69.4 80.3 60.0 14.0 265.0 
% within treatments  18.1% 28.3% 28.7% 19.6% 5.3% 100.0% 
not selected 
% of Total 14.1% 22.1% 22.4% 15.3% 4.1% 77.9% 
Count 5 14 27 25 4 75 
Expected Count 11.7 19.6 22.7 17.0 4.0 75.0 
% within treatments  6.7% 18.7% 36.0% 33.3% 5.3% 100.0% 
treatments that you 
think can be effective - 
Nutritional 
supplements 
selected 
% of Total 1.5% 4.1% 7.9% 7.4% 1.2% 22.1% 
Count 53 89 103 77 18 340 
Expected Count 53.0 89.0 103.0 77.0 18.0 340.0 
% within treatments  15.6% 26.2% 30.3% 22.6% 5.3% 100.0% 
Total 
% of Total 15.6% 26.2% 30.3% 22.6% 5.3% 100.0% 
 
Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 12.873(a) 4 .012 
Likelihood Ratio 13.571 4 .009 
Linear-by-Linear 
Association 
9.891 1 .002 
N of Valid Cases 
340     
 
a  1 cells (10.0%) have expected count less than 5. The minimum expected count is 3.97. 
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EFFECTIVE TREATMENTS VS. SEXUAL ORIENTATION 
 
 
sexual orientation 
    Heter Homo Bi-sexual Total 
Count 124 88 26 238 
Expected Count 111.7 100.1 26.2 238.0 
% within treatments  52.1% 37.0% 10.9% 100.0% 
not selected 
% of Total 40.1% 28.5% 8.4% 77.0% 
Count 21 42 8 71 
Expected Count 33.3 29.9 7.8 71.0 
% within treatments  29.6% 59.2% 11.3% 100.0% 
treatments that you 
think can be effective - 
Nutritional 
supplements 
selected 
% of Total 6.8% 13.6% 2.6% 23.0% 
Count 145 130 34 309 
Expected Count 145.0 130.0 34.0 309.0 
% within treatments  46.9% 42.1% 11.0% 100.0% 
Total 
% of Total 46.9% 42.1% 11.0% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 12.313(a) 2 .002 
Likelihood Ratio 12.467 2 .002 
Linear-by-Linear 
Association 
6.330 1 .012 
N of Valid Cases 
309     
a  0 cells (.0%) have expected count less than 5. The minimum expected count is 7.81. 
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sexual orientation 
    Heter Homo Bi-sexual Total 
Count 113 75 23 211 
Expected Count 99.0 88.8 23.2 211.0 
% within treatments  53.6% 35.5% 10.9% 100.0% 
not selected 
% of Total 36.6% 24.3% 7.4% 68.3% 
Count 32 55 11 98 
Expected Count 46.0 41.2 10.8 98.0 
% within treatments  32.7% 56.1% 11.2% 100.0% 
treatments that you 
think can be effective - 
Pharmaceutical 
antibodies (bactrim, 
etc) 
selected 
% of Total 10.4% 17.8% 3.6% 31.7% 
Count 145 130 34 309 
Expected Count 145.0 130.0 34.0 309.0 
% within treatments  46.9% 42.1% 11.0% 100.0% 
Total 
% of Total 46.9% 42.1% 11.0% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 12.972(a) 2 .002 
Likelihood Ratio 13.076 2 .001 
Linear-by-Linear 
Association 
6.674 1 .010 
N of Valid Cases 
309     
a  0 cells (.0%) have expected count less than 5. The minimum expected count is 10.78. 
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List of Crosstabs with No Significance 
 
Sources 
 
Books 
Newspapers 
Events (seminars, workshops, conferences) 
Medical websites 
Blogs, online bulletin boards 
Emails 
Community organizations 
Religious organizations 
Alternative medical doctors 
Other 
 
Source Credibility 
 
TV 
Radio 
Books 
Newspapers 
Magazines 
Out of home (billboards, bus ads, posters, flyers, brochures) 
HIV/AIDS groups websites 
Online newsletters, journals, etc 
Emails 
Social media-Facebook, Twitter, etc 
Religious organizations 
Conventional medical doctors 
Alternative medical doctors 
Other 
 
Perception Statements 
 
Giving antiretroviral drugs to people who are not infected is a good way to prevent   
HIV/AIDS 
HIV/AIDS infections are often the result of immoral behavior 
HIV/AIDS prevention efforts often receive more funding than treatment efforts 
Young people under 25 account for almost half of new HIV/AIDS infections globally 
Treatments Known 
 
UVBI (Ultraviolet blood irradiation) 
Silver colloid-IV 
Silver colloid-oral 
Selenium liver support-oral 
Chelation-oral 
Vitamins-IV 
Minerals-IV 
Venus flytrap-oral 
Other 
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List of Crosstabs with No Significance (Cont.) 
 
 
Effective Treatments 
 
Silver colloid-oral 
Chelation-IV 
Chelation-oral 
Vitamins-IV 
Minerals-IV 
Venus flytrap-oral 
Other 
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RELIABILITY STATISTICS 
CRONBACH’S ALPHA ANALYSIS TABLES 
 
Group 1: The Hedonist or the Moralist 
 
Cronbach's 
Alpha 
N of 
Items 
.685 6 
 
 Item Statistics 
 
  Mean 
Std. 
Deviation N 
How do you feel about-
Poor people are more 
likely to get HIV/AIDS 
3.6404 1.22626 342 
How do you feel about - 
HIV/AIDS is primarily a 
gay disease 
 
4.2602 1.01577 342 
How do you feel about - 
HIV/AIDS is God's way 
of punishing the wicked 
4.3830 .99385 342 
 
How do you feel about - 
People with HIV/AIDS 
deserve the same rights 
in the workplace as other 
workers 
4.4561 .95168 342 
 
How do you feel about - 
HIV/AIDS infections are 
often a result of immoral 
behavior 
3.7222 1.23323 342 
 
How do you feel about - 
Getting HIV/AIDS is 
usually a death sentence 
3.9240 1.14623 342 
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Group 2: The Cautious Optimist or the Raving Pessimist 
 
Cronbach's 
Alpha 
N of 
Items 
.619 6 
 
 Item Statistics 
 
  Mean 
Std. 
Deviation N 
How do you feel about-
Globally the number of 
people with HIV/AIDS 
is decreasing 
3.8830 1.08214 342 
 
How do you feel about- 
Antiretroviral drugs are 
a cure for HIV/AIDS 
3.9006 1.06479 342 
 
How do you feel about - 
Giving antiretroviral 
drugs to people not 
infected prevents 
HIV/AIDS 
3.7427 1.09565 342 
 
How do you feel about - 
You cannot get 
HIV/AIDS during sex if 
condoms are always 
used 
3.7047 1.19035 342 
 
How do you feel about - 
An effective HIV/AIDS 
vaccine is available 
3.5614 1.13361 342 
 
How do you feel about - 
Alternative medical 
treatments for 
HIV/AIDS have shown 
promising results 
2.5994 1.05580 342 
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Group 3: The Global Activist or the Political Ostrich 
 
 
Cronbach's 
Alpha 
N of 
Items 
.514 7 
 
 Item Statistics 
 
  Mean 
Std. 
Deviation N 
How to you feel about - 
A pregnant woman with 
HIV/AIDS cannot avoid 
having an HIV-positive 
baby 
3.8070 1.13755 342 
 
How do you feel about - 
HIV/AIDS prevention 
efforts often receive 
more funding than 
treatment efforts 
3.0409 1.00063 342 
 
How do you feel about - 
It is biologically easier 
for woman to get 
HIV/AIDS than it is for 
men 
3.2690 1.20513 342 
 
How do you feel about - 
Treating HIV/AIDS is a 
lucrative business for 
pharmaceutical 
companies 
2.4766 1.17315 342 
 
How do you feel about - 
Worldwide, more people 
get HIV/AIDS by 
heterosexual contact 
than by homosexual 
contact 
2.8538 1.08670 342 
 
How do you feel about - 
People who knowingly 
expose others to 
HIV/AIDS should be 
prosecuted as criminals 
2.4678 1.26670 342 
 
How do you feel about - 
Getting HIV/AIDS is 
usually a death sentence 
3.9240 1.14623 342 
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APPENDIX A 
A REFLECTIVE LOG 
 
 
 
 
Travelling high roads, visiting low places, 
 and following bunny trails 
 from Texas to Teesside and back home again 
 
  A1 
Reflective Log  
2005-2010 
 
 
This is a personal chronicle of my research journey over towering mountains of 
information, past pillars of statistics, through labyrinths of opinion and theory, and 
across ethical minefields. At the same time, there was the academic maze to navigate, 
with its ironclad procedures, reams of reports, and educational conventions. 
This was also an intensely personal journey that took me out of my comfort zone, 
where I encountered people and experiences that would never have touched my 
sheltered university life in Texas. 
Along the way, I logged thousands of actual miles travelling from Texas to 
Teesside, with forays north to Canada, south to Peru and Mexico, and across the pond 
to a number of European cities.  I met a wonderfully diverse group of individuals with 
fascinating—sometimes shocking—knowledge they were kind enough to share.  
This arduous pursuit was undertaken with the realisation there would be dead ends 
and missed markers aplenty, but I hoped by journey’s end logical patterns would 
emerge as the sanity of method came to the forefront. I admit I rambled down a goodly 
number of bunny trails—diversions that yielded no useful result—but isn’t that part of 
the research process? Over the years, I experienced curiosity (which set this endeavour 
in motion), frustration, steep learning curves, exhilaration, and empathy. At one point, I 
was told that writing a PhD thesis was the ‘largest and most self-indulgent thing’ I 
would ever do.  If that is the case, this reflective log is the most hedonistic thing of all. 
Certainly the entire project has been self-serving in that I have received immeasurable 
rewards, which have more than compensated for the time, expense, and discomfort—
both physical and emotional. 
This, then, is my five-year chronology of milestone places and experiences, 
combined with my serious—and sometimes not-so-serious—musings on the mundane 
as well as the profound. 
 
________________________  
2005 
________________________ 
 
Paris, September 2005 
The inspiration for this project was my desire to go to Paris. For years, I had longed 
to visit France. Time was passing and I was still in Texas, although I frequently 
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presented academic papers in major U.S. cities. So, in the Spring of 2005, I searched the 
Internet for communication conferences scheduled to meet in the City of Lights. 
Success! I found a call for abstracts by an organisation meeting at UNESCO. A 
colleague and I sent a proposal, which was accepted for presentation. In researching and 
writing my part of the paper, I was stunned by the scope of the HIV/AIDS epidemic. I 
also discovered the field of social marketing–heretofore unknown to me–and through 
my colleague I started to learn about the medical aspects of the disease. Our research 
suggested unhealthy relationships between drug companies and dissemination of 
information about medical issues, especially relating to diseases such as HIV/AIDS, 
where billions of dollars were being spent for prevention and treatment programs. We 
reported that companies such as Merck and Pfizer typically spent more on marketing 
their drugs than on research and development. 
Our paper included this statement: 
‘With this kind of investment at stake, it is not surprising the traditional 
medical establishment uses its influence and financial clout to control the 
dissemination of information. It does so by violating the most intrinsic 
human freedom and endangering the most basic of human capabilities—
access to knowledge.’ 
 
The paper was controversial, some even said it was ‘incendiary,’ but my interest was 
sparked. I had found my PhD topic. (And, yes, Paris is now one of my favourite cities; I 
have returned several times since.) 
MILESTONE: 
11-14 September 2005—Curing AIDS: Why Successful HIV/AIDS Treatments are Unknown 
to World Government Policy Makers. Fifth International Conference on the Capability 
Approach, UNESCO. Paris, France (co-author: James Adams) 
 
Teesside, September 2005   
 
While researching the converging topics of HIV/AIDS, social marketing, and their 
relationship to conventional and alternative medicine, I also began looking for a PhD 
program that would fit my life situation and make me eligible for promotion at the 
university in Texas where I teach communication classes. Bear’s Guide to Earning 
Degrees by Distance Learning helped me determine that part-time distance programs in 
public relations/social marketing were available, especially in Europe and Australia.  
Since leaving my job for a full-time research program was not feasible, I began to 
search for an English-language university with international GAAP certification that 
offered PhD marketing degrees via distance learning. Social marketing is not a common 
degree in the United States, so I turned my attention to universities in the UK.  Staff at 
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Teesside Business School agreed to meet with me and discuss my proposal while I was 
in Europe for the UNESCO conference.  In mid-September, the 6 a.m. train from 
London took me north to Middlesbrough and a taxi delivered me to the campus, where I 
found my way to the Business School for an appointment that would significantly affect 
the next five years of my life. 
After discussing my proposed topic with faculty and staff from the Teesside 
Business School, a question I was to answer many times over the next few years was 
broached: ‘Why travel so far to earn your degree and why are you specifically interested 
in Teesside?’  I explained that in addition to offering the kind of program and flexibility 
I needed to advance in my academic career, Teesside was squarely in the middle of my 
roots; my family originally came from Masongill, near Settle, Yorkshire. Masongill was 
the family seat of the Massengills during the Middle Ages.  Daniel Marsingell, a sailor 
from nearby Whitby, immigrated to Virginia in the mid-1650s and was the forbearer for 
the many Massingills now living in the States. I had learned these facts years ago from a 
hefty book in my personal library—The Massengills, Massengales and Variants 1472-
1931, written by Samuel Evans Massengil, M.D., and published in 1931. So, I feel a 
special affinity to Yorkshire and was delighted with the prospect of exploring the area 
while spending my annual residency at Teesside.  
Beyond these personal and professional motivations, however, I was intrigued with 
the idea of tackling a far-ranging project that would challenge me to understand cultures 
outside my experience and would allow me to become constructively involved in the 
international dialogue about social policies to combat HIV/AIDS. Happily, Terry 
Robinson, Reader in Marketing, and Helen Bussell, acting Assistant Dean in the 
Teesside Business School, enthusiastically agreed to supervise my research and my 
enrolment was approved in December of 2005. So at an age when many of my 
contemporaries were looking forward to retirement, I was blithely committing to a 
project that would devour much of my spare time and money for the next five years and 
would require me to travel to Teesside each year for several weeks in residence at the 
university.  
 
MILESTONE: 
December 2005—Officially enrolled at Teesside 
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________________________  
2006 
________________________
 
 
Huntsville, Texas, May 2006 
As one requirement for moving from enrolment to registration at Teesside, I 
completed a graduate level research methods class through Sam Houston State 
University, where I have been a tenured instructor for more than 15 years. This class 
gave me needed background in mixed methods research, with an emphasis on the 
qualitative techniques that would be dominant in much of my work. This class also 
reminded me of the student role I had not experienced in many years; I was accustomed 
to being the professor who assigned, facilitated and graded. Learning to switch back and 
forth between being student and instructor was valuable; it gave me insights that were 
helpful to me as learner and as educator. Also, since I had to take the class online due to 
my own teaching schedule, I gained valuable insights into the pros and cons of this 
method of teaching, which served me well a few years later when I began teaching some 
of my communication classes online. 
 
MILESTONE: 
May 2006—Earned an ‘A’ in research methods and packed my bags for my first residency at 
Teesside 
 
Teesside, May-June 2006   
My first annual trip to Teesside was a learning experience in logistics as I figured 
out how to get from London Gatwick to Kings Crossing to catch the northbound train. 
That was also the year of too-much luggage; I mistakenly packed one massive (and 
extremely heavy) suitcase, thinking its wheels would make it manageable. I soon 
realised my error when I discovered there were no escalators in the London tube and 
elevators were rare and well hidden.  After that experience, with each succeeding year, I 
would travel lighter, although a laptop computer was always mandatory, and it was the 
heaviest item in my luggage.  
Once my luggage and I made it to Middlesbrough that first year, I settled into a 
rented room in a house I shared with other students, one who was a graduate business 
school student from China with whom I developed a continuing friendship.  
 With my journalism background, being curious about people’s lives and asking 
incisive (some might say nosey) questions comes naturally, but following a strict 
research protocol during the interviewing process was a departure from my experiences 
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as a reporter. When I became a graduate student in England, it was helpful to have 
recently gone through the IRB (Institutional Review Board) process for Prison City, a 
book I co-wrote about communication in the Texas criminal justice system.  
Since I often presented papers at international conferences wearing the twin hats of a 
communication faculty member for Sam Houston State University in Texas and a 
graduate student at Teesside, I had to satisfy the research/ethics committees at both 
institutions. Of course, the applications had to be written in American English 
(organization, for example) for SHSU and in British English (organisation) for 
Teesside! Eventually I created my own ‘cheat sheet’ for the z words; for horizon, 
magazine, size, and citizen, it was okay to use z; in most other cases, I should convert 
the z to an s. The language selection in my word processing program was immensely 
helpful and soon all of my academic papers were written in UK English. 
Also, I quickly learned the terms thesis and dissertation have opposite meanings in 
Europe and in the U.S. In the states one writes a thesis as a requirement for a master’s 
degree and a dissertation to earn a PhD. At Teesside, I would be writing a thesis for my 
PhD. This would cause much confusion among my colleagues back in Texas, and meant 
that I would have completed a thesis for my master’s degree (from the University of 
Wyoming) and another for my PhD. So, I began the challenge of life with one foot in 
British academia and the other in higher education in the U.S. 
 
Stirling, Scotland, June 2006 
While I was working on my ethics application, my research proposal, and 
registration paperwork at Teesside, I contacted Laura McDermott, research officer at the 
Institute for Social Marketing (ISM) at the University of Stirling, and asked for an 
interview. She agreed and I was once again on a northbound train, first to Edinburgh, 
where I stayed in a bed and breakfast booked over the Internet. A map of the city and 
questions of bus drivers and various other citizens confused me further, so I had an 
extended walking tour of the city before finding my room. The next day, I retraced my 
path and found the bus to Stirling. As with many of my first visits to a new city, getting 
there was an exercise in critical thinking and problem solving.  
When I reached Stirling, attractively sited in the countryside, McDermott and 
several of her colleagues at the ISM were welcoming and encouraging. They shared 
case studies and behind-the-scenes strategies for some of their campaigns, including a 
draft report discussing which theoretical models were proving most effective in national 
anti-obesity campaigns. 
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Back at Teesside, I struggled to produce a comprehensive ethics application; since 
my project would involve interviews with and a survey of human subjects, and since my 
topic was HIV/AIDS, the application received careful scrutiny. My Teesside director of 
studies, Terry Robinson, was especially helpful as I edited and rewrote the application, 
which had the added benefit of helping me focus on my project’s purpose and protocol. 
By the time I completed my 2006 residency and headed home, the ethics application 
was approved and my request to be accepted as an MPhil candidate at Teesside had 
been submitted. (At that time, Teesside, like most British universities, first accepted 
graduate students as MPhil candidates and, when the student’s work warranted, he or 
she could apply to transfer to PhD status.) 
 
MILESTONES: 
Summer 2006—University of Teesside’s Research Ethics Committee approved my 
application 
September 2006—Registration as an MPhil candidate in the Teesside Business School was 
approved 
 
Texas and Mexico, Summer 2006 
Back in Texas, I taught summer school and attended my 25th high school reunion, in 
a world far removed from my experiences in the U.K.  Many of the 39 people from my 
high school class were at the reunion, and they were mystified that I would, first of all, 
begin work toward a doctorate at an age when most of them were grandparents with 
their golden retirement years in their sights. My colleagues at Sam Houston were 
equally confounded at the thought of me travelling halfway around the world each year 
to study in Europe. Several commented, ‘I can’t believe you travel all that way by 
yourself!’ My students, on the other hand, thought it sounded like a wonderful 
adventure, which of course it already was proving to be.  I explained to some of my 
colleagues that yet another reason I was pleased with my choice was the higher 
education culture in Europe. Everyone I encountered at Teesside and at various 
conferences I attended wanted me to succeed with my research and with earning my 
degree. I never experienced even a hint of the caste system of PhD vs. non-PhD that is 
so prevalent in many U.S. universities or encountered the ‘academic hazing’ I have 
frequently seen in U.S. academia.  
That summer I also took my second trip to a medical clinic in Mexico, where 
HIV/AIDS was being treated using alternative therapies. The clinic’s director was a 
client of The Massingill Agency, my firm that specialises in health care communication. 
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My research into HIV/AIDS medical issues was proving helpful in my work with this 
client. I summarised some of my secondary and primary research in an HIV/AIDS 
backgrounder for a media kit. I was surprised to learn many of the stereotypes about 
HIV/AIDS were false, but generally widespread, perceptions. I learned that in 2005, 
more new infections (13,000 daily) and deaths (8,000 daily) had occurred than during 
any previous year of the pandemic. I also noted that worldwide, about half of the 
infected were women, and heterosexual transmission was the most common means of 
infection. Even more frightening, I discovered that in the U.S. alone, an estimated one-
third (or more) of the HIV infections were undiagnosed.  
The most intriguing fact I learned while working with my Mexico clinic client was 
that an international team of researchers and physicians had begun IRB-sanctioned pilot 
programs using the latest nanotechnology and sub-nanotechnology. The early results in 
the summer of 2006 showed remarkable outcomes in patient blood tests measuring viral 
load reductions. My interest in emerging alternative treatments for HIV/AIDS was 
certainly captured by these statistics! 
 
Lima, Peru, August 2006 
At summer’s end, I travelled to Peru to attend a communication conference where I 
was an invited presenter on advertising campaigns that cross cultural boundaries.  I 
found the discussion about aspirational ads to be an intriguing question that related to 
my research into which behavioural change approaches were effective in combating 
HIV/AIDS. Although many advertising professionals were eschewing aspirational 
approaches as too elitist, some professionals think that is a short-sighted viewpoint, as 
explained in this blog: 
‘An aspiration is defined as “a strong desire, longing, aim or goal. To strive toward 
an end: to soar.” If you were to ask American families what they aspire to, you are likely 
to hear responses about health and happiness, giving their kids a better life, making 
sure college is paid for, vocational fulfilment, contentedness even. You see, while 
American consumers have bought into the cultural narrative that “progress” is 
constituted by attaining the most feature-laden cell phone, the things people 
fundamentally care about are unchanging! (Guest Blogger: Elizabeth Paul, The Martin 
Agency http://blog.communispace.com/index.php/2009/09/09/redefining-aspiration, 
Sept 2009). 
 
Aside from fulfilling a long-time desire to visit Peru, this international gathering of 
communicators raised some intriguing questions for me about culture and advertising, 
and helped me prepare for an upcoming Mexico conference on AIDS in Culture. It was 
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also my first bilingual (English/Spanish) conference, where simultaneous translations 
took place while the speakers were presenting.  
 
MILESTONE: 
3-6 August 2006—Aspiration Advertising Campaigns as Intercultural Conduits (invited 
presentation) Congress of the Americas. Lima, Peru  
 
Banff, Canada, October 2006 
I had attended many academic conferences over the years, but in October I travelled 
to Canada to present a poster at my first social marketing conference.  This was also the 
first poster presentation I had done—my desktop publishing skills and my B.A. in art 
found a practical use.   I had been to Banff before so I already knew it was 
breathtakingly beautiful, especially in the autumn. This conference was an excellent 
introduction to the international world of social marketing. I was fascinated by the 
research presentations, informed by their methodologies, and delighted with the variety 
of people I met. I returned home with a fistful of business cards and presentation 
handouts, some of which helped me plan the Phase 1 of my research—a content analysis 
of recent HIV/AIDS campaigns. 
 
MILESTONE: 
19-21 October 2006—HIV/AIDS Social Marketing: A Comparative History (poster session) 
Social Marketing Advances in Research and Theory (SMART) Conference. Banff, Canada 
 
Mexico City, December 2006 
Ciudad de México was an exciting place to be at the end of 2006. Civil unrest as a 
result of the recent presidential election generated all-night protests in the central 
zócalo, officially known as Plaza de la Constitución.  I was staying in a hotel one block 
from the city square and could hear the protestors chanting and singing through the 
night. During the day, every rooftop and every street was guarded by Policía Federal in 
full riot gear. Since it was also the celebration of the Virgin of Guadalupe, a national 
holiday, in the evening protestors rode through the streets on bicycles, wearing white 
and carrying colourful posters and red roses representing the Virgin, who is said to have 
appeared to a poor Indian on December 12, 1531, and was a key figure in acceptance of 
the Catholic religion by the indigenous peoples of Mexico. This combination of political 
and religious history was the background for the third AIDS in Culture conference, 
sponsored by CENSIDA (Mexico’s National Centre for Prevention and Control of 
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AIDS) and Enkidu, a gay activist magazine. At first, I was taken aback by the explicit 
nature of the some of the presentations, but as I talked with the organisers of the 
conference, I learned much about the disease’s scope and political issues in the 
country’s largest city. Once again, I collected business cards as well as personal stories 
from those attending the conference.  
Language was a barrier, but not an impossible obstacle; the editor of Enkidu served 
as interpreter for all presentations. I sometimes had problems remembering to say 
several sentences and then stop for the interpreter to give my comments in Spanish. I 
have not had the opportunity to attend that annual conference again, but I did attend a 
gathering of the conference organisers and local HIV activists when I returned to 
Mexico City two years later (See 2008 entry.). 
 
MILESTONE: 
9-12 December 2006—Getting the Word Out: Promoting Cures Through Social Marketing 
(paper presented as part of a special panel session, ’Making History: Curing AIDS with 
Nanotechnology’) AIDS in Culture III: Explorations in the Cultural History of AIDS. Mexico 
City (co-author: Lauren Maddox) 
 
Texas, Winter 2006 
What is the question, anyway? 
Refining my overall research question was an ongoing challenge; much easier said 
than done, as the saying goes. Seasons came and went, and my overall question evaded 
perfection, but siren-like, invited interminable tinkering.  While I tinkered, I applied for 
scholarships and grants, signed up for a social marketing listserv I learned about from 
one of my recent contacts, and submitted a proposal for a conference that would be 
close to home—in New Mexico, just west of my home state: only 743 miles (1195 
kilometers) away.  I also found myself struggling to remember to use the correct formal 
style for each project I was working on; I was alternatively working with Chicago style, 
MLA, APA, and also the official style required by Teesside: Harvard. 
 
________________________  
2007 
________________________ 
Huntsville, Spring 2007 
When (a few) funds came rolling in 
Some of the applications I made paid off—literally.  I was awarded the Scott Scribes 
Scholarship for Older Adults (I was glad to have the scholarship despite the name) by 
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the Writers’ League of Texas, which paid most of my Teesside tuition for the year. 
Also, I received a bursary from the Academy of Marketing to attend its 2007 Doctoral 
Colloquium in Surrey later that year.  I was very grateful for both, both for the votes of 
confidence in my work and for the financial assistance they brought. 
That spring also brought to fruition my first book project, which I had been working 
on for over three years as the lead author. Prison City: Life with the Death Penalty in 
Huntsville, Texas, was released by Peter Lang Publishing in April. Although neither 
fame nor fortune came with the publication of Prison City, (the royalties were just 
enough to take a couple of friends out to dinner in Houston), completing this book about 
the execution capital of the world cleared the way for me to focus exclusively on my 
HIV/AIDS research. Also, since Prison City examined how communication techniques 
used by inmates, information officers for the prison system, and community leaders 
affect the political, cultural, and economic landscape, similar issues applied to my 
Teesside project.  Additionally, the Prison City research revealed the incidence of 
HIV/AIDS in U.S. prisons was higher than among any other population in the country, 
which I found to be the case in other countries as well. All in all, the Prison City project 
was a good preface to my thesis work; I now knew I could do a large research and 
writing project that stretched over several years and required synthesising massive 
amounts of information. 
 
MILESTONE: 
April 2007—Massingill, Ruth and Sohn, Ardyth. Prison City: Life with the Death Penalty 
in Huntsville, Texas. New York: Peter Lang Publishing, Inc.  
 
St. Petersburg, Florida, May 2007 
Despite a broken nose (no, not as a result of asking nosey questions; I really did 
walk into a door—duh!), after my spring teaching term was over, my university 
department chair asked that I participate in a seminar, ‘Teaching diversity across the 
curriculum,’ given at the prestigious Poynter Institute in St. Petersburg, Florida. This 
intensive seminar provided useful training in how to better communicate with diverse 
populations and offered suggestions for being more inclusive of various cultural groups, 
including ethnic groups and gay and transgender populations. I quickly realised this 
experience would help me better understand social marketing campaigns directed 
toward specific groups where HIV/AIDS prevalence was a problem. The seminar also 
made me more aware of language and cultural issues that affected messages directed to 
specific audiences. 
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Teesside, June 2007 
When I returned to Texas, it was time to pack (as lightly as possible) for my annual 
residency at Teesside.  I made arrangements for the care of my animal companions and 
flew to Madrid to visit a long-time Texas friend, who lived near the city centre and 
taught English at the Spanish police academy. From Madrid, I took an overnight sleeper 
train to Paris (yes, I had to spend a weekend eating chocolate pastries and fresh 
strawberries in the city where my adventures began), then boarded more trains to 
London and on to Middlesbrough. Along the way, I was reminded that keyboards across 
Europe vary, which made me glad I had hauled my Mac laptop with me, despite the 
bulk and weight. I was also bemused by the subtle differences of design for practical 
items such as lavatories (I spent a minute or so in the public restroom at the Gardens of 
Versailles trying to turn the water on so I could wash my hands—the lever was on the 
floor.) 
That year, I was able to live in an on-campus residence hall, which was much more 
convenient as well as economical. I had a bed, a desk, a tiny bath and the shared use of a 
kitchen. The weeks I spent at Teesside each year were an interesting contrast to my 
multi-tasking life in the States. When I came to Teesside, I had no home or animals to 
care for, no car to maintain (I walked or took the train everywhere I went), and very few 
possessions that required my time. I washed my clothes by hand and dried them on the 
radiators. I didn’t iron and I carried only a few necessities in a tiny purse. I shopped 
carefully for groceries, aware the items I purchased would have to be carried back to my 
room. I realized that, at least for those weeks, having so few ‘things’ was a relief and 
being able to focus only on my research was a wonderful luxury. It also sharpened my 
thinking and increased my productivity. 
During that year’s residence at Teesside, I completed my application requesting 
transfer from MPhil to PhD. This process helped further clarify and focus my study. 
I was honoured to be invited to present my Phase I research during the University’s Post 
Graduate Research Students’ Networking Forum.  And, I was asked to write a short 
article for the postgraduate Business School newsletter.  My article, ‘From Texas to 
Teesside,’ began with this paragraph: 
‘It’s a long way from Houston, Texas, to Middlesbrough, but I quickly felt 
welcome when I first visited the Teesside campus almost two years ago to 
explore the possibility of becoming a distance learning student in social 
marketing… 
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…And ended like this: 
‘Now, when my colleagues and friends hear about my experiences at Teesside, 
they no longer ask “why”; they understand the reason I travel so far each year. In 
fact, I think they are a bit jealous! And, although I have resumed my “regular” life in 
Texas, I look forward to returning to Teesside next summer.’ 
 
Surrey, England, July 2007 
The doctoral colloquium was a positive experience that came at a point in my 
project where advice and encouragement from the professional world was most 
welcome. The conference was hosted by Kingston Business School, which is organised 
around a quad of ancient buildings reached by forest trails. The day of the colloquium 
was filled with presentations by a number of the doctoral students and workshops 
presented by marketing professionals. Practical suggestions abounded, and each student 
presenter received feedback on his/her work from a panel of international experts. In an 
introductory talk, one speaker commented that ‘most people only get one PhD, because 
they don’t want to go through (the process) again.’  I used some of the handouts from 
those sessions to help me at each stage in my project, including the tips to prepare for 
my viva (short for viva voce—‘lively discussion’), or the less poetic ‘oral defence.’ 
The information gleaned from the colloquium and the associated conference proved 
helpful when it was time to respond to questions from the assessors who examined my 
transfer document. Not surprisingly, the assessors pointed out I should clarify/rewrite 
the main research question. I agreed with their assessment and noted I was about to 
begin the second phase of my research, which would involve a number of semi-
structured interviews and should help focus my study. 
 
MILESTONES: 
 2-3 July 2007—A Practical Approach to Cultural Change: Using Social Marketing to 
Combat HIV/AIDS in Mexico, Academy of Marketing 2007, Doctoral Colloquium, Surrey, 
England 
Summer 2007—Teesside Business School approves transfer from MPhil to PhD status 
(later approved at the university level) 
 
Taos, New Mexico, October 2007 
During the autumn term (my Teesside director of studies asked that I learn to say 
‘autumn’ instead of ‘fall’ as we are wont to do in Texas), I prepared materials for a 1 ½ 
hour workshop focusing on visual and verbal persuasion methods in some of the social 
marketing campaigns from my content analysis. This conference setting was an 
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American West version of the Surrey conference; it was in the wilderness outside of the 
old Indian town of Taos. I took a bus from Taos to the campus hosting the conference, 
arriving at dusk and promptly getting lost on the winding forest paths. Finally, the sound 
of flutes led me to the conference centre, where a bonfire warmed the crisp mountain air 
and Indian musicians were performing ancient melodies. Even though I was only a short 
plane ride from home, I was assuredly in another country and another culture. To add to 
the international scene, my assigned roommate was Tugba (pronounced Tuba) 
Kalafatoglu, president of a global management and public affairs consulting firm in 
Istanbul. Tugba told me her firm advised politicians on message development and 
campaign strategies and assisted business leaders with global marketing and cross-
cultural leadership. Her business card joined my growing stack of international contacts. 
My workshop visuals generated a lively discussion about the HIV/AIDS campaigns 
and provided fresh insights from an audience that was not overly familiar with the topic. 
While preparing for this workshop, I had also begun work on a book chapter about 
social marketing in Mexico. Through the social marketing listserv I had been joined 
months earlier, I learned of plans for an international book of social marketing success 
stories and submitted a proposal. I was delighted to receive a contract to write a chapter 
based on my research of two Mexico initiatives.  
 
MILESTONE: 
4-6 October 2007—Motivating Change: Visual and Verbal Persuasion in HIV-AIDS Social 
Marketing, American Communication Association, Taos, New Mexico 
________________________  
2008 
________________________ 
 
Huntsville, February 2008 
2008 was to be the hardest year of my project due to injuries that made travel and 
even typing difficult and painful. I think of that year as being book ended with broken 
bones. A hard fall in the early spring broke my right shoulder and made writing or 
driving impossible for a number of weeks. Luckily, I was able to move some of the 
classes I was teaching that spring to an online format, and my next conference 
commitment was an Internet event. 
 
Internet, March 2008 
This was another first for me—a live online conference. It turned out to require at 
least as much preparation as a traditional conference presentation. I created a 
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PowerPoint, wrote a script to accompany the visuals, and recorded the commentary via 
phone prior to the conference. While the conference was in session, I monitored 
comments and responded to questions. The conference was sponsored by PSP-One 
(Private Sector Partnerships for Better Health), a USAID project to ‘increase the private 
sector’s provision of high-quality health products and services in developing countries.’ 
My script went through an approval process that erased any hint of criticism of the 
financial ties to health care in poor countries. The pro-business ‘spin’ was clear. 
Nevertheless, it was an interesting experience and one of the comments I received 
during the conference was from the director of Population Services International-
Mexico, who provided updated information about PSI’s social marketing approach in 
Mexico. We visited via email and phone and his input became part of the book chapter I 
was writing for Global trends and success stories. 
 
MILESTONE: 
10-15 March 2008—Taking Taboo Topics Public:  How Social Marketing Partnerships 
Combat HIV/AIDS in Mexico (part of a panel titled: ‘Partnership Based Approaches: What 
Works?’), Social Marketing in the Developing World: What Have we Accomplished and What 
Does the Future Hold? 2008 PSP-One on-line conference 
 
Szeged, Hungary, June 2008 
My physical therapists assured me the broken shoulder would be sufficiently healed 
for travel by June, but they were a bit optimistic. Nevertheless, I packed even lighter 
than the previous year, and set off for my conference presentation at the International 
Congress on Public and Nonprofit Marketing. I still am grateful to the many fellow 
passengers that summer who lifted my luggage in and out of the overhead bins and 
carried bags down flights of stairs for me. Conference organisers met my flight in 
Budapest and accompanied several conference attendees to our hotel in Szeged. By this 
point, my annual travel to different international locations had made my passport 
suspect to airport security and customs agents, who questioned me carefully and usually 
required a special security inspection of my person and my luggage. A British customs 
agent was particularly memorable; when she saw my U.S. passport, she sent me to the 
back of the line, then quizzed me at length about how long I would be in England and 
the exact date I would be leaving. But, for the most part, I encountered careful but 
cheerful people who gave me information and helped me understand travel requirements 
of their country. 
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The Szeged conference was attended by academics from universities across the EU 
and I added more business cards and memories to my collection. As usual, some people 
were intrigued by my topic and others were astonished at my choice. One colleague 
commented that she would not want to ‘touch anyone with HIV.’ 
 
MILESTONE: 
12-13 June 2008—Creating a Culture of Change: Social Marketing’s Global Initiative 
Against HIV/AIDS. VII International Congress on Public and Nonprofit Marketing. Szeged, 
Hungary 
 
Teesside, June 2008 
By this point, my annual return to Teesside was a homecoming of sorts. Everyone at 
the Business School welcomed me back and my supervisors made sure I had a desk and 
a computer as well as access codes for my stay. With such efficiency, I was able to 
settle in to work the day after I arrived and moved into my room in Parkside Residence 
Halls, overlooking the expansive and beautiful city park. I shared a kitchen with several 
other summer students, including a group of Chinese undergraduates who were studying 
English so they could enrol in classes in the autumn.  Internet access in my room was an 
added bonus and made it possible for me to work at all hours, even on weekends when 
the library had short hours. 
Amid my growing mounds of data, I began to draft chapters of my thesis. My wily 
director of studies insisted I begin with my methodology chapter, which he knew was 
the most difficult and also the chapter I was secretly dreading. By the end of my 
residency that year, I had several chapters in various stages.  
 
Mexico City, August 2008 
At the end of the summer, I had the opportunity to attend the International AIDS 
Conference in Mexico City. This biannual conference was truly a world event, drawing 
professionals and academics from the medical and social science areas, as well as local, 
national, and international organisations associated with HIV/AIDS prevention and 
treatment efforts. About 25,000 participants gathered in Mexico City, generating 
worldwide publicity. The conference was a whirlwind of demonstrations, concurrent 
presentations, information being dispensed in every possible medium, and informal and 
formal discussions about all aspects of the pandemic. Pharmaceutical sponsorship was 
highly visible, and ‘safe sex’ was a recurring theme.  
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Competition was stiff for presentation slots at the conference, even for poster 
presentations. My poster focused on three campaigns from my Phase I research that 
targeted women. AIDS XVII offered opportunities to make contacts with people central 
to some of the campaigns I examined during Phase I and to conduct interviews with key 
informants as a continuation of my Phase II research. I especially enjoyed my interview 
with the co-director of Instituto Promundo, a Brazilian NGO that partners with other 
Latin America organisations to create and implement HIV/AIDS social marketing 
campaigns. 
Those contacts and interviews also allowed me to update and obtain images for my 
book chapter in Social Marketing for Public Health: Global Trends and Success Stories, 
which would be edited by Philip Kotler, Nancy Lee, and Hong Cheng.  
 
MILESTONE: 
3-8 August 2008 –Until AIDS Do Us Part: Social Marketing Campaigns Empower Women 
At Risk in Uganda, Mexico, and the United States. XVII International AIDS Conference. 
Mexico City 
 
Huntsville, Winter 2008 
After so much travel, my broken shoulder was not healing well, so I declined an 
invitation to return to Mexico City in October to present a paper titled Virtual 
Virtuosity: How the ONE Campaign Uses Social Media to Combat Global Poverty and 
HIV/AIDS, at the 2nd Congress of the Americas. Unfortunately, staying in Texas proved 
unsafe; in November I fell and broke my right ankle, which kept me homebound until 
after the first of the year. But I did finish edits and rewrites on my book chapter, parts 
of which would reappear in greatly shortened form as a case study in my thesis. A 
bright spot during that time was an email with comments from Global Trends editor Phil 
Kotler (known as the ‘father of social marketing’): 
 
"I am absolutely pleased with what I read. Each chapter is a treasure-
trove of information, analysis, campaign description, and evaluation.! 
  
"My regard for the importance of the book has grown immensely. This 
book should have a long shelf life. The campaigns provide classic models of 
social marketing. Any social marketer tackling any of these issues will draw 
excellent guidance into developing his or her campaign.! 
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________________________  
2009 
________________________ 
Huntsville, Spring 2009 
This was a time when I focused on teaching my four spring term classes at Sam 
Houston, learned to manoeuvre on crutches and focused on getting my body back to its 
pre-broken condition. On the research front, I completed my Phase II work and prepared 
a complex poster summarising my content analysis results for a conference in 
Switzerland.  (All of the posters and projects mentioned in this Log are shown as 
subsequent appendices in this volume.) 
 
St. Gallen, Switzerland, June 2009 
In route to Teesside that summer, I first flew to Zurich to attend the First German-
Austrian Swiss AIDS-Congress SODAK 2009, ‘Prepare for the Long Run.’ The 
conference was held in St. Gallen, an hour’s train ride from the capital. In keeping with 
the congress theme, I had a poster presentation in the social science track that used cross 
tabulation matrixes summarising my content analysis research from Phase I. 
This conference attracted about 800 attendees, and the second congress was already 
scheduled for June of 2011. Although the congress call for abstracts included both 
medical and social science tracks, most of the attendees were from the medical 
community. Several medical professionals at the congress commented to me that my 
research on the cultural aspects that contribute to the AIDS pandemic is equally 
important in the battle against the disease and should have had a more prominent role in 
conference discussions. I also received a number of compliments on the production of 
my poster, which again utilised my desktop design skills to create a poster that was 
more elaborate and colourful than most others on display. 
Observations from attending conference sessions and from informal discussions with 
presenters and attendees included: 
 
•  Pharmaceutical companies were much in evidence as conference sponsors and as 
vendors dispensing literature and branded specialty items. 
•  Complacency was widely considered to be a prime enemy in the fight against HIV 
infection, as many people now consider that HIV/AIDS is not an automatic death 
sentence but can be treated with HAART therapy. (Not curable, but controllable) 
•  However, drug-resistant HIV is an increasing problem, fostering research and 
development of a host of new drugs. 
• With so many drugs available, interest in CAM therapy is greatly diminished. 
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• However, presentations included promising reports on the efficacy of green tea extract 
and stem cell studies.  
• Many of the new European social marketing campaigns for HIV/AIDS feature 
condoms as prominent elements, couples in suggestive poses, and graphic language. 
•  This conference primarily focused on HIV/AIDS as a biomedical problem, with culture 
and stigma taking a back seat. 
•  Condoms were repeatedly recommended as the fail-safe prevention method (and 
samples of various brands were available in most vendor booths). 
 
Like AIDS XVII, this congress was a source of interesting contacts as well as the 
newest medical information about conventional AIDS treatments. A highlight was 
attending the Swiss premiere for an HIV/AIDS documentary on HIV/AIDS in Europe, 
‘Blissfully Lost,’ which was created by a doctor who worked at a German HIV clinic and 
a filmmaker from Cape Town, South Africa. I learned about the documentary by 
chance—the only promotion for it was on a postcard I happened to pick up in sponsor 
GlaxoSmithKline’s booth. But the card’s one paragraph caught my attention: 
 
…28 years of public discourse, TV spots, posters, celebrity-upvalued 
campaigns and putting condoms over bananas have left their mark on the 
collective psyche. What do you think of HIV/AIDS? 
 
My interest peaked, I took a taxi to the small art theatre where the screening was 
scheduled. Only a handful of people attended, but I was pleased I had gone. The 
documentary included interviews with a diverse group of people and was designed to 
inform and promote dialogue about the disease. After the screening, I met the creators of 
the film and spent several hours at a local watering hole getting to know the two of them 
and learning about their lives and projects. We have kept in touch about the possibility 
of screening the documentary in Houston at some point.  
After the conference, it was back to Zurich for a weekend as a tourist and then a 
flight to Manchester and the now-familiar train trip to Middlesbrough and Teesside. 
 
MILESTONE: 
24-27 June 2009—Working Toward a World Without AIDS: How Social Marketing Inspires 
Long-term Cultural Change. First German-Austrian Swiss AIDS-Congress SODAK 2009. St. 
Gallen, Switzerland 
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Teesside, June 2009 
When I reached Teesside, I learned I was now attending the 2009/10 University of 
the Year; Teesside had been named to this prestigious honour by Times Higher 
Education.  It was a great achievement, especially for a so-called ‘new university’ like 
Teesside and there were posters and pennants everywhere. Again, I moved into Parkside 
Residence Halls, unpacked my one small suitcase, and connected my laptop. I was ready 
for my annual residency. I soon wished I had brought a fan; Middlesbrough was having a 
heat wave—not that hot by Texas standards, but there is little or no air conditioning in 
Middlesbrough, certainly not in the residence halls or in the Business School offices. 
Sweating (‘glowing’ as Texas ladies are supposed to say) while typing was the only 
choice. 
However, I still managed to organise and categorise my work to date. I refined and 
expanded my thesis outline and continued drafting (and revising) chapters. I also 
updated my literature review to include several articles and books that provided fresh 
insights as well as reinforcement of my own findings from Phases I and II. I consulted 
marketing texts on survey methodology to support my own research design for Phase 
III, using that information as background for writing the survey methodology. And, to 
further order my work in the coming months, I developed a status report form for 
tracking my thesis progress and setting goals for each chapter.  
Additionally, my Director of Studies and I revisited and re-checked my original 
ethical approval on 9 June 2009 and determined there had been no significant change in 
methodology that would impact ethical approval. This was important since I was 
planning a survey of patients and staff at an HIV/AIDS clinic in Houston. 
 The ever-expanding amount of information plus the genuine interest in my research 
topic from people I interviewed or consulted indicated I had chosen a significant area of 
study with many possibilities for making contributions to knowledge. It was also 
heartening that the panel of experts who pilot tested my survey expressed scholarly 
and professional interest in my research, asking that I share the results with them.  
 
Houston, Autumn, 2009 
Creating my survey was time-consuming, but was finally accomplished thanks to a 
panel of experts I assembled to pilot test the instrument. Getting permission to 
administer the survey at a Houston HIV/AIDS clinic was more difficult and required 
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persistence, persuasion, patience, and numerous meetings with clinic administrators.  
Five months later, approval was in hand, and I began to organise the logistics of 
travelling to Houston to survey clinic patients and staff. I recruited several of my 
undergraduate students to help with data collection. Some of the students were naturally 
outgoing and did not hesitate to approach everyone who came into the clinic. A couple 
of students were actually frightened—one told me she feared to use the restroom 
facilities at the clinic. Another student was horrified when she learned we would be 
working at an AIDS clinic. ‘So, some of the people might actually have AIDS? ‘ she 
asked in all seriousness.  
The patients were all ages, genders (sometimes difficult to determine), and ethnic 
group. Their educational background ranged from high school dropout to doctorate. But 
HIV/AIDS was the common thread that connected them all. Some spoke very freely 
about their HIV/AIDS experiences; most were appreciative we were collecting 
information to better inform people about the disease and possible treatments. Both staff 
and patients commented they found information in the survey that made them realise 
they needed to do more research into treatment choices. Some took time to tell us their 
personal stories. One of my student assistants wrote this entry in his own reflective log: 
 
"I remember one guy in particular who came in with a huge smile on his 
face.  When we asked him to participate in our survey, the man smiled, said 
no problem, and took a clipboard from my hand. As he was filling out the 
survey, he began to converse with us about how he got AIDS when he was a 
kid in high school and had no knowledge of AIDS or HIV. He said he's had 
AIDS for about half of his life, and that he belongs to a Houston organisation 
that raises money for AIDS and HIV awareness. He told me he had been 
working for this organisation for about 13 years and last year alone, he raised 
over $100,000 for HIV/AIDS education so kids could be more aware of the 
disease and learn to be safer about sex so they could live the life he never 
got to have. He then finished the survey, handed it to me, gave me a big 
smile and told me thanks for what we were doing. He told us that it meant a 
lot and that we had no clue how big of a difference we were actually making. I 
think I'll always remember him and that conversation because it really did 
touch my heart.! 
 
Some people were intent on taking the survey. One woman did not have her reading 
glasses with her and asked one of the students to read the survey so she could be 
included. The students kept commenting, ‘I can’t believe people are so open.’ By 
contrast, a couple of patients’ only question when asked to participate, was, ‘Is there an 
incentive?’ In fact, we did have a grab bag of candy and small party favours, which the 
respondents seemed to find a sufficient reward. There was clearly a feeling of 
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community at the clinic—people knew each other and were mostly positive and upbeat 
in their attitude toward life.  
The clinic administrators were surprised at the high rate of response to our survey—
we collected more than 340 valid surveys during four days. The elements that seemed to 
make the process go so smoothly included: 
• The ‘goodie bag’ was a fun element—the silly toys and candy made people smile. 
• People responded to the students and the fact the project was education based. 
• A polite but persistent approach paid off. 
• We had a good location in the front foyer; everyone who came in walked past us. 
• We had good signage—colourful and simple in both English and Spanish. 
• People liked being asked for their opinions and wanted to help with the project. 
 
________________________  
2010 
________________________
 
 
Huntsville, Spring 2010 
This spring was a whirlwind of research and teaching as I prepared for my annual 
residency, to take place in April instead of in the summer. This schedule would allow 
me to complete most of my thesis while I was at Teesside, do rewrites and edits over the 
summer and submit the final version by the end of the year. Since I would be leaving for 
England in the middle of the spring term, my three classes were set up as online 
courses—now I could teach from anywhere in the world as long as I had an Internet 
connection. 
The biggest challenge was all that needed to be done before I left Texas. In addition 
to putting all of my survey data into SPSS so I could ‘crunch the numbers,’ I needed to 
do my reaction interviews to the survey data. 
In the odd way that serendipity had so often come to my rescue since I began this 
project, it happened again. This time, the catalyst was a donkey named Ricardo. I am a 
passionate animal lover, and I learned of a no-kill animal shelter on the outskirts of 
Huntsville. I went for a tour, met the owner of the shelter and decided to sponsor an 
animal. I chose Ricardo, a beautiful donkey who had been rescued from the Grand 
Canyon several years ago. My monthly contribution would help keep Ricardo in donkey 
vittles and apple treats. I also learned the director of the shelter had been an HIV/AIDS 
counsellor and activist who helped found the Center for AIDS Information and 
Advocacy in Houston. He provided a referral to that organisation’s director, and to an 
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internationally known HIV/AIDS medical doctor, both who proved to be key informants 
for my reaction interviews.  
I was also excited to receive a copy of the Global Trends book, which was released 
internationally in soft cover that spring. 
 
MILESTONE: 
 Published—‘Love, Sex, and HIV/AIDS: Using Social Marketing to Redefine Gender 
Norms Among Mexican Youth,’ Chapter 4, Social Marketing for Public Health: Global Trends 
and Success Stories. Eds. Hong Cheng. Philip Kotler, and Nancy Lee. Sudbury, Mass.: Jones 
and Bartlett 
 
Teesside, April-May 2010 
On the road again: back to Teesside for my fifth—and last—residency. I was 
determined to work as many hours each day as I could so I would have most of my 
thesis written and reviewed before I returned to Texas. I took only a few items of 
clothing and left my cell phone at home. No distractions. So, I struggled with the SPSS 
data (with the help of a faculty expert in statistics), assimilated my interview data, 
interpreted, edited, wrote, and rewrote. And rewrote. This time I shivered in the chill air 
of April and was grateful for warm water in the down-the-hall bath I shared with three 
computer undergrads in a rented house several blocks from the university. I also 
continued to teach my three online classes; I graded the students’ final projects and 
posted their grades from England. My only leisure time was the Friday I ‘skipped 
school’ and took the train to my favourite Yorkshire town—Whitby, that seaside city 
from which my ancestor sailed centuries ago. Sitting in the train, I enjoyed anew the 
verdant fields, the flocks of sheep, and the quaint train station at every village. In 
Whitby I bought a few gifts to take to friends back in the States and ate lunch at my 
favourite waterfront restaurant. Then, it was time to catch the evening train back to 
Middlesbrough and my waiting laptop. 
 
 Huntsville, Summer 2010 
The writing and re-writing continued through the summer. I was drowning in data 
and some days it seemed I would never find the right words to introduce, explain, and 
conclude each chapter. Formatting proved to be hugely time-consuming. The thesis 
grew to two volumes—one for the body of the thesis, the other for the six appendices, 
even bulkier than the main document. A perfectionist by nature, I urged myself to 
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remember the advice from that doctoral colloquium in Surrey three years ago: ‘The 
perfect is the enemy of the good.’  I was determined to create a good thesis even if it 
could never be quite perfect. By the middle of August, everything was there, from 
abstract and acknowledgements to references and appendices. I was ready for my 
supervisors to do one last ‘big read’ before the volumes were shipped off the examiners. 
While my committee members valiantly tackled my thesis, I mined the chapter on 
my survey results to fashion a paper, which I submitted to the 2nd World Social 
Marketing Conference, to be held in Dublin in April 2011. 
 
Huntsville, Autumn 2010 
In late autumn, I received this heartening email:  
 
"I work for the Research team at The NSMC (previously the National 
Social Marketing Centre) which is based in London, UK. One of our 
resources, which is widely used within the social marketing industry, is 
ShowCase, an online database of social marketing case studies. We are 
always looking for new and innovative examples of social marketing good 
practice to contribute to our growing wealth of knowledge and learning.  In 
searching for suitable projects for ShowCase I came across 'Programme 
H,' which you had written about in the book 'Social Marketing Public 
Health: Global Trends and Success Stories'. Programme H is exactly the 
kind of social marketing/behaviour change project we would like to write 
up and publish on our website. 
Would you be interested in contributing to the write up of Programme 
H for ShowCase? Please confirm whether you would like to be featured 
on ShowCase.!  
 
Of course, my response was an enthusiastic ‘yes.’ The case study has since been 
written and edited and will appear in ShowCase in 2011. 
Additionally, my Dublin proposal was accepted, so I registered for the 2nd World 
Social Marketing Conference and marked my calendar to be in Ireland in April of 2011. 
I’m honoured to be one of the presenters at this international event that will feature the 
social marketing giants from around the world. 
Aside from completing the final edits on both volumes of my thesis, I ended 2010 
with one other positive note: I learned that Global Trends had been published in Google 
Books, extending its reach and usefulness as a social marketing text. 
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 Huntsville, December 2010 
Looking back… 
By the time I reached the fourth stage of this research expedition, I had crossed 
many borders—literally and figuratively. In a literal sense I had traversed many borders, 
trekking outside the ubiquitous portals of the Internet to personally visit an array of 
countries and speak with a diverse mix of people. My travels in pursuit of a degree led 
to encounters with a variety of natural and man-made disasters, but delays and minor 
discomfort were the only tolls I paid. These events stand out in my memory: 
Hurricane:  Sept 2005—My travel companions and I were stuck in London because 
Hurricane Rita closed the Houston airport (and the rest of the city, too). Rita was the 
most intense tropical cyclone ever observed in the Gulf of Mexico, coming inland with 
winds of 120 mph. Luckily, the B&B had vacancies for an extra three days and my 
plastic was up to the challenge. 
Terrorism: July 2007—A bomb at the Glasgow airport filled the southbound trains 
with travellers trying to make their flights in London, so I wedged myself onto a train to 
Surrey. When I was ready to head home from London on July 4, half of Heathrow 
Airport was closed due to another bomb threat, but my flight made it out on schedule. 
Volcano: April 2010—The Iceland volcano disrupted flights in much of Europe for 
several weeks. I was on the first plane out of Houston to Frankfurt after five days of 
closures. Arriving in Frankfurt, I became part of an ocean of people. I saw rooms of cots 
where people had been sleeping for days, and learned there were no flights to England. 
By mere chance I discovered my airline, Lufthansa, was running a few buses to major 
European airports. I managed to get the last seat on a bus headed for London. For 12 
hours we rolled across Europe with two 10-minute rest stops. At midnight, we crossed 
the channel at Dover, and then were deposited at Heathrow at 2 a.m. to make our way to 
our final destination. I spent the rest of the night sitting in Heathrow airport and visiting 
with a journalist from Birmingham who was on same bus. When morning came, we 
took the underground to the central train station, where I purchased a ticket to 
Middlesbrough. I was immensely grateful to be in England and not sleeping on a cot in 
the Frankfurt airport. 
But most of all, I am grateful to the many people who offered encouragement, 
advice, information, and insights. I met supportive and interesting people on trains, 
planes, and buses. Helpful people showed up at my office door in Texas, at my work 
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cubicle in Teesside, and at each conference I attended; my casual reading provided 
important links to people with diverse perspectives on my topic. 
On a personal level, I travelled beyond my comfort level and was prompted to 
extend my range of empathy and tolerance in ways I never before contemplated. 
Through it all, life went on, with its large and small triumphs and tribulations: financial 
problems, divorce, death of a parent, work crises, and losses of long-time friends and 
pets. 
On an academic level, I had journeyed across continents of knowledge previously 
unknown to me, emerging with a fuller understanding of just how much I still did not 
comprehend.  
When I called a temporary halt in my travels to reflect and record, I realized I had 
only charted a miniscule region; there are worlds more to explore. 
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APPENDIX B 
CONTENT ANALYSIS AND INTERVIEW DOCUMENTS 
 
           
B.1 Questionnaire to assess campaigns for content analysis  
 
B.2 Summary fact sheet for content analysis campaign (sample) 
 
B.3 Summary of the 18 campaigns used for content analysis 
 
B.4 Question bank for pre-survey interviews – Mexico 
 
B.5 Question bank for pre-survey interviews – Houston 
 
B.6 Question bank for reaction interviews (post-survey) 
 
B.7 List of exploratory research interviews 
 
B.8 List of key informants interviewed – pre-survey 
 
B.9 List of key informants interviewed – post-survey 
 
Name                                                                                                                    Fall 2006 
1 
 
APPENDIX B.1 
Content Analysis 
Social Marketing Campaign Name: 
Description: 
Year Began: 
 
Country: 
 __ Mexico 
 __ Uganda 
 __ United States 
 
Specifically Disseminated: _____________________________________________________________ 
 
Sponsorship: 
 __ Government dept (s) _________________________________________________________ 
 __ International organization(s): ___________________________________________________ 
 __ for –profit corporation / business(s): _____________________________________________ 
 __ industry association (s): _______________________________________________________ 
 __ pharmaceutical company (s): ___________________________________________________ 
 __ educational institution(s): ______________________________________________________ 
 
Specific intended target group: 
 __ no, campaign is aimed at a mass audience 
 __ yes, campaign is aimed at a very specific group 
 
 Is a specific group being targeted? 
 __men who have sex with men 
 __ teens/young adults 
 __sex workers 
 __people living with AIDS 
 __mature adults (30-64) 
 __parents 
 __at-risk groups 
 __other: ______________________________________________________________________ 
 
 Is a specific gender being targeted? 
 __ no; n/a 
 __ males specifically 
 __females specifically 
 
 Are there any other identifying characteristics of the group being targeted? 
 __n/a; no other identifying characteristics 
 __ yes – Specifically: _________________________________________________________ 
Type of Mixed Media Used: 
 __ billboards 
 __ banners 
 __cartoon / comics 
 __discussion groups 
 __ forums 
 __ literature / printed materials 
 __ postcards 
Name                                                                                                                    Fall 2006 
2 
 
 __ posters 
 __ radio commercials (Length: __________________________________) 
 __ television ads (Length: ______________________________________) 
 __ training 
 __ videos 
 __workshops 
 __ other: ______________________________________________________________________ 
 
Messages Presented: 
 
 
Slogan/Tag Line: 
_____________________________________________________________________________________ 
 
Message Recommendations / Purpose (check all that apply): 
 __ none 
 __ “safe sex” 
 __ protect yourself/take care of yourself 
 __ use condom 
 __ fewer partners/avoid multiple partners 
 __ monogamy/one partner 
 __ abstinence 
 __ get tested 
 __ don’t share needles 
 __ don’t be afraid of getting AIDS through casual contact situations 
 __ take responsibility 
 __ learn the facts/know the facts 
 __ write for info 
 __ phone for info 
 __ pick up information/brochure/pamphlet 
 __ get help/counseling/treatment 
 __ see your doctor 
 __ talk to your parents 
 __ talk to your kids 
 __ give money/donation 
 __ other: ______________________________________________________________________ 
 
Other Notes on Purpose: 
 
 
Call to Action Present: 
 __ no 
 __ yes 
 
 
Role of Spokesperson: 
 __ n/a/not sure 
 __ announcer 
 __ singer 
 __ average/neutral person 
 __ first-hand experience 
 __ victim/survivor/friend of victim 
 __ expert 
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 __ authority figure 
 __ government / political official 
 __ community leader 
 __ celebrity 
 __ cartoon figure 
 __ other: ______________________________________________________________________ 
 
 Name of Celebrity(s):____________________________________________________________ 
 
 If authority figure, expert, community leader, or government official, what occupation? 
 __ n/a 
 __ police officer 
 __ fire fighter 
 __ judge 
 __ teacher/professor 
 __ minister/priest 
 __ doctor 
 __ nurse 
 __ Other:______________________________________________________________________ 
  
Spokesperson Characteristics: 
 
 Sex: 
 __ n/a or not sure 
 __ male 
 __ female 
 
 Age: 
 __ n/a or not sure 
 __ child 
 __ teenager 
 __ young adult (18-30) 
 __ mature adult (30-64) 
 __ elderly (65+) 
 
 Race: 
 __ n/a or not sure 
 __ white 
 __ black 
 __ Hispanic 
 __ Asian  
 __ Other: _________________________________________________________________ 
 
 
 
 Reference to Cultural Roots: 
 __No/not sure 
 __Yes 
 
 If yes, cite specific examples: 
 __ Language 
 __ Country/area flag or seal 
 __ Clothing / style 
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 __ Music  
 __ Lifestyle 
 Other: ________________________________________________________________________ 
 
Product Promotion: 
 __ No/not sure 
 __ Yes 
 
 If yes, what is the product(s)? 
 __ Book/literature 
 __ Condoms – male 
 __ Condoms – female 
 __ Treatment Kits 
 __ Video  
 __ Other: 
 
Types of Appeals Present (Check all that apply):  Evidence of Appeals on Page 5 
 __ Decision-making 
 __ Fear 
 __ Positive / rational 
 __ Self-interest 
 __ Social-cognitive 
 __ Sustainable development 
 __ Two-step flow 
 
Overall Tone of Message: 
 __ Negative (threat, fear, sad) 
 __ Neutral 
 __ Positive (up-beat, humor) 
 __ Not sure 
 
Social Marketing Elements: 
 
 Product / Solutions:  Is there a clear social marketing product being offered? 
 __ No 
 __ Yes – Specifically: __________________________________________________________ 
 
Is there an “actual product” being offered? 
 __ No 
 __ Yes – Specifically: ________________________________________________________ 
 
Is there an ‘augmented product’ being offered 
 __ No 
 __ Yes - Specifically: ______________________________________________________ 
 
Price / Value:  Are issues of price addressed? 
 __ No 
 __ Yes – Specifically: _______________________________________________________  
 
Promotion / Information: Is adequate information being offered? 
 __ No 
 __ Yes – Specifically: ________________________________________________________ 
 
Name                                                                                                                    Fall 2006 
5 
 
Placement / Access: Are place and placement issues addressed? 
 __ No 
 __ Yes – Specifically: _______________________________________________________ 
 
Other Campaign Notes: 
 
 
 
 
 
Evidence of Appeals: 
 
Appeal: 
• __________________________________________________________________________ 
• __________________________________________________________________________ 
• __________________________________________________________________________ 
• __________________________________________________________________________ 
 
Appeal: 
• __________________________________________________________________________ 
• __________________________________________________________________________ 
• __________________________________________________________________________ 
• __________________________________________________________________________ 
 
Appeal: 
• __________________________________________________________________________ 
• __________________________________________________________________________ 
• __________________________________________________________________________ 
APPENDIX B.2 
Sugar Daddies 
Description:  Working to stop cross-generational sex, which is sex with a person at least 10 
   years older 
Currency:  Began in 2004 - 2005 
Int’l  Orgs:  PSI, National AIDS Committee 
Pharm Co.:   None Mentioned 
Purpose:  Sugar Daddy relationships are a major reason why HUV infection rates are up 
   to 6 times higher for teenage girls than their male counterparts.  Also to 
   break the silence, raise public awareness of dangers involved, and change 
   societal views (PSI Profile) 
Target Audience: Young women (15 – 24), their parents, and older male partners 
Where Dissm.:   Uganda, Cameroon, Kenya, in schools 
Media Mix Used: Television, radio, print, seminars (with media coverage of the seminars) (PSI 
   Profile). Government-sponsored posters, offering chastity scholarships, radio 
   soap opera (CSM). 
Msgs Present: Sugar Daddy + Young Girl = Danger (PSI Profile). Golden Rule approach 
(CSM).   Also, saving yourself for marriage is the right thing to do (GHF) 
Use of Celebrities: Yes, Tim Lwanga, Uganda’s Minister of Ethics and Integrity. Also 
Archbishops (PSI) 
Refs to Roots:  Having a sugar daddy could be a root, as it is a societal norm 
Prod. Promotion:  Deemphasize condoms 
  
APPENDIX B.3 
Summary of the 18 campaigns used for content analysis 
 
MEXICO 
   
1. Investing in People  
This five-year initiative to reduce barriers to behaviour change and care seeking 
began in 2003. It was a localised version of a series of similar campaigns that were 
underway in several countries. Focused in Mexico City, where the largest number of 
HIV/AIDS cases were found, Investing in People was the joint effort of a half-dozen 
international, national, and local organizations. A key technique was personal 
communication through workshops and conference presentations conducted by trained 
female advocates and local HIV/AIDS leaders 
(http://www.usaid.gov/policy/budget/cbj2006/lac/pdf/mx523-023.pdf). 
 
2. VIDA Menos Etiquetas 
Sponsored by Population Services International-Mexico, this gender-equity 
initiative  incorporated the research and successful techniques of Programas H and M 
to reach young people at risk. Menos Etiquetas used peer educators to initially broach 
themes that included gender norms, HIV/AIDS, and stigma. A traditional media mix 
including posters, postcards, stickers and flyers was teamed with below-the-line social 
media such as blogs and Bluetooth viral marketing (http://www.psi.org/mexico). 
 
3. Programa Hombres (Project H) 
Links between traditional gender attitudes and the spread of AIDS prompted a 
partnership of NGOs to develop Programa Hombres. This five-year initiative has been 
used in more than twenty countries, including Mexico, to persuade young Latino men 
to question traditional norms related to manhood. An extensive media mix included 
educational videos available in three languages—Spanish, English, and Portuguese—
interactive workshops, and collateral materials as well as radio, outdoor media, and 
direct mail. The campaign slogan, ‘In the Heat of the Moment,’ urged use of the Hora 
H condom brand, manufactured by the makers of Durex condoms and distributed in 
non-traditional venues such as funk balls and cafes (www.promundo.org.br).  
 
4. Programa Mujeres (Project M) 
Building on their success in educating young men about the costs of traditional 
macho culture, in 2005 the Program H partners and World Education launched 
Programa Mujeres to encourage young women to take control of their sexual and 
reproductive health. This social marketing campaign was based on research that 
included a review of Latin American literature to define the concept of female 
empowerment, focus group discussions with groups of young women aged 14-24 who 
lived in marginalised communities outside Queretaro, Mexico, and interviews with 
empowered young women (www.promundo.org.br). 
 
5. Tú No Me Conoces  (You Don't Know Me) 
The Tú No Me Conoces social marketing campaign promoted awareness of HIV 
risk and testing of Latinos living on the California-Mexico border. The 8-week 
campaign included Spanish-language radio, print media, a website, and a toll-free 
HIV-testing referral hotline. Campaign results included an increase in HIV testing at 
partner clinics; 28% of testers who heard or saw an HIV advertisement specifically 
identified the campaign. (http://www.docstoc.com/docs/43661964/Southern-
California-Border-HIVAIDS-Project-TU-NO-ME-CONOCES). 
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6. VIDA Digna (Life with Dignity) 
Reducing stigma and discrimination experienced by sex workers, gay men, men 
who have sex with men, drug users, and people living with AIDS was the central 
purpose of the three-year Vida Digna campaign, launched in 2005 by the Colectivo 
Sol alliance and funded by GlaxoSmithKline. The campaign was centred in the central 
states of Mexico, a conservative area characterised as having ‘the weakest civil society 
response to AIDS.’ Vida Digna used anonymous testimonials to urge tolerance and 
acceptance of people’s differences (http://www.aidsalliance.org/sw45511.asp).  
 
 
UGANDA 
   
1. ABCs (Abstinence, Being Faithful and Condoms) 
This campaign took a moralistic approach—‘Sex can wait until marriage’—and 
used outdoor media as well as local spokespeople such as community leaders and 
ministers to urge abstinence before marriage and fidelity to spouses. Practical AIDS 
information was provided and condom use was also advocated to reduce risk of 
infection. This program and others like it have generated international controversy 
about whether condoms are effective in reducing HIV prevalence and raising 
associated concerns about increased promiscuity 
(http://www.pbs.org/now/science/aidsdebate.html). 
 
2. Afford Good Life 
AFFORD was a five-year health marketing initiative led by the Johns Hopkins 
Bloomberg School of Public Health and funded by the U.S. Agency for International 
Development. Designed to increase accessibility and affordability of AIDS products 
and services, the campaign promoted Protector brand condoms, Pilpan oral 
contraceptives, and Inject injectable contraceptives. Consumers were encouraged to 
use these products properly and could access them at subsidised rates. A centrepiece of 
the campaign was ‘The Good Life Gameshow,’ an entertainment education quiz show 
using an integrated multimedia approach, including community interaction, and radio 
and television shows (http://www.jhuccp.org/africa/uganda/afford.shtml). 
 
3. Be a Man 
 Targeted primarily to young men 15 to 24, this campaign was launched in 2006 to 
prompt reflection on the costs of traditional male attitudes and behaviours, which 
research has shown contribute to an increase in HIV infections. ‘Society’s expectations 
of men are setting them up for failure,’ according to Vincent Kiwanuka, the Be a Man 
campaign’s coordinator. The media mix heavily utilised radio drama and television, 
including broadcasts during the World Cup. The goal was to encourage sexual 
relationships based on mutual respect and love 
(http://www.hcpartnership.org/Press/press2006-06-21.php). 
 
4. Onelove  
 Launched in January 2009, the South African Onelove campaign aimed to reduce 
new HIV infections in South Africa by 10% by 2011. The focus of the campaign, led 
by Soul City Institute for Health and Development Communication, was on multiple 
concurrent partnerships (MCP), one of the key drivers of the HIV pandemic in 
Southern Africa. The campaign’s goal was to shift social norms away from multiple 
sexual partnerships and encourage monogamous relationships. Onelove challenged 
gender stereotypes and cultural norms that reinforce MCP and highlighted the risks 
associated with transactional, drunk, and intergenerational sex. The campaign used 
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mass media, including the Soul City television drama series, a radio drama, print 
materials, and social mobilisation and advocacy 
(http://www.comminit.com/en/node/286237/347).  
 
5. PMTCT (Prevention of Mother to Child Transmission) 
‘The Social Marketing Approach to PMTCT’ is a Population Services International 
[PSI] project that used a branded franchise network of trained midwives to help 
pregnant women reduce transmission risk during birth. The midwives were also 
trained on HIV testing procedures and counselling skills. The central message of this 
campaign was it is possible to have an HIV-negative baby even when both parents are 
HIV positive. Since 2003, a broad media mix has disseminated this message to male 
partners of pregnant women 25-45, primarily in low-income, low-literary, peri-urban, 
and rural areas of Uganda (http://www.psiwash.org/resources/pubs/Uganda2004.pdf). 
 
6. Sugar Daddies 
Addressing the widespread problem of cross-generational sex (sex with a person at 
least 10 years older), this campaign, begun in 2004, sought to raise awareness of the 
dangers of ‘sugar daddy’ relationships. This practice is a major reason HIV infection 
rates have been six times higher for teenage girls than for their male counterparts. 
Target audiences include young women 15 to 24, their parents (who often encourage 
such relationships), and older male partners. The PSI-sponsored initiative features 
recognised male role models such as Uganda’s Minister of Ethics and Integrity Tim 
Lwanga urging men to ‘stop preying on young girls’ 
(http://psi.org/resources/pubs/cross-gen.pdf). 
 
 
UNITED STATES 
   
1. Be the Generation 
This program aimed to create a supportive environment for HIV vaccine research 
by mobilizing existing community partnerships and networks to educate key 
communities about this research in 20 U.S. cities where HIV vaccine clinical trials 
were ongoing or planned. Coordinated media and collateral materials segment targeted 
audiences by gender, ethnicity, and lifestyle, showing images of two people, one older 
and one younger. Extensive educational materials were available online. The uniform 
message was the young generation’s ‘great cause’ is to end AIDS and that a vaccine is 
the best hope of accomplishing that goal (www.bethegeneration.org). 
2. I am African /(Keep a Child Alive) 
This campaign, heavily saturated with celebrities, promoted the idea that everyone 
has some DNA with connections to an African heritage, so all people should work 
together to help with the AIDS problem. Begun in 2005, donations for AIDS drugs 
were particularly sought. I am African was linked with the Keep a Child Alive 
campaign, which sought to help AIDS orphans in Africa by providing them with 
ARVs [treatment cocktails]. The I am African images of celebrities such as Gwenyth 
Paltrow and Sting wearing ‘war paint’ with the campaign slogan beneath sparked 
controversy about the use of eye-catching visuals that ‘insensitively perpetuate 
stereotypical ways of thinking about AIDS or Africa’ (www.keepachildalive.org; 
http://percipere.typepad.com/media/2006/08/cause_celebre_o.html).  
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3. MTV Think 
This award-winning public information campaign began in 2006 and was notable 
for bringing MTV on board as a major sponsor. The goal was to reach sexually active 
16- to 24-year-olds with information about HIV and related issues, since according to 
UNAIDS, half of new HIV infections worldwide are among people under the age of 
25. Discussion of safe-sex issues, condom use, and HIV testing were urged through 
television and web media. According to sponsor The Kaiser Family Foundation, this 
was a ‘multi-platform, interactive community for the first generation of Americans 
who have lived their entire lives during the AIDS epidemic’ 
(http://www.kff.org/hivaids/phip060506nr.cfm). 
 
4. The New Faces of HIV in Houston 
 Due to HIV high prevalence among African Americans in Houston, in 2002 the 
Harris County Hospital District and the Houston Department of Health and Human 
Services launched a social marketing campaign to raise awareness and increase 
testing among this population. Media included radio, public transit, direct mail, and 
brochures targeting women. Images of both men and women were featured in the 
materials, with the slogan, ‘We look just like you, but you don’t have to be like us. Do 
the right thing. Get tested’ (http://www.hchdonline.com/HIV/newfaces.htm). 
 
5. ONE 
With more than 60 partners, this campaign was set up to rally Americans one by 
one to push for increased donations to fight poverty and AIDS. The campaign had a 
broad target audience, ranging from students to ministers to punk rockers to soccer 
moms. The call to action was ‘We’re not asking for your money, we’re asking for your 
voice.’ In line with this approach, on June 11, 2007, ONE launched ONE Vote ’08, its 
‘largest and boldest initiative ever,’ vowing to make extreme poverty and global 
disease an issue in the 2008 U.S. elections (www.one.org).  
 
6. We all have AIDS 
Launched in 2005 on World AIDS Day, this campaign created by American 
designer Kenneth Cole was heavily supported by celebrities and prominent AIDS 
activists. The message was to reduce stigma associated with AIDS to prevent, contain, 
and eradicate the disease. The consistent theme for all ads was ‘We all have AIDS…if 
one of us does.’ International celebrities participating included President Nelson 
Mandela, Arch Bishop Desmond Tutu, Sharon Stone, Will Smith, and Sir Elton John 
(www.WeAllHaveAIDS.com).  
 
 
 
 
 
APPENDIX B.4 
Using Social Media as a Health Promotion Tool: The Mexican Experience 
Date: _________________________________ 
Code: _________________________________ 
1. What is your academic or professional background? 
2. Describe the health organization you work for. 
3. What health campaigns have you been involved with? 
4. What has been your role in those campaigns? 
5. Background and rationale behind the campaign approach? 
6. Can you describe those campaigns? 
a. What was the target audience or target market?  Describe its characteristics. 
b. When was the campaign executed?  Scope/timeframe of campaign? 
c. What kind of research was conducted before designing the campaign? 
d. Who designed the campaign? 
e. What have you learned by executing this campaign? 
f. What were this campaign’s objectives? 
g. What were the messages disseminated? Why did you choose those messages? 
h. Who were the sponsors/partners? How were they selected? 
i. Were there medical advisers/image consultants, etc? 
j. Campaign strategies—which were most effective? (might include policies, internal PR, etc) 
k. What media outlets were used to disseminate information? Which were more effective? 
l. Was social media used? If so, who decided to use it? Have anybody assessed the used of 
social media? 
m. Who sponsored the campaign? 
n. Budget/funding sources? 
o. How do recipients of information perceive their choices as regards prevention techniques 
and treatment modalities? 
p. What are their unanswered questions, gaps in knowledge? 
q. How is campaign evaluation conducted? (Is there a written report available?) 
r. Role of controversy/political concerns in getting funding/approval for campaigns? 
s. The most important lessons learned? What will you do differently in future campaigns? 
t. Trends you see in the use of social marketing campaigns for disease 
preventions/information? 
u. Possible to get samples of materials? (Okay to reproduce images?) 
 
APPENDIX B.5 
Question bank for pre-survey interviews (Houston) 
 
 
1. Briefly, please talk about your professional background as it relates to HIV/AIDS. 
 
2. How long have you been working with fundraising/communications efforts to combat 
HIV/AIDS in Houston?  
 
3. Which techniques have you found are most effective in gaining the support of 
Houston policymakers/upstream audiences? 
 
4. Did you participate in developing the rationale behind the campaign approach for 
New Faces of Houston? 
 
5. Was it difficult to make the decision to be pictured in the campaign literature? (Only 
addressed to interviewees who were pictured in the campaign) 
 
6. What kinds of problems has being a spokesperson for the campaign created for you? 
(Same as #5) 
 
7. How important are sponsors/partners to successful HIV/AIDS campaigns?  
 
8. Which kinds of campaign media strategies do you think are most effective in 
Houston?  
 
9. How do recipients of HIV/AIDS information perceive their choices as regards 
prevention techniques and treatment modalities in this city?  
 
10. What are their unanswered questions, gaps in knowledge? 
 
11. In your experience, what is the role of controversy/political concerns in getting 
funding/approval for campaigns in Houston? 
 
12. What do you think were the most important lessons learned in this campaign?  
 
13. What would you like to see done differently in future HIV/AIDS campaigns? 
 
14. What trends do you see in the use of social marketing campaigns for HIV/AIDS 
prevention/information?  
 
15. Is there anything you would like to add that I have not asked? 
 
  
APPENDIX B.6 
Question bank for reaction interviews (post survey) 
 
 
 
1. Briefly, please talk about your professional background as it relates to HIV/AIDS. 
 
2. What are your initial reactions to the Legacy Clinic survey results? (Interviewer 
summarises highlights of results and shows charts of result trends). 
 
3. Regarding HIV/AIDS in Houston: What kinds of support have been provided by local 
or national policymakers?  
 
4. What techniques/approaches have been most effective in getting support? 
 
5. How important are sponsorships/partnerships in combating HIV/AIDS?  
 
6.  Do those sponsorships influence which products and treatments are considered 
mainstream? If so, how? 
 
7. What is the role of controversy in getting messages out about HIV/AIDS? 
 
8. After 30 years, what are the most important things we have we learned in the area of 
(medical, marketing, advocacy) for prevention and treatment of HIV/AIDS? 
 
9. Where do we go from here? What would you like to see done differently in the future 
regarding (medical, marketing, advocacy?) 
 
10. In general, how effective do you think social marketing campaigns are in motivating 
people to change their behaviour regarding preventing HIV/AIDS?  
 
11. Can social marketing campaigns motivate lifestyle changes regarding treatments for 
HIV/AIDS? 
 
12. Is there anything you would like to add that I have not asked? 
 
 
APPENDIX B.7 
List of exploratory research interviews  
2005-2010 
 
 
 
Dr. S.K. Banerjee, Homeopathic Physician, Kolkata, West Bengal, India. Email and 
telephone communication, June 2007. 
 
Kemper B. Crabb, Director of the Order of Servants of the King, a charity organisation 
that builds churches, schools, orphanages, and hospitals in remote areas of India, Nepal, 
and Uganda. Personal interview, March 2007. 
 
Sameer Deshpande, PhD, Assistant Professor, Marketing, University of Wisconsin, 
and Faculty member, Centre for Socially Responsible Marketing, Lethbridge, Alberta, 
Canada. Personal communication, October 2006. 
 
Tugba Kalafatoglu, Tugba Kalafatoglu and Associates, Istanbul, Turkey. Personal 
communication, October 2007. 
 
Dr. Susan Kern, Principle investigator, ‘Lazarus Study: HIV/AIDS Interaction with 
HIV/AIDS.’ Personal interview, June 2006. 
 
James Kiwanuka-Tondo, Assistant Professor, Department of Communication, North 
Carolina State University, Raleigh, NC. Personal and email communication, October 
2006. 
 
Dr. Jesus Meza Lueza, Profesor- Investigador, Comunicadio Y Periodismo, Campus 
Cuidad de Mexico. Personal communication, August 2006. 
 
Laura McDermott, Research Officer, Institute for Social Marketing, University of 
Stirling & The Open University, Stirling, Scotland. Personal interview, June 2006. 
 
John Harold Estrada Montoya, Profesor Investigador, Salud Pública, VIH/SIDA, 
Ciudad  Universitaria, Bogota, Colombia. Personal communication, August 2006. 
 
David Olson, Director of Public Affairs, Population Services International, 
Washington, DC. Personal communication, August 2008. 
 
Lars Ivar Owesen-Lein Borge, HIV/AIDS Activist and conference organiser, Mexico 
City. Personal interview, December 2006. 
 
Andrew Waldhausen, Director, Gay & Lesbian Network, South Africa. Personal 
interview, August 2008. 
 
Agustín Villalpando, Editor, Enkidu Magazine, Mexico City.  Personal 
communication, December 2006. 
 
 
APPENDIX B.8 
List of key informants interviewed—pre-survey 
 
 
TEXAS/USA 
 
Françoise Armand, Social Marketing and Pharmaceutical Partnerships Director, 
Private Sector Partnerships One, Bethesda, MD.  Email communication, March 2008. 
 
Dr. Carlos Arreola, a long-time HIV/AIDS counsellor and activist in the Houston area. 
Helped found the CFA (see glossary). Personal interview, March 2009. 
 
Barbara Bijelic, Research Assistant, PSP-One Program, International Health Division, 
Bethesda, MD. Email communication, January 2008. 
 
Susan Diemont-Conwell of Torma Communications in Houston helped design the 
campaign, New Faces of HIV in Houston. Telephone and email interviews, January 
2008. 
 
Dena Gray, a Houston activist and administrator for Houston’s Housing and Community 
Development Department, an agency that locates housing for people living with HIV/AIDS.  
She is responsible for public service funds totalling approximately $12 million annually. 
Gray was also pictured in the New Faces of HIV in Houston campaign. Email interview, 
January 2008. 
 
Maria de la Luz Martinez, Translation consultant, Austin, Texas. Email and telephone 
communication, May 2008. 
 
Beau J. Mitts, Manager, HIV Prevention Program, City of Houston. Personal 
interview, January 2008. 
 
Ken Malone, HIV Testing Project Coordinator, Thomas Street Health Centre, Houston, 
TX. Personal interview, September 2009. 
 
Eric Roland, Senior Director of Marketing, Legacy Community Health Services, 
Houston, TX.  Telephone and email interviews, February 2008. 
 
Karen Russell, Incremental Marketing, Inc., Clear Lake Shores, TX. Email interview, 
February 2008. 
 
Dr. Blair Winegar, Conventional medical doctor who completed his training in Texas. 
Personal communication, October 2009. 
 
Sandy Won, International Center for Research on Women (ICRW), Washington, DC. 
Email communication, February 2009. 
 
 
EUROPE 
 
Dr. Nele Jensen, who worked at an HIV/AIDS clinic in Germany, co-directed a 
documentary of interviews with HIV-positive people from all walks of life. Personal 
interview, June 2009. 
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Daréll Lourens, a South African filmmaker who filmed and edited The HIV/AIDS 
documentary, Blissfully Lost, which was financed by GlaxoSmithKline and was 
screened at the 2009 German-Austrian-Swiss AIDS Congress in St.Gallen. Personal 
interview, June 2009.  
 
Elizabeth Sutherland, PhD, Associate Scientist II, Health Services Research, Family 
Health International, Durham, NC. Personal communication, June 2009. 
 
 
MEXICO/LATIN AMERICA 
 
Pepe Aguilar, Director, DEMYSEX, Mexico.  Email communication, May 2008.  
 
Hilda Peñaloza Andaluz, Coordinadora Administrativa, Population Services 
International, México. Email communication, February 2009. 
 
Gerardo Ayala, Salud y Genero, Mexico. Email communication, February 2009. 
 
Gary Barker, PhD, Executive Director/Diretor Executivo, Instituto Promundo, Rio de 
Janeiro, Brasil. Email communication, April 2008. 
 
Alejandro Brito, Director, LETRA S, Mexico. Email communication, May 2008. 
 
Oliver LeTouzé, Director, PSI México. Email and telephone communication, April 
2008. 
 
Anna Luiza, Promundo Instituto, Brasil. Email communication, February 2009. 
 
Alejandra Megloli, Director, Mexfam, Mexico. Email communication, May 2008. 
 
 Marcos Nascimento, Co-Director, Promundo Instituto, Brasil.  Email and telephone 
communication, May 2008. 
 
Lars Ivar Owesen-Lein Borge, HIV/AIDS Activist and conference organiser, Mexico 
City. Personal interview, August 2008. 
 
Christine Ricardo, Co-Director, Promundo Instituto, Brasil, Email and personal 
interviews, August 2008. 
 
Agustín Villalpando, Editor, Enkidu Magazine, Mexico City.  Personal 
communication, August 2008. 
APPENDIX B.9 
List of key informants interviewed post-survey (reaction interviews) 
 
 
 
Dr. Jacques Clermont, Collaborator for INSERM, France’s National Institute of 
Health and Medical Research, commented from the perspective of an alternative 
medical doctor doing research and working with HIV/AIDS patients. 
 
Tina Megdal, Senior Director of Client Services, Legacy Clinic in Houston, provided 
observations on the results of the survey at Legacy. 
 
Amy Leonard, Health Educator for Legacy Clinic in Houston, provided observations 
on the results of the survey at Legacy. 
 
Dr. Mark Nichols, Vice President of Clinical Affairs for the Bering Dental Clinic in 
Houston, commented from the perspective of a conventional medical doctor working 
with HIV/AIDS patients.  
 
Paul Simmons, Executive Director of the Center for AIDS Information and Advocacy 
(CFA) in Houston, commented from the perspective of a long-time HIV/AIDS activist. 
 
  
Note: All were personal interviews, which took place in Houston in March and April of 
2010. 
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APPENDIX C 
SURVEY DOCUMENTS 
 
           
C.1 Research Subject Informed Consent Form 
 
C.2 HIV/AIDS Knowledge and Perceptions Survey (English) 
 
C.3 Survey: Versions 9.2, 9.3, and 9.4 of Page 2 
 
C.4 HIV/AIDS Knowledge and Perceptions Survey (Spanish) 
 
C.5 Survey Consultants  
 
C.6 Guidelines for Survey Data Collection 
 
C.7 Facsimiles of the Survey Signs (English) (Spanish) 
 
C.8 Comments from Legacy Survey Respondents 
APPENDIX C.1 
Research Subject Informed Consent Form 
 
Title of Project: 
Social Marketing Strategies for Combating HIV/AIDS in Rural and Disadvantaged 
Communities in Uganda, Mexico, and the Southern United States 
 
Prospective Research Subject:  
Read this consent form carefully and ask as many questions as you like before you 
decide whether you want to participate in this research study. You are free to ask 
questions at any time before, during, or after your participation in this research. There 
will be no penalty or loss of benefits to which you are otherwise entitled if you choose 
not to participate. 
 
Purpose and Procedures:  
You are being asked to participate in a research study designed to evaluate your 
knowledge and perceptions about HIV/AIDS. Your responses will help guide the 
design of a model for effectively disseminating information about HIV/AIDS.  
 
This survey is being administered to a sample of people whose principal commonality 
is that they are all receivers of information about prevention techniques and treatment 
modalities available for HIV/AIDS. You should not experience any discomfort as a 
result of participating in this study and you can decline to answer any question. Your 
responses will be strictly anonymous; they cannot be connected to you in any way. If 
this research is published, no information that would identify you will be written. You 
may stop the survey at any time.  
 
This survey is part of a research project being conducted by a Ph.D. candidate at the 
University of Teesside in Middlesbrough, England. For questions or concerns 
regarding this research, contact Ruth Massingill at 80 Waterwood, Huntsville, Texas 
77320, or at 1-936-581-1322. 
 
Authorization: 
I have read and understand this form, and I consent to voluntarily participate in this 
research study. I understand I will receive a copy of this form. I realize I am free to 
withdraw my consent and to withdraw from this study at any time without negative 
consequences.  
Participant Name (printed):______________________________________________ 
Participant Signature: 
_____________________________________________________________________ 
Date: 
______________________________________________________________________ 
APPENDIX C.2  
HIV/AIDS Knowledge and Perceptions Survey 
 
This is part of a research study regarding knowledge and perceptions about HIV, HIV/AIDS, 
and/or AIDS (referred to as HIV/AIDS in this survey). Your responses will help guide the design of 
a model for effectively informing people about HIV/AIDS.   
 
I. Are you 18 or older? (If not, stop survey.) 
II. Have you seen or heard information about prevention and treatment of HIV/AIDS? (If 
no, stop survey; if yes, proceed.) 
 
A. From which of these sources have you learned about HIV/AIDS in the past 4-5 years?  
Check ALL that apply. 
 
!  1. TV  ! 11. Online newsletters, journals, etc 
!  2. Radio  ! 12. Emails 
!  3. Books  ! 13. Social media (Facebook,Twitter, etc) 
!  4. Newspapers  ! 14. Community organizations 
!  5. Magazines  ! 15. Religious organizations 
!  6. Out of home (billboards, transit ads,   ! 16. Educational institutions  
  posters, flyers, brochures)   ! 17. Conventional medical doctors 
!  7. Events (seminars, workshops, conferences)  ! 18. Alternative medical doctors 
!  8. Medical websites  ! 19. Friends or family members 
!  9. HIV/AIDS groups’ websites  ! 20. People you work with 
! 10. Blogs, online bulletin boards  ! 21. Other (Specify)________________ 
 
B. Using the scale below, rate each of these sources of HIV/AIDS information according to 
how credible (believable) they have been in your experience.     
    
  Not at all Somewhat Undecided Credible Extremely
 credible    credible    credible 
   
1. TV  ! ! ! !     ! 
2. Radio !    !  !  !     ! 
3. Books ! ! ! !     ! 
4. Newspapers !    !  !  !     ! 
5. Magazines ! ! ! !     ! 
6. Out of home (billboards, bus ads,  
 posters, flyers, brochures)  ! ! ! !     ! 
7. Events (seminars,  
 workshops, conferences) ! ! ! !     ! 
8. Medical websites !    !  !  !     ! 
9. HIV/AIDS groups’ websites !    !  !  !     ! 
10. Blogs, online bulletin boards !    !  !  !     ! 
11. Online newsletters, journals, etc !    !  !  !     ! 
12. Emails !    !  !  !     ! 
13. Social media-Facebook,Twitter,etc !    !  !  !     ! 
14. Community organizations !    !  !  !     ! 
15. Religious organizations !    !  !  !     ! 
16. Educational institutions  !    !  !  !     ! 
17. Conventional medical doctors !    !  !  !     ! 
18. Alternative medical doctors !    !  !  !     ! 
19. Friends or family members !    !  !  !     ! 
20. People you work with !    !  !  !     ! 
21. Other (Specify)_____________ !    !  !  !     ! 
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C. Please check the response that best represents how you feel about these statements:  
 Strongly  Agree Neither Disagree Strongly Not   
 Agree  Agree Nor  Disagree Sure 
  Disagree   
1. Poor people are more likely to get HIV/AIDS.  !   ! ! !     ! ! 
 
2. Globally, the number of people with    
   HIV/AIDS is decreasing. !   ! ! ! ! ! 
 
3. HIV/AIDS is primarily a gay disease. !   ! ! ! ! ! 
 
4. Getting HIV/AIDS is usually a death sentence.  !   ! ! ! ! ! 
 
5. Antiretroviral drugs are a cure for HIV/AIDS. !   ! ! ! ! ! 
 
6. Giving antiretroviral drugs to people who are not 
   infected is a good way to prevent HIV/AIDS.  !   ! ! ! ! ! 
 
7. People who knowingly expose others to 
HIV/AIDS should be prosecuted as criminals. !   ! ! ! ! ! 
 
8. A pregnant woman with HIV/AIDS cannot  
 avoid having an HIV-positive baby.  !  !  ! ! ! ! 
 
9. You cannot get HIV/AIDS during sex if 
   condoms are always used. !  !  ! ! ! ! 
 
10. HIV/AIDS is God’s way of punishing  
the wicked. !   !  ! ! ! ! 
 
11. An effective HIV/AIDS vaccine is available. !   !  ! ! ! ! 
 
12. Alternative medical treatments for HIV/AIDS 
  have shown promising results. !   !  ! ! ! ! 
 
13. People with HIV/AIDS deserve the same  
 rights in the workplace as other workers. !   !  ! ! ! ! 
 
14. Treating HIV/AIDS is a lucrative business  
  for pharmaceutical companies. !   !  ! ! ! ! 
 
15. HIV/AIDS infections are often the result  
of immoral behavior.    !   !  ! ! ! ! 
 
16. It is biologically easier for women to get   
  HIV/AIDS than it is for men. !   !  ! ! ! ! 
 
17. HIV/AIDS prevention efforts often receive 
  more funding than treatment efforts.  !   !  ! ! ! ! 
 
18. Young people under 25 account for almost  
 half of new HIV/AIDS infections globally. !   !  ! ! ! ! 
 
19. I am not personally worried about  
getting HIV/AIDS. !   !  ! ! ! ! 
 
20. Worldwide, more people get HIV/AIDS by  
heterosexual contact than by homosexual contact. !   !  ! ! ! ! 
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D. Please mark ALL of the following HIV/AIDS treatments that you have heard of. 
! 1. UVBI (Ultraviolet blood irradiation) ! 11. Peroxide–IV    
! 2. Silver colloid–IV ! 12. Peroxide–oral  
! 3. Silver colloid–oral ! 13. Venus flytrap–oral   
! 4. Selenium liver support–oral ! 14. Porcine (pig) liver extracts–transdermal   
! 5. Chelation–IV ! 15. Nutritional supplements 
! 6. Chelation–oral ! 16. AZT (Azidothymidine)  
! 7. Vitamins–IV ! 17. HAART (Highly active antiretroviral therapy) 
! 8. Vitamins–oral ! 18. Pharmaceutical antibiotics (Bactrim, etc) 
! 9. Minerals–IV ! 19. Other (Specify)________________________ 
!10.Minerals–oral 
      
E. Based on your own knowledge or experience, please mark ALL of the following HIV/AIDS 
treatments that you think can be effective in treating HIV/AIDS. 
! 1. UVBI (Ultraviolet blood irradiation) ! 11. Peroxide–IV   
! 2. Silver colloid–IV ! 12. Peroxide–oral  
! 3. Silver colloid–oral ! 13. Venus flytrap–oral    
! 4. Selenium liver support–oral ! 14. Porcine (pig) liver extracts–transdermal   
! 5. Chelation–IV ! 15. Nutritional supplements  
! 6. Chelation–oral ! 16. AZT (Azidothymidine)  
! 7. Vitamins–IV ! 17. HAART (Highly active antiretroviral therapy) 
! 8. Vitamins–oral ! 18. Pharmaceutical antibiotics (Bactrim, etc) 
! 9. Minerals–IV ! 19. Other (Specify)______________________ 
!10.Minerals–oral     
F. Demographics (For statistical purposes only—your responses are anonymous.) 
 1. Age Group: !  18-25 !  26-36 !  37- 47 !  48-58 !  59+ 
2. Which gender do you most identify with?   !  Male !  Female 
3. Sexual orientation:  !  Heterosexual   !  Homosexual  !  Bisexual  !  Prefer not to say 
4. Which of the following groups do you most identify with? (Check only one.) 
 !  American Indian, Alaska Native  !  Hispanic 
   or Pacific Islander   !  White/Caucasian 
 !  Asian/Asian American   !  Multi-racial 
 !  Black/African American or Negro !  Other (Specify) _______________________ 
  
5. Which of the following best describes your education level? (Check only one.)   
 !  8th grade or less 
 !  Some high school 
 !  Graduated high school/have my GED 
 !  Graduated from college 
 !  Master’s degree or above 
6. Religious affiliation: _______________________________________     ! Prefer not to say  
7. Are you in a paid position with an organization involved with HIV/AIDS?     ! Yes   ! No  
8. Are you an unpaid volunteer with an organization involved with HIV/AIDS?  ! Yes   ! No 
9. My HIV status is:  !  Negative   !  Positive  !  Don’t know   !  Prefer not to say  
G. Other comments (Use back of page if needed) 
________________________________________________________________________________
________________________________________________________________________________ 
Thanks for your participation!                       V9.1 © Massingill 2009 
 
 
C. Please check the response that best represents how you feel about these statements: (V9.2) 
 Strongly  Agree Neither Disagree Strongly Not   
 Agree  Agree Nor  Disagree Sure 
  Disagree   
1. HIV/AIDS is God’s way of punishing  
the wicked. !   !  ! ! ! ! 
 
2. Getting HIV/AIDS is usually a death sentence.  !   ! ! ! ! ! 
 
3. Globally, the number of people with    
HIV/AIDS is decreasing. !   ! ! ! ! ! 
 
4. A pregnant woman with HIV/AIDS cannot  
avoid having an HIV-positive baby.  !  !  ! ! ! ! 
 
5. Poor people are more likely to get HIV/AIDS. !   ! ! ! ! ! 
 
6. HIV/AIDS prevention efforts often receive 
more funding than treatment efforts.  !   !  ! ! ! ! 
 
7. Worldwide, more people get HIV/AIDS by 
heterosexual contact than by homosexual contact. !   !  ! ! ! ! 
 
8. HIV/AIDS is primarily a gay disease. !   ! ! ! ! ! 
 
9. Giving antiretroviral drugs to people who are not 
infected is a good way to prevent HIV/AIDS.  !   ! ! ! ! ! 
 
10. I am not personally worried about  
getting HIV/AIDS. !   ! ! ! ! ! 
 
11. Alternative medical treatments for HIV/AIDS 
have shown promising results. !   !  ! ! ! ! 
 
12. Antiretroviral drugs are a cure for HIV/AIDS. !   !  ! ! ! ! 
 
13. An effective HIV/AIDS vaccine is available. !   !  ! ! ! ! 
 
14. You cannot get HIV/AIDS during sex if 
condoms are always used. !  !  ! ! ! ! 
 
15. People with HIV/AIDS deserve the same  
 rights in the workplace as other workers. !   !  ! ! ! ! 
 
16. People who knowingly expose others to 
HIV/AIDS should be prosecuted as criminals. !   ! ! ! ! ! 
 
17. Young people under 25 account for almost  
half of new HIV/AIDS infections globally. !   !  ! ! ! ! 
 
18. It is biologically easier for women to get   
HIV/AIDS than it is for men. !   !  ! ! ! ! 
 
19. HIV/AIDS infections are often the result  
of immoral behavior.    !   !  ! ! ! ! 
 
20. Treating HIV/AIDS is a lucrative business  
for pharmaceutical companies. !   !  ! ! ! !   
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C. Please check the response that best represents how you feel about these statements: (V9.3) 
 Strongly  Agree Neither Disagree Strongly Not   
 Agree  Agree Nor  Disagree Sure 
  Disagree   
1. Alternative medical treatments for HIV/AIDS 
  have shown promising results. !   !  ! ! ! ! 
 
2. Young people under 25 account for almost  
 half of new HIV/AIDS infections globally. !   !  ! ! ! ! 
 
3. People with HIV/AIDS deserve the same  
rights in the workplace as other workers. !   !  ! ! ! ! 
 
4. HIV/AIDS infections are often the result  
of immoral behavior.    !   !  ! ! ! ! 
 
5. HIV/AIDS prevention efforts often receive 
 more funding than treatment efforts.  !   !  ! ! ! ! 
 
6. Giving antiretroviral drugs to people who are not 
infected is a good way to prevent HIV/AIDS.  !   !  ! ! ! ! 
 
7. HIV/AIDS is primarily a gay disease. !   !  ! ! ! ! 
 
8. HIV/AIDS is God’s way of punishing  
the wicked. !   !  ! ! ! ! 
 
9. Getting HIV/AIDS is usually a death sentence.  !   !  ! ! ! ! 
 
10. An effective HIV/AIDS vaccine is available. !   !  ! ! ! ! 
 
11. Poor people are more likely to get HIV/AIDS. !   !  ! !     ! ! 
 
12. I am not personally worried about  
getting HIV/AIDS. !   !  ! ! ! ! 
 
13. Globally, the number of people with    
HIV/AIDS is decreasing. !   !  ! ! ! ! 
 
14. Worldwide, more people get HIV/AIDS by  
heterosexual contact than by homosexual contact. !   !  ! ! ! ! 
 
15. Antiretroviral drugs are a cure for HIV/AIDS. !   !  ! ! ! ! 
 
16. It is biologically easier for women to get   
HIV/AIDS than it is for men. !   !  ! ! ! ! 
 
17. People who knowingly expose others to 
HIV/AIDS should be prosecuted as criminals. !   !  ! ! ! ! 
 
18. A pregnant woman with HIV/AIDS cannot  
avoid having an HIV-positive baby.  !  !  ! ! ! ! 
 
19. You cannot get HIV/AIDS during sex if 
condoms are always used. !  !  ! ! ! ! 
 
20. Treating HIV/AIDS is a lucrative business  
for pharmaceutical companies. !   !  ! ! ! ! 
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C. Please check the response that best represents how you feel about these statements: (V9.4) 
 Strongly  Agree Neither Disagree Strongly Not   
 Agree  Agree Nor  Disagree Sure 
  Disagree   
1. An effective HIV/AIDS vaccine is available. !   !  ! ! ! ! 
 
2. Alternative medical treatments for HIV/AIDS 
  have shown promising results. !   !  ! ! ! ! 
 
3. A pregnant woman with HIV/AIDS cannot  
 avoid having an HIV-positive baby.  !  !  ! ! ! ! 
 
4. Young people under 25 account for almost  
 half of new HIV/AIDS infections globally. !   !  ! ! ! ! 
 
5. Getting HIV/AIDS is usually a death sentence.  !   !  ! ! ! ! 
 
6. HIV/AIDS prevention efforts often receive 
more funding than treatment efforts.  !   !  ! ! ! ! 
 
7. Giving antiretroviral drugs to people who are not 
infected is a good way to prevent HIV/AIDS.  !   !  ! ! ! ! 
 
8. People with HIV/AIDS deserve the same  
rights in the workplace as other workers. !   !  ! ! ! ! 
 
9. Antiretroviral drugs are a cure for HIV/AIDS. !   !  ! ! ! ! 
 
10. HIV/AIDS is God’s way of punishing  
the wicked. !   !  ! ! ! ! 
 
11. Worldwide, more people get HIV/AIDS by  
heterosexual contact than by homosexual contact. !   !  ! ! ! ! 
 
12. HIV/AIDS is primarily a gay disease. !   !  ! ! ! ! 
 
13. You cannot get HIV/AIDS during sex if 
condoms are always used. !  !  ! ! ! ! 
 
14. Poor people are more likely to get HIV/AIDS.!   !  ! !     ! ! 
 
15. Globally, the number of people with    
HIV/AIDS is decreasing. !   !  ! ! ! ! 
 
16. I am not personally worried about  
getting HIV/AIDS. !   !  ! ! ! ! 
 
17. It is biologically easier for women to get   
HIV/AIDS than it is for men. !   !  ! ! ! ! 
 
18. HIV/AIDS infections are often the result  
of immoral behavior.    !   !  ! ! ! ! 
 
19. Treating HIV/AIDS is a lucrative business  
for pharmaceutical companies. !   !  ! ! ! ! 
 
20. People who knowingly expose others to 
HIV/AIDS should be prosecuted as criminals. !   !  ! ! ! ! 
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Encuesta sobre conocimiento y percepción sobre VIH/SIDA (APP C.4)  
  
Esta encuesta es parte de una investigación sobre el conocimiento y las percepciones que tienen las 
personas sobre el VIH y el Síndrome de Inmunodeficiencia Adquirida (SIDA). Para acortar la 
información, esta encuesta menciona SIDA en lugar de Síndrome de Inmunodeficiencia Adquirida. Sus 
respuestas ayudarán a diseñar un modelo de educación para informar a las personas sobre la prevención y 
el tratamiento del VIH/SIDA. 
 
1. ¿Es usted mayor de 18 años? (Si no, encuesta sobre la parada.) 
II. ¿Ha visto información sobre prevención y el tratamiento del VIH/SIDA? (Si no, encuesta sobre la 
parada.) 
 
A. ¿De cúales de estos es recursos usted ha aprendido sobre VIH/SIDA en los pasados 4-5 
años? Seleccione todas las respuestas que apliquen.  
 
! 1. Televisión       ! 11. Periódicos en line  
! 2. Radio        ! 12. Correos electrónicos  
! 3. Libros       ! 13. Facebook,Twitter, My Space, etc. 
! 4. Periódicos       ! 14. Organizaciones comunitarias 
! 5. Revistas       ! 15. Organizaciones religiosas 
! 6.Anuncios fuera de la casa     ! 16. Instituciones educacionales 
 (carteleras, letreros, hojas sueltas)   ! 17. Doctores convencionales 
! 7. Eventos (semirios, talleres, conferencias)  ! 18. Doctores en medicina alternativa 
! 8. Páginas Web escritas por personal medico  ! 19. Amigos o familiares 
! 9. Páginas en la Web creadas por personas   ! 20. Personas con las que trabaja 
 que tienen VIH/SIDA     ! 21. Otro (Especifique)______________ 
! 10. Blogs, tablones de anuncios en line  
 
B. Seleccione la respuesta que major represente cuan creíble(verosímiles) usted piensa que 
son los siguientes recursos que hablan sobre VIH/SIDA. 
 
        No lo encuentro     Algo creíble     Inseguro  Creíble        Extremadamente  
      creíble                      creíble 
1. Televisión      !  !        !        !   ! 
2. Radio           !  !        !        !   ! 
3. Libros      !  !        !        !   ! 
4. Periódicos      !  !        !        !   ! 
5. Revistas      !  !        !        !   ! 
6. Anuncios fuera de la casa (carteleras,  
    letreros, hojas sueltas)    !  !        !        !   ! 
7. Eventos (semirios, talleres, conferencias)  !  !        !        !   ! 
8. Páginas Web escritas por personal medico !  !        !        !   ! 
9. Páginas en la Web creadas por personas 
    que tienen VIH/SIDA    !  !        !        !   ! 
10. Blogs, tablones de anuncios en line  !  !        !        !   ! 
11. Periódicos en line     !  !        !        !   ! 
12. Correos electrónicos     !  !        !        !   ! 
13. Facebook,Twitter, MySpace,etc  !  !        !        !   ! 
14. Organizaciones comunitarias  !  !        !        !   ! 
15. Organizaciones religiosas   !  !        !        !   ! 
16. Instituciones educacionales   !  !        !        !   ! 
17. Doctores convencionales   !  !        !        !   ! 
18. Doctores en medicina alternativa  !  !        !        !   ! 
19. Amigos o familiares    !  !        !        !   ! 
20. Personas con las que trabaja   !  !        !        !   ! 
21. Otro (Especifique)______________  !  !        !        !   ! 
 
VIH / SIDA 2 
C. Seleccione la respuesta que mejor represente lo que piensa sobre la siguiente 
información. Seleccione sólo una respuesta. 
              Estoy               Estoy algo Ni estoy    Estoy             Estoy             No estoy  
        completamente   de acuerdo      en acuerdo         algo en         completamente    seguro 
          de acuerdo              ni en acuerdo     desacuerdo        desacuerdo 
1. Las personas pobres tienen un riesgo  
mayor de contraer VIH/SIDA.    !       !  !        !       !  ! 
2. El número de personas con VIH/SIDA  
está disminuyendo.      !       !  !        !       !  ! 
3. El VIH/SIDA es una enfermedad que le  
da mayormente a los homosexuales.   !       !  !        !       !  ! 
4. Ser diagnósticado con VIH/SIDA es usualmente  
una sentencia de muerte.     !   !   !  !  !  ! 
5. Medicinas antiretrovirales curan el VIH/SIDA.  !   !   !  !  !  ! 
6. Recetar medicinas antiretrovirales a personas  
que no tienen VIH/SIDA es bueno de prevenir la  
enfermedad.        !   !   !  !  !  ! 
7. Las personas que saben que tienen HIV/SIDA y  
contagian a otras personas pueden ser acusadas  
legalmente.        !   !   !  !  !  ! 
8. Una mujer embarazada con VIH/SIDA no puede  
evitar tener un bebé que sea VIH-positivo.  !   !   !  !  !  ! 
9. Usted no contraerá VIH/SIDA cuando tiene  
relaciones sexuales si siempre usa condones.   !   !   !  !  !  ! 
10. El VIH/SIDA es una manera en que  
Dios castiga a las personas immorales.    !   !   !  !  !  ! 
11. Hay una vacuna que previene el VIH/SIDA.   !   !   !  !  !  ! 
12. Los tratamientos naturales para el VIH/SIDA  
han ayudado a las personas que tienen la enfermedad. !   !   !  !  !  ! 
13. Las personas que tienen VIH/SIDA merecen  
tener los mismos derechos que tienen otras personas  
en el área de trabajo.      !   !   !  !  !  ! 
14. El tratamiento médico del VIH/SIDA es un  
negocio lucrativo para las compañías farmacéuticas.  !   !   !  !  !  ! 
15. Las infecciones de VIH/SIDA son usualmente  
el resultado de un comportamiento immoral.  !   !   !  !  !  ! 
16. Comparado con los hombres, es más facil  
que una mujer contraiga VIH/SIDA debido  
la manera en que es su cuerpo.     !   !   !  !  !  ! 
17. Los esfuerzos para prevenir VIH/SIDA  
reciben más dinero que lo que se recibe para tartar 
la enfermedad.      !   !   !  !  !  ! 
18. Las personas de menos de 25 años representan  
casi la mitad de las nuevas infecciones de  
VIH/SIDA en el mundo.     !   !   !  !  !  ! 
19. Yo no estoy preocupado(a) de vaya a contraer 
 VIH/SIDA.        !   !   !  !  !  ! 
20. Mundialmente las personas se contagian más 
 con el VIH/SIDA porcontacto heterosexual que  
con el contacto entre personas del mismo sexo.   !   !   !  !  !  ! 
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D. Haga una marca a lado de los tratamientos de VIH/SIDA de los que haya escuchado o leído.  
! 1. UVBI (la irradiación ultravioleta de la sangre) ! 11. Peróxido – IV (intravenoso) 
! 2. Plata coloidal –IV (intravenoso)    ! 12. Peróxido –oral 
! 3. Plata coloidal–oral     ! 13. Atrapamoscas –oral 
! 4. Selenium apoyo de hígado–oral   ! 14. Extractos de hígado de cerdo– transdérmico 
! 5. Quelación – IV (intravenoso)    ! 15. Suplementos nutricionales 
! 6. Quelación –oral       ! 16. AZT (Azidothymidine) 
! 7. Vitaminas – IV (intravenoso)     ! 17. HAART (Terapia antiretroviral altamente activa) 
! 8. Vitaminas –oral       ! 18. Farmacéutico antibióticos (Bactrim, etc) 
! 9. Minerales – IV (intravenoso)     ! 19. Otro (Especifique)______________ 
!10. Minerales –oral 
 
E. De acuerdo con su propio conocimiento o experiencia, por favor marque TODOS los 
casil leros de los siguientes tratamientos del VIH / SIDA que cree que puede ser eficaz en el 
tratamiento del VIH / SIDA. 
 
! 1. UVBI (la irradiación ultravioleta de la sangre) ! 11. Peróxido – IV (intravenoso) 
! 2. Plata coloidal –IV (intravenoso)    ! 12. Peróxido –oral 
! 3. Plata coloidal–oral     ! 13. Atrapamoscas –oral 
! 4. Selenium apoyo de hígado–oral    ! 14. Extractos de hígado de cerdo– transdérmico 
! 5. Quelación – IV (intravenoso)    ! 15. Suplementos nutricionales 
! 6. Quelación –oral       ! 16. AZT (Azidothymidine) 
! 7. Vitaminas – IV (intravenoso)     ! 17. HAART (Terapia antiretroviral altamente activa) 
! 8. Vitaminas –oral       ! 18. Farmacéutico antibióticos (Bactrim, etc) 
! 9. Minerales – IV (intravenoso)     ! 19. Otro (Especifique)______________ 
!10. Minerales –oral 
F. Información demográfica (Sus repuestas serán confidenciales.) 
1. Edad:  ! 18-25 ! 26-36 ! 37- 47 ! 48-58 ! 59+ 
2. ¿Con qué género se identifica mejor? ! Masculino ! Femenino 
3. Orientació sexual:  ! Heterosexual  ! Homosexual  ! Bisexual   ! Prefiero no decir 
4. ¿Con cuál de los siguientes grupos usted se identifica más? (Seleccione sólo una contestación.) 
! Indion Americano, Original de Alaska   ! Hispano 
     O de las islas del Pacífico     ! Blanco/Caucasico 
! Asiatico/Asiatico Americano    ! Mezcla de razas 
! Negro/Africano Americano   !  Otro (Especifique)______________ 
5. ¿Cuál de las siguientes opciones mejor describe su educación académica? (Seleccione sólo una contestación.) 
! El grado octavo o menos 
! Algún instituto 
! Instituto/tiene graduado mi GED 
! Graduado colegial 
! Maestría o doctorado 
6. Afiliación religiosa: _______________________________________ ! Prefiero no decir 
7. ¿Trabaja usted en alguna organización que se encargue de educar, tratar personas que tienen 
HIV/AIDS, o que enseñe a prevenir la enfermedad? ! Sí ! No 
8. ¿Es usted un voluntario en alguna organización sobre HIV/AIDS? ! Sí ! No 
9. Mi HIV estatus es:  ! Negativo  ! Positivo  ! No sé   ! Prefiero no decir 
G. Otros comentarios (Use la parte de atrás de la página si necesita más espacio.) 
________________________________________________________________________________ 
________________________________________________________________________________ 
¡Gracias por participar!                                                                                          V9.1b © Massingill 2009 
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SURVEY CONSULTANTS  
 
 
Jacques Clermont, Doctor of Naturopathic Medicine and collaborator for INSERM, 
France’s National Institute of Health and Medical Research 
 
Solly Diaz, MHA, Division Manager-Southwest Region, City of Houston Department 
of Health and Human Services, Houston, Texas 
 
Hugh Fullerton, PhD., Researcher and retired educator, Texas 
 
Amy Leonard, Health Educator, Legacy Clinic, Houston, Texas 
 
Ken Malone, HIV Test Project Coordinator, HIV Services, Harris County Hospital 
District, Houston, Texas 
 
Tina Megdal, Senior Director of Client Services, Legacy Clinic, Houston, Texas 
 
Beau J. Mitts, MPH, Technical Assistance Manager, HIV/AIDS Care, Treatment, and 
Houston Program, Bureau of HIV/AIDS Prevention and Control, New York City 
Department of Health and Mental Hygiene.  (Formerly Manager, HIV Prevention 
Program, City of Houston Health and Human Services, Houston, Texas) 
 
Wanda Reyes, PhD, Assistant Professor of Mass Communication, Sam Houston State 
University, Huntsville, Texas 
 
Ardyth Broadrick Sohn, PhD., Professor and Director, Hank Greenspun Xchol of 
Journalism and Media Studies, University of Nevada Las Vegas, Las Vegas, Nevada  
 
Christopher White, PhD., Associate Professor of Mass Communication, Sam Houston 
State University, Huntsville, Texas 
 
 
 
 
 
APPENDIX C.6: Guidelines for Survey Data Collection 
 
1) Preparing—Read the consent form and the survey before going into the field. Take the 
survey and think about what questions respondents might have. 
 
2) Organize copies of the blank consent forms and the five versions of the survey in 
separate folders. Be sure to have separate folders for the five different versions of the 
surveys. All folders should be clearly labelled. Have several pens for respondents’ use. 
 
3) Have separate folders for completed surveys and signed consent forms. At no time 
should the consent forms be filed with the corresponding surveys. 
 
4) Approaching possible respondents—Greet the person, give your name and explain 
that you are asking people to take a brief survey about their knowledge and perceptions 
about HIV/AIDS. This is part of a research project to help find effective ways to inform 
people about HIV/AIDS. 
 
5) Time frame/anonymity—Explain that taking the survey will only take about 10-15 
minutes and will be anonymous—names will never be used but their information will be 
important and useful. 
 
6) Filter questions— 
a. Are you 18 or older? (No minors can take the survey.) 
b. Have you seen or heard information about prevention and treatment of HIV/AIDS?  
If NO, say thank you, and do not distribute a survey. If YES, continue.  
 
7) Distribution of different survey versions—Distribute version 1 of the survey to the 
first respondent, version 2 to the second respondent, and so on. After five surveys have 
been completed, begin the cycle over again.  
 
8) Getting consent forms signed—There must be a signed consent form for the survey to 
be valid. Give a copy of the consent form to the respondent and ask him/her to sign and 
return a copy. Stress again that surveys and consent forms will be kept separate and will 
not be linked in anyway. The person’s name will NEVER be used in any way. (If the 
person requests a copy of the consent form, give him/her a copy.) 
 
9) Answering questions respondents might ask: 
Q: Can I decline to answer a question?  YES 
Q: Can I stop the survey at any time?  YES 
Q: Whom can I contact if I have a question? Contact and phone # on the form. 
Q: Why must I sign a form? For a survey to be valid, respondents must give consent. 
 
10) Coding—At the end of the collection period, code the surveys and the consent forms 
using the collection site and date codes provided. Do NOT code the surveys in the 
presence of the respondents. 
 
11) Transporting the surveys—Surveys should be kept in a secure place while being 
transported to the site where they will be edited, coded, and tabulated. 
If you are 18 or older, please take a few 
minutes to fill out our HIV/AIDS survey.  
Your anonymous responses will help us find 
better ways to inform people about HIV/AIDS 
prevention and treatment. 
Thanks for your help!
Grab a  giftf
unny
This research project has IRB approval from the University of Teesside.
Take a  surveyq
uick
Si usted tiene 18 años o más, por favor, 
tómese unos minutos para participar en un 
encuesta sobre VIH/SIDA.  Su respuesta 
anónima nos ayudará a informar a gente
sobre el tratamiento y la prevención 
de VIH / SIDA. 
Gracias por tu ayuda!
Recibir un regalo!
Este proyecto de investigación aprobado por la Universidad de Teesside.
Participar en 
una encuesta 
APPENDIX C.8 
Comments from Legacy Survey (Nov/Dec 2009) 
 
Taking this survey made me realize how much I don't know about HIV/AIDS.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
Great work by everyone pulling together.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
I've been infected for 23 years.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
I am not very familiar with HIV/AIDS and its treatments or lack thereof. New to 
Houston and have never been face to face with HIV/AIDS and its effects and or the 
amount of people that have it. I suppose it's ok to say that I am not very educated in this 
matter.                                                                                                                                                                                                                                                                                                                                                                                                                                                      
Having 4 friends with HIV, I still don't know much about what they go through to stay 
well every day. I feel maybe that it’s not a open subject to talk about.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
We need more help to get good service.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
Thanks for your help.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
Thanks for all you do for the HIV community.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
I am transgender.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
Positive for 30 years and have never taken any drugs ever for the illness.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
Nice to participate.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
Answered "not sure" on items I don't know, #16, yes! But only if the other party is 
unaware of the infected person's condition; #19, depends on the person (ex are they 
rapists, cheating or just dating) question was too broad.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
Lots of treatments.... I didn't know any of them.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
I know that my God is good. I've been exposed since 1992 till now. I'm still here.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
All the best on your research project. Happy and safe Holidays and 2010.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
More education in schools; many people believe the #'s are going down drastically and 
there is a readily available cure.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
If it was not for the good doctors and caseworkers, I would have been very ill. This is a 
good clinic and I love how you all work with me and let me know I am not in the dark.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
The people helping out are doing a wonderful job.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
Part D: Some of these therapies used together can be effective treatments.           
I have been negative for the last 4 years of my life, and was HIV in 1987.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
Knowledge is power!  
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Work as LVN for HCHD.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
There are some religious teachings that I disagree with in regard to HIV education. I 
believe a full dissemination of scientifically proven HIV prevention methods should be 
mandatory for any organization funded for such efforts. The censorship of this education 
based on “beliefs” is ethically challenged.  While some religious organizations are 
beneficial in their teaching method, others try to enforce their beliefs on those in need.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
I myself have 2 sons with AIDS. Thanks for your support.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
I feel that people with no insurance is treated unfairly and results are not always correct.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
Thanks.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
Hoping for a cure.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
The research being done in vector treatment looks promising.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
I have had a family member living with AIDS for almost 10 years. In that time I have 
seen her almost die 5 times. With the meds she always got better.  She is living a full 
life and is very healthy. I believe given funding a cure could be found. I have to hope. 
Good luck with your school project.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
I think it's sad that we have gotten comfortable with these diseases and to really educate 
yourself, you have to make the effort. There needs to be awareness.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
I am a Leeper graduate of 2007.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
My daughter is HIV, possibly AIDS, age 33, contracted HIV at 21 from husband-Now 
ex.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
DCA Drug will cure Cancer & AIDS/HIV, but we can’t get it in the USA as a legal 
treatment.  Availability in Canada only.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
My boyfriend is HIV positive.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
I have some thoughts that I am infected with HIV one time and it was horrible.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
Thanks and good luck.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
I didn’t check any treatments because I have never heard of any of them.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
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1Taking Taboo Topics Public:
How Social Marketing Partnerships Combat
HIV/AIDS in Mexico
Ruth Massingill
University of Teesside, Middlesbrough, UK
Sam Houston State University, Texas, USA
PSP-One On-line Conference
March 10-15, 2008
Taking Taboo Topics Public:
How Social Marketing Partnerships Combat HIV/AIDS in Mexico
2Introduction
! Social marketing influences low-income, high-risk
populations to make healthy behaviour changes.
!Key tactic for combating HIV/AIDS
!Spread of infection can be
managed: level and prevalence
of HIV/AIDS are altered by
human intervention/
decisions.
Social marketing has been widely used to influence low-income, high-risk
populations to make healthy behaviour changes. This application of
marketing principles has also become an important tool for persuading
upstream audiences to make long-term policy changes that achieve
socially desirable goals.
As the human, social, and economic costs of the HIV/AIDS pandemic
mount, social marketing is now a key tactic for combating the disease.
This is particularly appropriate since the spread of the infection can be
managed. Passive contagion, a core tenet of classic disease diffusion
models, is not appropriate for HIV/AIDS since human intervention and
human decision-making can alter both the level and the prevalence of the
disease.
3A Case for Social Marketing in Mexico
! Increase in HIV/AIDS cases
each year since early 1980s
! Affecting youngest and most
productive populations as well
as poor and marginalized
! #4 cause of death for men 25-34
! Diverting resources from other
health, welfare, and education
priorities
As the human, social, and economic costs of the HIV/AIDS pandemic
mount, policymakers worldwide are earmarking funds and forming
alliances to combat the spread of the disease. Mexico, where the first
AIDS case was diagnosed in 1983, faces serious threats to social
sustainability as inflections steadily multiply. Recent reports show the
disease is increasingly affecting the youngest and most productive
populations as well as poor and marginalized groups.
Mexico ranks 13th globally and third in the Americas in the total number of
HIV cases reported; unfortunately, the increase in new cases has been
continuous since the early 1980s. With an estimated average of 4,000
new cases annually in Mexico, AIDS has become the No. 4 cause of
death for men in the 25 to 34 age group. Higher rates of HIV infection are
also being documented among injecting drug users and women.
4Overall Research Question
How have alliances of government
decision makers, the health
care community, and AIDS
activists allowed social
marketers to bring about
voluntary behavioural
changes in Mexico?
How have alliances of government decision makers, the health care
community, and AIDS activists allowed social marketers to bring about
voluntary behavioural changes in Mexico?
5A Population of Campaigns
! Six campaigns selected for
comparison
! Examined purpose, sponsors,
audience, where disseminated,
media mix, messages, product
promotion, and appeals
! Commonalities and unique
characteristics identified
! Research methods: content
analysis, semi-structured
interviews with key decision
makers
This presentation analyses six recent HIV/AIDS campaigns in Mexico,
examining their ability to motivate change and their potential for informing
target audiences about new health choices. Analysis of the campaigns
identified the commonalities and unique characteristics as regards
purpose, sponsors, target audience, dissemination methods, media mix,
messages, product promotion, and appeals used. Semi-structured
interviews with opinion leaders were used to explore the rationale behind
the content choices, cultural influences, and economic factors influencing
the public dissemination of HIV/AIDS information. The six campaigns
share a number of common concerns and objectives although each has a
unique theme and a distinctive focus and approach. All campaigns,
however, rely heavily on partnerships and present messages that openly
discuss once-taboo topics.
6Finding #1: Collaboration is Essential
!Social marketers do not have infrastructure/marketplace
environment of commercial marketers
! Build network of groups with common goals, varied
resources.
! Good example: “Investing in People” in Mexico City,
with largest number of AIDS cases …
! Taboo topic: Sex before marriage
Recognizing that expanding HIV/AIDS populations will devastate the
global economy, governments in both developing and industrialized
countries, often in conjunction with pharmaceutical companies, have
launched organized offensives, which include political commitment, law
enforcement, government policy, social marketing, and community
mobilization.
This global cooperation encourages alliances such as those forged to
support the campaigns in this study. From a practical standpoint, these
partnerships are essential because social marketers “do not have the
infrastructure and the marketplace environment commercial marketers
take for granted.” Rather than “divide and conquer,” in social marketing
the strategy is to build a network of groups and individuals with common
goals and varied resources.
The “Investing in People” campaign is a good example of such alliances…
7Partnership Lesson #1:
Build local, nat’l & internat’l alliances with common goals
Investing in People
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…This five-year initiative, which began in 2003, is centered in Mexico City,
where the largest number of HIV/AIDS cases are found. “Investing in
People” is the joint effort of a half-dozen international, national, and local
organizations. A key technique is personal communication through
workshops and conferences conducted by trained female advocates and
local HIV/AIDS leaders, who openly discuss sex before marriage, a once-
forbidden topic in this strongly Roman Catholic country.
8Finding #2: Focus on Prevention
!Messages usually focus on prevention
! Social marketing involves procuring, distributing
pharmaceuticals, OTC drugs, condoms
! Condom Social Marketing (CSM)
!Mexico: largest consumer of pharmaceuticals in Latin
America
! Taboo topic: Use of condoms
Most HIV/AIDS campaigns have a stronger focus on prevention messages
than treatment information, so social marketing assistance usually
involves procuring and distributing pharmaceuticals, over-the-counter
drugs, and condoms. For example, PSI [Population Services
International], the principal contractor for USAID’s 2005 behavioural
change campaign in Mexico, emphasizes prevention messages and
brand-specific advertising, especially of condoms. Under this
"manufacturer's model," partnerships are negotiated with commercial
manufacturers, suppliers, and distributors of health products, and products
are made available at lower than market costs. Brand-name condoms
and related products are always sold rather than given away, albeit at
reduced prices, because PSI's policy is "when products are given away…
the recipient often does not value them or even use them.” In fact,
promoting the use of condoms is such an integral part of HIV/AIDS social
marketing that the practice has its own acronym: Condom social
marketing [CSM], which is central to the Vida campaign strategy…
9Partnership Lesson #2:
Recruit commercial sponsors for additional resources
VIVE Condoms
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The VIVE condom brand, popular in several Latin American countries, is
the centerpiece of recent “Vida” educational efforts directed to prisoners
and other high-risk groups in southern and central Mexico. A recent
survey reported that Mexican society has become the largest consumer of
pharmaceuticals in Latin America and the ninth largest worldwide.
Pharmaceutical sales jumped from US$6.83 billion in 2002 to an
estimated US$11.3 billion in 2005. Given these numbers, it seems safe to
say that major pharmaceutical companies will continue to vie for
partnership status in social marketing initiatives and that condoms will
continue to be more accessible and socially acceptable.
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Finding #3: Stigma Goes Underground
!“Underground epidemic”
! People living with AIDS, esp. women fear rejection by
families and loss of jobs.
! “Vida Digna” in central Mexico, with “weakest civil
response to AIDS”…
! Taboo topic: Alternative lifestyles
HIV has been called an “underground epidemic” because of the stigma
and discrimination associated with the disease.
USAID, whose infectious disease objectives in Mexico are designed “to
contain and reduce HIV/AIDS in vulnerable populations,” focuses on
reducing barriers to behavior change and thereby preventing the
HIV/AIDS epidemic in Mexico from becoming generalized to the
population at large.
Reducing stigma and discrimination experienced by sex workers, gay
men, men who have sex with men, drug users, and people living with
AIDS is the central purpose of the three-year Vida Digna [Life with Dignity]
campaign, launched in 2005 by the Colectivo Sol alliance and funded by
GlaxoSmithKline…
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Partnership Lesson #3:
Involve the target audience from the outset
Vida Digna (Life with
Dignity)
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…The campaign is centered in the central states of Mexico, a
conservative area characterized as having “the weakest civil society
response to AIDS.” Vida Digna uses anonymous testimonials to urge
tolerance and acceptance of people’s differences. The International
HIV/AIDS Alliance’s research indicates people living with AIDS, especially
women, are fearful of rejection by their families and dismissal from their
jobs if their HIV status is revealed.
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Finding #4: Cultural/Gender Norms
!Machismo and homophobia fueling Mexico’s AIDS
epidemic
! Young men often control how and when young women
have sex
! Changing gender norms: “Programa Hombres” and
! “Programa Mujeres”--female empowerment
! Taboo topics: Women’s rights and homophobia
According to Mexico’s National Center for the Prevention and Control of
HIV/AIDS [Censida], changing how Mexicans view gender roles and
erasing widespread prejudice against gays will be necessary to effectively
combat the disease. Speaking at a conference in February of 2006,
Censida’s director, Jorge Saavedra, said machismo and homophobia are
fueling the country’s HIV/AIDS epidemic. Saavedra was quoted in
Dominican Today as saying machismo undermines prevention messages
and “puts women, as well as men, at risk,” and that “fighting homophobia
is one of the best ways to fight HIV.”
Links between traditional gender attitudes and the spread of AIDS
prompted a partnership of NGOs to develop Programa Hombres [often
called Program H]...
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Partnership Lesson #4:
Initiatives must be multimedia & multilingual
Programa Hombres (Project H)
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…This five-year initiative has been used in more than 20 countries,
including Mexico, to persuade young Latino men to question traditional
norms related to manhood since the male youth often control how and
when young women have sex. An extensive media mix included
educational videos available in three languages—Spanish, English, and
Portuguese—interactive workshops, and collateral materials, as well as
radio, outdoor media, and direct mail. The campaign slogan, “In the Heat
of the Moment,” urged use of the Hora H condom brand, manufactured by
the makers of Durex condoms and distributed in non-traditional venues
such as funk balls and cafes.
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Partnership Lesson #5:
Utilize global support for women
Programa Mujeres (Project M)
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Building on their success in educating young men about the costs of
traditional macho culture, in 2005 the Program H partners and World
Education launched Programa Mujeres [Project M] to encourage young
women to take control of their sexual and reproductive health. This social
marketing campaign was based on research that included a review of
Latin American literature to define the concept of female empowerment,
focus group discussions with groups of young women aged 14-24 who
lived in marginalized communities outside Queretaro, Mexico, and
interviews with empowered young women.
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Finding #5: Population Mobility Danger
! Travel or migration factor in AIDS prevalence
! Risk to partners at home
! U.S./Mexico: Border health initiative to make testing and
care more accessible and acceptable…
! Taboo topics: Sex outside of marriage, prostitution
Studies of highly mobile groups such as truck drivers, seasonal
employees, and sex workers have identified travel or migration as a factor
related to increased HIV/AIDS prevalence. Higher rates of infection are
also frequently found along transport routes and in border regions. In
addition, migration and mobility also increase vulnerability to HIV/AIDS for
the partners at home.
Not surprisingly then, HIV/AIDS is a significant problem along the 2,000-
mile border between the United States and Mexico, where mobility,
poverty, and lack of access to health care complicate prevention and care.
The SPNS [Special Projects of National Significance] Border Health
Initiative is administered by the U.S. Department of Health and Human
Services to raise awareness about HIV and to make testing and care
more accessible…
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Partnership Lesson #5:
Construct trans-border alliances
SPINS Border Health Initiative
!"#$%&'( A#"/+)4G )/4"%+"# K",K5" '/# ("4"( +, K()8'(G %'("3 (')*"
'P'("/"**3 8'2" +"*+)/0 8,(" '%%"**)&5"3 '#.'/%" *2)55*
)/ #"5)."()/0 -"'5+- '/# *,%)'5 *"(.)%"* +, K",K5" P)+- @A7?
)*+',#-+'( 9::O<
.$%/&%#&Q >6?6 7"K'(+8"/+ ,4 L"'5+- '/# L$8'/ ?"(.)%"*3
B@!C @%+
0"1*'/2'&( E)0('/+ 4'(8 P,(2"(*3 +('/*<&,(#"( K,K$5'+),/*3 *"F P,(2"(*
34'#'( 93:::<8)5" &,(#"( &"+P""/ >6?6 '/# E"F)%,3 +($%2 *+,K*
'/# &,(#"( %(,**)/0*3 '/# %,88$/)+)"*
5'1*- 5*6( _/"<+,<,/" ,$+("'%-3 ('#),3 NM3 K(,8,+,("* U.,5$/+""(
-"'5+- P,(2"(*W3 K()/+"# 8'+"()'5*
5'&&-7'&( ],5# 8"**'0"* +-'+ LAM )* ' %,88$/)+G K(,&5"83 )#"/+)4G
+"*+)/0 '/# %5)/)%'5 ("*,$(%"*3 ("."(*" %$5+$('5
/,(8* U$*" ,4 ?K'/)*- 5'/0$'0"3 %$5+$('55G *K"%)4)%W
.$'-8'#&( R,%'53 P"55<2/,P/ 8"#)' K"(*,/'5)+)"*
0$$'-:&( 7"%)*),/<8'2)/03 *,%)'5 %,0/)+)."
…In many of the rural border communities people are reluctant and
embarrassed to openly discuss HIV/AIDS or the sex worker industry.
Relying heavily on social marketing, SPNS utilizes Spanish language
media to blanket the transient communities with “bold” HIV messages
designed to “reverse the cultural norm that topics related to sexuality,
including HIV, are not discussed in public” and to educate Latinos about
the risk of the disease. SPINS border outreach initiatives are designed to
be culturally sensitive to the Latino culture, which values trust and
relationship building.
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Conclusions
!Communications about AIDS is
complex and highly political
!HIV/AIDS crosses all boundaries;
no one unaffected
!Social marketing is able to create
upstream and downstream
behaviour changes
!Partnerships are crucial
!Taboo topics must be discussed
As demonstrated by these six Mexico-based campaigns, the content of
social marketing messages about HIV/AIDS, the role of stigma and
culture, and the economic realities of the global medical market created by
the epidemic form a complex and politically charged environment that
influences public dissemination of information.
As HIV/AIDS social marketing establishes a track record in Mexico,
organizations using such initiatives can begin to analyze long-term results.
Nevertheless, it already seems clear that the power of social marketing is
a strong tool for motivating change and informing target audiences about
new health choices. Over a period of less than two decades, alliances of
HIV/AIDS social marketers have been able to operate successfully in the
maelstrom of cultural, political, economic, and social concerns while
bringing about voluntary behavioral changes among both downstream and
upstream audiences.
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ABSTRACT 
Social marketing [SM] is a key tactic for combating HIV/AIDS. When SM builds successful 
partnerships with upstream audiences who focus on downstream targets, a community’s social 
fabric can be permanently altered. 
This paper scrutinises how SM techniques are used to disseminate HIV/AIDS information, 
often with conventional medicine’s sponsorship and alternative medicine’s increasing influence. 
Analysis of eighteen SM campaigns from Uganda, Mexico, and the U.S. indicates public 
communication revolves around 1) cultural content of SM messages about HIV/AIDS, 2) 
political expediency, and 3) economic realities of the global marketplace, forming a complex 
environment that influences dissemination of information about health care options. Semi-
structured interviews with opinion leaders involved in designing, sponsoring, and implementing 
selected campaigns provide insights into lesson learned so far from these initiatives. 
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CREATING A CULTURE OF CHANGE: 
SOCIAL MARKETING’S GLOBAL INITIATIVE AGAINST HIV/AIDS  
INTRODUCTION 
For more than three decades, social marketing, “the application of the principles and tools of 
marketing to achieve socially desirable goals,” (Kotler and Zaltman, 1971: 5) has been widely 
used to influence low-income and high-risk populations to make healthy behaviour changes.  
Although these campaigns often created awareness among specific target audiences and even 
persuaded members of at-risk groups to adopt lifestyle changes, it became increasing obvious 
that the burden of deep societal change could not rest exclusively on these downstream targets 
(Andreasen, 2006). As a result, social marketing has come to be seen as a tool for social change 
on all levels. When social marketing can build partnerships that include governments, non-
government organizations [NGOs], international agencies, and private businesses—so-called 
upstream audiences—working in conjunction with downstream targets, then the entire social 
fabric of a community can be permanently altered (Andreasen, 2006). 
Therefore, social marketing has been a key tactic in combating HIV/AIDS, both in 
developing and in industrialized countries, for the past 20 years. These campaigns typically 
define a purpose relating to a specific target audience, use a variety of media to disseminate the 
campaign message, and are based on a recognized behavioural change model (McDermott, et 
al., 2005). Numerous international organizations now have a track record of designing and 
implementing social marketing campaigns in countries where inflection rates are on the rise. As 
the human, social, and economic costs of the HIV/AIDS pandemic mount, policymakers 
worldwide are earmarking funds and forming alliances to combat the spread of the disease.  
This research explores links between social marketing and HIV/AIDS while mapping 
connections to the conventional and alternative medical communities. It is not unusual to find 
literature relating to any two of these terms, but rarely are all woven together. This project 
defines and contextualises social marketing, then it scrutinises how dissemination of HIV/AIDS 
information uses social marketing techniques, usually in partnership with conventional 
medicine. Alternative medicine’s increasing influence and the consequent ramifications for 
audiences of HIV/AIDS social marketing campaigns are also investigated. This combination of 
topics—social marketing for HIV/AIDS as related to conventional and alternative medicine—is 
one that has not been explored in the manner outlined in this study, so the potential for 
contributing to the current body of knowledge is significant. 
RESEARCH QUESTIONS 
1. What is social marketing? What can it accomplish? How does it work? 
2. How has social marketing been used to combat HIV/AIDS in both developing and 
industrialised countries?   
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3. What political and economic factors affect dissemination of information about 
HIV/AIDS treatment and prevention? What role do the media play? 
4. What are specific examples of recent HIV/AIDS social marketing campaigns?  
5. What commonalities and unique characteristics can be identified in this population of 
campaigns as regards purpose, sponsors, target audience, dissemination methods, media mix, 
messages, product promotion, and appeals used? What lessons have been learned so far? 
METHODOLOGY 
To answer these questions, this study began with a comprehensive literature review, 
followed by content analysis of a population of 18 social marketing campaigns selected from 
three countries that represent diverse situations regarding the disease. This analysis provided 
context for semi-structured interviews with key informants from selected campaigns. The ethical 
guidelines of the U.K. Market Research Society Code of Conduct were examined and adhered to 
throughout the course of this study.  
Literature Review: Areas of literature reviewed included social marketing [history, theory, and 
practice], HIV/AIDS [history, scope, and projections], social marketing as a tactic for combating 
HIV/AIDS, health communications and pharmaceutical-dominated marketing, health activism, 
Complementary and Alternative Medicine (CAM) and conventional medical approaches to 
HIV/AIDS, criminal justice concerns as relating to prisoner health care, and an overview of 
media coverage of these issues. 
Content Analysis: A population of six HIV/AIDS social marketing campaigns was selected for 
each of the three countries targeted for this study—Mexico, Uganda, and the southern United 
States. The HIV/AIDS initiatives that were included each contained the recognized elements of 
social marketing campaigns, as well as several additional criteria selected by the researcher. 
Previous literature review revealed widespread agreement that social marketing combines a mix 
of several essential components:  Behavioural change, informed by research, is the purpose 
behind any social marketing intervention. Also required is consumer orientation, in which the 
social marketer segments and profiles the target audience with the aim of building a long-term 
interactive relationship. Another common ingredient is facilitating a voluntary exchange from 
which both parties derive benefits. Finally, the successful social marketer thinks strategically, 
setting specific and measurable long-term objectives, using the marketing mix, and considering 
the appeal of competing behaviours (Andreasen, 2006; McDermott et al., 2005). 
Beyond meeting this definition for social marketing, criteria for campaign selection 
included currency—active as recently as 2004— implementation by a recognized international 
organization, and participation of a major medical organization or pharmaceutical company. The 
points of analysis were easily comparable aspects: purpose, target audience segmentation, where 
the campaign was disseminated, media mix used, messages presented, and types of appeals 
employed. The most common social marketing appeals to motivate health-related behaviour 
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change were determined through extensive literature review and informal interviews with social 
marketing researchers at the Institute for Social Marketing at Stirling University in Scotland. 
Semi-structured Interviews: Interviews to date have included representatives from 
sponsoring organizations Population Services International, Instituto Promundo, Mexfam, 
Democracy and Sexuality (DEMYSEX) and LETRA S, as well as campaign spokespeople, 
health agency officials, medical practitioners, and community HIV/AIDS activists.  
FINDINGS 
I. CONVERGENCE OF SOCIAL MARKETING, HIV/AIDS, AND MEDICAL COMMUNITIES 
The areas where social marketing, HIV/AIDS communications, and the conventional and 
alternative medical establishments overlap were of particular interest. Societal issues such as 
evolving public perceptions, the changing political landscape, international economics, and 
media agendas related to these topics are pertinent since they affect the global HIV/AIDS 
situation on a daily basis.  
Research question 1: What is social marketing? What can it accomplish? How does it 
work? 
Social marketing was first defined as a discipline 35 years ago, but has rapidly gained 
recognition as a “bridging mechanism” between behavioural science and the “socially useful 
implementation of what that knowledge allows” (Kotler and Zaltman, 1971:12). Social 
marketing's roots in commercial marketing are undisputed, with a strong influence by the 4Ps of 
marketing—product, promotion, price, and placement—although this model is sometimes 
viewed as insufficiently customer-based for social marketing’s framework (Niblett, 2005). 
Social marketing ideally combines several elements. Behavioural change, informed by 
research, lies behind any social marketing intervention. Also required is consumer orientation, 
which segments audiences and builds long-term interactive relationships. Facilitating a 
voluntary exchange with mutual benefits is necessary. Successful social marketers think 
strategically, set long-term objectives, use the marketing mix, and consider the competition 
(Andreasen, 2006; McDermott et al., 2005; Dev and Schultz, 2005). 
As early as the 1960s, commercial marketing was incorporated into health education 
campaigns in developing countries (Ling et al., 1992) and continued to play an important role in 
influencing behaviours of populations at risk for diseases such as HIV/AIDS, malaria, and 
alcoholism (Rogers et al., 1991). When the effort extends beyond informing to persuading, it is 
called “health activism” and involves “attempts to change the status quo, including social 
norms, embedded practices, policies, and power relationships”(Zoller, 2005:361). 
In 1981, however, Bloom and Novelli found many social marketing campaigns lacked rigor 
and theory. They recommended using research to segment audiences, design programs, and 
create strategic campaigns. Social marketing's popularity grew when its potential was publicised 
by Lefebvre and Flora (1988) and Hastings and Haywood (1991) in medical journals. As the 
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link between public health and commerce (Hastings and Saren, 2003), social marketing is the 
primary method international organisations such as UNAIDS use to combat global health issues. 
Hastings and Donovan (2002) as well as Andreasen argue social marketing should be 
repositioned as an “approach to social change that reaches both upstream and downstream” 
(Andreasen, 2006: viii). However, Niblet cautions partnerships are key to this process because 
social marketers lack “infrastructure and the marketplace environment commercial marketers 
take for granted” (2005:3).  
Although social marketing is not a theory, it informs and structures its framework using 
psychology, sociology, anthropology, and communications (Kotler and Zaltman, 1971). Social 
marketers may employ the health belief model (Basu, 2003), the transtheoretical model of health 
behaviour change [stages of change], diffusion of innovation, social cognitive theory, or theory 
of reasoned action (McDermott et al., 2006; Lefebvre, 2001: 507-515). Nevertheless, many 
disregard theoretical approaches, preferring to be “broadly eclectic and intuitive tinkerers” 
(Walsh et al, 1993: 115). Despite criticisms of manipulation, overuse of fear appeals (Hastings 
et al, 2004), and improper use of incentives (Dholakia and Dholakia, 2001), social marketing 
demonstrably effects social change. 
Research question 2: How has social marketing been used to combat HIV/AIDS in both 
developing and industrialised countries?   
Perhaps the most highly visible social problem in the world today is HIV/AIDS. Since it 
was first diagnosed 25 years ago, HIV/AIDS has become one of the most deadly health issues 
worldwide, with an estimated 40 million people—2.3 of them children—now living with the 
disease. Contrary to popular perception, about half of the infected are women and heterosexual 
transmission is now the most common means of infection (UNAIDS, 2006). HIV/AIDS is called 
an “underground epidemic” because of associated stigma and discrimination, which discourage 
people from getting tested or accessing care (HIV infection, 2003). 
Where HIV/AIDS is rampant, social marketing is widely used to motivate low-income and 
high-risk audiences to adopt healthy behaviours. Population Services International, the first 
organisation to use social marketing to combat AIDS, uses targeted Behaviour Change 
Communications (BCC) to focus on prevention messages. Brand-specific advertising is often an 
integral part of HIV/AIDS campaigns, representing a major expense for drug companies, which 
spend on average two-and-half times more on marketing than on research (Hamber, 2005). With 
this kind of investment at stake, critics say the conventional medical establishment uses 
influence and financial clout (Moynihan and Cassels, 2005) to shape dissemination of health 
information.  
Research Question 3: What political and economic factors affect dissemination of 
information about HIV/AIDS treatment and prevention? What role do the media play? 
Additionally, in the wake of widespread media coverage about selective reporting of clinical 
drug trials, U.S. political leaders have questioned "whether the pharmaceutical industry has 
systematically misled physicians and patients by suppressing important data on their drugs" 
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(Graham, 2004: 21). These concerns, combined with reports documenting the deplorable state of 
public health care, are spurring public interest in complementary and alternative medicine 
[CAM], creating a more positive climate for alternative treatments in general (Tindel, 2005; 
Abraham, 2007). Likewise, in the UK, recent media coverage of controversial public funding 
for CAM, which is strongly supported by Prince Charles, has brought the topic to the forefront 
of public attention (Booth and Henderson, 2006). 
Examining the media’s role from a dissemination standpoint, clearly new interactive 
methods of building social networking communities have revolutionised how target audiences 
access and use information, significantly altering the international dialogue about HIV/AIDS. 
Many of the campaigns analysed rely heavily on online media, especially if they are targeting 
young, politically active, or well-educated audiences. 
In toto, these factors form a complex and politically charged environment that influences 
dissemination of information about health care options and offers a multitude of possibilities for 
fresh interpretations of the cross-disciplinary relationships and concepts involved.   
II. DECONSTRUCTING 18 HIV/AIDS SOCIAL MARKETING CAMPAIGNS 
Research question 4: What are specific examples of recent HIV/AIDS social marketing 
campaigns?  
Dozens of social marketing HIV/AIDS campaigns are underway in the three countries 
targeted for this study. Campaigns from Mexico, Uganda, and the U.S. demonstrate how NGOS 
and government leaders use social marketing to motivate changes in cultural attitudes and 
health-related behaviours. The campaigns selected for study: 
MEXICO 
1. Investing in People  
This five-year initiative to reduce barriers to behaviour change and care seeking began in 
2003. It is a localised version of a series of similar campaigns currently underway in several 
countries. Focused in Mexico City, where the largest number of HIV/AIDS cases is found, 
“Investing in People” is the joint effort of a half-dozen international, national, and local 
organizations. A key technique is personal communication through workshops and conference 
presentations conducted by trained female advocates and local HIV/AIDS leaders. 
2.  VIVE Condoms 
The VIVE condom brand, popular in several Latin American countries, is the centrepiece of 
recent “Vida” educational campaigns directed to prisoners as well as other high-risk groups in 
southern and central Mexico. Population Services International, the primary sponsor for this 
campaign, uses both traditional [pharmacies, health clinics] and non-traditional [bars, hotels, 
brothels, salons] sales outlets to make condoms accessible and socially acceptable. The slogan is 
"Vive to mejor momento" or "live your best moment.” 
3. VIDA Digna (Life with Dignity) 
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Reducing stigma and discrimination experienced by sex workers, gay men, men who have 
sex with men, drug users, and people living with AIDS is the central purpose of the three-year 
“Vida Digna” campaign, launched in 2005 by the Colectivo Sol alliance and funded by 
GlaxoSmithKline. The campaign is centred in the central states of Mexico, a conservative area 
characterised as having “the weakest civil society response to AIDS.” Vida Digna uses 
anonymous testimonials to urge tolerance and acceptance of people’s differences.  
4. Programa Hombres (Project H) 
Links between traditional gender attitudes and the spread of AIDS prompted a partnership 
of NGOs to develop Programa Hombres. This five-year initiative has been used in more than 
twenty countries, including Mexico, to persuade young Latino men to question traditional norms 
related to manhood. An extensive media mix includes educational videos available in three 
languages—Spanish, English, and Portuguese—interactive workshops, and collateral materials 
as well as radio, outdoor media, and direct mail. The campaign slogan, “In the Heat of the 
Moment,” urges use of the Hora H condom brand, manufactured by the makers of Durex 
condoms and distributed in non-traditional venues such as funk balls and cafes. 
5. Programa Mujeres (Project M) 
Building on their success in educating young men about the costs of traditional macho 
culture, in 2005 the Program H partners and World Education launched Programa Mujeres to 
encourage young women to take control of their sexual and reproductive health. This social 
marketing campaign was based on research that included a review of Latin American literature 
to define the concept of female empowerment, focus group discussions with groups of young 
women aged 14-24 who lived in marginalised communities outside Queretaro, Mexico, and 
interviews with empowered young women. 
6. SPNS Border Initiative 
The SPNS [Special Projects of National Significance] Border Health Initiative is 
administered by the U.S. Department of Health and Human Services to raise awareness about 
HIV and to make testing and care more accessible. Relying heavily on social marketing, SPNS 
utilises Spanish language media to blanket the transient communities with “bold” HIV messages 
designed to “reverse the cultural norm that topics related to sexuality, including HIV, are not 
discussed in public” and to educate Latinos about the risk of the disease. SPNS border outreach 
initiatives are designed to be culturally sensitive to the Latino culture. 
UGANDA 
1. ABCs (Abstinence, Being Faithful and Condoms) 
This campaign takes a moralistic approach—“Sex can wait until marriage”—and uses 
outdoor media as well as local spokespeople such as community leaders and ministers to urge 
abstinence before marriage and fidelity to spouses. Practical AIDS information is provided and 
condom use is also advocated to reduce risk of infection. This program and others like it have 
generated international controversy about whether condoms are effective in reducing HIV 
prevalence and raising associated concerns about increased promiscuity. 
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2. Afford 
AFFORD is a five-year health marketing initiative led by the Johns Hopkins Bloomberg 
School of Public Health and funded by the U.S. Agency for International Development. 
Designed to increase accessibility and affordability of AIDS products and services, the 
campaign promotes Protector brand condoms, Pilpan oral contraceptives, and Inject injectable 
contraceptives. Consumers are encouraged to use these products properly and have access to 
them at subsidised rates. A centrepiece of the campaign is “The Good Life Gameshow,” an 
entertainment education quiz show using community interaction, and radio and television 
shows. 
3. PMTCT (Prevention of Mother to Child Transmission) 
“The Social Marketing Approach to PMTCT" is a Population Services International [PSI] 
project that uses a branded franchise network of trained midwives to help pregnant women reduce 
transmission risk during birth. The midwives are also trained on HIV testing procedures and 
counselling skills. The central message is that it is possible to have an HIV-negative baby even 
when both parents are HIV positive. Since 2003, a broad media mix has disseminated this message 
to male partners of pregnant women 25-45, primarily in low-income, low-literary, rural areas. 
4.  Trust Condoms 
Designed to reach people in rural, isolated areas of the country, particularly women, this 
campaign’s central purpose is to launch a new condom brand. The stated rationale for the effort, 
which began in 2006, is that combating the AIDS pandemic must go hand-in-hand with 
sensitising those who live in outlying areas. The British and Norwegian governments 
contributed funds for the campaign. 
5.  Be a Man 
Targeted primarily to young men 15 to 24, this campaign was launched in 2006 to prompt 
reflection on the costs of traditional male attitudes and behaviours, which recent research has 
shown are contributing to an increase in HIV infections. “Society’s expectations of men are 
setting them up for failure,” according to Vincent Kiwanuka, the “Be a Man” campaign’s 
coordinator. The media mix heavily utilises radio drama and television, including broadcasts 
during the World Cup. The goal is to encourage sexual relationships based on mutual respect. 
6.  Sugar Daddies 
Addressing the widespread problem of cross-generational sex (sex with a person at least 10 
years older), this campaign, begun in 2004, seeks to raise awareness of the dangers of “sugar 
daddy” relationships. This practice is a major reason HIV infection rates are six times higher for 
teenage girls than for their male counterparts. Target audiences include young women 15 to 24, 
their parents (who often encourage such relationships), and older male partners. The PSI-
sponsored initiative features recognised male role models such as Uganda’s Minister of Ethics 
and Integrity Tim Lwanga urging men to “stop preying on young girls.” 
UNITED STATES 
1. We all have AIDS 
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Launched in 2005 on World AIDS Day, this campaign created by American designer 
Kenneth Cole is heavily supported by celebrities and prominent AIDS activists. The message is 
to reduce stigma associated with AIDS to prevent, contain, and eradicate the disease. The 
consistent theme for all ads is “We all have AIDS…if one of us does.” International celebrities 
participating include President Nelson Mandela, Arch Bishop Desmond Tutu, Sharon Stone, 
Will Smith, and Sir Elton John. 
2.  ONE 
With more than sixty partners, this campaign’s purpose is to rally Americans one by one to 
push for increased donations to fight poverty and AIDS. The campaign has a broad target 
audience, ranging from students to ministers to punk rockers to soccer moms. The call to action 
is “We’re not asking for your money, we’re asking for your voice.” In line with this approach, 
June 11, 2007, ONE launched ONE Vote ’08, its “largest and boldest initiative ever,” vowing to 
make extreme poverty and global disease an issue in the 2008 election. 
3. I am African /Keep a Child Alive 
This campaign, also heavily saturated with celebrities, promotes the idea that everyone has 
some DNA with connections to an African heritage, so all people should work together to help 
with the AIDS problem. Begun in 2005 and updated every year since, donations for AIDS drugs 
are particularly sought. “I am African” is linked with the “Keep a Child Alive” campaign, which 
seeks to help AIDS orphans in Africa by providing them with ARVs [treatment cocktails]. 
Images of celebrities such as Gwenyth Paltrow and Sting wearing “war paint” with the 
campaign slogan beneath has sparked controversy about the use of eye-catching visuals that 
“insensitively perpetuate stereotypical ways of thinking about AIDS or Africa.” 
4.  Be the Generation 
This program seeks to create a supportive environment for HIV vaccine research by 
mobilizing existing community partnerships and networks to educate key communities about 
this research in twenty U.S. cities where HIV vaccine clinical trials are ongoing or planned. 
Coordinated media and collateral materials segment target audiences by gender, ethnicity, and 
lifestyle, showing images of two people, one older and one younger. Extensive educational 
materials are available online. The uniform message is that the young generation’s “great cause” 
is to end AIDS and that a vaccine is the best hope of accomplishing that goal. 
5.  MTV Think 
This award-winning public information campaign began in 2006 and is notable for bringing 
MTV on board as a major sponsor. The goal is to reach sexually active 16- to 24-year-olds with 
information about HIV and related issues, since according to UNAIDS, half of new HIV 
infections worldwide are among people under the age of 25. Discussion of safe-sex issues, 
condom use, and HIV testing are urged through television and web media. According to sponsor 
The Kaiser Family Foundation, this is a “multi-platform, interactive community for the first 
generation of Americans who have lived their entire lives during the AIDS epidemic.” 
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6. The New Faces of HIV in Houston 
 Due to high HIV prevalence among African Americans in Houston, in 2002 the Harris 
County Hospital District and the Houston Department of Health and Human Services launched a 
social marketing campaign to raise awareness and increase testing among this population. Media 
include radio, public transit, direct mail, and brochures targeting women. Images of both men and 
women are featured in the materials, with the slogan, “We look just like you, but you don’t have 
to be like us. Do the right thing. Get tested.” 
Research question 5: What commonalities and unique characteristics can be identified in 
this population of campaigns as regards purpose, sponsors, target audience, dissemination 
methods, media mix, messages, product promotion, and appeals used? What lessons have 
been learned so far? 
The campaigns share a number of common concerns and objectives although each has a 
unique theme and a distinctive focus and approach. Each uses a customised media mix to 
disseminate messages to selected audience(s), but core commonalities are evident throughout. 
Behavioural models underlying the campaigns were carefully examined. 
First and foremost, collaboration is essential; each campaign involves multiple organisations 
and community groups designed to build participation in and acceptance for individual and 
policy change. From a worldview, each country’s HIV/AIDS problem has far-reaching 
implications. Recognising that expanding HIV/AIDS populations will devastate the global 
economy, governments in both developing and industrialised countries, in conjunction with 
pharmaceutical companies such as Pfizer, have launched a variety of organised offensives, 
which include political commitment, law enforcement, government policy, social marketing, 
and community mobilisation (Pfizer, 2006). This global cooperation encourages alliances such 
as those forged to support the campaigns in this study. 
Secondly, the campaigns all incorporate prevention strategies, with condom use being a 
frequent tactic. In keeping with its inclusive approach, social marketing assistance usually 
involves procuring and distributing pharmaceuticals, over-the-counter drugs, and condoms. It 
also supports capacity building and financial sustainability programs for non-government 
organisations [NGOs] or for-profit companies (USAID, 2005). 
In recognition of cultural obstacles, the campaigns each address aspects of stigma and 
traditional cultural norms. USAID, whose infectious disease objectives are designed “to contain 
and reduce HIV/AIDS in vulnerable populations,” focuses on reducing barriers to behaviour 
change and thereby preventing the HIV/AIDS epidemic in countries such as Mexico from 
becoming generalised to the population at large (USAID Health Profile, 2005). It is generally 
recognised that changing how people view gender roles and erasing widespread prejudice 
against gays will be necessary to effectively combat HIV/AIDS.  
A number of social marketing campaigns draw on research showing that in many cultures, 
young men often control how and when young women have sex. Some of the traditional gender 
norms the campaigns were designed to change are 1)Men should initiate sexual activity early in 
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life, 2) Men should have multiple sexual partners, 3) Men should maintain control over their 
female partners, and 4) Unsafe sex is more enjoyable than safer sex. Addressing these gender 
norms, especially among young people, is increasingly recognised as a vital strategy to prevent 
the spread of HIV infection (Promoting, 2006). 
 Modern-day mobility and lifestyle patterns are also considerations in crafting social 
marketing campaigns for at-risk populations, especially for migrant populations or in border 
areas. Studies of highly mobile groups such as truck drivers, seasonal employees, and sex 
workers have identified travel or migration as a factor related to increased HIV/AIDS 
prevalence. Higher rates of infection are also frequently found along transport routes and in 
border regions. In addition, migration and mobility also increase vulnerability to HIV/AIDS for 
the partners at home (Population Mobility, 2001: 4). 
Persuasive messages for the campaigns are informed by the tenets of one or more established 
behavioural models. Early generations of HIV social marketing campaigns frequently built their 
messages around the health belief model, which uses fear or anxiety-arousing messages. In the 
long term, however, the use of fear appeals draws mixed responses, both from observers and 
from the targeted audiences. Hastings and colleagues noted fear appeals have been “embraced 
with enthusiasm by social marketers” (2004: 962), but cautions fear appeals, in addition to 
encouraging “health fatalism,” may actually have negative long-term effects on the brand. A 
more effective appeal, especially for young people, according to Backer, Rogers, and Sopory, is 
the positive rational/emotional approach, which uses fear to grab attention, then relates the fear 
to a positive outcome (Backer, et al., 1992). The use of external incentives, central to most 
social marketing approaches, also has potential pitfalls because they can be interpreted as 
coercion or bribery and not deliver the long-term behavioural change desired (Dholakia and 
Dholakia, 2001: 498). The personal benefits inherent in self-interest appeals, however, are 
frequently used to advantage. Based on the well-established Maslow’s hierarchy of needs, self-
interest appeals target common human needs ranging from physiological to safety, social, ego, 
and self-fulfilment (Wilcox, 2002). 
Consequently, the current generation of social marketing campaigns is usually grounded in 
theoretical models other than fear or short-term benefits. In a report prepared for the UK's 
National Social Marketing Strategy for Health, McDermott and colleagues (2006) found 
nutrition social marketing interventions were most frequently based on social cognitive theory, 
which emphases observational learning and self-efficacy and is frequently used in campaigns 
where individuals have choices of how to respond to their environments (Lefebvre, 2001). A 
somewhat similar appeal is the behavioural decision making model, which uses risk 
comparisons and probability (Maibach and Parrott, 1995).  
Another popular approach, according to McDermott's report, was the transtheoretical model, 
known as “stages of change,” which assumes few people are ready to take action and must be 
moved through early stages of indecision. Lefebvre pointed out one of the few population-based 
models available to social marketers is diffusion of innovation, which segments any target into 
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types of adopters (innovator, early adopter, early majority, late majority, and laggard) and 
suggests the marketer begin with one or two segments (2001:507-515). On a broader policy 
level, upstream appeals often reference the goal of sustainable development, which takes a 
generational view and focuses on people’s power to make decisions about the future of their 
society (Dubois, 2003). Typically, each social marketing initiative in this study combines 
aspects from several of these approaches to ensure acceptance and motivate lasting social 
change. 
SUMMARY OF LESSONS LEARNED  
Interviews with key informants revealed important lessons from campaign implementation. 
Most important are that successful campaigns: 1) Build local, national, and international 
alliances with common goals, 2) Recruit commercial sponsors for additional support, 3) Involve 
the target audiences from the outset, 4) Incorporate multimedia and multilingual tactics, 5) 
Utilize global support for women, 6) Construct trans-border alliances, and 7) Tackle once-taboo 
topics openly and candidly. 
ANALYSIS AND EVALUATION  
PRELIMINARY REFLECTIONS 
After literature review, content analysis, and a number of semi-structured interviews were 
completed, it became clear that public communication about HIV/AIDS essentially revolves 
around three factors: culture, politics, and economics. The specifics of these issues vary from one 
country to the next, but the global implications cross all physical and conceptual boundaries. 
Cultural:  
Although categorised as an underground epidemic because of stigma and discrimination 
associated with the disease, HIV/AIDS has become everyman’s—and everywoman’s—problem. 
The actual prevalence numbers are uncertain because of reluctance to seek testing and treatment, 
but it is certain the global pandemic has spread each year since the first diagnosis in 1981. 
HIV/AIDS is now both a horizontal epidemic—affecting both sexes—as well as a vertical 
epidemic—being transferred from mothers to children.  
Social marketing has gained widespread acceptance among international organisations as 
the tool of choice to motivate healthy lifestyle choices and to promote long-term policy changes. 
These initiatives typically use culturally sensitive approaches to build rapport and persuade. 
However, the visual/verbal presentation varies widely, depending on the target audience, and 
appeals vary from personal fear to altruistic concern. HIV/AIDS campaigns are typically 
targeted to audiences segmented by such factors as demographics [often using ethnicity, gender, 
or age], behaviour [such as sex workers], or lifestyle [frequently the gay community]. The 
Mexico and U.S. campaigns share many commonalities, but each reflects the audience’s cultural 
differences. Finally, the phenomenon of complacency, sometimes called 
“disinhibition”(Abraham, 2007), may be driving a decline in safe sex practices, especially in 
Western countries where anti-retroviral drugs [ARVs] are widely available and considered a 
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kind of “cure” for the disease. This may be an example of misperceptions arising out of media 
and social marketing messages. Regardless, such a trend toward increased risky sexual 
behaviour among some groups calls into question the way HIV/AIDS information has been 
presented and perceived. 
Political  
Politics, the universal tactic of negotiation and compromise, comes into play at every level 
of human discourse and HIV/AIDS is no exception, as policymakers pursue agendas with a 
wide range of goals. Therefore, communication about the disease is invariably shaped by 
political concerns and people live or die as a result of those decisions.  
From a practical standpoint, most campaigns emphasise prevention over treatment since 
there is no known “cure” for the disease and the primary political directive is to reduce rates of 
infection. It follows, then, that the downstream audience is often the target, with a focus on 
short-term behavioural change. Additionally, campaign evaluation is difficult, so measurement 
of effectiveness is frequently based on product successes such as increased condom sales.   
As previously explained, collaboration is essential, but “communication by committee” is 
time-consuming and fraught with dissention. Still, most social marketing initiatives rely on 
partnerships that cross all boundaries—cultural, political, and geographical—but those partners 
may have differing viewpoints and aims. For example, in 2003 U.S. President Bush approved a 
five-year African aid package, saying his country had a "moral duty to act…[since] every day of 
delay means 8,000 more AIDS deaths in Africa and 14,000 more infections" (Campaigners, 
2003). Bush’s plan was criticised because a third of the money slated for prevention had to 
promote abstinence rather than safer sex. Similarly, in countries like Mexico, which is 
predominately Roman Catholic, earmarking funds for a disease often associated with lifestyles 
or practices that conflict with the teachings of the church is a political hurdle.  
An intriguing political response to the problem of attracting substantial support is the 
“positioning” of women as the primary victims— “the innocents”—in the battle against AIDS. 
This widespread rhetoric is designed to gain broad political support from faith-based 
organisations as well as from political leaders looking for the most acceptable route to public 
approval. Since women comprise about half of those infected worldwide, this marketing 
approach lends itself to a wide range of emotional/rational appeals. On the eve of the June 2007 
EU summit, Bill Gates, a major contributor of funds to fight AIDS, appealed to the G8 countries 
to pledge new resources to “beat AIDS.” Gates said in part, “A top priority must be to address 
the prevention needs of women and girls…biologically, women are twice as likely as men to 
contract HIV. And many women—including those who are married—have little power to ensure 
their partners are faithful or use condoms” (Gates, 2007).  
Financial  
Whether the focus of the discussion is on individual health care, allotment of national 
resources, or international business, economics is a principal catalyst for action. AIDS 
represents both crisis and opportunity in the world of finance.  
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On the global scale, concern about projected costs of AIDS treatment is spurring 
policymakers to look for far-reaching solutions to avoid a future collapse of their health care 
systems. In terms of opportunity, the disease offers possibilities of massive profits for 
aggressive marketers. Promoting the use of condoms is such an integral part of HIV/AIDS 
social marketing that the practice has its own acronym: condom social marketing [CSM] 
(Condom, 2006). After realising sales in Mexico of 19 million condoms in 2004, the charitable 
organisation DKT International noted “dynamic social marketing” was essential to its success 
(DKT, 2005).  
Even greater opportunities abound when it comes to conventional drug treatments for AIDS 
victims. In industrialised countries such as the United States, Americans with adequate 
insurance or personal funds can receive HAART [Highly Active Anti-retroviral Treatment] and 
monitoring for about £5,000/year. The cost of current treatments clearly separates the haves 
from the have-nots; only one-fifth of infected people in developing countries are receiving anti-
retroviral therapy, primarily due to cost constraints.  
In this rush to find effective treatments and ultimately a cure, there have been many 
stumbles and some documented deceits, such as selective reporting of clinical drug trials, as 
acknowledged by the International Committee of Medical Journal Editors (Graham, 2004:18). 
In 2003, the Panos Institute, a global network based in London that focuses on “amplifying the 
voices of the poor and marginalised,” issued a report examining how communication has been 
used to respond to the AIDS pandemic and calling for media to support informed debate rather 
than merely disseminating information (Missing, 2003).  
Finally, some critics claim that medical innovations such as nanotechnology are changing the 
landscape of possibilities regarding treatment and new discoveries about the cause of AIDS are 
not being published in medical journals or pursued by conventional medicine (Siegal, 2003). 
The conventional medicine community, on the other hand, cites the benefits of international 
alliances and increased life expectancies for those receiving HAART (Sepkowitz, 2006).  
As the international debate continues, these three factors—cultural content of social 
marketing messages about HIV/AIDS, the role of political expediency, and the economic 
realities of the global medical market created by the epidemic—form a complex and politically 
charged environment that influences public dissemination of information about health care 
options. The deeper beneath the surface one looks, the more relationships, conflicts, and 
knowledge gaps are uncovered, justifying further study. 
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Issues: When world leaders completed their 25th annual tally of the 
unrelenting progress of the AIDS pandemic, it was sadly apparent women 
have achieved global infection equity. Women are biologically twice as likely 
to contract HIV as men and now make up more than 50 percent of adults 
living with the disease (UNAIDS, 2007). From the cradle to the grave, 
women’s health destinies are often linked to cultural traditions of female 
acquiescence and powerlessness, as well as gender norms that give men 
control of when and how women have sex.  
Description: To combat these too-common circumstances, alliances of 
local, national, and international groups are designing social marketing 
campaigns to empower women.  
This study tells the human stories behind recent successful initiatives that 
targeted women at risk in three countries:  
- Sugar Daddies addressed the widespread problem of cross-generational 
sex in Uganda, where HIV infection rates are six times higher for teenage 
girls than for their male counterparts.  
- The New Faces of HIV in Houston was launched to increase testing among 
African American women, who account for 70 percent of the newly 
diagnosed HIV-positive women in the United States.  
- Programa Mujeres encouraged Mexican women aged 14-24 to take control 
of their sexual and reproductive health in a society where traditional gender 
roles fuel annual increases in HIV infections.  
Lessons learned: Although these empowerment projects were worlds 
apart in language and culture, each targeted highly vulnerable groups. 
Relying on global support for the HIV prevention needs of women, the 
campaigns demonstrated important lessons for future initiatives: forging 
collaborative partnerships with common goals and varied resources; 
involving the target audience at every stage; and crafting culturally 
sensitive multimedia, multilingual messages.  
Next steps: Examples of materials and experiences from participants in 
these campaigns will inspire audiences to contribute ideas for continuing this 
worldwide empowerment of women.  
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MAKING HISTORY: CURING HIV/AIDS WITH NANOTECHNOLOGY 
 
PANEL SESSION INTRODUCTION 
 
 HIV/AIDS has killed at least 28 million people since 1982 (USAID, 2006). The number 
of HIV/AIDS infected now surpasses 50 million. In the 25 years since the first reported cases of 
HIV/AIDS in 1981, the disease has become a global pandemic. Unfortunately, the epidemic’s 
history is a story of largely unfulfilled hopes for various treatments. 
 
 However, new nanotechnology treatments are offering solutions. In 2005, silver 
nanoparticles were demonstrated in vitro to attach and inhibit HIV-1 from binding to host cells 
through size-dependent interaction (see, Elechiguerra, et al., Interaction of silver nanoparticles 
with HIV-1, J. Nanobiotechnology. 2005, 3, 6.).  In 2006, U.S. physicians demonstrated 
remarkable results in follow-up human pilot programs in Texas. 
 
 Social marketing will be a key tactic for informing both policy makers—and the public—
of these successes, because social marketing can operate in the maelstrom of cultural, political, 
economic and social concerns.  
PART I: BRIEF HISTORY OF HIV/AIDS TREATMENTS 
 
The history of drug treatment regimens for HIV/AIDS is complex.  It is complicated by 
problems with toxicity, compliance, side effects and cost. In 1987, AZT (zidovudine) was the 
first drug approved for treatment of AIDS. By the mid-1990s, a number of new drugs were 
being developed, such as Highly Active Anti-Retroviral Therapy (HAART). HAART treatment 
involves a combination of three classes of drugs: protease inhibitors, nucleoside reverse 
transcriptase inhibitors and non-nucleoside reverse transcriptase inhibitors, all of which interfere 
with the enzymes the virus uses to replicate itself. A viral load below 50—the level at which the 
virus is no longer detectable in blood—is the goal of therapy, but is seldom achieved. 
 
Newer research shows, however, that the most effective drug therapies fail to prevent 
replication of the virus. This unfortunate result makes eliminating HIV with antiretroviral 
therapy unrealistic. Also, the virus often develops resistance during therapy, resulting in a steady 
viral load increase. Additionally, co-infections are on the rise. These co-infections include both 
fungal and bacterial infections, as well as common viral infections such as CMV 
(cytomegalovirus, which affects vision) and viral pneumonia.  
  
Fortunately, nanotechnological solutions to HIV/AIDS hold great promise. The 
interaction of nano- and sub-nanoparticles with biomolecules and microorganisms is an 
expanding field of research (see, e.g., Elechiguerra, et al., Interaction of silver nanoparticles 
with HIV-1, J. Nanobiotechnology. 2005, 3, 6.). 
Medical literature shows a variety of viruses have been successfully treated with silver-based 
drugs (Rentz, Viral pathogens and severe acute respiratory syndrome: Oligodynamic Ag+ for 
direct immune intervention, J. Nutritional & Environmental Medicine. 2003, Jun; 13(2): 109-
18).  
 
Emerging medical studies confirm the stellar, broad-spectrum virotoxic efficacy of 
oligodynamic noble metals both in vitro and in vivo (Gordon & Holtorf, A Promising Cure for 
URTI Pandemics, Including H5N1 and SARS: Has the Final Solution to the Coming Plagues 
Been Discovered? [Part II]. Townsend Letter, Feb/Mar 2006. This includes some of the most 
formidable viral organisms like HIV (including co-infections) (Id.; see also; Dean, et al., 
Reduction of viral load in AIDS patients with intravenous mild-silver protein—Three case 
reports, Clinical Practice of Alternative Medicine, Spring 2001; Oka, et al., 1994; Hussain, et 
al., Cystine protects Na, K-ATPase and isolated human lymphocytes from silver toxicity, 
Biochem. Biophys. Res. Comm., 1992, 189.1444-1449; Aiken, In vitro MIC Test Against HIV-1, 
published account via email, AA-90 Results. Vanderbilt School of Medicine, Dec. 16, 1997; et 
al., 2005; Zhong-Yin, et al., Zinc inhibition of rennin and the protease from Human 
Immunodeficiency Virus Type 1, Biochemistry, 1991 Sept 10.30(36): 8717-21). 
 
This portion of the panel and supporting paper will briefly discuss the 25-year history of 
HIV/AIDS treatments, as well as present a synopsis of current nanotechnology treatments.  
 
PART II: U.S. CASE STUDIES (2006) 
 
In 2006, U.S. physicians operating under Investigational Review Board (IRB) authority 
demonstrated highly encouraging results using silver nanoparticles to treat HIV/AIDS patients 
during a pilot program in Texas. This pilot program followed up a University of Texas 
(Austin)—University of Mexico (Monterrey) study published in 2005, which demonstrated 
silver nanoparticles in vitro attached to and inhibited HIV-1 from binding to host cells through 
size-dependent interaction (see, Elechiguerra, et al., Interaction of silver nanoparticles with 
HIV-1, J. Nanobiotechnology. 2005, 3, 6.).  
 
Under this IRB program, patients received oral-only administration of tiny silver 
particles set in water.  HIV-infected patients, after examination and blood test, orally ingested a 
nanoparticle-sized solution for 30 days, then retested for improved CD4 counts and viral load. 
The program consisted of an initial physician examination, two blood tests (one at 15 days, the 
last at 30 days) to measure CD4 and viral loads, then a final analysis of results.  
 
Patients in this pilot program were on both conventional therapy and non-conventional 
therapy. The best results were obtained with patients who were not on conventional therapy. 
One HIV-positive patient showed a remarkable drop of over 68% viral load in only 15 days.  
 
This portion of the panel and supporting paper are based upon three case studies from 
the pilot program. 
 
 
PART III: GETTING THE WORD OUT: PROMOTING CURES THROUGH SOCIAL MARKETING 
 
For more than three decades, social marketing has been widely used to motivate low-income 
and high-risk audiences. Where successful treatments exist, social marketing should now be 
used to inform governmental policy makers and the public of their existence. This appears 
especially true with new nanotechnological treatments now in the process of being made 
available. 
 
Social marketing has been a key tactic in combating HIV/AIDS, both in developing and 
industrialized countries, for the past 20 years. Social marketing campaigns have previously 
focused on prevention and treatment messages; yet, these campaigns have also addressed the 
cultural concerns and stigma related to the disease.  
 
In Mexico, where the increase in new HIV cases has been continuous since 1981, social 
marketing is the tool of choice for promoting positive change, both for individuals (downstream 
audiences) and for broader social policy (upstream audiences), with the goal of preventing this 
“underground epidemic” from becoming generalized to the population at large (HIV Infection, 
2003; USAID, 2005). Numerous campaigns address this challenge, including USAID initiatives, 
whose infectious disease objectives in Mexico target stigma and discrimination. The principal 
contractor for the USAID campaign, Population Services International [PSI], was the first 
organization to use social marketing to combat the AIDS epidemic. In addition to procuring and 
distributing pharmaceuticals, over-the-counter drugs and condoms, PSI trains government 
officials in marketing and communication techniques. 
  
Mexico is a highly competitive market for products such as condoms, according to the 
Washington-based charitable organization DKT International. After realizing sales in Mexico of 
19 million condoms in 2004, DKT noted “dynamic social marketing” was essential (DKT, 
2005). Likewise, PSI, in conjunction with CENSIDA [The National Center for the Prevention 
and Control of HIV/AIDS] and CONASIDA [The National Council for Prevention and Control 
of AIDS], is using extensive condom social marketing in high-risk areas of southern Mexico 
(PSI, 2006). 
 
 Since HIV/AIDS is also a significant problem along the U.S.-Mexico border, programs 
such as the SPNS (Special Projects of National Significance) Border Health Initiative rely 
heavily on social marketing campaigns, using Spanish language media to blanket the transient 
communities with “bold” HIV messages (Innovative, 2005). Innovative media strategies also 
characterize Project Hombres, Project Diversity and Project Mujeres, which were developed by 
a partnership of Latin American NGOs to combat Mexico’s cultural, gender and lifestyle 
barriers (World, 2006).   
 As HIV/AIDS social marketing establishes a track record in Mexico, organizations using 
this technique can begin to analyze results. For example, PANCEA, a three-year NIH-funded 
research project in Mexico and four other countries, is studying the effectiveness of the eight 
prevention modalities commonly used to respond to the HIV epidemic (PANCEA, 2005). 
 Building on these self-evaluations, this portion of the panel and supporting paper use the 
essential elements of social marketing to compare Mexico HIV/AIDS campaigns, identifying 
commonalities as well as unique characteristics in purpose, targeted audience, content/focus and 
strategic approach. The result is a practical overview of how social marketing can successfully 
operate in the maelstrom of cultural, political, economic and social concerns while bringing 
about voluntary behavioural changes among both downstream and upstream audiences. 
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ABSTRACT 
 
Social marketing has been widely used to influence low-income, high-risk 
populations to make healthy behaviour changes. This application of marketing 
principles has also become an important tool for persuading upstream audiences to 
make long-term policy changes that achieve socially desirable goals. As the human, 
social, and economic costs of the HIV/AIDS pandemic mount, social marketing is now 
a key tactic for combating the disease. This paper analyses six recent HIV/AIDS 
campaigns in Mexico, examining their ability to motivate change and their potential for 
informing target audiences about new health choices. Although each campaign has a 
unique theme and a distinctive focus, all share common objectives. Collaboration is 
essential; each campaign involves multiple organizations, thereby building acceptance 
for change at all levels. The campaigns all incorporate prevention strategies, and in 
recognition of Mexico’s cultural obstacles, each addresses aspects of stigma and 
traditional cultural norms. Persuasive messages are informed by the tenets of 
established behavioural models. As a result, alliances of HIV/AIDS social marketers in 
Mexico have been able to operate successfully in the maelstrom of cultural, political, 
economic, and social concerns while bringing about voluntary behavioural changes 
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APPENDIX F 
SPSS TABLES FROM CHAPTER 7 
 
 
  
F.1 Cross Tabulation Tables with Significance  
Or a Tendency toward Significance  
Using Pearson’s Chi-Square Test of Association     
 
F.1.a. Crosstabs: Sources and Demographic Variables   F1 
F.1.b. Crosstabs: Source Credibility and Demographic Variables  F18 
F.1.c. Crosstabs: Perception Statements and Demographic Variables F29 
F.1.d. Crosstabs: Treatments Known and Demographic Variables  F71 
F.1.e. Crosstabs: Effective Treatments and Demographic Variables F93 
 
F.2 List of Crosstabs with No Significance     F114 
 
F.3 Reliability Statistics: Cronbach’s Alpha Analysis Tables  F116 
F 1 
 
CROSSTABS:  SOURCES AND DEMOGRAPHIC VARIABLES 
 
SOURCES VS. GENDER 
 
Which gender do you 
identify yourself with 
    male female Total 
Count 77 18 95 
Expected Count 63.0 32.0 95.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
TV 
81.1% 18.9% 100.0% 
not selected 
% of Total 23.8% 5.6% 29.3% 
Count 138 91 229 
Expected Count 152.0 77.0 229.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
TV 
60.3% 39.7% 100.0% 
sources you have 
learned about 
HIV/AIDS in the last 
4-5 years- TV 
selected 
% of Total 42.6% 28.1% 70.7% 
Count 215 109 324 
Expected Count 215.0 109.0 324.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
TV 
66.4% 33.6% 100.0% 
Total 
% of Total 66.4% 33.6% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 13.001(b) 1 .000     
Continuity 
Correction(a) 
12.086 1 .001     
Likelihood Ratio 13.850 1 .000     
Fisher's Exact Test       .000 .000 
Linear-by-Linear 
Association 
12.961 1 .000     
N of Valid Cases 324         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 31.96. 
F 2 
 
 
  
Which gender do you 
identify yourself with 
    male female Total 
Count 133 48 181 
Expected Count 120.1 60.9 181.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
Radio 
73.5% 26.5% 100.0% 
not selected 
% of Total 41.0% 14.8% 55.9% 
Count 82 61 143 
Expected Count 94.9 48.1 143.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
Radio 
57.3% 42.7% 100.0% 
sources you have 
learned about 
HIV/AIDS in the last 4-
5 years- Radio 
selected 
% of Total 25.3% 18.8% 44.1% 
Count 215 109 324 
Expected Count 215.0 109.0 324.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
Radio 
66.4% 33.6% 100.0% 
Total 
% of Total 66.4% 33.6% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 9.320(b) 1 .002     
Continuity 
Correction(a) 
8.611 1 .003     
Likelihood Ratio 9.301 1 .002     
Fisher's Exact Test       .003 .002 
Linear-by-Linear 
Association 
9.291 1 .002     
N of Valid Cases 324         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 48.11. 
F 3 
 
 
  
Which gender do you 
identify yourself with 
    male female Total 
Count 66 47 113 
Expected Count 75.0 38.0 113.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
Magazine 
58.4% 41.6% 100.0% 
not selected 
% of Total 20.4% 14.5% 34.9% 
Count 149 62 211 
Expected Count 140.0 71.0 211.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
Magazine 
70.6% 29.4% 100.0% 
sources you have 
learned about 
HIV/AIDS in the last 4-
5 years- Magazine 
selected 
% of Total 46.0% 19.1% 65.1% 
Count 215 109 324 
Expected Count 215.0 109.0 324.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
Magazine 
66.4% 33.6% 100.0% 
Total 
% of Total 66.4% 33.6% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 4.914(b) 1 .027     
Continuity 
Correction(a) 
4.382 1 .036     
Likelihood Ratio 4.849 1 .028     
Fisher's Exact Test       .036 .019 
Linear-by-Linear 
Association 
4.898 1 .027     
N of Valid Cases 324         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 38.02. 
F 4 
 
 
    
Which gender do 
you identify 
yourself with Total 
    male female male 
sources you have learned 
about HIV/AIDS in the last 
4-5 years- Out of Home, 
billboards, transit 
ads,posters,flyers,brochures 
not 
selected 
Count 
144 57 201 
    Expected Count 133.4 67.6 201.0 
    % within Sources  71.6% 28.4% 100.0% 
    % of Total 44.4% 17.6% 62.0% 
  selected Count 71 52 123 
    Expected Count 81.6 41.4 123.0 
    % within Sources  57.7% 42.3% 100.0% 
    % of Total 21.9% 16.0% 38.0% 
Total Count 215 109 324 
  Expected Count 215.0 109.0 324.0 
  % within Sources  66.4% 33.6% 100.0% 
  % of Total 66.4% 33.6% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 6.621(b) 1 .010     
Continuity 
Correction(a) 
6.013 1 .014     
Likelihood Ratio 6.552 1 .010     
Fisher's Exact Test       .011 .007 
Linear-by-Linear 
Association 
6.601 1 .010     
N of Valid Cases 324         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 41.38. 
F 5 
 
 
SOURCES VS. STATUS 
 
My HIV status is 
    Negative Positive Total 
Count 24 65 89 
Expected Count 32.6 56.4 89.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
TV 
27.0% 73.0% 100.0% 
not selected 
% of Total 8.2% 22.3% 30.5% 
Count 83 120 203 
Expected Count 74.4 128.6 203.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
TV 
40.9% 59.1% 100.0% 
sources you have 
learned about 
HIV/AIDS in the last 
4-5 years- TV 
selected 
% of Total 28.4% 41.1% 69.5% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
TV 
36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 5.164(b) 1 .023     
Continuity 
Correction(a) 
4.582 1 .032     
Likelihood Ratio 5.311 1 .021     
Fisher's Exact Test       .025 .015 
Linear-by-Linear 
Association 
5.147 1 .023     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 32.61. 
F 6 
 
 
  
My HIV status is 
    Negative Positive Total 
Count 50 118 168 
Expected Count 61.6 106.4 168.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
Radio 
29.8% 70.2% 100.0% 
not selected 
% of Total 17.1% 40.4% 57.5% 
Count 57 67 124 
Expected Count 45.4 78.6 124.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
Radio 
46.0% 54.0% 100.0% 
sources you have 
learned about 
HIV/AIDS in the last 4-
5 years- Radio 
selected 
% of Total 19.5% 22.9% 42.5% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
Radio 
36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 8.071(b) 1 .004     
Continuity 
Correction(a) 
7.388 1 .007     
Likelihood Ratio 8.046 1 .005     
Fisher's Exact Test       .005 .003 
Linear-by-Linear 
Association 
8.043 1 .005     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 45.44. 
 
F 7 
 
 
  
My HIV status is 
    Negative Positive Total 
Count 55 119 174 
Expected Count 63.8 110.2 174.0 
% within sources you 
have learned about 
HIV/AIDS in the last 
4-5 years- Out of 
Home, billboards, 
transit 
ads,posters,flyers,bro
chures 
31.6% 68.4% 100.0% 
not selected 
% of Total 18.8% 40.8% 59.6% 
Count 52 66 118 
Expected Count 43.2 74.8 118.0 
% within sources you 
have learned about 
HIV/AIDS in the last 
4-5 years- Out of 
Home, billboards, 
transit 
ads,posters,flyers,bro
chures 
44.1% 55.9% 100.0% 
sources you have 
learned about 
HIV/AIDS in the last 4-
5 years- Out of Home, 
billboards, transit 
ads,posters,flyers,broch
ures 
selected 
% of Total 17.8% 22.6% 40.4% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within sources you 
have learned about 
HIV/AIDS in the last 
4-5 years- Out of 
Home, billboards, 
transit 
ads,posters,flyers,bro
chures 
36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 4.701(b) 1 .030     
Continuity 
Correction(a) 
4.180 1 .041     
Likelihood Ratio 4.676 1 .031     
Fisher's Exact Test       .035 .021 
Linear-by-Linear 
Association 
4.685 1 .030     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 43.24. 
F 8 
 
 
 
  
My HIV status is 
    Negative Positive Total 
Count 78 108 186 
Expected Count 68.2 117.8 186.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
HIV/AIDS groups’ 
websites 
41.9% 58.1% 100.0% 
not selected 
% of Total 26.7% 37.0% 63.7% 
Count 29 77 106 
Expected Count 38.8 67.2 106.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
HIV/AIDS groups’ 
websites 
27.4% 72.6% 100.0% 
sources you have 
learned about 
HIV/AIDS in the last 4-
5 years- HIV/AIDS 
groups’ websites 
selected 
% of Total 9.9% 26.4% 36.3% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
HIV/AIDS groups’ 
websites 
36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 6.180(b) 1 .013     
Continuity 
Correction(a) 
5.568 1 .018     
Likelihood Ratio 6.316 1 .012     
Fisher's Exact Test       .016 .009 
Linear-by-Linear 
Association 
6.159 1 .013     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 38.84. 
F 9 
 
 
 
  
My HIV status is 
    Negative Positive Total 
Count 77 153 230 
Expected Count 84.3 145.7 230.0 
% within sources you 
have learned about 
HIV/AIDS in the last 
4-5 years- Online 
newsletter, journals 
33.5% 66.5% 100.0% 
not 
selected 
% of Total 26.4% 52.4% 78.8% 
Count 30 32 62 
Expected Count 22.7 39.3 62.0 
% within sources you 
have learned about 
HIV/AIDS in the last 
4-5 years- Online 
newsletter, journals 
48.4% 51.6% 100.0% 
sources you have 
learned about 
HIV/AIDS in the last 
4-5 years- Online 
newsletter,journals,ect 
selected 
% of Total 10.3% 11.0% 21.2% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within sources you 
have learned about 
HIV/AIDS in the last 
4-5 years- Online 
newsletter, journals 
36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 4.676(b) 1 .031     
Continuity 
Correction(a) 
4.055 1 .044     
Likelihood Ratio 4.565 1 .033     
Fisher's Exact Test       .038 .023 
Linear-by-Linear 
Association 
4.660 1 .031     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 22.72. 
F 10 
 
 
 
  
My HIV status is 
    Negative Positive Total 
Count 86 167 253 
Expected Count 92.7 160.3 253.0 
% within sources you 
have learned about 
HIV/AIDS in the last 
4-5 years-Social 
media, facebook, 
Twitter 
34.0% 66.0% 100.0% 
not 
selected 
% of Total 29.5% 57.2% 86.6% 
Count 21 18 39 
Expected Count 14.3 24.7 39.0 
% within sources you 
have learned about 
HIV/AIDS in the last 
4-5 years- Social 
media facebook, 
Twitter 
53.8% 46.2% 100.0% 
sources you have 
learned about 
HIV/AIDS in the last 
4-5 years- Social 
media,facebook,Twitte
r,ect 
selected 
% of Total 7.2% 6.2% 13.4% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within sources you 
have learned about 
HIV/AIDS in the last 
4-5 years-Social media 
facebook, Twitter 
36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 5.737(b) 1 .017     
Continuity 
Correction(a) 
4.914 1 .027     
Likelihood Ratio 5.535 1 .019     
Fisher's Exact Test       .020 .014 
Linear-by-Linear 
Association 
5.718 1 .017     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 14.29. 
F 11 
 
 
 
  
My HIV status is 
    Negative Positive Total 
Count 68 144 212 
Expected Count 77.7 134.3 212.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years-
Edu institutions 
32.1% 67.9% 100.0% 
not selected 
% of Total 23.3% 49.3% 72.6% 
Count 39 41 80 
Expected Count 29.3 50.7 80.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years-
Edu institutions 
48.8% 51.3% 100.0% 
sources you have 
learned about 
HIV/AIDS in the last 4-
5 years-Educational 
institutions 
selected 
% of Total 13.4% 14.0% 27.4% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years-
Edu  institutions 
36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 6.956(b) 1 .008     
Continuity 
Correction(a) 
6.256 1 .012     
Likelihood Ratio 6.820 1 .009     
Fisher's Exact Test       .010 .007 
Linear-by-Linear 
Association 
6.932 1 .008     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 29.32. 
F 12 
 
 
 
  
My HIV status is 
    Negative Positive Total 
Count 44 106 150 
Expected Count 55.0 95.0 150.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
Friends or family 
members 
29.3% 70.7% 100.0% 
not selected 
% of Total 15.1% 36.3% 51.4% 
Count 63 79 142 
Expected Count 52.0 90.0 142.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
Friends or family 
members 
44.4% 55.6% 100.0% 
sources you have 
learned about 
HIV/AIDS in the last 4-
5 years- Friends or 
family members 
selected 
% of Total 21.6% 27.1% 48.6% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
Friends or family 
members 
36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 7.101(b) 1 .008     
Continuity 
Correction(a) 
6.468 1 .011     
Likelihood Ratio 7.127 1 .008     
Fisher's Exact Test       .011 .005 
Linear-by-Linear 
Association 
7.076 1 .008     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 52.03. 
F 13 
 
 
 
  
My HIV status is 
    Negative Positive Total 
Count 68 149 217 
Expected Count 79.5 137.5 217.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
People you work 
with 
31.3% 68.7% 100.0% 
not selected 
% of Total 23.3% 51.0% 74.3% 
Count 39 36 75 
Expected Count 27.5 47.5 75.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
People you work 
with 
52.0% 48.0% 100.0% 
sources you have 
learned about 
HIV/AIDS in the last 
4-5 years- People you 
work with 
selected 
% of Total 13.4% 12.3% 25.7% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within sources 
you have learned 
about HIV/AIDS in 
the last 4-5 years- 
People you work 
with 
36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 10.251(b) 1 .001     
Continuity 
Correction(a) 
9.380 1 .002     
Likelihood Ratio 10.009 1 .002     
Fisher's Exact Test       .002 .001 
Linear-by-Linear 
Association 
10.216 1 .001     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 27.48. 
F 14 
 
 
 
SOURCES VS. SEXUAL ORIENTATION 
 
    sexual orientation Total 
    heterosexual homosexual bi-sexual 1.00 
sources you 
have 
learned 
about 
HIV/AIDS 
in the last 
4-5 years- 
HIV/AIDS 
groups’ 
websites 
not selected Count 
109 73 16 198 
    Expected 
Count 
92.9 83.3 21.8 198.0 
    % within 
sources  55.1% 36.9% 8.1% 100.0% 
    % of Total 35.3% 23.6% 5.2% 64.1% 
   
selected 
 
Count 
 
36 
 
57 
 
18 
 
111 
    Expected 
Count 
52.1 46.7 12.2 111.0 
    % within 
sources  
         32.4% 51.4% 16.2% 100.0% 
    % of Total 11.7% 18.4% 5.8% 35.9% 
 
Total 
 
Count 
 
145 
 
130 
 
34 
 
309 
  Expected 
Count 
145.0 130.0 34.0 309.0 
  % within 
sources  
46.9% 42.1% 11.0% 100.0% 
  % of Total 46.9% 42.1% 11.0% 100.0% 
 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 15.578(a) 2 .000 
Likelihood Ratio 15.750 2 .000 
Linear-by-Linear 
Association 
14.892 1 .000 
N of Valid Cases 
309     
a  0 cells (.0%) have expected count less than 5. The minimum expected count is 12.21. 
 
F 15 
 
SOURCES VS. AGE 
 
Age group 
    18-25 26-36 37-47 48-58 59 + Total 
Count 42 67 98 74 17 298 
Expecte
d Count 
46.5 78.0 90.3 67.5 15.8 298.0 
% 
within 
sources  14.1% 22.5% 32.9% 24.8% 5.7% 100.0% 
not 
selected 
% of 
Total 
12.4% 19.7% 28.8% 21.8% 5.0% 87.6% 
 
Count 
 
11 
 
22 
 
5 
 
3 
 
1 
 
42 
Expecte
d Count 
6.5 11.0 12.7 9.5 2.2 42.0 
% 
within 
sources  26.2% 52.4% 11.9% 7.1% 2.4% 100.0% 
sources 
you 
have 
learned 
about 
HIV/AI
DS in 
the last 
4-5 
years- 
Social 
media,fa
cebook,
Twitter,
ect 
 
selected 
% of 
Total 
3.2% 6.5% 1.5% .9% .3% 12.4% 
 
Count 
 
53 
 
89 
 
103 
 
77 
 
18 
 
340 
Expecte
d Count 
53.0 89.0 103.0 77.0 18.0 340.0 
% 
within 
sources  15.6% 26.2% 30.3% 22.6% 5.3% 100.0% 
 
Total 
% of 
Total 
15.6% 26.2% 30.3% 22.6% 5.3% 100.0% 
 
                                   Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 27.230(a) 4 .000 
Likelihood Ratio 27.492 4 .000 
Linear-by-Linear 
Association 
17.841 1 .000 
N of Valid Cases 
340     
a  1 cells (10.0%) have expected count less than 5. The minimum expected count is 2.22. 
 
F 16 
 
SOURCES VS. ETHNIC GROUP 
 
which group do you identify with? 
    
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/african 
american or 
negro hispanic 
White / 
caucasian multiracial other Total 
Count 6 3 88 42 66 10 6 221 
Expected Count 5.9 2.6 79.5 34.6 82.8 11.7 3.9 221.0 
% within sources  2.7% 1.4% 39.8% 19.0% 29.9% 4.5% 2.7% 100.0% 
not selected 
% of Total 1.8% .9% 26.0% 12.4% 19.5% 2.9% 1.8% 65.2% 
Count 3 1 34 11 61 8 0 118 
Expected Count 3.1 1.4 42.5 18.4 44.2 6.3 2.1 118.0 
% within sources  2.5% .8% 28.8% 9.3% 51.7% 6.8% .0% 100.0% 
sources you have learned 
about HIV/AIDS in the last 
4-5 years- Conventional 
medical doctors 
selected 
% of Total .9% .3% 10.0% 3.2% 18.0% 2.4% .0% 34.8% 
Count 9 4 122 53 127 18 6 339 
Expected Count 9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
% within sources  2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
Total 
% of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
 
F 17 
 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 21.106(a) 6 .002 
Likelihood Ratio 23.099 6 .001 
Linear-by-Linear 
Association 5.224 1 .022 
N of Valid Cases 
339     
a  5 cells (35.7%) have expected count less than 5. The minimum expected count is 1.39. 
 
 
 
F 18 
 
CROSSTABS: 
SOURCE CREDIBILITY AND DEMOGRAPHIC VARIABLES 
 
SOURCE CREDIBILITY VS. STATUS 
My HIV status is 
    Negative Positive Total 
Count 1 8 9 
Expected 
Count 
3.4 5.6 9.0 
% within 
Sources 
11.1% 88.9% 100.0% 
not at all 
credible 
% of Total 
 
             .5%            3.7% 4.1% 
Count 5 14 19 
Expected 
Count 
7.2 11.8 19.0 
% within 
Sources 
26.3% 73.7% 100.0% 
somewhat 
credible 
% of Total 2.3% 6.5% 8.8% 
Count 12 30 42 
Expected 
Count 
15.9 26.1 42.0 
% within 
Sources 
28.6% 71.4% 100.0% 
undecided 
% of Total 5.5% 13.8% 19.4% 
Count 27 42 69 
Expected 
Count 
26.1 42.9 69.0 
% within 
Sources 
39.1% 60.9% 100.0% 
credible 
% of Total 12.4% 19.4% 31.8% 
Count 37 41 78 
Expected 
Count 
29.5 48.5 78.0 
% within 
Sources 
47.4% 52.6% 100.0% 
Rate each of 
these 
sources of 
HIV/AIDS 
information 
according to 
how 
credible 
they have 
been in your 
experience-
events, 
seminars, 
workshops, 
conferences 
extremely 
credible 
% of Total 17.1% 18.9% 35.9% 
Count 82 135 217 
Expected 
Count 
82.0 135.0 217.0 
% within 
Sources 
37.8% 62.2% 100.0% 
Total 
% of Total 37.8% 62.2% 100.0% 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 8.447(a) 4 .077 
Likelihood Ratio 9.022 4 .061 
Linear-by-Linear 
Association 
8.171 1 .004 
N of Valid Cases 
217     
a  1 cells (10.0%) have expected count less than 5. The minimum expected count is 3.40. 
F 19 
 
 
My HIV status is 
   Negative Positive Total 
Count 0 8 8 
Expected 
Count 
2.9 5.1 8.0 
% within 
Sources  .0% 100.0% 100.0% 
not at all 
credible 
% of Total .0% 3.5% 3.5% 
Count 15 14 29 
Expected 
Count 
10.5 18.5 29.0 
% within 
Sources 
51.7% 48.3% 100.0% 
somewhat 
credible 
% of Total 6.5% 6.1% 12.6% 
Count 17 38 55 
Expected 
Count 
19.8 35.2 55.0 
% within 
Sources  30.9% 69.1% 100.0% 
undecided 
% of Total 7.4% 16.5% 23.9% 
Count 26 51 77 
Expected 
Count 
27.8 49.2 77.0 
% within 
Sources  33.8% 66.2% 100.0% 
credible 
% of Total 11.3% 22.2% 33.5% 
Count 25 36 61 
Expected 
Count 
22.0 39.0 61.0 
% within 
Sources  
41.0% 59.0% 100.0% 
Rate each of 
these sources 
of HIV/AIDS 
information 
according to 
how credible 
they have 
been in your 
experience-
community 
organizations 
extremely 
credible 
% of Total 10.9% 15.7% 26.5% 
Count 83 147 230 
Expected 
Count 
83.0 147.0 230.0 
% within 
Sources  
36.1% 63.9% 100.0% 
Total 
% of Total 36.1% 63.9% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 9.045(a) 4 .060 
Likelihood Ratio 11.565 4 .021 
Linear-by-Linear 
Association 
.456 1 .500 
N of Valid Cases 
230     
a  1 cells (10.0%) have expected count less than 5. The minimum expected count is 2.89. 
 
  
F 20 
 
My HIV status is 
    Negative Positive Total 
Count 1 7 8 
Expected 
Count 
3.0 5.0 8.0 
% within 
Sources  12.5% 87.5% 100.0% 
not at all 
credible 
% of Total .5% 3.2% 3.6% 
Count 11 13 24 
Expected 
Count 
9.0 15.0 24.0 
% within 
Sources  
45.8% 54.2% 100.0% 
somewhat 
credible 
% of Total 5.0% 5.9% 10.8% 
Count 8 33 41 
Expected 
Count 
15.3 25.7 41.0 
% within 
Sources  19.5% 80.5% 100.0% 
undecided 
% of Total 3.6% 14.9% 18.5% 
Count 34 47 81 
Expected 
Count 
30.3 50.7 81.0 
% within 
Sources  42.0% 58.0% 100.0% 
credible 
% of Total 15.3% 21.2% 36.5% 
Count 29 39 68 
Expected 
Count 
25.4 42.6 68.0 
% within 
Sources  42.6% 57.4% 100.0% 
Rate each of 
these 
sources of 
HIV/AIDS 
information 
according to 
how 
credible 
they have 
been in your 
experience-
educational 
institutions 
extremely 
credible 
% of Total 13.1% 17.6% 30.6% 
Count 83 139 222 
Expected 
Count 
83.0 139.0 222.0 
% within 
Sources  37.4% 62.6% 100.0% 
Total 
% of Total 37.4% 62.6% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 9.976(a) 4 .041 
Likelihood Ratio 10.886 4 .028 
Linear-by-Linear 
Association 
2.611 1 .106 
N of Valid Cases 
222     
a  1 cells (10.0%) have expected count less than 5. The minimum expected count is 2.99. 
 
  
F 21 
 
My HIV status is 
    Negative Positive Total 
Count 7 31 38 
Expected 
Count 
14.7 23.3 38.0 
% within 
Sources  18.4% 81.6% 100.0% 
not at all 
credible 
% of Total 3.3% 14.5% 17.8% 
Count 13 25 38 
Expected 
Count 
14.7 23.3 38.0 
% within 
Sources  34.2% 65.8% 100.0% 
somewhat 
credible 
% of Total 6.1% 11.7% 17.8% 
Count 25 39 64 
Expected 
Count 
24.8 39.2 64.0 
% within 
Sources  
39.1% 60.9% 100.0% 
undecided 
% of Total 11.7% 18.2% 29.9% 
Count 18 24 42 
Expected 
Count 
16.3 25.7 42.0 
% within 
Sources  42.9% 57.1% 100.0% 
credible 
% of Total 8.4% 11.2% 19.6% 
Count 20 12 32 
Expected 
Count 
12.4 19.6 32.0 
% within 
Sources  62.5% 37.5% 100.0% 
Rate each of 
these 
sources of 
HIV/AIDS 
information 
according to 
how 
credible 
they have 
been in your 
experience-
people you 
work with 
extremely 
credible 
% of Total 9.3% 5.6% 15.0% 
Count 83 131 214 
Expected 
Count 
83.0 131.0 214.0 
% within 
Sources 38.8% 61.2% 100.0% 
Total 
% of Total 38.8% 61.2% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 14.848(a) 4 .005 
Likelihood Ratio 15.338 4 .004 
Linear-by-Linear 
Association 
13.554 1 .000 
N of Valid Cases 
214     
a  0 cells (.0%) have expected count less than 5. The minimum expected count is 12.41. 
 
 
F 22 
 
SOURCE CREDIBILITY VS. AGE 
   Age group Total 
    18-25 26-36 37-47 48-58 59 + 18-25 
Rate each 
of these 
sources of 
HIV/AIDS 
information 
according 
to how 
credible 
they have 
been in 
your 
experience- 
Medical 
Websites 
not at all 
credible 
Count 
6 1 5 3 0 15 
    Expected 
Count 
2.2 4.7 4.6 2.9 .6 15.0 
    % within 
Sources  40.0% 6.7% 33.3% 20.0% .0% 100.0% 
    % of 
Total 
2.3% .4% 2.0% 1.2% .0% 5.9% 
  somewhat 
credible 
Count 
2 2 3 4 2 13 
    Expected 
Count 
1.9 4.1 4.0 2.5 .5 13.0 
    % within 
Sources  
15.4% 15.4% 23.1% 30.8% 15.4% 100.0% 
    % of 
Total 
.8% .8% 1.2% 1.6% .8% 5.1% 
  undecided Count 6 7 11 9 1 34 
    Expected 
Count 
5.0 10.6 10.4 6.6 1.3 34.0 
    % within 
Sources  17.6% 20.6% 32.4% 26.5% 2.9% 100.0% 
    % of 
Total 
2.3% 2.7% 4.3% 3.5% .4% 13.3% 
  credible Count 7 41 31 15 2 96 
    Expected 
Count 
14.3 30.0 29.3 18.8 3.8 96.0 
    % within 
Sources  
7.3% 42.7% 32.3% 15.6% 2.1% 100.0% 
    % of 
Total 
2.7% 16.0% 12.1% 5.9% .8% 37.5% 
  extremely 
credible 
Count 
17 29 28 19 5 98 
    Expected 
Count 
14.5 30.6 29.9 19.1 3.8 98.0 
    % within 
Sources  
17.3% 29.6% 28.6% 19.4% 5.1% 100.0% 
    % of 
Total 
6.6% 11.3% 10.9% 7.4% 2.0% 38.3% 
F 23 
 
Total Count 38 80 78 50 10 256 
  Expected 
Count 
38.0 80.0 78.0 50.0 10.0 256.0 
  % within 
Sources  14.8% 31.3% 30.5% 19.5% 3.9% 100.0% 
  % of 
Total 
14.8% 31.3% 30.5% 19.5% 3.9% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 29.176(a) 16 .023 
Likelihood Ratio 28.049 16 .031 
Linear-by-Linear 
Association 
.015 1 .902 
N of Valid Cases 
256     
a  13 cells (52.0%) have expected count less than 5. The minimum expected count is .51. 
 
F 24 
 
SOURCE CREDIBILITY VS. ETHNIC GROUP 
    which group do you identify with? Total 
    
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/ 
african 
american 
or negro hispanic 
white/ 
caucasian multiracial other 
american indian, 
alaskan native, or 
pacific islander 
Rate each of 
these sources of 
HIV/AIDS 
information 
according to 
how credible 
they have been 
in your 
experience-
blogs, online 
bulletin boards 
not at all 
credible 
Count 
0 0 7 2 19 1 1 30 
    Expected 
Count 
.6 .4 10.4 4.6 11.8 1.7 .5 30.0 
    % within 
Sources 
.0% .0% 23.3% 6.7% 63.3% 3.3% 3.3% 100.0% 
    % of 
Total 
.0% .0% 3.0% .8% 8.1% .4% .4% 12.7% 
  somewhat 
credible 
Count 
1 0 8 3 14 2 2 30 
    Expected 
Count 
.6 .4 10.4 4.6 11.8 1.7 .5 30.0 
F 25 
 
    % within 
Sources  3.3% .0% 26.7% 10.0% 46.7% 6.7% 6.7% 100.0% 
    % of 
Total 
.4% .0% 3.4% 1.3% 5.9% .8% .8% 12.7% 
  undecided Count 2 2 28 13 42 5 1 93 
    Expected 
Count 
2.0 1.2 32.3 14.2 36.6 5.1 1.6 93.0 
    % within 
Sources  2.2% 2.2% 30.1% 14.0% 45.2% 5.4% 1.1% 100.0% 
    % of 
Total 
.8% .8% 11.9% 5.5% 17.8% 2.1% .4% 39.4% 
  credible Count 1 0 20 14 11 3 0 49 
    Expected 
Count 
1.0 .6 17.0 7.5 19.3 2.7 .8 49.0 
    % within 
Sources  
2.0% .0% 40.8% 28.6% 22.4% 6.1% .0% 100.0% 
    % of 
Total 
.4% .0% 8.5% 5.9% 4.7% 1.3% .0% 20.8% 
  extremely 
credible 
Count 
1 1 19 4 7 2 0 34 
    Expected 
Count 
.7 .4 11.8 5.2 13.4 1.9 .6 34.0 
    % within 
Sources  
2.9% 2.9% 55.9% 11.8% 20.6% 5.9% .0% 100.0% 
    % of 
Total 
.4% .4% 8.1% 1.7% 3.0% .8% .0% 14.4% 
F 26 
 
Total Count 5 3 82 36 93 13 4 236 
  Expected 
Count 
5.0 3.0 82.0 36.0 93.0 13.0 4.0 236.0 
  % within 
Sources  2.1% 1.3% 34.7% 15.3% 39.4% 5.5% 1.7% 100.0% 
  % of 
Total 
2.1% 1.3% 34.7% 15.3% 39.4% 5.5% 1.7% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 37.884(a) 24 .036 
Likelihood Ratio 38.451 24 .031 
Linear-by-Linear 
Association 
15.108 1 .000 
N of Valid Cases 
236     
a  21 cells (60.0%) have expected count less than 5. The minimum expected count is .38. 
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SOURCE CREDIBILITY VS. SEXUAL ORIENTATION 
   sexual orientation Total 
    heterosexual homosexual bi-sexual  
Rate each of 
these sources 
of HIV/AIDS 
information 
according to 
how credible 
they have 
been in your 
experience-
friends or 
family 
members 
not at all 
credible 
Count 
13 8 7 28 
    Expected 
Count 
12.6 12.4 3.0 28.0 
    % within 
Sources  
46.4% 28.6% 25.0% 100.0% 
    % of Total 5.1% 3.1% 2.7% 11.0% 
  somewhat 
credible 
Count 
24 15 5 44 
    Expected 
Count 
19.8 19.5 4.7 44.0 
    % within 
Sources  
54.5% 34.1% 11.4% 100.0% 
    % of Total 9.4% 5.9% 2.0% 17.3% 
  undecided Count 19 35 4 58 
    Expected 
Count 
26.2 25.7 6.1 58.0 
    % within 
Sources  
32.8% 60.3% 6.9% 100.0% 
    % of Total 7.5% 13.7% 1.6% 22.7% 
  credible Count 34 36 7 77 
    Expected 
Count 
34.7 34.1 8.2 77.0 
    % within 
Sources  44.2% 46.8% 9.1% 100.0% 
    % of Total 13.3% 14.1% 2.7% 30.2% 
  extremely 
credible 
Count 
25 19 4 48 
    Expected 
Count 
21.6 21.3 5.1 48.0 
    % within 
Sources  
52.1% 39.6% 8.3% 100.0% 
    % of Total 9.8% 7.5% 1.6% 18.8% 
Total Count 115 113 27 255 
  Expected 
Count 
115.0 113.0 27.0 255.0 
  % within 
Sources  
45.1% 44.3% 10.6% 100.0% 
  % of Total 45.1% 44.3% 10.6% 100.0% 
 
F 28 
 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 16.345(a) 8 .038 
Likelihood Ratio 15.050 8 .058 
Linear-by-Linear 
Association 
.924 1 .337 
N of Valid Cases 
255     
a  2 cells (13.3%) have expected count less than 5. The minimum expected count is 2.96. 
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CROSSTABS:  
PERCEPTION STATEMENTS AND DEMOGRAPHIC VARIABLES 
 
PERCEPTION STATEMENTS VS. STATUS 
    My HIV status is Total 
    Negative Positive Negative 
How do you 
feel about-
Poor people 
are more 
likely to get 
HIV/AIDS 
strongly agree Count 
1 10 11 
    Expected Count 4.0 7.0 11.0 
    % within Statements 9.1% 90.9% 100.0% 
    % of Total .3% 3.4% 3.8% 
  agree Count 21 24 45 
    Expected Count 16.5 28.5 45.0 
    % within Statements 46.7% 53.3% 100.0% 
    % of Total 7.2% 8.2% 15.4% 
  neither agree 
nor disagree 
Count 
29 33 62 
    Expected Count 22.7 39.3 62.0 
    % within Statements 46.8% 53.2% 100.0% 
    % of Total 9.9% 11.3% 21.2% 
  disagree Count 24 48 72 
    Expected Count 26.4 45.6 72.0 
    % within Statements 33.3% 66.7% 100.0% 
    % of Total 8.2% 16.4% 24.7% 
  strongly 
disagree 
Count 
32 70 102 
    Expected Count 37.4 64.6 102.0 
    % within Statements 31.4% 68.6% 100.0% 
    % of Total 11.0% 24.0% 34.9% 
Total Count 107 185 292 
  Expected Count 107.0 185.0 292.0 
  % within Statements 36.6% 63.4% 100.0% 
  % of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 9.845(a) 4 .043 
Likelihood Ratio 10.574 4 .032 
Linear-by-Linear 
Association 
1.374 1 .241 
N of Valid Cases 
292     
a  1 cells (10.0%) have expected count less than 5. The minimum expected count is 4.03. 
 
F 30 
 
 
    My HIV status is Total 
    Negative Positive Negative 
How do you 
feel about - 
HIV/AIDS is 
primarily a 
gay disease 
strongly agree Count 
2 6 8 
    Expected Count 2.9 5.1 8.0 
    % within Statements 25.0% 75.0% 100.0% 
    % of Total .7% 2.1% 2.7% 
  agree Count 8 4 12 
    Expected Count 4.4 7.6 12.0 
    % within Statements 66.7% 33.3% 100.0% 
    % of Total 2.7% 1.4% 4.1% 
  neither agree 
nor disagree 
Count 
6 23 29 
    Expected Count 10.6 18.4 29.0 
    % within Statements 20.7% 79.3% 100.0% 
    % of Total 2.1% 7.9% 9.9% 
  disagree Count 28 51 79 
    Expected Count 28.9 50.1 79.0 
    % within Statements 35.4% 64.6% 100.0% 
    % of Total 9.6% 17.5% 27.1% 
  strongly 
disagree 
Count 
63 101 164 
    Expected Count 60.1 103.9 164.0 
    % within Statements 38.4% 61.6% 100.0% 
    % of Total 21.6% 34.6% 56.2% 
Total Count 107 185 292 
  Expected Count 107.0 185.0 292.0 
  % within Statements 36.6% 63.4% 100.0% 
  % of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 8.576(a) 4 .073 
Likelihood Ratio 8.674 4 .070 
Linear-by-Linear 
Association 
.146 1 .703 
N of Valid Cases 
292     
a  2 cells (20.0%) have expected count less than 5. The minimum expected count is 2.93. 
 
F 31 
 
  
    My HIV status is Total 
    Negative Positive Negative 
How do you 
feel about - 
Getting 
HIV/AIDS is 
usually a 
death 
sentence 
strongly agree Count 
2 7 9 
    Expected Count 3.3 5.7 9.0 
    % within Statements 22.2% 77.8% 100.0% 
    % of Total .7% 2.4% 3.1% 
  agree Count 14 9 23 
    Expected Count 8.4 14.6 23.0 
    % within Statements 60.9% 39.1% 100.0% 
    % of Total 4.8% 3.1% 7.9% 
  neither agree 
nor disagree 
Count 
19 26 45 
    Expected Count 16.5 28.5 45.0 
    % within Statements 42.2% 57.8% 100.0% 
    % of Total 6.5% 8.9% 15.4% 
  disagree Count 38 55 93 
    Expected Count 34.1 58.9 93.0 
    % within Statements 40.9% 59.1% 100.0% 
    % of Total 13.0% 18.8% 31.8% 
  strongly 
disagree 
Count 
34 88 122 
    Expected Count 44.7 77.3 122.0 
    % within Statements 27.9% 72.1% 100.0% 
    % of Total 11.6% 30.1% 41.8% 
Total Count 107 185 292 
  Expected Count 107.0 185.0 292.0 
  % within Statements 36.6% 63.4% 100.0% 
  % of Total 36.6% 63.4% 100.0% 
 
Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 11.982(a) 4 .017 
Likelihood Ratio 11.916 4 .018 
Linear-by-Linear 
Association 
5.289 1 .021 
N of Valid Cases 
292     
a  1 cells (10.0%) have expected count less than 5. The minimum expected count is 3.30. 
 
F 32 
 
  
    My HIV status is Total 
    Negative Positive Negative 
How do you 
feel about- 
Antiretroviral 
drugs are a 
cure for 
HIV/AIDS 
strongly agree Count 
1 10 11 
    Expected Count 4.0 7.0 11.0 
    % within Statements 9.1% 90.9% 100.0% 
    % of Total .3% 3.4% 3.8% 
  agree Count 2 7 9 
    Expected Count 3.3 5.7 9.0 
    % within Statements 22.2% 77.8% 100.0% 
    % of Total .7% 2.4% 3.1% 
  neither agree 
nor disagree 
Count 
29 40 69 
    Expected Count 25.3 43.7 69.0 
    % within Statements 42.0% 58.0% 100.0% 
    % of Total 9.9% 13.7% 23.6% 
  disagree Count 42 53 95 
    Expected Count 34.8 60.2 95.0 
    % within Statements 44.2% 55.8% 100.0% 
    % of Total 14.4% 18.2% 32.5% 
  strongly 
disagree 
Count 
33 75 108 
    Expected Count 39.6 68.4 108.0 
    % within Statements 30.6% 69.4% 100.0% 
    % of Total 11.3% 25.7% 37.0% 
Total Count 107 185 292 
  Expected Count 107.0 185.0 292.0 
  % within Statements 36.6% 63.4% 100.0% 
  % of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 9.332(a) 4 .053 
Likelihood Ratio 10.208 4 .037 
Linear-by-Linear 
Association 
.027 1 .870 
N of Valid Cases 
292     
a  2 cells (20.0%) have expected count less than 5. The minimum expected count is 3.30. 
F 33 
 
 
    My HIV status is Total 
    Negative Positive Negative 
How do you 
feel about - 
People who 
knowingly 
expose others to 
HIV/AIDS 
should be 
prosecuted as 
criminals 
strongly agree Count 
40 43 83 
    Expected Count 30.4 52.6 83.0 
    % within Statements 48.2% 51.8% 100.0% 
    % of Total 13.7% 14.7% 28.4% 
  agree Count 33 43 76 
    Expected Count 27.8 48.2 76.0 
    % within Statements 43.4% 56.6% 100.0% 
    % of Total 11.3% 14.7% 26.0% 
  neither agree 
nor disagree 
Count 
24 55 79 
    Expected Count 28.9 50.1 79.0 
    % within Statements 30.4% 69.6% 100.0% 
    % of Total 8.2% 18.8% 27.1% 
  disagree Count 5 22 27 
    Expected Count 9.9 17.1 27.0 
    % within Statements 18.5% 81.5% 100.0% 
    % of Total 1.7% 7.5% 9.2% 
  strongly 
disagree 
Count 
5 22 27 
    Expected Count 9.9 17.1 27.0 
    % within Statements 18.5% 81.5% 100.0% 
    % of Total 1.7% 7.5% 9.2% 
Total Count 107 185 292 
  Expected Count 107.0 185.0 292.0 
  % within Statements 36.6% 63.4% 100.0% 
  % of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 15.249(a) 4 .004 
Likelihood Ratio 15.945 4 .003 
Linear-by-Linear 
Association 
14.376 1 .000 
N of Valid Cases 
292     
a  0 cells (.0%) have expected count less than 5. The minimum expected count is 9.89. 
 
F 34 
 
  
    My HIV status is Total 
    Negative Positive Negative 
How do you 
feel about - 
HIV/AIDS is 
God's way of 
punishing the 
wicked 
strongly agree Count 
2 5 7 
    Expected Count 2.6 4.4 7.0 
    % within Statements 28.6% 71.4% 100.0% 
    % of Total .7% 1.7% 2.4% 
  agree Count 7 3 10 
    Expected Count 3.7 6.3 10.0 
    % within Statements 70.0% 30.0% 100.0% 
    % of Total 2.4% 1.0% 3.4% 
  neither agree 
nor disagree 
Count 
6 18 24 
    Expected Count 8.8 15.2 24.0 
    % within Statements 25.0% 75.0% 100.0% 
    % of Total 2.1% 6.2% 8.2% 
  disagree Count 14 39 53 
    Expected Count 19.4 33.6 53.0 
    % within Statements 26.4% 73.6% 100.0% 
    % of Total 4.8% 13.4% 18.2% 
  strongly 
disagree 
Count 
78 120 198 
    Expected Count 72.6 125.4 198.0 
    % within Statements 39.4% 60.6% 100.0% 
    % of Total 26.7% 41.1% 67.8% 
Total Count 107 185 292 
  Expected Count 107.0 185.0 292.0 
  % within Statements 36.6% 63.4% 100.0% 
  % of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 9.424(a) 4 .051 
Likelihood Ratio 9.413 4 .052 
Linear-by-Linear 
Association 
.173 1 .678 
N of Valid Cases 
292     
a  3 cells (30.0%) have expected count less than 5. The minimum expected count is 2.57. 
F 35 
 
  
    My HIV status is Total 
    Negative Positive Negative 
How do you 
feel about - 
People with 
HIV/AIDS 
deserve the 
same rights in 
the workplace 
as other 
workers 
strongly agree Count 
0 8 8 
    Expected Count 2.9 5.1 8.0 
    % within Statements .0% 100.0% 100.0% 
    % of Total .0% 2.7% 2.7% 
  agree Count 3 4 7 
    Expected Count 2.6 4.4 7.0 
    % within Statements 42.9% 57.1% 100.0% 
    % of Total 1.0% 1.4% 2.4% 
  neither agree 
nor disagree 
Count 
9 10 19 
    Expected Count 7.0 12.0 19.0 
    % within Statements 47.4% 52.6% 100.0% 
    % of Total 3.1% 3.4% 6.5% 
  disagree Count 29 28 57 
    Expected Count 20.9 36.1 57.0 
    % within Statements 50.9% 49.1% 100.0% 
    % of Total 9.9% 9.6% 19.5% 
  strongly 
disagree 
Count 
66 135 201 
    Expected Count 73.7 127.3 201.0 
    % within Statements 32.8% 67.2% 100.0% 
    % of Total 22.6% 46.2% 68.8% 
Total Count 107 185 292 
  Expected Count 107.0 185.0 292.0 
  % within Statements 36.6% 63.4% 100.0% 
  % of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 11.914(a) 4 .018 
Likelihood Ratio 14.388 4 .006 
Linear-by-Linear 
Association 
.054 1 .817 
N of Valid Cases 
292     
a  3 cells (30.0%) have expected count less than 5. The minimum expected count is 2.57. 
 
F 36 
 
  
    My HIV status is Total 
    Negative Positive Negative 
How do you 
feel about - 
Treating 
HIV/AIDS is a 
lucrative 
business for 
pharmaceutical 
companies 
strongly agree Count 
17 58 75 
    Expected Count 27.5 47.5 75.0 
    % within Statements 22.7% 77.3% 100.0% 
    % of Total 5.8% 19.9% 25.7% 
  agree Count 34 44 78 
    Expected Count 28.6 49.4 78.0 
    % within Statements 43.6% 56.4% 100.0% 
    % of Total 11.6% 15.1% 26.7% 
  neither agree 
nor disagree 
Count 
38 50 88 
    Expected Count 32.2 55.8 88.0 
    % within Statements 43.2% 56.8% 100.0% 
    % of Total 13.0% 17.1% 30.1% 
  disagree Count 12 15 27 
    Expected Count 9.9 17.1 27.0 
    % within Statements 44.4% 55.6% 100.0% 
    % of Total 4.1% 5.1% 9.2% 
  strongly 
disagree 
Count 
6 18 24 
    Expected Count 8.8 15.2 24.0 
    % within Statements 25.0% 75.0% 100.0% 
    % of Total 2.1% 6.2% 8.2% 
Total Count 107 185 292 
  Expected Count 107.0 185.0 292.0 
  % within Statements 36.6% 63.4% 100.0% 
  % of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 11.662(a) 4 .020 
Likelihood Ratio 12.139 4 .016 
Linear-by-Linear 
Association 
1.485 1 .223 
N of Valid Cases 
292     
a  0 cells (.0%) have expected count less than 5. The minimum expected count is 8.79. 
F 37 
 
  
    My HIV status is Total 
    Negative Positive Negative 
How do you 
feel about - I 
am not 
personally 
worried 
about getting 
HIV/AIDS 
strongly agree Count 
8 14 22 
    Expected Count 8.1 13.9 22.0 
    % within Statements 36.4% 63.6% 100.0% 
    % of Total 2.7% 4.8% 7.5% 
  agree Count 26 10 36 
    Expected Count 13.2 22.8 36.0 
    % within Statements 72.2% 27.8% 100.0% 
    % of Total 8.9% 3.4% 12.3% 
  neither agree 
nor disagree 
Count 
24 57 81 
    Expected Count 29.7 51.3 81.0 
    % within Statements 29.6% 70.4% 100.0% 
    % of Total 8.2% 19.5% 27.7% 
  disagree Count 23 40 63 
    Expected Count 23.1 39.9 63.0 
    % within Statements 36.5% 63.5% 100.0% 
    % of Total 7.9% 13.7% 21.6% 
  strongly 
disagree 
Count 
26 64 90 
    Expected Count 33.0 57.0 90.0 
    % within Statements 28.9% 71.1% 100.0% 
    % of Total 8.9% 21.9% 30.8% 
Total Count 107 185 292 
  Expected Count 107.0 185.0 292.0 
  % within Statements 36.6% 63.4% 100.0% 
  % of Total 36.6% 63.4% 100.0% 
  
Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 23.678(a) 4 .000 
Likelihood Ratio 22.979 4 .000 
Linear-by-Linear 
Association 
6.726 1 .010 
N of Valid Cases 
292     
a  0 cells (.0%) have expected count less than 5. The minimum expected count is 8.06. 
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PERCEPTION STATEMENTS VS. ETHNIC GROUP 
 
which group do you identify with? 
    
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/african 
american or 
negro hispanic 
White / 
caucasian multiracial other Total 
Count 3 1 27 9 9 7 2 58 
Expected Count 1.5 .7 20.9 9.1 21.7 3.1 1.0 58.0 
% within statements 5.2% 1.7% 46.6% 15.5% 15.5% 12.1% 3.4% 100.0% 
strongly agree 
% of Total .9% .3% 8.0% 2.7% 2.7% 2.1% .6% 17.1% 
Count 1 1 38 10 35 3 1 89 
Expected Count 2.4 1.1 32.0 13.9 33.3 4.7 1.6 89.0 
% within statements 1.1% 1.1% 42.7% 11.2% 39.3% 3.4% 1.1% 100.0% 
agree 
% of Total .3% .3% 11.2% 2.9% 10.3% .9% .3% 26.3% 
Count 2 2 44 22 62 7 3 142 
Expected Count 3.8 1.7 51.1 22.2 53.2 7.5 2.5 142.0 
% within statements 1.4% 1.4% 31.0% 15.5% 43.7% 4.9% 2.1% 100.0% 
neither agree nor 
disagree 
% of Total .6% .6% 13.0% 6.5% 18.3% 2.1% .9% 41.9% 
Count 2 0 8 7 13 0 0 30 
Expected Count .8 .4 10.8 4.7 11.2 1.6 .5 30.0 
% within statements 6.7% .0% 26.7% 23.3% 43.3% .0% .0% 100.0% 
disagree 
% of Total .6% .0% 2.4% 2.1% 3.8% .0% .0% 8.8% 
Count 1 0 5 5 8 1 0 20 
Expected Count .5 .2 7.2 3.1 7.5 1.1 .4 20.0 
% within statements 5.0% .0% 25.0% 25.0% 40.0% 5.0% .0% 100.0% 
How do you feel 
about - Alternative 
medical treatments 
for HIV/AIDS have 
shown promising 
results 
strongly disagree 
% of Total .3% .0% 1.5% 1.5% 2.4% .3% .0% 5.9% 
F 39 
 
Count 9 4 122 53 127 18 6 339 
Expected Count 9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
% within statements 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
Total 
% of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 33.366(a) 24 .097 
Likelihood Ratio 36.283 24 .052 
Linear-by-Linear 
Association 1.664 1 .197 
N of Valid Cases 
339     
a  21 cells (60.0%) have expected count less than 5. The minimum expected count is .24. 
 
F 40 
 
 
   Which group do you identify with? Total 
    
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/ 
african 
american 
or negro Hispanic 
white/ 
Caucasian multiracial other 
american 
indian, 
alaskan 
native, or 
pacific 
islander 
How do you 
feel about-
Poor people 
are more 
likely to get 
HIV/AIDS 
strongly 
agree 
Count 
2 0 6 3 4 2 0 17 
    Expected 
Count 
.5 .2 6.1 2.7 6.4 .9 .3 17.0 
    % within 
Statements 11.8% .0% 35.3% 17.6% 23.5% 11.8% .0% 100.0% 
    % of Total .6% .0% 1.8% .9% 1.2% .6% .0% 5.0% 
  agree Count 2 0 13 13 24 2 1 55 
    Expected 
Count 
1.5 .6 19.8 8.6 20.6 2.9 1.0 55.0 
    % within 
Statements 
3.6% .0% 23.6% 23.6% 43.6% 3.6% 1.8% 100.0% 
    % of Total .6% .0% 3.8% 3.8% 7.1% .6% .3% 16.2% 
  neither 
agree 
nor 
disagree 
Count 
3 1 33 7 25 4 0 73 
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    Expected 
Count 
1.9 .9 26.3 11.4 27.3 3.9 1.3 73.0 
    % within 
Statements 
4.1% 1.4% 45.2% 9.6% 34.2% 5.5% .0% 100.0% 
    % of Total .9% .3% 9.7% 2.1% 7.4% 1.2% .0% 21.5% 
  disagree Count 0 3 31 12 34 6 0 86 
    Expected 
Count 
2.3 1.0 30.9 13.4 32.2 4.6 1.5 86.0 
    % within 
Statements 
.0% 3.5% 36.0% 14.0% 39.5% 7.0% .0% 100.0% 
    % of Total .0% .9% 9.1% 3.5% 10.0% 1.8% .0% 25.4% 
  strongly 
disagree 
Count 
2 0 39 18 40 4 5 108 
    Expected 
Count 
2.9 1.3 38.9 16.9 40.5 5.7 1.9 108.0 
    % within 
Statements 
1.9% .0% 36.1% 16.7% 37.0% 3.7% 4.6% 100.0% 
    % of Total .6% .0% 11.5% 5.3% 11.8% 1.2% 1.5% 31.9% 
Total Count 9 4 122 53 127 18 6 339 
  Expected 
Count 
9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
  % within 
Statements 
2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
  % of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
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 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 35.416(a) 24 .062 
Likelihood Ratio 37.491 24 .039 
Linear-by-Linear 
Association 
.952 1 .329 
N of Valid Cases 
339     
a  20 cells (57.1%) have expected count less than 5. The minimum expected count is .20. 
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    Which group do you identify with? Total 
    
american 
indian, 
alaskan 
native, 
or 
pacific 
islander 
asian/asian 
american 
black/ 
african 
american 
or negro Hispanic 
white/ 
Caucasian multiracial other 
american 
indian, 
alaskan 
native, or 
pacific 
islander 
How do you 
feel about-
Globally the 
number of 
people with 
HIV/AIDS is 
decreasing 
strongly 
agree 
Count 
2 0 9 1 1 1 1 15 
    Expected 
Count 
.4 .2 5.4 2.3 5.6 .8 .3 15.0 
    % within 
Statements 13.3% .0% 60.0% 6.7% 6.7% 6.7% 6.7% 100.0% 
    % of Total .6% .0% 2.7% .3% .3% .3% .3% 4.4% 
  agree Count 1 0 6 4 4 0 0 15 
    Expected 
Count 
.4 .2 5.4 2.3 5.6 .8 .3 15.0 
    % within 
Statements 
6.7% .0% 40.0% 26.7% 26.7% .0% .0% 100.0% 
    % of Total .3% .0% 1.8% 1.2% 1.2% .0% .0% 4.4% 
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  neither 
agree 
nor 
disagree 
Count 
1 3 35 15 25 5 2 86 
    Expected 
Count 
2.3 1.0 30.9 13.4 32.2 4.6 1.5 86.0 
    % within 
Statements 
1.2% 3.5% 40.7% 17.4% 29.1% 5.8% 2.3% 100.0% 
    % of Total .3% .9% 10.3% 4.4% 7.4% 1.5% .6% 25.4% 
  disagree Count 2 1 35 12 48 4 0 102 
    Expected 
Count 
2.7 1.2 36.7 15.9 38.2 5.4 1.8 102.0 
    % within 
Statements 2.0% 1.0% 34.3% 11.8% 47.1% 3.9% .0% 100.0% 
    % of Total .6% .3% 10.3% 3.5% 14.2% 1.2% .0% 30.1% 
  strongly 
disagree 
Count 
3 0 37 21 49 8 3 121 
    Expected 
Count 
3.2 1.4 43.5 18.9 45.3 6.4 2.1 121.0 
    % within 
Statements 
2.5% .0% 30.6% 17.4% 40.5% 6.6% 2.5% 100.0% 
    % of Total .9% .0% 10.9% 6.2% 14.5% 2.4% .9% 35.7% 
Total Count 9 4 122 53 127 18 6 339 
  Expected 
Count 
9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
  % within 
Statements 
2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
  % of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
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 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 36.290(a) 24 .051 
Likelihood Ratio 37.135 24 .042 
Linear-by-Linear 
Association 
9.076 1 .003 
N of Valid Cases 
339     
a  20 cells (57.1%) have expected count less than 5. The minimum expected count is .18. 
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Which group do you identify with? 
   
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/ 
african 
american 
or negro Hispanic 
white/ 
Caucasian multiracial other Total 
Count 3 0 5 0 2 1 0 11 
Expected 
Count 
.3 .1 4.0 1.7 4.1 .6 .2 11.0 
% within 
Statements 27.3% .0% 45.5% .0% 18.2% 9.1% .0% 100.0% 
strongly 
agree 
% of Total .9% .0% 1.5% .0% .6% .3% .0% 3.2% 
Count 0 0 6 2 5 1 0 14 
Expected 
Count 
.4 .2 5.0 2.2 5.2 .7 .2 14.0 
% within 
Statements 
.0% .0% 42.9% 14.3% 35.7% 7.1% .0% 100.0% 
agree 
% of Total .0% .0% 1.8% .6% 1.5% .3% .0% 4.1% 
Count 3 1 11 4 13 2 0 34 
Expected 
Count 
.9 .4 12.2 5.3 12.7 1.8 .6 34.0 
% within 
Statements 
8.8% 2.9% 32.4% 11.8% 38.2% 5.9% .0% 100.0% 
neither 
agree nor 
disagree 
% of Total .9% .3% 3.2% 1.2% 3.8% .6% .0% 10.0% 
How do 
you feel 
about - 
HIV/AIDS 
is 
primarily 
a gay 
disease 
disagree Count 1 1 38 14 39 3 1 97 
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Expected 
Count 
2.6 1.1 34.9 15.2 36.3 5.2 1.7 97.0 
% within 
Statements 1.0% 1.0% 39.2% 14.4% 40.2% 3.1% 1.0% 100.0% 
  
% of Total .3% .3% 11.2% 4.1% 11.5% .9% .3% 28.6% 
Count 2 2 62 33 68 11 5 183 
Expected 
Count 
4.9 2.2 65.9 28.6 68.6 9.7 3.2 183.0 
% within 
Statements 
1.1% 1.1% 33.9% 18.0% 37.2% 6.0% 2.7% 100.0% 
  
strongly 
disagree 
% of Total .6% .6% 18.3% 9.7% 20.1% 3.2% 1.5% 54.0% 
Count 9 4 122 53 127 18 6 339 
Expected 
Count 
9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
% within 
Statements 
2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
Total 
% of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 43.208(a) 24 .009 
Likelihood Ratio 28.976 24 .221 
Linear-by-Linear 
Association 
7.353 1 .007 
N of Valid Cases 
339     
a  22 cells (62.9%) have expected count less than 5. The minimum expected count is .13. 
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Which group do you identify with? 
    
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/ 
african 
american 
or negro Hispanic 
white/ 
Caucasian multiracial other Total 
Count 3 0 5 5 2 1 0 16 
Expected 
Count 
.4 .2 5.8 2.5 6.0 .8 .3 16.0 
% within 
Statements 18.8% .0% 31.3% 31.3% 12.5% 6.3% .0% 100.0% 
strongly 
agree 
% of Total .9% .0% 1.5% 1.5% .6% .3% .0% 4.7% 
Count 1 0 7 2 2 0 0 12 
Expected 
Count 
.3 .1 4.3 1.9 4.5 .6 .2 12.0 
% within 
Statements 8.3% .0% 58.3% 16.7% 16.7% .0% .0% 100.0% 
agree 
% of Total .3% .0% 2.1% .6% .6% .0% .0% 3.5% 
Count 1 1 30 13 24 6 3 78 
Expected 
Count 
2.1 .9 28.1 12.2 29.2 4.1 1.4 78.0 
% within 
Statements 
1.3% 1.3% 38.5% 16.7% 30.8% 7.7% 3.8% 100.0% 
neither 
agree nor 
disagree 
% of Total .3% .3% 8.8% 3.8% 7.1% 1.8% .9% 23.0% 
Count 2 3 39 18 48 6 0 116 
How do 
you feel 
about- 
Antiretrov
iral drugs 
are a cure 
for 
HIV/AIDS 
disagree 
Expected 
3.1 1.4 41.7 18.1 43.5 6.2 2.1 116.0 
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Count 
% within 
Statements 1.7% 2.6% 33.6% 15.5% 41.4% 5.2% .0% 100.0% 
  
% of Total .6% .9% 11.5% 5.3% 14.2% 1.8% .0% 34.2% 
Count 2 0 41 15 51 5 3 117 
Expected 
Count 
3.1 1.4 42.1 18.3 43.8 6.2 2.1 117.0 
% within 
Statements 
1.7% .0% 35.0% 12.8% 43.6% 4.3% 2.6% 100.0% 
  
strongly 
disagree 
% of Total .6% .0% 12.1% 4.4% 15.0% 1.5% .9% 34.5% 
Count 9 4 122 53 127 18 6 339 
Expected 
Count 
9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
% within 
Statements 
2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
Total 
% of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 40.546(a) 24 .019 
Likelihood Ratio 35.501 24 .061 
Linear-by-Linear 
Association 
7.045 1 .008 
N of Valid Cases 
339     
a  22 cells (62.9%) have expected count less than 5. The minimum expected count is .14. 
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Which group do you identify with? 
    
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/ 
african 
american 
or negro Hispanic 
white/ 
Caucasian multiracial other Total 
Count 4 0 8 7 4 1 0 24 
Expected 
Count 
.6 .3 8.6 3.8 9.0 1.3 .4 24.0 
% within 
Statements 16.7% .0% 33.3% 29.2% 16.7% 4.2% .0% 100.0% 
strongly 
agree 
% of Total 1.2% .0% 2.4% 2.1% 1.2% .3% .0% 7.1% 
Count 0 0 17 6 15 1 0 39 
Expected 
Count 
1.0 .5 14.0 6.1 14.6 2.1 .7 39.0 
% within 
Statements 
.0% .0% 43.6% 15.4% 38.5% 2.6% .0% 100.0% 
agree 
% of Total .0% .0% 5.0% 1.8% 4.4% .3% .0% 11.5% 
Count 2 0 23 4 12 2 1 44 
Expected 
Count 
1.2 .5 15.8 6.9 16.5 2.3 .8 44.0 
% within 
Statements 
4.5% .0% 52.3% 9.1% 27.3% 4.5% 2.3% 100.0% 
neither 
agree nor 
disagree 
% of Total .6% .0% 6.8% 1.2% 3.5% .6% .3% 13.0% 
Count 1 3 40 20 64 6 3 137 
How do 
you feel 
about - 
You 
cannot get 
HIV/AIDS 
during sex 
if 
condoms 
are always 
used 
disagree 
Expected 
3.6 1.6 49.3 21.4 51.3 7.3 2.4 137.0 
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Count 
% within 
Statements 
.7% 2.2% 29.2% 14.6% 46.7% 4.4% 2.2% 100.0% 
  
% of Total .3% .9% 11.8% 5.9% 18.9% 1.8% .9% 40.4% 
Count 2 1 34 16 32 8 2 95 
Expected 
Count 
2.5 1.1 34.2 14.9 35.6 5.0 1.7 95.0 
% within 
Statements 2.1% 1.1% 35.8% 16.8% 33.7% 8.4% 2.1% 100.0% 
  
strongly 
disagree 
% of Total .6% .3% 10.0% 4.7% 9.4% 2.4% .6% 28.0% 
Count 9 4 122 53 127 18 6 339 
Expected 
Count 
9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
% within 
Statements 
2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
Total 
% of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 45.213(a) 24 .005 
Likelihood Ratio 39.125 24 .026 
Linear-by-Linear 
Association 
7.517 1 .006 
N of Valid Cases 
339     
a  19 cells (54.3%) have expected count less than 5. The minimum expected count is .28. 
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Which group do you identify with? 
    
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/ 
african 
american 
or negro Hispanic 
white/ 
Caucasian multiracial other Total 
Count 2 0 11 4 3 1 0 21 
Expected 
Count 
.6 .2 7.6 3.3 7.9 1.1 .4 21.0 
% within 
Statements 9.5% .0% 52.4% 19.0% 14.3% 4.8% .0% 100.0% 
strongly 
agree 
% of Total .6% .0% 3.2% 1.2% .9% .3% .0% 6.2% 
Count 0 0 16 7 5 2 0 30 
Expected 
Count 
.8 .4 10.8 4.7 11.2 1.6 .5 30.0 
% within 
Statements 
 .0% 53.3% 23.3% 16.7% 6.7% .0% 100.0% 
agree 
% of Total .0% .0% 4.7% 2.1% 1.5% .6% .0% 8.8% 
Count 1 1 50 16 30 5 4 107 
Expected 
Count 
2.8 1.3 38.5 16.7 40.1 5.7 1.9 107.0 
% within 
Statements .9% .9% 46.7% 15.0% 28.0% 4.7% 3.7% 100.0% 
neither 
agree nor 
disagree 
% of Total .3% .3% 14.7% 4.7% 8.8% 1.5% 1.2% 31.6% 
Count 5 3 22 16 47 6 0 99 
How do 
you feel 
about - An 
effective 
HIV/AIDS 
vaccine is 
available 
disagree 
Expected 
2.6 1.2 35.6 15.5 37.1 5.3 1.8 99.0 
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Count 
% within 
Statements 5.1% 3.0% 22.2% 16.2% 47.5% 6.1% .0% 100.0% 
  
% of Total 1.5% .9% 6.5% 4.7% 13.9% 1.8% .0% 29.2% 
Count 1 0 23 10 42 4 2 82 
Expected 
Count 
2.2 1.0 29.5 12.8 30.7 4.4 1.5 82.0 
% within 
Statements 1.2% .0% 28.0% 12.2% 51.2% 4.9% 2.4% 100.0% 
  
strongly 
disagree 
% of Total .3% .0% 6.8% 2.9% 12.4% 1.2% .6% 24.2% 
Count 9 4 122 53 127 18 6 339 
Expected 
Count 
9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
% within 
Statements 
2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
Total 
% of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 50.452(a) 24 .001 
Likelihood Ratio 54.079 24 .000 
Linear-by-Linear 
Association 
14.490 1 .000 
N of Valid Cases 
339     
a  20 cells (57.1%) have expected count less than 5. The minimum expected count is .25. 
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Which group do you identify with? 
    
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/ 
African 
American 
or negro Hispanic 
White / 
Caucasian multiracial other Total 
Count 2 0 33 6 35 6 2 84 
Expected 
Count 
2.2 1.0 30.2 13.1 31.5 4.5 1.5 84.0 
% within 
Statements 2.4% .0% 39.3% 7.1% 41.7% 7.1% 2.4% 100.0% 
strongly 
agree 
% of Total .6% .0% 9.7% 1.8% 10.3% 1.8% .6% 24.8% 
Count 2 0 25 16 45 3 1 92 
Expected 
Count 
2.4 1.1 33.1 14.4 34.5 4.9 1.6 92.0 
% within 
Statements 
2.2% .0% 27.2% 17.4% 48.9% 3.3% 1.1% 100.0% 
agree 
% of Total .6% .0% 7.4% 4.7% 13.3% .9% .3% 27.1% 
Count 3 3 45 13 33 7 3 107 
Expected 
Count 
2.8 1.3 38.5 16.7 40.1 5.7 1.9 107.0 
% within 
Statements 2.8% 2.8% 42.1% 12.1% 30.8% 6.5% 2.8% 100.0% 
neither 
agree nor 
disagree 
% of Total .9% .9% 13.3% 3.8% 9.7% 2.1% .9% 31.6% 
Count 1 1 10 8 10 0 0 30 
How do 
you feel 
about - 
Treating 
HIV/AIDS 
is a 
lucrative 
business 
for 
pharma-
ceutical 
companies 
disagree 
Expected 
.8 .4 10.8 4.7 11.2 1.6 .5 30.0 
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Count 
% within 
Statements 3.3% 3.3% 33.3% 26.7% 33.3% .0% .0% 100.0% 
  
% of Total .3% .3% 2.9% 2.4% 2.9% .0% .0% 8.8% 
Count 1 0 9 10 4 2 0 26 
Expected 
Count 
.7 .3 9.4 4.1 9.7 1.4 .5 26.0 
% within 
Statements 3.8% .0% 34.6% 38.5% 15.4% 7.7% .0% 100.0% 
  
strongly 
disagree 
% of Total .3% .0% 2.7% 2.9% 1.2% .6% .0% 7.7% 
Count 9 4 122 53 127 18 6 339 
Expected 
Count 
9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
% within 
Statements 
2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
Total 
% of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 39.433(a) 24 .025 
Likelihood Ratio 42.250 24 .012 
Linear-by-Linear 
Association 
4.052 1 .044 
N of Valid Cases 
339     
a  21 cells (60.0%) have expected count less than 5. The minimum expected count is .31. 
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Which group do you identify with? 
 
   
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/ 
african 
american 
or negro Hispanic 
white/ 
Caucasian multiracial other Total 
Count 4 0 9 0 9 3 1 26 
Expected 
Count 
.7 .3 9.4 4.1 9.7 1.4 .5 26.0 
% within 
Statements 
15.4% .0% 34.6% .0% 34.6% 11.5% 3.8% 100.0% 
strongly 
agree 
% of Total 1.2% .0% 2.7% .0% 2.7% .9% .3% 7.7% 
Count 0 0 10 10 17 2 2 41 
Expected 
Count 
1.1 .5 14.8 6.4 15.4 2.2 .7 41.0 
% within 
Statements 
.0% .0% 24.4% 24.4% 41.5% 4.9% 4.9% 100.0% 
agree 
% of Total .0% .0% 2.9% 2.9% 5.0% .6% .6% 12.1% 
Count 2 1 33 13 43 5 0 97 
Expected 
Count 
2.6 1.1 34.9 15.2 36.3 5.2 1.7 97.0 
% within 
Statements 
2.1% 1.0% 34.0% 13.4% 44.3% 5.2% .0% 100.0% 
neither 
agree nor 
disagree 
% of Total .6% .3% 9.7% 3.8% 12.7% 1.5% .0% 28.6% 
Count 1 2 31 11 27 4 1 77 
How do 
you feel 
about - I 
am not 
personally 
worried 
about 
getting 
HIV/AIDS 
disagree 
Expected 
Count 
2.0 .9 27.7 12.0 28.8 4.1 1.4 77.0 
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% within 
Statements 
1.3% 2.6% 40.3% 14.3% 35.1% 5.2% 1.3% 100.0% 
  
% of Total .3% .6% 9.1% 3.2% 8.0% 1.2% .3% 22.7% 
Count 2 1 39 19 31 4 2 98 
Expected 
Count 
2.6 1.2 35.3 15.3 36.7 5.2 1.7 98.0 
% within 
Statements 
2.0% 1.0% 39.8% 19.4% 31.6% 4.1% 2.0% 100.0% 
  
strongly 
disagree 
% of Total .6% .3% 11.5% 5.6% 9.1% 1.2% .6% 28.9% 
Count 9 4 122 53 127 18 6 339 
Expected 
Count 
9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
% within 
Statements 
2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
Total 
% of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
 
Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 39.077(a) 24 .027 
Likelihood Ratio 36.587 24 .048 
Linear-by-Linear 
Association 
1.067 1 .302 
N of Valid Cases 
339     
a  19 cells (54.3%) have expected count less than 5. The minimum expected count is .31. 
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    Which group do you identify with? Total 
    
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/ 
african 
american 
or negro Hispanic 
white/ 
Caucasian multiracial other 
american 
indian, 
alaskan 
native, or 
pacific 
islander 
How do you 
feel about - 
Worldwide, 
more people 
get 
HIV/AIDS 
by 
heterosexual 
contact than 
by 
homosexual 
contact 
strongly 
agree 
Count 
1 0 15 8 6 2 0 32 
    Expected 
Count 
.8 .4 11.5 5.0 12.0 1.7 .6 32.0 
    % within 
Statements 3.1% .0% 46.9% 25.0% 18.8% 6.3% .0% 100.0% 
    % of Total .3% .0% 4.4% 2.4% 1.8% .6% .0% 9.4% 
  agree Count 0 2 23 5 13 1 0 44 
    Expected 
Count 
1.2 .5 15.8 6.9 16.5 2.3 .8 44.0 
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    % within 
Statements 
.0% 4.5% 52.3% 11.4% 29.5% 2.3% .0% 100.0% 
    % of Total .0% .6% 6.8% 1.5% 3.8% .3% .0% 13.0% 
  neither 
agree 
nor 
disagree 
Count 
2 2 52 27 50 8 4 145 
    Expected 
Count 
3.8 1.7 52.2 22.7 54.3 7.7 2.6 145.0 
    % within 
Statements 
1.4% 1.4% 35.9% 18.6% 34.5% 5.5% 2.8% 100.0% 
    % of Total .6% .6% 15.3% 8.0% 14.7% 2.4% 1.2% 42.8% 
  disagree Count 2 0 22 9 39 5 1 78 
    Expected 
Count 
2.1 .9 28.1 12.2 29.2 4.1 1.4 78.0 
    % within 
Statements 
2.6% .0% 28.2% 11.5% 50.0% 6.4% 1.3% 100.0% 
    % of Total .6% .0% 6.5% 2.7% 11.5% 1.5% .3% 23.0% 
  strongly 
disagree 
Count 
4 0 10 4 19 2 1 40 
    Expected 
Count 
1.1 .5 14.4 6.3 15.0 2.1 .7 40.0 
    % within 
Statements 
10.0% .0% 25.0% 10.0% 47.5% 5.0% 2.5% 100.0% 
    % of Total 1.2% .0% 2.9% 1.2% 5.6% .6% .3% 11.8% 
Total Count 9 4 122 53 127 18 6 339 
  Expected 
Count 
9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
  % within 
Statements 
2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
  % of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
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 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 39.799(a) 24 .022 
Likelihood Ratio 39.215 24 .026 
Linear-by-Linear 
Association 
5.690 1 .017 
N of Valid Cases 
339     
a  19 cells (54.3%) have expected count less than 5. The minimum expected count is .38. 
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PERCEPTION STATEMENTS VS. AGE 
 
Age group 
    18-25 26-36 37-47 48-58 59 + Total 
Count 1 6 3 1 0 11 
Expected Count 1.7 2.9 3.3 2.5 .6 11.0 
% within Statements 9.1% 54.5% 27.3% 9.1% .0% 100.0% 
strongly agree 
% of Total .3% 1.8% .9% .3% .0% 3.2% 
Count 5 1 5 2 1 14 
Expected Count 2.2 3.7 4.2 3.2 .7 14.0 
% within Statements 35.7% 7.1% 35.7% 14.3% 7.1% 100.0% 
agree 
% of Total 1.5% .3% 1.5% .6% .3% 4.1% 
Count 10 5 11 5 2 33 
Expected Count 5.1 8.6 10.0 7.5 1.7 33.0 
% within Statements 30.3% 15.2% 33.3% 15.2% 6.1% 100.0% 
neither agree nor 
disagree 
% of Total 2.9% 1.5% 3.2% 1.5% .6% 9.7% 
Count 15 17 31 29 5 97 
Expected Count 15.1 25.4 29.4 22.0 5.1 97.0 
% within Statements 15.5% 17.5% 32.0% 29.9% 5.2% 100.0% 
disagree 
% of Total 4.4% 5.0% 9.1% 8.5% 1.5% 28.5% 
Count 22 60 53 40 10 185 
Expected Count 28.8 48.4 56.0 41.9 9.8 185.0 
% within Statements 11.9% 32.4% 28.6% 21.6% 5.4% 100.0% 
How do you 
feel about - 
HIV/AIDS is 
primarily a 
gay disease 
strongly disagree 
% of Total 6.5% 17.6% 15.6% 11.8% 2.9% 54.4% 
Count 53 89 103 77 18 340 
Expected Count 53.0 89.0 103.0 77.0 18.0 340.0 
% within Statements 15.6% 26.2% 30.3% 22.6% 5.3% 100.0% 
Total 
% of Total 15.6% 26.2% 30.3% 22.6% 5.3% 100.0% 
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 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 28.254(a) 16 .029 
Likelihood Ratio 27.695 16 .034 
Linear-by-Linear 
Association 
1.894 1 .169 
N of Valid Cases 
340     
a  11 cells (44.0%) have expected count less than 5. The minimum expected count is .58. 
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Age group 
    18-25 26-36 37-47 48-58 59 + Total 
Count 11 14 17 17 0 59 
Expected Count 9.2 15.4 17.9 13.4 3.1 59.0 
% within Statements 18.6% 23.7% 28.8% 28.8% .0% 100.0% 
strongly agree 
% of Total 3.2% 4.1% 5.0% 5.0% .0% 17.4% 
Count 11 19 34 20 4 88 
Expected Count 13.7 23.0 26.7 19.9 4.7 88.0 
% within Statements 12.5% 21.6% 38.6% 22.7% 4.5% 100.0% 
agree 
% of Total 3.2% 5.6% 10.0% 5.9% 1.2% 25.9% 
Count 24 44 45 25 5 143 
Expected Count 22.3 37.4 43.3 32.4 7.6 143.0 
% within Statements 16.8% 30.8% 31.5% 17.5% 3.5% 100.0% 
neither agree nor 
disagree 
% of Total 7.1% 12.9% 13.2% 7.4% 1.5% 42.1% 
Count 4 8 1 11 6 30 
Expected Count 4.7 7.9 9.1 6.8 1.6 30.0 
% within Statements 13.3% 26.7% 3.3% 36.7% 20.0% 100.0% 
disagree 
% of Total 1.2% 2.4% .3% 3.2% 1.8% 8.8% 
Count 3 4 6 4 3 20 
Expected Count 3.1 5.2 6.1 4.5 1.1 20.0 
% within Statements 15.0% 20.0% 30.0% 20.0% 15.0% 100.0% 
How do you feel 
about - Alternative 
medical treatments 
for HIV/AIDS 
have shown 
promising results 
strongly disagree 
% of Total .9% 1.2% 1.8% 1.2% .9% 5.9% 
Count 53 89 103 77 18 340 
Expected Count 53.0 89.0 103.0 77.0 18.0 340.0 
% within Statements 15.6% 26.2% 30.3% 22.6% 5.3% 100.0% 
Total 
% of Total 15.6% 26.2% 30.3% 22.6% 5.3% 100.0% 
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 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 37.986(a) 16 .002 
Likelihood Ratio 39.001 16 .001 
Linear-by-Linear 
Association 
1.318 1 .251 
N of Valid Cases 
340     
a  7 cells (28.0%) have expected count less than 5. The minimum expected count is 1.06. 
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PERCEPTION STATEMENTS VS. SEXUAL ORIENTATION 
 
sexual orientation 
    
Heterosex
ual 
Homosex
ual Bi-sexual Total 
Count 12 5 1 18 
Expected Count 8.4 7.6 2.0 18.0 
% within Statements 66.7% 27.8% 5.6% 100.0% 
strongly agree 
% of Total 3.9% 1.6% .3% 5.8% 
Count 8 12 0 20 
Expected Count 9.4 8.4 2.2 20.0 
% within Statements 40.0% 60.0% .0% 100.0% 
agree 
% of Total 2.6% 3.9% .0% 6.5% 
Count 19 31 9 59 
Expected Count 27.7 24.8 6.5 59.0 
% within Statements 32.2% 52.5% 15.3% 100.0% 
neither agree nor 
disagree 
% of Total 6.1% 10.0% 2.9% 19.1% 
Count 55 36 17 108 
Expected Count 50.7 45.4 11.9 108.0 
% within Statements 50.9% 33.3% 15.7% 100.0% 
disagree 
% of Total 17.8% 11.7% 5.5% 35.0% 
Count 51 46 7 104 
Expected Count 48.8 43.8 11.4 104.0 
% within Statements 49.0% 44.2% 6.7% 100.0% 
How to you feel 
about - A pregnant 
woman with 
HIV/AIDS cannot 
avoid having an 
HIV-positive baby 
strongly disagree 
% of Total 16.5% 14.9% 2.3% 33.7% 
Count 145 130 34 309 
Expected Count 145.0 130.0 34.0 309.0 
% within Statements 46.9% 42.1% 11.0% 100.0% 
Total 
% of Total 46.9% 42.1% 11.0% 100.0% 
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 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 16.908(a) 8 .031 
Likelihood Ratio 17.302 8 .027 
Linear-by-Linear 
Association 
3.753 1 .053 
N of Valid Cases 
309     
a  2 cells (13.3%) have expected count less than 5. The minimum expected count is 3.52. 
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    Heterosexual Homosexual Bi-sexual 1.00 
How do you feel 
about - Worldwide, 
more people get 
HIV/AIDS by 
heterosexual contact 
than by homosexual 
contact 
strongly agree Count 
15 12 0 27 
    Expected Count 12.7 11.4 3.0 27.0 
    % within Statements 55.6% 44.4% .0% 100.0% 
    % of Total 4.9% 3.9% .0% 8.7% 
  agree Count 17 18 6 41 
    Expected Count 19.2 17.2 4.5 41.0 
    % within Statements 41.5% 43.9% 14.6% 100.0% 
    % of Total 5.5% 5.8% 1.9% 13.3% 
  neither agree 
nor disagree 
Count 
60 53 21 134 
    Expected Count 62.9 56.4 14.7 134.0 
    % within Statements 44.8% 39.6% 15.7% 100.0% 
    % of Total 19.4% 17.2% 6.8% 43.4% 
  disagree Count 39 26 4 69 
    Expected Count 32.4 29.0 7.6 69.0 
    % within Statements 56.5% 37.7% 5.8% 100.0% 
    % of Total 12.6% 8.4% 1.3% 22.3% 
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  strongly 
disagree 
Count 
14 21 3 38 
    Expected Count 17.8 16.0 4.2 38.0 
    % within Statements 36.8% 55.3% 7.9% 100.0% 
    % of Total 4.5% 6.8% 1.0% 12.3% 
Total Count 145 130 34 309 
  Expected Count 145.0 130.0 34.0 309.0 
  % within Statements 46.9% 42.1% 11.0% 100.0% 
  % of Total 46.9% 42.1% 11.0% 100.0% 
 
Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 13.307(a) 8 .102 
Likelihood Ratio 16.158 8 .040 
Linear-by-Linear 
Association 
.024 1 .878 
N of Valid Cases 
309     
a  3 cells (20.0%) have expected count less than 5. The minimum expected count is 2.97. 
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    sexual orientation Total 
    heterosexual homosexual bi-sexual 1.00 
How do you feel about - 
It is biologically easier 
for woman to get 
HIV/AIDS than it is for 
men 
strongly agree Count 
22 7 3 32 
    Expected Count 15.0 13.5 3.5 32.0 
    % within statements 68.8% 21.9% 9.4% 100.0% 
    % of Total 7.1% 2.3% 1.0% 10.4% 
  agree Count 19 10 6 35 
    Expected Count 16.4 14.7 3.9 35.0 
    % within statements 54.3% 28.6% 17.1% 100.0% 
    % of Total 6.1% 3.2% 1.9% 11.3% 
  neither agree nor 
disagree 
Count 56 47 12 115 
    Expected Count 54.0 48.4 12.7 115.0 
    % within statements 48.7% 40.9% 10.4% 100.0% 
    % of Total 18.1% 15.2% 3.9% 37.2% 
  disagree Count 23 32 9 64 
    Expected Count 30.0 26.9 7.0 64.0 
    % within statements 35.9% 50.0% 14.1% 100.0% 
    % of Total 7.4% 10.4% 2.9% 20.7% 
  strongly disagree Count 25 34 4 63 
    Expected Count 29.6 26.5 6.9 63.0 
    % within statements 39.7% 54.0% 6.3% 100.0% 
    % of Total 8.1% 11.0% 1.3% 20.4% 
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Total Count 145 130 34 309 
  Expected Count 145.0 130.0 34.0 309.0 
  % within statements 46.9% 42.1% 11.0% 100.0% 
  % of Total 46.9% 42.1% 11.0% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 16.908(a) 8 .031 
Likelihood Ratio 17.302 8 .027 
Linear-by-Linear 
Association 3.753 1 .053 
N of Valid Cases 
309     
a  2 cells (13.3%) have expected count less than 5. The minimum expected count is 3.52. 
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CROSSTABS:  
TREATMENTS KNOWN AND DEMOGRAPHIC VARIABLES 
 
TREATMENTS KNOWN VS. SEXUAL ORIENTATION 
  
    sexual orientation Total 
    Heterosexual Homosexual Bi-sexual 1.00 
treatments 
that you 
have heard 
of - 
Chelation-
IV 
not 
selected 
Count 
143 122 34 299 
    Expected Count 140.3 125.8 32.9 299.0 
    % within 
treatments  47.8% 40.8% 11.4% 100.0% 
    % of Total 46.3% 39.5% 11.0% 96.8% 
  selected Count 2 8 0 10 
    Expected Count 4.7 4.2 1.1 10.0 
    % within 
treatments  20.0% 80.0% .0% 100.0% 
    % of Total .6% 2.6% .0% 3.2% 
Total Count 145 130 34 309 
  Expected Count 145.0 130.0 34.0 309.0 
  % within 
treatments  
46.9% 42.1% 11.0% 100.0% 
  % of Total 46.9% 42.1% 11.0% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 6.268(a) 2 .044 
Likelihood Ratio 7.075 2 .029 
Linear-by-Linear 
Association 
.580 1 .446 
N of Valid Cases 
309     
a  3 cells (50.0%) have expected count less than 5. The minimum expected count is 1.10. 
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    sexual orientation Total 
    Heter Homo 
Bi-
sexual 1.00 
treatments that you 
have heard of - 
Nutritional 
supplements 
not 
selected 
Count 
121 84 25 230 
    Expected Count 107.9 96.8 25.3 230.0 
    % within treatments  52.6% 36.5% 10.9% 100.0% 
    % of Total 39.2% 27.2% 8.1% 74.4% 
  selected Count 24 46 9 79 
    Expected Count 37.1 33.2 8.7 79.0 
    % within treatments  30.4% 58.2% 11.4% 100.0% 
    % of Total 7.8% 14.9% 2.9% 25.6% 
Total Count 145 130 34 309 
  Expected Count 145.0 130.0 34.0 309.0 
  % within treatments  46.9% 42.1% 11.0% 100.0% 
  % of Total 46.9% 42.1% 11.0% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 12.792(a) 2 .002 
Likelihood Ratio 12.945 2 .002 
Linear-by-Linear 
Association 
6.739 1 .009 
N of Valid Cases 
309     
a  0 cells (.0%) have expected count less than 5. The minimum expected count is 8.69. 
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    sexual orientation Total 
    Heter Homo 
Bi-
sexual 1.00 
treatments that you 
have heard of – AZT 
(Azidothymidine) 
not 
selected 
Count 
82 46 17 145 
    Expected Count 68.0 61.0 16.0 145.0 
    % within treatments  56.6% 31.7% 11.7% 100.0% 
    % of Total 26.5% 14.9% 5.5% 46.9% 
  selected Count 63 84 17 164 
    Expected Count 77.0 69.0 18.0 164.0 
    % within treatments  38.4% 51.2% 10.4% 100.0% 
    % of Total 20.4% 27.2% 5.5% 53.1% 
Total Count 145 130 34 309 
  Expected Count 145.0 130.0 34.0 309.0 
  % within treatments  46.9% 42.1% 11.0% 100.0% 
  % of Total 46.9% 42.1% 11.0% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 12.476(a) 2 .002 
Likelihood Ratio 12.599 2 .002 
Linear-by-Linear 
Association 
4.796 1 .029 
N of Valid Cases 
309     
a  0 cells (.0%) have expected count less than 5. The minimum expected count is 15.95. 
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    sexual orientation Total 
    Heter Homo 
Bi-
sexual 1.00 
treatments that you have 
heard of - 
Pharmaceutical 
antibodies (bactrim, etc) 
not 
selected 
Count 
103 67 21 191 
    Expected Count 89.6 80.4 21.0 191.0 
    % within treatments  53.9% 35.1% 11.0% 100.0% 
    % of Total 33.3% 21.7% 6.8% 61.8% 
  selected Count 42 63 13 118 
    Expected Count 55.4 49.6 13.0 118.0 
    % within treatments  35.6% 53.4% 11.0% 100.0% 
    % of Total 13.6% 20.4% 4.2% 38.2% 
Total Count 145 130 34 309 
  Expected Count 145.0 130.0 34.0 309.0 
  % within treatments  46.9% 42.1% 11.0% 100.0% 
  % of Total 46.9% 42.1% 11.0% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 11.038(a) 2 .004 
Likelihood Ratio 11.091 2 .004 
Linear-by-Linear 
Association 
5.441 1 .020 
N of Valid Cases 
309     
a  0 cells (.0%) have expected count less than 5. The minimum expected count is 12.98. 
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TREATMENTS KNOWN VS, STATUS 
  
My HIV status is 
    Negative Positive Total 
Count 95 144 239 
Expected Count 87.6 151.4 239.0 
% within 
treatments  
39.7% 60.3% 100.0% 
not selected 
% of Total 32.5% 49.3% 81.8% 
Count 12 41 53 
Expected Count 19.4 33.6 53.0 
% within 
treatments  
22.6% 77.4% 100.0% 
treatments that you 
have heard of - 
Vitamins-Oral 
selected 
% of Total 4.1% 14.0% 18.2% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within 
treatments  
36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 5.469(b) 1 .019     
Continuity 
Correction(a) 
4.756 1 .029     
Likelihood Ratio 5.800 1 .016     
Fisher's Exact Test       .027 .013 
Linear-by-Linear 
Association 
5.450 1 .020     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 19.42. 
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My HIV status is 
    Negative Positive Total 
Count 100 160 260 
Expected Count 95.3 164.7 260.0 
% within 
treatments  
38.5% 61.5% 100.0% 
not selected 
% of Total 34.2% 54.8% 89.0% 
Count 7 25 32 
Expected Count 11.7 20.3 32.0 
% within 
treatments  
21.9% 78.1% 100.0% 
treatments that you 
have heard of - 
Minerals-Oral 
selected 
% of Total 2.4% 8.6% 11.0% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within 
treatments  
36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 3.376(b) 1 .066     
Continuity 
Correction(a) 
2.700 1 .100     
Likelihood Ratio 3.622 1 .057     
Fisher's Exact Test       .080 .047 
Linear-by-Linear 
Association 
3.365 1 .067     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 11.73. 
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My HIV status is 
    Negative Positive Total 
Count 106 175 281 
Expected Count 103.0 178.0 281.0 
% within 
treatments  
37.7% 62.3% 100.0% 
not selected 
% of Total 36.3% 59.9% 96.2% 
Count 1 10 11 
Expected Count 4.0 7.0 11.0 
% within 
treatments  
9.1% 90.9% 100.0% 
treatments that you 
have heard of - 
Peroxide-IV 
selected 
% of Total .3% 3.4% 3.8% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within 
treatments  
36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 3.738(b) 1 .053     
Continuity 
Correction(a) 
2.606 1 .106     
Likelihood Ratio 4.574 1 .032     
Fisher's Exact Test       .060 .046 
Linear-by-Linear 
Association 
3.725 1 .054     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  1 cells (25.0%) have expected count less than 5. The minimum expected count is 4.03. 
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My HIV status is 
    Negative Positive Total 
Count 106 176 282 
Expected Count 103.3 178.7 282.0 
% within 
treatments  
37.6% 62.4% 100.0% 
not selected 
% of Total 36.3% 60.3% 96.6% 
Count 1 9 10 
Expected Count 3.7 6.3 10.0 
% within 
treatments  10.0% 90.0% 100.0% 
treatments that you 
have heard of - 
Peroxide-Oral 
selected 
% of Total .3% 3.1% 3.4% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within 
treatments  
36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 3.166(b) 1 .075     
Continuity 
Correction(a) 
2.089 1 .148     
Likelihood Ratio 3.829 1 .050     
Fisher's Exact Test       .099 .067 
Linear-by-Linear 
Association 
3.155 1 .076     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  1 cells (25.0%) have expected count less than 5. The minimum expected count is 3.66. 
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My HIV status is 
    Negative Positive Total 
Count 89 127 216 
Expected Count 79.2 136.8 216.0 
% within treatments  41.2% 58.8% 100.0% 
not selected 
% of Total 30.5% 43.5% 74.0% 
Count 18 58 76 
Expected Count 27.8 48.2 76.0 
% within treatments  23.7% 76.3% 100.0% 
treatments that you 
have heard of - 
Nutritional 
supplements 
selected 
% of Total 6.2% 19.9% 26.0% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within treatments  36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 7.433(b) 1 .006     
Continuity 
Correction(a) 
6.697 1 .010     
Likelihood Ratio 7.781 1 .005     
Fisher's Exact Test       .008 .004 
Linear-by-Linear 
Association 
7.407 1 .006     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 27.85. 
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My HIV status is 
    Negative Positive Total 
Count 68 67 135 
Expected Count 49.5 85.5 135.0 
% within treatments  50.4% 49.6% 100.0% 
not selected 
% of Total 23.3% 22.9% 46.2% 
Count 39 118 157 
Expected Count 57.5 99.5 157.0 
% within treatments  24.8% 75.2% 100.0% 
treatments that you 
have heard of – AZT 
(azidothymidine) 
selected 
% of Total 13.4% 40.4% 53.8% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within treatments  36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 20.377(b) 1 .000     
Continuity 
Correction(a) 
19.293 1 .000     
Likelihood Ratio 20.543 1 .000     
Fisher's Exact Test       .000 .000 
Linear-by-Linear 
Association 
20.308 1 .000     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 49.47. 
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My HIV status is 
    Negative Positive Total 
Count 75 93 168 
Expected Count 61.6 106.4 168.0 
% within treatments  44.6% 55.4% 100.0% 
not selected 
% of Total 25.7% 31.8% 57.5% 
Count 32 92 124 
Expected Count 45.4 78.6 124.0 
% within treatments  25.8% 74.2% 100.0% 
treatments that you 
have heard of - 
HAART (Highly 
active antiretroviral 
therapy) 
selected 
% of Total 11.0% 31.5% 42.5% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within treatments  36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 10.903(b) 1 .001     
Continuity 
Correction(a) 
10.107 1 .001     
Likelihood Ratio 11.128 1 .001     
Fisher's Exact Test       .001 .001 
Linear-by-Linear 
Association 
10.866 1 .001     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 45.44. 
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My HIV status is 
    Negative Positive Total 
Count 82 96 178 
Expected Count 65.2 112.8 178.0 
% within treatments  46.1% 53.9% 100.0% 
not selected 
% of Total 28.1% 32.9% 61.0% 
Count 25 89 114 
Expected Count 41.8 72.2 114.0 
% within treatments  21.9% 78.1% 100.0% 
treatments that you have 
heard of - 
Pharmaceutical 
antibodies (bactrim, etc) 
selected 
% of Total 8.6% 30.5% 39.0% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within treatments  36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 17.440(b) 1 .000     
Continuity 
Correction(a) 
16.416 1 .000     
Likelihood Ratio 18.117 1 .000     
Fisher's Exact Test       .000 .000 
Linear-by-Linear 
Association 
17.380 1 .000     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 41.77. 
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TREATMENTS KNOWN VS. ETHNIC GROUP 
 
Which group do you identify with? 
    
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/ 
african 
american 
or negro Hispanic 
white/ 
Caucasian multiracial other Total 
Count 7 4 111 45 93 13 6 279 
Expected 
Count 
7.4 3.3 100.4 43.6 104.5 14.8 4.9 279.0 
% within 
treatments  
2.5% 1.4% 39.8% 16.1% 33.3% 4.7% 2.2% 100.0% 
not 
selected 
% of Total 2.1% 1.2% 32.7% 13.3% 27.4% 3.8% 1.8% 82.3% 
Count 2 0 11 8 34 5 0 60 
Expected 
Count 
1.6 .7 21.6 9.4 22.5 3.2 1.1 60.0 
% within 
treatments  
3.3% .0% 18.3% 13.3% 56.7% 8.3% .0% 100.0% 
treatments 
that you 
have heard 
of - 
Vitamins-
Oral 
selected 
% of Total .6% .0% 3.2% 2.4% 10.0% 1.5% .0% 17.7% 
Count 9 4 122 53 127 18 6 339 
Expected 
Count 
9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
% within 
treatments  
2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
Total 
% of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
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 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 17.270(a) 6 .008 
Likelihood Ratio 19.226 6 .004 
Linear-by-Linear 
Association 
7.534 1 .006 
N of Valid Cases 
339     
a  6 cells (42.9%) have expected count less than 5. The minimum expected count is .71. 
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Which group do you identify with? 
    
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/ 
african 
american 
or negro Hispanic 
white/ 
Caucasian multiracial other Total 
Count 7 4 119 53 121 17 6 327 
Expected 
Count 
8.7 3.9 117.7 51.1 122.5 17.4 5.8 327.0 
% within 
treatments  
2.1% 1.2% 36.4% 16.2% 37.0% 5.2% 1.8% 100.0% 
not 
selected 
% of Total 2.1% 1.2% 35.1% 15.6% 35.7% 5.0% 1.8% 96.5% 
Count 2 0 3 0 6 1 0 12 
Expected 
Count 
.3 .1 4.3 1.9 4.5 .6 .2 12.0 
% within 
treatments  
16.7% .0% 25.0% .0% 50.0% 8.3% .0% 100.0% 
treatments 
that you 
have heard 
of - 
Peroxide-
Oral 
selected 
% of Total .6% .0% .9% .0% 1.8% .3% .0% 3.5% 
Count 9 4 122 53 127 18 6 339 
Expected 
Count 
9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
% within 
treatments  
2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
Total 
% of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
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 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 12.665(a) 6 .049 
Likelihood Ratio 9.998 6 .125 
Linear-by-Linear 
Association 
.212 1 .645 
N of Valid Cases 
339     
a  8 cells (57.1%) have expected count less than 5. The minimum expected count is .14. 
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    Which group do you identify with? Total 
    
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/ 
african 
american 
or negro Hispanic 
white/ 
Caucasian multiracial other 
american 
indian, 
alaskan 
native, or 
pacific 
islander 
treatments 
that you 
have heard 
of - Porcine 
(pig) liver 
extracts-
transdermal 
not 
selected 
Count 
8 4 119 52 127 18 5 333 
    Expected 
Count 
8.8 3.9 119.8 52.1 124.8 17.7 5.9 333.0 
    % within 
treatments  
2.4% 1.2% 35.7% 15.6% 38.1% 5.4% 1.5% 100.0% 
    % of Total 2.4% 1.2% 35.1% 15.3% 37.5% 5.3% 1.5% 98.2% 
  selected Count 1 0 3 1 0 0 1 6 
    Expected 
Count 
.2 .1 2.2 .9 2.2 .3 .1 6.0 
    % within 
treatments  
16.7% .0% 50.0% 16.7% .0% .0% 16.7% 100.0% 
    % of Total .3% .0% .9% .3% .0% .0% .3% 1.8% 
Total Count 9 4 122 53 127 18 6 339 
  Expected 
Count 
9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
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  % within 
treatments  
2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
  % of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 15.197(a) 6 .019 
Likelihood Ratio 10.539 6 .104 
Linear-by-Linear 
Association 
1.430 1 .232 
N of Valid Cases 
339     
a  8 cells (57.1%) have expected count less than 5. The minimum expected count is .07. 
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    Which group do you identify with? Total 
    
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/ 
african 
american 
or negro Hispanic 
white/ 
Caucasian multiracial other 
american 
indian, 
alaskan 
native, or 
pacific 
islander 
treatments 
that you 
have heard 
of - 
Nutritional 
supplements 
not 
selected 
Count 
7 4 101 44 86 9 5 256 
    Expected 
Count 
6.8 3.0 92.1 40.0 95.9 13.6 4.5 256.0 
    % within 
treatments  
2.7% 1.6% 39.5% 17.2% 33.6% 3.5% 2.0% 100.0% 
    % of Total 2.1% 1.2% 29.8% 13.0% 25.4% 2.7% 1.5% 75.5% 
  selected Count 2 0 21 9 41 9 1 83 
    Expected 
Count 
2.2 1.0 29.9 13.0 31.1 4.4 1.5 83.0 
    % within 
treatments  
2.4% .0% 25.3% 10.8% 49.4% 10.8% 1.2% 100.0% 
    % of Total .6% .0% 6.2% 2.7% 12.1% 2.7% .3% 24.5% 
Total Count 9 4 122 53 127 18 6 339 
  Expected 
Count 
9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
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  % within 
treatments  
2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
  % of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 17.139(a) 6 .009 
Likelihood Ratio 17.363 6 .008 
Linear-by-Linear 
Association 
9.726 1 .002 
N of Valid Cases 
339     
a  6 cells (42.9%) have expected count less than 5. The minimum expected count is .98. 
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TREATMENTS KNOWN VS. AGE 
 
     Age group Total 
    18-25 26-36 37-47 48-58 59 + 18-25 
treatments that you 
have heard of – AZT 
(Azidothymidine) 
not 
selected 
 
Count 37 47 42 31 8 165 
    Expected Count 25.7 43.2 50.0 37.4 8.7 165.0 
    % within treatments  22.4% 28.5% 25.5% 18.8% 4.8% 100.0% 
    % of Total 10.9% 13.8% 12.4% 9.1% 2.4% 48.5% 
  selected Count 16 42 61 46 10 175 
    Expected Count 27.3 45.8 53.0 39.6 9.3 175.0 
    % within treatments  9.1% 24.0% 34.9% 26.3% 5.7% 100.0% 
    % of Total 4.7% 12.4% 17.9% 13.5% 2.9% 51.5% 
Total Count 53 89 103 77 18 340 
  Expected Count 53.0 89.0 103.0 77.0 18.0 340.0 
  % within treatments  15.6% 26.2% 30.3% 22.6% 5.3% 100.0% 
  % of Total 15.6% 26.2% 30.3% 22.6% 5.3% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 14.970(a) 4 .005 
Likelihood Ratio 15.229 4 .004 
Linear-by-Linear 
Association 
10.856 1 .001 
N of Valid Cases 
340     
a  0 cells (.0%) have expected count less than 5. The minimum expected count is 8.74. 
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Age group 
    18-25 26-36 37-47 48-58 59 + Total 
Count 43 59 53 49 12 216 
Expected Count 33.7 56.5 65.4 48.9 11.4 216.0 
% within treatments  19.9% 27.3% 24.5% 22.7% 5.6% 100.0% 
not selected 
% of Total 12.6% 17.4% 15.6% 14.4% 3.5% 63.5% 
Count 10 30 50 28 6 124 
Expected Count 19.3 32.5 37.6 28.1 6.6 124.0 
% within treatments  8.1% 24.2% 40.3% 22.6% 4.8% 100.0% 
Treatments that you 
have heard of - 
Pharmaceutical 
antibodies (bactrim, etc) 
selected 
% of Total 2.9% 8.8% 14.7% 8.2% 1.8% 36.5% 
Count 53 89 103 77 18 340 
Expected Count 53.0 89.0 103.0 77.0 18.0 340.0 
% within treatments  15.6% 26.2% 30.3% 22.6% 5.3% 100.0% 
Total 
% of Total 15.6% 26.2% 30.3% 22.6% 5.3% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 13.938(a) 4 .007 
Likelihood Ratio 14.481 4 .006 
Linear-by-Linear 
Association 
3.963 1 .046 
N of Valid Cases 
340     
a  0 cells (.0%) have expected count less than 5. The minimum expected count is 6.56. 
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CROSSTABS: EFFECTIVE TREATMENTS AND DEMOGRAPHIC VARIABLES 
 
EFFECTIVE TREATMENTS VS. ETHNIC GROUP 
  
    which group do you identify with? Total 
    
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/ 
african 
american 
or negro Hispanic 
white/ 
Caucasian multiracial other 
american 
indian, 
alaskan 
native, or 
pacific 
islander 
treatments 
that you 
think can be 
effective - 
UVBI 
(ultraviolet 
blood 
irradiation) 
not 
selected 
Count 
5 4 115 52 122 15 6 319 
    Expected 
Count 
8.5 3.8 114.8 49.9 119.5 16.9 5.6 319.0 
    % within 
treatments  
1.6% 1.3% 36.1% 16.3% 38.2% 4.7% 1.9% 100.0% 
    % of Total 1.5% 1.2% 33.9% 15.3% 36.0% 4.4% 1.8% 94.1% 
  selected Count 4 0 7 1 5 3 0 20 
    Expected 
Count 
.5 .2 7.2 3.1 7.5 1.1 .4 20.0 
    % within 
treatments  
20.0% .0% 35.0% 5.0% 25.0% 15.0% .0% 100.0% 
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    % of Total 1.2% .0% 2.1% .3% 1.5% .9% .0% 5.9% 
Total Count 9 4 122 53 127 18 6 339 
  Expected 
Count 
9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
  % within 
treatments  2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
  % of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 30.895(a) 6 .000 
Likelihood Ratio 17.748 6 .007 
Linear-by-Linear 
Association 
3.386 1 .066 
N of Valid Cases 
339     
a  6 cells (42.9%) have expected count less than 5. The minimum expected count is .24. 
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which group do you identify with? 
    
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/ 
african 
american 
or negro Hispanic 
white/ 
Caucasian multiracial other Total 
Count 7 4 117 50 126 17 5 326 
Expected 
Count 
8.7 3.8 117.3 51.0 122.1 17.3 5.8 326.0 
% within 
treatments  
2.1% 1.2% 35.9% 15.3% 38.7% 5.2% 1.5% 100.0% 
not 
selected 
% of Total 2.1% 1.2% 34.5% 14.7% 37.2% 5.0% 1.5% 96.2% 
Count 2 0 5 3 1 1 1 13 
Expected 
Count 
.3 .2 4.7 2.0 4.9 .7 .2 13.0 
% within 
treatments  
15.4% .0% 38.5% 23.1% 7.7% 7.7% 7.7% 100.0% 
treatments 
that you 
think can 
be 
effective - 
Selenium 
liver 
support-
oral 
selected 
% of Total .6% .0% 1.5% .9% .3% .3% .3% 3.8% 
Count 9 4 122 53 127 18 6 339 
Expected 
Count 
9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
% within 
treatments  
2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
Total 
% of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
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 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 14.934(a) 6 .021 
Likelihood Ratio 11.141 6 .084 
Linear-by-Linear 
Association 
2.015 1 .156 
N of Valid Cases 
339     
a  8 cells (57.1%) have expected count less than 5. The minimum expected count is .15. 
F 97 
 
  
Which group do you identify with? 
    
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/ 
african 
american 
or negro Hispanic 
white/ 
Caucasian multiracial other Total 
Count 9 4 120 52 127 17 5 334 
Expected 
Count 
8.9 3.9 120.2 52.2 125.1 17.7 5.9 334.0 
% within 
treatments  2.7% 1.2% 35.9% 15.6% 38.0% 5.1% 1.5% 100.0% 
not 
selected 
% of Total 2.7% 1.2% 35.4% 15.3% 37.5% 5.0% 1.5% 98.5% 
Count 0 0 2 1 0 1 1 5 
Expected 
Count 
.1 .1 1.8 .8 1.9 .3 .1 5.0 
% within 
treatments  
.0% .0% 40.0% 20.0% .0% 20.0% 20.0% 100.0% 
treatments 
that you 
think can 
be 
effective - 
Peroxide-
Oral 
selected 
% of Total .0% .0% .6% .3% .0% .3% .3% 1.5% 
Count 9 4 122 53 127 18 6 339 
Expected 
Count 
9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
% within 
treatments  
2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
Total 
% of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
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 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 13.772(a) 6 .032 
Likelihood Ratio 8.629 6 .196 
Linear-by-Linear 
Association 
1.021 1 .312 
N of Valid Cases 
339     
a  8 cells (57.1%) have expected count less than 5. The minimum expected count is .06. 
F 99 
 
  
    Which group do you identify with? Total 
    
american 
indian, 
alaskan 
native, or 
pacific 
islander 
asian/asian 
american 
black/african 
american or 
negro Hispanic 
white/ 
Caucasian multiracial other 
american 
indian, 
alaskan 
native, or 
pacific 
islander 
treatments that you 
think can be effective - 
Porcine (pig) liver 
extracts-transdermal 
not selected Count 
8 4 120 52 127 18 5 334 
    Expected Count 8.9 3.9 120.2 52.2 125.1 17.7 5.9 334.0 
    % within treatments  2.4% 1.2% 35.9% 15.6% 38.0% 5.4% 1.5% 100.0% 
    % of Total 2.4% 1.2% 35.4% 15.3% 37.5% 5.3% 1.5% 98.5% 
  selected Count 1 0 2 1 0 0 1 5 
    Expected Count .1 .1 1.8 .8 1.9 .3 .1 5.0 
    % within treatments 20.0% .0% 40.0% 20.0% .0% .0% 20.0% 100.0% 
    % of Total .3% .0% .6% .3% .0% .0% .3% 1.5% 
Total Count 9 4 122 53 127 18 6 339 
  Expected Count 9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
  % within treatments  2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
  % of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
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 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 17.595(a) 6 .007 
Likelihood Ratio 10.074 6 .122 
Linear-by-Linear 
Association .808 1 .369 
N of Valid Cases 
339     
a  8 cells (57.1%) have expected count less than 5. The minimum expected count is .06. 
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    Which group do you identify with? Total 
    
american indian, 
alaskan native, or 
pacific islander 
asian/asian 
american 
black/african 
american or 
negro Hispanic 
white/ 
Caucasian multiracial other 
american 
indian, 
alaskan 
native, or 
pacific 
islander 
treatments that you 
think can be effective  
Nutritional 
supplements 
not 
selected 
Count 
6 4 99 44 100 7 6 266 
    Expected Count 7.1 3.1 95.7 41.6 99.7 14.1 4.7 266.0 
    % within treatments  2.3% 1.5% 37.2% 16.5% 37.6% 2.6% 2.3% 100.0% 
    % of Total 1.8% 1.2% 29.2% 13.0% 29.5% 2.1% 1.8% 78.5% 
  selected Count 3 0 23 9 27 11 0 73 
    Expected Count 1.9 .9 26.3 11.4 27.3 3.9 1.3 73.0 
    % within treatments  4.1% .0% 31.5% 12.3% 37.0% 15.1% .0% 100.0% 
    % of Total .9% .0% 6.8% 2.7% 8.0% 3.2% .0% 21.5% 
Total Count 9 4 122 53 127 18 6 339 
  Expected Count 9.0 4.0 122.0 53.0 127.0 18.0 6.0 339.0 
  % within treatments  2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
  % of Total 2.7% 1.2% 36.0% 15.6% 37.5% 5.3% 1.8% 100.0% 
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 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 21.347(a) 6 .002 
Likelihood Ratio 19.866 6 .003 
Linear-by-Linear 
Association 
1.756 1 .185 
N of Valid Cases 
339     
a  6 cells (42.9%) have expected count less than 5. The minimum expected count is .86. 
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EFFECTIVE TREATMENTS VS. STATUS 
  
My HIV status is 
    Negative Positive Total 
Count 101 183 284 
Expected Count 104.1 179.9 284.0 
% within treatments  35.6% 64.4% 100.0% 
not selected 
% of Total 34.6% 62.7% 97.3% 
Count 6 2 8 
Expected Count 2.9 5.1 8.0 
% within treatments  75.0% 25.0% 100.0% 
treatments that you 
think can be 
effective - silver 
colloid-IV 
selected 
% of Total 2.1% .7% 2.7% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within treatments  36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 5.212(b) 1 .022     
Continuity 
Correction(a) 
3.652 1 .056     
Likelihood Ratio 5.019 1 .025     
Fisher's Exact Test       .055 .030 
Linear-by-Linear 
Association 
5.195 1 .023     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  1 cells (25.0%) have expected count less than 5. The minimum expected count is 2.93. 
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My HIV status is 
    Negative Positive Total 
Count 96 148 244 
Expected Count 89.4 154.6 244.0 
% within treatments  39.3% 60.7% 100.0% 
not selected 
% of Total 32.9% 50.7% 83.6% 
Count 11 37 48 
Expected Count 17.6 30.4 48.0 
% within treatments  22.9% 77.1% 100.0% 
treatments that you 
think can be 
effective - 
Vitamins-Oral 
selected 
% of Total 3.8% 12.7% 16.4% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within treatments  36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 4.662(b) 1 .031     
Continuity 
Correction(a) 
3.982 1 .046     
Likelihood Ratio 4.945 1 .026     
Fisher's Exact Test       .034 .021 
Linear-by-Linear 
Association 
4.646 1 .031     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 17.59. 
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My HIV status is 
    Negative Positive Total 
Count 101 158 259 
Expected Count 94.9 164.1 259.0 
% within treatments  39.0% 61.0% 100.0% 
not selected 
% of Total 34.6% 54.1% 88.7% 
Count 6 27 33 
Expected Count 12.1 20.9 33.0 
% within treatments  18.2% 81.8% 100.0% 
treatments that you 
think can be 
effective - Minerals-
Oral 
selected 
% of Total 2.1% 9.2% 11.3% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within treatments  36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 5.462(b) 1 .019     
Continuity 
Correction(a) 
4.602 1 .032     
Likelihood Ratio 6.011 1 .014     
Fisher's Exact Test       .021 .013 
Linear-by-Linear 
Association 
5.443 1 .020     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 12.09. 
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    My HIV status is Total 
    Negative Positive Negative 
treatments that you 
think can be effective  
Nutritional 
supplements 
not selected Count 
92 133 225 
    Expected Count 82.4 142.6 225.0 
    % within treatments  40.9% 59.1% 100.0% 
    % of Total 31.5% 45.5% 77.1% 
  selected Count 15 52 67 
    Expected Count 24.6 42.4 67.0 
    % within treatments  22.4% 77.6% 100.0% 
    % of Total 5.1% 17.8% 22.9% 
Total Count 107 185 292 
  Expected Count 107.0 185.0 292.0 
  % within treatments  36.6% 63.4% 100.0% 
  % of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 7.611(b) 1 .006     
Continuity 
Correction(a) 
6.835 1 .009     
Likelihood Ratio 8.046 1 .005     
Fisher's Exact Test       .006 .004 
Linear-by-Linear 
Association 
7.585 1 .006     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 24.55. 
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My HIV status is 
    Negative Positive Total 
Count 77 106 183 
Expected Count 67.1 115.9 183.0 
% within treatments  42.1% 57.9% 100.0% 
not selected 
% of Total 26.4% 36.3% 62.7% 
Count 30 79 109 
Expected Count 39.9 69.1 109.0 
% within treatments  27.5% 72.5% 100.0% 
treatments that you 
think can be 
effective - AZT 
(azidothymidine) 
selected 
% of Total 10.3% 27.1% 37.3% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within treatments  36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 6.232(b) 1 .013     
Continuity 
Correction(a) 
5.621 1 .018     
Likelihood Ratio 6.361 1 .012     
Fisher's Exact Test       .017 .008 
Linear-by-Linear 
Association 
6.211 1 .013     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 39.94. 
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My HIV status is 
    Negative Positive Total 
Count 79 96 175 
Expected Count 64.1 110.9 175.0 
% within treatments  45.1% 54.9% 100.0% 
not selected 
% of Total 27.1% 32.9% 59.9% 
Count 28 89 117 
Expected Count 42.9 74.1 117.0 
% within treatments  23.9% 76.1% 100.0% 
treatments that you 
think can be 
effective - HAART 
(Highly active 
antiretroviral 
therapy) selected 
% of Total 9.6% 30.5% 40.1% 
Count 107 185 292 
Expected Count 107.0 185.0 292.0 
% within treatments  36.6% 63.4% 100.0% 
Total 
% of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 13.589(b) 1 .000     
Continuity 
Correction(a) 
12.691 1 .000     
Likelihood Ratio 13.992 1 .000     
Fisher's Exact Test       .000 .000 
Linear-by-Linear 
Association 
13.542 1 .000     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 42.87. 
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    My HIV status is Total 
    Negative Positive Negative 
treatments that you 
think can be effective  
Pharmaceutical 
antibodies (bactrim, 
etc) 
not 
selected 
Count 
91 109 200 
    Expected Count 73.3 126.7 200.0 
    % within treatments  45.5% 54.5% 100.0% 
    % of Total 31.2% 37.3% 68.5% 
  selected Count 16 76 92 
    Expected Count 33.7 58.3 92.0 
    % within treatments  17.4% 82.6% 100.0% 
    % of Total 5.5% 26.0% 31.5% 
Total Count 107 185 292 
  Expected Count 107.0 185.0 292.0 
  % within treatments  36.6% 63.4% 100.0% 
  % of Total 36.6% 63.4% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 21.445(b) 1 .000     
Continuity 
Correction(a) 
20.251 1 .000     
Likelihood Ratio 23.056 1 .000     
Fisher's Exact Test       .000 .000 
Linear-by-Linear 
Association 
21.372 1 .000     
N of Valid Cases 292         
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 33.71. 
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 EFFECTIVE TREATMENTS VS. AGE 
 
  
Age group 
    18-25 26-36 37-47 48-58 59 + Total 
Count 49 87 103 76 18 333 
Expected Count 51.9 87.2 100.9 75.4 17.6 333.0 
% within treatments  14.7% 26.1% 30.9% 22.8% 5.4% 100.0% 
not selected 
% of Total 14.4% 25.6% 30.3% 22.4% 5.3% 97.9% 
Count 4 2 0 1 0 7 
Expected Count 1.1 1.8 2.1 1.6 .4 7.0 
% within treatments  57.1% 28.6% .0% 14.3% .0% 100.0% 
treatments that you 
think can be 
effective - Peroxide-
IV 
selected 
% of Total 1.2% .6% .0% .3% .0% 2.1% 
Count 53 89 103 77 18 340 
Expected Count 53.0 89.0 103.0 77.0 18.0 340.0 
% within treatments  15.6% 26.2% 30.3% 22.6% 5.3% 100.0% 
Total 
% of Total 15.6% 26.2% 30.3% 22.6% 5.3% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 10.697(a) 4 .030 
Likelihood Ratio 10.044 4 .040 
Linear-by-Linear 
Association 
6.145 1 .013 
N of Valid Cases 
340     
a  5 cells (50.0%) have expected count less than 5. The minimum expected count is .37. 
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Age group 
    18-25 26-36 37-47 48-58 59 + Total 
Count 48 75 76 52 14 265 
Expected Count 41.3 69.4 80.3 60.0 14.0 265.0 
% within treatments  18.1% 28.3% 28.7% 19.6% 5.3% 100.0% 
not selected 
% of Total 14.1% 22.1% 22.4% 15.3% 4.1% 77.9% 
Count 5 14 27 25 4 75 
Expected Count 11.7 19.6 22.7 17.0 4.0 75.0 
% within treatments  6.7% 18.7% 36.0% 33.3% 5.3% 100.0% 
treatments that you 
think can be effective - 
Nutritional 
supplements 
selected 
% of Total 1.5% 4.1% 7.9% 7.4% 1.2% 22.1% 
Count 53 89 103 77 18 340 
Expected Count 53.0 89.0 103.0 77.0 18.0 340.0 
% within treatments  15.6% 26.2% 30.3% 22.6% 5.3% 100.0% 
Total 
% of Total 15.6% 26.2% 30.3% 22.6% 5.3% 100.0% 
 
Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 12.873(a) 4 .012 
Likelihood Ratio 13.571 4 .009 
Linear-by-Linear 
Association 
9.891 1 .002 
N of Valid Cases 
340     
 
a  1 cells (10.0%) have expected count less than 5. The minimum expected count is 3.97. 
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EFFECTIVE TREATMENTS VS. SEXUAL ORIENTATION 
 
 
sexual orientation 
    Heter Homo Bi-sexual Total 
Count 124 88 26 238 
Expected Count 111.7 100.1 26.2 238.0 
% within treatments  52.1% 37.0% 10.9% 100.0% 
not selected 
% of Total 40.1% 28.5% 8.4% 77.0% 
Count 21 42 8 71 
Expected Count 33.3 29.9 7.8 71.0 
% within treatments  29.6% 59.2% 11.3% 100.0% 
treatments that you 
think can be effective - 
Nutritional 
supplements 
selected 
% of Total 6.8% 13.6% 2.6% 23.0% 
Count 145 130 34 309 
Expected Count 145.0 130.0 34.0 309.0 
% within treatments  46.9% 42.1% 11.0% 100.0% 
Total 
% of Total 46.9% 42.1% 11.0% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 12.313(a) 2 .002 
Likelihood Ratio 12.467 2 .002 
Linear-by-Linear 
Association 
6.330 1 .012 
N of Valid Cases 
309     
a  0 cells (.0%) have expected count less than 5. The minimum expected count is 7.81. 
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sexual orientation 
    Heter Homo Bi-sexual Total 
Count 113 75 23 211 
Expected Count 99.0 88.8 23.2 211.0 
% within treatments  53.6% 35.5% 10.9% 100.0% 
not selected 
% of Total 36.6% 24.3% 7.4% 68.3% 
Count 32 55 11 98 
Expected Count 46.0 41.2 10.8 98.0 
% within treatments  32.7% 56.1% 11.2% 100.0% 
treatments that you 
think can be effective - 
Pharmaceutical 
antibodies (bactrim, 
etc) 
selected 
% of Total 10.4% 17.8% 3.6% 31.7% 
Count 145 130 34 309 
Expected Count 145.0 130.0 34.0 309.0 
% within treatments  46.9% 42.1% 11.0% 100.0% 
Total 
% of Total 46.9% 42.1% 11.0% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 12.972(a) 2 .002 
Likelihood Ratio 13.076 2 .001 
Linear-by-Linear 
Association 
6.674 1 .010 
N of Valid Cases 
309     
a  0 cells (.0%) have expected count less than 5. The minimum expected count is 10.78. 
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List of Crosstabs with No Significance 
 
Sources 
 
Books 
Newspapers 
Events (seminars, workshops, conferences) 
Medical websites 
Blogs, online bulletin boards 
Emails 
Community organizations 
Religious organizations 
Alternative medical doctors 
Other 
 
Source Credibility 
 
TV 
Radio 
Books 
Newspapers 
Magazines 
Out of home (billboards, bus ads, posters, flyers, brochures) 
HIV/AIDS groups websites 
Online newsletters, journals, etc 
Emails 
Social media-Facebook, Twitter, etc 
Religious organizations 
Conventional medical doctors 
Alternative medical doctors 
Other 
 
Perception Statements 
 
Giving antiretroviral drugs to people who are not infected is a good way to prevent   
HIV/AIDS 
HIV/AIDS infections are often the result of immoral behavior 
HIV/AIDS prevention efforts often receive more funding than treatment efforts 
Young people under 25 account for almost half of new HIV/AIDS infections globally 
Treatments Known 
 
UVBI (Ultraviolet blood irradiation) 
Silver colloid-IV 
Silver colloid-oral 
Selenium liver support-oral 
Chelation-oral 
Vitamins-IV 
Minerals-IV 
Venus flytrap-oral 
Other 
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List of Crosstabs with No Significance (Cont.) 
 
 
Effective Treatments 
 
Silver colloid-oral 
Chelation-IV 
Chelation-oral 
Vitamins-IV 
Minerals-IV 
Venus flytrap-oral 
Other 
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RELIABILITY STATISTICS 
CRONBACH’S ALPHA ANALYSIS TABLES 
 
Group 1: The Hedonist or the Moralist 
 
Cronbach's 
Alpha 
N of 
Items 
.685 6 
 
 Item Statistics 
 
  Mean 
Std. 
Deviation N 
How do you feel about-
Poor people are more 
likely to get HIV/AIDS 
3.6404 1.22626 342 
How do you feel about - 
HIV/AIDS is primarily a 
gay disease 
 
4.2602 1.01577 342 
How do you feel about - 
HIV/AIDS is God's way 
of punishing the wicked 
4.3830 .99385 342 
 
How do you feel about - 
People with HIV/AIDS 
deserve the same rights 
in the workplace as other 
workers 
4.4561 .95168 342 
 
How do you feel about - 
HIV/AIDS infections are 
often a result of immoral 
behavior 
3.7222 1.23323 342 
 
How do you feel about - 
Getting HIV/AIDS is 
usually a death sentence 
3.9240 1.14623 342 
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Group 2: The Cautious Optimist or the Raving Pessimist 
 
Cronbach's 
Alpha 
N of 
Items 
.619 6 
 
 Item Statistics 
 
  Mean 
Std. 
Deviation N 
How do you feel about-
Globally the number of 
people with HIV/AIDS 
is decreasing 
3.8830 1.08214 342 
 
How do you feel about- 
Antiretroviral drugs are 
a cure for HIV/AIDS 
3.9006 1.06479 342 
 
How do you feel about - 
Giving antiretroviral 
drugs to people not 
infected prevents 
HIV/AIDS 
3.7427 1.09565 342 
 
How do you feel about - 
You cannot get 
HIV/AIDS during sex if 
condoms are always 
used 
3.7047 1.19035 342 
 
How do you feel about - 
An effective HIV/AIDS 
vaccine is available 
3.5614 1.13361 342 
 
How do you feel about - 
Alternative medical 
treatments for 
HIV/AIDS have shown 
promising results 
2.5994 1.05580 342 
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Group 3: The Global Activist or the Political Ostrich 
 
 
Cronbach's 
Alpha 
N of 
Items 
.514 7 
 
 Item Statistics 
 
  Mean 
Std. 
Deviation N 
How to you feel about - 
A pregnant woman with 
HIV/AIDS cannot avoid 
having an HIV-positive 
baby 
3.8070 1.13755 342 
 
How do you feel about - 
HIV/AIDS prevention 
efforts often receive 
more funding than 
treatment efforts 
3.0409 1.00063 342 
 
How do you feel about - 
It is biologically easier 
for woman to get 
HIV/AIDS than it is for 
men 
3.2690 1.20513 342 
 
How do you feel about - 
Treating HIV/AIDS is a 
lucrative business for 
pharmaceutical 
companies 
2.4766 1.17315 342 
 
How do you feel about - 
Worldwide, more people 
get HIV/AIDS by 
heterosexual contact 
than by homosexual 
contact 
2.8538 1.08670 342 
 
How do you feel about - 
People who knowingly 
expose others to 
HIV/AIDS should be 
prosecuted as criminals 
2.4678 1.26670 342 
 
How do you feel about - 
Getting HIV/AIDS is 
usually a death sentence 
3.9240 1.14623 342 
 
